Citrus Sinensis ID: 021084

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------
Protein Sequence
MDKFFNLKDFDVKPKHPSRESLRRWRSFCTIVKNPTRRFRMVANLDRRSEADKKIRQMQEQLRLALCIRDTLKLIESHEDVPIGDTDAGRFQEFVDDIISTVKCGDVKEKIRLALCIQETALQLIEVLSLLSLEDVSSSEYTMTEAAEAGRFQDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA
Secondary Structure (PSIPRED)
ccccccccccccccccccHHHHHHHHHHccccccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHcHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHccccccccccccccccHHHHHHHHHHHHccccccccccccccEEEccEEccccccEEEEEEcccccEEEEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEcEEEEccEEEEEEEEcccccHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
ccHHccccccccccccccHHHHHHHHHHcEEccccccEEEEEccccHHHHHHHHHccHHHHHHHHHHHHHHHHHHccccccccccccccHHHHcHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEEEccccEEEEEEEEEccEEEEEEEEccccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccEEcccc
Coil and Loop (DISEMBL)
mdkffnlkdfdvkpkhpsreslRRWRSFCTIVKNPTRRFRMVANLDRRSEADKKIRQMQEQLRLALCIRDTLKLieshedvpigdtdagrFQEFVDDIIstvkcgdvKEKIRLALCIQETALQLIEVLSLLsledvssseytMTEAaeagrfqdlfddvasisddDAEISLLMELVYNFSLNEKYRRRIMSwqkgaplgsgsfgsvyegftddgFFFAVKEvslqdqgtqgEQSVLQLEQEISLLGqfehdnivqyfgtekdeNKLYIFLELVTQGSLAKIYqeyhlkdsqvsAYTWQILNGLKylheqnvihrpga
Flexible Loop (DISEMBL)
mdkffnlkdfdvkpkhpsreslrrwrsfctivknptrrfrmvanldrrseadkKIRQMQEQLRLALCIRDTLKLieshedvpigdtdagrFQEFVDDIISTVKCGDVKEKIRLALCIQETALQLIEVLSLLSLEDVSSSEYTMTEAAEAGRFQDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA
Low Complexity Region (SEG)
MDKFFNLKDFDVKPKHPSRESLRRWRSFCTIVKNPTRRFRMVANLDRRSEADKKIRQMQEQLRLALCIRDTLKLIESHEDVPIGDTDAGRFQEFVDDIISTVKCGDVKEKIRLALCIQETALQlievlsllsledvssseYTMTEAAEAGRFQDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA
Disordered region (IsUnstruct)
**********************RRWRSFCTIVKNPTRRFRMVANL**************EQLRLALCIRDTLKLIESHEDVPIGDTDAGRFQEFVDDIISTVKCGDVKEKIRLALCIQETALQLIEVLSLLSLEDVSSSEYTMTEAAEAGRFQDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQ********SVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI*****
Disordered Region (DISOPRED)
**KF****DF**************WRSFCTIVKNPTRRFRMVANLD*********************IRDTLKLIESHE****************************************************************************************************************WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVS***************EQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRP**
Disordered Region (DISEMBL)
MDKFFNLKDFDVK********LRRWRSFCTIVKNPTRRFRMVANLDRRSEADKKIRQMQEQLRLALCIRDTLKLIESHEDVPIGDTDAGRFQEFVDDIISTVKCGDVKEKIRLALCIQETALQLIEVLSLLSLEDVSSSEYTMTEAAEAGRFQDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSL*********SVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA
Disordered Region (DISPRO)
*****NLKDFDVKPKHPSRESLRRWRSFCTIVKNPTRRFRMVANLDRRSEADKKIRQMQEQLRLALCIRDTLKLIESHEDVPIGDTDAGRFQEFVDDIISTVK************************************************************************************RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDKFFNLKDFDVKPKHPSRESLRRWRSFCTIVKNPTRRFRMVANLDRRSEADKKIRQMQEQLRLALCIRDTLKLIESHEDVPIGDTDAGRFQEFVDDIISTVKCGDVKEKIRLALCIQETALQLIEVLSLLSLEDVSSSEYTMTEAAEAGRFQDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	317	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	yes	no	0.397	0.207	0.674	1e-42
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.397	0.066	0.634	1e-38
Q56UN5	1328	Mitogen-activated protein	no	no	0.429	0.102	0.398	4e-20
O22040	666	Mitogen-activated protein	no	no	0.394	0.187	0.384	4e-19
P53599	1579	MAP kinase kinase kinase	yes	no	0.388	0.077	0.406	5e-19
E9Q3S4	1311	Mitogen-activated protein	yes	no	0.388	0.093	0.416	5e-19
O14299	1401	MAP kinase kinase kinase	yes	no	0.384	0.087	0.4	9e-19
P25390	1331	Serine/threonine-protein	no	no	0.391	0.093	0.385	9e-19
Q9FZ36	651	Mitogen-activated protein	no	no	0.388	0.188	0.382	1e-18
Q54R82	942	Mitogen-activated protein	no	no	0.394	0.132	0.379	2e-18

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  174 bits (440), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 85/126 (67%), Positives = 98/126 (77%)

Query: 189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           I SWQKG  LG GSFGSVYEG + DG FFAVKEVSL DQG+Q ++ + QLE EI LL Q 
Sbjct: 330 ITSWQKGQLLGRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQL 389

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           +H NIV+Y GT KD + LYIFLELVTQGSL K+YQ Y L+DS VS YT QIL+GLKYLH+
Sbjct: 390 QHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHD 449

Query: 309 QNVIHR 314
           +  IHR
Sbjct: 450 KGFIHR 455

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  160 bits (404), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 80/126 (63%), Positives = 93/126 (73%)

Query: 189  IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
            I  WQKG  LG GS GSVYEG + DG FFA KEVSL DQG+Q  + + Q+E  I+LL Q 
Sbjct: 1623 ITCWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQL 1682

Query: 249  EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
            +H NIV+Y GT KDE+ LYIFLELVTQGSL K+YQ   L DS VS YT QIL+GLKYLH+
Sbjct: 1683 QHQNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHD 1742

Query: 309  QNVIHR 314
            +  IHR
Sbjct: 1743 KGFIHR 1748

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1

 Score = 99.0 bits (245), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 55/138 (39%), Positives = 75/138 (54%), Gaps = 2/138 (1%)

Query: 179  FSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGT-QGEQSVLQ 237
            FS N       + W KG  LG G++G+VY G T  G   AVK+V+L        E+   +
Sbjct: 1048 FSENSLKSEEPILWTKGEILGKGAYGTVYCGLTSQGQLIAVKQVALDTSNKLAAEKEYRK 1107

Query: 238  LEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYT 296
            L++E+ LL   +H NIV Y GT   EN + IF+E V  GS++ I   +  L +     YT
Sbjct: 1108 LQEEVDLLKALKHVNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGPLPEMVFCKYT 1167

Query: 297  WQILNGLKYLHEQNVIHR 314
             QIL G+ YLHE  V+HR
Sbjct: 1168 KQILQGVAYLHENCVVHR 1185

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score = 95.5 bits (236), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 50/130 (38%), Positives = 79/130 (60%), Gaps = 5/130 (3%)

Query: 190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQS---VLQLEQEISLL 245
           +SW+KG  +G G+FG+VY G   D G   AVK+V +       E++   + +LE+E+ LL
Sbjct: 67  ISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLL 126

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLK 304
               H NIV+Y GT ++++ L I LE V  GS++ + +++    +S V  YT Q+L GL+
Sbjct: 127 KNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLE 186

Query: 305 YLHEQNVIHR 314
           YLH   ++HR
Sbjct: 187 YLHNHAIMHR 196

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P53599|SSK2_YEAST MAP kinase kinase kinase SSK2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SSK2 PE=1 SV=1

 Score = 95.5 bits (236), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 52/128 (40%), Positives = 77/128 (60%), Gaps = 5/128 (3%)

Query: 190  MSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQL-EQEISLLGQ 247
            M WQK   +G G+FG VY     D+G   AVKE+++QD  ++  Q +  L ++E+S+L  
Sbjct: 1264 MRWQKRNFIGGGTFGRVYSAVDLDNGEILAVKEINIQD--SKSMQKIFPLIKEEMSVLEI 1321

Query: 248  FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS-AYTWQILNGLKYL 306
              H NIV Y+G E   +K+ IF+E    GSLA + +   ++D  V+  YT Q+L GL YL
Sbjct: 1322 LNHPNIVSYYGVEVHRDKVNIFMEYCEGGSLAALLEHGRIEDEMVTQVYTLQLLEGLAYL 1381

Query: 307  HEQNVIHR 314
            HE  ++HR
Sbjct: 1382 HESGIVHR 1389

Kinase involved in a signal transduction pathway that is activated by changes in the osmolarity of the extracellular environment. Activates the PBS2 MAP kinase kinase by phosphorylation.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1

 Score = 95.5 bits (236), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 52/125 (41%), Positives = 72/125 (57%), Gaps = 2/125 (1%)

Query: 192  WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGT-QGEQSVLQLEQEISLLGQFEH 250
            W KG  LG G++G+VY G T  G   AVK+V+L        E+   +L++E+ LL   +H
Sbjct: 1044 WTKGEILGRGAYGTVYCGLTSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKALKH 1103

Query: 251  DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
             NIV Y GT  +EN L IF+E V  GS++ I   +  L +     YT QIL G+ YLH+ 
Sbjct: 1104 VNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHDN 1163

Query: 310  NVIHR 314
             V+HR
Sbjct: 1164 CVVHR 1168

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O14299|WIS4_SCHPO MAP kinase kinase kinase wis4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=wis4 PE=3 SV=1

 Score = 94.4 bits (233), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 50/125 (40%), Positives = 72/125 (57%), Gaps = 3/125 (2%)

Query: 192  WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
            WQ+G  + SG FG VY G   + G   AVKE+ LQD  T    +V Q+  E+++L +  H
Sbjct: 1037 WQQGHFVRSGMFGDVYTGVNMETGDLLAVKEIKLQDSRT-FRSTVDQIHNEMTVLERLNH 1095

Query: 251  DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQV-SAYTWQILNGLKYLHEQ 309
             N+V Y+G E    K+YIF+E    GSLA +     ++D  V   Y  Q+L GL Y+H Q
Sbjct: 1096 PNVVTYYGVEVHREKVYIFMEFCQGGSLADLLAHGRIEDENVLKVYVVQLLEGLAYIHSQ 1155

Query: 310  NVIHR 314
            +++HR
Sbjct: 1156 HILHR 1160

Involved in a signal transduction pathway that is activated in under conditions of heat shock, oxidative stress or limited nutrition. Unlike win1, it is not activated by changes in the osmolarity of the extracellular environment. Activates the wis1 MAP kinase kinase by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P25390|SSK22_YEAST Serine/threonine-protein kinase SSK22 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SSK22 PE=1 SV=2

 Score = 94.4 bits (233), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 49/127 (38%), Positives = 76/127 (59%), Gaps = 3/127 (2%)

Query: 190  MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
            M WQK + +G G+FG VY     ++G   AVKE+ + D  T  +   L +++E+++L   
Sbjct: 1032 MRWQKRSFIGGGTFGQVYSAINLENGEILAVKEIKIHDTTTMKKIFPL-IKEEMTVLEML 1090

Query: 249  EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS-AYTWQILNGLKYLH 307
             H NIVQY+G E   +K+ IF+E    GSLA +     ++D  V+  YT+++L GL YLH
Sbjct: 1091 NHPNIVQYYGVEVHRDKVNIFMEYCEGGSLASLLDHGRIEDEMVTQVYTFELLEGLAYLH 1150

Query: 308  EQNVIHR 314
            +  V+HR
Sbjct: 1151 QSGVVHR 1157

Kinase involved in a signal transduction pathway that is activated by changes in the osmolarity of the extracellular environment. Activates the PBS2 MAP kinase kinase by phosphorylation.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score = 94.4 bits (233), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/128 (38%), Positives = 76/128 (59%), Gaps = 5/128 (3%)

Query: 192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQS---VLQLEQEISLLGQ 247
           W+KG  +G G+FG+VY G   D G   AVK+V +       E++   + +LE+E+ LL  
Sbjct: 68  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYL 306
             H NIV+Y GT +++  L I LE V  GS++ + +++    +S V  YT Q+L GL+YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187

Query: 307 HEQNVIHR 314
           H   ++HR
Sbjct: 188 HNHAIMHR 195

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score = 93.6 bits (231), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/129 (37%), Positives = 76/129 (58%), Gaps = 4/129 (3%)

Query: 190 MSWQKGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGE--QSVLQLEQEISLLG 246
           + WQKG  LG G +GSVY G   D G  FAVK++ + D  +  +    +L   +EI ++ 
Sbjct: 168 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMR 227

Query: 247 QFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKY 305
              HDNIV+Y GT  D++ L +FLE +  GS++ +  ++    ++ +  YT QIL GL +
Sbjct: 228 SLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSF 287

Query: 306 LHEQNVIHR 314
           LH  ++IHR
Sbjct: 288 LHANSIIHR 296

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	317
359486016	559	PREDICTED: mitogen-activated protein kin	0.488	0.277	0.677	2e-57
298204644	719	unnamed protein product [Vitis vinifera]	0.488	0.215	0.677	7e-57
255545546	555	Mitogen-activated protein kinase kinase	0.485	0.277	0.668	4e-55
224082218	548	predicted protein [Populus trichocarpa]	0.444	0.257	0.723	3e-54
255587684	451	Mitogen-activated protein kinase kinase	0.419	0.294	0.766	3e-54
218193598	632	hypothetical protein OsI_13190 [Oryza sa	0.488	0.245	0.653	6e-54
222625638	575	hypothetical protein OsJ_12265 [Oryza sa	0.488	0.269	0.653	6e-54
115454833	654	Os03g0703400 [Oryza sativa Japonica Grou	0.488	0.237	0.653	7e-54
223946959	629	unknown [Zea mays] gi|413933338|gb|AFW67	0.488	0.246	0.647	9e-54
357117897	646	PREDICTED: mitogen-activated protein kin	0.488	0.239	0.660	1e-53

>gi|359486016|ref|XP_002264549.2| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  228 bits (582), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 105/155 (67%), Positives = 134/155 (86%)

Query: 160 ASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAV 219
           ++ +D+D + S+ +E +Y  S N +++R I SWQ+G  LGSGSFG+VYEG+TDDGFFFAV
Sbjct: 254 STSNDEDEDSSMTLEPIYGISPNGQFKRTINSWQRGELLGSGSFGTVYEGYTDDGFFFAV 313

Query: 220 KEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLA 279
           KEVSL DQG+QG+QS+ QLEQEISLL QFEH+NIV+Y+GT+KD++KLYIFLELVT+GSL 
Sbjct: 314 KEVSLLDQGSQGKQSIYQLEQEISLLSQFEHENIVRYYGTDKDDSKLYIFLELVTKGSLL 373

Query: 280 KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            +YQ+Y L++SQ SAYT QILNGLKYLHEQNV+HR
Sbjct: 374 SLYQKYDLRESQASAYTRQILNGLKYLHEQNVVHR 408

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|298204644|emb|CBI23919.3| unnamed protein product [Vitis vinifera]

 Score =  227 bits (578), Expect = 7e-57,   Method: Compositional matrix adjust.
 Identities = 105/155 (67%), Positives = 134/155 (86%)

Query: 160 ASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAV 219
           ++ +D+D + S+ +E +Y  S N +++R I SWQ+G  LGSGSFG+VYEG+TDDGFFFAV
Sbjct: 414 STSNDEDEDSSMTLEPIYGISPNGQFKRTINSWQRGELLGSGSFGTVYEGYTDDGFFFAV 473

Query: 220 KEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLA 279
           KEVSL DQG+QG+QS+ QLEQEISLL QFEH+NIV+Y+GT+KD++KLYIFLELVT+GSL 
Sbjct: 474 KEVSLLDQGSQGKQSIYQLEQEISLLSQFEHENIVRYYGTDKDDSKLYIFLELVTKGSLL 533

Query: 280 KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            +YQ+Y L++SQ SAYT QILNGLKYLHEQNV+HR
Sbjct: 534 SLYQKYDLRESQASAYTRQILNGLKYLHEQNVVHR 568

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  221 bits (562), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/154 (66%), Positives = 127/154 (82%)

Query: 161 SISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVK 220
           + S+DD   S   EL+ N S +E++RR I  W+KG  LG GSFGSVYEG   DGFFFA+K
Sbjct: 252 TTSNDDDSSSTTTELMSNISPHERFRRMISDWEKGDLLGRGSFGSVYEGIAHDGFFFAIK 311

Query: 221 EVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK 280
           EVSL DQG+QG+QS+ QLEQEI+LL QFEH+NIV+Y+GT+KD++ LYIFLELVTQGSL  
Sbjct: 312 EVSLLDQGSQGKQSIYQLEQEIALLSQFEHENIVRYYGTDKDDSNLYIFLELVTQGSLMN 371

Query: 281 IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +YQ YHL+DSQVSAYT QIL+GLKYLH++NV+HR
Sbjct: 372 LYQRYHLRDSQVSAYTRQILHGLKYLHDRNVVHR 405

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa]

 Score =  218 bits (555), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 102/141 (72%), Positives = 123/141 (87%)

Query: 174 ELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQ 233
           E + N S N ++RR I  W+KG  LG GSFGSVYEG +DDGFFFAVKEVSL DQG+QG+Q
Sbjct: 258 EPMSNISPNLRFRRSITDWEKGELLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQGKQ 317

Query: 234 SVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS 293
           S+ QLEQEI+LL +FEH+NIVQY+GT+KDE+KLYIFLELVT+GSL K+YQ Y+L+DSQVS
Sbjct: 318 SIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLKLYQRYNLRDSQVS 377

Query: 294 AYTWQILNGLKYLHEQNVIHR 314
           AYT QIL+GLKYLH+QNV+HR
Sbjct: 378 AYTRQILHGLKYLHDQNVVHR 398

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587684|ref|XP_002534356.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223525440|gb|EEF28029.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  218 bits (555), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 102/133 (76%), Positives = 117/133 (87%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQE 241
           N K RR I SW KG  LGSGSFG+VYEG TDDGFFFA+KEVSL DQG+QG+QS+LQLEQE
Sbjct: 168 NGKVRRSIFSWIKGDVLGSGSFGTVYEGLTDDGFFFAIKEVSLLDQGSQGKQSILQLEQE 227

Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
           ISLL  FEH+NIV+Y GTEKDE KLYIFLEL T+GSLA++YQ+YHL+DS VSAYT QILN
Sbjct: 228 ISLLRAFEHENIVRYLGTEKDEAKLYIFLELATKGSLARLYQKYHLRDSHVSAYTRQILN 287

Query: 302 GLKYLHEQNVIHR 314
           GLKYLH++NV+HR
Sbjct: 288 GLKYLHDRNVVHR 300

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218193598|gb|EEC76025.1| hypothetical protein OsI_13190 [Oryza sativa Indica Group]

 Score =  217 bits (552), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 102/156 (65%), Positives = 130/156 (83%), Gaps = 1/156 (0%)

Query: 159 VASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFA 218
           +++ +DDDA  S   E ++  S N K++R+I SW +GA LGSGSFG VYEG +D+G FFA
Sbjct: 328 LSTTNDDDAS-STTTEAMFIISPNGKFKRKIKSWMRGALLGSGSFGMVYEGISDEGAFFA 386

Query: 219 VKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL 278
           VKEVSL DQG+  +QS+L LEQEI+LL QFEH+NIVQY+GT+K+E+KLYIF+ELVTQGSL
Sbjct: 387 VKEVSLLDQGSNAQQSILALEQEIALLSQFEHENIVQYYGTDKEESKLYIFIELVTQGSL 446

Query: 279 AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +YQ+Y L+DSQVSAYT QILNGL YLHE+NV+HR
Sbjct: 447 SSLYQKYKLRDSQVSAYTRQILNGLVYLHERNVVHR 482

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|222625638|gb|EEE59770.1| hypothetical protein OsJ_12265 [Oryza sativa Japonica Group]

 Score =  217 bits (552), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 102/156 (65%), Positives = 130/156 (83%), Gaps = 1/156 (0%)

Query: 159 VASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFA 218
           +++ +DDDA  S   E ++  S N K++R+I SW +GA LGSGSFG VYEG +D+G FFA
Sbjct: 271 LSTTNDDDAS-STTTEAMFIISPNGKFKRKIKSWMRGALLGSGSFGMVYEGISDEGAFFA 329

Query: 219 VKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL 278
           VKEVSL DQG+  +QS+L LEQEI+LL QFEH+NIVQY+GT+K+E+KLYIF+ELVTQGSL
Sbjct: 330 VKEVSLLDQGSNAQQSILALEQEIALLSQFEHENIVQYYGTDKEESKLYIFIELVTQGSL 389

Query: 279 AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +YQ+Y L+DSQVSAYT QILNGL YLHE+NV+HR
Sbjct: 390 SSLYQKYKLRDSQVSAYTRQILNGLVYLHERNVVHR 425

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115454833|ref|NP_001051017.1| Os03g0703400 [Oryza sativa Japonica Group] gi|41469440|gb|AAS07241.1| putative protein kinase [Oryza sativa Japonica Group] gi|108710641|gb|ABF98436.1| Mitogen-activated protein kinase 1, putative, expressed [Oryza sativa Japonica Group] gi|113549488|dbj|BAF12931.1| Os03g0703400 [Oryza sativa Japonica Group]

 Score =  217 bits (552), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 102/156 (65%), Positives = 130/156 (83%), Gaps = 1/156 (0%)

Query: 159 VASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFA 218
           +++ +DDDA  S   E ++  S N K++R+I SW +GA LGSGSFG VYEG +D+G FFA
Sbjct: 350 LSTTNDDDAS-STTTEAMFIISPNGKFKRKIKSWMRGALLGSGSFGMVYEGISDEGAFFA 408

Query: 219 VKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL 278
           VKEVSL DQG+  +QS+L LEQEI+LL QFEH+NIVQY+GT+K+E+KLYIF+ELVTQGSL
Sbjct: 409 VKEVSLLDQGSNAQQSILALEQEIALLSQFEHENIVQYYGTDKEESKLYIFIELVTQGSL 468

Query: 279 AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +YQ+Y L+DSQVSAYT QILNGL YLHE+NV+HR
Sbjct: 469 SSLYQKYKLRDSQVSAYTRQILNGLVYLHERNVVHR 504

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|223946959|gb|ACN27563.1| unknown [Zea mays] gi|413933338|gb|AFW67889.1| putative MAP kinase superfamily protein isoform 1 [Zea mays] gi|413933339|gb|AFW67890.1| putative MAP kinase superfamily protein isoform 2 [Zea mays] gi|413933340|gb|AFW67891.1| putative MAP kinase superfamily protein isoform 3 [Zea mays]

 Score =  216 bits (551), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 101/156 (64%), Positives = 131/156 (83%), Gaps = 1/156 (0%)

Query: 159 VASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFA 218
           +++ +DDDA  S   E ++  S N K++R+I SW +GA LGSGSFG VYEG +D+G FFA
Sbjct: 328 LSTTNDDDAS-STTTEAMFIISPNGKFKRKIKSWMRGALLGSGSFGMVYEGISDEGAFFA 386

Query: 219 VKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL 278
           VKEVSL DQG+  +QS++ LEQEI+LLGQFEH+NIVQY+GT+K+E+KLYIF+ELVTQGSL
Sbjct: 387 VKEVSLLDQGSNAQQSIVALEQEIALLGQFEHENIVQYYGTDKEESKLYIFIELVTQGSL 446

Query: 279 AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +YQ+Y L++SQVSAYT QILNGL YLHE+NV+HR
Sbjct: 447 SSLYQKYKLRESQVSAYTRQILNGLVYLHERNVVHR 482

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357117897|ref|XP_003560698.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Brachypodium distachyon]

 Score =  216 bits (550), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 103/156 (66%), Positives = 129/156 (82%), Gaps = 1/156 (0%)

Query: 159 VASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFA 218
           +++ +DDDA  S   E V+  S N K++R I SW +GA LGSGSFG VYEG +D+G FFA
Sbjct: 343 LSTTNDDDAS-STNTEAVFIISPNGKFKRNIKSWMRGALLGSGSFGMVYEGISDEGAFFA 401

Query: 219 VKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL 278
           VKEVSL DQG+  +QS+L LEQEI+LL QFEH+NIVQY+GT+K+E+KLYIF+ELVTQGSL
Sbjct: 402 VKEVSLLDQGSNAQQSILALEQEIALLSQFEHENIVQYYGTDKEESKLYIFIELVTQGSL 461

Query: 279 AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +YQ+Y L+DSQVSAYT QILNGL YLHE+NV+HR
Sbjct: 462 SSLYQKYKLRDSQVSAYTRQILNGLVYLHERNVVHR 497

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	317
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.526	0.274	0.56	9.6e-41
TAIR|locus:2133539	773	MAPKKK9 "mitogen-activated pro	0.391	0.160	0.629	2.8e-37
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.441	0.25	0.559	9.9e-36
TAIR|locus:2118116	1895	WRKY19 [Arabidopsis thaliana (	0.397	0.066	0.634	5.3e-35
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.388	0.139	0.488	2.2e-25
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.391	0.203	0.444	1.7e-22
CGD|CAL0001272	1484	SSK2 [Candida albicans (taxid:	0.485	0.103	0.361	1.5e-21
UNIPROTKB|Q5A6J4	1484	SSK2 "Likely protein kinase" [	0.485	0.103	0.361	1.5e-21
UNIPROTKB|F1S0D3	1325	YSK4 "Uncharacterized protein"	0.425	0.101	0.410	1e-20
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.388	0.171	0.420	1.6e-20

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 433 (157.5 bits), Expect = 9.6e-41, P = 9.6e-41
 Identities = 98/175 (56%), Positives = 117/175 (66%)

Query:   145 EAAEAG-RF---QDLFDDVASISDDDAEISLLMELVYNFS-LNEKYRRRIMSWQKGAPLG 199
             EA E G RF    D  D+  S + ++ + S     V N S +       I SWQKG  LG
Sbjct:   284 EAEEMGARFIQLGDTADETCSFTTNEGDSS---STVSNTSPIYPDGGAIITSWQKGQLLG 340

Query:   200 SGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGT 259
              GSFGSVYEG + DG FFAVKEVSL DQG+Q ++ + QLE EI LL Q +H NIV+Y GT
Sbjct:   341 RGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGT 400

Query:   260 EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
              KD + LYIFLELVTQGSL K+YQ Y L+DS VS YT QIL+GLKYLH++  IHR
Sbjct:   401 AKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHR 455

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 408 (148.7 bits), Expect = 2.8e-37, P = 2.8e-37
 Identities = 78/124 (62%), Positives = 97/124 (78%)

Query:   191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
             SWQKG  L  GSFGSVYE  ++DG FFAVKEVSL DQG+Q ++ + QLE EI+LL Q EH
Sbjct:   500 SWQKGQLLRQGSFGSVYEAISEDGDFFAVKEVSLLDQGSQAQECIQQLEGEIALLSQLEH 559

Query:   251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
              NI++Y GT+KD + LYIFLELVTQGSL ++Y+ Y ++DS +S YT QIL+GLKYLH + 
Sbjct:   560 QNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGLKYLHHKG 619

Query:   311 VIHR 314
              IHR
Sbjct:   620 FIHR 623

GO:0005737 "cytoplasm" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0031347 "regulation of defense response" evidence=IMP

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 9.9e-36, P = 9.9e-36
 Identities = 80/143 (55%), Positives = 102/143 (71%)

Query:   174 ELVYNFSLNEKYRRR--IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG 231
             +L+ N  L E +R+   I SW KG  LG GS+ SVYE  ++DG FFAVKEVSL D+G Q 
Sbjct:   284 KLMRN-KLIENFRKPEDITSWLKGQLLGRGSYASVYEAISEDGDFFAVKEVSLLDKGIQA 342

Query:   232 EQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQ 291
             ++ + QLE EI+LL Q +H NIV+Y GT KD +KLYIFLELVTQGS+ K+Y+ Y L  + 
Sbjct:   343 QECIQQLEGEIALLSQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERYQLSYTV 402

Query:   292 VSAYTWQILNGLKYLHEQNVIHR 314
             VS YT QIL GL YLH++  +HR
Sbjct:   403 VSLYTRQILAGLNYLHDKGFVHR 425

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)]

 Score = 394 (143.8 bits), Expect = 5.3e-35, P = 5.3e-35
 Identities = 80/126 (63%), Positives = 93/126 (73%)

Query:   189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
             I  WQKG  LG GS GSVYEG + DG FFA KEVSL DQG+Q  + + Q+E  I+LL Q 
Sbjct:  1623 ITCWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQL 1682

Query:   249 EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
             +H NIV+Y GT KDE+ LYIFLELVTQGSL K+YQ   L DS VS YT QIL+GLKYLH+
Sbjct:  1683 QHQNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHD 1742

Query:   309 QNVIHR 314
             +  IHR
Sbjct:  1743 KGFIHR 1748

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=IEA;ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005622 "intracellular" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006952 "defense response" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017111 "nucleoside-triphosphatase activity" evidence=IEA

GO:0043531 "ADP binding" evidence=IEA

GO:0043565 "sequence-specific DNA binding" evidence=IEA

GO:0009941 "chloroplast envelope" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 299 (110.3 bits), Expect = 2.2e-25, P = 2.2e-25
 Identities = 61/125 (48%), Positives = 84/125 (67%)

Query:   192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
             W+KG  LG GSFG VY GF ++ G   A+KEV+L     +  +S  QL QEIS+L +  H
Sbjct:   400 WKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRH 459

Query:   251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
              NIVQY+G+E  ++KLYI+LE V+ GS+ K+ QEY    ++ +  YT QIL+GL YLH +
Sbjct:   460 QNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAK 519

Query:   310 NVIHR 314
             N +HR
Sbjct:   520 NTVHR 524

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 269 (99.8 bits), Expect = 1.7e-22, P = 1.7e-22
 Identities = 56/126 (44%), Positives = 79/126 (62%)

Query:   191 SWQKGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
             +W+KG  LGSG+FG VY GF  + G   A+KEV +       ++ + QL QEI+LL Q  
Sbjct:   213 TWKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLC 272

Query:   250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHE 308
             H NIVQY+G+E  E  L ++LE V+ GS+ K+ ++Y    +  +  YT QIL GL YLH 
Sbjct:   273 HPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAYLHG 332

Query:   309 QNVIHR 314
             +N +HR
Sbjct:   333 RNTVHR 338

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

CGD|CAL0001272 SSK2 [Candida albicans (taxid:5476)]

 Score = 257 (95.5 bits), Expect = 1.5e-21, Sum P(2) = 1.5e-21
 Identities = 60/166 (36%), Positives = 92/166 (55%)

Query:   153 QDLFDDVASISD-DDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFT 211
             Q+ F  +  + D  D+E   L  L  +FS +   R     WQKGA +G G+FG V+    
Sbjct:  1144 QEEFQSIGRVLDVSDSEYQFLTLLASSFS-SVSIR-----WQKGACIGRGTFGQVFSAVN 1197

Query:   212 -DDGFFFAVKEVSLQDQGTQGEQSVL-QLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF 269
              D G   AVKE++  D  +Q  ++++  +++E+++L    H N+VQYFG E   +K+YIF
Sbjct:  1198 LDTGGVMAVKEITFHD--SQSVKTIVPSIKEEMTVLEMLNHPNVVQYFGVEVHRDKVYIF 1255

Query:   270 LELVTQGSLAKIYQEYHLKDSQV-SAYTWQILNGLKYLHEQNVIHR 314
             +E    GSLA +     ++D  V   Y  Q+L GL YLH+  V+HR
Sbjct:  1256 MEFCEGGSLAGLLTHGRIEDEMVIQVYALQMLEGLAYLHQSGVVHR 1301

GO:0031098 "stress-activated protein kinase signaling cascade" evidence=IMP

GO:0034599 "cellular response to oxidative stress" evidence=IMP

GO:0071470 "cellular response to osmotic stress" evidence=IMP

GO:0071276 "cellular response to cadmium ion" evidence=IMP

GO:0005829 "cytosol" evidence=IEA

GO:0005934 "cellular bud tip" evidence=IEA

GO:0005935 "cellular bud neck" evidence=IEA

GO:0007346 "regulation of mitotic cell cycle" evidence=IEA

GO:0030036 "actin cytoskeleton organization" evidence=IEA

GO:0051519 "activation of bipolar cell growth" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0000161 "MAPK cascade involved in osmosensory signaling pathway" evidence=IEA

GO:0007234 "osmosensory signaling via phosphorelay pathway" evidence=IEA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA

UNIPROTKB|Q5A6J4 SSK2 "Likely protein kinase" [Candida albicans SC5314 (taxid:237561)]

 Score = 257 (95.5 bits), Expect = 1.5e-21, Sum P(2) = 1.5e-21
 Identities = 60/166 (36%), Positives = 92/166 (55%)

Query:   153 QDLFDDVASISD-DDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFT 211
             Q+ F  +  + D  D+E   L  L  +FS +   R     WQKGA +G G+FG V+    
Sbjct:  1144 QEEFQSIGRVLDVSDSEYQFLTLLASSFS-SVSIR-----WQKGACIGRGTFGQVFSAVN 1197

Query:   212 -DDGFFFAVKEVSLQDQGTQGEQSVL-QLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF 269
              D G   AVKE++  D  +Q  ++++  +++E+++L    H N+VQYFG E   +K+YIF
Sbjct:  1198 LDTGGVMAVKEITFHD--SQSVKTIVPSIKEEMTVLEMLNHPNVVQYFGVEVHRDKVYIF 1255

Query:   270 LELVTQGSLAKIYQEYHLKDSQV-SAYTWQILNGLKYLHEQNVIHR 314
             +E    GSLA +     ++D  V   Y  Q+L GL YLH+  V+HR
Sbjct:  1256 MEFCEGGSLAGLLTHGRIEDEMVIQVYALQMLEGLAYLHQSGVVHR 1301

GO:0031098 "stress-activated protein kinase signaling cascade" evidence=IMP

GO:0034599 "cellular response to oxidative stress" evidence=IMP

GO:0071276 "cellular response to cadmium ion" evidence=IMP

GO:0071470 "cellular response to osmotic stress" evidence=IMP

UNIPROTKB|F1S0D3 YSK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 247 (92.0 bits), Expect = 1.0e-20, Sum P(2) = 1.0e-20
 Identities = 57/139 (41%), Positives = 80/139 (57%)

Query:   179 FSLNE-KYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG-EQSVL 236
             FS N  KY   ++ W KG  LG G++G+VY G T  G   AVK+V+L        E+   
Sbjct:  1045 FSENSLKYEEPVL-WTKGEILGKGAYGTVYCGLTSHGELIAVKQVALDTSDKSATEKEYR 1103

Query:   237 QLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAY 295
             +L++E+ LL   +H NIV Y GT  +EN + IF+E V  GS++ I   +  L ++    Y
Sbjct:  1104 KLQEEVDLLKALKHINIVAYLGTCLEENIVSIFMEFVPGGSISSIINRFGPLPETVFCKY 1163

Query:   296 TWQILNGLKYLHEQNVIHR 314
             T QIL G+ YLHE  V+HR
Sbjct:  1164 TKQILQGVAYLHENCVVHR 1182

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 252 (93.8 bits), Expect = 1.6e-20, P = 1.6e-20
 Identities = 53/126 (42%), Positives = 77/126 (61%)

Query:   192 WQKGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
             W+KG  +G G+FGSVY     + G   A+KEV L     +  + + QLEQEI LL   +H
Sbjct:   346 WKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQH 405

Query:   251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHE 308
              NIVQYFG+E  E++ +I+LE V  GS+ K  +++   + +S V  +T  IL+GL YLH 
Sbjct:   406 PNIVQYFGSETVEDRFFIYLEYVHPGSINKYIRDHCGTMTESVVRNFTRHILSGLAYLHN 465

Query:   309 QNVIHR 314
             +  +HR
Sbjct:   466 KKTVHR 471

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	317
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-56
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-40
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-33
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-28
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-27
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-27
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-25
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-19
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-19
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-18
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-18
pfam12515	47	pfam12515, CaATP_NAI, Ca2+-ATPase N terminal autoi	3e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-14
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-11
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-10
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-09
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-08
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-07
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-06
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-06
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-06
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-05
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-05
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-04
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-04
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.001
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	0.001
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	0.001
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	0.002
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.002
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.002
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.004
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.004
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	0.004

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  183 bits (465), Expect = 2e-56
 Identities = 76/126 (60%), Positives = 95/126 (75%), Gaps = 2/126 (1%)

Query: 191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
            W+KG  LGSGSFGSVYEG   DDG FFAVKEVSL D G  G+++V QLEQEI+LL + +
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHE 308
           H NIVQY GTE++E+ LYIFLELV  GSLAK+ ++Y    +  +  YT QIL GL+YLH+
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 309 QNVIHR 314
           +N +HR
Sbjct: 121 RNTVHR 126

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  142 bits (360), Expect = 1e-40
 Identities = 56/128 (43%), Positives = 76/128 (59%), Gaps = 7/128 (5%)

Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
            W +G  LG GSFGSVY     D G   AVK V L       E+ +  LE+EI +L   +
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQ 57

Query: 250 HDNIVQYFGTEKDE--NKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYL 306
           H NIV+Y+G+E+DE  N L IFLE V+ GSL+ + +++  L +  +  YT QIL GL YL
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 307 HEQNVIHR 314
           H   ++HR
Sbjct: 118 HSNGIVHR 125

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-33
 Identities = 52/124 (41%), Positives = 77/124 (62%), Gaps = 5/124 (4%)

Query: 193 QKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           Q G  +G G+FG VY+G   + G F A+K++SL+      E+++  + QEI LL   +H 
Sbjct: 3   QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHP 59

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQN 310
           NIV+Y G+ +  + LYI LE    GSL +I +++    +S V+ Y +Q+L GL YLHEQ 
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 311 VIHR 314
           VIHR
Sbjct: 120 VIHR 123

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  118 bits (299), Expect = 9e-32
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 6/125 (4%)

Query: 192 WQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++    LG GSFG VY       G   A+K +  +      ++   ++ +EI +L + +H
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI----KKDRERILREIKILKKLKH 56

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
            NIV+ +   +DE+KLY+ +E    G L  + ++   L + +   Y  QIL+ L+YLH +
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 310 NVIHR 314
            ++HR
Sbjct: 117 GIVHR 121

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  112 bits (282), Expect = 2e-29
 Identities = 45/125 (36%), Positives = 72/125 (57%), Gaps = 5/125 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           WQ+G  +G G+FG VY     D G   AVKE+ +QD   +   ++ ++  E+ +L   +H
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK---TIKEIADEMKVLELLKH 58

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQV-SAYTWQILNGLKYLHEQ 309
            N+V+Y+G E    K+YIF+E  + G+L ++ +   + D  V   YT Q+L GL YLH  
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 310 NVIHR 314
            ++HR
Sbjct: 119 GIVHR 123

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  109 bits (273), Expect = 4e-28
 Identities = 52/125 (41%), Positives = 73/125 (58%), Gaps = 2/125 (1%)

Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGT-QGEQSVLQLEQEISLLGQFEH 250
           W KG  LG G++G+VY G T+ G   AVK+V L        E+   +L++E+ LL   +H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
            NIVQY GT  D+N + IF+E V  GS++ I   +  L +     YT QIL+G+ YLH  
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 310 NVIHR 314
            V+HR
Sbjct: 122 CVVHR 126

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 2e-27
 Identities = 48/125 (38%), Positives = 71/125 (56%), Gaps = 2/125 (1%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W++G  LG G+FG VY  +  D G   AVK+V       + ++ V  LE EI LL   +H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
           + IVQY+G  +D+  L IF+E +  GS+    + Y  L ++    YT QIL G++YLH  
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 310 NVIHR 314
            ++HR
Sbjct: 124 MIVHR 128

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  107 bits (268), Expect = 2e-27
 Identities = 57/129 (44%), Positives = 77/129 (59%), Gaps = 6/129 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE---QSVLQ-LEQEISLLG 246
           W KGA +GSGSFGSVY G     G   AVK+V L       +   +S+L  L +EI+LL 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 247 QFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKY 305
           + +H+NIVQY G+  D + L IFLE V  GS+A +   Y   +++ V  +  QIL GL Y
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 306 LHEQNVIHR 314
           LH + +IHR
Sbjct: 122 LHNRGIIHR 130

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  106 bits (268), Expect = 3e-27
 Identities = 39/125 (31%), Positives = 63/125 (50%), Gaps = 5/125 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++    LGSGSFG+VY+      G   AVK +  + + ++ +Q+  +   EI +L +  H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR---EIRILRRLSH 57

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
            NIV+     +D++ LY+ +E    G L         L + +      QIL GL+YLH  
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 310 NVIHR 314
            +IHR
Sbjct: 118 GIIHR 122

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  101 bits (253), Expect = 1e-25
 Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 7/120 (5%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G FG+VY       G   A+K +  +D  +  E+    L +EI +L +  H NIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE----LLREIEILKKLNHPNIVKL 56

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--QILNGLKYLHEQNVIHR 314
           +G  +DEN LY+ +E    GSL  + +E   K S+        QIL GL+YLH   +IHR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  101 bits (254), Expect = 3e-25
 Identities = 47/130 (36%), Positives = 67/130 (51%), Gaps = 7/130 (5%)

Query: 192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSL----QDQGTQGEQSVLQ-LEQEISLL 245
           W KG  +G G++G VY       G   AVK+V L      +    ++ +++ L  EI  L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLK 304
              +H NIVQY G E  E  L IFLE V  GS+    + Y   ++  V  +T Q+L GL 
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 305 YLHEQNVIHR 314
           YLH + ++HR
Sbjct: 123 YLHSKGILHR 132

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =   99 bits (250), Expect = 1e-24
 Identities = 37/126 (29%), Positives = 71/126 (56%), Gaps = 8/126 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++    +G G FG VY+      G   A+K + L+   ++ ++  +    EI +L + +H
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE---SKEKKEKII--NEIQILKKCKH 56

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
            NIV+Y+G+   +++L+I +E  + GSL  + +  +  L +SQ++    ++L GL+YLH 
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 309 QNVIHR 314
             +IHR
Sbjct: 117 NGIIHR 122

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 5e-22
 Identities = 44/121 (36%), Positives = 63/121 (52%), Gaps = 8/121 (6%)

Query: 197 PLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
            +GSG++G VY+      G   A+K + L+            ++QEIS+L +  H NIV 
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVA 64

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           YFG+    +KL+I +E    GSL  IYQ     L + Q++    + L GL YLHE   IH
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIH 124

Query: 314 R 314
           R
Sbjct: 125 R 125

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 90.3 bits (224), Expect = 4e-21
 Identities = 44/127 (34%), Positives = 71/127 (55%), Gaps = 5/127 (3%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQS--VLQLEQEISLLGQF 248
           W KG  LG+G+F S Y+      G   AVK+V+   + T  EQ   V  L +EI L+ + 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYV-RNTSSEQEEVVEALRKEIRLMARL 60

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLH 307
            H +I++  G   +++   +F+E +  GS++ +  +Y   K++ +  YT Q+L GL YLH
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 308 EQNVIHR 314
           E  +IHR
Sbjct: 121 ENQIIHR 127

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 10/120 (8%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG GS+GSVY+    + G   A+K V +       E+ + ++ +EIS+L Q +   IV+Y
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIVKY 63

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+      L+I +E    GS++ I +     L + +++A  +Q L GL+YLH    IHR
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR 123

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 86.8 bits (216), Expect = 7e-20
 Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 9/123 (7%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG VY      DG  + +KE+ L +     E+       E+ +L +  H NI++Y
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKY 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQNV 311
           + + +++ KL I +E    G L++  ++         + Q+  +  Q+   LKYLH + +
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124

Query: 312 IHR 314
           +HR
Sbjct: 125 LHR 127

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 85.5 bits (211), Expect = 2e-19
 Identities = 49/129 (37%), Positives = 71/129 (55%), Gaps = 4/129 (3%)

Query: 190 MSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           ++W++G  LG G+FG VY  +  D G   A K+V    +  +  + V  LE EI LL   
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 249 EHDNIVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKY 305
           +H+ IVQY+G  +D  E  L IF+E +  GS+    + Y  L +S    YT QIL G+ Y
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 306 LHEQNVIHR 314
           LH   ++HR
Sbjct: 122 LHSNMIVHR 130

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.5 bits (211), Expect = 2e-19
 Identities = 51/128 (39%), Positives = 69/128 (53%), Gaps = 4/128 (3%)

Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           +W+ G  LG G+FG VY  +  D G   AVK+V       +  + V  LE EI LL    
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 250 HDNIVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYL 306
           HD IVQY+G  +D  E KL IF+E +  GS+    + Y  L ++    YT QIL G+ YL
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 307 HEQNVIHR 314
           H   ++HR
Sbjct: 123 HSNMIVHR 130

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 85.5 bits (211), Expect = 3e-19
 Identities = 49/128 (38%), Positives = 69/128 (53%), Gaps = 4/128 (3%)

Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           +W+ G  LG G+FG VY  +  D G   AVK+V    +  +  + V  LE EI LL    
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 250 HDNIVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYL 306
           H+ IVQY+G  +D  E  L IF+E +  GS+    + Y  L ++    YT QIL G+ YL
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 307 HEQNVIHR 314
           H   ++HR
Sbjct: 123 HSNMIVHR 130

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 84.9 bits (211), Expect = 4e-19
 Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 13/130 (10%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFF-----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
             G  LG G+FG VY+G             AVK +    +    EQ + +  +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL----KEDASEQQIEEFLREARIMRK 57

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLK 304
            +H N+V+  G   +E  LYI +E +  G L   Y       L  S + ++  QI  G++
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL-LSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 305 YLHEQNVIHR 314
           YL  +N IHR
Sbjct: 117 YLESKNFIHR 126

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 84.1 bits (209), Expect = 6e-19
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 12/125 (9%)

Query: 198 LGSGSFGSVYEGFTDDGFFF-----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FG VY+G             AVK +    +    EQ + +  +E  ++ + +H N
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKLDHPN 62

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           IV+  G   +E  L I +E +  G L    +  +   L  S + ++  QI  G++YL  +
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 310 NVIHR 314
           N IHR
Sbjct: 123 NFIHR 127

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 18/145 (12%)

Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQ 233
           L Y +  +E   R +        LG G++G VY           A+KE+  +D      +
Sbjct: 1   LEYEYEYDENGERVV--------LGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SR 47

Query: 234 SVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQE----YHLKD 289
            V  L +EI+L    +H NIVQY G++ +     IF+E V  GSL+ + +         +
Sbjct: 48  YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE 107

Query: 290 SQVSAYTWQILNGLKYLHEQNVIHR 314
             +  YT QIL GLKYLH+  ++HR
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHR 132

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 82.3 bits (204), Expect = 3e-18
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 7/125 (5%)

Query: 193 QKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           ++   LG GS G VY+      G  +A+K++ +       +Q    L +E+  L   E  
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ----LLRELKTLRSCESP 59

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ- 309
            +V+ +G    E ++ I LE +  GSLA + ++   + +  ++    QIL GL YLH + 
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 310 NVIHR 314
           ++IHR
Sbjct: 120 HIIHR 124

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 81.8 bits (203), Expect = 5e-18
 Identities = 33/132 (25%), Positives = 59/132 (44%), Gaps = 18/132 (13%)

Query: 197 PLGSGSFGSVYEGFTDDGFFF----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
            LG G+FG VY+G            AVK  +L++  ++ E+      +E  ++ +  H N
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVK--TLKEDASEEERK--DFLKEARVMKKLGHPN 57

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSL----------AKIYQEYHLKDSQVSAYTWQILNG 302
           +V+  G   +E  LY+ LE +  G L              ++  L    + ++  QI  G
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 303 LKYLHEQNVIHR 314
           ++YL  +  +HR
Sbjct: 118 MEYLASKKFVHR 129

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 81.0 bits (201), Expect = 8e-18
 Identities = 36/130 (27%), Positives = 57/130 (43%), Gaps = 13/130 (10%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFF-----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           + G  LG G+FG VY+G             AVK  +L++  +  E+   +  +E S++ +
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK--TLKEGAS--EEEREEFLEEASIMKK 57

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLK 304
             H NIV+  G       LYI  E +  G L   +       L    +     QI  G++
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDL-LDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 305 YLHEQNVIHR 314
           YL  +N +HR
Sbjct: 117 YLESKNFVHR 126

Length = 258

>gnl|CDD|204949 pfam12515, CaATP_NAI, Ca2+-ATPase N terminal autoinhibitory domain

 Score = 73.9 bits (182), Expect = 3e-17
 Identities = 22/45 (48%), Positives = 28/45 (62%)

Query: 7  LKDFDVKPKHPSRESLRRWRSFCTIVKNPTRRFRMVANLDRRSEA 51
             FD+  K+ S E+LRRWR    +VKN  RRFR  A+L +R EA
Sbjct: 3  DDPFDIPAKNSSEEALRRWRQAVGLVKNARRRFRYTADLAKRCEA 47

This domain family is found in eukaryotes, and is approximately 50 amino acids in length. The family is found in association with pfam00689, pfam00122, pfam00702, pfam00690. There is a conserved RRFR sequence motif. There are two completely conserved residues (F and W) that may be functionally important. This family is the N terminal autoinhibitory domain of an endosomal Ca2+-ATPase. Length = 47

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 5/118 (4%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG VY+          A+K + L++     E  +  ++QEI  L Q     I +Y
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+    +KL+I +E    GS   + +   L ++ ++    ++L GL+YLHE+  IHR
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 1e-16
 Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 8/126 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W+    LG G+FG VY+    + G F A K + ++ +    +  V     EI +L + +H
Sbjct: 7   WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-----EIDILSECKH 61

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
            NIV  +     ENKL+I +E    G+L  I  E    L + Q+     Q+L  L +LH 
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 309 QNVIHR 314
             VIHR
Sbjct: 122 HKVIHR 127

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 34/126 (26%), Positives = 65/126 (51%), Gaps = 7/126 (5%)

Query: 192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +QK   +G G++G VY+      G   A+K++ L+ + ++G        +EI LL +  H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPK--TALREIKLLKELNH 57

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            NI++     + +  LY+  E +    L K+ +  +  L +S + +Y +Q+L GL + H 
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 309 QNVIHR 314
             ++HR
Sbjct: 117 HGILHR 122

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 37/126 (29%), Positives = 66/126 (52%), Gaps = 12/126 (9%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
            +K   +G G+ G VY+      G   A+K++ L+ Q  +       +  EI ++   +H
Sbjct: 24  LEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKH 74

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
            NIV Y+ +    ++L++ +E +  GSL  I  +    + + Q++    ++L GL+YLH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 309 QNVIHR 314
           QNVIHR
Sbjct: 135 QNVIHR 140

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG+G+ G V +      G   AVK + L       E    Q+ +E+ +L +     IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL----EINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQ-NVIH 313
           +G   +   + I +E +  GSL KI +E    + +  +      +L GL YLHE+  +IH
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 314 R 314
           R
Sbjct: 125 R 125

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.5 bits (178), Expect = 9e-15
 Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 7/121 (5%)

Query: 198 LGSGSFGS-VYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G+FG       T+D      KEV+L     +  +  L    EI +L   +H NI+ Y
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQHPNIIAY 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           +    D+N L I +E    G+L       +    ++  V  Y +QI++ + Y+H+  ++H
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124

Query: 314 R 314
           R
Sbjct: 125 R 125

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 74.0 bits (180), Expect = 9e-15
 Identities = 40/129 (31%), Positives = 65/129 (50%), Gaps = 9/129 (6%)

Query: 191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-E 249
           S++    LG GSFG VY     D    A+K ++ + +     + V +  +EI +L     
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESK--SKEVERFLREIQILASLNH 56

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH----LKDSQVSAYTWQILNGLKY 305
             NIV+ +   +DE  LY+ +E V  GSL  + ++      L +S+      QIL+ L+Y
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 306 LHEQNVIHR 314
           LH + +IHR
Sbjct: 117 LHSKGIIHR 125

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 39/125 (31%), Positives = 56/125 (44%), Gaps = 11/125 (8%)

Query: 198 LGSGSFGSVYEG---FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G FG V         D     V   SL   G   EQ     E+EI +L   +H+NIV
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EEQHRSDFEREIEILRTLDHENIV 69

Query: 255 QYFG--TEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQ 309
           +Y G   +     L + +E +  GSL + Y + H   +   ++  ++ QI  G+ YL  Q
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128

Query: 310 NVIHR 314
             IHR
Sbjct: 129 RYIHR 133

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.2 bits (172), Expect = 6e-14
 Identities = 41/123 (33%), Positives = 61/123 (49%), Gaps = 9/123 (7%)

Query: 198 LGSGSFGSVYE-GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG GS+GSVY+     D  F+A+KEV L     +  +  +    EI +L    H NI+ Y
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN---EIRILASVNHPNIISY 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVSAYTWQILNGLKYLHEQNV 311
                D NKL I +E    G L+K   +       + + ++     Q+L GL+ LHEQ +
Sbjct: 65  KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI 124

Query: 312 IHR 314
           +HR
Sbjct: 125 LHR 127

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 69.8 bits (171), Expect = 8e-14
 Identities = 34/121 (28%), Positives = 61/121 (50%), Gaps = 7/121 (5%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V++     D   +A+K++ L     +  +  +    E  +L + +   I++Y
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID---EARVLAKLDSSYIIRY 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + +  D+ KL I +E    G L K+ +      L + QV  +  QIL GL +LH + ++H
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILH 124

Query: 314 R 314
           R
Sbjct: 125 R 125

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 67.5 bits (166), Expect = 6e-13
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 9/126 (7%)

Query: 193 QKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQG-EQSVLQLEQEISLLGQFEH 250
           +K   LG G++G VY+      G   A+K++ L D   +G   + L+   EISLL + +H
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR---EISLLKELKH 57

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIY--QEYHLKDSQVSAYTWQILNGLKYLHE 308
            NIV+       E KLY+  E      L K    +   L  + + +  +Q+L GL Y H 
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 309 QNVIHR 314
             ++HR
Sbjct: 117 HRILHR 122

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 67.2 bits (165), Expect = 9e-13
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 11/123 (8%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G VY+      G   A+K++ + +   +G    +   +EI LL +  H NIV+ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM-ENEKEG--FPITAIREIKLLQKLRHPNIVRL 63

Query: 257 FG--TEKDENKLYIFLELVT---QGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
               T K +  +Y+  E +     G L     E    +SQ+  Y  Q+L GL+YLH   +
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNGI 121

Query: 312 IHR 314
           +HR
Sbjct: 122 LHR 124

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 21/133 (15%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           PLG GS G V+    +D     AVK++ L D      QSV    +EI ++ + +HDNIV+
Sbjct: 12  PLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVK 66

Query: 256 YF------GTEKDE--------NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +      G++  E        N +YI  E + +  LA + ++  L +     + +Q+L 
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLR 125

Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  NV+HR
Sbjct: 126 GLKYIHSANVLHR 138

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 34/125 (27%), Positives = 65/125 (52%), Gaps = 10/125 (8%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQ-GTQGEQSVLQLEQEISLLGQFEHDNIV 254
            +G G F  VY+     DG   A+K+V + +    +  Q  L+   EI LL Q +H N++
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQLDHPNVI 65

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVSAYTWQILNGLKYLHEQ 309
           +Y  +  + N+L I LEL   G L+++ + +      + +  +  Y  Q+ + L+++H +
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125

Query: 310 NVIHR 314
            ++HR
Sbjct: 126 RIMHR 130

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 4/119 (3%)

Query: 198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G FG V           FA+K V  +     G+Q  +  E+EI  L +  H  IV+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI--LEECNHPFIVKL 58

Query: 257 FGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + T KD+  +Y+ +E    G L   +       +     Y   ++   +YLH + +I+R
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.5 bits (159), Expect = 3e-12
 Identities = 42/119 (35%), Positives = 67/119 (56%), Gaps = 7/119 (5%)

Query: 198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG++G VY+    + G   A+K + L+     GE   + ++QEI ++   +H NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAV-VQQEIIMMKDCKHSNIVAY 71

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           FG+    +KL+I +E    GSL  IY     L +SQ++  + + L GL YLH +  +HR
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.5 bits (159), Expect = 3e-12
 Identities = 36/118 (30%), Positives = 66/118 (55%), Gaps = 5/118 (4%)

Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V++G  +      A+K + L+    + E  +  ++QEI++L Q +   + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+   + KL+I +E +  GS   + +   L ++Q++    +IL GL YLH +  IHR
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.1 bits (158), Expect = 4e-12
 Identities = 37/118 (31%), Positives = 65/118 (55%), Gaps = 5/118 (4%)

Query: 198 LGSGSFGSVYEGFTDDGF-FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG VY+G  +      A+K + L+    + E  +  ++QEI++L Q +   I +Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+     KL+I +E +  GS   + +   L+++ ++    +IL GL YLH +  IHR
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 42/128 (32%), Positives = 64/128 (50%), Gaps = 8/128 (6%)

Query: 191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 57

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAK---IYQEYHLKDSQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K         +    + +Y +Q+L GL + 
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 117 HSHRVLHR 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 33/121 (27%), Positives = 63/121 (52%), Gaps = 7/121 (5%)

Query: 198 LGSGSFGSVY-EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG +Y      D     +KE+ L     + +++    ++E+ LL + +H NIV +
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVTF 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIH 313
           F + ++  +L+I +E    G L K           + Q+ ++  QI  GLK++H++ ++H
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILH 124

Query: 314 R 314
           R
Sbjct: 125 R 125

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 14/131 (10%)

Query: 191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQ-DQGTQGEQSVLQLEQEISLLGQF 248
           ++++   LG G++ +VY+G     G   A+KE+ L  ++GT          +EISL+ + 
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKEL 55

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVSAYTWQILNGL 303
           +H+NIV+       ENKL +  E + +    K Y + H     L  + V ++T+Q+L G+
Sbjct: 56  KHENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 304 KYLHEQNVIHR 314
            + HE  V+HR
Sbjct: 114 AFCHENRVLHR 124

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 42/119 (35%), Positives = 64/119 (53%), Gaps = 7/119 (5%)

Query: 198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG++G VY+      G   AVK + L+     G+   L ++QEI ++ + +H NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSL-IQQEIFMVKECKHCNIVAY 71

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           FG+     KL+I +E    GSL  IY     L + Q++    + L GL YLH +  +HR
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 35/121 (28%), Positives = 56/121 (46%), Gaps = 10/121 (8%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG FG V+EG   +    A+K +   D   Q +      ++E+  L +  H +++  F
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-----FQKEVQALKRLRHKHLISLF 68

Query: 258 GTEKDENKLYIFLELVTQGSLAKIY----QEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
                   +YI  EL+ +GSL   +    +   L  + +     Q+  G+ YL EQN IH
Sbjct: 69  AVCSVGEPVYIITELMEKGSL-LAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127

Query: 314 R 314
           R
Sbjct: 128 R 128

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 16/130 (12%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG+V +     DG     KE+   D G   E+   QL  E+++L + +H NIV+Y
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 257 FGTEKDENK--LYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLH-- 307
           +    D +   LYI +E    G LA++ Q+      ++++  +     Q+L  L   H  
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 308 ---EQNVIHR 314
                 V+HR
Sbjct: 125 SDPGNTVLHR 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 42/124 (33%), Positives = 63/124 (50%), Gaps = 11/124 (8%)

Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D  G   AVK +  ++ G Q        ++EI++L    H+N
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSG---WKKEINILKTLYHEN 67

Query: 253 IVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           IV+Y G  +E+    L + +E V  GSL     ++ L  +Q+  +  QI  G+ YLH Q+
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 311 VIHR 314
            IHR
Sbjct: 128 YIHR 131

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 30/121 (24%), Positives = 58/121 (47%), Gaps = 8/121 (6%)

Query: 198 LGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           +  G++G V+   +  T D   +A+K +   D     +  V Q+  E  +L Q +   +V
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVV 56

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + + + + +  LY+ +E +  G LA + +    L +     Y  +I+  L+YLH   +IH
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 314 R 314
           R
Sbjct: 117 R 117

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 8/127 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +QK   +G G++G VY+      G   A+K++ L +   +G  S     +EISLL +  H
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAI--REISLLKELNH 57

Query: 251 DNIVQYFGTEKDENKLYI---FLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            NIV+       ENKLY+   FL+L  +  +        L    + +Y +Q+L G+ Y H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCH 116

Query: 308 EQNVIHR 314
              V+HR
Sbjct: 117 SHRVLHR 123

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 61.6 bits (149), Expect = 5e-11
 Identities = 35/118 (29%), Positives = 63/118 (53%), Gaps = 5/118 (4%)

Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V++G  +      A+K + L+    + E  +  ++QEI++L Q +   + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+     KL+I +E +  GS   + +     + Q++    +IL GL YLH +  IHR
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 125

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 61.4 bits (150), Expect = 6e-11
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 11/126 (8%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQEI-SLLGQFE 249
           G  +G GSF +V      +    +A+K +    L  +     + V   E+E+ + L    
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKI-EKEVLTRLNG-- 60

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  I++ + T +DE  LY  LE    G L + I +   L +     Y  +IL  L+YLH 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 309 QNVIHR 314
           + +IHR
Sbjct: 121 KGIIHR 126

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 61.8 bits (151), Expect = 7e-11
 Identities = 43/125 (34%), Positives = 62/125 (49%), Gaps = 11/125 (8%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           P+GSG++G V        G   A+K++S         + +L+   EI LL    H+NI+ 
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---EIKLLRHLRHENIIG 63

Query: 256 YF-----GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
                   + +D N +YI  EL+ +  L K I     L D  +  + +QIL GLKYLH  
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA 122

Query: 310 NVIHR 314
           NVIHR
Sbjct: 123 NVIHR 127

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 7/127 (5%)

Query: 191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
            ++K   +G G++G+V++    +     A+K V L D       S L+   EI LL + +
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLH 307
           H NIV+ +     + KL +  E   Q  L K +   +  +    V ++ +Q+L GL + H
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 308 EQNVIHR 314
             NV+HR
Sbjct: 117 SHNVLHR 123

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 35/127 (27%), Positives = 66/127 (51%), Gaps = 8/127 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +Q+   +G G++G+VY G     G   A+K ++L       +  V  +++E++LL Q   
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58

Query: 251 D---NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
               NI +Y+G+     +L+I +E    GS+  + +   + +  +S    ++L  LKY+H
Sbjct: 59  SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 308 EQNVIHR 314
           +  VIHR
Sbjct: 119 KVGVIHR 125

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 14/127 (11%)

Query: 199 GSGSFGSVYEGFTDDGF---FFAVKE-VSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           G G++G VY+    +G     +A+K+    ++Q T   QS  +   EI+LL + +H+N+V
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR---EIALLRELKHENVV 65

Query: 255 QYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYT-----WQILNGLKYLH 307
                  E  +  +Y+  +         I      K   +         WQILNG+ YLH
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125

Query: 308 EQNVIHR 314
              V+HR
Sbjct: 126 SNWVLHR 132

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 59.8 bits (146), Expect = 2e-10
 Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 4/119 (3%)

Query: 198 LGSGSFGSVYE-GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG GSFG V      D G  +A+K   L+ +     + V     E ++L +  H  IV+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMK--VLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 257 FGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
               + E KLY+ LE    G L   + +E    + +   Y  +I+  L+YLH   +I+R
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 33/131 (25%), Positives = 71/131 (54%), Gaps = 14/131 (10%)

Query: 198 LGSGSFGSVYEGFTDDG--FFFAVKEVSLQD-----QGTQGEQSVLQLEQEISLLG-QFE 249
           LGSG+FG VY+    +      A+KE+++ +        + ++S+  +  E++++  Q  
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIY-----QEYHLKDSQVSAYTWQILNGLK 304
           H NIV+Y+ T  + ++LYI ++L+    L + +     ++    + ++     Q++  L+
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 305 YLH-EQNVIHR 314
           YLH E+ ++HR
Sbjct: 128 YLHKEKRIVHR 138

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 9/120 (7%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+EG  ++    AVK +     GT   +  L    E  ++ +  H  ++Q +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLA---EAQIMKKLRHPKLIQLY 67

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  EL+  GSL +  Q      LK  Q+     Q+ +G+ YL  QN IHR
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 38/125 (30%), Positives = 57/125 (45%), Gaps = 6/125 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           W+    LG G+FG VY+    +    A  +V      T+ E+ +     EI +L   +H 
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVI----DTKSEEELEDYMVEIDILASCDHP 62

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQ 309
           NIV+       EN L+I +E    G++  +  E    L + Q+     Q L  L YLHE 
Sbjct: 63  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 310 NVIHR 314
            +IHR
Sbjct: 123 KIIHR 127

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 22/138 (15%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEISLLGQ- 247
           +++ A +G G++G+VY+    + G F A+K+V   L ++G     S L+   EI+LL Q 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI--PLSTLR---EIALLKQL 55

Query: 248 --FEHDNIVQ-----YFGTEKDENKLYIFLELVTQGSLAKIYQEYH----LKDSQVSAYT 296
             FEH NIV+     +      E KL +  E V Q  LA  Y        L    +    
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLAT-YLSKCPKPGLPPETIKDLM 113

Query: 297 WQILNGLKYLHEQNVIHR 314
            Q+L G+ +LH   ++HR
Sbjct: 114 RQLLRGVDFLHSHRIVHR 131

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 11/126 (8%)

Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG VY+G      ++    AVK        +  E+ +    QE  ++ QF+H
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL----QEAYIMRQFDH 66

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G   + N ++I +EL   G L    Q  +Y L  + +  Y++Q+   L YL  
Sbjct: 67  PHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 309 QNVIHR 314
           +  +HR
Sbjct: 126 KRFVHR 131

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 38/125 (30%), Positives = 56/125 (44%), Gaps = 10/125 (8%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           + GA +G G FG V  G    G   AVK   L+D  T    +      E S++    H N
Sbjct: 9   KLGATIGKGEFGDVMLG-DYRGQKVAVK--CLKDDST----AAQAFLAEASVMTTLRHPN 61

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQ---EYHLKDSQVSAYTWQILNGLKYLHEQ 309
           +VQ  G     N LYI  E + +GSL    +      +  +Q   +   +  G++YL E+
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 310 NVIHR 314
           N +HR
Sbjct: 122 NFVHR 126

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 3e-10
 Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 6/119 (5%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G+FG VY+G        AVK            + +    QE  +L Q++H NIV+  
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFL----QEAEILKQYDHPNIVKLI 58

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G    +  +YI +ELV  GSL    +  +  L   ++   +     G++YL  +N IHR
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 9/120 (7%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G  +     AVK +     GT   ++ LQ   E  ++ +  HD +VQ +
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQ---EAQIMKKLRHDKLVQLY 67

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
               +E  +YI  E +++GSL    +      L+  Q+     QI  G+ YL  +N IHR
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 39/136 (28%), Positives = 60/136 (44%), Gaps = 14/136 (10%)

Query: 191 SWQKGAPLGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           S      LG G+FG VYEG       D     V   +L +  ++ ++S   +E  I  + 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI--MS 64

Query: 247 QFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQ-------- 298
           +F H NIV+  G   +    +I LEL+  G L    +E   +  + S+ T +        
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 299 ILNGLKYLHEQNVIHR 314
           +  G KYL E + IHR
Sbjct: 125 VAKGCKYLEENHFIHR 140

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 36/124 (29%), Positives = 59/124 (47%), Gaps = 14/124 (11%)

Query: 198 LGSGSFGSVYEGF--TDDGFFFAVKEVSL----QDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G+FGSV +G      G      EV++    Q+    G++  L+   E S++ Q +H 
Sbjct: 3   LGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHP 56

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQN 310
            IV+  G  K E  L + +EL   G L K  ++   +  S +     Q+  G+ YL  ++
Sbjct: 57  CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 311 VIHR 314
            +HR
Sbjct: 116 FVHR 119

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 33/125 (26%), Positives = 60/125 (48%), Gaps = 12/125 (9%)

Query: 198 LGSGSFGSVYE-GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G+ GSV +    + G  FA+K +   D     ++   Q+ +E+ +    +   IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQK---QILRELEINKSCKSPYIVKY 64

Query: 257 FGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAY-----TWQILNGLKYLHEQ 309
           +G   ++  + + I +E    GSL  IY++   +  ++           +L GL YLH +
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 310 NVIHR 314
            +IHR
Sbjct: 125 KIIHR 129

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 58.2 bits (141), Expect = 8e-10
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 10/120 (8%)

Query: 198 LGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           +G GS G V    +  T  G   AVK++ L+ Q     Q    L  E+ ++  ++H NIV
Sbjct: 27  IGEGSTGIVCIATDKST--GRQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIV 79

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + + +    ++L++ +E +  G+L  I     + + Q++     +L  L +LH Q VIHR
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 58.7 bits (142), Expect = 9e-10
 Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 12/120 (10%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG+ G+VY+      G  +A+K +     G   +    Q+ +EI +L    H N+V+ 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRDVNHPNVVKC 137

Query: 257 FGTEKDENKLYIFLELVTQGSL--AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                   ++ + LE +  GSL    I  E  L D        QIL+G+ YLH ++++HR
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHIVHR 192

Length = 353

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 38/126 (30%), Positives = 58/126 (46%), Gaps = 8/126 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W+    LG G+FG VY+    + G   A K +      T+ E+ +     EI +L    H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNH 68

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
             IV+  G    + KL+I +E    G++  I  E    L + Q+     Q+L  L+YLH 
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 309 QNVIHR 314
             +IHR
Sbjct: 129 MKIIHR 134

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 39/123 (31%), Positives = 65/123 (52%), Gaps = 8/123 (6%)

Query: 197 PLGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
            +G GS+G V       DG  + +K+++L++   +  ++    EQE  LL Q +H NIV 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVA 63

Query: 256 YFGT-EKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNV 311
           Y  + E ++  LYI +     G L    +E     L ++QV  +  QI   L+YLHE+++
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123

Query: 312 IHR 314
           +HR
Sbjct: 124 LHR 126

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 10/124 (8%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           +G G F  VY      DG   A+K+V + D    +     ++   EI LL Q  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIK 66

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVSAYTWQILNGLKYLHEQN 310
           Y+ +  ++N+L I LEL   G L+++ + +      + +  V  Y  Q+ + L+++H + 
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126

Query: 311 VIHR 314
           V+HR
Sbjct: 127 VMHR 130

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 17/148 (11%)

Query: 177 YNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSV 235
           Y   LN+        +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS+
Sbjct: 4   YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSI 57

Query: 236 LQLEQ---EISLLGQFEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYH 286
           +  ++   E+ LL   +H+N++          + ++ N +Y+   L+    L  I +   
Sbjct: 58  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK 116

Query: 287 LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           L D  V    +QIL GLKY+H  ++IHR
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSADIIHR 144

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 36/122 (29%), Positives = 65/122 (53%), Gaps = 9/122 (7%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLE-QEISLLGQFEHDNIVQ 255
           +G G++G VY+G     G   A+K++ L+ +    E+ V     +EISLL + +H NIV 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESE----EEGVPSTAIREISLLKELQHPNIVC 63

Query: 256 YFGTEKDENKLYIFLELVT---QGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
                  E++LY+  E ++   +  L  + +  ++    V +Y +QIL G+ + H + V+
Sbjct: 64  LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123

Query: 313 HR 314
           HR
Sbjct: 124 HR 125

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 38/134 (28%), Positives = 69/134 (51%), Gaps = 13/134 (9%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
            +KY R    ++K   +G G+ G+VY       G   A+K+++LQ Q  +       +  
Sbjct: 18  KKKYTR----FEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE-----LIIN 65

Query: 241 EISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQIL 300
           EI ++ + +H NIV Y  +    ++L++ +E +  GSL  +  E  + + Q++A   + L
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125

Query: 301 NGLKYLHEQNVIHR 314
             L++LH   VIHR
Sbjct: 126 QALEFLHSNQVIHR 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 18/126 (14%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEV-----SLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G+FGSVY     + G   A+K++     S ++         + L +  SL    EH 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--------CMNLREVKSLRKLNEHP 58

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHE 308
           NIV+     ++ ++LY   E + +G+L ++ ++       +S + +  +QIL GL ++H+
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 309 QNVIHR 314
               HR
Sbjct: 118 HGFFHR 123

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 6/119 (5%)

Query: 199 GSGSFGSVYE-GFTDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFEHDNIVQY 256
           G G+FG V      D    FA+K ++ Q    +G  ++VL    E  +L +  H  +V  
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQELNHPFLVNL 65

Query: 257 FGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + + +DE  +Y+ ++L+  G L   + Q+    + QV  +  +I+  L+YLH + +IHR
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHR 124

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 33/123 (26%), Positives = 61/123 (49%), Gaps = 9/123 (7%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
            +G G+   VY      +    A+K + L+   T    SV +L +E+  + Q  H N+V+
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNHPNVVK 63

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKI----YQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           Y+ +    ++L++ +  ++ GSL  I    Y    L ++ ++    ++L GL+YLH    
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123

Query: 312 IHR 314
           IHR
Sbjct: 124 IHR 126

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 56.8 bits (138), Expect = 3e-09
 Identities = 36/132 (27%), Positives = 66/132 (50%), Gaps = 16/132 (12%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE---QSVLQLEQEISLLGQ 247
           ++KG  LG G++  VY+    + G   A+K++ L ++    +    + L+   EI LL +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR---EIKLLQE 58

Query: 248 FEHDNI---VQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNG 302
            +H NI   +  FG + + N ++ F+E      L K+ +     L  + + +Y    L G
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFME----TDLEKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 303 LKYLHEQNVIHR 314
           L+YLH   ++HR
Sbjct: 115 LEYLHSNWILHR 126

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 10/128 (7%)

Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           +++K   LG GS+ +VY+G +   G   A+KE+ L+      E +     +E SLL   +
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE----HEEGAPFTAIREASLLKDLK 61

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYL 306
           H NIV        +  L +  E +    L + Y +     L    V  + +Q+L GL Y 
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYL-DTDLKQ-YMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 307 HEQNVIHR 314
           H++ V+HR
Sbjct: 120 HQRRVLHR 127

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 55.6 bits (135), Expect = 7e-09
 Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 26/130 (20%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ------EISLLGQFEH 250
           LG+GSFG V        G ++A+K +S           +++L+Q      E  +L    H
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAK--------IVKLKQVEHVLNEKRILQSIRH 60

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS------QVSAYTWQILNGLK 304
             +V  +G+ +D++ LY+ +E V  G L       HL+ S          Y  Q++  L+
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELF-----SHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 305 YLHEQNVIHR 314
           YLH  ++++R
Sbjct: 116 YLHSLDIVYR 125

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 37/132 (28%), Positives = 65/132 (49%), Gaps = 13/132 (9%)

Query: 192 WQKGAPLGSGSFG---SVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           ++    LG G++G   S     T +    A+K+++         +  L+   E+ LL  F
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR---ELKLLRHF 58

Query: 249 -EHDNIVQYFGTE----KDENKLYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNG 302
             H NI   +  +     + N+LY++ EL+ +  L +I +    L D+   ++ +QIL G
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCG 117

Query: 303 LKYLHEQNVIHR 314
           LKY+H  NV+HR
Sbjct: 118 LKYIHSANVLHR 129

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)

Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK+  LQ       + +   E+EI +L   +HDN
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKK--LQHST---AEHLRDFEREIEILKSLQHDN 66

Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++   L   ++  Y  QI  G++YL  
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 309 QNVIHR 314
           +  +HR
Sbjct: 127 KRYVHR 132

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 5/119 (4%)

Query: 198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V +      G   A+K+    +     +++ L+   E+ +L Q  H+NIV  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVNL 65

Query: 257 FGTEKDENKLYIFLELVTQGSLAKI-YQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
               + + +LY+  E V +  L  +      L    V +Y WQ+L  + Y H  N+IHR
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHR 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 6/119 (5%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G+FG V++G   D    AVK      +    ++  ++   E  +L Q++H NIV+  
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTC----KEDLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G       +YI +ELV  G      ++    LK  Q+  +      G+ YL  +N IHR
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 25/76 (32%), Positives = 43/76 (56%), Gaps = 1/76 (1%)

Query: 240 QEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQ 298
           +EI +L Q  H+N+V      + + +LY+  E V    L  + +  + L +S+V  Y +Q
Sbjct: 49  REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ 108

Query: 299 ILNGLKYLHEQNVIHR 314
           IL G+++ H  N+IHR
Sbjct: 109 ILRGIEFCHSHNIIHR 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 34/120 (28%), Positives = 59/120 (49%), Gaps = 9/120 (7%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ ++    AVK +        G  SV    +E +L+   +HD +V+ +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK------PGTMSVQAFLEEANLMKTLQHDKLVRLY 67

Query: 258 GTEKDENKLYIFLELVTQGSL---AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E + +GSL    K  +   +   ++  ++ QI  G+ Y+  +N IHR
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 28/137 (20%), Positives = 54/137 (39%), Gaps = 21/137 (15%)

Query: 195 GAPLGSGSFGSVYEGF-----TDDGFF-FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
              LG GSFG VYEG        +     A+K  ++ +  +  E+  ++   E S++ +F
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIK--TVNENASMRER--IEFLNEASVMKEF 66

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS---------AYTW-- 297
              ++V+  G         + +EL+ +G L    +    +                    
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 298 QILNGLKYLHEQNVIHR 314
           +I +G+ YL  +  +HR
Sbjct: 127 EIADGMAYLAAKKFVHR 143

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 6/118 (5%)

Query: 198 LGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK++ L+ Q     Q    L  E+ ++  ++H+N+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +    ++L++ +E +  G+L  I     + + Q++A    +L  L  LH Q VIHR
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 24/95 (25%), Positives = 50/95 (52%)

Query: 220 KEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLA 279
           K+V+++    + +Q    L  E+ ++  + H+N+V  + +    ++L++ +E +  G+L 
Sbjct: 48  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107

Query: 280 KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            I     + + Q++     +L  L YLH Q VIHR
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 28/79 (35%), Positives = 46/79 (58%), Gaps = 6/79 (7%)

Query: 241 EISLLGQFEHDNIVQYF-----GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAY 295
           EI +L +F+H+NI+         + +  N +YI  EL+ +  L K+ +  HL +  +  +
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYF 111

Query: 296 TWQILNGLKYLHEQNVIHR 314
            +QIL GLKY+H  NV+HR
Sbjct: 112 LYQILRGLKYIHSANVLHR 130

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 25/79 (31%), Positives = 44/79 (55%), Gaps = 6/79 (7%)

Query: 241 EISLLGQFEHDNIV---QYFGTEKDENK-LYIFLELVTQGSLAK-IYQEYHLKDSQVSAY 295
           E+ +L  F+HDNI+           + K +Y+ ++L+ +  L   I+ +  L +  +  +
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYF 112

Query: 296 TWQILNGLKYLHEQNVIHR 314
            +Q+L GLKY+H  NVIHR
Sbjct: 113 LYQLLRGLKYIHSANVIHR 131

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 38/122 (31%), Positives = 67/122 (54%), Gaps = 10/122 (8%)

Query: 198 LGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           +G GSFG+VY      T++    AVK++S    G Q  +    + +E+  L Q +H N +
Sbjct: 29  IGHGSFGAVYFATNSHTNE--VVAVKKMSYS--GKQTNEKWQDIIKEVKFLQQLKHPNTI 84

Query: 255 QYFGTEKDENKLYIFLE--LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           +Y G    E+  ++ +E  L +   L +++++  L++ +++A T   L GL YLH  N+I
Sbjct: 85  EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 313 HR 314
           HR
Sbjct: 144 HR 145

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.4 bits (125), Expect = 7e-08
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 17/128 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD-NIVQ 255
           +G+G++G VY+G     G   A+K + +   G + E+    ++QEI++L ++ H  NI  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEE----IKQEINMLKKYSHHRNIAT 67

Query: 256 YFGTEKDEN------KLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYL 306
           Y+G    +N      +L++ +E    GS+  + +      LK+  ++    +IL GL +L
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 307 HEQNVIHR 314
           H+  VIHR
Sbjct: 128 HQHKVIHR 135

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 7e-08
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 19/136 (13%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-E 249
           ++    +G G++G VY+      G   A+K + +       E    ++++E ++L ++  
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSN 61

Query: 250 HDNIVQYFG--TEKD----ENKLYIFLELVTQGSLAKIYQEYHLKDSQVS----AYTWQ- 298
           H NI  ++G   +K+    +++L++ +EL   GS+  + +    K  ++     AY  + 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 299 ILNGLKYLHEQNVIHR 314
            L GL YLHE  VIHR
Sbjct: 122 TLRGLAYLHENKVIHR 137

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 42/131 (32%), Positives = 65/131 (49%), Gaps = 16/131 (12%)

Query: 197 PLGSGSFGSVYEGFTD--DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           P+G G+FG V+   TD  DG   A+K++    Q     + V +   E+ +L  F+HDN++
Sbjct: 7   PIGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFR---ELKMLCFFKHDNVL 62

Query: 255 QYFGTEKDEN-----KLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHE 308
                 +  +     ++Y+  EL+ Q  L K I     L    V  + +QIL GLKYLH 
Sbjct: 63  SALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 309 QNVIHR---PG 316
             ++HR   PG
Sbjct: 122 AGILHRDIKPG 132

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 38/122 (31%), Positives = 65/122 (53%), Gaps = 10/122 (8%)

Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           +G GSFG+VY  F  D       A+K++S    G Q  +    + +E+  L +  H N +
Sbjct: 23  IGHGSFGAVY--FARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTI 78

Query: 255 QYFGTEKDENKLYIFLE--LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           QY G    E+  ++ +E  L +   L +++++  L++ +++A T   L GL YLH  N+I
Sbjct: 79  QYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 313 HR 314
           HR
Sbjct: 138 HR 139

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 7e-08
 Identities = 30/122 (24%), Positives = 65/122 (53%), Gaps = 7/122 (5%)

Query: 197 PLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           P+  G+FGSVY   +  T D  +FA+K +   D   + + + ++ E+ I ++ Q E   +
Sbjct: 3   PISKGAFGSVYLAKKRSTGD--YFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYV 59

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVI 312
            + + + + ++ LY+ +E +  G  A + +    L +     Y  +++ G++ LH++ +I
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119

Query: 313 HR 314
           HR
Sbjct: 120 HR 121

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 8/121 (6%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG+VY           A+K++S    G Q  +    + +E+  L Q  H N ++Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIH 313
            G    E+  ++ +E    GS + I  E H   L++ +++A     L GL YLH    IH
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDIL-EVHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138

Query: 314 R 314
           R
Sbjct: 139 R 139

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 43/130 (33%), Positives = 62/130 (47%), Gaps = 21/130 (16%)

Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D+ G   AVK  SL+ +   G   +  L++EI +L    H+N
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPE--SGGNHIADLKKEIEILRNLYHEN 67

Query: 253 IVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEY------HLKDSQVSAYTWQILNGLK 304
           IV+Y G  TE   N + + +E +  GSL    +EY       +   Q   Y  QI  G+ 
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSL----KEYLPRNKNKINLKQQLKYAVQICKGMD 123

Query: 305 YLHEQNVIHR 314
           YL  +  +HR
Sbjct: 124 YLGSRQYVHR 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 39/132 (29%), Positives = 57/132 (43%), Gaps = 19/132 (14%)

Query: 198 LGSGSFGSVYEGFTDDGFF-------FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           LGSG+FG VYEG   D           AVK  +L+   T  E+   +  +E  L+  F H
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKK--EFLKEAHLMSNFNH 58

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL------AKIYQEYH--LKDSQVSAYTWQILNG 302
            NIV+  G        YI +EL+  G L      A++ +     L   ++      +  G
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 303 LKYLHEQNVIHR 314
             YL + + IHR
Sbjct: 119 CVYLEQMHFIHR 130

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.2 bits (125), Expect = 9e-08
 Identities = 38/123 (30%), Positives = 61/123 (49%), Gaps = 10/123 (8%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G++GSVY+      G   A+KE+ L+      E    Q+  E+ +L +     IV +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----ESKFNQIIMELDILHKAVSPYIVDF 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAY-TWQILNGLKYLHEQ-NV 311
           +G    E  +Y+ +E +  GSL K+Y            V    T+ ++ GLK+L E+ N+
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 312 IHR 314
           IHR
Sbjct: 125 IHR 127

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 33/127 (25%), Positives = 67/127 (52%), Gaps = 7/127 (5%)

Query: 192 WQKGAPLGSGSFG-SVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           + K   +G GSFG ++     +DG  + +KE+++     +  +   +  +E+++L   +H
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKH 58

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHL--KDSQVSAYTWQILNGLKYLH 307
            NIVQY  + ++   LYI ++    G L  KI  +  +   + Q+  +  QI   LK++H
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 308 EQNVIHR 314
           ++ ++HR
Sbjct: 119 DRKILHR 125

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 41/147 (27%), Positives = 74/147 (50%), Gaps = 18/147 (12%)

Query: 179 FSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQD---QGTQGEQS 234
           FS++E+Y       QKGA LG G++G V + + T  G   A+K+V + +     T+  Q 
Sbjct: 4   FSISERYI------QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQL 57

Query: 235 VLQ------LEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-EYHL 287
           V          +E+ ++ + +H+NI+       + + + + ++++    L K+   +  L
Sbjct: 58  VGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRL 116

Query: 288 KDSQVSAYTWQILNGLKYLHEQNVIHR 314
            +SQV     QILNGL  LH+   +HR
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHR 143

Length = 335

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 33/118 (27%), Positives = 61/118 (51%), Gaps = 6/118 (5%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+ G+VY       G   A+K+++LQ Q  +       +  EI ++ + ++ NIV Y
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE-----LIINEILVMRENKNPNIVNY 81

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             +    ++L++ +E +  GSL  +  E  + + Q++A   + L  L +LH   VIHR
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 10/120 (8%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     A+K +    QG+   ++ L    E +L+ Q +H  +V+ +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFL---AEANLMKQLQHPRLVRLY 67

Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K  +   L  +++     QI  G+ ++  +N IHR
Sbjct: 68  AVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 38/132 (28%), Positives = 63/132 (47%), Gaps = 18/132 (13%)

Query: 192 WQKGAPLGSGSFGSVYEG---FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           ++K   +G G++G VY+     T++    A+K++ L +Q  +G  S     +EISLL + 
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRL-EQEDEGVPSTAI--REISLLKEM 58

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVT------QGSLAKIYQEYHLKDSQVSAYTWQILNG 302
           +H NIV+       E +LY+  E +         S     +   L    +  Y +QIL G
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL----IKTYLYQILRG 114

Query: 303 LKYLHEQNVIHR 314
           + Y H   V+HR
Sbjct: 115 IAYCHSHRVLHR 126

Length = 294

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 32/119 (26%), Positives = 64/119 (53%), Gaps = 8/119 (6%)

Query: 198 LGSGSFGSVYEGFTDD--GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           +G G+ G+V+    D   G   A+K+++LQ Q  +       +  EI ++ + ++ NIV 
Sbjct: 27  IGQGASGTVFTA-IDVATGQEVAIKQINLQKQPKKE-----LIINEILVMKELKNPNIVN 80

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +  +    ++L++ +E +  GSL  +  E  + ++Q++A   + L  L++LH   VIHR
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHR 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 37/128 (28%), Positives = 67/128 (52%), Gaps = 17/128 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD-NIVQ 255
           +G+G++G VY+G     G   A+K + +    T+ E+   +++ EI++L ++ H  NI  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEE--EIKLEINMLKKYSHHRNIAT 77

Query: 256 YFGT------EKDENKLYIFLELVTQGS---LAKIYQEYHLKDSQVSAYTWQILNGLKYL 306
           Y+G          +++L++ +E    GS   L K  +   LK+  ++    +IL GL +L
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 307 HEQNVIHR 314
           H   VIHR
Sbjct: 138 HAHKVIHR 145

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 10/122 (8%)

Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           +G GSFG+VY  F  D       A+K++S    G Q  +    + +E+  L + +H N +
Sbjct: 33  IGHGSFGAVY--FARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 255 QYFGTEKDENKLYIFLE--LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           +Y G    E+  ++ +E  L +   L +++++  L++ +++A T   L GL YLH  N+I
Sbjct: 89  EYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 313 HR 314
           HR
Sbjct: 148 HR 149

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 51.3 bits (122), Expect = 2e-07
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 6/118 (5%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+ G+VY       G   A+++++LQ Q  +       +  EI ++ + ++ NIV Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRENKNPNIVNY 82

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             +    ++L++ +E +  GSL  +  E  + + Q++A   + L  L++LH   VIHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 39/128 (30%), Positives = 65/128 (50%), Gaps = 10/128 (7%)

Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           S++K   LG GS+ +VY+G +  +G   A+K + LQ++    E +     +E SLL   +
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE----EGTPFTAIREASLLKGLK 61

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYL 306
           H NIV        +  L +  E V    L + Y + H   L    V  + +Q+L GL Y+
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYV-HTDLCQ-YMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 307 HEQNVIHR 314
           H++ ++HR
Sbjct: 120 HQRYILHR 127

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 5/97 (5%)

Query: 218 AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGS 277
           AVK + L+ Q     Q    L  E+ ++  ++H N+V+ + +     +L++ +E +  G+
Sbjct: 50  AVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 278 LAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           L  I  +  L + Q++     +L  L YLH Q VIHR
Sbjct: 105 LTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 36/120 (30%), Positives = 57/120 (47%), Gaps = 10/120 (8%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G FG V+ G  +     A+K +     GT   ++ LQ   E  ++ +  HD +V  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQ---EAQIMKKLRHDKLVPLY 67

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
               +E  +YI  E + +GSL    +E    +LK  Q+     QI +G+ Y+   N IHR
Sbjct: 68  AVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 31/124 (25%), Positives = 55/124 (44%), Gaps = 9/124 (7%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           G          + +         AVK+++L       ++ +  L+QEI    Q +H NI+
Sbjct: 7   GKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCS---KEDLKLLQQEIITSRQLQHPNIL 62

Query: 255 QYFGTEKDENKLYIFLELVTQGS---LAKIYQEYHLKDSQVSAYTWQ-ILNGLKYLHEQN 310
            Y  +   +++LY+   L+  GS   L K +    L +    A+  + +LN L Y+H + 
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL-AIAFILKDVLNALDYIHSKG 121

Query: 311 VIHR 314
            IHR
Sbjct: 122 FIHR 125

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 25/138 (18%)

Query: 198 LGSGSFGSVYEG------FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G+FG V+ G        +D    AVK +    + T    +    E+E  LL  F+H+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQHE 68

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ---------------EYHLKDSQVSAYT 296
           NIV+++G   + +   +  E +  G L K  +                  L  SQ+    
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 297 WQILNGLKYLHEQNVIHR 314
            QI +G+ YL  Q+ +HR
Sbjct: 129 VQIASGMVYLASQHFVHR 146

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 32/125 (25%), Positives = 63/125 (50%), Gaps = 16/125 (12%)

Query: 198 LGSGSFGSVY-EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ------EISLLGQFEH 250
           +G+G+FG V+         ++A+K +++ +        V++L+Q      E  +L +  H
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPE--------VIRLKQEQHVHNEKRVLKEVSH 60

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
             I++ F TE D+  LY+ +E V  G L + +       +S    Y  +I+  L+YLH +
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 310 NVIHR 314
            +++R
Sbjct: 121 EIVYR 125

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 34/122 (27%), Positives = 51/122 (41%), Gaps = 8/122 (6%)

Query: 198 LGSGSFGSVYEG--FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           LG GSFG V  G   T  G    V    L+              +E +++   +H+N+++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSLDHENLIR 60

Query: 256 YFGTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
            +G       L +  EL   GSL    +     H   S +  Y  QI NG++YL  +  I
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 313 HR 314
           HR
Sbjct: 120 HR 121

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 10/121 (8%)

Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG GS+ +VY+G +  +G   A+K +S++ +    E       +E SLL   +H NIV  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTE----EGVPFTAIREASLLKGLKHANIVLL 68

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIH 313
                 +  L    E +    LA+ Y   H   L    V  + +Q+L GL Y+H Q+++H
Sbjct: 69  HDIIHTKETLTFVFEYM-HTDLAQ-YMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 314 R 314
           R
Sbjct: 127 R 127

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 44/145 (30%), Positives = 63/145 (43%), Gaps = 33/145 (22%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           R +  ++K   +G G++G VY    T  G   A+K+V + D    G   +  L +EI+LL
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-DNERDG-IPISSL-REITLL 60

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIY--QEYHLKD-------------- 289
               H NIV+               E+V    L  I+   EY  +D              
Sbjct: 61  LNLRHPNIVE-------------LKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE 107

Query: 290 SQVSAYTWQILNGLKYLHEQNVIHR 314
           SQV     Q+L GL+YLHE  +IHR
Sbjct: 108 SQVKCLMLQLLRGLQYLHENFIIHR 132

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 11/125 (8%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           P+GSG++G V   F T  G   A+K++S   +  Q      +  +E+ LL   +H+N++ 
Sbjct: 22  PVGSGAYGQVCSAFDTKTGRKVAIKKLS---RPFQSAIHAKRTYRELRLLKHMDHENVIG 78

Query: 256 ----YFGTEKDEN--KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
               +      E+   +Y+   L+    L  I +   L D  +    +QIL GLKY+H  
Sbjct: 79  LLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA 137

Query: 310 NVIHR 314
            +IHR
Sbjct: 138 GIIHR 142

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 29/119 (24%), Positives = 49/119 (41%), Gaps = 8/119 (6%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG FG V+ G        A+K +    +G   E   ++   E  ++ +  H N+VQ +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIE---EAKVMMKLSHPNLVQLY 65

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G    +  ++I  E +  G L    +E    L    +      +   ++YL     IHR
Sbjct: 66  GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 32/133 (24%), Positives = 60/133 (45%), Gaps = 20/133 (15%)

Query: 193 QKGAPLGSGSFGSVYEG-FTDDG----FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +K   LGSG+FG+VY+G +  +G       A+K +  ++   +  + +L    E  ++  
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEIL---DEAYVMAS 65

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQ----GSLAKIYQEYHLKDSQVSAYTW--QILN 301
            +H ++V+  G           ++L+TQ    G L    + +           W  QI  
Sbjct: 66  VDHPHVVRLLGICLSSQ-----VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120

Query: 302 GLKYLHEQNVIHR 314
           G+ YL E+ ++HR
Sbjct: 121 GMSYLEEKRLVHR 133

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 36/119 (30%), Positives = 58/119 (48%), Gaps = 3/119 (2%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V       DG F+AVK +  +    + EQ  +  E+ + LL   +H  +V  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61

Query: 257 FGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             + +  +KLY  L+ V  G L   + +E    + +   Y  +I + L YLH  N+I+R
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 34/126 (26%), Positives = 57/126 (45%), Gaps = 12/126 (9%)

Query: 198 LGSGSFGSVY---EGFTDDGFFFAV-KEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG GSFG+VY   +          V KE+ +   G       +Q  QE  LL + +H  I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV---GELNPNETVQANQEAQLLSKLDHPAI 64

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVSAYTWQILNGLKYLHE 308
           V++  +  + +   I  E      L    +E       L ++QV  +  Q+L G+ Y+H+
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 309 QNVIHR 314
           + ++HR
Sbjct: 125 RRILHR 130

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 34/120 (28%), Positives = 61/120 (50%), Gaps = 6/120 (5%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLE--QEISLLGQFEHDNIVQ 255
           LGSG+FG+V +G        + K V+++          L+ E  +E +++ Q ++  IV+
Sbjct: 3   LGSGNFGTVKKGMYK--MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             G  + E+   + +EL   G L K  Q+  H+ +  ++    Q+  G+KYL E N +HR
Sbjct: 61  MIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 33/124 (26%), Positives = 63/124 (50%), Gaps = 10/124 (8%)

Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSL-QDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           +G G F  VY      D    A+K+V + +    +  Q  ++   EI LL Q  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQEYHLK-----DSQVSAYTWQILNGLKYLHEQN 310
           Y  +  ++N+L I LEL   G L+++ + +  +     +  V  Y  Q+ + ++++H + 
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 311 VIHR 314
           V+HR
Sbjct: 127 VMHR 130

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 15/131 (11%)

Query: 196 APLGSGSFGSVYEG--FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ---FEH 250
           A +G G++G V++     + G F A+K V +Q   T  E   L   +E+++L     FEH
Sbjct: 7   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ---TGEEGMPLSTIREVAVLRHLETFEH 63

Query: 251 DNIVQYFGT-----EKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGL 303
            N+V+ F          E KL +  E V Q     + +  E  +    +    +Q+L GL
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 304 KYLHEQNVIHR 314
            +LH   V+HR
Sbjct: 124 DFLHSHRVVHR 134

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 39/129 (30%), Positives = 62/129 (48%), Gaps = 23/129 (17%)

Query: 198 LGSGSFGSV----YEGFTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLG 246
           LG GSFG V     +G TD+   +AVK    +V LQD   + T  E+ VL L        
Sbjct: 3   LGKGSFGKVLLAELKG-TDE--LYAVKVLKKDVILQDDDVECTMTEKRVLAL-------- 51

Query: 247 QFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKY 305
             +H  + Q     + +++L+  +E V  G L    Q      + +   Y  +I+ GL++
Sbjct: 52  AGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 306 LHEQNVIHR 314
           LHE+ +I+R
Sbjct: 112 LHERGIIYR 120

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 36/123 (29%), Positives = 55/123 (44%), Gaps = 10/123 (8%)

Query: 198 LGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G G FG V  G            A+K  +L+   +  ++  L    E S++GQF+H NI
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIK--TLKAGSSDKQR--LDFLTEASIMGQFDHPNI 67

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++  G       + I  E +  GSL K  +E        Q+      I +G+KYL E N 
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 312 IHR 314
           +HR
Sbjct: 128 VHR 130

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 11/145 (7%)

Query: 177 YNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSV 235
           Y   LN+        +Q   P+GSG++GSV   + T      AVK++S   Q     +  
Sbjct: 2   YRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT 61

Query: 236 LQLEQEISLLGQFEHDNIVQYF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKD 289
            +   E+ LL   +H+N++          + ++ N++Y+   L+    L  I +   L D
Sbjct: 62  YR---ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSD 117

Query: 290 SQVSAYTWQILNGLKYLHEQNVIHR 314
             V    +Q+L GLKY+H   +IHR
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHR 142

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 28/140 (20%)

Query: 198 LGSGSFGSVY--EGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G+FG V+  E +    T D    AVK  +L+D      +     ++E  LL   +H+
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 67

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSA 294
           +IV+++G   D + L +  E +  G L K  + +                  L  SQ+  
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 295 YTWQILNGLKYLHEQNVIHR 314
              QI +G+ YL  Q+ +HR
Sbjct: 128 IASQIASGMVYLASQHFVHR 147

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 47.2 bits (113), Expect = 5e-06
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 4/77 (5%)

Query: 241 EISLLGQF-EHDNIVQYFGTEKDENK--LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW 297
           EI  L +  +H NIV+     K EN   +Y+  E + +  L  + +   L+D       +
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMY 114

Query: 298 QILNGLKYLHEQNVIHR 314
           Q+L  LKY+H  NVIHR
Sbjct: 115 QLLKALKYIHSGNVIHR 131

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 46.8 bits (111), Expect = 5e-06
 Identities = 32/121 (26%), Positives = 60/121 (49%), Gaps = 7/121 (5%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+FG V+      D     +K++ ++ Q T+ E+   Q   E  +L    H NI++Y
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVE-QMTKDERLAAQ--NECQVLKLLSHPNIIEY 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           +    ++  L I +E    G+LA+  Q+     L +  +  +  QIL  L ++H + ++H
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124

Query: 314 R 314
           R
Sbjct: 125 R 125

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 12/123 (9%)

Query: 198 LGSGSFGS---VYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           +G GSFG    V    +D    +A+KE+ L    +  E S     +E  LL + +H NIV
Sbjct: 8   VGEGSFGRALLVQHVNSDQ--KYAMKEIRLPKSSSAVEDS----RKEAVLLAKMKHPNIV 61

Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTW--QILNGLKYLHEQNV 311
            +  + + +  LYI +E    G L  KI  +      + +   W  Q+  G++++HE+ V
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 312 IHR 314
           +HR
Sbjct: 122 LHR 124

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 14/149 (9%)

Query: 173 MELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQG 231
           M+  Y F+  +    ++  ++ G  LG+GSFG V        G ++A+K   L+ +    
Sbjct: 1   MKAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILK 58

Query: 232 EQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS- 290
            + V  + QE S+L +  H  IV    + +DEN++Y  LE V  G L       HL+ + 
Sbjct: 59  MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT-----HLRKAG 113

Query: 291 ----QVSA-YTWQILNGLKYLHEQNVIHR 314
                V+  Y  +++   +YLH +++I+R
Sbjct: 114 RFPNDVAKFYHAELVLAFEYLHSKDIIYR 142

Length = 329

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.0 bits (111), Expect = 7e-06
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 22/146 (15%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
           N+  R    S++ G  +G+GSFG VYE    D     A+K+V LQD   +         +
Sbjct: 58  NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYK--------NR 108

Query: 241 EISLLGQFEHDNIV---QYFGTEK-DENKLYIFLELVTQ--GSLAKIYQEYHLKDSQ--- 291
           E+ ++    H NI+    Y+ TE   +N+  IFL +V +        Y +++ +++    
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168

Query: 292 ---VSAYTWQILNGLKYLHEQNVIHR 314
              V  Y++Q+   L Y+H + + HR
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHR 194

Length = 440

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 19/140 (13%)

Query: 188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           ++  ++    LG G+FG VY+      G   A+K++ +     + +   +   +EI +L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH---NEKDGFPITALREIKILK 62

Query: 247 QFEHDNIVQ-----YFGTEKDENKLYIFLELVT-------QGSLAKIYQEYHLKDSQVSA 294
           + +H N+V          +K + K      +VT        G L        L +SQ+  
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLEN--PSVKLTESQIKC 119

Query: 295 YTWQILNGLKYLHEQNVIHR 314
           Y  Q+L G+ YLHE +++HR
Sbjct: 120 YMLQLLEGINYLHENHILHR 139

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 36/123 (29%), Positives = 62/123 (50%), Gaps = 14/123 (11%)

Query: 198 LGSGSFGSVYEG---FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G++ +VY+G    TD+    A+KE+ L+ +    E +     +E+SLL   +H NIV
Sbjct: 14  LGEGTYATVYKGRSKLTDN--LVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIV 67

Query: 255 ---QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  TEK    ++ +L+   +  L       ++ +  V  + +Q+L GL Y H + V
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKV 125

Query: 312 IHR 314
           +HR
Sbjct: 126 LHR 128

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V+         FFA+K    +V L D   + T  E+ VL L         +E
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL--------AWE 54

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD-SQVSAYTWQILNGLKYLHE 308
           H  +   + T + +  L+  +E +  G L    Q  H  D  + + Y  +I+ GL++LH 
Sbjct: 55  HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114

Query: 309 QNVIHR 314
           + +++R
Sbjct: 115 KGIVYR 120

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 32/134 (23%), Positives = 61/134 (45%), Gaps = 12/134 (8%)

Query: 183 EKYRRRIMSWQKGAPLGSGSFGSVYE-GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQE 241
           EKY       +K + +G GS+G V++    + G   A+K+    +     ++  L+   E
Sbjct: 1   EKY-------EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---E 50

Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQIL 300
           I +L Q +H N+V      + + KL++  E      L ++ +    + +  +    WQ L
Sbjct: 51  IRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTL 110

Query: 301 NGLKYLHEQNVIHR 314
             + + H+ N IHR
Sbjct: 111 QAVNFCHKHNCIHR 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 14/123 (11%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G +G VYEG +       AVK +       +    V +  +E +++ + +H N+VQ 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW-----QILNGLKYLHEQNV 311
            G    E   YI  E +T G+L    +E      +V+A        QI + ++YL ++N 
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKKNF 125

Query: 312 IHR 314
           IHR
Sbjct: 126 IHR 128

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 22/138 (15%)

Query: 191 SWQKGAPLGSGSFGSVYE-GFTDDGFFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLG 246
           +W+    +G G++G VY+     DG   AVK    +S  D+  + E ++LQ         
Sbjct: 23  TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN----- 77

Query: 247 QFEHDNIVQYFGT--EKDE---NKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYT 296
              H N+V+++G   + D+    +L++ LEL   GS+ ++ +        L ++ +S   
Sbjct: 78  ---HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 297 WQILNGLKYLHEQNVIHR 314
           +  L GL++LH   +IHR
Sbjct: 135 YGALLGLQHLHNNRIIHR 152

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 7/120 (5%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+FG V+ G    D    AVK      + T       +  QE  +L Q+ H NIV+ 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            G    +  +YI +ELV  G      +     LK  ++         G++YL  ++ IHR
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 37/129 (28%), Positives = 64/129 (49%), Gaps = 13/129 (10%)

Query: 197 PLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV- 254
            +GSG++GSV        G   A+K++S   +  Q E    +  +E++LL   +H+N++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 255 --QYFGTEKDENKLYIFLELV--TQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
               F +    ++   F  ++   Q  L KI   + L + +V    +Q+L GLKY+H   
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI-MGHPLSEDKVQYLVYQMLCGLKYIHSAG 137

Query: 311 VIHR---PG 316
           +IHR   PG
Sbjct: 138 IIHRDLKPG 146

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 3/119 (2%)

Query: 198 LGSGSFGSVY-EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V       DG F+AVK +  +    + EQ+ +  E+ + LL   +H  +V  
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61

Query: 257 FGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             + +   KLY  L+ V  G L   + +E    + +   Y  ++ + + YLH  N+I+R
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 14/125 (11%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG---EQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V+ G          KEV++  +  +    E+       E S++GQF H NI+
Sbjct: 13  IGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW-----QILNGLKYLHEQ 309
           +  G         I  E +  G+L K  ++    D + S+Y        I  G+KYL + 
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 310 NVIHR 314
           N +HR
Sbjct: 127 NYVHR 131

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 77

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 78  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135

Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHR 161

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V          FFA+K    +V L+D   + T  E+ VL L         +E
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL--------AWE 54

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHE 308
           H  +   F T + +  L+  +E +  G L    Q      +++   Y  +I+ GL++LH+
Sbjct: 55  HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 309 QNVIHR 314
           + +I+R
Sbjct: 115 KGIIYR 120

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 30/119 (25%), Positives = 53/119 (44%), Gaps = 8/119 (6%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +GSG FG V+ G+  +    A+K +       +G  S     +E  ++ +  H  +VQ +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHEQNVIHR 314
           G   + + + +  E +  G L+   +    K SQ +       +  G+ YL   NVIHR
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 25/79 (31%), Positives = 38/79 (48%), Gaps = 5/79 (6%)

Query: 241 EISLLGQFEHDNIVQ----YFGTEKDE-NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAY 295
           EI LL   +H+N++          ++  N +YI  EL+       I     L D     +
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYF 113

Query: 296 TWQILNGLKYLHEQNVIHR 314
            +Q+L GLKY+H  NV+HR
Sbjct: 114 LYQLLRGLKYIHSANVLHR 132

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 23/136 (16%)

Query: 188 RIMSWQKGAPLGSGSFG---SVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVL--QLEQEI 242
           R +  Q   P+G G+FG   S  +  T  G   A+K++ ++   T     VL  +  +E+
Sbjct: 11  RYVDLQ---PVGMGAFGLVCSARDQLT--GQNVAIKKI-MKPFST----PVLAKRTYREL 60

Query: 243 SLLGQFEHDNIVQ----YFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQ 298
            LL    H+NI+     +    +D   +Y   EL+    L ++     L+   +  + +Q
Sbjct: 61  KLLKHLRHENIISLSDIFISPLED---IYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQ 116

Query: 299 ILNGLKYLHEQNVIHR 314
           IL GLKY+H   V+HR
Sbjct: 117 ILRGLKYVHSAGVVHR 132

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 16/126 (12%)

Query: 198 LGSGSFGSVYEG-FTDDG---FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G+G FG V  G     G    F A+K +    +    E+       E S++GQF+H NI
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTL----KSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW-----QILNGLKYLHE 308
           +   G       + I  E +  G+L    +     D Q +          I  G+KYL E
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSE 124

Query: 309 QNVIHR 314
            N +HR
Sbjct: 125 MNYVHR 130

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 36/136 (26%), Positives = 64/136 (47%), Gaps = 20/136 (14%)

Query: 188 RIMSWQKGAPLGSGSFGSVYEG---FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           ++ ++ K   LG G++ +V++G    T++    A+KE+ L+ +    E +     +E+SL
Sbjct: 4   KMETYIKLEKLGEGTYATVFKGRSKLTEN--LVALKEIRLEHE----EGAPCTAIREVSL 57

Query: 245 LGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH------LKDSQVSAYTWQ 298
           L   +H NIV        +  L +  E      L K  ++Y       +    V  + +Q
Sbjct: 58  LKDLKHANIVTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 299 ILNGLKYLHEQNVIHR 314
           IL GL Y H + V+HR
Sbjct: 113 ILRGLAYCHRRKVLHR 128

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 27/120 (22%), Positives = 57/120 (47%), Gaps = 7/120 (5%)

Query: 198 LGSGSFGSVYE-GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+ G V++    + G   A+K+V+L+          L+   EI  L   +H  +V+ 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQHPYVVKL 64

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                  +   + +E +    L+++ ++    L ++QV +Y   +L G+ Y+H   ++HR
Sbjct: 65  LDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHR 123

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVY---EGFTDDGFFFAV--KEVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V       TD+ +   +  K+V +QD   + T  E+ VL L  +   L    
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL---- 63

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
                Q     +  ++LY  +E V  G L   I Q    K+     Y  +I  GL +LH 
Sbjct: 64  ----TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119

Query: 309 QNVIHR 314
           + +I+R
Sbjct: 120 KGIIYR 125

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 30/119 (25%), Positives = 54/119 (45%), Gaps = 8/119 (6%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V  G     +  A+K +       +G  S  +  +E  ++ +  H+ +VQ +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMKLSHEKLVQLY 65

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G    +  +YI  E ++ G L    +E+    + SQ+      +  G+ YL  +  IHR
Sbjct: 66  GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 30/125 (24%), Positives = 54/125 (43%), Gaps = 12/125 (9%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+FG+V +      G   AVK +         EQ  L ++ ++ +    +   IV++
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK--EQKRLLMDLDVVMRSS-DCPYIVKF 68

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIY------QEYHLKDSQVSAYTWQILNGLKYLHEQ- 309
           +G    E   +I +EL+   SL K Y       +  + +  +       +  L YL E+ 
Sbjct: 69  YGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127

Query: 310 NVIHR 314
            +IHR
Sbjct: 128 KIIHR 132

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 43.9 bits (103), Expect = 4e-05
 Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 25/137 (18%)

Query: 198 LGSGSFGSVY--EGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G+FG V+  E +      D    AVK  +L+D      +      +E  LL   +H+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 67

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--------------HLKDSQVSAYTW 297
           +IV+++G   + + L +  E +  G L K  + +               L  SQ+     
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 298 QILNGLKYLHEQNVIHR 314
           QI  G+ YL  Q+ +HR
Sbjct: 128 QIAAGMVYLASQHFVHR 144

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 40/146 (27%), Positives = 61/146 (41%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVY--EGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G FG V   E +       D     AVK   L+D  T  + + L  E E+  L+
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATDKDLADLISEMELMKLI 74

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-----------------EYHLK 288
           G+  H NI+   G    E  LY+ +E   +G+L +  +                 E  L 
Sbjct: 75  GK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              + +  +Q+  G++YL  +  IHR
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHR 158

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 31/149 (20%), Positives = 58/149 (38%), Gaps = 33/149 (22%)

Query: 195 GAPLGSGSFGSVY-------EGFTDDGFF----------FAVKEVSLQDQGTQGEQSVLQ 237
              LG G FG V+       + F++  F            AVK   L+   +   +    
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVK--VLRPDASDNARE--D 65

Query: 238 LEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW 297
             +E+ +L +    NI +  G    +  L + +E +  G L +  Q++  + S ++  + 
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 298 ------------QILNGLKYLHEQNVIHR 314
                       QI +G++YL   N +HR
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHR 154

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 32/133 (24%), Positives = 50/133 (37%), Gaps = 20/133 (15%)

Query: 198 LGSGSFGSVYEGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G FG V+                 VK  +LQ   T+ E    +  +E+ +  +  H 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVK--ALQK--TKDENLQSEFRRELDMFRKLSHK 68

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD----------SQVSAYTWQILN 301
           N+V+  G  ++    Y+ LE    G L +  +    KD           Q  A   QI  
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 302 GLKYLHEQNVIHR 314
           G+ +L     +HR
Sbjct: 129 GMDHLSNARFVHR 141

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V      + G  +AVK    +V LQD   + T  E+ +L L +         
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------- 54

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  + Q +   +  ++L+  +E V  G L   I +     +++   Y  +I + L +LH+
Sbjct: 55  HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114

Query: 309 QNVIHR 314
           + +I+R
Sbjct: 115 KGIIYR 120

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.4 bits (102), Expect = 7e-05
 Identities = 37/131 (28%), Positives = 59/131 (45%), Gaps = 16/131 (12%)

Query: 193 QKGAPLGSGSFGSVYEGF---TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           +K   LGSG FG+V++G      D     V   ++QD+   G Q+  ++   +  +G  +
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD 67

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQ----GSLAKIYQEYHLKDSQVSAYTW--QILNGL 303
           H  IV+  G     +     L+LVTQ    GSL    +++           W  QI  G+
Sbjct: 68  HAYIVRLLGICPGAS-----LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 304 KYLHEQNVIHR 314
            YL E  ++HR
Sbjct: 123 YYLEEHRMVHR 133

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 12/130 (9%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +Q+  P+GSG+ G V   F T  G   AVK++S   +  Q +    +  +E+ LL    H
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLKCVNH 79

Query: 251 DNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLK 304
            NI+          + ++   +Y+ +EL+       I+ E  L   ++S   +Q+L G+K
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQMLCGIK 137

Query: 305 YLHEQNVIHR 314
           +LH   +IHR
Sbjct: 138 HLHSAGIIHR 147

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 21/130 (16%)

Query: 198 LGSGSFGSVY----EGFTDDGFFFAVKEVS----LQDQGTQ----GEQSVLQLEQEISLL 245
           LG+G++G V+     G  D G  +A+K +     +Q   T      E+ VL+  +    L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLK 304
                   V      + + KL++ L+ V  G L   +YQ  H  +S+V  Y  +I+  L 
Sbjct: 68  --------VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119

Query: 305 YLHEQNVIHR 314
           +LH+  +I+R
Sbjct: 120 HLHQLGIIYR 129

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVY--------EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G FG V         +   +     AVK   L+D  T  + S L  E E+  ++
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK--MLKDDATDKDLSDLVSEMEMMKMI 74

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-----------------EYHLK 288
           G+  H NI+   G    +  LY+ +E  ++G+L +  +                 E  L 
Sbjct: 75  GK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              + +  +Q+  G++YL  Q  IHR
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHR 158

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 24/89 (26%), Positives = 42/89 (47%), Gaps = 27/89 (30%)

Query: 241 EISLLGQFEHDNIVQY----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD------- 289
           EI++L + +H NIV       G   + +K+Y+ +E          Y E+ LK        
Sbjct: 54  EINILLKLQHPNIVTVKEVVVG--SNLDKIYMVME----------YVEHDLKSLMETMKQ 101

Query: 290 ----SQVSAYTWQILNGLKYLHEQNVIHR 314
               S+V     Q+L+G+ +LH+  ++HR
Sbjct: 102 PFLQSEVKCLMLQLLSGVAHLHDNWILHR 130

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 32/124 (25%), Positives = 62/124 (50%), Gaps = 9/124 (7%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI-- 253
            +GSG++G+V        G   A+K++    +  Q E    +  +E+ LL   +H+N+  
Sbjct: 22  QVGSGAYGTVCSALDRRTGAKVAIKKLY---RPFQSELFAKRAYRELRLLKHMKHENVIG 78

Query: 254 -VQYFGTEKDENKLYIF-LELVTQGS-LAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
            +  F  +   ++ + F L +   G+ L K+ +   L + ++    +Q+L GLKY+H   
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG 138

Query: 311 VIHR 314
           +IHR
Sbjct: 139 IIHR 142

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 3/119 (2%)

Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V       DG  +AVK +  +    + EQ  +  E+ + LL   +H  +V  
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61

Query: 257 FGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             + +   KLY  L+ V  G L   + +E    + +   Y  +I + L YLH  N+++R
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 36/153 (23%), Positives = 59/153 (38%), Gaps = 35/153 (22%)

Query: 193 QKGAPLGSGSFGSVYEGFTDD-----GFF-FAVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
             G  LG G FG V +          G+   AVK   L++  +  E  +  L  E +LL 
Sbjct: 3   VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK--MLKENASSSE--LRDLLSEFNLLK 58

Query: 247 QFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-------------------- 286
           Q  H ++++ +G    +  L + +E    GSL    +E                      
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 287 -----LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                L    + ++ WQI  G++YL E  ++HR
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 33/138 (23%), Positives = 67/138 (48%), Gaps = 22/138 (15%)

Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLG 246
           +W+    +G G++G V++     +G   AVK    +   D+  + E ++L+         
Sbjct: 19  TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK--------A 70

Query: 247 QFEHDNIVQYFGT-----EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS----AYTW 297
             +H N+V+++G       K+ ++L++ LEL   GS+  + + +  +  ++     AY  
Sbjct: 71  LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130

Query: 298 -QILNGLKYLHEQNVIHR 314
            + L GL++LH    IHR
Sbjct: 131 HEALMGLQHLHVNKTIHR 148

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 39/144 (27%), Positives = 70/144 (48%), Gaps = 22/144 (15%)

Query: 188 RIMSWQKGAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R+  ++    +G+G FG V+      T +  FF  K +S +  G + E+   QL  E+++
Sbjct: 11  RLNEYEVIKKIGNGRFGEVFLVKHKRTQE--FFCWKAISYR--GLK-EREKSQLVIEVNV 65

Query: 245 LGQFEHDNIVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVSAYTW 297
           + + +H NIV+Y      K   KLYI +E    G L++  Q+ +     +++  +   T 
Sbjct: 66  MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 298 QILNGLKYLHE-------QNVIHR 314
           Q+L+ L Y H        + V+HR
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHR 149

Length = 1021

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 37/132 (28%), Positives = 58/132 (43%), Gaps = 18/132 (13%)

Query: 196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG---QFEHD 251
           A +G G++G+VY+      G F A+K V +Q   T  +   L   +E++LL     F+H 
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQ---TNEDGLPLSTVREVALLKRLEAFDHP 62

Query: 252 NIVQYFGT-----EKDENKLYIFLELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNG 302
           NIV+            E K+ +  E V Q    + Y +      L    +     Q L G
Sbjct: 63  NIVRLMDVCATSRTDRETKVTLVFEHVDQD--LRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 303 LKYLHEQNVIHR 314
           L +LH   ++HR
Sbjct: 121 LDFLHANCIVHR 132

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 2/76 (2%)

Query: 241 EISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQ 298
           E   LGQF+H NIV+  G     N + I  E ++ G+L    +  E  L   Q+      
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115

Query: 299 ILNGLKYLHEQNVIHR 314
           + +G+KYL E   +H+
Sbjct: 116 LASGMKYLSEMGYVHK 131

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 33/137 (24%), Positives = 63/137 (45%), Gaps = 22/137 (16%)

Query: 188 RIMSWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           ++ ++ K   LG G++ +V++G +       A+KE+ L+ +    E +     +E+SLL 
Sbjct: 3   KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE----EGAPCTAIREVSLLK 58

Query: 247 QFEHDNIVQYFGTEKDENKLYIFLELVTQ---------GSLAKIYQEYHLKDSQVSAYTW 297
             +H NIV        E  L +  E +           G+L  ++         V  + +
Sbjct: 59  NLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--------VKIFMF 110

Query: 298 QILNGLKYLHEQNVIHR 314
           Q+L GL Y H++ ++HR
Sbjct: 111 QLLRGLSYCHKRKILHR 127

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 31/130 (23%), Positives = 65/130 (50%), Gaps = 21/130 (16%)

Query: 198 LGSGSFGSVY----EGFTDDGFFFAVK--------EVSLQDQGTQGEQSVLQLEQEISLL 245
           LG+G++G V+        D G  +A+K        + +   + T+ E++VL+  ++   L
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLK 304
               +      F TE    KL++ L+ V+ G +   +YQ  +  + +V  Y+ +I+  L+
Sbjct: 68  VTLHYA-----FQTEA---KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119

Query: 305 YLHEQNVIHR 314
           +LH+  +++R
Sbjct: 120 HLHKLGIVYR 129

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 17/133 (12%)

Query: 194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSL-QDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           +G  +G G++G VY+    DG     KE +L Q +GT    S  +   EI+LL + +H N
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACR---EIALLRELKHPN 59

Query: 253 IV--QYFGTEKDENKLYIFLELVTQG--SLAKIY-------QEYHLKDSQVSAYTWQILN 301
           ++  Q       + K+++  +        + K +       +   L  S V +  +QIL+
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119

Query: 302 GLKYLHEQNVIHR 314
           G+ YLH   V+HR
Sbjct: 120 GIHYLHANWVLHR 132

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 17/130 (13%)

Query: 198 LGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G VY+    D G   A+K+V L ++    E   +   +EI +L Q  H NIV  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNL 71

Query: 257 ----------FGTEKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLK 304
                        +KD+   Y+  E +    L  + +    H  +  + ++  Q+L GL 
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 305 YLHEQNVIHR 314
           Y H++N +HR
Sbjct: 131 YCHKKNFLHR 140

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 41.0 bits (96), Expect = 3e-04
 Identities = 30/119 (25%), Positives = 53/119 (44%), Gaps = 8/119 (6%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG FG V+ G        A+K +   ++G   E+  ++   E  ++ +  H  +VQ +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIE---EAKVMMKLSHPKLVQLY 65

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G    +  LYI  E +  G L    ++    L    + +    +  G++YL   + IHR
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 37/132 (28%), Positives = 56/132 (42%), Gaps = 14/132 (10%)

Query: 193 QKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
             G  LG+G+FG V E        +D     AVK   L+      E+  L  E +I S L
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK--MLKPTAHSSEREALMSELKIMSHL 95

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ---EYHLKDSQVSAYTWQILNG 302
           G   H+NIV   G       + +  E    G L    +   E  L    + ++++Q+  G
Sbjct: 96  GN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 303 LKYLHEQNVIHR 314
           + +L  +N IHR
Sbjct: 154 MAFLASKNCIHR 165

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 33/124 (26%), Positives = 64/124 (51%), Gaps = 14/124 (11%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVK----EVSLQDQGTQGEQSVL-QLEQEISLLGQFEHDN 252
           LGSG+FG V +G       + ++    +V+++    + E+SV  ++ +E  ++ Q ++  
Sbjct: 3   LGSGNFGCVKKGV------YKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIY--QEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           IV+  G  + E  L + +E+ + G L K    ++  +  S V     Q+  G+KYL  +N
Sbjct: 57  IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 311 VIHR 314
            +HR
Sbjct: 116 FVHR 119

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 34/126 (26%), Positives = 60/126 (47%), Gaps = 15/126 (11%)

Query: 198 LGSGSFGSVYE-GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G++G V +      G   AVK +  ++  Q    EQ  L ++ +IS+    +    V
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----EQKRLLMDLDISMRSV-DCPYTV 63

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQV-----SAYTWQILNGLKYLHEQ 309
            ++G    E  ++I +E++   SL K Y++ + K   +           I+  L+YLH +
Sbjct: 64  TFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122

Query: 310 -NVIHR 314
            +VIHR
Sbjct: 123 LSVIHR 128

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 36/144 (25%), Positives = 61/144 (42%), Gaps = 28/144 (19%)

Query: 195 GAPLGSGSFGSVYEG------FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V +         ++    AVK   L+D  T+ + S L  E E+  ++G+
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK-------IYQEYHLKDSQVS------- 293
             H NI+   G    E  LY+ +E    G+L           +     D +         
Sbjct: 75  --HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              ++ +Q+  G+++L  +  IHR
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHR 156

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 40.3 bits (94), Expect = 6e-04
 Identities = 33/124 (26%), Positives = 62/124 (50%), Gaps = 14/124 (11%)

Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +G G FG+V +G +T  G   AVK +          Q+ L+   E +++ +  H N+
Sbjct: 11  GEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTA----QAFLE---ETAVMTKLHHKNL 61

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQ---EYHLKDSQVSAYTWQILNGLKYLHEQN 310
           V+  G     N LYI +EL+++G+L    +      +   Q+  ++  +  G++YL  + 
Sbjct: 62  VRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120

Query: 311 VIHR 314
           ++HR
Sbjct: 121 LVHR 124

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 34/149 (22%), Positives = 64/149 (42%), Gaps = 21/149 (14%)

Query: 180 SLNEKYRRRIMSWQKGAPLGSGSFGSVYEG---FTDDGFFFAVKEVSLQDQGTQGEQSVL 236
                +   +  ++K A +G G+FG V++     T      A+K+V L +   +G   + 
Sbjct: 2   QYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQ--IVALKKV-LMENEKEG-FPIT 57

Query: 237 QLEQEISLLGQFEHDNIVQYF--------GTEKDENKLYIFLELVTQ---GSLAKIYQEY 285
            L +EI +L   +H+N+V              + +   Y+  E       G L+    ++
Sbjct: 58  AL-REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF 116

Query: 286 HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            L  S++      +LNGL Y+H   ++HR
Sbjct: 117 TL--SEIKKVMKMLLNGLYYIHRNKILHR 143

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 40.3 bits (94), Expect = 7e-04
 Identities = 32/118 (27%), Positives = 50/118 (42%), Gaps = 1/118 (0%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+GSFG V      +  F  V     +      ++ V  +  E  +L    H   V  +
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQNVIHR 314
           G+ KDE+ LY+ LE V  G      +      + V   Y  QI+   +YL   N+++R
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155

Length = 340

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.5 bits (94), Expect = 8e-04
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 16/132 (12%)

Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 73

Query: 249 EHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+          + ++   +Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 74  NHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 131

Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 132 IKHLHSAGIIHR 143

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 40.4 bits (94), Expect = 9e-04
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 16/147 (10%)

Query: 177 YNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQ 233
           Y+  + +     +  +Q   P+GSG+ G V   +  D       A+K++S   +  Q + 
Sbjct: 11  YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQT 65

Query: 234 SVLQLEQEISLLGQFEHDNIV---QYFGTEK---DENKLYIFLELVTQGSLAKIYQEYHL 287
              +  +E+ L+    H NI+     F  +K   +   +YI +EL+   +L ++ Q   L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MEL 123

Query: 288 KDSQVSAYTWQILNGLKYLHEQNVIHR 314
              ++S   +Q+L G+K+LH   +IHR
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHR 150

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 33/124 (26%), Positives = 58/124 (46%), Gaps = 13/124 (10%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V       +  F+AVK +  +    + E+  +  E+ + LL   +H  +V  
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 61

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLK------DSQVSAYTWQILNGLKYLHEQN 310
             + +  +KLY  L+ +  G L      YHL+      + +   Y  +I + L YLH  N
Sbjct: 62  HFSFQTADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHSLN 116

Query: 311 VIHR 314
           +++R
Sbjct: 117 IVYR 120

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 31/153 (20%)

Query: 184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           K R  ++ W+    LG G+FG V+           D    AVK  +L++     E +   
Sbjct: 3   KRRDIVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEAS---ESARQD 53

Query: 238 LEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL----------AKIYQEYH- 286
            ++E  LL   +H +IV+++G   +   L +  E +  G L          AKI      
Sbjct: 54  FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113

Query: 287 -----LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                L   Q+ A   QI +G+ YL   + +HR
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLHFVHR 146

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 33/127 (25%), Positives = 55/127 (43%), Gaps = 18/127 (14%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQD-------QGTQGEQSVLQLEQEISLLGQF 248
           P+  G+FG VY G   ++   +AVK V   D          Q E+  L L +       F
Sbjct: 11  PISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-----PF 65

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLH 307
               IV  + + +  N +Y+ +E +  G +  +   Y   D +++  Y  ++   L YLH
Sbjct: 66  ----IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 308 EQNVIHR 314
              +IHR
Sbjct: 122 RHGIIHR 128

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 39.7 bits (92), Expect = 0.001
 Identities = 29/120 (24%), Positives = 54/120 (45%), Gaps = 4/120 (3%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LGSG+FG+VY+G +  +G    +         T G ++ ++   E  ++   +H ++V+ 
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--QILNGLKYLHEQNVIHR 314
            G       + +  +L+  G L     E+           W  QI  G+ YL E+ ++HR
Sbjct: 75  LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVY--EGFTDDG------FFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G FG V   E    D          AVK   L+   T+ + S L  E E+  ++
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK--MLKSDATEKDLSDLISEMEMMKMI 80

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EY-----HLKDSQVS 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY      + + Q+S
Sbjct: 81  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138

Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                +  +Q+  G++YL  +  IHR
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHR 164

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 34/121 (28%), Positives = 50/121 (41%), Gaps = 12/121 (9%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G FG V  G    G   AVK +   D   Q          E S++ Q  H N+VQ  
Sbjct: 14  IGKGEFGDVMLG-DYRGNKVAVKCIK-NDATAQA------FLAEASVMTQLRHSNLVQLL 65

Query: 258 GTEKDEN-KLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIH 313
           G   +E   LYI  E + +GSL    +      L    +  ++  +   ++YL   N +H
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125

Query: 314 R 314
           R
Sbjct: 126 R 126

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 25/137 (18%)

Query: 194 KGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +G  +G G++G VY+    DG     +A+K++    +GT    S  +   EI+LL + +H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACR---EIALLRELKH 57

Query: 251 DNIV---QYFGTEKD----------ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW 297
            N++   + F +  D          E+ L+  ++        K  +   L    V +  +
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK--KPVQLPRGMVKSLLY 115

Query: 298 QILNGLKYLHEQNVIHR 314
           QIL+G+ YLH   V+HR
Sbjct: 116 QILDGIHYLHANWVLHR 132

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQ 255
           +G G+F  V +      G ++A+K   ++      EQ V  L +EI  L +   H NI++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKC--MKKHFKSLEQ-VNNL-REIQALRRLSPHPNILR 62

Query: 256 YFGTEKDE--NKLYIFLELVTQGSLAKIY-----QEYHLKDSQVSAYTWQILNGLKYLHE 308
                 D    +L +  EL+       +Y     ++  L + +V +Y +Q+L  L ++H 
Sbjct: 63  LIEVLFDRKTGRLALVFELMDM----NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118

Query: 309 QNVIHR 314
             + HR
Sbjct: 119 NGIFHR 124

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 17/62 (27%), Positives = 31/62 (50%)

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           +VQ F   +D+  LY+ +E +  G L  +   Y + +     YT +++  L  +H   +I
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164

Query: 313 HR 314
           HR
Sbjct: 165 HR 166

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 22/76 (28%), Positives = 36/76 (47%), Gaps = 2/76 (2%)

Query: 241 EISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQ 298
           E S++GQF+H NI+   G       + I  E +  GSL    +++       Q+      
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG 114

Query: 299 ILNGLKYLHEQNVIHR 314
           I +G+KYL +   +HR
Sbjct: 115 IASGMKYLSDMGYVHR 130

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 26/86 (30%), Positives = 39/86 (45%), Gaps = 9/86 (10%)

Query: 198 LGSGSFGSVYEGF-----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG  +FG +Y+G       D     A+K  +L+D      Q   + +QE SL+ +  H N
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKD--INNPQQWGEFQQEASLMAELHHPN 68

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSL 278
           IV   G    E  + +  E + QG L
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDL 94

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	317
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.95
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.93
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.93
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.92
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.91
KOG0605	550	consensus NDR and related serine/threonine kinases	99.91
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.9
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.9
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.9
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.89
KOG0610	459	consensus Putative serine/threonine protein kinase	99.89
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.89
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.89
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.88
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.88
KOG0198	313	consensus MEKK and related serine/threonine protei	99.88
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.88
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.88
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.88
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.88
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.88
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.88
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.88
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.87
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.87
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.87
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.87
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.87
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.87
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.87
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.87
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.87
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.87
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.87
PF12515	47	CaATP_NAI: Ca2+-ATPase N terminal autoinhibitory d	99.87
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.87
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.87
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.86
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.86
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.86
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.86
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.86
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.86
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.86
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.86
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.86
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.86
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.85
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.85
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.85
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.85
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.85
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.85
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.85
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.85
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.85
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.85
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.85
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.85
KOG0589	426	consensus Serine/threonine protein kinase [General	99.85
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.84
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.84
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.84
KOG0578	550	consensus p21-activated serine/threonine protein k	99.84
KOG0586	596	consensus Serine/threonine protein kinase [General	99.84
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.84
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.84
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.84
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.84
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.84
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.84
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.84
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.83
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.83
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.83
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.83
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.83
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.83
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.83
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.83
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.83
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.83
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.83
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.83
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.83
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.83
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.83
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.83
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.83
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.83
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.83
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.83
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.83
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.83
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.83
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.83
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.83
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.83
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.83
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.83
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.83
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.83
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.82
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.82
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.82
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.82
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.82
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.82
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.82
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.82
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.82
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.82
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.82
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.82
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.82
PTZ00267	478	NIMA-related protein kinase; Provisional	99.82
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.82
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.82
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.82
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.82
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.82
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.82
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.82
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.82
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.82
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.82
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.81
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.81
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.81
PHA03212	391	serine/threonine kinase US3; Provisional	99.81
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.81
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.81
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.81
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.81
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.81
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.81
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.81
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.81
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.81
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.81
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.81
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.81
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.81
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.81
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.81
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.81
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.81
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.81
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.81
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.81
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.81
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.81
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.81
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.81
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.81
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.81
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.81
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.8
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.8
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.8
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.8
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.8
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.8
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.8
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.8
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.8
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.8
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.8
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.8
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.8
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.8
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.8
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.8
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.8
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.8
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.8
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.8
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.8
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.8
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.8
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.8
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.8
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.8
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.8
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.8
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.8
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.8
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.79
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.79
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.79
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.79
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.79
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.79
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.79
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.79
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.79
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.79
PHA03209	357	serine/threonine kinase US3; Provisional	99.79
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.79
PTZ00283	496	serine/threonine protein kinase; Provisional	99.79
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.79
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.79
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.79
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.79
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.79
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.79
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.79
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.79
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.79
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.79
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.79
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.79
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.79
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.79
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.79
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.79
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.79
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.79
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.79
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.79
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.79
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.79
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.79
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.79
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.79
PTZ00036	440	glycogen synthase kinase; Provisional	99.78
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.78
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.78
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.78
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.78
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.78
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.78
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.78
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.78
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.78
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.78
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.78
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.78
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.78
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.78
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.78
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.78
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.78
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.78
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.78
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.78
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.78
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.78
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.78
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.78
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.78
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.78
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.78
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.78
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.78
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.77
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.77
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.77
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.77
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.77
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.77
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.77
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.77
PHA03211	461	serine/threonine kinase US3; Provisional	99.77
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.77
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.77
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.77
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.77
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.77
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.77
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.77
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.77
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.77
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.77
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.77
PLN00009	294	cyclin-dependent kinase A; Provisional	99.77
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.77
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.77
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.77
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.77
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.77
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.77
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.77
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.77
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.77
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.77
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.77
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.77
PHA02988	283	hypothetical protein; Provisional	99.77
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.77
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.76
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.76
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.76
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.76
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.76
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.76
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.76
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.76
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.76
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.76
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.76
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.76
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.76
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.76
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.76
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.76
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.76
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.76
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.76
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.76
PHA03207	392	serine/threonine kinase US3; Provisional	99.76
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.76
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.76
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.76
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.76
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.76
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.76
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.75
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.75
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.75
KOG0584	632	consensus Serine/threonine protein kinase [General	99.75
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.75
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.75
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.75
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.75
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.75
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.75
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.75
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.75
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.74
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.74
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.74
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.74
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.74
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.74
PTZ00284	467	protein kinase; Provisional	99.74
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.74
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.74
PRK09188	365	serine/threonine protein kinase; Provisional	99.74
KOG1152	772	consensus Signal transduction serine/threonine kin	99.74
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.74
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.73
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.73
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.73
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.73
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.73
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.73
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.73
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.73
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.73
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.72
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.72
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.72
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.71
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.71
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.71
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.71
PHA03210	501	serine/threonine kinase US3; Provisional	99.71
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.71
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.71
PRK10345	210	hypothetical protein; Provisional	99.71
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.71
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.71
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.71
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.71
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.7
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.7
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.7
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.7
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.69
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.69
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.69
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.69
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.69
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.68
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.68
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.67
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.67
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.67
KOG3653	534	consensus Transforming growth factor beta/activin	99.66
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.66
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.65
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.65
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.65
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.65
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.64
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.63
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.62
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.62
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.62
PHA02882	294	putative serine/threonine kinase; Provisional	99.61
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.61
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.57
PRK14879	211	serine/threonine protein kinase; Provisional	99.56
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.56
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.56
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.56
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.55
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.55
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.55
smart00090	237	RIO RIO-like kinase.	99.55
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.55
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.54
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.54
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.53
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.47
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.47
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.46
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.45
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.45
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.45
PRK12274	218	serine/threonine protein kinase; Provisional	99.41
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.41
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.41
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.39
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.35
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.35
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.32
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.3
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.27
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.2
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.06
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.04
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.96
KOG0204	1034	consensus Calcium transporting ATPase [Inorganic i	98.95
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.83
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.75
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.72
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.71
PLN00181	793	protein SPA1-RELATED; Provisional	98.64
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.63
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.63
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.63
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.36
KOG1243	690	consensus Protein kinase [General function predict	98.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.35
KOG3087	229	consensus Serine/threonine protein kinase [General	98.31
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.13
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.04
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.02
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.02
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	97.76
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.73
PRK09902	216	hypothetical protein; Provisional	97.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	97.64
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.59
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.5
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.42
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	97.34
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.18
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.16
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.07
PF01636	239	APH: Phosphotransferase enzyme family This family	96.98
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	96.92
PLN02876	822	acyl-CoA dehydrogenase	96.9
PRK10593	297	hypothetical protein; Provisional	96.85
COG0661	517	AarF Predicted unusual protein kinase [General fun	96.68
KOG2270	520	consensus Serine/threonine protein kinase involved	96.65
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.42
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.36
KOG0606	1205	consensus Microtubule-associated serine/threonine	95.97
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	95.78
PRK09550	401	mtnK methylthioribose kinase; Reviewed	94.9
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.89
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	92.38
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	92.13
KOG0576	829	consensus Mitogen-activated protein kinase kinase	91.3
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	91.2
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	90.01
PLN02756	418	S-methyl-5-thioribose kinase	89.23
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	86.94
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	86.26
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	86.03
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	84.71
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	82.79
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	82.59
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	81.04
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	80.9
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	80.82
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	80.82
PRK05231	319	homoserine kinase; Provisional	80.17

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=9.6e-28  Score=219.41  Aligned_cols=127  Identities=28%  Similarity=0.483  Sum_probs=117.8

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+...||.|+||+||+|++ .++..||||.+.+..   -.....+.+..|+.+|+.++|||||.+++++.+++.+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~---l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK---LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc---cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            467899999999999999999999 888999999997542   2556778899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||||.||+|.++++.. .+++..+..++.||+.||++||+++|||||||
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLK  136 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLK  136 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence            9999999999999999876 69999999999999999999999999999998

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=5.2e-26  Score=208.13  Aligned_cols=130  Identities=26%  Similarity=0.325  Sum_probs=113.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccH--HHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGE--QSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ..+.|.+.+.||+|+||.|-+|.. .+|+.||||++.++.....+.  .....+.+|+++|++|+|||||+++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456678899999999999999988 999999999998765443222  12233579999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..||||||+.||+|.+.+-. +.+.+..-..++.||+.|+.|||++||+|||||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiK  303 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIK  303 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCC
Confidence            99999999999999997754 458888889999999999999999999999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.8e-25  Score=211.96  Aligned_cols=126  Identities=33%  Similarity=0.529  Sum_probs=116.7

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..|..++.||+|||+.||.+++ .+|..||+|++++..  .......+.+.+|+++.+.|+|||||+++++|++.+++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~--l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL--LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH--hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            4599999999999999999999 999999999998654  3345567889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|+|+.++|..+++.. .+++.++..++.||+.||.|||+++|||||||
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLK  145 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLK  145 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccc
Confidence            99999999999999754 59999999999999999999999999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-25  Score=199.99  Aligned_cols=129  Identities=25%  Similarity=0.358  Sum_probs=118.0

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.++++||+|+||.||.++. .+++.||+|++++....  ..........|..+|..++||+||.++..|+++..
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv--~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV--EKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh--hhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            4467899999999999999999998 89999999999876532  33456778899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|+||++||+|...|++ +.|++..+..|+.+|+.||.|||++||||||||
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlK  152 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLK  152 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            9999999999999999985 569999999999999999999999999999998

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.6e-24  Score=202.80  Aligned_cols=129  Identities=26%  Similarity=0.495  Sum_probs=115.1

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .+...+.|..++.||+|+||.||++++ .+|+.||+|.++....   .+....-..+||.+|++|+||||+++.+.....
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~---~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE---KEGFPITAIREIKILRRLDHPNIIKLEEIVTSK  188 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC---CCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence            345567899999999999999999999 9999999999986532   334455677999999999999999999999876


Q ss_pred             --CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 --NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 --~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        +.+|||+|||+. ||.-++...  +|++.++.+|+.||+.||+|||++||+|||||
T Consensus       189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK  245 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIK  245 (560)
T ss_pred             CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeecccc
Confidence              789999999977 999999876  59999999999999999999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.91  E-value=4.4e-24  Score=201.14  Aligned_cols=130  Identities=19%  Similarity=0.333  Sum_probs=118.8

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      +..+++|.++.+||+|+||.||+|+. .+|..||+|++++..  -.....+..+..|-.+|...++|+||+++..|++..
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~--M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSE--MLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHH--HHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            45788999999999999999999998 899999999998754  233455677889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++||||||+|||++..+|... .+++..+.+|+.+++.|++.||..|+||||||
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIK  268 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIK  268 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCC
Confidence            999999999999999988765 49999999999999999999999999999998

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.90  E-value=2e-23  Score=189.35  Aligned_cols=126  Identities=26%  Similarity=0.426  Sum_probs=114.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC-E
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN-K  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~  265 (317)
                      ..++.+.+..||+|..|+||+|.+ .+++.+|+|++..    ..++...+++.+|++++..++||+||.+||+|..++ .
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            345666789999999999999999 8999999999954    445677888999999999999999999999999998 5


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      ++|+||||.||+|.+++.. +++++.....++.+|++||.|||. .+|||||||
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIK  206 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIK  206 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCC
Confidence            9999999999999999875 569999999999999999999996 899999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=3.8e-24  Score=195.61  Aligned_cols=127  Identities=23%  Similarity=0.461  Sum_probs=118.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..+|.+.+.||+|+||.|-++.. ..|+.||||.+++..  ..+++..-.+.+|+++|+.|+||||++++.+|...+.+.
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            35788999999999999999988 899999999998654  456777888999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||..+|.|++|+... .+++.++..++.||..|+.|+|.+++||||||
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLK  180 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLK  180 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccc
Confidence            999999999999999765 59999999999999999999999999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.7e-23  Score=193.21  Aligned_cols=131  Identities=26%  Similarity=0.410  Sum_probs=114.9

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCC
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDEN  264 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~  264 (317)
                      ...+.|.+++.||+|+||.|+.|.+ .++..||+|++.............+.+.+|+.+++.+. ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4577999999999999999999988 88999999977654221111234456668999999998 999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||.||+|.+++.+ +++.+..+..++.|++.|++|||++||+|||||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK  147 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLK  147 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence            99999999999999999877 669999999999999999999999999999998

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-23  Score=198.37  Aligned_cols=130  Identities=28%  Similarity=0.443  Sum_probs=116.0

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      +....+|..++.||.|+|++|++|++ .+++.||||++.+...  ..+.-..-+..|-.+|..| +||.|++++..|++.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I--ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI--IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH--HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence            45678999999999999999999998 8999999999976542  2233345567788888888 899999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+|+|+||+++|+|.++|+..+ |++..+++|+.||+.||+|||++||||||||
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlK  201 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLK  201 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCC
Confidence            99999999999999999998765 9999999999999999999999999999998

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=2.4e-23  Score=190.94  Aligned_cols=129  Identities=19%  Similarity=0.307  Sum_probs=116.1

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...+.|++++.||+|.-|+||+|+. .++..+|+|++.+..  ........+...|-+||+.++||+++.+|..|+.+..
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~--l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES--LASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH--HhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            3456788999999999999999988 778999999997653  2234556778889999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .|++||||+||+|..+++..+   |++..+++|+.+++.||+|||..|||+||||
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLK  206 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLK  206 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCC
Confidence            999999999999999998653   9999999999999999999999999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.89  E-value=4.4e-23  Score=182.11  Aligned_cols=129  Identities=26%  Similarity=0.414  Sum_probs=118.1

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+++|..+..||.|+||.|.+++. .+|..||+|++.+..  .......+...+|..+|+.+.||+++.+++.|.+.++
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~--vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK--VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH--HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            4578899999999999999999998 889999999997653  3344566778899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||||++||.|..++++ ++|++..+++|+.||+.||+|||+++|++||||
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLK  171 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLK  171 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCC
Confidence            9999999999999999976 469999999999999999999999999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.89  E-value=8.7e-23  Score=191.30  Aligned_cols=126  Identities=33%  Similarity=0.437  Sum_probs=108.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC-EEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN-KLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~  267 (317)
                      ...+.+...||+|+||+||++.+.....||+|.+.....   +......|.+|+.+|.+++|||||+++|++..+. .++
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~---~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDF---DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhc---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            344456667999999999999665544599999975432   2223778999999999999999999999999887 799


Q ss_pred             EEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQN-VIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~g-IvHrDLK  317 (317)
                      |||||+++|+|..++..   ..+++..+..++.||+.||.|||+++ |||||||
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK  170 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLK  170 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccC
Confidence            99999999999999966   46999999999999999999999999 9999998

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.4e-22  Score=188.15  Aligned_cols=126  Identities=20%  Similarity=0.371  Sum_probs=112.1

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||+|.+ .++..||||++....  .........+..|+.++..++||||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE--MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            4789999999999999999998 789999999997432  1123345567889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||+||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk  128 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK  128 (364)
T ss_pred             EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence            99999999999988654 58999999999999999999999999999998

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.7e-22  Score=189.01  Aligned_cols=126  Identities=19%  Similarity=0.345  Sum_probs=111.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+++.||+|+||.||++.+ .+++.||+|++....  .........+..|+.++..++||||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE--MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            4688999999999999999988 889999999986432  1123345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++||+|.+++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlk  128 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK  128 (377)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            99999999999988654 58999999999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-22  Score=182.99  Aligned_cols=124  Identities=42%  Similarity=0.719  Sum_probs=109.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC--E
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN--K  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~  265 (317)
                      ..+|..++.||+|+||.||++.. .+|..+|||.+....    ... .+.+.+|+.+|.+++|||||+++|......  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            45677899999999999999998 679999999987541    111 677899999999999999999999754444  7


Q ss_pred             EEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++|||+++|+|.+++.+.+  +++..+..++.|+++||.|||++||||||||
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK  144 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIK  144 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcc
Confidence            999999999999999998764  9999999999999999999999999999998

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.88  E-value=5.2e-22  Score=187.17  Aligned_cols=126  Identities=21%  Similarity=0.337  Sum_probs=112.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|++.+.||+|+||.||+|.+ .++..||+|++....  .........+..|+.++..++||||+++++.+.+...+|+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD--MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            4788999999999999999988 789999999997432  1123345667889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||+||+|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlK  128 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK  128 (363)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCC
Confidence            9999999999998865 458999999999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.88  E-value=6.8e-22  Score=187.58  Aligned_cols=125  Identities=19%  Similarity=0.367  Sum_probs=112.0

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|.+++.||+|+||.||+|.+ .++..||+|++....  .........+..|+.++..++||||+++++++.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD--VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            588999999999999999988 889999999997532  12334456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlK  128 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK  128 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCc
Confidence            9999999999988654 58999999999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.3e-22  Score=188.84  Aligned_cols=132  Identities=27%  Similarity=0.459  Sum_probs=113.2

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCC---------ccHHHHHHHHHHHHHhccCCCCceee
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGT---------QGEQSVLQLEQEISLLGQFEHDNIVQ  255 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~---------~~~~~~~~~~~Ei~il~~l~hpnIv~  255 (317)
                      ...+++|.++..||+|.||.|-++++ .+++.||||++.+.....         ......+.+.+|+.+|++|+|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            45688999999999999999999999 899999999998643211         11112357889999999999999999


Q ss_pred             eeeEEEe--CCEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          256 YFGTEKD--ENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       256 l~~~~~~--~~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.+..+  .+.+|||+|||..|.+...-.... +++.+++.|+.+++.||+|||.+||||||||
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIK  237 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIK  237 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccc
Confidence            9999866  568999999999998877655555 8999999999999999999999999999998

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.88  E-value=6.4e-22  Score=187.23  Aligned_cols=126  Identities=17%  Similarity=0.334  Sum_probs=111.1

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+++.||+|+||.||++.+ .++..||+|++....  .........+.+|+.++..++||||+++++.+.+++.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH--HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            3689999999999999999998 789999999986432  1112334567899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||+||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlk  128 (376)
T cd05598          79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK  128 (376)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence            99999999999998764 47899999999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.88  E-value=9.8e-23  Score=180.45  Aligned_cols=124  Identities=23%  Similarity=0.382  Sum_probs=109.8

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +.|..+..+|+|+||+||+|++ .+|+.||||.+.-.   ..++...+-.++|+++|++++|||+|.++.+|.....+++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es---edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES---EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC---CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            4677889999999999999999 89999999999633   4445666678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||+. ++-+-+..  ++++...+..|+.|++.|+.|+|+++|||||||
T Consensus        79 VFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIK  128 (396)
T KOG0593|consen   79 VFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIK  128 (396)
T ss_pred             Eeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCC
Confidence            9999977 55555554  359999999999999999999999999999998

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.88  E-value=5.4e-22  Score=184.61  Aligned_cols=129  Identities=26%  Similarity=0.451  Sum_probs=114.1

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+..|+.++..++||||+++++++..++.
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE--ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            3467899999999999999999998 789999999997432  1122345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk  145 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK  145 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            99999999999999988654 58999999999999999999999999999997

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=5.5e-23  Score=176.67  Aligned_cols=130  Identities=31%  Similarity=0.487  Sum_probs=117.1

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ...+++|.+++.||+|-||.||+|+. .++..||+|++.+..  ........++.+|+++-+.|+||||++++++|.+..
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            45578999999999999999999998 889999999997654  223344567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+++||.++|+++..++.+   ++++..+..|+.|++.||.|+|.++|||||||
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiK  151 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIK  151 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCC
Confidence            999999999999999999843   38999999999999999999999999999998

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.87  E-value=1.2e-21  Score=185.91  Aligned_cols=125  Identities=19%  Similarity=0.353  Sum_probs=111.6

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|.+++.||+|+||.||+|.+ .++..||+|++....  .........+..|+.++..++||||+++++.+.+++.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD--VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            588999999999999999998 789999999987432  12234456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+||+|.+++... .+++..+..++.||+.||.|||++||||||||
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlK  128 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIK  128 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999988654 58899999999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.87  E-value=1e-21  Score=185.90  Aligned_cols=131  Identities=20%  Similarity=0.300  Sum_probs=115.7

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .....++|.+.+.||+|+||.||++.+ .++..+|+|++....  .........+..|+.++..++||||+++++++.++
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            344467899999999999999999998 788999999986432  11223345677899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+|||||+||+|.+++....+++..+..++.||+.||.|||++||+|||||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLK  169 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK  169 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            999999999999999999988889999999999999999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=8e-22  Score=182.37  Aligned_cols=129  Identities=22%  Similarity=0.388  Sum_probs=118.0

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      |+...+.|.+...||.|..++||+|+. .++..||||++....    .......+.+|+..|+.++||||+.++..|..+
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk----c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK----CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh----hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            555678999999999999999999998 889999999998643    233478899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+|+||.||.+|++.++++.   .++++..+..|+++++.||.|||.+|.||||||
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvK  153 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVK  153 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccc
Confidence            999999999999999999975   369999999999999999999999999999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.87  E-value=1.8e-22  Score=180.88  Aligned_cols=129  Identities=24%  Similarity=0.367  Sum_probs=112.4

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-  262 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-  262 (317)
                      -+..++.|+.++.|++|+||.||+|++ .++..||+|.+++.....   .....-++|+.+|.+++|||||.+-.+... 
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~---GFPItsLREIniLl~~~H~NIV~vkEVVvG~  147 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE---GFPITSLREINILLKARHPNIVEVKEVVVGS  147 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC---CCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence            456788899999999999999999999 899999999998754222   222345699999999999999999988865 


Q ss_pred             -CCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       -+.+|||||||+. +|..++.+.  +|...++..++.|++.||+|||.+.|+|||||
T Consensus       148 ~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK  204 (419)
T KOG0663|consen  148 NMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLK  204 (419)
T ss_pred             ccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccc
Confidence             4679999999977 999999764  49999999999999999999999999999998

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.87  E-value=1.6e-21  Score=184.54  Aligned_cols=131  Identities=21%  Similarity=0.297  Sum_probs=116.0

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .....++|.+.+.||+|+||.||+|.+ .++..+|+|++....  .........+..|+.++..++||||+++++.+..+
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344568999999999999999999998 789999999986432  11223345678899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+|||||+||+|.+++....+++..+..++.||+.||.|||++||+|||||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk  169 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK  169 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence            999999999999999999988889999999999999999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.87  E-value=3.1e-22  Score=174.44  Aligned_cols=124  Identities=24%  Similarity=0.435  Sum_probs=111.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|...+.+|+|.||+||+|++ .+|+.||||.++..+...   .......+|+.+|+.++||||+.+.++|...+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd---Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD---GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc---CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            4677889999999999999999 999999999998654322   223456799999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||++. +|...+++..  ++..++..|+.+++.||+|||++.|+|||||
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlK  128 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLK  128 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCC
Confidence            9999976 9999998764  8899999999999999999999999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=8.2e-22  Score=180.03  Aligned_cols=126  Identities=23%  Similarity=0.374  Sum_probs=111.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE--VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            4688999999999999999998 789999999987432  1122345668899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++|+|.+++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  128 (291)
T cd05612          79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK  128 (291)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            99999999999998654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.4e-22  Score=194.22  Aligned_cols=130  Identities=23%  Similarity=0.328  Sum_probs=117.2

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      +..+++|.++.+||+|+||.|+++.. .++..||||++++....  ....++..+.|.+++... +||++++++.+|++.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il--~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL--QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee--ccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            56688999999999999999999998 88999999999876533  345577788888888777 599999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .++|+||||+.||++..+.+...|++..+..|+.+|+.||.|||++||||||||
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlK  495 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLK  495 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecc
Confidence            999999999999997766676789999999999999999999999999999998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.2e-21  Score=184.20  Aligned_cols=129  Identities=27%  Similarity=0.449  Sum_probs=113.3

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .+...+++|.....||+|+||.||+|...+|..||||.+....    ... ...|..|+.++.+++|||+|+++|+|.+.
T Consensus        69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~----~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~  143 (361)
T KOG1187|consen   69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNS----GQG-EREFLNEVEILSRLRHPNLVKLLGYCLEG  143 (361)
T ss_pred             HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCC----Ccc-hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence            4677788999999999999999999988888999999775321    111 34599999999999999999999999998


Q ss_pred             C-EEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCC
Q 021084          264 N-KLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQ---NVIHRPGA  317 (317)
Q Consensus       264 ~-~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIvHrDLK  317 (317)
                      + ..+||+||+++|+|.+.+...   .++|.....|+.+++.||+|||..   .|||||||
T Consensus       144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK  204 (361)
T KOG1187|consen  144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK  204 (361)
T ss_pred             CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence            8 599999999999999998653   679999999999999999999985   49999998

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.9e-21  Score=180.89  Aligned_cols=126  Identities=21%  Similarity=0.324  Sum_probs=112.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+..|+.++..++||||+++++++...+.+|+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL--LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            4689999999999999999998 689999999997532  1122345668899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  128 (333)
T cd05600          79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK  128 (333)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            99999999999998754 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.87  E-value=1.5e-21  Score=184.63  Aligned_cols=129  Identities=20%  Similarity=0.293  Sum_probs=114.5

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.+.+.||+|+||.||++.+ .++..||+|++....  .........+..|+.++..++||||+++++++.+++.
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE--MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3467899999999999999999988 789999999996432  1122334457789999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|||||+||+|.+++....+++..+..++.||+.||.|||++||+|||||
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk  169 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVK  169 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            9999999999999999988889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PF12515 CaATP_NAI: Ca2+-ATPase N terminal autoinhibitory domain; InterPro: IPR024750 This entry represents the N-terminal autoinhibitory calmodulin-binding domain characteristic of certain calcium-transporting ATPases []

Probab=99.87  E-value=4.7e-23  Score=131.50  Aligned_cols=46  Identities=46%  Similarity=0.885  Sum_probs=43.6

Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHhhhhhhcCCCcccccccccCcchH
Q 021084            4 FFNLKDFDVKPKHPSRESLRRWRSFCTIVKNPTRRFRMVANLDRRSE   50 (317)
Q Consensus         4 ~~~~~~f~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~   50 (317)
                      |++ ++|+|++||+|+|+|+|||+|++||+||+||||||+||+|+++
T Consensus         1 yl~-~~Fdi~~Kn~s~e~l~rWR~a~~lv~N~~RRFR~~~dL~k~~e   46 (47)
T PF12515_consen    1 YLD-DNFDIPAKNSSEEALRRWRQAVGLVKNARRRFRYTADLKKREE   46 (47)
T ss_pred             CCc-cccCCCCCCCCHHHHHHHHHHhHHhccccceeeecccHhhHhc
Confidence            676 9999999999999999999999999999999999999998874

This domain binds calmodulin in a calcium-dependent fashion and has a conserved RRFR sequence motif. There are two completely conserved residues (F and W) that may be functionally important.; GO: 0005516 calmodulin binding

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.87  E-value=2.8e-21  Score=182.54  Aligned_cols=128  Identities=29%  Similarity=0.439  Sum_probs=115.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENK  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~  265 (317)
                      ....|.+.+.||+|.||.||.|.. .+|..+|+|.+.+....  .......+.+|+.+|..+. |||||.++++|.+...
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~--~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR--GKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc--ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            345789999999999999999998 77999999999865432  2235567889999999998 9999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||+|.||.|.+.+...++++..+..++.|++.|+.|||+.||||||||
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlK  162 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLK  162 (382)
T ss_pred             EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Confidence            9999999999999998866569999999999999999999999999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.2e-21  Score=187.03  Aligned_cols=130  Identities=27%  Similarity=0.482  Sum_probs=113.3

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe--cCC---CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeE
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT--DDG---FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGT  259 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~--~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~  259 (317)
                      |...-++-.+.+.||+|+||.||+|..  .++   ..||+|.....  ..........+++|+++|..++|||||+++|+
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~--~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS--SELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc--ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            455556666779999999999999987  222   23899988642  13456778899999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          260 EKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       260 ~~~~~~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      .....++++|||+|+||+|.++|+..+  ++..+...++.+.+.||+|||++++|||||
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDI  288 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDI  288 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhH
Confidence            999999999999999999999998765  999999999999999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=3.4e-23  Score=181.75  Aligned_cols=127  Identities=31%  Similarity=0.485  Sum_probs=112.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeee-EEEeCCE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFG-TEKDENK  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~  265 (317)
                      ...+|++.+.||+|+||.||++.. .+|..+|.|.+.   ....+....+.+..|+.+|++|+|||||++++ .|..+..
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~---f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ---FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc---hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            456788999999999999999998 999999999987   33556677888999999999999999999998 5655555


Q ss_pred             -EEEEEecCCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH--CC--cEecCCC
Q 021084          266 -LYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHE--QN--VIHRPGA  317 (317)
Q Consensus       266 -~~lVmE~~~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~--~g--IvHrDLK  317 (317)
                       ++||||+|.+|+|..+++..     .+++..++.++.|++.||..+|+  .+  |+|||||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK  155 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK  155 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence             99999999999999998643     39999999999999999999999  45  9999998

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.86  E-value=3e-21  Score=181.66  Aligned_cols=126  Identities=21%  Similarity=0.355  Sum_probs=111.8

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||++.+ .++..||+|++....  .........+..|+.++..++||+|+++++.+.+.+.+|+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD--MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4688999999999999999988 789999999997432  1123345678889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||+||+|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLk  128 (360)
T cd05627          79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK  128 (360)
T ss_pred             EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC
Confidence            9999999999998865 458999999999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-22  Score=188.91  Aligned_cols=125  Identities=24%  Similarity=0.417  Sum_probs=109.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCC-
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDEN-  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-  264 (317)
                      ..++|.+++.||.|+||.||+|.. .+|..||||.++.+-.   ..+..- =++|+.-|.+|+ |||||++.+++.+.+ 
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~---s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY---SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc---cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            467899999999999999999988 8899999999875432   222222 248999999998 999999999999987 


Q ss_pred             EEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||+. +|+++++..+  |++..+..|+.||++||+|+|.+|+.|||+|
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlK  137 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLK  137 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence            99999999955 9999997654  9999999999999999999999999999998

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.86  E-value=2.7e-21  Score=180.95  Aligned_cols=130  Identities=24%  Similarity=0.309  Sum_probs=112.8

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cC-CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~-~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ....++|.+.+.||+|+||.||+|.+ .+ +..||+|.+....  .........+..|+.++..++||||+++++++.+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK--IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            34567899999999999999999986 33 4689999986432  11233456788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+|||||
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk  158 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLK  158 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC
Confidence            9999999999999999998654 58999999999999999999999999999997

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.86  E-value=4.2e-21  Score=178.08  Aligned_cols=120  Identities=21%  Similarity=0.269  Sum_probs=105.9

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVT  274 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~  274 (317)
                      +.||+|+||.||+|.+ .+|..||+|++....  .........+..|+.++..++||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV--IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            3689999999999988 789999999997432  1223345567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          275 QGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       275 ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlk  122 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK  122 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC
Confidence            99999988654 58999999999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=4.6e-21  Score=178.51  Aligned_cols=126  Identities=18%  Similarity=0.262  Sum_probs=111.3

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||++.. .++..||+|++....  .........+..|+.++..++||||+.+++++.+++.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE--MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            4789999999999999999988 789999999987422  1122334567889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++||+|.+++..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  129 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK  129 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCC
Confidence            9999999999999875  358999999999999999999999999999997

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=3.7e-21  Score=179.76  Aligned_cols=126  Identities=21%  Similarity=0.353  Sum_probs=112.3

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|++.....  ........+..|+.++..++||||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            4789999999999999999998 7899999999975321  122345668899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++|+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlk  128 (350)
T cd05573          79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIK  128 (350)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            99999999999998764 68999999999999999999999999999997

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.86  E-value=1e-21  Score=186.08  Aligned_cols=124  Identities=27%  Similarity=0.444  Sum_probs=114.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||+|+. .+.+.||+|.+.+.   .........+.+|++++..++|||||.++++|++..++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~---gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS---GRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhc---CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            5788899999999999999988 88999999999754   3455667889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||.| +|..++.. +.++++.+..++.|++.||.|||+++|+|||+|
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~k  127 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMK  127 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence            9999977 99999965 569999999999999999999999999999997

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.86  E-value=8.7e-21  Score=176.63  Aligned_cols=126  Identities=17%  Similarity=0.235  Sum_probs=110.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||++.+ .++..||+|++....  .........+..|..++..++||+|+.+++++.+.+.+|+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE--MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4789999999999999999988 788999999986421  1122334557789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++||+|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlk  129 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK  129 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCc
Confidence            9999999999999975  458999999999999999999999999999997

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.86  E-value=7.5e-21  Score=176.49  Aligned_cols=120  Identities=21%  Similarity=0.285  Sum_probs=105.8

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVT  274 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~  274 (317)
                      +.||+|+||.||++.+ .+|..||+|++....  .........+..|+.++..++||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV--IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            3689999999999988 789999999997532  1123345567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          275 QGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       275 ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|..++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk  122 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK  122 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            99999888654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.85  E-value=7.5e-21  Score=176.41  Aligned_cols=124  Identities=23%  Similarity=0.330  Sum_probs=107.3

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHH---hccCCCCceeeeeeEEEeCCEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL---LGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i---l~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      |.+.+.||+|+||.||+|.+ .++..||+|+++....  ......+.+..|+.+   +..++||||+++++++...+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            67889999999999999988 7899999999975321  122234556666554   46778999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||++||+|..++....+++..+..++.||+.||.|||++||+|||||
T Consensus        79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlk  128 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLK  128 (324)
T ss_pred             EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCC
Confidence            99999999999999988889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.85  E-value=1e-20  Score=172.27  Aligned_cols=125  Identities=17%  Similarity=0.248  Sum_probs=108.8

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|...+.||+|+||.||+|.+ .++..||+|.+.....  ........+.+|+.++..++||+|+.+++++.+.+.+|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh--hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            477889999999999999988 8899999999874321  1122334577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++|+|..++..   ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dik  129 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLK  129 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence            999999999887753   248899999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.85  E-value=1.1e-20  Score=175.61  Aligned_cols=126  Identities=20%  Similarity=0.304  Sum_probs=112.4

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||++.+ .++..||+|++....  .........+..|+.++..++||||+++++++...+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV--LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            4689999999999999999988 789999999997532  1223345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlk  129 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK  129 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCc
Confidence            99999999999999764  58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-21  Score=184.66  Aligned_cols=126  Identities=26%  Similarity=0.385  Sum_probs=110.4

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |......+++++.||+|.||.||.|.......||+|.++...      ...+.|.+|+.+|++|+|++||+++++|..+.
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~------m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS------MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc------cChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            333344566789999999999999988777799999997431      22356889999999999999999999999988


Q ss_pred             EEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      .+|||||||+.|+|.++|+.   ..+...+...++.||++||+||+++++|||||
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDL  329 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDL  329 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhh
Confidence            99999999999999999986   23888999999999999999999999999998

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.85  E-value=1.3e-20  Score=175.38  Aligned_cols=120  Identities=21%  Similarity=0.286  Sum_probs=106.2

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVT  274 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~  274 (317)
                      +.||+|+||.||++.+ .++..||+|++....  .........+..|+.++..++||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV--IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            3689999999999988 789999999997532  1223445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          275 QGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       275 ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|..++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDik  122 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK  122 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccC
Confidence            99999888654 58999999999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.2e-20  Score=174.07  Aligned_cols=118  Identities=28%  Similarity=0.332  Sum_probs=104.7

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQG  276 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~gg  276 (317)
                      ||+|+||.||+|.+ .++..||+|++....  .........+..|+.++..++||||+++++++...+.+|+||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH--IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            79999999999998 788999999987432  122344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          277 SLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       277 sL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|.+++.. +.+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlk  120 (312)
T cd05585          79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK  120 (312)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC
Confidence            99998865 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=2.9e-21  Score=185.90  Aligned_cols=129  Identities=27%  Similarity=0.461  Sum_probs=116.6

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..++-|++++.||.|+.|.|-+|++ .+|+..|||++.+..  .........+.+|+-+|+-+.||||+.+++++.+..+
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            3477899999999999999999999 999999999998653  2333445668899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIY-QEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l-~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|.||++||.|++++ ..+++++.++..++.||+.|+.|||..+|+|||||
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLK  139 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLK  139 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Confidence            99999999999999976 45679999999999999999999999999999998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.85  E-value=5.7e-21  Score=177.93  Aligned_cols=128  Identities=24%  Similarity=0.362  Sum_probs=106.9

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeee
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFG  258 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~  258 (317)
                      ....++|++.+.||+|+||.||+|.+      .++..||+|++...    ........+..|+.++..+ +||||+++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~   78 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----ATASEHKALMSELKILIHIGNHLNVVNLLG   78 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----cchHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence            34456899999999999999999964      34568999998632    2233456788999999999 8999999999


Q ss_pred             EEEe-CCEEEEEEecCCCCCHHHHHHhC----------------------------------------------------
Q 021084          259 TEKD-ENKLYIFLELVTQGSLAKIYQEY----------------------------------------------------  285 (317)
Q Consensus       259 ~~~~-~~~~~lVmE~~~ggsL~~~l~~~----------------------------------------------------  285 (317)
                      ++.. .+.+|++|||+++|+|.+++...                                                    
T Consensus        79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (338)
T cd05102          79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN  158 (338)
T ss_pred             EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence            8876 45689999999999999988642                                                    


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          286 -----------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       286 -----------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                 .+++..+..++.||+.||.|||++||+|||||
T Consensus       159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiK  201 (338)
T cd05102         159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLA  201 (338)
T ss_pred             cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCc
Confidence                       26677888999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.85  E-value=1.5e-20  Score=171.30  Aligned_cols=124  Identities=26%  Similarity=0.452  Sum_probs=108.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|.+.+.||.|+||.||+|.+ .++..||+|++.....    ......+.+|+.++..++||||+++++++...+..|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE----EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc----CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            56899999999999999999988 7899999999864321    112345678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++ +|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk  130 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK  130 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            99999975 999888653  37889999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=2.1e-20  Score=170.18  Aligned_cols=125  Identities=19%  Similarity=0.271  Sum_probs=108.8

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|++.+.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.++..++||||+.+++.+..++.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            478899999999999999988 7899999999864321  1222344577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++|+|.+++..   ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  129 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK  129 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Confidence            999999999988753   348999999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.85  E-value=1.9e-20  Score=168.53  Aligned_cols=125  Identities=26%  Similarity=0.364  Sum_probs=109.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ..+|++.+.||+|+||.||+|..    ..+..||+|.++..    ........+..|+.++..++||||+++++++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            35688999999999999999975    24568999988642    22344567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..|+||||+++|+|.+++...  .+++..+..++.|++.||+|||++|++|||||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dik  134 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLA  134 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence            999999999999999998753  58999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.85  E-value=2.5e-20  Score=170.95  Aligned_cols=125  Identities=25%  Similarity=0.341  Sum_probs=107.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEec-----------------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTD-----------------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD  251 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp  251 (317)
                      .++|.+.+.||+|+||.||+|.+.                 ++..||+|.+...    ........+.+|+.++.+++||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----ANKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----CCHHHHHHHHHHHHHHhhcCCC
Confidence            457889999999999999999752                 2347999988642    2344566789999999999999


Q ss_pred             ceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 021084          252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--------------------HLKDSQVSAYTWQILNGLKYLHEQNV  311 (317)
Q Consensus       252 nIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~--------------------~l~~~~~~~i~~qil~aL~yLH~~gI  311 (317)
                      ||+++++++.+.+..|+||||+++|+|.+++...                    .+++..+..++.||+.||.|||++||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            9999999999999999999999999999988643                    25677888999999999999999999


Q ss_pred             EecCCC
Q 021084          312 IHRPGA  317 (317)
Q Consensus       312 vHrDLK  317 (317)
                      +|||||
T Consensus       160 vH~dlk  165 (304)
T cd05096         160 VHRDLA  165 (304)
T ss_pred             cccCcc
Confidence            999997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.85  E-value=3.2e-21  Score=181.22  Aligned_cols=126  Identities=27%  Similarity=0.439  Sum_probs=112.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE-E
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK-L  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~  266 (317)
                      .++|..++++|+|+||.++++++ .++..|++|.+.......   ........|+.+++++.|||||.+.+.|..++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~---~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE---PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc---hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            56788999999999999999988 788899999998764332   334467899999999999999999999998887 9


Q ss_pred             EEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+||+||++.+.+...   .|+++.+..++.|++.|+.|||+++|+|||||
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK  133 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLK  133 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccch
Confidence            9999999999999988653   38999999999999999999999999999997

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.84  E-value=2.8e-20  Score=173.25  Aligned_cols=126  Identities=18%  Similarity=0.253  Sum_probs=110.3

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||++.. .++..+|+|++....  .........+..|+.++..++||+|+.+++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            4788999999999999999988 778899999986421  1122234457789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++|+|.+++..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlk  129 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIK  129 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            9999999999999976  458999999999999999999999999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.84  E-value=2.7e-20  Score=173.21  Aligned_cols=120  Identities=21%  Similarity=0.310  Sum_probs=105.4

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .++..||+|+++...  .........+..|..++..+ +||||+++++++.+.+.+|+|||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL--VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            3689999999999988 789999999997532  12233456678899999888 7999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|..++.. +++++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  123 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLK  123 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            99999988754 469999999999999999999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.84  E-value=3.1e-20  Score=172.21  Aligned_cols=125  Identities=23%  Similarity=0.272  Sum_probs=107.8

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC-ceeeeeeEEEeCCEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD-NIVQYFGTEKDENKLYI  268 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~l  268 (317)
                      +|.+.+.||+|+||.||+|.+ .++..||+|++.....  ........+..|..++..+.|+ +|+.+++++...+.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            578999999999999999988 7788999999975321  1223456678899999988665 68889999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk  128 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK  128 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            99999999999988654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.4e-21  Score=182.81  Aligned_cols=124  Identities=27%  Similarity=0.445  Sum_probs=113.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ...|.....||+|+.|.||.+.. .++..||||.+.+...     ...+.+..|+.+|+..+|+|||.+++.|.-.+.+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-----CchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            45677889999999999999988 8899999999986542     22456789999999999999999999999889999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||++||+|.+++....+++.++..|+.++++||.|||.+||+|||||
T Consensus       347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIK  396 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIK  396 (550)
T ss_pred             EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccc
Confidence            99999999999999998889999999999999999999999999999998

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.84  E-value=1.8e-20  Score=179.36  Aligned_cols=129  Identities=22%  Similarity=0.357  Sum_probs=116.6

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ....+.|.+...||+|.|+.|.++.+ .++..||||.+.+.   ..+......+.+|+++|+.++|||||+++.+...+.
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt---~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKT---QLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhc---ccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            44578899999999999999999999 89999999999754   334445566889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+.+|.+++++... .+.+..+..++.|++.|++|||+++|||||||
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk  182 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLK  182 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccc
Confidence            999999999999999998765 47778899999999999999999999999998

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.84  E-value=3.2e-20  Score=172.20  Aligned_cols=120  Identities=22%  Similarity=0.285  Sum_probs=105.3

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVT  274 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~  274 (317)
                      +.||+|+||.||++.+ .++..||+|++....  .........+..|+.++..++||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV--IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            3689999999999988 789999999997532  1223345567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          275 QGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       275 ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +|+|..++... .+++..+..++.||+.||.|||+ +||+|||||
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDik  123 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK  123 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence            99999988654 58999999999999999999997 799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.84  E-value=3.4e-20  Score=170.11  Aligned_cols=124  Identities=30%  Similarity=0.487  Sum_probs=107.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||.|+||.||+|.+ .++..||+|++.....    ......+.+|+.+++.++||||+++++++.++...|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE----EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc----cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence            46899999999999999999998 6899999999864321    112335678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||++ ++|.+++..  +.+++..+..++.|++.||.|||++||+|||||
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk  130 (303)
T cd07869          80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK  130 (303)
T ss_pred             EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            9999996 578777754  348999999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.84  E-value=3e-20  Score=168.70  Aligned_cols=118  Identities=22%  Similarity=0.308  Sum_probs=102.9

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQG  276 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~gg  276 (317)
                      ||+|+||+||++.+ .+++.||+|.+....  .........+..|+.++..++||||+.+.+++.....+|+||||++||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKR--LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHH--HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            79999999999988 789999999987432  112233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          277 SLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       277 sL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|..++..     ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  124 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK  124 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99887742     348999999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.84  E-value=1.4e-20  Score=178.38  Aligned_cols=130  Identities=25%  Similarity=0.373  Sum_probs=110.0

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQY  256 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l  256 (317)
                      ++....++|.+.+.||+|+||.||+|..      .++..||+|+++...    .....+.+.+|+.++..+ +||||+++
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~il~~l~~HpnIv~l  104 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHINIVNL  104 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----CcHHHHHHHHHHHHHHHhcCCcceeee
Confidence            3445566899999999999999999963      356689999986321    223456788999999999 89999999


Q ss_pred             eeEEEeCCEEEEEEecCCCCCHHHHHHhC---------------------------------------------------
Q 021084          257 FGTEKDENKLYIFLELVTQGSLAKIYQEY---------------------------------------------------  285 (317)
Q Consensus       257 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~~---------------------------------------------------  285 (317)
                      ++++...+..++|||||++|+|.+++...                                                   
T Consensus       105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  184 (375)
T cd05104         105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD  184 (375)
T ss_pred             eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence            99999999999999999999999988532                                                   


Q ss_pred             -------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          286 -------------------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       286 -------------------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                               .+++..+..++.||+.||.|||++||+|||||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  241 (375)
T cd05104         185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLA  241 (375)
T ss_pred             cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCc
Confidence                                     25677888999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.84  E-value=3e-21  Score=187.19  Aligned_cols=124  Identities=28%  Similarity=0.501  Sum_probs=108.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC-----
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE-----  263 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----  263 (317)
                      ..|..-+.||+|+||.||++++ .+|..||||.++...    .....+...+|+++|++++|||||+++++-.+.     
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            3466778999999999999997 899999999997532    334466788999999999999999999876543     


Q ss_pred             -CEEEEEEecCCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQE----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ....+|||||+||||..++++    .++++.+...++.++..||.|||.+||||||||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlK  147 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLK  147 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCC
Confidence             357899999999999999975    469999999999999999999999999999998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.84  E-value=3e-21  Score=184.18  Aligned_cols=129  Identities=26%  Similarity=0.377  Sum_probs=115.5

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      +.|.+..+...++..||+|+||+||+|.+..  .||||++...   ...+...+.|..|+.++++.+|.||+-|.|+|..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~---~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVD---DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecC---CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            5577778888899999999999999997643  5999999865   3455688999999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++. .||+.+|.|-+|+.++..  -.|.....+.|+.||++||.|||.++|||||||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLK  515 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLK  515 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcc
Confidence            887 999999999999998854  458888999999999999999999999999998

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.84  E-value=3.6e-20  Score=168.16  Aligned_cols=125  Identities=19%  Similarity=0.370  Sum_probs=109.1

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|++....   ........+.+|+.++..++||||+++++++...+.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            4689999999999999999998 788999999987532   122345667899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++++++..+... ..+++..+..++.|++.||.|||+.||+|||||
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk  127 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK  127 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            9999999877666543 358999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.83  E-value=1.8e-20  Score=169.63  Aligned_cols=125  Identities=30%  Similarity=0.537  Sum_probs=108.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc-eeeeeeEEEeCC--
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN-IVQYFGTEKDEN--  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~--  264 (317)
                      ...|..++.||+|+||+||+|+. .+|..||+|+++.....   +.......+|+.+++.++|+| |+.+++++.+..  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~---EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE---EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc---cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            45577788899999999999998 89999999999875432   123345679999999999999 999999998877  


Q ss_pred             ----EEEEEEecCCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 ----KLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ----~~~lVmE~~~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          .+++|+||+.. +|..++...     +++...+..++.||+.||+|||++||+|||||
T Consensus        87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLK  147 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLK  147 (323)
T ss_pred             cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Confidence                89999999965 999998753     47888899999999999999999999999998

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.83  E-value=5.6e-20  Score=170.92  Aligned_cols=126  Identities=21%  Similarity=0.319  Sum_probs=108.8

Q ss_pred             CeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      +|.+.+.||+|+||.||++..    .++..||+|++..... .........+..|+.++..+ +||+|+.+++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            488999999999999999876    3688999999874321 11223455678899999999 59999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlk  132 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIK  132 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Confidence            9999999999999998865 458999999999999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=8.2e-20  Score=163.31  Aligned_cols=128  Identities=38%  Similarity=0.693  Sum_probs=112.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|++|.||.|.+ .++..+|+|.+...............+.+|+.++..++||||+++++++.....+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999988 789999999987543222233345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++++|.+++... .+++..+..++.|++.||.|||+.||+|||||
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~  131 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIK  131 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999988654 58899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.83  E-value=4.9e-20  Score=170.40  Aligned_cols=119  Identities=25%  Similarity=0.358  Sum_probs=103.9

Q ss_pred             ccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEe
Q 021084          196 APLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      +.||+|+||.||++..    .+|..||+|++.....   .......+..|+.++..++||||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            5799999999999875    4688999999974321   12234457789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+++|+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  125 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK  125 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence            99999999988654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.83  E-value=9.5e-20  Score=169.56  Aligned_cols=125  Identities=23%  Similarity=0.380  Sum_probs=112.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|++.+.||+|+||.||++.+ .++..+|+|.+...    ........+.+|+.++..++||||+++++++...+.++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            46899999999999999999998 78999999998742    23345667899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      +||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+|||||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlk  131 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVK  131 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCC
Confidence            999999999999998764 589999999999999999999986 69999997

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.83  E-value=6.7e-20  Score=170.15  Aligned_cols=121  Identities=21%  Similarity=0.330  Sum_probs=106.5

Q ss_pred             eecccccc--CCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          194 KGAPLGSG--SFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       194 ~~~~LG~G--~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      ++++||+|  +||+||++.. .+|..||+|.+....   ........+..|+.+++.++||||+++++++..++..|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA---CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhh---ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            46789999  7889999988 899999999986432   22344566778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++|+|.+++..   .++++..+..++.|++.||.|||++||+|||||
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlk  128 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVK  128 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence            99999999999864   348999999999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.83  E-value=5.2e-20  Score=170.85  Aligned_cols=125  Identities=24%  Similarity=0.277  Sum_probs=107.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l  268 (317)
                      +|...+.||+|+||.||+|.+ .++..||+|++.....  ........+..|..++..+. ||+|+.+++++...+.+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            467889999999999999988 7899999999874321  12233456778888888775 5778889999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDik  128 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLK  128 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            9999999999998876 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.83  E-value=1.1e-19  Score=163.02  Aligned_cols=126  Identities=26%  Similarity=0.417  Sum_probs=111.7

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||.|+||.||+|.. .++..||+|.+....  .........+..|+.+++.++||||+++++++...+..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE--MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc--cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            6799999999999999999988 789999999886532  2234556678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||+++|+|.+++..     ..+++..+..++.|++.||.|||++||+|+|||
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  133 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIK  133 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCC
Confidence            9999999999988752     237889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.83  E-value=2.7e-20  Score=176.43  Aligned_cols=131  Identities=26%  Similarity=0.394  Sum_probs=110.6

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceee
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQ  255 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~  255 (317)
                      +.|....++|.+.+.||+|+||.||+|.+ .     ++..||+|.+....    .......+.+|+.++..+ +||||++
T Consensus        31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~~h~nIv~  106 (374)
T cd05106          31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----HTDEREALMSELKILSHLGQHKNIVN  106 (374)
T ss_pred             ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----CHHHHHHHHHHHHHHHhhccCCceee
Confidence            33455567899999999999999999875 2     34579999986421    233456788999999999 8999999


Q ss_pred             eeeEEEeCCEEEEEEecCCCCCHHHHHHhC--------------------------------------------------
Q 021084          256 YFGTEKDENKLYIFLELVTQGSLAKIYQEY--------------------------------------------------  285 (317)
Q Consensus       256 l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~--------------------------------------------------  285 (317)
                      +++++...+.+|+|||||++|+|.+++...                                                  
T Consensus       107 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (374)
T cd05106         107 LLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP  186 (374)
T ss_pred             EeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence            999999999999999999999999987531                                                  


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          286 ---------------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       286 ---------------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                           ++++..+..++.||+.||.|||++||+|||||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLk  239 (374)
T cd05106         187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVA  239 (374)
T ss_pred             ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCc
Confidence                                 26778889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.83  E-value=5.9e-20  Score=170.19  Aligned_cols=120  Identities=22%  Similarity=0.272  Sum_probs=103.3

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .++..||+|++.....  ........+..|..++..+ +||||+.+++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            3689999999999988 7789999999875321  1223445677888888765 8999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|..++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDik  123 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLK  123 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            99999988764 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.83  E-value=8.2e-20  Score=169.99  Aligned_cols=120  Identities=23%  Similarity=0.319  Sum_probs=104.5

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||++.+ .++..||+|++....  .........+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH--hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            3689999999999998 788999999997542  12234455677888888766 8999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|..++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dik  123 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK  123 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            99999988765 459999999999999999999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.83  E-value=9.2e-20  Score=169.02  Aligned_cols=125  Identities=23%  Similarity=0.274  Sum_probs=107.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+..|..++..+ +||+|+.+++++...+.+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            578899999999999999988 788999999997532  11223344566777777776 68999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++|+|..++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  128 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK  128 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCC
Confidence            9999999999988865 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.83  E-value=4.4e-20  Score=176.48  Aligned_cols=132  Identities=26%  Similarity=0.402  Sum_probs=111.5

Q ss_pred             chHHHHhccCeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCcee
Q 021084          182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIV  254 (317)
Q Consensus       182 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv  254 (317)
                      ..+|....++|.+++.||+|+||.||+|.+ .     .+..||+|++...    ......+.+..|+.++..+. ||||+
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~~l~~l~~HpnIv  104 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----ARSSEKQALMSELKIMTHLGPHLNIV  104 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhcCCCCCee
Confidence            345666678999999999999999999976 2     2347999998642    22344567899999999996 99999


Q ss_pred             eeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-------------------------------------------------
Q 021084          255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY-------------------------------------------------  285 (317)
Q Consensus       255 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-------------------------------------------------  285 (317)
                      ++++++...+.+|||||||++|+|.+++...                                                 
T Consensus       105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (400)
T cd05105         105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD  184 (400)
T ss_pred             eEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence            9999999999999999999999999887531                                                 


Q ss_pred             ------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          286 ------------------------------------------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       286 ------------------------------------------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                                                      .+++..+..++.||+.||.|||++||+|||||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik  264 (400)
T cd05105         185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA  264 (400)
T ss_pred             ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence                                                            26777888999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.83  E-value=6.8e-20  Score=169.53  Aligned_cols=120  Identities=26%  Similarity=0.388  Sum_probs=101.1

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc-CCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ-FEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .++..||+|+++....  ........+..|..++.. .+||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            3689999999999988 7889999999975321  112233445566666654 48999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|..++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlk  123 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLK  123 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence            999999988654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.83  E-value=6.7e-21  Score=172.66  Aligned_cols=119  Identities=26%  Similarity=0.434  Sum_probs=101.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .-.|.-.+++|.|+||.||.|.. .++..+|||........         -.+|+.+|..++|||||++..+|...    
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---------knrEl~im~~l~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---------KNRELQIMRKLDHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---------CcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence            34577889999999999999988 77899999988643221         12799999999999999999888542    


Q ss_pred             -CEEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       -...+||||+|. +|+.+++.     .+++...+.-++.||++||.|||+.||+|||||
T Consensus        94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIK  152 (364)
T KOG0658|consen   94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIK  152 (364)
T ss_pred             hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCC
Confidence             256789999987 99999883     468888999999999999999999999999998

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.83  E-value=5.9e-20  Score=170.38  Aligned_cols=121  Identities=25%  Similarity=0.356  Sum_probs=104.1

Q ss_pred             ccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEe
Q 021084          196 APLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      +.||+|+||.||++..    .++..||+|++..... .........+..|+.++..++||||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            5799999999999976    3678999999874321 1122334567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |++||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  127 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLK  127 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99999999988654 47888999999999999999999999999997

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.83  E-value=1.2e-19  Score=184.03  Aligned_cols=127  Identities=25%  Similarity=0.426  Sum_probs=113.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+..|+.++..++||||+++++++...+.+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD--MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh--ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            57899999999999999999998 689999999997533  223445567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||+.|++|.+++... .+++..+..|+.||+.||.|||.+||||||||
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLK  131 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK  131 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCcc
Confidence            999999999999998754 47899999999999999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.83  E-value=1.1e-19  Score=163.02  Aligned_cols=124  Identities=32%  Similarity=0.506  Sum_probs=110.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++....     ......+.+|+.++..++||||+++++.+...+.+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            45789999999999999999998 788999999986431     123346778999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|||||
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  133 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK  133 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            99999999999998864 458999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.83  E-value=9.1e-20  Score=169.19  Aligned_cols=120  Identities=27%  Similarity=0.347  Sum_probs=101.4

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHH-HhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS-LLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .+|..||+|++.....  ........+..|.. +++.++||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV--LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            3689999999999988 7899999999975321  12223344555554 567789999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|..++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlk  123 (325)
T cd05604          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLK  123 (325)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            99999988765 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.83  E-value=6.8e-20  Score=163.21  Aligned_cols=123  Identities=33%  Similarity=0.516  Sum_probs=109.3

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |++++.||+|+||.||++.+ .++..||+|.+...   ............|+.++..++||||+++++++.....+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKS---EIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEEST---THHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccc---cccccccchhhhhhhccccccccccccccccccccccccccc
Confidence            78899999999999999998 77889999999853   222233334456999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++++|.+++. ...+++..+..++.||+.||.|||++||+|+|||
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dik  125 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIK  125 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999997 6779999999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.83  E-value=6.5e-20  Score=169.98  Aligned_cols=120  Identities=24%  Similarity=0.359  Sum_probs=103.4

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .++..||+|++.....  ........+..|..++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            3689999999999988 7899999999874321  1223345667888888766 7999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|..++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlk  123 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLK  123 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence            99999998865 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.83  E-value=1.4e-19  Score=168.70  Aligned_cols=125  Identities=22%  Similarity=0.393  Sum_probs=111.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|++.+.||.|+||.||++.+ .++..+|+|.+...    ........+.+|+.++..++||||+++++++...+.+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            46899999999999999999988 78899999988643    13344567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      +||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+|||||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlk  131 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK  131 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence            999999999999998754 488999999999999999999985 79999997

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.83  E-value=9.8e-20  Score=169.12  Aligned_cols=123  Identities=24%  Similarity=0.408  Sum_probs=105.3

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC-----C
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE-----N  264 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~  264 (317)
                      +|.+.+.||+|+||.||+|.+ .++..||+|.+....   ........+.+|+.+++.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            588999999999999999998 789999999986321   1223345688999999999999999999988543     3


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||. ++|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  130 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLK  130 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            5899999995 5898888654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.83  E-value=1.5e-19  Score=164.59  Aligned_cols=125  Identities=19%  Similarity=0.283  Sum_probs=108.9

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|+..+.||+|+||.||++.+ .+++.||+|.+.....  ........+..|+.++..++|++|+.+++.+...+.+|+|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc--cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            367888999999999999988 7899999999875321  1223345577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||++|++|.+++...   ++++..+..++.|++.||.|||+.||+|||||
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dik  129 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK  129 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence            9999999999988542   48899999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.83  E-value=9.9e-20  Score=168.81  Aligned_cols=120  Identities=28%  Similarity=0.384  Sum_probs=101.0

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHH-HhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS-LLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .+|..||+|++.....  ........+..|.. +++.++||||+++++.+...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            3689999999999998 7899999999974321  11122334445544 567889999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|..++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dik  123 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLK  123 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence            999999988654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.83  E-value=1.5e-19  Score=164.59  Aligned_cols=125  Identities=20%  Similarity=0.288  Sum_probs=108.7

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|+..+.||+|+||.||++.+ .+++.+|+|.+....  .........+..|+.++..++|+||+.+++.+..++.+|++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR--IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh--hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            367788999999999999988 789999999986432  11223345577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++..   .++++..+..++.|++.||.|||+.||+|||||
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dik  129 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK  129 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence            999999999988753   258999999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.83  E-value=1.1e-19  Score=168.88  Aligned_cols=120  Identities=21%  Similarity=0.303  Sum_probs=105.4

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.. .++..||+|++....  .........+..|+.++..+ +||+|+.+++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            3699999999999988 788999999997532  12234456688899998888 6999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|..++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlk  123 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLK  123 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            99999988765 469999999999999999999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=1e-19  Score=164.54  Aligned_cols=124  Identities=33%  Similarity=0.547  Sum_probs=112.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||.|+||.||++.+ .++..+|+|.+..     ........+..|+.+++.++||||+++++.+..+..+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee-----CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            45688999999999999999988 6889999999863     23445677889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++..  ..+++..+..++.|++.||.|||++||+|+|||
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~  130 (280)
T cd06611          79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK  130 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99999999999999865  358999999999999999999999999999997

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.83  E-value=1.4e-19  Score=164.81  Aligned_cols=126  Identities=25%  Similarity=0.391  Sum_probs=111.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||++.+ .++..+|+|++....  .........+..|+.+++.++||||+++++++...+.+|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK--IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            4689999999999999999988 789999999987432  1223445678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++++|.+++... .+++..+..++.|++.||.|||++||+|+|||
T Consensus        79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~  128 (290)
T cd05580          79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK  128 (290)
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence            99999999999998654 58999999999999999999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.83  E-value=1.3e-19  Score=162.50  Aligned_cols=127  Identities=32%  Similarity=0.629  Sum_probs=111.9

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCC-ccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGT-QGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +|+..+.||+|+||.||.+.+ .++..+|+|++....... ........+..|+.+++.++||||+++++++...+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999988 889999999987533211 123356788999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+|||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~  130 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK  130 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999999875 458999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.82  E-value=1.1e-19  Score=168.38  Aligned_cols=120  Identities=27%  Similarity=0.377  Sum_probs=100.8

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHH-HhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS-LLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .++..||+|++.....  ........+..|.. ++..++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            3689999999999998 7899999999874321  11222334455544 678899999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|...+.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlk  123 (321)
T cd05603          79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLK  123 (321)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence            99999888765 458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.82  E-value=6.9e-20  Score=171.98  Aligned_cols=122  Identities=25%  Similarity=0.423  Sum_probs=106.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|..++.||+|+||.||+|.+ .+++.||+|++...    ........+.+|+.++..++||||+++++++...+.+|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            45677889999999999999988 78999999998632    23345567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+.+|+|...   ....+..+..++.||+.||.|||++||+|||||
T Consensus       149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  195 (353)
T PLN00034        149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIK  195 (353)
T ss_pred             EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence            99999999998653   235677788899999999999999999999997

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.82  E-value=2.5e-19  Score=160.75  Aligned_cols=128  Identities=38%  Similarity=0.663  Sum_probs=111.4

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CCEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--ENKL  266 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~  266 (317)
                      .+|.+.+.||+|+||.||.+.+ .++..||+|.+...............+.+|+.++..++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5788999999999999999988 789999999986543323334456788899999999999999999999876  3578


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||+++++|.+++... .+++..+..++.|++.||.|||++||+|+|||
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~  133 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIK  133 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            9999999999999998664 57888999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.82  E-value=9.9e-20  Score=168.53  Aligned_cols=120  Identities=25%  Similarity=0.341  Sum_probs=104.3

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .++..||+|++.....  ........+..|..++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            3689999999999988 7789999999975321  1223345667888888877 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|..++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk  123 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLK  123 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCC
Confidence            999999988765 69999999999999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.82  E-value=1.1e-19  Score=168.10  Aligned_cols=120  Identities=24%  Similarity=0.376  Sum_probs=102.1

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc-CCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ-FEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .++..||+|+++....  ........+..|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            3689999999999998 7789999999975321  111223455667777775 49999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|..++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdik  123 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLK  123 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC
Confidence            999999998764 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.82  E-value=2.5e-19  Score=164.99  Aligned_cols=124  Identities=23%  Similarity=0.398  Sum_probs=110.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|++.+.||+|+||.||++.+ .++..+|+|.+...    ........+..|+.++..++||||+++++++..++.+|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            4688999999999999999988 78899999988642    233455678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      ||||+++++|.+++.. ..+++..+..++.|++.||.|||+ +||+|||||
T Consensus        77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~  127 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVK  127 (308)
T ss_pred             EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCC
Confidence            9999999999999865 458999999999999999999997 699999997

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.82  E-value=2e-19  Score=160.04  Aligned_cols=127  Identities=60%  Similarity=0.995  Sum_probs=113.4

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|+..+.||+|+||.||+|.. .++..|++|.+...............+..|+.++..++||||+++++++.....+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            467789999999999999988 5899999999976543334455667899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++...+ +++..+..++.|++.||.|||+.||+|+|||
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  129 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIK  129 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99999999999987655 8999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.82  E-value=1.6e-19  Score=184.66  Aligned_cols=127  Identities=16%  Similarity=0.251  Sum_probs=111.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|.+.+.||+|+||.||+|.+ .+++.||+|++....  .........+.+|+.+++.++||||+++++++.+++..|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly   78 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY   78 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence            46899999999999999999998 789999999986432  223445667899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||++||+|.+++...            +++...+..++.||+.||+|||++||+|||||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLK  140 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLK  140 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence            999999999999988631            24566778899999999999999999999998

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.82  E-value=1.5e-19  Score=162.34  Aligned_cols=124  Identities=32%  Similarity=0.546  Sum_probs=110.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||.+.+ .++..||+|.++...     ......+.+|+.++..++||||+++++.+...+.+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            34788889999999999999988 789999999987432     233456778999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+|+|||
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  133 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK  133 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99999999999998864 458999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.82  E-value=1.7e-19  Score=165.91  Aligned_cols=124  Identities=27%  Similarity=0.467  Sum_probs=107.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..+|+|.+.....    ......+.+|+.++..++||||+++++++..++..|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc----CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            46799999999999999999988 7889999999875321    112335678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++ +|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlk  131 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK  131 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99999975 888877643  37889999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.82  E-value=1.3e-19  Score=167.73  Aligned_cols=120  Identities=25%  Similarity=0.351  Sum_probs=102.1

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc-CCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ-FEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .+|..||+|+++.....  .......+..|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            3699999999999998 78999999999753211  11234456677777765 48999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|..++... .+++..+..++.|++.||+|||++||+|||||
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlk  123 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLK  123 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            999999988654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.82  E-value=1.4e-19  Score=167.85  Aligned_cols=120  Identities=25%  Similarity=0.342  Sum_probs=99.8

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHH-HHhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||+|+||.||+|.+ .++..||+|++.....  ........+..|. .++..++||||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI--LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            3699999999999998 7888999999974321  1112223344444 4567889999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlk  123 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK  123 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            999999988654 58899999999999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.82  E-value=1.2e-19  Score=162.02  Aligned_cols=122  Identities=25%  Similarity=0.362  Sum_probs=107.8

Q ss_pred             cCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      ++|.+.+.||+|+||.||++...++..+|+|.+....      .....+..|+.++..++||||+++++++...+.+|+|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            4688899999999999999988777789999875321      1234678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++|+|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  127 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA  127 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence            999999999999864  348899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.82  E-value=2.3e-19  Score=175.35  Aligned_cols=123  Identities=21%  Similarity=0.288  Sum_probs=107.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cC-CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~-~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..|.+.+.||+|+||.||.+.. .+ +..+|+|.+..     ........+..|+.+++.++|||||++++++...+.+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            3489999999999999999987 45 67889887642     23344556778999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||++||+|.+++..     ..+++..+..++.|++.||.|||++||+|||||
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk  196 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK  196 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcC
Confidence            99999999999987753     248899999999999999999999999999998

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.82  E-value=1.1e-19  Score=162.29  Aligned_cols=125  Identities=26%  Similarity=0.403  Sum_probs=112.6

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|++.+.||.|+||.||+|.+ .++..||+|++....  .........+..|+.+++.++||||+++++.+..+..+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK--CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh--hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            588999999999999999988 689999999997532  22234567889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+.|++|..++... .+++..+..++.|++.||.|||++|++|+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~  127 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIK  127 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            9999999999999766 79999999999999999999999999999996

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.82  E-value=3.4e-19  Score=163.12  Aligned_cols=126  Identities=25%  Similarity=0.435  Sum_probs=113.4

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ....+|.+.+.||+|+||.||++.+ .++..+++|.+....     ......+.+|+.+++.+.||||+++++.+..+..
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            3456899999999999999999988 788999999987432     1234568899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .|+||||+++++|.+++....+++..+..++.|++.||.|||+.||+|||||
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLk  143 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK  143 (296)
T ss_pred             EEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9999999999999999988789999999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.82  E-value=3e-19  Score=163.53  Aligned_cols=125  Identities=26%  Similarity=0.437  Sum_probs=113.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...+|.+.+.||+|+||.||++.+ .++..||+|.+....     ......+..|+.++..++||||+++++++..++.+
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            346899999999999999999988 789999999987432     12345678999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++....+++..+..++.|++.||.|||+.||+|||||
T Consensus        92 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~  142 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK  142 (297)
T ss_pred             EEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            999999999999999988889999999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.82  E-value=1.8e-19  Score=160.30  Aligned_cols=118  Identities=30%  Similarity=0.448  Sum_probs=105.1

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVT  274 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~  274 (317)
                      +.||+|+||.||+|.+ .++..+|+|.+..    .........+.+|+.++..++||||+++++++.....+|+||||++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCc----cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            3689999999999988 7899999998753    2234455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          275 QGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       275 ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~  121 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA  121 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence            99999998653  48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.6e-21  Score=172.04  Aligned_cols=131  Identities=19%  Similarity=0.248  Sum_probs=116.9

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      -+..+++|..+++||+|.||.|.+|+. .+++.||+|++++....  ....+..-..|-++|..++||++..+...|+..
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii--akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII--AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhee--ehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            455678999999999999999999988 89999999999865432  334455567888999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||+.||.|+..+++. .|++..+.++..+|+.||.|||+++||+||||
T Consensus       241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK  295 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLK  295 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeech
Confidence            9999999999999999988765 49999999999999999999999999999998

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.2e-20  Score=180.35  Aligned_cols=117  Identities=38%  Similarity=0.639  Sum_probs=106.8

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVT  274 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~  274 (317)
                      -+||+|+||+||.|++ .+....|||.++.     ......+.+..|+.+.+.|+|.|||+|+|.+..++++-|+||-+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            4799999999999999 8888999999973     344567789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhC--CC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          275 QGSLAKIYQEY--HL--KDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       275 ggsL~~~l~~~--~l--~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+|.++++..  ++  .+..+-+|.+||++||.|||.+.|||||||
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIK  702 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIK  702 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeecccc
Confidence            99999999863  45  788889999999999999999999999998

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.82  E-value=2.4e-19  Score=163.65  Aligned_cols=126  Identities=25%  Similarity=0.498  Sum_probs=110.3

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||.|+||.||+|.+ .++..||+|.+...............+..|+.++..++||||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477889999999999999988 6899999999975433222233445677899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+ +|+|.+++....  +++..+..++.||+.||.|||++||+|+|||
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~  129 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLK  129 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence            9999 889999997654  8999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.82  E-value=1.9e-19  Score=161.38  Aligned_cols=126  Identities=28%  Similarity=0.473  Sum_probs=111.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||++.. .++..+|+|.+....  .........+.+|+.++..++||||+++++++..++.+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh--hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            5788899999999999999987 789999999886532  2233445678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||+++++|.+++..     ..+++..+..++.|++.||.|||++|++|+|||
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  133 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIK  133 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            9999999999998863     347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.82  E-value=2.7e-19  Score=162.22  Aligned_cols=118  Identities=22%  Similarity=0.282  Sum_probs=101.1

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQG  276 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~gg  276 (317)
                      ||+|+||.||++.. .+|..||+|.+.....  ........+..|+.++..++||||+++++.+..+..+|+||||++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL--KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHh--hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            79999999999988 7899999999864321  11122334567999999999999999999999999999999999999


Q ss_pred             CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          277 SLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       277 sL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|.+++...   ++++..+..++.|++.||.|||+.||+|||||
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik  122 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK  122 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCC
Confidence            999887542   48888999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.82  E-value=4.6e-19  Score=158.64  Aligned_cols=126  Identities=25%  Similarity=0.460  Sum_probs=112.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||+|.. .+|..||+|.++...  .........+.+|+.++..++|+||+++++.+...+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFE--MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccc--ccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            6799999999999999999988 689999999987532  2233446678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++|+|..++..     ..+++..+..++.|++.||.|||+.||+|||||
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~  133 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIK  133 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcC
Confidence            9999999999998864     237899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.81  E-value=9.8e-20  Score=162.77  Aligned_cols=125  Identities=27%  Similarity=0.414  Sum_probs=111.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ...+|.+.+.||.|+||.||+|.+..+..+++|.+...     .......+..|+.++..++||||+++++++.....+|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            34578899999999999999998866999999998643     2233556889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++|+|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~  131 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLA  131 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccC
Confidence            999999999999999752   48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.81  E-value=2e-19  Score=160.86  Aligned_cols=125  Identities=26%  Similarity=0.427  Sum_probs=110.3

Q ss_pred             HhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...++|++.+.||+|+||.||+|...++..||+|.+...      ....+.+..|+.++..++||||+++++.+...+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            345689999999999999999998877788999987532      12356788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||+++|+|.+++..   ..+++..+..++.|++.||.|||+.|++|||||
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~  130 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLR  130 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence            999999999999999864   347888899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.81  E-value=4.2e-19  Score=159.20  Aligned_cols=127  Identities=41%  Similarity=0.707  Sum_probs=111.4

Q ss_pred             CeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCC-CccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQG-TQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||+|+||.||+|...++..+|+|.+...... .........+.+|+.+++.++||||+++++++.+.+.+|++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47788999999999999998888999999998754221 11233456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+|+|||
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  129 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK  129 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcC
Confidence            999999999999876 458999999999999999999999999999996

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.81  E-value=2.1e-19  Score=171.35  Aligned_cols=118  Identities=18%  Similarity=0.195  Sum_probs=105.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...+|.+.+.||+|+||.||+|.+ .+++.||+|...           ...+.+|+.+++.++||||+++++++......
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            346799999999999999999998 889999999653           12356899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||++. ++|..++.. .++++..+..++.||+.||.|||++||||||||
T Consensus       159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiK  209 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIK  209 (391)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            99999995 588887754 458999999999999999999999999999998

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=2.4e-19  Score=166.59  Aligned_cols=118  Identities=22%  Similarity=0.320  Sum_probs=99.4

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEEeCCEEEEEEecC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      ||+|+||.||+|.+ .++..||+|++.....  ...........|..++..+   +||||+.+++.+.....+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            79999999999988 7899999999864321  1122333455566666554   7999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|..++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlk  123 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLK  123 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence            999999888654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.81  E-value=2.1e-19  Score=162.68  Aligned_cols=116  Identities=19%  Similarity=0.261  Sum_probs=99.2

Q ss_pred             cccccCCeeEEEEEe-cC------------------------CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC
Q 021084          197 PLGSGSFGSVYEGFT-DD------------------------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD  251 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~-~~------------------------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp  251 (317)
                      .||+|+||.||+|.. .+                        ...+++|.+...     .......+..|+.+++.++||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----HRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----HHHHHHHHHHHHHHHhcCCCC
Confidence            599999999999864 11                        135788887522     233456788899999999999


Q ss_pred             ceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       252 nIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++++++...+..|+||||+++|+|..++..  +.+++..+..++.||+.||+|||++||+|||||
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlk  144 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVC  144 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCC
Confidence            999999999999999999999999999998864  458999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.81  E-value=7.8e-19  Score=156.55  Aligned_cols=123  Identities=24%  Similarity=0.379  Sum_probs=109.5

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||.|+||.||++.+ .++..+|+|.+....    .....+.+..|+.++..++||||+++++.+.+++.+|++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            478899999999999999988 789999999986432    233456788899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++|+|.+++..   ..+++..+..++.|++.||.|||++||+|+|||
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~  127 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIK  127 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            999999999998864   237899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.81  E-value=1.6e-21  Score=168.39  Aligned_cols=126  Identities=26%  Similarity=0.418  Sum_probs=112.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.|.+.+.||+|.|+.|++|.+ .+|+.+|+|.+......   ....+.+.+|+++-..|+||||++++......+..|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~---~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc---cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            45677889999999999999988 89999999999765432   236778899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHH-HHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~-~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+|++.|++|.. +.++.-+++..+..++.||++||.|+|.+||||||+|
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvk  137 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLK  137 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCC
Confidence            9999999999965 5566568899999999999999999999999999997

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.81  E-value=2.5e-19  Score=160.43  Aligned_cols=124  Identities=31%  Similarity=0.396  Sum_probs=109.8

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..++|.+.+.||+|+||.||+|...++..||+|.+....      .....+..|+.++..++||||+++++++...+.+|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc------ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            346789999999999999999988677889999986422      12456788999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  130 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA  130 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            999999999999998653   48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.81  E-value=6.8e-19  Score=159.49  Aligned_cols=120  Identities=24%  Similarity=0.368  Sum_probs=106.7

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|++.+.||+|+||.||+|.+ .++..||+|.+...    ........+..|+.++..++||||+++++.+...+..++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            577889999999999999988 78999999998643    1233456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|..+   ..+++..+..++.|++.||.|||+.||+|+|||
T Consensus        78 ~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  122 (279)
T cd06619          78 TEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK  122 (279)
T ss_pred             EecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCC
Confidence            999999999755   347888899999999999999999999999997

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.81  E-value=7.9e-19  Score=156.44  Aligned_cols=124  Identities=27%  Similarity=0.401  Sum_probs=111.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|+..+.||.|+||.||.+.. .++..+++|.+....   ........+.+|+.++++++||||+++++++...+.++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            588999999999999999988 889999999987542   2334456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++...   .+++..+..++.|++.||.|||+.|++|+|||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~  128 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIK  128 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence            9999999999998764   48899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.81  E-value=5.9e-19  Score=159.95  Aligned_cols=123  Identities=31%  Similarity=0.442  Sum_probs=106.8

Q ss_pred             cCeeeeccccccCCeeEEEEEe-----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--  262 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--  262 (317)
                      .+|++.+.||+|+||.||.+..     .++..||+|.+..     ........+..|+.++..++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-----STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            4688999999999999999863     4688999999863     234456678899999999999999999998754  


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+|+||||+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlk  135 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLA  135 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence            45689999999999999998653  48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.81  E-value=3.2e-19  Score=159.65  Aligned_cols=123  Identities=24%  Similarity=0.365  Sum_probs=108.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..+|.+.+.||+|+||.||.+....+..+|+|.+....      .....+.+|+.++..++||||+++++++...+.+|+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS------MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc------ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            35688999999999999999977666679999886321      123568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||+++|+|.+++...  .+++..+..++.|++.||.|||+.|++|+|||
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  127 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA  127 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence            99999999999998753  48999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.81  E-value=2.6e-19  Score=162.41  Aligned_cols=124  Identities=30%  Similarity=0.500  Sum_probs=110.7

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|++++.||+|+||.||++.+ .++..||+|.+...    ........+.+|+.++..++||||+++++.+...+.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            3678899999999999999988 68999999988642    233445678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~----~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      ||||+++++|..++...    .+++..+..++.|++.||.|||+ .||+|||||
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~  130 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK  130 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCC
Confidence            99999999999998764    68999999999999999999997 599999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.81  E-value=1.8e-19  Score=172.26  Aligned_cols=97  Identities=25%  Similarity=0.359  Sum_probs=80.9

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQY  256 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l  256 (317)
                      .|....++|.+.+.||+|+||.||+|.+      ..+..||+|++....    .......+..|+.+|..+. ||||+++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~~H~niv~~  106 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----RSSEKQALMSELKIMSHLGPHLNIVNL  106 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence            3555667788999999999999999975      235689999996421    2233456889999999997 9999999


Q ss_pred             eeEEEeCCEEEEEEecCCCCCHHHHHHh
Q 021084          257 FGTEKDENKLYIFLELVTQGSLAKIYQE  284 (317)
Q Consensus       257 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~  284 (317)
                      ++++...+.+|+|||||++|+|.+++..
T Consensus       107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~  134 (401)
T cd05107         107 LGACTKGGPIYIITEYCRYGDLVDYLHR  134 (401)
T ss_pred             EEEEccCCCcEEEEeccCCCcHHHHHHh
Confidence            9999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.81  E-value=5.9e-19  Score=158.26  Aligned_cols=127  Identities=43%  Similarity=0.748  Sum_probs=110.4

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc----cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ----GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      +|.+...||.|+||.||.|.+ .++..+|+|.+........    .......+..|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467889999999999999988 7789999998865432221    12334678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|||||
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~  133 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIK  133 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence            99999999999999999764 58899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.81  E-value=4.4e-19  Score=159.50  Aligned_cols=125  Identities=26%  Similarity=0.391  Sum_probs=108.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCC---CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDG---FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ..+|++.+.||+|+||.||+|.+ .++   ..+|+|.+...    ........+..|+.++..++||||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            35788999999999999999987 333   37899987532    22334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++++|.+++...  .+++..+..++.|++.||.|||++|++|||||
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlk  133 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA  133 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhc
Confidence            999999999999999998754  47899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.81  E-value=6.2e-19  Score=161.89  Aligned_cols=126  Identities=21%  Similarity=0.301  Sum_probs=111.2

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||++.+ .++..|++|.+....  .........+..|+.++..++||||+++++.+..++.+|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN--LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh--hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence            4688999999999999999988 788999999986432  1123345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++|++|.+++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  128 (305)
T cd05609          79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLK  128 (305)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence            99999999999998654 48899999999999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=9.7e-19  Score=156.10  Aligned_cols=124  Identities=35%  Similarity=0.550  Sum_probs=111.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||.|+||.||+|.. .++..+++|++....     ......+..|+.+++.++||||+++++.+...+.+|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            36799999999999999999988 778899999997432     224577889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++..  ..+++..+..++.|++.||.|||++||+|+|||
T Consensus        77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~  128 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIK  128 (262)
T ss_pred             EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Confidence            99999999999998865  468999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.81  E-value=4.2e-19  Score=163.08  Aligned_cols=126  Identities=23%  Similarity=0.415  Sum_probs=107.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCE--EEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFF--FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~--vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..  +++|.+..    .........+.+|+.++.++ +||||+++++++...
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            356889999999999999999987 56654  46666542    22334556788999999999 899999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||+++|+|.+++...                 .+++..+..++.|++.||+|||++||+|||||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlk  151 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA  151 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence            9999999999999999998643                 36888999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=7e-19  Score=162.13  Aligned_cols=126  Identities=21%  Similarity=0.342  Sum_probs=112.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|++.+.||+|+||.||+|.. .++..||+|.+....  .........+..|+.++..++||||+++++.+......|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE--MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc--cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            3688999999999999999988 679999999997542  2222356678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+.|++|.+++...   .+++..+..++.|++.||.|||+.|++|+|||
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  130 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLK  130 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            99999999999998753   48999999999999999999999999999997

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.81  E-value=7.4e-19  Score=156.32  Aligned_cols=124  Identities=27%  Similarity=0.456  Sum_probs=111.0

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||+|++|.||++.. .++..|++|.+....   ........+..|+.+++.++||||+++++++...+.+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK---MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh---CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            477889999999999999988 789999999987432   2344567788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||++|++|.+++...   .+++..+..++.|++.||.|||+.||+|+|||
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~  128 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIK  128 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9999999999998663   48899999999999999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.81  E-value=5.7e-19  Score=161.74  Aligned_cols=124  Identities=27%  Similarity=0.476  Sum_probs=108.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|.+.+.||.|+||.||+|.+ .++..||+|.+.....    ......+..|+.++..++||||+++++++..++.+|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc----cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            57899999999999999999988 7889999999875321    112335678999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||++ ++|.+++...  .+++..+..++.|++.||.|||++||+|+|||
T Consensus        81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlk  131 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK  131 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            9999997 4898887653  48899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.81  E-value=1e-18  Score=156.98  Aligned_cols=128  Identities=38%  Similarity=0.698  Sum_probs=110.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CCEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--ENKL  266 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~  266 (317)
                      .+|...+.||+|+||.||++.+ .++..|++|.+...............+.+|+.++..++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999988 789999999987543223333456678899999999999999999998875  4678


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||+++++|.+++... .+++.....++.|++.||.|||++||+|||||
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~  133 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIK  133 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            9999999999999988654 58899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.81  E-value=3.3e-19  Score=160.72  Aligned_cols=124  Identities=24%  Similarity=0.385  Sum_probs=108.1

Q ss_pred             cCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .+|.+...||.|+||.||+|...      +...+++|.+...    ........+..|+.++.+++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            57889999999999999999852      3467899987532    2233566788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY----------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~----------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +..|+||||+++|+|.+++...          .+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlk  144 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLA  144 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCc
Confidence            9999999999999999998653          38899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.81  E-value=2.1e-19  Score=168.16  Aligned_cols=127  Identities=25%  Similarity=0.366  Sum_probs=106.1

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGT  259 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~  259 (317)
                      ...++|++.+.||+|+||.||+|.+      .+++.||||.++..    ........+..|+.++..+ +||||++++++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC----CChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            3456899999999999999999973      45789999998642    1233456788999999999 78999999998


Q ss_pred             EEe-CCEEEEEEecCCCCCHHHHHHhC-----------------------------------------------------
Q 021084          260 EKD-ENKLYIFLELVTQGSLAKIYQEY-----------------------------------------------------  285 (317)
Q Consensus       260 ~~~-~~~~~lVmE~~~ggsL~~~l~~~-----------------------------------------------------  285 (317)
                      +.. +..++++||||++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            765 45689999999999999988542                                                     


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          286 ---------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       286 ---------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                     .+++..+..++.|++.||.|||++||+|||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik  206 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLA  206 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCc
Confidence                           25677788899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.81  E-value=6e-19  Score=160.76  Aligned_cols=124  Identities=30%  Similarity=0.496  Sum_probs=111.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      -+.|++++.||.|+||.||+|.+ .++..+++|.+..     ........+..|+.+++.++||||+++++.+..++.+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            35688999999999999999988 7789999999863     23455677889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|..++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk  137 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK  137 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCC
Confidence            99999999999887753  458999999999999999999999999999997

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.81  E-value=7.1e-19  Score=159.15  Aligned_cols=125  Identities=22%  Similarity=0.395  Sum_probs=109.4

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|++...||+|+||.||++.+ .++..||+|++.....   .....+.+..|+.+++.++||||+++++++..+..+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED---DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc---CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            4688999999999999999988 6799999999864321   12223457799999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++++|..++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~  127 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK  127 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence            99999998888877543 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.81  E-value=5.2e-19  Score=159.03  Aligned_cols=125  Identities=28%  Similarity=0.432  Sum_probs=109.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC---EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF---FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ..+|++.+.||+|+||.||+|.. .++.   .||+|.+...    ........+..|+.++..++||||+++++++..+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            35688999999999999999987 4443   6999988532    23445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+++||||+++++|.+++...  .+++..+..++.|++.||.|||++|++|+|||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~  133 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLA  133 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence            999999999999999998753  48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.81  E-value=3.8e-19  Score=164.21  Aligned_cols=124  Identities=23%  Similarity=0.408  Sum_probs=106.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC----EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF----FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ..+|++.+.||+|+||.||+|.+ .++.    .||+|.+..    .........+..|+.+++.++||||+++++++...
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            35789999999999999999986 4444    489998853    22344566788999999999999999999998765


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..+++++|+++|+|.+++...  .+++..+..++.||+.||+|||++||+|||||
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlk  136 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLA  136 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccc
Confidence             578999999999999998764  47888899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=1.2e-18  Score=156.48  Aligned_cols=128  Identities=38%  Similarity=0.649  Sum_probs=111.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--CEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--NKL  266 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~  266 (317)
                      .+|.+.+.||+|+||.||++.+ .++..||+|.+...............+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688999999999999999988 7899999998864322223345567888999999999999999999998763  568


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+|||
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~  133 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIK  133 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            999999999999998875 458899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.80  E-value=3.1e-19  Score=168.74  Aligned_cols=123  Identities=30%  Similarity=0.489  Sum_probs=106.5

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC-----
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN-----  264 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----  264 (317)
                      +|++.+.||+|+||.||++.+ .++..||+|.+...   .........+.+|+.++..++||||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV---FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc---ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            477889999999999999998 78999999988632   223344567889999999999999999999998876     


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk  130 (372)
T cd07853          78 EIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIK  130 (372)
T ss_pred             eEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            8999999996 478777654 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.80  E-value=8.1e-19  Score=160.72  Aligned_cols=124  Identities=24%  Similarity=0.451  Sum_probs=112.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..+|.+.+.||.|+||.||++.+ .++..|++|.+....     ......+.+|+.+++.++||||+.+++++.....+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            45799999999999999999988 889999999986432     223456789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|..++....+++..+..++.|++.||.|||++|++|||||
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~  142 (296)
T cd06655          93 VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK  142 (296)
T ss_pred             EEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99999999999999988889999999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.80  E-value=4.5e-19  Score=163.00  Aligned_cols=130  Identities=25%  Similarity=0.428  Sum_probs=110.6

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-c-------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCcee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-D-------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV  254 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv  254 (317)
                      ++....++|.+++.||+|+||.||.+.+ .       +...+|+|.+...    ........+..|+.++..+ +||||+
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNII   87 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEe
Confidence            4555567899999999999999999975 1       2346999988632    1233456788899999999 799999


Q ss_pred             eeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       255 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++++...+.+|+||||+++|+|.+++...                 .+++..+..++.|++.||+|||++|++|||||
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  167 (307)
T cd05098          88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA  167 (307)
T ss_pred             eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            9999999999999999999999999998652                 37888899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.80  E-value=8.3e-19  Score=158.63  Aligned_cols=124  Identities=29%  Similarity=0.528  Sum_probs=111.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..|+..+.||.|+||.||.|.+ .++..+|+|.+....    .......+..|+.+++.++||||+++++.+.+.+..|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            3566788999999999999988 678999999987432    23446778899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++||+|.+++..+++++..+..++.|++.||.|||+.|++|+||+
T Consensus        80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~  128 (277)
T cd06640          80 IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK  128 (277)
T ss_pred             EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCC
Confidence            9999999999999988889999999999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.80  E-value=6.3e-19  Score=181.26  Aligned_cols=128  Identities=28%  Similarity=0.472  Sum_probs=111.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--C
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--E  263 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~  263 (317)
                      ..+++|.++..||.|+||.||+|.+ .++..+|+|++....   ........+..|+.++..++|||||+++++|..  .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~---l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG---LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc---cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            4467999999999999999999998 788899999987432   233456778899999999999999999998855  4


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-------CcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQ-------NVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~-------gIvHrDLK  317 (317)
                      ..+||||||+++|+|.+++..     ..+++..++.|+.||+.||.|||+.       +|||||||
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLK  152 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLK  152 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCc
Confidence            679999999999999998864     3589999999999999999999985       49999998

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.80  E-value=7.6e-19  Score=165.19  Aligned_cols=126  Identities=28%  Similarity=0.436  Sum_probs=107.0

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--  263 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--  263 (317)
                      ...++|.+.+.||+|+||.||++.+ .+|..||+|.+....   ........+.+|+.++..++||||+++++++...  
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   94 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence            4468999999999999999999988 789999999986432   2334456778999999999999999999998654  


Q ss_pred             ----CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ----NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ----~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          ..+|+||||+++ +|...+. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk  150 (359)
T cd07876          95 LEEFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  150 (359)
T ss_pred             ccccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence                357999999976 6666654 358889999999999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.80  E-value=6.5e-19  Score=158.14  Aligned_cols=125  Identities=29%  Similarity=0.413  Sum_probs=109.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|.+.+.||+|+||.||+|.. .   +...+|+|.++..    ........+..|+.++..++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            35688999999999999999987 2   2458999987632    23344567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..|++|||+++++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~  133 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLA  133 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            999999999999999998653  58999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.80  E-value=7.1e-19  Score=159.97  Aligned_cols=124  Identities=28%  Similarity=0.484  Sum_probs=108.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|.+.+.||.|++|.||+|.+ .++..||+|.+.......    ....+.+|+.+++.++||||+++++++.+.+..|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            57899999999999999999988 688999999987532111    1234568999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++ +|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~  130 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLK  130 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Confidence            99999975 999988653  47899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.80  E-value=8.2e-19  Score=158.79  Aligned_cols=123  Identities=30%  Similarity=0.515  Sum_probs=107.1

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||.|++|.||+|.+ .++..||+|.+....   ........+..|+.++..++||||+++++++..++.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc---ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            478899999999999999988 789999999986432   1222345677899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||++ ++|.+++..    ..+++..+..++.|++.||.|||++||+|||||
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~  128 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLK  128 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence            99997 588888754    348999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.80  E-value=6.7e-19  Score=160.97  Aligned_cols=124  Identities=27%  Similarity=0.453  Sum_probs=112.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||++.+ .++..|++|.+...     .......+..|+.++..++||||+++++.+...+..|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            47899999999999999999987 78899999998632     2223466889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||+++++|.+++....+++..+..++.|++.||.|||++|++|||||
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~  142 (293)
T cd06647          93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK  142 (293)
T ss_pred             EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCC
Confidence            99999999999999988889999999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.80  E-value=5.9e-19  Score=159.97  Aligned_cols=125  Identities=26%  Similarity=0.403  Sum_probs=108.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .++|++.+.||+|+||.||+|..     .++..+++|.+...    ........+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            46788999999999999999974     35678999988632    2334456788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY------------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~------------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...|++|||+++++|.+++...                  .+++..+..++.|++.||.|||++||+|||||
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  151 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLA  151 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccc
Confidence            9999999999999999988521                  26788889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.80  E-value=4.6e-19  Score=159.03  Aligned_cols=123  Identities=28%  Similarity=0.426  Sum_probs=109.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..+|.+.+.||.|+||.||+|.+ .++..+|+|.+...      ......+.+|+.++..++||||+++++++...+.++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            45688899999999999999988 77899999988532      223456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++...   .+++..+..++.|++.||.|||++|++|||||
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk  131 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA  131 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC
Confidence            999999999999998653   38899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.80  E-value=5.7e-19  Score=157.82  Aligned_cols=125  Identities=30%  Similarity=0.408  Sum_probs=110.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...++|.+.+.||+|+||.||++...++..+|+|.+....      .....+..|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT------MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc------cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            3467899999999999999999988777889999886422      1235688999999999999999999999998999


Q ss_pred             EEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||+++++|.+++...   .+++..+..++.|++.||.|||++||+|+|||
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~  130 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA  130 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence            9999999999999998653   48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.80  E-value=1.1e-18  Score=155.19  Aligned_cols=124  Identities=24%  Similarity=0.393  Sum_probs=110.8

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|...+.||+|+||.||++.. .++..+|+|.+....   ........+..|+.+++.++||||+++++.+...+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            588899999999999999988 789999999987532   2234467788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++...   .+++..+..++.|++.||.|||++||+|+|||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~  128 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLK  128 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999998753   38899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.80  E-value=8.1e-19  Score=158.73  Aligned_cols=123  Identities=30%  Similarity=0.564  Sum_probs=110.4

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      -|...+.||.|+||.||+|.+ .++..+|+|.+...    ........+.+|+.++..++||||+++++++..++..|+|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            356778899999999999988 78899999987532    2233456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++....+++..+..++.|++.||.|||+.|++|+|||
T Consensus        81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~  128 (277)
T cd06641          81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK  128 (277)
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCC
Confidence            999999999999988889999999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.80  E-value=7.9e-19  Score=157.99  Aligned_cols=127  Identities=37%  Similarity=0.608  Sum_probs=109.6

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCC-----ccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGT-----QGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~-----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      +|.+.+.||.|+||.||+|.. .++..+|+|.+.......     ......+.+..|+.++..++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            577889999999999999988 789999999886422111     11223456888999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+++||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  135 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLK  135 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCC
Confidence            99999999999999999876 458899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.80  E-value=2.7e-19  Score=167.05  Aligned_cols=126  Identities=29%  Similarity=0.436  Sum_probs=108.7

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC---
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE---  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---  263 (317)
                      ..++|.+.+.||.|+||.||+|.+ .++..||+|.+....   ........+.+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            356899999999999999999998 788999999986421   2223445677899999999999999999987543   


Q ss_pred             ---CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ---NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ---~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ..+|++|+++ +++|..++....+++..+..++.||+.||.|||++||+|||||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdik  145 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLK  145 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence               4579999998 7799999888889999999999999999999999999999997

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.80  E-value=2.2e-19  Score=178.04  Aligned_cols=128  Identities=20%  Similarity=0.354  Sum_probs=109.7

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEE-E
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTE-K  261 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~-~  261 (317)
                      +.....++++.+.|.+|||+.||++.+ ..|..||+|++-     ..++.....+.+|+.+|+.|. |+|||.|++.. .
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~-----~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMY-----VNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeee-----cCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            344455778899999999999999999 555999999886     346778889999999999995 99999999932 1


Q ss_pred             e------CCEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          262 D------ENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       262 ~------~~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                      .      .-.+.|.||||.||.|-+++..   .+|++.+++.|+.|+++|+.+||...  |||||||
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLK  173 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLK  173 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhh
Confidence            1      2458899999999999999863   35999999999999999999999996  9999998

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.80  E-value=4.6e-19  Score=158.60  Aligned_cols=124  Identities=23%  Similarity=0.386  Sum_probs=107.3

Q ss_pred             HhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...++|++.+.||+|+||.||+|...++..||+|.+....      .....+..|+.++..++||||+++++++. .+.+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS------MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI   75 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC------CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence            3456789999999999999999988888899999986332      12346889999999999999999999874 4668


Q ss_pred             EEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |++|||+++++|.+++..   ..+++..+..++.|++.||.|||+.|++|||||
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~  129 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLR  129 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence            999999999999998864   248889999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.80  E-value=5.7e-19  Score=157.79  Aligned_cols=122  Identities=24%  Similarity=0.314  Sum_probs=107.1

Q ss_pred             cCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .+|.+.+.||+|+||.||++.+.++..+|+|.+.....      ....+..|+.++..++||||+++++++...+..|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            35778999999999999999877777899998853221      124577899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||++|++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~  127 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLA  127 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            9999999999998653  48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.80  E-value=7.9e-19  Score=159.80  Aligned_cols=123  Identities=28%  Similarity=0.458  Sum_probs=108.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .+|.+.+.||.|+||.||++..      .++..+|+|.+..     ........+..|+.++.+++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            5788999999999999999974      2356789998752     2344566789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||+++++|.+++...              .+++..+..++.|++.||+|||++|++|||||
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlk  147 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA  147 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccC
Confidence            9999999999999999998643              28999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.80  E-value=5.8e-19  Score=158.56  Aligned_cols=121  Identities=29%  Similarity=0.428  Sum_probs=103.6

Q ss_pred             eeeccccccCCeeEEEEEec-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          193 QKGAPLGSGSFGSVYEGFTD-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.+.||.|.||.||+|...     .+..|+||.+..    .........+..|+..+.+++||||++++|++...+.++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence            46789999999999999775     357899999842    334455788999999999999999999999999888899


Q ss_pred             EEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||++|+|.+++...   .+++.....++.|++.||.|||+++|+|+||+
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~  130 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLS  130 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999875   58999999999999999999999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.80  E-value=1.1e-18  Score=158.05  Aligned_cols=121  Identities=31%  Similarity=0.545  Sum_probs=108.0

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |++.+.||.|+||.||++.+ .++..+++|.+..     ........+..|+.+++.++||||+++++.+..++..|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC-----CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence            56788999999999999988 6788999998853     23445667889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++++|..++..  .++++..+..++.|++.||.|||+.||+|||||
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlk  130 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK  130 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            99999999988754  458999999999999999999999999999997

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.80  E-value=3.6e-19  Score=160.90  Aligned_cols=123  Identities=31%  Similarity=0.549  Sum_probs=110.3

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|...+.||+|+||.||+|.+ .++..||+|.+...    ........+..|+.+++.++||||+++++.+..++.+|+|
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc----cchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            456778899999999999988 77889999988632    1233456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++....+++..+..++.|++.||.|||++|++|+|||
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~  128 (277)
T cd06642          81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK  128 (277)
T ss_pred             EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCC
Confidence            999999999999988889999999999999999999999999999996

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.80  E-value=7e-19  Score=160.13  Aligned_cols=127  Identities=24%  Similarity=0.343  Sum_probs=106.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTE  260 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~  260 (317)
                      ...++|.+.+.||+|+||.||+|...      .+..||+|.+...    ........+..|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            44678999999999999999998642      2458999987532    2223345678899999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          261 KDENKLYIFLELVTQGSLAKIYQEY-----------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       261 ~~~~~~~lVmE~~~ggsL~~~l~~~-----------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+..|+||||+++|+|.+++...           ..+...+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dik  146 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLA  146 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCC
Confidence            9999999999999999999998642           13566788899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.80  E-value=6.1e-19  Score=161.76  Aligned_cols=130  Identities=25%  Similarity=0.460  Sum_probs=110.3

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe--------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCcee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT--------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV  254 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~--------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv  254 (317)
                      .|....++|.+.+.||+|+||.||.+..        .++..+|+|.+...    ........+..|+.++..+ +||||+
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~   84 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNII   84 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCch
Confidence            3556677899999999999999999964        23457999987532    2234456788999999999 899999


Q ss_pred             eeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       255 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++++...+.+|++|||+++|+|.+++...                 .+++..+..++.||+.||.|||++||+|||||
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk  164 (304)
T cd05101          85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA  164 (304)
T ss_pred             heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            9999999999999999999999999998652                 36778889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.80  E-value=9.8e-19  Score=159.31  Aligned_cols=125  Identities=24%  Similarity=0.325  Sum_probs=108.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cC----------------CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DD----------------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD  251 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~----------------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp  251 (317)
                      ..+|.+.+.||+|+||.||++.. ..                +..+|+|.+...    ........+..|+.++..++||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----ASDNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhcCCC
Confidence            45788999999999999999876 32                246899988632    2234567788999999999999


Q ss_pred             ceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       252 nIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++++++...+.++++|||+++++|.+++...            .+++..+..++.|++.||.|||++||+|||||
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk  157 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA  157 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            9999999999999999999999999999998654            37899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.80  E-value=1.1e-18  Score=158.25  Aligned_cols=123  Identities=33%  Similarity=0.467  Sum_probs=106.6

Q ss_pred             Ce-eeeccccccCCeeEEEEEe-----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--
Q 021084          191 SW-QKGAPLGSGSFGSVYEGFT-----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--  262 (317)
Q Consensus       191 ~y-~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--  262 (317)
                      +| ++.+.||+|+||+||++..     .++..+|+|.+...    ........+.+|+.+++.++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE----CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc----cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            44 7889999999999988642     46789999998642    122345678899999999999999999998865  


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+|++|||+++++|.+++....+++..+..++.|++.||.|||++||+|||||
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlk  134 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLA  134 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccC
Confidence            3468999999999999999988889999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.80  E-value=2e-18  Score=156.99  Aligned_cols=123  Identities=28%  Similarity=0.487  Sum_probs=99.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-c-CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEE----
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-D-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEK----  261 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----  261 (317)
                      +|.+.+.||+|+||.||+|.+ . ++..||+|.+.......   .....+.+|+.++..+   +||||+++++++.    
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC---CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            688999999999999999987 3 56889999987543211   1223445666666554   7999999999885    


Q ss_pred             -eCCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 -DENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 -~~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ....+++||||++ ++|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk  137 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK  137 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence             2456999999996 5899888643   48899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.80  E-value=9.8e-19  Score=157.27  Aligned_cols=118  Identities=23%  Similarity=0.362  Sum_probs=99.0

Q ss_pred             ccccccCCeeEEEEEec---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          196 APLGSGSFGSVYEGFTD---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      +.||+|+||.||+|...   ....+++|.+..    .........+.+|+.+++.++||||+++++.+...+.+|+||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRA----SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCc----cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            35899999999999653   344677776642    22334456688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQEYH------LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~~~------l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|+|.+++....      .++..+..++.||+.||.|||++||+|||||
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  127 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLA  127 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEeccccc
Confidence            99999999986532      3567788999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=1.3e-18  Score=156.88  Aligned_cols=124  Identities=29%  Similarity=0.492  Sum_probs=112.1

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||.|+||.||++.+ .++..+|+|.+....    .......+..|+.+++.++||||+++++++.++..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            3678889999999999999988 789999999986431    23345668899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||+++++|.+++....+++..+..++.|++.||.|||+.|++|+||+
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~  125 (274)
T cd06609          77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIK  125 (274)
T ss_pred             EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999999999999988889999999999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=2.5e-20  Score=188.05  Aligned_cols=132  Identities=20%  Similarity=0.271  Sum_probs=117.2

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      +.....++|.++++||+|+||.|.+++. .+++.||+|++.+...  .......-|..|-.+|...+.+.|++++.+|++
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM--lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM--LKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH--hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455567999999999999999999998 8999999999975321  112234568888899999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..++|+|||||+||+|-.++.+.. +++..+.+|+..|+.||.-||+.|+||||||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiK  202 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIK  202 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCC
Confidence            999999999999999999999877 9999999999999999999999999999998

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.79  E-value=1.8e-18  Score=154.56  Aligned_cols=124  Identities=35%  Similarity=0.761  Sum_probs=112.1

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||+|+||.||.+.. .++..|++|.+....   ........+..|+.+++.++||||+++++.+...+.+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD---NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc---cchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            578899999999999999988 688999999987543   2245678899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+++++|.+++...+ +++..+..++.|++.||.|||+.||+|+|||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~  126 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK  126 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99999999999987653 7889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.79  E-value=1.1e-18  Score=157.78  Aligned_cols=125  Identities=31%  Similarity=0.434  Sum_probs=108.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      .++|.+.+.||+|+||.||+|.+ .     .+..|++|.+...    ........+..|+.+++.++||||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            35688999999999999999987 4     5678999987532    223344568899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY--------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~--------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+..++||||++|++|.+++...        .+++..+..++.||+.||.|||++|++|||||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk  143 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIA  143 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence            99999999999999999998653        37889999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.79  E-value=8.1e-19  Score=156.52  Aligned_cols=122  Identities=30%  Similarity=0.439  Sum_probs=109.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..+|.+.+.||.|+||.||+|.. .|..+|+|.+....      ...+.+..|+.++..++||||+++++++.+.+..|+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDS------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccch------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            46788999999999999999965 47889999986321      146678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++++|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~  129 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA  129 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcc
Confidence            99999999999998754   48999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.79  E-value=1.1e-18  Score=158.49  Aligned_cols=123  Identities=29%  Similarity=0.452  Sum_probs=106.7

Q ss_pred             CeeeeccccccCCeeEEEEEe-----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--  263 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--  263 (317)
                      .|++.+.||+|+||.||.+..     .++..||+|.+...    ........+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc----ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            367889999999999999973     46789999998632    2334456789999999999999999999998774  


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+++||||++|++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlk  136 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA  136 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            6789999999999999998654  47899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.79  E-value=1.6e-18  Score=155.84  Aligned_cols=123  Identities=34%  Similarity=0.561  Sum_probs=107.1

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +++.....||+|+||.||+|.+ .++..|++|.+...     .......+.+|+.++..++||||+++++++..++.+++
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3444456899999999999987 77889999988632     33455678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC--CC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY--HL--KDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~--~l--~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||+++++|.+++...  .+  ++..+..++.|++.||.|||++||+|||||
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~  135 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK  135 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence            99999999999998753  35  788888999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.79  E-value=1.8e-18  Score=156.49  Aligned_cols=123  Identities=22%  Similarity=0.391  Sum_probs=109.7

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||.|+||.||+|.+ .+|..||+|.+.....   .......+..|+.+++.++||||+++++++..+..+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL---EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc---cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            488999999999999999988 7899999999875431   223456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+ +++|.+++..  ..+++..+..++.||+.||.|||+.||+|+|||
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  126 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK  126 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcC
Confidence            9999 9999998864  348999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.79  E-value=8e-19  Score=160.31  Aligned_cols=125  Identities=22%  Similarity=0.330  Sum_probs=106.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cC--------------CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCce
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DD--------------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI  253 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~--------------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI  253 (317)
                      ..+|++.+.||+|+||.||+|.. ..              ...||+|.+...    ........+.+|+.++..++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i   79 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----VTKTARNDFLKEIKIMSRLKNPNI   79 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCc
Confidence            35788999999999999999875 21              235899988632    233445678899999999999999


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++++++...+..|+||||+++++|.+++...             .+++..+..++.|++.||.|||++|++|||||
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  156 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA  156 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence            99999999999999999999999999988643             25778889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.79  E-value=1.1e-18  Score=160.96  Aligned_cols=131  Identities=27%  Similarity=0.457  Sum_probs=110.6

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEe--------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCce
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFT--------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNI  253 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~--------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnI  253 (317)
                      ..|....++|.+.+.||+|+||.||++..        .....+|+|.+...    ........+..|+.++..+ +||||
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i   80 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNI   80 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCe
Confidence            34555567899999999999999999975        13457899987632    2234456788999999999 69999


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +++++++...+.+|++|||+++|+|.+++...                 .+++..+..++.|++.||.|||++||+||||
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl  160 (314)
T cd05099          81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL  160 (314)
T ss_pred             eeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence            99999999999999999999999999998642                 3788889999999999999999999999999


Q ss_pred             C
Q 021084          317 A  317 (317)
Q Consensus       317 K  317 (317)
                      |
T Consensus       161 k  161 (314)
T cd05099         161 A  161 (314)
T ss_pred             c
Confidence            7

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.79  E-value=8.1e-19  Score=165.15  Aligned_cols=118  Identities=23%  Similarity=0.209  Sum_probs=103.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...+|.+.+.||+|+||.||+|.+ .++..||+|+....           ....|+.++..++||||+++++++...+..
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  132 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT  132 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence            345799999999999999999988 67889999975321           123689999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||++. ++|.+++..  ..+++..+..++.||+.||.|||++||||||||
T Consensus       133 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  184 (357)
T PHA03209        133 CMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVK  184 (357)
T ss_pred             EEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99999995 588887754  358999999999999999999999999999998

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=2.1e-20  Score=172.64  Aligned_cols=124  Identities=30%  Similarity=0.557  Sum_probs=113.8

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..|..++.||+|+||.||+|.+ .+++.||+|++....    .....+.+.+|+.++.++++|||.++|+.+..+..+|+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~----~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE----AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh----cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            4577779999999999999999 899999999998643    34456778899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCCC-CHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEYHL-KDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~l-~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||.||++.++++.+++ .+..+..++.+++.||.|||.++.+|||||
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIK  138 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIK  138 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceeccccc
Confidence            9999999999999998875 899999999999999999999999999998

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.7e-18  Score=169.94  Aligned_cols=127  Identities=21%  Similarity=0.288  Sum_probs=109.7

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC--
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN--  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--  264 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++....   ........+..|+.++..++|+||++++..+...+  
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG---MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            356899999999999999999988 789999999997542   23455667889999999999999999988775432  


Q ss_pred             ------EEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 ------KLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ------~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                            .+++||||+++|+|.+++..     ..+++..+..++.|++.||.|||++||+|||||
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLK  170 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIK  170 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence                  47899999999999998864     248899999999999999999999999999998

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.79  E-value=2.9e-19  Score=160.02  Aligned_cols=117  Identities=19%  Similarity=0.276  Sum_probs=100.5

Q ss_pred             ccccccCCeeEEEEEe-cCC-------CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          196 APLGSGSFGSVYEGFT-DDG-------FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~-------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +.||.|+||.||+|.. ..+       ..+++|.+..     ......+.+..|+.+++.++||||+++++++..++..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            3699999999999976 333       3478887642     22344567888999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++|+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlk  127 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVC  127 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence            999999999999999754  37899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.79  E-value=1.2e-18  Score=158.14  Aligned_cols=125  Identities=23%  Similarity=0.356  Sum_probs=111.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|++.+.||+|+||.||++.+ .++..||+|++...    ........+..|+.++..++||||+++++.+...+.+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            45788899999999999999988 78999999988643    22344667889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +||||+++++|.+++... .+++..+..++.|++.||.|||+ .||+|||||
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~  131 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIK  131 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCC
Confidence            999999999999988764 58999999999999999999997 699999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.79  E-value=1.2e-18  Score=158.72  Aligned_cols=130  Identities=25%  Similarity=0.463  Sum_probs=110.8

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQY  256 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l  256 (317)
                      .+....++|.+.+.||+|+||.||++.. .     ....+|+|.+...    ........+.+|+.++..+ +||||+++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~   81 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL   81 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----CCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            3455567899999999999999999976 2     2368999988632    2233456688999999999 89999999


Q ss_pred             eeEEEeCCEEEEEEecCCCCCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          257 FGTEKDENKLYIFLELVTQGSLAKIYQE-----------------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       257 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++...+.++++|||+++|+|..++..                 ..+++..+..++.|++.||.|||++||+|||||
T Consensus        82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk  159 (293)
T cd05053          82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA  159 (293)
T ss_pred             EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            9999999999999999999999999864                 237888999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.79  E-value=1.1e-18  Score=157.72  Aligned_cols=126  Identities=24%  Similarity=0.397  Sum_probs=107.2

Q ss_pred             hccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ..++|++.+.||+|+||.||.|.+      .++..||+|.+...    ........+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            456799999999999999999865      23567999987532    22234566889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEY-----------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~-----------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .....++||||+++|+|.+++...           .+++..+..++.|++.||.|||+.|++|||||
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlk  146 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLA  146 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcc
Confidence            999999999999999999998652           24677888999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.79  E-value=1.1e-18  Score=157.39  Aligned_cols=126  Identities=23%  Similarity=0.360  Sum_probs=108.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ..++|.+.+.||+|+||.||++.. .     ++..||+|.+...    ........+..|+.++..++||||+++++++.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            456899999999999999999976 2     2378999987532    22344567889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEY-----------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~-----------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .....|+||||+++|+|.+++...           .+++..+..++.|++.||.|||+.||+|||||
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~  146 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLA  146 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence            999999999999999999998642           25778889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=2.3e-19  Score=162.48  Aligned_cols=124  Identities=28%  Similarity=0.474  Sum_probs=110.4

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-----C
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-----E  263 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~  263 (317)
                      ..|..++.||.|+||.|+.+.+ .+|..||||.+...   .......++..+|+.+|+.++|+||+.+.+.+..     -
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~---F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP---FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh---hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3455689999999999999999 89999999988622   3455667889999999999999999999998865     4


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+|+|+|+| +.+|..+++.+. ++...+..++.|++.||.|+|+.||+|||||
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLK  152 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLK  152 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccc
Confidence            6799999999 559999999887 9999999999999999999999999999998

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.79  E-value=1.2e-18  Score=157.75  Aligned_cols=125  Identities=26%  Similarity=0.391  Sum_probs=108.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCC-----CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDG-----FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ..+|++.+.||+|+||.||+|.. ..+     ..+|+|.+...    ........+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            45788999999999999999986 333     57999987532    234455678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-----------------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+..|++|||+++|+|.+++..                 ..+++..+..++.|++.||.|||++||+|||||
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlk  151 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLA  151 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence            9999999999999999999864                 237788899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.79  E-value=8.8e-19  Score=160.95  Aligned_cols=129  Identities=24%  Similarity=0.389  Sum_probs=110.6

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeee
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYF  257 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~  257 (317)
                      ++...++|.+.+.||+|+||.||++.+      .++..+|+|.+...    ......+.+..|+.+++++ +||||++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT----AHSSEREALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc----CChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence            444456799999999999999999974      23457999987632    1234456788999999999 899999999


Q ss_pred             eEEEeCCEEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          258 GTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       258 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++...+.+|++|||+++|+|.+++....   +++..+..++.|++.||.|||++||+|+|||
T Consensus       106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  168 (302)
T cd05055         106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLA  168 (302)
T ss_pred             EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhc
Confidence            99999999999999999999999987532   8999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.79  E-value=1.1e-18  Score=162.39  Aligned_cols=130  Identities=25%  Similarity=0.456  Sum_probs=109.6

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-c-------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCcee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-D-------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV  254 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv  254 (317)
                      +|.....+|.+++.||+|+||.||.+.+ .       .+..+|+|.+...    ........+..|+.++.++ +||||+
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv   81 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNII   81 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCee
Confidence            4555566899999999999999999975 2       1236899987532    2334567788999999999 899999


Q ss_pred             eeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       255 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++++...+.++++|||+++|+|.+++...                 .+++..+..++.|++.||.|||++||+|||||
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk  161 (334)
T cd05100          82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA  161 (334)
T ss_pred             eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence            9999999999999999999999999998642                 26778888999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.79  E-value=2.7e-18  Score=152.95  Aligned_cols=124  Identities=26%  Similarity=0.440  Sum_probs=109.9

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|++.+.||+|+||.||.+.. .++..||+|.+.....   .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM---SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC---ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            488999999999999999988 7889999999875321   233456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++...   .+++..+..++.|++.||.|||++|++|+||+
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~  128 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIK  128 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            9999999999988653   47889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.79  E-value=1.2e-18  Score=159.18  Aligned_cols=124  Identities=23%  Similarity=0.329  Sum_probs=106.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-----------------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-----------------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN  252 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn  252 (317)
                      ++|++.+.||+|+||.||++..                 .++..+|+|.+...    ........+..|+.++..++|||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCC
Confidence            4689999999999999999853                 13457899988632    23445567889999999999999


Q ss_pred             eeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCC------------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH------------LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       253 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~------------l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+++++++...+..|++|||+++|+|.+++....            +++..+..++.|++.||.|||++||+|||||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk  157 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA  157 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            9999999999999999999999999999986532            5677899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=1.7e-18  Score=156.26  Aligned_cols=123  Identities=28%  Similarity=0.531  Sum_probs=109.6

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC---CCceeeeeeEEEeCCEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE---HDNIVQYFGTEKDENKL  266 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~  266 (317)
                      .|+..+.||.|+||.||+|.+ .++..+|+|.+....    .......+..|+.+++.+.   |||++++++++.....+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            467788999999999999998 789999999986421    2234556778999988886   99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||++|++|.+++..+.+++..+..++.|++.||.|||+.||+|+||+
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~  128 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIK  128 (277)
T ss_pred             EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcC
Confidence            999999999999999988889999999999999999999999999999996

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.79  E-value=1.7e-18  Score=160.81  Aligned_cols=119  Identities=24%  Similarity=0.427  Sum_probs=104.7

Q ss_pred             cccccc--CCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          196 APLGSG--SFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       196 ~~LG~G--~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      ..||+|  +||+||.+.+ .+|+.||+|++....   ......+.+.+|+.+++.++||||++++++|..++.+|+||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN---CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            456666  9999999998 789999999986432   2334457888999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+++|.+++...   ++++..+..++.|++.||+|||++||+|||||
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlk  128 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK  128 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999988753   48899999999999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.79  E-value=1.5e-18  Score=155.41  Aligned_cols=125  Identities=23%  Similarity=0.355  Sum_probs=108.6

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ....++|.+.+.||+|+||.||++....+..+|+|.+...      ......+.+|+.++..++|+||+++++.+.. ..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   74 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP   74 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence            3456789999999999999999998777778999987521      2235678899999999999999999999887 77


Q ss_pred             EEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++|||+++++|.+++...   .+++..+..++.|++.||.|||+.|++|||||
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~  129 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR  129 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence            89999999999999998753   37888899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.79  E-value=8.3e-19  Score=160.34  Aligned_cols=121  Identities=26%  Similarity=0.445  Sum_probs=108.3

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |.....||+|+||.||++.+ .++..||+|.+...     .......+..|+.++..++||||+++++.+..++..|+||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            34456799999999999988 78899999998632     2344567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++++|.+++....+++..+..++.||+.||.|||++||+|||||
T Consensus        99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk  145 (292)
T cd06658          99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK  145 (292)
T ss_pred             eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence            99999999999987789999999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.79  E-value=3.7e-18  Score=152.62  Aligned_cols=124  Identities=25%  Similarity=0.433  Sum_probs=110.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|++.+.||.|+||.||+|.. .++..+++|++....    .......+..|+.+++.++||||+++++.+..+..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK----CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC----cchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            4788999999999999999987 788899999986432    12256778899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||++++++|.+++..    ..+++..+..++.|++.||.|||++||+|||||
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~  129 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIK  129 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999999865    248899999999999999999999999999996

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.79  E-value=1.3e-18  Score=159.06  Aligned_cols=124  Identities=26%  Similarity=0.446  Sum_probs=106.4

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCC--EEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGF--FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      ++|.+.+.||+|+||.||+|.. .++.  .+++|.++.    .........+..|+.++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE----FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc----cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            5788999999999999999987 4443  468887752    12334456788999999999 79999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|++|||+++|+|.+++...                 .+++..+..++.|++.||+|||++||+|||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlk  146 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLA  146 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCC
Confidence            99999999999999998643                 37788999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.79  E-value=1.4e-18  Score=163.11  Aligned_cols=127  Identities=25%  Similarity=0.391  Sum_probs=107.5

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC-
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE-  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-  263 (317)
                      ....++|.+.+.||+|+||.||++.+ .++..+|+|.+...   .........+.+|+.+++.++||||+++++++... 
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   89 (355)
T cd07874          13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_pred             hhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc---ccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence            34578999999999999999999988 78999999998643   22334456778999999999999999999988653 


Q ss_pred             -----CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -----NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -----~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                           ..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+|||||
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDik  146 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  146 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence                 357999999976 67766653 58899999999999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.79  E-value=1e-18  Score=157.77  Aligned_cols=125  Identities=30%  Similarity=0.443  Sum_probs=108.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ..+|.+.+.||+|+||.||+|...      ++..||+|.+...    ........+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            456888999999999999999762      3478999988632    223345788999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY---------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~---------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ....|+||||+++++|.+++...               .+++..+..++.|++.||.|||++|++|||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlk  149 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLA  149 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccc
Confidence            99999999999999999998643               26788899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.79  E-value=2.3e-18  Score=155.82  Aligned_cols=124  Identities=23%  Similarity=0.403  Sum_probs=107.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC----EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF----FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .++|++.+.||+|+||.||+|.. .+|.    .+|+|.+...    ........+.+|+.++..++||||+++++++.. 
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----TSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            35788999999999999999986 4443    5888887532    224456778899999999999999999999887 


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...++||||+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~  136 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLA  136 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccC
Confidence            7899999999999999998764  48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.79  E-value=2.2e-18  Score=155.93  Aligned_cols=122  Identities=31%  Similarity=0.554  Sum_probs=106.8

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|++.+.||.|++|.||+|.+ .+|..||+|++.....    ......+..|+.+++.++||||+++++++...+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE----EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc----ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            588999999999999999998 7899999999875321    12234567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++ +|.+++...    .+++..+..++.|++.||.|||+.||+|||||
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~  127 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLK  127 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            999985 888887643    48999999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.79  E-value=2.4e-18  Score=152.79  Aligned_cols=118  Identities=31%  Similarity=0.512  Sum_probs=104.1

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCC
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQ  275 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~g  275 (317)
                      +.||+|+||.||+|...++..+|+|.+...    ........+..|+.++..++||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED----LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            368999999999998778889999987532    2334455688999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          276 GSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       276 gsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|.+++...  .+++..+..++.|++.||.|||++|++|||||
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~  120 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA  120 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccC
Confidence            9999988653  47899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.79  E-value=1.8e-18  Score=156.22  Aligned_cols=124  Identities=31%  Similarity=0.417  Sum_probs=108.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--  262 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--  262 (317)
                      ..|++.+.||+|+||.||++..     .++..+|+|.+....    .......+..|+.+++.+.||||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG----EEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc----chHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            3567789999999999999975     247899999987432    11356778999999999999999999999877  


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ....+++|||+++++|.+++....  +++..+..++.|++.||.|||++||+|+|||
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~  136 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLA  136 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            668999999999999999997655  8999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.79  E-value=2.3e-18  Score=155.72  Aligned_cols=118  Identities=21%  Similarity=0.307  Sum_probs=102.9

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQG  276 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~gg  276 (317)
                      ||+|+||.||+|.+ .+|..||+|.+....  .........+..|+.++..++||||+++++.+...+.+|+||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKR--LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhh--hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            68999999999988 789999999987432  112223455678999999999999999999999999999999999999


Q ss_pred             CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          277 SLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       277 sL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|.+++...   .+++..+..++.|++.||.|||++|++|||||
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~  122 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK  122 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            999988653   48999999999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.79  E-value=9.9e-19  Score=156.45  Aligned_cols=123  Identities=28%  Similarity=0.388  Sum_probs=106.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..++|++.+.||+|+||.||+|...++..+|+|.+.....      ....+.+|+.++++++|||++++++++. ....|
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            3567889999999999999999877778899999864321      1246889999999999999999999875 45689


Q ss_pred             EEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~  129 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR  129 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence            999999999999998653   38899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.78  E-value=1.7e-18  Score=167.64  Aligned_cols=119  Identities=27%  Similarity=0.375  Sum_probs=100.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      ..+|.+++.||+|+||.||+|.+ .++..||||.+....         ....+|+.+|+.++||||+++++++...    
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            46799999999999999999988 789999999885321         1234799999999999999998877432    


Q ss_pred             ----CEEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ----NKLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ----~~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          ..+++||||+++ +|.+++..     ..+++..+..++.||+.||.|||++||||||||
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLK  197 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLK  197 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcC
Confidence                357899999976 77776642     358999999999999999999999999999998

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.78  E-value=1.4e-18  Score=154.79  Aligned_cols=115  Identities=20%  Similarity=0.341  Sum_probs=98.2

Q ss_pred             ccccccCCeeEEEEEe-cCC----------CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          196 APLGSGSFGSVYEGFT-DDG----------FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~----------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      +.||+|+||.||++.+ .++          ..+++|.+....      .....+.+|+.+++.++||||+++++++.. +
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH------RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch------hhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            3689999999999988 444          247777664221      115678899999999999999999999988 7


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..++||||+++|+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlk  128 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVC  128 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCc
Confidence            789999999999999998754  48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.78  E-value=2.6e-18  Score=155.77  Aligned_cols=124  Identities=27%  Similarity=0.415  Sum_probs=103.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC----EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF----FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .++|++.+.||+|+||.||+|.. .++.    .+++|.+..    .........+..|+.++..++||||+++++++.. 
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-   80 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-   80 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence            35788899999999999999987 5565    366666532    2233445678888889999999999999998764 


Q ss_pred             CEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+++|||+++|+|.+++..  ..+++..+..++.||+.||.|||++|++|||||
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlk  136 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLA  136 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccC
Confidence            557899999999999999865  348999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.78  E-value=1.2e-18  Score=156.38  Aligned_cols=122  Identities=25%  Similarity=0.383  Sum_probs=105.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .++|.+.+.||+|+||.||+|.+.++..+|+|.+.....      ....+..|+.++..++||||+++++.+.. ...|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            457999999999999999999885556799999864221      23467899999999999999999998754 56899


Q ss_pred             EEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.||+|||||
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~  129 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR  129 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence            9999999999999975   247889999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.78  E-value=1.8e-18  Score=156.83  Aligned_cols=127  Identities=24%  Similarity=0.455  Sum_probs=107.8

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEE-
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEK-  261 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-  261 (317)
                      +....++|.+.+.||+|+||.||++.+ .++..+|+|++....      .....+..|+.++..+ +||||+++++++. 
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            455678999999999999999999988 788999999875321      1224567899999998 7999999999874 


Q ss_pred             ----eCCEEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 ----DENKLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ----~~~~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          .++.+++||||++|++|.+++..     ..+++..+..++.|++.||.|||+++|+|||||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  151 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVK  151 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence                35679999999999999988752     348888999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.78  E-value=1.8e-19  Score=160.83  Aligned_cols=118  Identities=26%  Similarity=0.392  Sum_probs=107.2

Q ss_pred             eccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEEEec
Q 021084          195 GAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      .+.||+|+|+.|--|.. .+|..||||++.+.     ......++.+|++++..+ .|+||++++.+|.++..+|||||-
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            46899999999999988 99999999999753     334567788999999999 799999999999999999999999


Q ss_pred             CCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |.||+|...++. ..|++.++..++++|+.||.|||.+||.|||||
T Consensus       158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlK  203 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLK  203 (463)
T ss_pred             ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCC
Confidence            999999887754 569999999999999999999999999999998

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.78  E-value=1.1e-18  Score=157.93  Aligned_cols=125  Identities=26%  Similarity=0.455  Sum_probs=109.7

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|++.+.||+|+||.||+|.+ .++..||+|.+....   ......+.+..|+.++..++||||+++++++..++..|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---CcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            4688999999999999999988 679999999876432   122345567889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++++|..+.... .+++..+..++.|++.||.|||+.||+|+|||
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~  127 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK  127 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            99999999998877543 58999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.78  E-value=1.8e-18  Score=155.55  Aligned_cols=117  Identities=20%  Similarity=0.278  Sum_probs=99.6

Q ss_pred             ccccccCCeeEEEEEecC-------------CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          196 APLGSGSFGSVYEGFTDD-------------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~-------------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      +.||+|+||.||+|...+             ...+++|.+..     ........+..|+.++..++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            368999999999997521             23578887653     223445578889999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ....+++|||+++|+|..++..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk  132 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVC  132 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCC
Confidence            9999999999999999998864  348999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1e-19  Score=173.25  Aligned_cols=123  Identities=28%  Similarity=0.473  Sum_probs=109.3

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |.-++.||.|+||.||.+++ .+...||||.+.-.  +......+..++.|+..|.++.|||+|.|-|+|......||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS--GKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeecccc--ccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            44578899999999999999 88999999988643  2445566788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||-| +-.+++.  ..++.+.++..|+.+.++||.|||+++.||||||
T Consensus       106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiK  153 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIK  153 (948)
T ss_pred             HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhcc
Confidence            99955 8888774  4579999999999999999999999999999998

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.78  E-value=2.7e-18  Score=154.15  Aligned_cols=123  Identities=26%  Similarity=0.409  Sum_probs=103.9

Q ss_pred             eeeeccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE--
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK--  265 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--  265 (317)
                      |.+++.||+|+||.||.|.. .   .+..+|+|.+...   .........+..|+.+++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD---IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC---cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            56789999999999999986 3   3478999998643   2234456678999999999999999999998866443  


Q ss_pred             ----EEEEEecCCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 ----LYIFLELVTQGSLAKIYQE-------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ----~~lVmE~~~ggsL~~~l~~-------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          .+++|||+++|+|..++..       ..+++..+..++.|++.||.|||++||+|||||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlk  140 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLA  140 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence                8999999999999998743       247889999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.78  E-value=5.5e-18  Score=154.16  Aligned_cols=124  Identities=27%  Similarity=0.411  Sum_probs=107.8

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CCEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--ENKL  266 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~  266 (317)
                      ++|...+.||.|++|.||.|.+ .++..+|+|.+....    .......+.+|+++++.++||||+++++++..  .+.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC----chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            4688999999999999999998 788999999987432    22445678899999999999999999998865  4578


Q ss_pred             EEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++..     ..+++..+..++.||+.||.|||+.|++|+||+
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~  132 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK  132 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            999999999999987653     347889999999999999999999999999996

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.78  E-value=4.5e-18  Score=151.53  Aligned_cols=124  Identities=31%  Similarity=0.450  Sum_probs=107.7

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-CCEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-ENKLYI  268 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~l  268 (317)
                      +|.+.+.||.|++|.||.+.+ .++..+|+|.+....   ........+..|+.+++.++|||++++++.+.. ...+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            488999999999999999988 778899999986432   233445668899999999999999999998764 457899


Q ss_pred             EEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||+++++|.+++...   .+++.++..++.|++.||.|||++||+|||||
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~  129 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLK  129 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            99999999999988652   38999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.78  E-value=2.8e-18  Score=156.41  Aligned_cols=124  Identities=28%  Similarity=0.432  Sum_probs=107.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ..+|.+.+.||+|+||.||.|..      .++..+++|.+.     .........+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecC-----CccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            35688999999999999999975      234568888875     2233445678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+..++||||+++++|.+++...                 .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  150 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLA  150 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccC
Confidence            99999999999999999998643                 27888999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.78  E-value=3.3e-18  Score=153.62  Aligned_cols=125  Identities=28%  Similarity=0.414  Sum_probs=108.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC---EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF---FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|...+.||+|+||.||+|.. .++.   .+|+|.+...    ........+..|+.++..++||||+++.+++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            34678889999999999999987 4443   7899987532    12344567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..|+||||+++++|.+++...  .+++..+..++.|++.||.|||+.||+|||||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlk  134 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLA  134 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence            999999999999999998653  48999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.78  E-value=4.2e-18  Score=154.49  Aligned_cols=123  Identities=28%  Similarity=0.485  Sum_probs=99.9

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEEe----
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEKD----  262 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~----  262 (317)
                      +|.+.+.||+|+||.||+|.+ .++..||+|.+.......   .....+..|+.+++.+   +||||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED---GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC---CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            478899999999999999998 789999999987542211   1122344566666554   79999999998864    


Q ss_pred             -CCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ...++++|||+++ +|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik  135 (288)
T cd07863          78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK  135 (288)
T ss_pred             CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence             3568999999975 888888653   48999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.78  E-value=9.9e-19  Score=163.38  Aligned_cols=129  Identities=24%  Similarity=0.370  Sum_probs=107.1

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeee
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYF  257 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~  257 (317)
                      |...-++|++.+.||+|+||.||+|..      .+++.||+|++...    ........+..|+.++.++ +||||++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~~~~l~~h~niv~~~   77 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG----ATASEYKALMTELKILIHIGHHLNVVNLL   77 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC----CCHHHHHHHHHHHHHHHhhccCcchhhee
Confidence            334456799999999999999999964      23578999988632    1233456778999999999 899999999


Q ss_pred             eEEEe-CCEEEEEEecCCCCCHHHHHHh----------------------------------------------------
Q 021084          258 GTEKD-ENKLYIFLELVTQGSLAKIYQE----------------------------------------------------  284 (317)
Q Consensus       258 ~~~~~-~~~~~lVmE~~~ggsL~~~l~~----------------------------------------------------  284 (317)
                      +++.. ...++++|||+++++|.+++..                                                    
T Consensus        78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (337)
T cd05054          78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE  157 (337)
T ss_pred             eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence            98865 4678999999999999998753                                                    


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          285 ----------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       285 ----------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                ..+++..+..++.||+.||.|||++||+|||||
T Consensus       158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDik  200 (337)
T cd05054         158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLA  200 (337)
T ss_pred             cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence                      147888899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.78  E-value=2.6e-18  Score=154.57  Aligned_cols=118  Identities=23%  Similarity=0.328  Sum_probs=99.5

Q ss_pred             ccccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          196 APLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      +.||+|+||.||+|..   .++..+|+|.+....    .......+.+|+.++..++||||+++++++.....+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            3589999999999975   345678999876432    223345688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQEY------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~~------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|+|.+++...      ..++..+..++.|++.||.|||+.|++|||||
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlk  127 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLA  127 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccC
Confidence            9999999998642      24566778899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.78  E-value=2.7e-18  Score=156.35  Aligned_cols=123  Identities=28%  Similarity=0.474  Sum_probs=104.9

Q ss_pred             CeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      +|++.+.||+|+||.||+|.. .     ....+++|.+...    ........+..|+.++..++||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            477889999999999999976 2     2356888887532    22344567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-------------------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-------------------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+++|||+++|+|.+++...                         .+++..+..++.|++.||.|||++||+|||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik  154 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA  154 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence            999999999999999988642                         36788889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=5e-19  Score=166.33  Aligned_cols=126  Identities=27%  Similarity=0.326  Sum_probs=114.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+-|.+.+.||+|.|.+|-++++ .+|..||||++.+...   +.-....+.+|+++|+-++|||||++|.+..++..+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl---D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc---chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            45678889999999999999998 9999999999986542   3344567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+|+=.+|+|++|+-.  .++.+..+..|+.||+.|+.|+|...+||||||
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLK  145 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLK  145 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCC
Confidence            99999999999999854  469999999999999999999999999999998

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.1e-19  Score=168.40  Aligned_cols=156  Identities=17%  Similarity=0.177  Sum_probs=135.0

Q ss_pred             CCCCCchHHHHHHHhhhhcCCcchHHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHH
Q 021084          160 ASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQL  238 (317)
Q Consensus       160 ~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~  238 (317)
                      ......+...+........|.+.+.++...+.|..-++||+|+||.||-|+. .+|+.||+|.+.++..  .........
T Consensus       155 ~~~pF~~f~~S~yf~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi--Kkr~ge~ma  232 (591)
T KOG0986|consen  155 RGDPFQEFLESDYFTRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI--KKRKGETMA  232 (591)
T ss_pred             ccchHhHhHHHHHHHHHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH--HHhhhhHHh
Confidence            3344455666677777888888888888889999999999999999999988 8999999999876542  223344567


Q ss_pred             HHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecC
Q 021084          239 EQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRP  315 (317)
Q Consensus       239 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrD  315 (317)
                      +.|-.+|.+++.|+||.+-.+|.+++.+|+||..|+||+|...|.+.   +|++..+.+|+.+|+.||++||+.+||+||
T Consensus       233 LnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRD  312 (591)
T KOG0986|consen  233 LNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRD  312 (591)
T ss_pred             hHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeecc
Confidence            78999999999999999999999999999999999999998877653   599999999999999999999999999999


Q ss_pred             CC
Q 021084          316 GA  317 (317)
Q Consensus       316 LK  317 (317)
                      ||
T Consensus       313 LK  314 (591)
T KOG0986|consen  313 LK  314 (591)
T ss_pred             CC
Confidence            98

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.78  E-value=2.5e-18  Score=156.23  Aligned_cols=125  Identities=22%  Similarity=0.372  Sum_probs=108.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      .++|.+...||+|+||.||++.+.      ++..+|+|.+...    ........+..|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC----cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            467889999999999999999762      5678999988632    233445678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY-----------------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~-----------------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ....|++|||+++|+|.+++...                       .+++..+..++.|++.||.|||++|++|||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~  157 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA  157 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence            99999999999999999998642                       26778889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.78  E-value=2e-18  Score=155.48  Aligned_cols=126  Identities=28%  Similarity=0.444  Sum_probs=111.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~  267 (317)
                      ++|.+.+.||+|+||.||++.. .++..||+|++....  .........+..|+.++..+. ||||+++++++...+.++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHh--ccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            4688999999999999999988 789999999986532  122334467888999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+|||
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~  129 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLK  129 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            999999999999998766 68999999999999999999999999999996

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.78  E-value=2.8e-18  Score=152.72  Aligned_cols=124  Identities=27%  Similarity=0.470  Sum_probs=109.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||+|+||.||++.. .+|..+|+|.+.....   .......+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM---PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc---cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            478899999999999999988 7889999999875321   122345677999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+++++|.+++...   .+++..+..++.|++.||.|||++|++|+|||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~  128 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIK  128 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence            9999999999988653   37899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.78  E-value=1.9e-18  Score=158.38  Aligned_cols=121  Identities=27%  Similarity=0.435  Sum_probs=107.5

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |.....||.|+||.||++.+ .++..||+|.+....     ......+.+|+.++..++||||+++++.+..++..|++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            33455799999999999988 789999999986432     122456789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++++|..++....+++..+..++.|++.||.|||++||+|||||
T Consensus        98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~  144 (297)
T cd06659          98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK  144 (297)
T ss_pred             ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999888789999999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.78  E-value=3.3e-18  Score=160.00  Aligned_cols=126  Identities=23%  Similarity=0.430  Sum_probs=109.8

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC--
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN--  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--  264 (317)
                      ..++|.+.+.||+|+||.||++.+ .++..||+|.+...   .........+..|+.+++.++||||+++++++....  
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            356899999999999999999988 78999999998532   223334556889999999999999999999987643  


Q ss_pred             ----EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 ----KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ----~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          .+|+||||+ |++|.+++....+++..+..++.|++.||.|||+.||+|||||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlk  145 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLK  145 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence                469999999 7799999988789999999999999999999999999999997

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.78  E-value=2.9e-18  Score=156.26  Aligned_cols=125  Identities=24%  Similarity=0.419  Sum_probs=108.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--CE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--NK  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~  265 (317)
                      .++|.+.+.||.|+||.||+|.+ .++..+++|.++....   .......+.+|+.++..++||||+++++++...  +.
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE---KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc---cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence            46788999999999999999988 6889999999975432   122334567899999999999999999999887  89


Q ss_pred             EEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++ +|.+++...  .+++..+..++.|++.||.|||++||+|+|||
T Consensus        81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~  133 (293)
T cd07843          81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLK  133 (293)
T ss_pred             EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence            9999999975 999988653  38999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.78  E-value=3.9e-18  Score=154.62  Aligned_cols=123  Identities=27%  Similarity=0.431  Sum_probs=107.4

Q ss_pred             cCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .+|.....||+|+||.||++..      .++..+|+|.+..     ........+..|+.++..++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4677889999999999999964      2466889998752     2345566789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +..|++|||+++++|.+++...                .+++..+..++.|++.||.|||++||+|||||
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlk  149 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLA  149 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence            9999999999999999998653                37888999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=5.5e-20  Score=176.17  Aligned_cols=123  Identities=32%  Similarity=0.544  Sum_probs=110.3

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +-|.++..||.|+||.||++.. .++-..|.|++.     ..+....+.++-|+.||..|+||+||++++.|...+.+||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            3466788999999999999988 667777888886     4566778899999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.|||+||-+..++-.  ..+++.++..+++|++.||.|||+++|||||||
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLK  157 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLK  157 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhcc
Confidence            9999999999987754  359999999999999999999999999999998

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.78  E-value=3.7e-18  Score=160.82  Aligned_cols=125  Identities=26%  Similarity=0.395  Sum_probs=106.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC---
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE---  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---  263 (317)
                      ..++|.+.+.||+|+||.||.+.+ .++..||+|++....   ........+.+|+.+++.++||||+++++++...   
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---cCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            467899999999999999999988 789999999986432   2233456678999999999999999999987543   


Q ss_pred             ---CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ---NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ---~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+|||||
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk  153 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  153 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC
Confidence               468999999965 77777653 58889999999999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.78  E-value=5.3e-20  Score=163.12  Aligned_cols=119  Identities=30%  Similarity=0.560  Sum_probs=108.8

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |.++..||+|+||.||++.+ .+|..+|||.++..       ...+.+..|+.+|.+++.|++|+|||.+.....+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            45778999999999999988 89999999998632       34778999999999999999999999999989999999


Q ss_pred             ecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||..|++.++++  +..+++.++..++...+.||+|||...-||||||
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIK  156 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIK  156 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcc
Confidence            9999999999886  4469999999999999999999999999999998

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.77  E-value=2.7e-18  Score=153.71  Aligned_cols=122  Identities=28%  Similarity=0.393  Sum_probs=104.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .++|.+...||.|+||.||++.+..+..+|+|.+....      .....+.+|+.+++.++|||++++++++. .+..|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            45688999999999999999987666679999875321      12356788999999999999999998875 456899


Q ss_pred             EEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||+++|+|.+++...   .+++..+..++.|++.||.|||+.||+|+|||
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~  129 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR  129 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC
Confidence            99999999999998653   37889999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.77  E-value=3.1e-18  Score=155.14  Aligned_cols=125  Identities=26%  Similarity=0.432  Sum_probs=109.3

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|.+....   ........+..|+.+++.++||||+++++++..++..++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc---ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            4689999999999999999988 678999999886432   123345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||++++.+..+... .++++..+..++.||+.||.|||++|++|+|||
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  127 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK  127 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            9999998777766654 458999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.77  E-value=5.1e-18  Score=153.50  Aligned_cols=124  Identities=23%  Similarity=0.362  Sum_probs=106.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC----EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF----FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ..+|++.+.||+|+||.||+|.+ .++.    .||+|.+...    ........+..|+.++..++||||+.+++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            45788999999999999999986 5554    4899988632    2334456788999999999999999999998754


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..+++|+|+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlk  136 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLA  136 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence             478999999999999998753  48999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.77  E-value=2.1e-18  Score=166.51  Aligned_cols=120  Identities=29%  Similarity=0.399  Sum_probs=108.0

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-C-----CceeeeeeEEEeC
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-H-----DNIVQYFGTEKDE  263 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~  263 (317)
                      +|.+.+.||+|+||.|.+|.+ .+++.||||+++.      ......+...|+.+|..|+ |     -|+|+++++|...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            688999999999999999999 8999999999964      2345566778999999886 3     4999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||+|.+.. +|+++++.+   +++...++.++.||+.||.+||..||||+|||
T Consensus       261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLK  316 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLK  316 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            999999999955 999999875   48899999999999999999999999999998

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.77  E-value=3.9e-18  Score=153.34  Aligned_cols=122  Identities=25%  Similarity=0.389  Sum_probs=101.2

Q ss_pred             eeeccccccCCeeEEEEEe-cCCC--EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe------C
Q 021084          193 QKGAPLGSGSFGSVYEGFT-DDGF--FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD------E  263 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~-~~~~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~  263 (317)
                      .+++.||+|+||.||+|.. .++.  .+|+|.++..   .........+..|+.++..++||||+++++.+..      .
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA---ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccC---cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            4678899999999999987 4443  6899988643   2234556788899999999999999999998743      2


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+++|||+++|+|.+++..       ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  139 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLA  139 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence            357899999999999987732       237899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.77  E-value=4.4e-18  Score=154.89  Aligned_cols=124  Identities=29%  Similarity=0.462  Sum_probs=106.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|.+.....    ......+.+|+.++..++|+||+++++++..++..|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE----EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc----CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            46899999999999999999988 7899999999864321    112234568999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+. ++|.+++..  ..+++..+..++.|++.||.|||+.||+|+|||
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk  130 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK  130 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999996 577766543  347888899999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.77  E-value=2.1e-18  Score=162.56  Aligned_cols=120  Identities=28%  Similarity=0.375  Sum_probs=105.9

Q ss_pred             eccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          195 GAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      .++||+|.||+||-|.+ .+|+.||||++.+.+.....   ...+..|+.+|..++||.||.+...|++++.++.|||-+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq---esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl  645 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ---ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL  645 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch---HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence            36899999999999998 99999999999876543332   367889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .|.-|.-++..  +++++....+++.||+.||.|||.+||||+|||
T Consensus       646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLK  691 (888)
T KOG4236|consen  646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLK  691 (888)
T ss_pred             cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCC
Confidence            77555556643  569999999999999999999999999999998

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.77  E-value=1.8e-18  Score=156.66  Aligned_cols=123  Identities=28%  Similarity=0.515  Sum_probs=106.6

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||+|+||.||+|.+ .+|..+|+|.++....   .......+..|+.+++.++||||+++++++.+...+|++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            478889999999999999998 7899999999875321   122234567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++ +|.+++..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~  126 (284)
T cd07839          78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLK  126 (284)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence            999975 78877754  458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.77  E-value=4.1e-18  Score=165.47  Aligned_cols=117  Identities=22%  Similarity=0.240  Sum_probs=104.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ...|.+.+.||+|+||.||+|.+ .++..||+|....           ..+.+|+.+|..++|||||++++++...+..|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            45799999999999999999998 7789999996421           23458999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||++. ++|..++...  .+++..+..++.||+.||.|||++||||||||
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLK  287 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIK  287 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCC
Confidence            9999995 5888887643  58999999999999999999999999999998

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.77  E-value=4.9e-18  Score=152.16  Aligned_cols=116  Identities=27%  Similarity=0.420  Sum_probs=99.6

Q ss_pred             cccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          197 PLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      .||+|+||.||+|..   .++..+|+|++...    ........+.+|+.++.+++||||+++++++.. ...++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeC
Confidence            389999999999976   34567999988632    234455678899999999999999999998764 5689999999


Q ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|.+++..  ..+++..+..++.|++.||.|||++|++|||||
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  122 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA  122 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccc
Confidence            99999999864  358999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.77  E-value=8.2e-18  Score=150.13  Aligned_cols=124  Identities=30%  Similarity=0.457  Sum_probs=111.7

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+.+.||.|++|.||++.+ .++..|++|.+....    .......+..|+..+..++||||+++++++...+.+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI   76 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence            3688999999999999999998 679999999986432    11456778899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      ||||+++++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||+
T Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~  127 (264)
T cd06623          77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK  127 (264)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCC
Confidence            9999999999999875 568999999999999999999999 999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.77  E-value=3.9e-18  Score=153.61  Aligned_cols=117  Identities=20%  Similarity=0.246  Sum_probs=97.2

Q ss_pred             cccccCCeeEEEEEecCC---CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          197 PLGSGSFGSVYEGFTDDG---FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      .||+|+||.||++...++   ..+++|.+...    ........+.+|+.++..++||||+++++.+......|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            599999999999976333   34556655432    22334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|.+++...     .+++..+..++.||+.||.|||+.||+|||||
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dik  126 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLA  126 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCc
Confidence            999999998753     25666778899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.77  E-value=7e-19  Score=174.04  Aligned_cols=127  Identities=26%  Similarity=0.400  Sum_probs=110.8

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeE
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGT  259 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~  259 (317)
                      .....+....+.||+|+||.||+|+.      .+...||||.++.    ..+.+....|.+|+++|..++|||||+++|+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            34456677889999999999999975      2356899999863    3345578899999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhC-----------C----CCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          260 EKDENKLYIFLELVTQGSLAKIYQEY-----------H----LKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       260 ~~~~~~~~lVmE~~~ggsL~~~l~~~-----------~----l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      |..++.+|+|+|||..|||.++|...           .    ++..+...|+.||+.||+||-++.+|||||
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDL  629 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDL  629 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccch
Confidence            99999999999999999999998632           1    678889999999999999999999999998

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.77  E-value=4.2e-18  Score=153.10  Aligned_cols=123  Identities=28%  Similarity=0.526  Sum_probs=105.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC---
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE---  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~---  263 (317)
                      .+.|.+.+.||+|+||.||+|.. .++..+|+|.+....      .....+..|+.++..+ +||||+++++++...   
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            45677889999999999999988 789999999986432      1234577899999888 799999999998753   


Q ss_pred             ---CEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ---NKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ---~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ..+|++|||+++++|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~  138 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK  138 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence               5689999999999999998753   48899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.77  E-value=4.6e-18  Score=151.04  Aligned_cols=121  Identities=31%  Similarity=0.517  Sum_probs=106.6

Q ss_pred             eeeccccccCCeeEEEEEe-cCC----CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          193 QKGAPLGSGSFGSVYEGFT-DDG----FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~-~~~----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.+.||.|+||.||.+.. ..+    ..+|+|.+...    ........+..|+.++..++||||+++++++...+..|
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED----ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC----CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            4678899999999999988 444    88999998632    22225677889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++....   +++..+..++.|++.||.|||+.|++|+|||
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~  130 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA  130 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccc
Confidence            9999999999999986543   8999999999999999999999999999997

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.77  E-value=6.2e-18  Score=151.30  Aligned_cols=118  Identities=25%  Similarity=0.337  Sum_probs=104.9

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQG  276 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~gg  276 (317)
                      ||.|+||.||+|.+ .++..+|+|++....  .......+.+..|+.++..++||||+++++.+.++..+|++|||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH--IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhc--chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            69999999999998 679999999997542  222334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          277 SLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       277 sL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|.+++... .+++..+..++.|++.||.|||++|++|+|||
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~  120 (262)
T cd05572          79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK  120 (262)
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            999998764 47899999999999999999999999999996

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.77  E-value=2.7e-18  Score=155.53  Aligned_cols=125  Identities=21%  Similarity=0.324  Sum_probs=106.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ..+|.+.+.||.|+||.||+|.. .     .+..+|+|++...    ........+..|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK----AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            34577889999999999999976 2     2578999998632    223345678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-----------------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ....++++||+++++|.+++..                 ..+++..+..++.|++.||.|||++||+|||||
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlk  151 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLA  151 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            9999999999999999998852                 237788889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.77  E-value=4.5e-18  Score=151.10  Aligned_cols=118  Identities=28%  Similarity=0.481  Sum_probs=104.9

Q ss_pred             ccccccCCeeEEEEEe-cC---CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEe
Q 021084          196 APLGSGSFGSVYEGFT-DD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      +.||+|+||.||+|.. ..   +..+++|.+....    .......+..|+.++..++||||+++++++.....++++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeecccc----chhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            4689999999999988 44   8899999987432    12246778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQE----------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~----------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+++++|.+++..          ..+++..+..++.|++.||.|||++||+|||||
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~  132 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA  132 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccC
Confidence            9999999999976          348999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.77  E-value=5.3e-18  Score=151.08  Aligned_cols=123  Identities=22%  Similarity=0.375  Sum_probs=107.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..+|.+.+.||.|+||.||++.+..+..+|+|.+.....      ....+..|+.++..++||||+++++++.....+|+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            346888999999999999999876678899998763221      12457889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||+++++|.+++...  .+++..+..++.|++.||.|||+.|++|||||
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~  127 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA  127 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            99999999999998753  48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.77  E-value=1.1e-17  Score=148.22  Aligned_cols=124  Identities=27%  Similarity=0.505  Sum_probs=111.0

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||.|+||.||++.+ .++..+++|++....   ........+..|++++..++|||++++.+.+.....++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN---MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc---CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            578899999999999999998 689999999987432   2234566788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++..     ..+++..+..++.|++.||.|||++|++|+||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~  130 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK  130 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCC
Confidence            999999999998865     458999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.77  E-value=6.5e-18  Score=153.99  Aligned_cols=124  Identities=28%  Similarity=0.463  Sum_probs=106.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+...||.|++|.||+|.+ .++..||+|.+.....   .......+..|+.+++.++||||+++++++.....+|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc---cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            5799999999999999999988 6899999998864321   22334567789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++ +|.+++....   +++..+..++.||+.||.|||++||+|||||
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~  129 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLK  129 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            9999964 7887775432   5788888999999999999999999999996

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=1.3e-17  Score=147.88  Aligned_cols=124  Identities=42%  Similarity=0.738  Sum_probs=111.4

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||+|++|.||++.+ .++..|++|.+....   ........+..|+.++..++|||++++++++...+.++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            478899999999999999988 688999999997542   2234567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  126 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK  126 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            999999999998865 468999999999999999999999999999996

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.77  E-value=6.6e-18  Score=150.98  Aligned_cols=117  Identities=29%  Similarity=0.451  Sum_probs=101.3

Q ss_pred             cccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          197 PLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      .||+|+||.||+|..   .++..+|+|++...   .........+..|+.++..++||||+++++++.. ...++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND---NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCC---CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecC
Confidence            589999999999964   46789999988633   2334556778999999999999999999998764 5679999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlk  122 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLA  122 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence            99999999865 358999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.77  E-value=6.4e-18  Score=152.25  Aligned_cols=118  Identities=25%  Similarity=0.461  Sum_probs=100.8

Q ss_pred             ccccccCCeeEEEEEe-cCCC--EEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEEEe
Q 021084          196 APLGSGSFGSVYEGFT-DDGF--FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      +.||+|+||.||+|.. .++.  .+++|.+..    .........+..|+.++.++ +||||+++++++...+.+|++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc----cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3689999999999988 5554  467787752    22334456788999999999 89999999999999999999999


Q ss_pred             cCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+++|+|.+++...                 .+++..+..++.|++.||+|||++|++|||||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dik  139 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA  139 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence            99999999998643                 26888999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.77  E-value=4.7e-18  Score=158.36  Aligned_cols=124  Identities=30%  Similarity=0.501  Sum_probs=108.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|.+.+.||+|+||.||+|.+ .+|..||+|.+...    ........+..|+.++..++||||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF----EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc----ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            46899999999999999999988 78999999998632    1223456678899999999999999999887653    


Q ss_pred             -CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..+|++|||+.+ +|..++....+++..+..++.|++.||.|||++||+|||||
T Consensus        80 ~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlk  133 (336)
T cd07849          80 FNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLK  133 (336)
T ss_pred             cceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence             358999999965 89998888889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.77  E-value=6.5e-18  Score=153.68  Aligned_cols=126  Identities=21%  Similarity=0.327  Sum_probs=107.7

Q ss_pred             CeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      +|++.+.||.|+||.||.+..    .+|..||+|++..... .......+.+..|+.++..+ +||+|+.+++.+..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            478899999999999999986    3789999999864321 11223345677899999999 69999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++++|.+++.. .++++..+..++.|++.||.|||+.|++|||||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~  132 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIK  132 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            9999999999999998865 458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.77  E-value=5e-19  Score=146.69  Aligned_cols=123  Identities=29%  Similarity=0.494  Sum_probs=108.3

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|...++||+|+||+||+++. .++..||+|.++.....   +.......+|+.+++.++|.|||++++....+..+-+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd---egvpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC---CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            456678899999999999998 88999999999876433   33344567999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||.. +|..++.+  +.++...+..++.|++.||.|+|++++.|||||
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlk  128 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLK  128 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCC
Confidence            999966 89988865  448899999999999999999999999999998

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.77  E-value=9.7e-18  Score=152.58  Aligned_cols=121  Identities=26%  Similarity=0.440  Sum_probs=108.0

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |.....||.|++|.||++.+ .++..+++|.+...     .......+.+|+.++..++||||+++++++...+..|+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            34457899999999999987 78899999988632     2233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||++|++|.+++...++++..+..++.|++.||.|||++||+|||||
T Consensus        96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~  142 (285)
T cd06648          96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK  142 (285)
T ss_pred             eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999988789999999999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.77  E-value=7.8e-18  Score=149.72  Aligned_cols=122  Identities=32%  Similarity=0.553  Sum_probs=109.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||.|+||.||+|.. .++..+++|.+...       .....+.+|+.+++.++||||+++++.+.....+|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            35788999999999999999988 66899999998632       11567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++..  ..+++..+..++.|++.||.|||+.||+|+||+
T Consensus        75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~  126 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK  126 (256)
T ss_pred             EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99999999999999864  348999999999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.77  E-value=4.4e-18  Score=151.65  Aligned_cols=118  Identities=25%  Similarity=0.434  Sum_probs=104.9

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQG  276 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~gg  276 (317)
                      ||.|+||.||++.+ .+|..+++|.+....  .........+..|+.++..++||||+++++.+......|++|||++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchh--hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            68999999999998 679999999986432  122345677889999999999999999999999999999999999999


Q ss_pred             CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          277 SLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       277 sL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|.+++.. ..+++..+..++.||+.||.|||++|++|+||+
T Consensus        79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~  120 (265)
T cd05579          79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK  120 (265)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCC
Confidence            99999876 458999999999999999999999999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.77  E-value=1.2e-17  Score=148.83  Aligned_cols=124  Identities=29%  Similarity=0.438  Sum_probs=108.1

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CCEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--ENKLY  267 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~  267 (317)
                      +|.+.+.||.|+||.||++.+ .++..+|+|.+...   .........+..|+.+++.++||||+++++.+..  ...+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG---NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc---cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            478899999999999999988 78899999998643   2234456778899999999999999999998754  56789


Q ss_pred             EEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-----HCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLH-----EQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH-----~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++..     ..+++..+..++.||+.||.|||     +.+|+|+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~  137 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK  137 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCC
Confidence            99999999999998864     35889999999999999999999     8999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=6.4e-18  Score=151.58  Aligned_cols=124  Identities=27%  Similarity=0.511  Sum_probs=108.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCC-
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDEN-  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~-  264 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..+++|++....      .....+..|+.++.++ +||||+++++++.... 
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            467899999999999999999998 678899999986432      1345688999999998 7999999999997644 


Q ss_pred             -----EEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 -----KLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 -----~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                           .+|+||||+++++|.+++..     ..+++..+..++.|++.||.|||+.|++|+||+
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~  140 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK  140 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence                 58999999999999998753     358999999999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.77  E-value=6e-18  Score=151.37  Aligned_cols=124  Identities=28%  Similarity=0.430  Sum_probs=110.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|...+.||.|+||.||++.+ .++..+|+|.+....    .......+.+|+.+++.++||||+++++.+...+.+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI----NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI   76 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc----ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence            3577889999999999999988 689999999987432    23455678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +|||+++++|.+++..  ..+++..+..++.|++.||.|||+ .|++|+|||
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~  128 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK  128 (265)
T ss_pred             EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCC
Confidence            9999999999999975  458899999999999999999999 999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA02988 hypothetical protein; Provisional

Probab=99.77  E-value=7.6e-18  Score=153.45  Aligned_cols=119  Identities=18%  Similarity=0.204  Sum_probs=102.8

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe----CCEEEEEEe
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD----ENKLYIFLE  271 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lVmE  271 (317)
                      ..||+|++|.||+|.. +|..||+|.+....  .......+.+.+|+.+|.+++||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFH--KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccc--cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5689999999999976 68899999987532  2233445778899999999999999999999877    457899999


Q ss_pred             cCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          272 LVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      |+++|+|.+++... .+++.....++.|++.||.|||+ .+++|||||
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlk  150 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT  150 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCC
Confidence            99999999998754 48889999999999999999998 499999997

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.77  E-value=4.8e-18  Score=152.85  Aligned_cols=124  Identities=28%  Similarity=0.435  Sum_probs=105.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cC---CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ..+|.+.+.||+|+||.||+|.+ ..   ...+++|.....    ......+.+..|+.+++.++||||+++++++.+ .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC----TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            35688999999999999999986 22   347899987532    224456788999999999999999999998876 4


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..|+||||+++|+|.+++...  .+++..+..++.|++.||.|||+.|++|||||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~  134 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA  134 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence            578999999999999999764  38899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.76  E-value=6.9e-18  Score=154.43  Aligned_cols=128  Identities=23%  Similarity=0.445  Sum_probs=107.5

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ...+++|.+...||+|+||.||+|.+ .++..||+|.+.....   .......+.+|+.+++.++||||+++++++....
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC---cCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            44577899999999999999999988 7899999999864321   1122334568999999999999999999886643


Q ss_pred             --------EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 --------KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 --------~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                              ..++||||+.+ +|.+++...  .+++..+..++.|++.||.|||++|++|+|||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~  146 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMK  146 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence                    46999999965 888877654  58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.76  E-value=4.4e-18  Score=154.11  Aligned_cols=123  Identities=31%  Similarity=0.514  Sum_probs=107.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|+..+.||.|++|.||+|.+ .++..||+|.+....   ........+..|+.+++.++||||+++++++...+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc---cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            478899999999999999988 789999999886432   1222345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||++ ++|..++..   ..+++..+..++.|++.||+|||+.|++|||||
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~  127 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK  127 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99996 588888754   348899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.76  E-value=8.8e-18  Score=151.93  Aligned_cols=125  Identities=27%  Similarity=0.317  Sum_probs=108.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEecC-----CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDD-----GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-  262 (317)
                      .++|.+.+.||+|+||.||.|.+..     +..+++|.+..    .........+..|+.++..++||||+++++++.. 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4678999999999999999998743     67899998752    2344556778899999999999999999998765 


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE---------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~---------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +...+++++|+++|+|.+++..         ..+++..+..++.|++.||.|||++|++|||||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~  144 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIA  144 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence            5778999999999999999865         347899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.76  E-value=6.9e-18  Score=154.34  Aligned_cols=118  Identities=27%  Similarity=0.454  Sum_probs=106.6

Q ss_pred             eccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          195 GAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      ...||+|+||.||++.. .++..+|+|.+...     .......+.+|+.+++.++||||+++++.+...+..|++|||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            36799999999999988 78999999987532     2234566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++|.+++....+++..+..++.|++.||.|||+.|++|+|||
T Consensus       100 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~  143 (292)
T cd06657         100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK  143 (292)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99999999887789999999999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=6.2e-19  Score=179.22  Aligned_cols=128  Identities=29%  Similarity=0.491  Sum_probs=111.6

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC-
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE-  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-  263 (317)
                      .....+|..+..||+||||.||+++. -+|+.||||.|+..   . +......+.+|+.++++|+|||||+|+..|... 
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~---~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK---A-SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST  550 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc---h-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence            34567889999999999999999999 89999999999854   2 456677889999999999999999999765221 


Q ss_pred             --------------------------------------------------------------------------------
Q 021084          264 --------------------------------------------------------------------------------  263 (317)
Q Consensus       264 --------------------------------------------------------------------------------  263 (317)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------CEEEEEEecCCCCCHHHHHHhCCCC--HHHHHHHHHHHHHHH
Q 021084          264 --------------------------------------NKLYIFLELVTQGSLAKIYQEYHLK--DSQVSAYTWQILNGL  303 (317)
Q Consensus       264 --------------------------------------~~~~lVmE~~~ggsL~~~l~~~~l~--~~~~~~i~~qil~aL  303 (317)
                                                            ..+||-||||+..+|.+++..+.+.  ...++.++.||++||
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence                                                  2478999999998899999888764  788899999999999


Q ss_pred             HHHHHCCcEecCCC
Q 021084          304 KYLHEQNVIHRPGA  317 (317)
Q Consensus       304 ~yLH~~gIvHrDLK  317 (317)
                      .|+|++||||||||
T Consensus       711 aYIH~~giIHRDLK  724 (1351)
T KOG1035|consen  711 AYIHDQGIIHRDLK  724 (1351)
T ss_pred             HHHHhCceeeccCC
Confidence            99999999999998

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.76  E-value=1.1e-18  Score=166.01  Aligned_cols=124  Identities=23%  Similarity=0.339  Sum_probs=109.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .....+.+.||+|.||.|.+|....+..||+|.++.    .........|..|+++|.+|+|||||.++|+|..++.+|+
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~----~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRP----DATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCc----ccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            356778899999999999999888889999999974    2334556889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCCC---CHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          269 FLELVTQGSLAKIYQEYHL---KDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~l---~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +|||++.|+|.+++.....   .......|+.||+.||+||.+.++|||||
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~  663 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDL  663 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccc
Confidence            9999999999999987632   33445679999999999999999999997

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.76  E-value=1.1e-17  Score=151.13  Aligned_cols=123  Identities=23%  Similarity=0.399  Sum_probs=102.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHH-hccCCCCceeeeeeEEEeCCEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL-LGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ++|.+.+.||+|+||.||++.+ .+|..||+|.++...   ... ....+..|+.+ ++.++||||+++++++..++.+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC---CcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            4788999999999999999998 789999999987432   111 22344455554 66679999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      ++|||++ |+|.+++..     ..+++..+..++.|++.||.|||++ +++|||||
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlk  131 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK  131 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence            9999996 588887754     2489999999999999999999997 99999997

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.76  E-value=9.5e-18  Score=157.06  Aligned_cols=131  Identities=30%  Similarity=0.479  Sum_probs=111.0

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ..+-...++|.+.+.||+|+||.||++.+ .++..||+|++...   .........+.+|+.++.+++||||+++++++.
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            33444568899999999999999999988 78999999988642   122233556788999999999999999999886


Q ss_pred             eC------CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DE------NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~------~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..      ..+|++++++ |++|.+++....+++..+..++.|++.||.|||++||+|||||
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  147 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  147 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            43      4578899987 7799999887789999999999999999999999999999997

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.76  E-value=1.2e-17  Score=151.51  Aligned_cols=119  Identities=24%  Similarity=0.296  Sum_probs=97.1

Q ss_pred             cccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHH---HHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          197 PLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI---SLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      .||+|+||.||++.+ .++..+|+|.+........  .....+..|.   .++...+||||+.+++.+...+..|+||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc--hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            489999999999988 7899999999875432111  1112233333   334445899999999999999999999999


Q ss_pred             CCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|+|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dik  124 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLK  124 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCC
Confidence            999999988864 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.76  E-value=2e-17  Score=146.38  Aligned_cols=124  Identities=45%  Similarity=0.819  Sum_probs=111.3

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--CEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--NKLY  267 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~  267 (317)
                      +|...+.||+|++|.||.|.+ .++..+++|++....   ........+..|+.++++++||||+++++.+...  ..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG---DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            477889999999999999988 689999999987542   2245567889999999999999999999999988  8999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~  128 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIK  128 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            999999999999998765 68999999999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.76  E-value=1.2e-17  Score=151.96  Aligned_cols=126  Identities=27%  Similarity=0.484  Sum_probs=107.8

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ....++|.+...||+|+||.||++.. .++..+|+|++....      .....+..|+.++.++ +|||++++++++...
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34578899999999999999999988 789999999985321      1234567888899888 899999999998753


Q ss_pred             -----CEEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -----NKLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -----~~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                           +.+|+||||+++++|.+++..     ..+++..+..++.|++.||.|||+.||+|||||
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk  155 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVK  155 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence                 468999999999999998752     358999999999999999999999999999997

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.76  E-value=1.4e-17  Score=151.20  Aligned_cols=124  Identities=29%  Similarity=0.490  Sum_probs=111.8

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..+.|.....||+|+||.||.+.+ .++..+++|++.....      ....+..|+.++..++||||+++++.+...+..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            355688889999999999999988 5889999999974321      456688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+++||+++++|.+++...  .+++..+..++.|++.||.|||+.||+|+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~  143 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIK  143 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            9999999999999999876  68999999999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.76  E-value=5.5e-18  Score=158.42  Aligned_cols=123  Identities=33%  Similarity=0.520  Sum_probs=107.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|.+.+.||.|+||.||+|.+ .++..||+|.+....     ......+.+|+.+++.++||||+++++++...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            36899999999999999999998 789999999986432     13346678899999999999999999776543    


Q ss_pred             ----------CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ----------NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ----------~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                ..+|+||||++ ++|.+++..+.+++..+..++.||+.||.|||+.||+|||||
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dik  141 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLK  141 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence                      46899999997 599999887789999999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.76  E-value=7.8e-18  Score=153.78  Aligned_cols=127  Identities=28%  Similarity=0.512  Sum_probs=107.6

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC-
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN-  264 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-  264 (317)
                      ...++|.+.+.||.|+||.||+|.+ .++..||+|.+.....   .......+..|+.++..++||||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            3467899999999999999999998 7789999999875422   1222345678999999999999999999987654 


Q ss_pred             ---------EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 ---------KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ---------~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                               .+|+||||+++ ++..++...  .+++..+..++.|++.||.|||+.||+|||||
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~  143 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIK  143 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence                     89999999976 777776643  58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.4e-18  Score=166.56  Aligned_cols=129  Identities=18%  Similarity=0.324  Sum_probs=114.3

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..-.-|..++.||-|+||.|.++.. ++...||+|.+++.+  ......+.....|-.||...+++.||+++..|++++.
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD--Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn  703 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD--VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN  703 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH--HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence            3344688999999999999999987 888899999998654  2334456667788899999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||+|++||++..+|-+.+ |++..+.+|+.++..|+++.|..|+||||||
T Consensus       704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiK  756 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK  756 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccC
Confidence            999999999999999876655 8899999999999999999999999999998

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.76  E-value=1.4e-17  Score=153.10  Aligned_cols=125  Identities=26%  Similarity=0.421  Sum_probs=108.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..|...+.||+|+||.||++.. .++..||+|++....  .........+..|+.++..++||||+++++++...+..|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc--cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            4578889999999999999988 689999999986432  2234455678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++| ++.+++.  ...+++..+..++.|++.||.|||++||+||||+
T Consensus        93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~  142 (307)
T cd06607          93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIK  142 (307)
T ss_pred             EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence            9999975 7777664  3458999999999999999999999999999996

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.76  E-value=8.3e-18  Score=149.39  Aligned_cols=124  Identities=33%  Similarity=0.488  Sum_probs=110.0

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||.|+||.||++.+ .++..+++|.+....   ........+..|+.+++.++||||+++++++......|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            478899999999999999988 788999999987432   1234456778899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++..     ..+++..+..++.|++.||.|||+.|++|+|||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~  130 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK  130 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            999999999998865     458899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.76  E-value=5.7e-19  Score=167.61  Aligned_cols=122  Identities=27%  Similarity=0.375  Sum_probs=104.3

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      +.|.+..+...-++-||+|+-|.||+|+. .++.||||.++-            .-..++..|.+|+||||+.|.|+|..
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecC
Confidence            34555555555577899999999999965 446799998751            11257888999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+|||||||+.|-|+.+|+.+. ++......+..+|+.||.|||.+.|||||||
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLK  239 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLK  239 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccC
Confidence            999999999999999999998764 8888899999999999999999999999998

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.76  E-value=1.1e-17  Score=153.84  Aligned_cols=126  Identities=29%  Similarity=0.493  Sum_probs=107.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--C
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--N  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~  264 (317)
                      ..++|.+.+.||.|+||.||+|.+ .+|..||+|.+......   ......+.+|+.++..++||||+++++++...  +
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER---DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC---CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            467899999999999999999998 78999999998754321   12223456799999999999999999998764  5


Q ss_pred             EEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+++||||+.+ +|.+++..  ..+++..+..++.||+.||.|||+.|++|||||
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  135 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLK  135 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            78999999965 88888765  458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.76  E-value=4.8e-18  Score=173.49  Aligned_cols=125  Identities=30%  Similarity=0.444  Sum_probs=110.8

Q ss_pred             hccCeeeeccccccCCeeEEEEEe--cCCC----EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT--DDGF----FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ......+.+.||+|.||.||.|..  ..|.    .||+|.++.    ..+.+....|.+|..+|+.++|||||+++|++.
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~----~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR----LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc----cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            345677889999999999999986  3343    488888763    445677889999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEY--------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~--------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +....+|++|||.||+|..+|++.        .++..+...++.||+.|+.||+++++|||||
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL  828 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL  828 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence            999999999999999999999865        2889999999999999999999999999998

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.76  E-value=8.1e-18  Score=150.20  Aligned_cols=122  Identities=26%  Similarity=0.405  Sum_probs=104.7

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE-eCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK-DENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~  266 (317)
                      ...+|.+.+.||+|+||.||++.. .+..+|+|.+...       .....+..|+.+++.++|||++++++++. ..+.+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            356789999999999999999954 4778999987521       12456889999999999999999999764 45679


Q ss_pred             EEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||+++++|.+++....   +++..+..++.|++.||.|||++||+|||||
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  129 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLA  129 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccc
Confidence            99999999999999987543   7889999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.76  E-value=1.1e-17  Score=159.54  Aligned_cols=118  Identities=21%  Similarity=0.241  Sum_probs=103.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+|.++..||.|+||.||+|..   ..+..||+|.+...          ....+|+.+++.++||||+++++++.....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            45799999999999999999975   34678999987531          124579999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|++||++. ++|.+++.. ..+++..+..++.||+.||.|||++||||||||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlk  212 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK  212 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            999999996 588888754 458999999999999999999999999999998

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.76  E-value=1e-17  Score=152.51  Aligned_cols=124  Identities=28%  Similarity=0.457  Sum_probs=104.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE--
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK--  265 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~--  265 (317)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|.+.....   .......+.+|+.++..+ +||||+++++++.....  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD---EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc---ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            4688999999999999999998 7899999998864321   122335677899999999 56999999999987665  


Q ss_pred             ---EEEEEecCCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 ---LYIFLELVTQGSLAKIYQE------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ---~~lVmE~~~ggsL~~~l~~------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         +|++|||+++ +|.+++..      ..+++..+..++.||+.||.|||++||+|||||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~  137 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK  137 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence               8999999986 88887743      237899999999999999999999999999997

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.76  E-value=1.3e-17  Score=155.23  Aligned_cols=126  Identities=25%  Similarity=0.363  Sum_probs=109.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-CCE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-ENK  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~  265 (317)
                      ..++|.+.+.||.|+||.||++.+ .++..||+|.+....   ........+..|+.++..++||||+++++++.. ...
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            457899999999999999999988 789999999886432   122334567789999999999999999999876 567


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|++|||+ +++|..++...++++..+..++.|++.||.|||++||+|||||
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~  135 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK  135 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            89999999 5699999988889999999999999999999999999999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.76  E-value=7.6e-18  Score=155.26  Aligned_cols=115  Identities=26%  Similarity=0.471  Sum_probs=96.4

Q ss_pred             eccccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CCEEEEE
Q 021084          195 GAPLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--ENKLYIF  269 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV  269 (317)
                      +..||+|+||.||+|..   .++..||+|.+....       ....+.+|+.+++.++||||+++++++..  ...+|++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            46899999999999986   356899999886321       12346689999999999999999998854  5678999


Q ss_pred             EecCCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY----------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~----------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+.+ +|.+++...          .+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlk  135 (317)
T cd07868          79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK  135 (317)
T ss_pred             EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCC
Confidence            999965 888877521          38889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.76  E-value=1.2e-17  Score=151.15  Aligned_cols=124  Identities=27%  Similarity=0.515  Sum_probs=106.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEe---
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKD---  262 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---  262 (317)
                      ..+.|++...||.|+||.||+|.+ .++..+|+|++...      ......+..|+.++..+ +||||+++++++..   
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            356788899999999999999998 78899999998632      12335677889989888 79999999999853   


Q ss_pred             ---CCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ---ENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ---~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ...+|++|||+++|+|.+++...   .+++..+..++.|++.||.|||+.||+|+|||
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~  148 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIK  148 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence               46799999999999999988653   37888899999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.76  E-value=3.3e-18  Score=163.89  Aligned_cols=136  Identities=26%  Similarity=0.446  Sum_probs=113.4

Q ss_pred             hhcCCcchHHHHhccCeeeeccccccCCeeEEEEEec---CC--CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC
Q 021084          176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTD---DG--FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH  250 (317)
Q Consensus       176 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~---~~--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h  250 (317)
                      ++..+....|........+.+.||.|.||.||.|...   .|  -.||||..+.    .......+.|+.|..+|+.++|
T Consensus       375 ty~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~----d~t~d~tekflqEa~iMrnfdH  450 (974)
T KOG4257|consen  375 TYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKT----DCTPDDTEKFLQEASIMRNFDH  450 (974)
T ss_pred             cccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhcc----CCChhhHHHHHHHHHHHHhCCC
Confidence            5555555556666666677889999999999999862   23  3578887764    2344557899999999999999


Q ss_pred             CceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       251 pnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      ||||+++|+|... ..|||||.++-|.|..+++.+.  ++......++.||+.||.|||+.++|||||
T Consensus       451 phIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDI  517 (974)
T KOG4257|consen  451 PHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDI  517 (974)
T ss_pred             cchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhh
Confidence            9999999998864 5899999999999999998765  778888899999999999999999999998

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.76  E-value=6.2e-18  Score=150.75  Aligned_cols=121  Identities=25%  Similarity=0.486  Sum_probs=104.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..++|.+.+.||+|+||.||.+. .++..+|+|.+...       .....+..|+.++..++||||+++++++...+ .+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~   74 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCD-------VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LY   74 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc-cCCCceEEEeecCc-------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cE
Confidence            34678999999999999999985 56778999988532       12356889999999999999999999987654 79


Q ss_pred             EEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|||+++++|.+++...   .+++..+..++.|++.||.|||++|++|||||
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~  127 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA  127 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence            999999999999998753   37888999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.75  E-value=1.4e-17  Score=152.90  Aligned_cols=124  Identities=27%  Similarity=0.482  Sum_probs=104.7

Q ss_pred             CeeeeccccccCCeeEEEEEe-c--CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--CE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-D--DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--NK  265 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~--~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~  265 (317)
                      .|.+...||+|+||.||+|.+ .  ++..||+|.+.....  ........+..|+.++..++||||+++++++...  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            478889999999999999988 5  689999999875321  1222345677899999999999999999999988  88


Q ss_pred             EEEEEecCCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++ +|.+++..      ..+++..+..++.|++.||.|||+.||+|||||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlk  135 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLK  135 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence            9999999975 67766642      247889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.75  E-value=1.8e-17  Score=155.45  Aligned_cols=125  Identities=26%  Similarity=0.410  Sum_probs=107.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC---
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE---  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---  263 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|.+....   ........+.+|+.+++.++||||+++++++...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc---cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            457899999999999999999998 789999999886321   2334456677899999999999999999988643   


Q ss_pred             ---CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ---NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ---~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ...|+||||+.+ +|.+.+... ++...+..++.|++.||.|||++||+|||||
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk  145 (353)
T cd07850          91 EEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  145 (353)
T ss_pred             cccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence               357999999965 888887654 8999999999999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.75  E-value=2.5e-17  Score=149.29  Aligned_cols=119  Identities=24%  Similarity=0.302  Sum_probs=97.3

Q ss_pred             cccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHH---HHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          197 PLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQE---ISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      .||+|+||.||++.+ .+++.||+|.+.........  ....+..|   +..+....||+|+.+++.+...+.+|+||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch--hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence            489999999999988 78999999998754322111  11112233   3445556899999999999999999999999


Q ss_pred             CCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++||+|..++... .+++..+..++.|++.||.|||+.||+|||||
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~  124 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLK  124 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCC
Confidence            9999999988654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.75  E-value=1.3e-18  Score=166.95  Aligned_cols=124  Identities=31%  Similarity=0.545  Sum_probs=109.3

Q ss_pred             eeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE--EEEE
Q 021084          193 QKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK--LYIF  269 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~lV  269 (317)
                      +....||+|+|-+||+|.+ .+|..||--.++.... ...+...++|..|+.+|+.|+||||++++.+|.+...  +.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHh-hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            4567899999999999999 8899998776665433 3456678899999999999999999999999988554  8899


Q ss_pred             EecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ--NVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~--gIvHrDLK  317 (317)
                      +|.+..|+|..|+++. .++...+..|++||+.||.|||++  +|||||||
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLK  172 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLK  172 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccc
Confidence            9999999999999765 488999999999999999999999  79999998

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.75  E-value=2.2e-17  Score=147.61  Aligned_cols=120  Identities=24%  Similarity=0.424  Sum_probs=99.1

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHH-hccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL-LGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      +.||.|+||.||+|.+ .++..||+|.++....  ........+..|..+ ....+|||++++++++...+.+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            5699999999999988 7889999999864321  111222334445444 44558999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~  124 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK  124 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99999999876 458999999999999999999999999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.75  E-value=6e-18  Score=151.23  Aligned_cols=127  Identities=25%  Similarity=0.364  Sum_probs=105.8

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|.+.+.||+|+||.||++.+ ..+..+++|.++..............+..|+.++..++||||+++++++.+....|+|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            478899999999999999988 5566677776653222222233344567889999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+++++|.+++..     ..+++..+..++.|++.||.|||+.|++|+|||
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~  133 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK  133 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Confidence            999999999988753     348999999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.75  E-value=1.9e-17  Score=147.90  Aligned_cols=117  Identities=28%  Similarity=0.423  Sum_probs=100.3

Q ss_pred             ccccccCCeeEEEEEe-cC---CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEe
Q 021084          196 APLGSGSFGSVYEGFT-DD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      +.||+|+||.||+|.. ..   +..+|+|.+....    .......+..|+.+++.+.||||+++++++. ...+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH----IAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEeccccc----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            4699999999999976 32   3789999986432    1134567889999999999999999999876 456899999


Q ss_pred             cCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+++|+|.+++...+ +++..+..++.|++.||.|||+.|++|+|||
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~  122 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLA  122 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcc
Confidence            999999999997655 8999999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.75  E-value=1.3e-17  Score=148.75  Aligned_cols=117  Identities=30%  Similarity=0.463  Sum_probs=101.8

Q ss_pred             ccccccCCeeEEEEEe-c-CC--CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEe
Q 021084          196 APLGSGSFGSVYEGFT-D-DG--FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~-~~--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      +.||+|++|.||++.+ . .+  ..+|+|.+.....    ......+..|+.++++++||||+++++.+.. ..++++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            3689999999999987 3 33  3689998864321    1566789999999999999999999999988 89999999


Q ss_pred             cCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+++++|.+++...   .+++..+..++.|++.||.|||++|++|+|||
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~  124 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLA  124 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence            99999999998764   48899999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.75  E-value=3.7e-19  Score=181.73  Aligned_cols=126  Identities=37%  Similarity=0.706  Sum_probs=112.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .-+|+.+..||.|.||.||.|.. .+|...|+|.+.....   .......+.+|+.++..++|||+|+++|+-...+.++
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~---~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS---DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc---ccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34688889999999999999988 8999999999986542   2555677889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||.||+|.+++..++ .++.....+..|++.||.|||++||||||||
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK 1361 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIK 1361 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCC
Confidence            9999999999999999876 5666677899999999999999999999998

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.75  E-value=3.9e-17  Score=143.95  Aligned_cols=122  Identities=30%  Similarity=0.558  Sum_probs=110.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      +|...+.||+|++|.||++.+ .++..+++|++....     ......+.+|+.++..++||+++++++.+......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            477889999999999999988 688999999987432     13456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||+++++|.+++...  .+++..+..++.|++.||.|||++|++||||+
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~  125 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIK  125 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCC
Confidence            9999999999998765  68999999999999999999999999999996

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.75  E-value=3.1e-17  Score=151.56  Aligned_cols=123  Identities=27%  Similarity=0.445  Sum_probs=106.7

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |...+.||+|+||.||++.+ .++..+|+|.+....  .........+..|+.+++.++|||++++++++..+...|+||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC--CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            66788999999999999988 788999999986432  223345567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||++| +|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~  152 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK  152 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99975 77776643  458999999999999999999999999999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.75  E-value=2.4e-17  Score=146.49  Aligned_cols=118  Identities=31%  Similarity=0.475  Sum_probs=104.3

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCC
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQ  275 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~g  275 (317)
                      +.||.|+||.||++.+..++.||+|.+....    .......+..|+.+++.++||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTL----PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            3689999999999988559999999886432    224566788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          276 GSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       276 gsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|.+++...  .+++..+..++.|++.||.|||++|++|||||
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~  120 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA  120 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcC
Confidence            9999998653  47888899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.74  E-value=1.9e-17  Score=151.97  Aligned_cols=124  Identities=24%  Similarity=0.440  Sum_probs=104.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC----EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF----FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .++|+..+.||+|+||.||+|.+ .++.    .+|+|.+...    ........+..|+.++..++||||+++++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            45678899999999999999987 5554    4688877532    2233445688999999999999999999998764


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..++++||+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dik  136 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLA  136 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccc
Confidence             467999999999999998754  47889999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.74  E-value=3.3e-17  Score=147.76  Aligned_cols=119  Identities=17%  Similarity=0.243  Sum_probs=98.2

Q ss_pred             ccCeeeeccc--cccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhc-cCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPL--GSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG-QFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~L--G~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|.+.+.+  |+|+||.||++.. .++..+|+|.+.......          .|+.... ..+||||+++++.+...+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            4455666665  9999999999988 788999999987432111          0111111 127999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++++|.+++... .+++..+..++.|++.||.|||+.|++|||||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  136 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK  136 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            999999999999999998765 68999999999999999999999999999997

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.74  E-value=1.8e-17  Score=149.93  Aligned_cols=122  Identities=32%  Similarity=0.535  Sum_probs=106.4

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |++.+.||.|++|.||+|.+ .+|..||+|++.....   .......+..|+.+++.++|||++++++++.+++..|++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc---cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            56788999999999999988 7899999999875421   1223356778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||++ ++|.+++...   .+++..+..++.|++.||.|||++|++||||+
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~  126 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLK  126 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence            9995 5899988654   48999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.74  E-value=2.1e-17  Score=150.17  Aligned_cols=126  Identities=23%  Similarity=0.316  Sum_probs=107.7

Q ss_pred             CeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      +|.+.+.||+|+||.||++..    .++..||+|.++.... .........+..|+.++..+ +||||+.+++.+..+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            478899999999999999875    3678999999874321 11223455678999999999 69999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.|++|||||
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~  132 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIK  132 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            9999999999999998865 458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.74  E-value=1.2e-17  Score=155.41  Aligned_cols=124  Identities=26%  Similarity=0.460  Sum_probs=106.3

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe----CC
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD----EN  264 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~  264 (317)
                      ++|.+.+.||.|+||.||+|.. .++..||+|.+....   ........+..|+.++..++||||+++++++..    ..
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc---ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            6789999999999999999988 789999999987432   122345667789999999999999999998753    45


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+. |+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  134 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLK  134 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            7899999995 589888864 358999999999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.74  E-value=1.6e-17  Score=154.79  Aligned_cols=126  Identities=25%  Similarity=0.411  Sum_probs=107.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEe--C
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKD--E  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~  263 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..+|+|.+....   ........+..|+.++.++ +||||+++++++..  .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            356788999999999999999988 678999999885321   1223345677899999999 99999999999865  3


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+|+||||+++ +|..++....+++..+..++.||+.||.|||++||+|||||
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~  134 (337)
T cd07852          82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLK  134 (337)
T ss_pred             ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            468999999974 99999887778999999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PTZ00284 protein kinase; Provisional

Probab=99.74  E-value=2.8e-17  Score=160.19  Aligned_cols=124  Identities=17%  Similarity=0.215  Sum_probs=98.8

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC------CCCceeeeeeE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF------EHDNIVQYFGT  259 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~  259 (317)
                      ...++|.+.+.||+|+||.||+|.+ .++..||||+++...      .....+..|+.++..+      +|++++.++++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3457899999999999999999988 788999999986321      1122334455555544      45668899888


Q ss_pred             EEeC-CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          260 EKDE-NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       260 ~~~~-~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +... +++|+||+++ |++|.+++.. +.+++..+..++.||+.||.|||+ .||||||||
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK  259 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK  259 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence            8764 6799999998 6688887754 469999999999999999999998 599999998

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.74  E-value=3.8e-17  Score=147.60  Aligned_cols=122  Identities=28%  Similarity=0.542  Sum_probs=106.8

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--CEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--NKLYI  268 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~l  268 (317)
                      |.+.+.||.|+||.||+|.. .++..+|+|.+....   ........+..|+.++..++|||++++++++...  +..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            56789999999999999988 678999999997542   1223345677899999999999999999999988  89999


Q ss_pred             EEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++ +|.+++...  .+++..+..++.||+.||.|||+.|++|+|||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~  127 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIK  127 (287)
T ss_pred             Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCc
Confidence            9999975 898888654  68999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.74  E-value=3.4e-17  Score=152.31  Aligned_cols=127  Identities=25%  Similarity=0.438  Sum_probs=105.2

Q ss_pred             cCee-eeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccH---------HHHHHHHHHHHHhccCCCCceeeeee
Q 021084          190 MSWQ-KGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGE---------QSVLQLEQEISLLGQFEHDNIVQYFG  258 (317)
Q Consensus       190 ~~y~-~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~---------~~~~~~~~Ei~il~~l~hpnIv~l~~  258 (317)
                      ++|. +.+.||.|+||.||+|.+ .++..||+|.+..........         .....+.+|+.++..++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 457799999999999998 789999999986532211000         01124678999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++...+..|+||||+. |+|.+++... .+++..+..++.|++.||.|||+.||+|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~  146 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLS  146 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence            9999999999999997 5899888653 58999999999999999999999999999997

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.9e-17  Score=155.31  Aligned_cols=123  Identities=15%  Similarity=0.060  Sum_probs=94.8

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-c-CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceee-eeeEEE
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-D-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ-YFGTEK  261 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~  261 (317)
                      .....++|.+.+.||+|+||+||+|.+ . ++..+|||++...............+.+|+.+|..++|+|++. +++   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            345567899999999999999999987 3 6778899987522110112334567899999999999999985 443   


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC-C
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG-A  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL-K  317 (317)
                       .+..|+|||||+|++|... .  ...   ...++.|++.||.|||++||+|||| |
T Consensus        90 -~~~~~LVmE~~~G~~L~~~-~--~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~K  139 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHLA-R--PHG---DPAWFRSAHRALRDLHRAGITHNDLAK  139 (365)
T ss_pred             -cCCcEEEEEccCCCCHHHh-C--ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCC
Confidence             2458999999999999732 1  111   1467899999999999999999999 6

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.74  E-value=2.3e-18  Score=163.73  Aligned_cols=132  Identities=19%  Similarity=0.354  Sum_probs=110.4

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc---cHHHHHHHHHHHHHhccCC---CCceeeeee
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFE---HDNIVQYFG  258 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~---hpnIv~l~~  258 (317)
                      .....+|..++.+|.|+||.|++|.+ .....|+||.+.+.+.-..   .......+-.|+.+|..++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            34466899999999999999999998 6788999999876432111   0111233568999999997   999999999


Q ss_pred             EEEeCCEEEEEEecC-CCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKDENKLYIFLELV-TQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~-~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|++++++||+||-- +|.+|++++... .+++.++..|+.|++.|+++||++||||||||
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdik  697 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIK  697 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccc
Confidence            999999999999965 355899999765 49999999999999999999999999999998

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.74  E-value=1.5e-17  Score=149.29  Aligned_cols=118  Identities=31%  Similarity=0.449  Sum_probs=100.5

Q ss_pred             ccccccCCeeEEEEEe-cC------CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          196 APLGSGSFGSVYEGFT-DD------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +.||+|+||.||+|.. ..      +..+|+|.+...    ........+.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            3689999999999976 22      257999987532    122345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY--------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~--------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||+++++|.+++...        .+++..+..++.|++.||.|||+.|++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~  133 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA  133 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            99999999999998642        37788899999999999999999999999997

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.73  E-value=2.6e-17  Score=151.43  Aligned_cols=119  Identities=24%  Similarity=0.338  Sum_probs=99.5

Q ss_pred             eeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          194 KGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      +++.+|.|++  ||.+.. .++..||+|++...   .........+..|+.+++.++||||+++++++...+.+|++|||
T Consensus         6 i~~~~~~~~~--v~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           6 IGKCFEDLMI--VHLAKHKPTNTLVAVKKINLD---SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhHhhcCCce--EEEEEecCCCCEEEEEEEecc---ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence            3444444444  555544 58999999999753   12344567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|+|.+++..   ..+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk  128 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVK  128 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            999999999875   348899999999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.73  E-value=4.5e-17  Score=147.01  Aligned_cols=121  Identities=22%  Similarity=0.415  Sum_probs=101.6

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeC--CEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDE--NKLY  267 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~  267 (317)
                      |.+.+.||+|+||.||+|.+ .++..+|+|.+.....   .... .....|+.++.++. ||||+++++++.++  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK---SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC---Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            56789999999999999988 7899999998864321   1111 23447888888884 99999999999987  8999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++ +|.+.+..  ..+++..+..++.|++.||.|||+.||+|||||
T Consensus        77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~  127 (282)
T cd07831          77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIK  127 (282)
T ss_pred             EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence            99999975 78777764  358999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.73  E-value=7.9e-17  Score=148.69  Aligned_cols=123  Identities=28%  Similarity=0.450  Sum_probs=105.9

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |.....||+|+||.||+|.+ .++..+++|.+....  .........+..|+.++..++|||++++++++.+....|+||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc--cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            55667899999999999988 789999999987432  223344567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+.+ ++.+++..  ..+++..+..++.|++.||.|||++||+|+|||
T Consensus       101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~  148 (313)
T cd06633         101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK  148 (313)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            99965 77777653  358899999999999999999999999999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.73  E-value=5.6e-17  Score=145.70  Aligned_cols=127  Identities=24%  Similarity=0.527  Sum_probs=106.5

Q ss_pred             CeeeeccccccCCeeEEEEEe-c-CCCEEEEEEEeecCCC-----CccHHHHHHHHHHHHHhcc-CCCCceeeeeeEEEe
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-D-DGFFFAVKEVSLQDQG-----TQGEQSVLQLEQEISLLGQ-FEHDNIVQYFGTEKD  262 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~-~~~~vAvK~i~~~~~~-----~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~  262 (317)
                      +|.+.+.||+|+||.||++.+ . .+..+|+|.+......     .........+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            477889999999999999988 4 5789999998643221     1233445667788888865 799999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      .+..|++|||++|++|.+++..     ..+++..+..++.|++.||.|||+ .|++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~  141 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLT  141 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCC
Confidence            9999999999999999988743     348899999999999999999996 789999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.73  E-value=3.5e-17  Score=144.97  Aligned_cols=118  Identities=28%  Similarity=0.393  Sum_probs=105.3

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQG  276 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~gg  276 (317)
                      ||.|+||.||.+.+ .++..+|+|.+....  .........+..|+.+++.++||||+++++.+..++.+|++|||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK--IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhh--hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            69999999999988 679999999987543  222345667889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          277 SLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       277 sL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|.+++... .+++..+..++.|++.||.|||+.|++|+|||
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~  120 (250)
T cd05123          79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK  120 (250)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence            999998765 58999999999999999999999999999996

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.73  E-value=5e-17  Score=145.31  Aligned_cols=118  Identities=25%  Similarity=0.425  Sum_probs=98.4

Q ss_pred             ccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE-eCCEEEEEE
Q 021084          196 APLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK-DENKLYIFL  270 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lVm  270 (317)
                      +.||+|+||.||+|.. .   .+..+|+|.+..    .........+..|+.+++.++||||+++++++. .++..+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR----ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCc----cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            3689999999999976 2   345799998742    223345677889999999999999999999775 456689999


Q ss_pred             ecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++|+|.+++...  ..++..+..++.|++.||.|||+.||+|||||
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  125 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLA  125 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence            999999999998753  35777788899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.73  E-value=5.9e-17  Score=145.72  Aligned_cols=123  Identities=24%  Similarity=0.375  Sum_probs=102.2

Q ss_pred             eeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC---
Q 021084          192 WQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN---  264 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---  264 (317)
                      |.+.+.||+|+||.||+|..    .++..+|+|++...   .......+.+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc---cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            56778999999999999975    24689999998643   223345667889999999999999999999886532   


Q ss_pred             ---EEEEEEecCCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 ---KLYIFLELVTQGSLAKIYQEY-------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ---~~~lVmE~~~ggsL~~~l~~~-------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ..+++++|+++|+|..++...       .++...+..++.|++.||+|||++||+|||||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dik  140 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLA  140 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccc
Confidence               357899999999998876421       36888899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.73  E-value=2.9e-17  Score=153.63  Aligned_cols=126  Identities=28%  Similarity=0.476  Sum_probs=109.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE-
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK-  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-  265 (317)
                      ..++|.+...||+|+||.||+|.+ .++..||+|.+...   .........+.+|+.+++.++||||+++++++..... 
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc---cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            356899999999999999999998 78899999988642   1223344567789999999999999999998866554 


Q ss_pred             -----EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 -----LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 -----~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                           +|+|+||+ +++|.+++...++++..+..++.|++.||.|||+.||+|||||
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk  145 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLK  145 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence                 89999999 6699999988889999999999999999999999999999997

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.73  E-value=5e-17  Score=149.61  Aligned_cols=115  Identities=27%  Similarity=0.480  Sum_probs=95.5

Q ss_pred             eccccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CCEEEEE
Q 021084          195 GAPLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--ENKLYIF  269 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV  269 (317)
                      +..||+|+||.||+|..   .++..||+|.+....       ....+.+|+.+++.++||||+++++++..  +..+|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            46799999999999986   356789999886321       12346789999999999999999998854  5688999


Q ss_pred             EecCCCCCHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE----------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~----------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+.+ +|.+++..          ..+++..+..++.||+.||.|||++||+|||||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlk  135 (317)
T cd07867          79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLK  135 (317)
T ss_pred             EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCC
Confidence            999965 78777642          137888899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.72  E-value=4.6e-17  Score=151.80  Aligned_cols=125  Identities=26%  Similarity=0.440  Sum_probs=106.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      ..+|.+...||+|+||.||.+.+ .++..||+|.+....   ........+..|+.++..++||||+++++++...    
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            35789999999999999999988 789999999986432   1223345677899999999999999999988654    


Q ss_pred             -CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..+|++|||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++|||||
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlk  135 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLK  135 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence             35899999996 689888865 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.72  E-value=6.3e-17  Score=139.25  Aligned_cols=121  Identities=15%  Similarity=0.118  Sum_probs=91.5

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccH---------------------HHHHHHHHHHHHhccCCCCce
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGE---------------------QSVLQLEQEISLLGQFEHDNI  253 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~---------------------~~~~~~~~Ei~il~~l~hpnI  253 (317)
                      ...||+|+||.||.|.+.+|..||+|+++.........                     ........|+.++..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999988889999999997643211110                     001223459999999988776


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCCCHHHH-HHhCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecCCC
Q 021084          254 VQYFGTEKDENKLYIFLELVTQGSLAKI-YQEYHLKDSQVSAYTWQILNGLKYL-HEQNVIHRPGA  317 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~ggsL~~~-l~~~~l~~~~~~~i~~qil~aL~yL-H~~gIvHrDLK  317 (317)
                      ..........  .+|||||++|+++... +...+++...+..++.|++.+|.|| |+.||+|||||
T Consensus        82 ~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlk  145 (190)
T cd05147          82 PCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLS  145 (190)
T ss_pred             CCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            4433332222  3899999999877654 4566799999999999999999999 79999999998

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.72  E-value=6.6e-17  Score=147.98  Aligned_cols=125  Identities=25%  Similarity=0.517  Sum_probs=104.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      +++|.+.+.||.|+||.||+|.+ .++..+|+|.+.......   .....+.+|+.++..++||||+++++++...    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD---GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC---CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            68999999999999999999998 788999999987543211   1223456899999999999999999887543    


Q ss_pred             ----CEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ----NKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ----~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          ..+|+||||+.+ +|...+..  ..+++..+..++.|++.||.|||++||+|+|||
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~  142 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIK  142 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence                357999999965 77776654  358999999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.71  E-value=1e-17  Score=146.87  Aligned_cols=129  Identities=22%  Similarity=0.353  Sum_probs=112.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCC---CccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQG---TQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ...|.-.+.||.|..++|..|.+ .+|..+|+|++......   .......+.-..|+.+|.++ .||+|+.+.++|+++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            45566778899999999999987 89999999999754322   22344456677899999988 899999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+++|+|.|+.|.|.+++.+. .+++..+..|+.|+++|+.|||.++|||||||
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLK  150 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLK  150 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccC
Confidence            9999999999999999999764 59999999999999999999999999999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.71  E-value=4.3e-17  Score=171.97  Aligned_cols=118  Identities=24%  Similarity=0.415  Sum_probs=102.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ...|.....||+|+||.||+|.. .++..||+|.+....  .       ....|+..+.+++|||||++++++.+.+..|
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN--S-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc--c-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            45567778999999999999988 789999999885321  1       1124578899999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH---EQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH---~~gIvHrDLK  317 (317)
                      +||||+++|+|.+++..  +++..+..++.|++.||+|||   +.+|+|||||
T Consensus       760 lv~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk  810 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS  810 (968)
T ss_pred             EEEeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCC
Confidence            99999999999999964  889999999999999999999   6699999997

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.71  E-value=4.9e-17  Score=150.72  Aligned_cols=123  Identities=32%  Similarity=0.513  Sum_probs=107.3

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC-----
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN-----  264 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----  264 (317)
                      +|.+.+.||.|+||.||+|.. .++..||+|.+....   ........+..|+.+++.++||||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            588899999999999999998 679999999986431   12344567889999999999999999999988765     


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|++|||+++ +|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlk  130 (330)
T cd07834          78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLK  130 (330)
T ss_pred             ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            79999999974 898888654 58999999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.71  E-value=4.1e-17  Score=147.17  Aligned_cols=122  Identities=30%  Similarity=0.515  Sum_probs=107.4

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |...+.||+|+||.||.|.. .++..+|+|.+....   ........+..|+.+++.++||||+++++++...+.+++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            56778899999999999988 679999999997542   12233456778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++ +|.+++...  .+++..+..++.|++.||.|||++||+||||+
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~  125 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLK  125 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99974 999999765  68999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.71  E-value=4.3e-17  Score=160.28  Aligned_cols=129  Identities=22%  Similarity=0.298  Sum_probs=98.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe--cCCCEEEEEEEeecC------------CCCccHHHHHHHHHHHHHhccCCCCce
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT--DDGFFFAVKEVSLQD------------QGTQGEQSVLQLEQEISLLGQFEHDNI  253 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~------------~~~~~~~~~~~~~~Ei~il~~l~hpnI  253 (317)
                      ..++|.+++.||+|+||.||+|..  .++...+.|.+....            ...........+.+|+.+|..++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            357899999999999999999865  233333333111000            001122345568899999999999999


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH------LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~------l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++++++...+..|++|+++. ++|..++....      .....+..++.||+.||.|||++||||||||
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK  294 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK  294 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            999999999999999999995 47877765433      3355678899999999999999999999998

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.71  E-value=5.7e-17  Score=146.59  Aligned_cols=121  Identities=26%  Similarity=0.440  Sum_probs=103.7

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV  269 (317)
                      |.+.+.||.|+||.||+|.. .++..+++|.+.....   . .......+|+..+..+. ||||+++++++..++..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            56788999999999999988 6788999998864321   1 12223457889999998 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+ +|+|.+++...   .+++..+..++.|++.||.|||++|++|+|||
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~  126 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLK  126 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9999 77999887653   58999999999999999999999999999996

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.71  E-value=6.7e-17  Score=145.82  Aligned_cols=122  Identities=28%  Similarity=0.523  Sum_probs=106.5

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |.+.+.||.|++|.||+|.. .++..+++|.+....   ........+..|+.+++.++||||+++++++..++.++++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            55678899999999999988 689999999986432   22234567888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||+++ +|.+++...  .+++..+..++.|++.||.|||++||+|+|||
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  125 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK  125 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcC
Confidence            99976 888877654  68999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PRK10345 hypothetical protein; Provisional

Probab=99.71  E-value=1.1e-16  Score=139.70  Aligned_cols=114  Identities=18%  Similarity=0.358  Sum_probs=91.2

Q ss_pred             eeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-----CCCceeeeeeEEEeC---C
Q 021084          194 KGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-----EHDNIVQYFGTEKDE---N  264 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~---~  264 (317)
                      -...||+|+||.||.  + .++.. +||++....     ......+.+|+.++..+     .||||++++|++.++   +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccc-----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            357899999999995  5 45544 689886432     12345688999999999     679999999999886   3


Q ss_pred             E-EEEEEec--CCCCCHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHHCCcEecCCC
Q 021084          265 K-LYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGL-KYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~-~~lVmE~--~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL-~yLH~~gIvHrDLK  317 (317)
                      . +.+||||  +++|+|.+++++..+++.  ..++.|++.++ +|||+++|||||||
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlK  132 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELK  132 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCC
Confidence            4 4478999  558999999988777666  35688888888 99999999999998

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.71  E-value=1.7e-16  Score=146.15  Aligned_cols=124  Identities=28%  Similarity=0.470  Sum_probs=105.9

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|...+.||.|+||.||+|.+ .++..+|+|.+....  .........+..|+.+++.++|||++++++++......++|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc--ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            366678899999999999998 788999999986432  22334456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+. |++.+++..  ..+++..+..++.|++.||.|||+.|++|||||
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~  142 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK  142 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            99996 578776643  348899999999999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.4e-17  Score=159.57  Aligned_cols=128  Identities=27%  Similarity=0.418  Sum_probs=112.8

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ++|.....+.....+||-|.||.||.|.+ .-...||||.++.      +.-.++.|+.|+.+|+.++|||+|+++|+|.
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------DtMeveEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh------cchhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            35665566677788999999999999988 6678899999852      3345788999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      ....+|||+|||..|+|.+||+...   ++......++.||..||+||..+++|||||
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDL  391 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDL  391 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhh
Confidence            9999999999999999999998754   666777889999999999999999999997

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=6.8e-17  Score=151.24  Aligned_cols=121  Identities=26%  Similarity=0.357  Sum_probs=105.2

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-----C---CceeeeeeEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-----H---DNIVQYFGTE  260 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~  260 (317)
                      ++|.+.++||.|.|++||+|.+ .+.+.||+|+.+-      .+...+..+.|+.+|+++.     |   .+||++++.|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            5899999999999999999998 8889999999862      3456677889999999882     2   4899999999


Q ss_pred             Ee----CCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          261 KD----ENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       261 ~~----~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      .-    +.++|||+|++ |.+|-.+|...   +++...+..|+.||+.||.|||.. ||||-|||
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK  215 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK  215 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence            54    67899999999 66888888653   599999999999999999999965 99999998

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.71  E-value=7.7e-17  Score=159.64  Aligned_cols=127  Identities=24%  Similarity=0.461  Sum_probs=108.9

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEe
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKD  262 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  262 (317)
                      .+...+.|.+..+||.|.+|.||++.. .+++..|+|+.....      ..-+.+..|.++++.. +|||++.++|+|..
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~------d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE------DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc------cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            445577899999999999999999998 899999999986432      1223455777777766 89999999999854


Q ss_pred             -----CCEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -----ENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -----~~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                           ++.+|||||||.||+..++++.   ..+.|..+.+|+..++.||.+||.+.++|||||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDik  150 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIK  150 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeeccc
Confidence                 6789999999999999999875   348999999999999999999999999999998

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.70  E-value=2.2e-17  Score=142.92  Aligned_cols=127  Identities=20%  Similarity=0.298  Sum_probs=111.1

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--  262 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--  262 (317)
                      ...-++|.+.+.||.|||+-||+++. .++..||+|.+..     ...+..+..++|+...++++|||+++++++...  
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-----~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-----HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeec-----cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            34456899999999999999999988 8999999999874     334567788999999999999999999887643  


Q ss_pred             ---CCEEEEEEecCCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          263 ---ENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       263 ---~~~~~lVmE~~~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                         ....||+++|...|+|.+.+...     .+++.++..|+.++++||++||+..  +.|||||
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiK  156 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIK  156 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCC
Confidence               34599999999999999988642     3899999999999999999999998  9999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.70  E-value=4.1e-17  Score=159.79  Aligned_cols=123  Identities=26%  Similarity=0.392  Sum_probs=110.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cC---CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ....+.++||.|.||.|+.|+. ..   ...||||.++.    ...+.....|+.|+.||.+++||||+++.|+......
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~----GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA----GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeecc----CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            3557889999999999999987 33   45899999963    4566778889999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +.||+|||++|+|+.+|+.+  .|+..+..-+++.|+.||.||-+.|+|||||
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDL  757 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDL  757 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhh
Confidence            99999999999999999753  5899999999999999999999999999997

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.70  E-value=2.8e-16  Score=146.12  Aligned_cols=123  Identities=28%  Similarity=0.456  Sum_probs=102.0

Q ss_pred             CeeeeccccccCCeeEEEEEe-cC--CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEe----
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DD--GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKD----  262 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~--~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----  262 (317)
                      +|.+.+.||+|+||.||++.+ .+  +..||+|.+....   ........+..|+.++..+ +||||+++++.+..    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            478899999999999999988 55  8899999986321   1223355678899999998 69999999987543    


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+|++|+|+. ++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlk  132 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLK  132 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            246889999996 589888754 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=1.5e-17  Score=149.55  Aligned_cols=132  Identities=20%  Similarity=0.259  Sum_probs=114.3

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEE
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEK  261 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~  261 (317)
                      ++...+.+|.++.+||+|+|..|.+++. .+.+.||+|++++...+  +.+.......|-.+.... +||++|-++.+|+
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n--ddedidwvqtek~vfe~asn~pflvglhscfq  321 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ  321 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC--CcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence            4667788999999999999999999988 88999999999865433  233344555666666655 8999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +...+++|.||++||+|...+++ .+++++.+.++..+|+.||.|||+.|||+||||
T Consensus       322 tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlk  378 (593)
T KOG0695|consen  322 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLK  378 (593)
T ss_pred             ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecc
Confidence            99999999999999999888765 459999999999999999999999999999998

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.69  E-value=1.3e-17  Score=143.12  Aligned_cols=119  Identities=21%  Similarity=0.422  Sum_probs=105.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeC--C
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDE--N  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~  264 (317)
                      .++|++.+.+|+|.|+.||.|.. .+...++||++++        ...+.+.+|+.+|..|. ||||+++++...++  .
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            67899999999999999999988 8889999999863        23457889999999995 99999999999774  5


Q ss_pred             EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+|+||+++.+...+..  .++..++..++.|++.||.|||++||+|||+|
T Consensus       109 tpaLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVK  159 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVK  159 (338)
T ss_pred             CchhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCC
Confidence            6889999999988777665  37888899999999999999999999999998

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.69  E-value=2.5e-16  Score=142.93  Aligned_cols=123  Identities=24%  Similarity=0.398  Sum_probs=102.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~  267 (317)
                      ++|.....||+|+||.||++.+ .++..+|+|.+....    .......+..|+.++.++. ||||+++++++..++..+
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            3556678899999999999988 789999999986432    1234567889999999995 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQ------EYHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~------~~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      ++|||+.+ ++.++..      ...+++..+..++.|++.||+|||+. ||+|||||
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk  135 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVK  135 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCC
Confidence            99999864 6655432      24589999999999999999999975 99999997

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.69  E-value=2.7e-16  Score=143.64  Aligned_cols=129  Identities=23%  Similarity=0.396  Sum_probs=106.6

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEE
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEK  261 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~  261 (317)
                      .+....++|.+.+.||+|+||.||+|.+ .++..||+|.+....    .......+..|+.++..+ .||||+++++++.
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC----ChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            3555678899999999999999999988 569999999987432    122344566677766666 5999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +...+|++|||+++ +|.+++..  ..+++..+..++.|++.||.|||+ .||+|||||
T Consensus        85 ~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~  142 (296)
T cd06618          85 TDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVK  142 (296)
T ss_pred             cCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCc
Confidence            99999999999854 78777654  358899999999999999999997 599999996

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.69  E-value=6.3e-16  Score=139.74  Aligned_cols=122  Identities=30%  Similarity=0.491  Sum_probs=101.2

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEEeCCE--
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEKDENK--  265 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~--  265 (317)
                      |++.+.||+|+||.||++.+ .++..||+|.+.....   .......+..|+.++..+   +||||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            67889999999999999998 6699999999975432   122234455677666555   69999999999988776  


Q ss_pred             ---EEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 ---LYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ---~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ++++|||+++ +|.+++...   .+++..+..++.|++.||.|||+.|++|+|||
T Consensus        78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~  134 (287)
T cd07838          78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLK  134 (287)
T ss_pred             CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence               9999999975 898887653   48999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.69  E-value=4e-16  Score=134.21  Aligned_cols=121  Identities=14%  Similarity=0.141  Sum_probs=92.9

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCcc---------------------HHHHHHHHHHHHHhccCCCCce
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG---------------------EQSVLQLEQEISLLGQFEHDNI  253 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~---------------------~~~~~~~~~Ei~il~~l~hpnI  253 (317)
                      ...||+|+||.||+|.+.+|..||||+++........                     ......+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999998788999999999864211000                     0112234678999999999987


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCCCHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          254 VQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~ggsL~-~~l~~~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      .....+....  .||||||++|+++. ..+...+++...+..++.|++.+|.+||+ .||+|||||
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlk  145 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLS  145 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            5544433332  48999999988554 34566678888999999999999999999 999999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.68  E-value=2.6e-16  Score=139.36  Aligned_cols=107  Identities=15%  Similarity=0.187  Sum_probs=92.4

Q ss_pred             cCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCCCHH
Q 021084          201 GSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLA  279 (317)
Q Consensus       201 G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~ggsL~  279 (317)
                      |.+|.||++.+ .+++.||+|.+....          .+..|...+....||||+++++++...+.+|++|||++||+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            88999999999 889999999986431          1223444455567999999999999999999999999999999


Q ss_pred             HHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          280 KIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       280 ~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++.. .++++..+..++.|++.||.|||++||+|||||
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk  112 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN  112 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            98754 458999999999999999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.68  E-value=3.7e-16  Score=146.06  Aligned_cols=124  Identities=27%  Similarity=0.436  Sum_probs=104.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|.+...||+|+||.||+|.+ .+|..||+|.+....   ........+..|+.++..++||||+++++++...    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---ccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence            36899999999999999999988 789999999986432   1223345678999999999999999999998754    


Q ss_pred             --CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 --NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 --~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        ..+|+||||+.. +|..++. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        91 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlk  144 (342)
T cd07879          91 EFQDFYLVMPYMQT-DLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLK  144 (342)
T ss_pred             CCceEEEEeccccc-CHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence              357999999964 7777653 468999999999999999999999999999997

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.67  E-value=5.6e-18  Score=163.36  Aligned_cols=126  Identities=36%  Similarity=0.535  Sum_probs=112.9

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..-++|.++..+|+|+||.||++++ .++...|+|+++...     ......+..|+-+++.++|||||.|+|.+...+.
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC-----CccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            4467899999999999999999999 899999999998643     2334556789999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+.||||.||+|.++.. .+.+++.++....++.++||.|||++|-+|||||
T Consensus        87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiK  139 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIK  139 (829)
T ss_pred             cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCccccccc
Confidence            999999999999999764 4569999999999999999999999999999998

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.67  E-value=4.3e-17  Score=144.62  Aligned_cols=119  Identities=24%  Similarity=0.248  Sum_probs=101.0

Q ss_pred             ccCeee-eccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEe---
Q 021084          189 IMSWQK-GAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKD---  262 (317)
Q Consensus       189 ~~~y~~-~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---  262 (317)
                      +++|.+ -++||-|-.|.|..|.+ .++..+|+|++.-      .    ....+|+++.-.. .|||||+++++|..   
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------S----PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------C----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            556655 36899999999999988 8999999999852      2    2344777766655 79999999998754   


Q ss_pred             -CCEEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ...+.+|||.++||.|...++..+   |++.++..|+.||+.|+.|||+.+|.|||||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlK  188 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLK  188 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCC
Confidence             566889999999999999998654   9999999999999999999999999999998

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=1.4e-17  Score=153.07  Aligned_cols=130  Identities=24%  Similarity=0.258  Sum_probs=110.6

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      .....+|..+.+||+|+||.|.++.. .+...||||++++......  ..++--+.|-++|.-. +-|++++++.+|++-
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd--DDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD--DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec--CcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            44567889999999999999999977 7788999999986543222  2344455677777665 578999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||+.||+|...+++ +++.+..+.+|+.+|+.||-|||++|||+||||
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK  477 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK  477 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeecc
Confidence            999999999999999888876 459999999999999999999999999999998

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.66  E-value=1.8e-16  Score=147.92  Aligned_cols=120  Identities=25%  Similarity=0.391  Sum_probs=102.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhc--cCCCCceeeeeeEEEeCC--
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG--QFEHDNIVQYFGTEKDEN--  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~~--  264 (317)
                      ....++.+.||+|.||.||+|... ++.||||+++.        +..+.+..|-.+.+  .+.|+||++|+++-....  
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            445667899999999999999653 48999999863        33456667776665  458999999999876554  


Q ss_pred             --EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEecCCC
Q 021084          265 --KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ---------NVIHRPGA  317 (317)
Q Consensus       265 --~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~---------gIvHrDLK  317 (317)
                        .++||++|-+.|+|.++|..+.++|....+++..|++||+|||.-         +|+|||||
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlk  343 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLK  343 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccccc
Confidence              899999999999999999999999999999999999999999964         69999997

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.66  E-value=8.2e-17  Score=156.09  Aligned_cols=121  Identities=26%  Similarity=0.358  Sum_probs=104.2

Q ss_pred             CeeeeccccccCCeeEEEEEe--cCC--CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT--DDG--FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~--~~~--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...+.+.||+|+||+|+.|.+  ..|  ..||||.+.....    ......|++|+.+|.+|+|||++++||++.+ ..+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l----~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL----NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc----chhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            344678999999999999987  334  4789999974321    2267889999999999999999999999987 678


Q ss_pred             EEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          267 YIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      .||||++++|+|.+.|..   ..|.......|+.||+.||.||.++++|||||
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDL  238 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDL  238 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhh
Confidence            999999999999998876   23778888999999999999999999999997

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=9.3e-17  Score=148.91  Aligned_cols=128  Identities=23%  Similarity=0.332  Sum_probs=110.4

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCC--CccHHHHHHHHHHHHHhccCCCCceeeeeeEEE-eCCE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQG--TQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK-DENK  265 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~  265 (317)
                      ++|.++..||+|+|+.||++.+ ...+.||+|+-..+...  .......+...+|..+.+.|+||.||+++++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            4688899999999999999998 77889999986543321  223445666789999999999999999999995 4678


Q ss_pred             EEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHC--CcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQ--NVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~--gIvHrDLK  317 (317)
                      +|-|+|||+|.+|..+++..+ +++.++..|+.||+.||.||...  .|||-|||
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLK  597 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLK  597 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Confidence            999999999999999998765 89999999999999999999977  79999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.65  E-value=2.5e-15  Score=130.36  Aligned_cols=122  Identities=30%  Similarity=0.529  Sum_probs=108.3

Q ss_pred             eeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      |.+...||.|++|.||++.. .++..+++|.+......    .....+..|+..+..++|+|++++++++......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            55778999999999999988 56899999998743211    25678889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |++++++|.+++....  +++..+..++.+++.+|.|||++|++|+||+
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~  125 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLK  125 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999997654  8899999999999999999999999999986

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.65  E-value=4.2e-15  Score=126.41  Aligned_cols=116  Identities=36%  Similarity=0.615  Sum_probs=103.6

Q ss_pred             ccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 021084          198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQG  276 (317)
Q Consensus       198 LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~gg  276 (317)
                      ||+|++|.||++.. .++..+++|.+.....    ......+.+|+..+..+.|++|+++++++......+++||+++|+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccc----hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            68999999999988 5699999999874321    113567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          277 SLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       277 sL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|.+++...  .++...+..++.+++.+|.|||+.|++|+||+
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~  119 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK  119 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            999999875  68999999999999999999999999999986

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.65  E-value=8.2e-17  Score=143.51  Aligned_cols=126  Identities=25%  Similarity=0.492  Sum_probs=104.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-c--C--CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-D--D--GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~--~--~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ....|+....||+|+||.||++.. .  +  .+.+|+|.++.....   ........+|+.++..++||||+++..+|..
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~---tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG---TGISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC---CCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            356788899999999999999954 2  2  347999998754221   1222345689999999999999999998877


Q ss_pred             -CCEEEEEEecCCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQEY------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~~~------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       +..+|+++||.+. +|..+++-.      .++...+..|+.||+.|+.|||++=|+|||||
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLK  159 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLK  159 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCC
Confidence             8899999999977 999988632      38889999999999999999999999999998

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=9.6e-18  Score=157.52  Aligned_cols=129  Identities=22%  Similarity=0.317  Sum_probs=113.2

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+.+++.+..||-|+||.|=++.. .....+|+|++++....  +....+.+..|-++|..++.|+||++|..|.+..+
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV--dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV--DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc--chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            3467788899999999999999877 44446999999876533  33445678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|++||-|-||.|..+++.. .|+...+.+|+..+++|++|||++|||+||||
T Consensus       495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLK  547 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLK  547 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCC
Confidence            99999999999999999764 59999999999999999999999999999998

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.63  E-value=3.1e-16  Score=137.59  Aligned_cols=123  Identities=15%  Similarity=0.263  Sum_probs=107.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeee-EEEeCCE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFG-TEKDENK  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~-~~~~~~~  265 (317)
                      .+.|.+.+.+|.|-||.+.+|++ .+...+++|.++..      ......|.+|+..--.| .|.||+..++ +|++.+.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p------~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP------QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc------hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            45688899999999999999999 88899999988632      23456788998766666 5889997664 6788899


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.++|||+|.|+|.+-+...++.+.....++.|+++|+.|||++++||||||
T Consensus        97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK  148 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLK  148 (378)
T ss_pred             EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccc
Confidence            9999999999999998888889999999999999999999999999999998

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.62  E-value=2.7e-16  Score=154.76  Aligned_cols=119  Identities=28%  Similarity=0.474  Sum_probs=104.3

Q ss_pred             eeeccccccCCeeEEEEEe-cCCC----EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          193 QKGAPLGSGSFGSVYEGFT-DDGF----FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~-~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +..++||+|+||+||+|.+ ..|+    +||+|++..    ....+....++.|+-+|.+++|||++++++++.... +-
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~----~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE----FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeec----cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            3568899999999999988 5454    788898853    345556778999999999999999999999998876 88


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      ||++|+++|+|.++++..  .+.......|..||++||.|||.+++|||||
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdL  824 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDL  824 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhh
Confidence            999999999999999754  4888889999999999999999999999998

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=9.7e-16  Score=145.46  Aligned_cols=129  Identities=25%  Similarity=0.362  Sum_probs=111.4

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      +.+.-..|++++.||+||.+.||++...+...||+|.+...   ..+.+....+..|+..|.+| .|.+||+++++-..+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~---~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL---EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh---hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            33444578999999999999999998887788888877533   45678889999999999999 699999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+||||||= ..+|..+|+.+.  ++...+..|..||+.|+.++|.+||||.|||
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLK  487 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLK  487 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCC
Confidence            9999999965 559999998765  3334788999999999999999999999998

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1.4e-15  Score=141.15  Aligned_cols=119  Identities=23%  Similarity=0.345  Sum_probs=100.6

Q ss_pred             cCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhc--cCCCCceeeeeeEEEeC----
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG--QFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~----  263 (317)
                      .+..+.+.||+|.||.||+| ...|..||||++.-.     ++   ..+.+|.++..  .|+|+||+.|+++-..+    
T Consensus       211 rqI~L~e~IGkGRyGEVwrG-~wrGe~VAVKiF~sr-----dE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRG-RWRGEDVAVKIFSSR-----DE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             heeEEEEEecCccccceeec-cccCCceEEEEeccc-----ch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            46778999999999999999 667889999999632     22   23456666665  45999999999876443    


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ--------NVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~--------gIvHrDLK  317 (317)
                      ..+|||++|-+.|+|+++|.+..++......++..++.||+|||..        .|.|||||
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK  343 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK  343 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence            3699999999999999999999999999999999999999999964        49999998

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.61  E-value=1.2e-14  Score=133.07  Aligned_cols=127  Identities=20%  Similarity=0.330  Sum_probs=92.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cC---CCEEEEEEEeecCCCCccHHH------HHHHHHHHHHhccCCCCceeeeeeE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DD---GFFFAVKEVSLQDQGTQGEQS------VLQLEQEISLLGQFEHDNIVQYFGT  259 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~---~~~vAvK~i~~~~~~~~~~~~------~~~~~~Ei~il~~l~hpnIv~l~~~  259 (317)
                      ++|++.+.||+|+||.||+|.. .+   +..+|+|+..........+..      ......++..+..+.|++++.++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5799999999999999999987 44   556777764432211101100      0112334455677899999999987


Q ss_pred             EEeCC----EEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          260 EKDEN----KLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       260 ~~~~~----~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +....    ..+++|+++.. ++.+++.... .++..+..++.|++.||.|||++||+|||||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiK  153 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIK  153 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            76543    45788888744 7777766543 6888899999999999999999999999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.61  E-value=3.7e-15  Score=145.58  Aligned_cols=131  Identities=20%  Similarity=0.329  Sum_probs=95.0

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-----------------cCCCEEEEEEEeecCCCCcc---------HHHHHHHHH
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-----------------DDGFFFAVKEVSLQDQGTQG---------EQSVLQLEQ  240 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vAvK~i~~~~~~~~~---------~~~~~~~~~  240 (317)
                      ...++|.+.+.||+|+||.||+|..                 ..++.||||.+.........         ....+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3477999999999999999999864                 23567999998643211000         001122334


Q ss_pred             HHHHhccCCCCce-----eeeeeEEEe--------CCEEEEEEecCCCCCHHHHHHhC----------------------
Q 021084          241 EISLLGQFEHDNI-----VQYFGTEKD--------ENKLYIFLELVTQGSLAKIYQEY----------------------  285 (317)
Q Consensus       241 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lVmE~~~ggsL~~~l~~~----------------------  285 (317)
                      |+.++.+++|.++     +.++++|..        .+..|+||||+++++|.+++...                      
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6667777766544     667776643        35689999999999999987531                      


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          286 ---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       286 ---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         .+++..+..++.|++.||.|||+.+|+|||||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLK  336 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIK  336 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence               13456788899999999999999999999997

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.57  E-value=3.1e-15  Score=137.97  Aligned_cols=124  Identities=22%  Similarity=0.380  Sum_probs=108.5

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeE
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGT  259 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~  259 (317)
                      .+.....|...++||.|+|++||++.+ .   ....||+|.+....       ...++..|+++|..+ .+.||+.+.++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-------~p~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-------SPSRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-------CchHHHHHHHHHHHhccchhhhcchhh
Confidence            344556788999999999999999987 4   67899999986432       234688999999998 68999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          260 EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       260 ~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +...+..++||||++..+..++...  ++...+..+++.++.||.++|.+||||||||
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiK  159 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIK  159 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCC
Confidence            9999999999999999999988875  6678899999999999999999999999998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.56  E-value=2.8e-14  Score=124.06  Aligned_cols=118  Identities=13%  Similarity=0.081  Sum_probs=94.6

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCc---cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      +.||+|++|.||+|.. .|..+++|..........   .......+.+|+.++..+.|++|+....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999976 667899997653221111   111234578899999999999988877777777888999999


Q ss_pred             CCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|++|.+++.....   ....++.+++.+|.+||+.|++|||++
T Consensus        81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~  122 (211)
T PRK14879         81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLT  122 (211)
T ss_pred             eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            999999999875332   778899999999999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.56  E-value=2e-14  Score=124.44  Aligned_cols=123  Identities=23%  Similarity=0.273  Sum_probs=104.4

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC-CceeeeeeEEEeCC
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH-DNIVQYFGTEKDEN  264 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~  264 (317)
                      ...+.|.+++.||+|+||.+|.|.. .+|..||||+-+...   .    .-.+..|..+...|.+ +.|+.+..+..+..
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~   84 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---K----HPQLLYESKVYRILQGGVGIPHIRHYGTEKD   84 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---C----CcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence            4468999999999999999999988 899999999875321   1    1246678888888854 67777788888888


Q ss_pred             EEEEEEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +-.+||+.+ |.+|.+++.  +..++...+..++-|++.-++|+|.+++||||||
T Consensus        85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIK  138 (341)
T KOG1163|consen   85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIK  138 (341)
T ss_pred             cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCC
Confidence            899999998 889999875  4569999999999999999999999999999998

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.56  E-value=2.5e-14  Score=125.84  Aligned_cols=119  Identities=10%  Similarity=0.028  Sum_probs=95.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHH------HHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQ------LEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      -++|+..+.+|.|+||.||+... ++..+|+|++.....  ..+.....      +.+|+..+.++.||+|+.+..++..
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~--~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVK--RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcC--chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            46899999999999999999744 577899999975432  22333333      5799999999999999999888654


Q ss_pred             C--------CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 E--------NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~--------~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .        +..+|+|||++|.+|.++..   +++    ....+++.+|..||..|++|||||
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dik  162 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPH  162 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCC
Confidence            3        35899999999999988732   333    346699999999999999999997

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.56  E-value=4.2e-14  Score=123.53  Aligned_cols=112  Identities=32%  Similarity=0.544  Sum_probs=99.2

Q ss_pred             CCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCCCHHH
Q 021084          202 SFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK  280 (317)
Q Consensus       202 ~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~  280 (317)
                      +||.||+|.. .++..+++|++......    .....+..|+..++.++|+||+++++.+......+++|||+++++|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK----KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc----cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            5899999988 67999999998743211    115788899999999999999999999999999999999999999999


Q ss_pred             HHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          281 IYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       281 ~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.... ++...+..++.+++.+|.|||+.||+|+||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~  114 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLK  114 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcC
Confidence            987655 8999999999999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=7.4e-17  Score=140.17  Aligned_cols=125  Identities=22%  Similarity=0.461  Sum_probs=104.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-----  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----  262 (317)
                      .+.|.....||+|.||.||+++. .+|+.||+|.+-......   .......+|+.+|..+.|+|++.++..|..     
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe---GfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc---CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            45677788999999999999988 888899998765432111   223345689999999999999999887743     


Q ss_pred             ---CCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ---ENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ---~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ...+|+||.+|+. +|..++.+.  +++..++..++.+++.||.|+|.+.|+|||+|
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK  151 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK  151 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence               3469999999977 999999765  48999999999999999999999999999997

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.55  E-value=3.1e-14  Score=141.67  Aligned_cols=121  Identities=20%  Similarity=0.294  Sum_probs=85.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cC----CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeE---
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGT---  259 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~----~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~---  259 (317)
                      ..++|.+.+.||+|+||.||+|.+ .+    +..||+|.+....     .  .+....+  .+....+.+++.+...   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~--~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----A--VEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----h--hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            467899999999999999999998 66    7899999875311     1  1111111  1111122222222211   


Q ss_pred             ---EEeCCEEEEEEecCCCCCHHHHHHhCCCC---------------------HHHHHHHHHHHHHHHHHHHHCCcEecC
Q 021084          260 ---EKDENKLYIFLELVTQGSLAKIYQEYHLK---------------------DSQVSAYTWQILNGLKYLHEQNVIHRP  315 (317)
Q Consensus       260 ---~~~~~~~~lVmE~~~ggsL~~~l~~~~l~---------------------~~~~~~i~~qil~aL~yLH~~gIvHrD  315 (317)
                         ......+++||||+++++|.+++....++                     ...+..++.||+.||.|||++||||||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               24567899999999999999998754321                     234567999999999999999999999


Q ss_pred             CC
Q 021084          316 GA  317 (317)
Q Consensus       316 LK  317 (317)
                      ||
T Consensus       281 LK  282 (566)
T PLN03225        281 VK  282 (566)
T ss_pred             CC
Confidence            98

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.55  E-value=3.1e-14  Score=132.39  Aligned_cols=121  Identities=24%  Similarity=0.322  Sum_probs=100.1

Q ss_pred             CeeeeccccccCCeeEEEEEe-cC-CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC----CCceeeeeeEE-EeC
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE----HDNIVQYFGTE-KDE  263 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~-~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~----hpnIv~l~~~~-~~~  263 (317)
                      +|.+.+.||+|+||.||.|.+ .+ ...+|+|..........     ..+..|..++..+.    .++++.+++.+ ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            899999999999999999988 33 35889998764321111     14567788888775    36899999999 578


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..-|+||+.+ |.+|.++....   .++...+..++.|++.+|.+||+.|+||||||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiK  149 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIK  149 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcC
Confidence            8899999998 78999988543   49999999999999999999999999999998

>smart00090 RIO RIO-like kinase

Probab=99.55  E-value=2.6e-14  Score=127.21  Aligned_cols=123  Identities=15%  Similarity=0.127  Sum_probs=92.5

Q ss_pred             CeeeeccccccCCeeEEEEE-e-cCCCEEEEEEEeecCCCCcc-------------------HHHHHHHHHHHHHhccCC
Q 021084          191 SWQKGAPLGSGSFGSVYEGF-T-DDGFFFAVKEVSLQDQGTQG-------------------EQSVLQLEQEISLLGQFE  249 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~-~-~~~~~vAvK~i~~~~~~~~~-------------------~~~~~~~~~Ei~il~~l~  249 (317)
                      -|.+.+.||+|+||.||+|. + .+|..||+|+++........                   ......+..|+.++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46788999999999999998 4 78999999999754311000                   011234678999999997


Q ss_pred             CC--ceeeeeeEEEeCCEEEEEEecCCCCCHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCC
Q 021084          250 HD--NIVQYFGTEKDENKLYIFLELVTQGSLAKIY-QEYHLKDSQVSAYTWQILNGLKYLHEQN-VIHRPGA  317 (317)
Q Consensus       250 hp--nIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l-~~~~l~~~~~~~i~~qil~aL~yLH~~g-IvHrDLK  317 (317)
                      +.  .++.+++.    ...++||||++|++|.... ....+....+..++.|++.+|.+||++| |+|||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik  176 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS  176 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence            53  34444442    2358999999998887654 4445666667889999999999999999 9999997

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.55  E-value=2e-14  Score=144.30  Aligned_cols=129  Identities=26%  Similarity=0.449  Sum_probs=111.5

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe----cC----CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCcee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT----DD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV  254 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~----~~----~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv  254 (317)
                      .|.....+..+.+.||.|.||.|++|..    ..    ...||||.++..    ........+..|+.+|+.+ .||||+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~----~~~~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN----ASSSEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccc----cCcHHHHHHHHHHHHHHHhcCCcchh
Confidence            4555556667778999999999999964    11    457899988642    2335678899999999999 699999


Q ss_pred             eeeeEEEeCCEEEEEEecCCCCCHHHHHHhCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----------------LKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       255 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~-----------------l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      .++|++...+.+++|+||+..|+|..+++..+                 ++..+...++.||+.||+||++.++|||||
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL  444 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL  444 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence            99999999999999999999999999998777                 888999999999999999999999999997

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.54  E-value=1.1e-14  Score=133.13  Aligned_cols=122  Identities=20%  Similarity=0.240  Sum_probs=106.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC--C----ceeeeeeEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH--D----NIVQYFGTEK  261 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h--p----nIv~l~~~~~  261 (317)
                      ..+|.+...+|+|+||.|-.|.+ .++..||+|+++.      -....+..+-|+++|.++.+  |    -+|++.++|.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            56899999999999999999988 6789999999852      33456667789999999832  2    3778888999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+++|||+|.+ |-++++++..++   ++...+..+.+|++.++.|||+++++|-|||
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLK  219 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLK  219 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCC
Confidence            999999999998 669999998764   8999999999999999999999999999998

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=5.4e-16  Score=136.19  Aligned_cols=123  Identities=33%  Similarity=0.533  Sum_probs=102.4

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC-----
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN-----  264 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----  264 (317)
                      +.+--+.||-|+||+||.+.+ .+|+.||+|.+..-   ..+-...+++.+|+.+|...+|.|++..++..+...     
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv---fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV---FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH---HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            334568899999999999999 89999999988632   223344677889999999999999999999876643     


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|.++|.+.. +|..++-+ ..++.+.+.-++.||+.||.|||+.||.|||||
T Consensus       131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIK  183 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIK  183 (449)
T ss_pred             HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCC
Confidence            36788888855 88887654 458999999999999999999999999999998

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.53  E-value=6.2e-14  Score=120.85  Aligned_cols=114  Identities=16%  Similarity=0.124  Sum_probs=88.6

Q ss_pred             cccccCCeeEEEEEecCCCEEEEEEEeecCCCCc---cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          197 PLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      .||+|+||.||++. .++..+++|..........   ......++.+|+.++..+.|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            48999999999996 5678899998653221111   1122356788999999998887665555556667789999999


Q ss_pred             CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|++|.+++.....      .++.|++.+|.+||+.|++|+|+|
T Consensus        80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~  117 (199)
T TIGR03724        80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLT  117 (199)
T ss_pred             CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCC
Confidence            99999998765321      789999999999999999999986

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.47  E-value=9.6e-14  Score=134.11  Aligned_cols=121  Identities=27%  Similarity=0.341  Sum_probs=101.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      ....|.+...+|.|+|+.|-.|.+ .++..+++|++.....         ....|+.++... +||||+++++.+.++.+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCcceeecceecCCce
Confidence            356788888899999999999988 8899999999975421         112455444444 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .|+|||.+.|+.+.+.+...+....++..|+.||+.|+.|||++|+||||||
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLk  442 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLK  442 (612)
T ss_pred             eeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCC
Confidence            9999999999988777665554447888999999999999999999999997

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.47  E-value=3.7e-13  Score=133.44  Aligned_cols=119  Identities=13%  Similarity=0.092  Sum_probs=92.1

Q ss_pred             CeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCC---ccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGT---QGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .|...+.||+|+||.||++..... .+++|+........   ........+.+|+.++..++|++++....++......+
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            345678999999999999976433 34444432211111   11223456889999999999999988877777777789


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||++|++|.+++.       ....++.|++.+|.|||+.||+|||||
T Consensus       413 lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlk  455 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLT  455 (535)
T ss_pred             EEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCC
Confidence            9999999999999875       356789999999999999999999997

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.46  E-value=2.2e-13  Score=119.91  Aligned_cols=132  Identities=23%  Similarity=0.357  Sum_probs=111.9

Q ss_pred             cchHHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeee
Q 021084          181 LNEKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFG  258 (317)
Q Consensus       181 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~  258 (317)
                      ..+++...+++.+.+..||.|+.|.|+++.. .+|...|||.+...    ...+..++++..+.++.+.+ .|.||+.+|
T Consensus        83 ~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt----~Nkee~kRILmDldvv~~s~dcpyIV~c~G  158 (391)
T KOG0983|consen   83 GGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT----GNKEENKRILMDLDVVLKSHDCPYIVQCFG  158 (391)
T ss_pred             CCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc----CCHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence            3566777788888999999999999999998 88999999999753    34556778888888887774 899999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      +|..+..+++.||.|.. -+..+++.  +++++..+-.+..-++.||.||-.+ ||||||+|
T Consensus       159 yFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvK  219 (391)
T KOG0983|consen  159 YFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK  219 (391)
T ss_pred             EEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccC
Confidence            99999999999999843 45566553  4689998999999999999999965 99999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.45  E-value=1.6e-13  Score=116.32  Aligned_cols=125  Identities=22%  Similarity=0.363  Sum_probs=103.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      ..++...+..||+|++|.|-+.++ .+|...|+|.+...-    ..+...+++.|+.+.... ..|++|.++|.+...+.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv----n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV----NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc----ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            344455667899999999999988 999999999997542    234556777888876554 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQ-----EYHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~-----~~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      +||.||.|.- +|..+..     .+.+++..+-.|+..++.||.|||++ .+||||+|
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvK  176 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVK  176 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCC
Confidence            9999999954 7776543     23489999999999999999999987 99999998

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.45  E-value=2.7e-14  Score=125.10  Aligned_cols=127  Identities=26%  Similarity=0.403  Sum_probs=104.0

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHH-hccCCCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL-LGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~  263 (317)
                      ....++.+-+..||.|+||+|++-.+ .+|+..|||.++...    .....+++..|... ++.-+.|+||+++|++..+
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n----~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E  135 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN----IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE  135 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc----chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence            33445666788999999999999988 899999999998643    24456677777765 4455899999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQ------EYHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~------~~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      +..||-||.|.- +|..+.+      ...+++..+-.|+...+.||.||-.. .|||||+|
T Consensus       136 GdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK  195 (361)
T KOG1006|consen  136 GDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK  195 (361)
T ss_pred             CceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence            999999999954 7766542      34689998889999999999999965 89999998

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.45  E-value=3.6e-13  Score=121.45  Aligned_cols=119  Identities=20%  Similarity=0.325  Sum_probs=103.1

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .|+++++||.|+||+++.|.. -++.+||||.-+.+.   .    .-++..|.+..+.| ..++|+..+.+.+.+.+-.|
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---E----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC---C----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            688999999999999999988 899999999866432   1    22466777777777 57899999999999988999


Q ss_pred             EEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||++ |.+|.+++.  ..+|+...+..++.||+.-++|+|++.+|+||||
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIK  151 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIK  151 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccC
Confidence            99998 889999875  3459999999999999999999999999999998

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.41  E-value=1.5e-12  Score=112.77  Aligned_cols=111  Identities=15%  Similarity=0.040  Sum_probs=83.5

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCEEEEEEec
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      ....|++|+||+||.+.. .+..++.+.+....... ..-....+.+|+++|.+|. |++++.++++    +..|++|+|
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~-~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWL-RGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhh-hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            567899999999997744 77778877665322110 1111235789999999994 5889999886    346999999


Q ss_pred             CCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          273 VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       273 ~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +.|.+|...+...      ...++.|++.+|.++|++|||||||
T Consensus        80 I~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL  117 (218)
T PRK12274         80 LAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDL  117 (218)
T ss_pred             ecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCC
Confidence            9999997654321      2357889999999999999999999

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.41  E-value=7.3e-13  Score=114.44  Aligned_cols=117  Identities=18%  Similarity=0.168  Sum_probs=87.5

Q ss_pred             eeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCcc-----------------HHHHHHHHHHHHHhccCCCCc--
Q 021084          192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG-----------------EQSVLQLEQEISLLGQFEHDN--  252 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~-----------------~~~~~~~~~Ei~il~~l~hpn--  252 (317)
                      |.+.+.||+|+||.||++...+|..+|||+++........                 ......+..|+.++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            6778999999999999998788999999998753211000                 011123567888888887774  


Q ss_pred             eeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       253 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++..++    ....++||||++|++|..+...     .....++.+++.++.++|+.||+|||||
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~  152 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLS  152 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence            444433    2446899999999998775431     3456788999999999999999999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.41  E-value=3.5e-13  Score=133.40  Aligned_cols=116  Identities=33%  Similarity=0.446  Sum_probs=94.3

Q ss_pred             eeeeccccccCCee-EEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEE
Q 021084          192 WQKGAPLGSGSFGS-VYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       192 y~~~~~LG~G~fg~-Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      |.-.+.+|.|+.|+ ||+| ...|+.||||.+-.        ....-..+|+.+|... .|||||++++.-.++...||.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G-~ye~R~VAVKrll~--------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa  581 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRG-VYEGREVAVKRLLE--------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA  581 (903)
T ss_pred             eccHHHcccCCCCcEEEEE-eeCCceehHHHHhh--------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence            34457889999986 6888 45667999998742        2344566999999877 799999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCC--C---CHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYH--L---KDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~--l---~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .|.|.. +|.+++....  +   .......++.|++.||++||+.+|||||||
T Consensus       582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLk  633 (903)
T KOG1027|consen  582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLK  633 (903)
T ss_pred             ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCC
Confidence            999955 9999997631  1   113457889999999999999999999998

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.39  E-value=1.1e-11  Score=111.41  Aligned_cols=122  Identities=32%  Similarity=0.496  Sum_probs=106.0

Q ss_pred             eeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC-ceeeeeeEEEeCCEEEEEE
Q 021084          192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD-NIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lVm  270 (317)
                      |.+...||.|+||.||.+.+.  ..+++|.+.....  ........+.+|+.++..+.|+ +|+.+.+.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLE--SKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhc--cchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            678889999999999999777  7889999875432  1113567788999999999988 7999999998888899999


Q ss_pred             ecCCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++.++++.+++...    .++......++.|++.++.|+|..|++|||||
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~k  128 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK  128 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            999999999887765    58899999999999999999999999999997

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.1e-12  Score=134.58  Aligned_cols=128  Identities=20%  Similarity=0.257  Sum_probs=99.7

Q ss_pred             chHHHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC---CCceeeeee
Q 021084          182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE---HDNIVQYFG  258 (317)
Q Consensus       182 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~  258 (317)
                      ...+......|.+.+.||+|+||.||.|...+|+.||+|+-+....  ..-....+      ++.+|+   -+.|..+..
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI~~q------~~~RLk~~~~~~~~~~~~  761 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYICLQ------VMERLKPQMLPSIMHISS  761 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeeehHH------HHHhhchhhhcchHHHHH
Confidence            3344555567999999999999999999987799999998764321  11111122      222332   355666666


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +....+.-++|++|.+.|+|-++++..+ +++..++.+..||+.-++.||..+|||+|||
T Consensus       762 a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiK  821 (974)
T KOG1166|consen  762 AHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIK  821 (974)
T ss_pred             HHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCC
Confidence            6677788899999999999999998554 8999999999999999999999999999998

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.35  E-value=5.9e-13  Score=119.36  Aligned_cols=123  Identities=25%  Similarity=0.384  Sum_probs=101.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      ..+|.-+..+|.|.- .|..+.+ -.+.+||+|.+.....   ......+..+|+.++..++|+||++++.+|...    
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~---n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ---NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc---cCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            456778889999988 6666666 7889999998765422   233456678999999999999999999998653    


Q ss_pred             --CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 --NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 --~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        ..+|+|||+|.. +|...+. ..++-..+..++.|++.|+.|||+.||+|||||
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLk  145 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLK  145 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccC
Confidence              458999999965 9988877 457888899999999999999999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.32  E-value=3.4e-12  Score=120.85  Aligned_cols=121  Identities=21%  Similarity=0.291  Sum_probs=105.1

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC------CCceeeeeeEEEe
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE------HDNIVQYFGTEKD  262 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~  262 (317)
                      ++|.+....|+|-||+|..|.+ ..|..||||+|..+      +...+.=+.|+++|++|+      --|++.|+..|..
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN------E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN------EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc------hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            4788899999999999999998 77889999999743      334445568999999995      3589999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEYH----LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~~----l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+++|||+|.+.- +|.++++..+    +....+..|+.|+..||..|-.+||+|.|||
T Consensus       506 knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIK  563 (752)
T KOG0670|consen  506 KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIK  563 (752)
T ss_pred             cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccC
Confidence            9999999999854 9999998654    7778889999999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.30  E-value=1.2e-11  Score=105.38  Aligned_cols=118  Identities=19%  Similarity=0.254  Sum_probs=78.3

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHH-------------------HHHHHHHHHhccCCCCc--e
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSV-------------------LQLEQEISLLGQFEHDN--I  253 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~-------------------~~~~~Ei~il~~l~hpn--I  253 (317)
                      .+.||+|+||.||.|.+.++..||||++.............                   .....|...+..+.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988889999999987532111110000                   01135555666554432  3


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCCCHHH-HHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          254 VQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~ggsL~~-~l~~~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +..++.    ...++||||++|+++.. .+...... ..+..++.+++.++.++|. .||+|||||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~  142 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLS  142 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCC
Confidence            444433    23589999999954322 22221111 5678899999999999999 999999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.27  E-value=4e-11  Score=106.90  Aligned_cols=117  Identities=15%  Similarity=0.110  Sum_probs=84.9

Q ss_pred             cccc-ccCCeeEEEEEecCCCEEEEEEEeecCC--------CCccHHHHHHHHHHHHHhccCCCCce--eeeeeEEEeC-
Q 021084          196 APLG-SGSFGSVYEGFTDDGFFFAVKEVSLQDQ--------GTQGEQSVLQLEQEISLLGQFEHDNI--VQYFGTEKDE-  263 (317)
Q Consensus       196 ~~LG-~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~-  263 (317)
                      ..|| .|+.|+||.+... +..+++|.+.....        ..........+.+|+.++..+.|++|  +..+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4576 7888888888554 67899998854211        00111234567889999999988775  6666654332 


Q ss_pred             C---EEEEEEecCCC-CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 N---KLYIFLELVTQ-GSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~---~~~lVmE~~~g-gsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .   ..++|||+++| .+|.+++....++..    .+.|++.+|.+||++||+|||||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlk  169 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLN  169 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCC
Confidence            2   23599999997 699999887666654    35789999999999999999997

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.20  E-value=5.8e-11  Score=96.14  Aligned_cols=110  Identities=16%  Similarity=0.166  Sum_probs=89.6

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC--CceeeeeeEEEeCCEEEEEEe
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH--DNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lVmE  271 (317)
                      +.+.||.|.++.||++.... ..+++|......    .   ...+..|+.++..+.+  ++++++++++..++..+++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~----~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSRE----K---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCC----c---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            35679999999999997744 689999875321    1   3467789999999976  589999988888888999999


Q ss_pred             cCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCC
Q 021084          272 LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ---NVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~---gIvHrDLK  317 (317)
                      |++|+++..+      +......++.+++.+|.+||..   +++|+|||
T Consensus        74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~  116 (155)
T cd05120          74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH  116 (155)
T ss_pred             ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCC
Confidence            9998877654      4556677899999999999985   79999986

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.06  E-value=1.2e-10  Score=107.47  Aligned_cols=130  Identities=22%  Similarity=0.285  Sum_probs=95.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCC-----------------------------------CEEEEEEEeecCCCCc
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDG-----------------------------------FFFAVKEVSLQDQGTQ  230 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~-----------------------------------~~vAvK~i~~~~~~~~  230 (317)
                      ..+++|.++..||+|....||.+.. .+|                                   -+.|||.+-.-.....
T Consensus       154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~  233 (598)
T KOG4158|consen  154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG  233 (598)
T ss_pred             cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence            3477899999999999999998854 211                                   1456665543222233


Q ss_pred             cHHHHHHHHHHHH------H--------hcc--------CCCCceeeeeeEEEeC-------------------------
Q 021084          231 GEQSVLQLEQEIS------L--------LGQ--------FEHDNIVQYFGTEKDE-------------------------  263 (317)
Q Consensus       231 ~~~~~~~~~~Ei~------i--------l~~--------l~hpnIv~l~~~~~~~-------------------------  263 (317)
                      +......+.+|.-      .        ...        -.|||||++.++|.+.                         
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence            3334444444431      0        111        2599999999987442                         


Q ss_pred             --CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 --NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 --~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        ..+|+||..++. +|..++-....+.....-++.|+++|+.|||.+||.|||+|
T Consensus       314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlK  368 (598)
T KOG4158|consen  314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLK  368 (598)
T ss_pred             CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhccc
Confidence              468999999966 99999998888999999999999999999999999999998

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.04  E-value=2.4e-10  Score=105.27  Aligned_cols=126  Identities=23%  Similarity=0.267  Sum_probs=101.4

Q ss_pred             HhccCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTE  260 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~  260 (317)
                      ....+++....+-+|.||.||.|.+.      +.+.+-+|.++.    ..++-....+..|...+..+.|||+.++.+++
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            33456788889999999999999652      234455565532    34556677889999999999999999999988


Q ss_pred             Ee-CCEEEEEEecCCCCCHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          261 KD-ENKLYIFLELVTQGSLAKIYQEY---------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       261 ~~-~~~~~lVmE~~~ggsL~~~l~~~---------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      .. ....+.++.++.-|+|..++...         .++..+...++.|++.|++|||++||||.||
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDi  422 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDI  422 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchh
Confidence            65 55678889999999999998722         2677788899999999999999999999998

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.96  E-value=3.3e-10  Score=113.21  Aligned_cols=123  Identities=23%  Similarity=0.322  Sum_probs=96.1

Q ss_pred             eeccccccCCeeEEEEEe-cCCCEEEEEEEeecC-CCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEe
Q 021084          194 KGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~-~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      ....+|.|++|.|+.+.. .....++.|...... ...........+..|+.+-..+.|||++..+..+.......-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            567899999998888766 555556666554211 112233333447888888999999999888777766555555699


Q ss_pred             cCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||++ +|+.++... .+...++..++.|++.|+.|||+.||.|||||
T Consensus       402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK  447 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLK  447 (601)
T ss_pred             cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCc
Confidence            9999 999998876 78999999999999999999999999999998

>KOG0204 consensus Calcium transporting ATPase [Inorganic ion transport and metabolism]

Probab=98.95  E-value=4.9e-10  Score=111.42  Aligned_cols=118  Identities=28%  Similarity=0.335  Sum_probs=89.4

Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHhhhhhhcCCCcccccccccCcchHHHHHHHHHHHHHHHHH-HHHHHHHHHhhcCCCC
Q 021084            4 FFNLKDFDVKPKHPSRESLRRWRSFCTIVKNPTRRFRMVANLDRRSEADKKIRQMQEQLRLAL-CIRDTLKLIESHEDVP   82 (317)
Q Consensus         4 ~~~~~~f~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   82 (317)
                      ++. ++|....+|+|.++++|||.| +.++|++|||||+++|++..+..++|+    |+|++. +++||.+|+.++... 
T Consensus         2 ~~~-~~~~~~~~n~~~~~~~~~~~a-~~~~~~~~~~~~~~~l~~~~~~~~~r~----~~r~~~~~~~a~~~~~~~~~~~-   74 (1034)
T KOG0204|consen    2 LLD-KDFVVSMKNSSIEALQRWRLA-YIVLEASRRFRFGASLKKLRELMEPRR----KIRSAVLVSKAAALFIDAGSRT-   74 (1034)
T ss_pred             Ccc-cccccccccchhhhhhhhhhh-hhhcccchhhccccCHHHHHHHHHHHh----hhhhhhcccchhhhhhcccccc-
Confidence            454 889888899999999999966 599999999999999999998888875    899966 999999999997321 


Q ss_pred             CCCCCCCCcccchhhhhhccccchhhHhHHHHHHHHHHHHHhHhhhhccccccccC
Q 021084           83 IGDTDAGRFQEFVDDIISTVKCGDVKEKIRLALCIQETALQLIEVLSLLSLEDVSS  138 (317)
Q Consensus        83 ~~~~~~~~f~i~~~~L~s~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~  138 (317)
                       +-.    -+|++++|..++++||++.--..     -...-++..++......++.
T Consensus        75 -e~~----~~i~~e~l~~i~~~~~~~~L~~~-----gGv~gL~~~LKt~~~~Gi~~  120 (1034)
T KOG0204|consen   75 -EYT----LGIGAEELVKIVKEHDLKALNAY-----GGVEGLCKKLKTDPNEGISG  120 (1034)
T ss_pred             -ccc----cccCHHHHHHHhhccchhhhhhc-----cCHHHHHHHhccCcccCCCC
Confidence             101    17999999999999998653322     23334444454444444444

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.83  E-value=1.5e-08  Score=98.01  Aligned_cols=118  Identities=18%  Similarity=0.109  Sum_probs=75.0

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCc------------------------c-HHHH----------HHHHH
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ------------------------G-EQSV----------LQLEQ  240 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~------------------------~-~~~~----------~~~~~  240 (317)
                      +.||.|++|.||+|...+|+.||||+.++......                        + ....          ..+..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            67999999999999889999999999864310000                        0 0000          02445


Q ss_pred             HHHHhccC-----CCCceeeeeeEE-EeCCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 021084          241 EISLLGQF-----EHDNIVQYFGTE-KDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILN-GLKYLHEQNV  311 (317)
Q Consensus       241 Ei~il~~l-----~hpnIv~l~~~~-~~~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~-aL~yLH~~gI  311 (317)
                      |+..+..+     +++++ .+-..+ ......+|||||++|++|.++....  +.+   ...++.+++. .+..+|..|+
T Consensus       203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            55555544     23433 222222 2234469999999999998876432  232   2345555555 4778999999


Q ss_pred             EecCCC
Q 021084          312 IHRPGA  317 (317)
Q Consensus       312 vHrDLK  317 (317)
                      +|+|+|
T Consensus       279 ~H~D~h  284 (437)
T TIGR01982       279 FHADLH  284 (437)
T ss_pred             eeCCCC
Confidence            999986

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.82  E-value=5.3e-08  Score=83.94  Aligned_cols=119  Identities=14%  Similarity=0.123  Sum_probs=83.0

Q ss_pred             eccccccCCeeEEEEEec-------CCCEEEEEEEeecCCCC--------cc---------HHHHHH----HHHHHHHhc
Q 021084          195 GAPLGSGSFGSVYEGFTD-------DGFFFAVKEVSLQDQGT--------QG---------EQSVLQ----LEQEISLLG  246 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~-------~~~~vAvK~i~~~~~~~--------~~---------~~~~~~----~~~Ei~il~  246 (317)
                      ...||.|--+.||.|...       .+..+|||+.+......        .+         ......    ...|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            357999999999999764       35799999987421100        00         111222    348999999


Q ss_pred             cCCC--CceeeeeeEEEeCCEEEEEEecCCCCCHH-HHHHhCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecCCC
Q 021084          247 QFEH--DNIVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYL-HEQNVIHRPGA  317 (317)
Q Consensus       247 ~l~h--pnIv~l~~~~~~~~~~~lVmE~~~ggsL~-~~l~~~~l~~~~~~~i~~qil~aL~yL-H~~gIvHrDLK  317 (317)
                      ++..  -+++..+++    ..-+|||||+.++.+. ..+++..++...+..+..|++.+|..| |..||||+||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            8843  456666654    3458999999765442 234444566666778889999999999 89999999985

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.75  E-value=2.2e-09  Score=109.71  Aligned_cols=123  Identities=20%  Similarity=0.176  Sum_probs=100.3

Q ss_pred             CeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      ++...+.||++.|=.|.+|.+..|. |+||++-+..... +-....+.+.|++ ...+++||++.+.-+......-|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~-sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTI-SLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCC-CchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6778899999999999999887776 9999997654322 2233444445555 55668999999988877778889999


Q ss_pred             ecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|... +|++.+...+ +..-+-++|+.|++.||.-+|..||+|||||
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIK  147 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIK  147 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            99966 9999998777 5667788999999999999999999999998

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.72  E-value=2.5e-09  Score=94.50  Aligned_cols=117  Identities=21%  Similarity=0.333  Sum_probs=96.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .++..+..+|.....|..|+|++ .|..+++|++....   -.......|..|+-.|.-+.||||+.++|.|..+.++.+
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~---~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~  264 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRW-QGNDIVAKILNVRE---VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI  264 (448)
T ss_pred             hhhhhhhhhhccCCCcccccccc-cCcchhhhhhhhhh---cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence            34455667788999999999965 34456778776543   233444568888888888899999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHC
Q 021084          269 FLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      +..||+.|+|+.++....   ++..++..++.+++.|++|||+.
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl  308 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL  308 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc
Confidence            999999999999998654   67788999999999999999986

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.71  E-value=1.5e-08  Score=99.75  Aligned_cols=122  Identities=15%  Similarity=0.105  Sum_probs=73.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEecC-CCEEEEEEEeecCCCC-------------------------ccH----HHHHH
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGT-------------------------QGE----QSVLQ  237 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~-------------------------~~~----~~~~~  237 (317)
                      ....|.. ..||+|++|.||.|...+ |+.||||++++.....                         ...    +....
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3455665 789999999999999854 9999999997431000                         000    11112


Q ss_pred             ------HHHHHHHhccCC----CCceeeeeeEEEe-CCEEEEEEecCCCCCHHHH--HHhCC-----CCHHHHHHHHHHH
Q 021084          238 ------LEQEISLLGQFE----HDNIVQYFGTEKD-ENKLYIFLELVTQGSLAKI--YQEYH-----LKDSQVSAYTWQI  299 (317)
Q Consensus       238 ------~~~Ei~il~~l~----hpnIv~l~~~~~~-~~~~~lVmE~~~ggsL~~~--l~~~~-----l~~~~~~~i~~qi  299 (317)
                            +..|+..+.++.    +...+.+-..+.+ ....+|||||+.|+++.++  +...+     +....+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                  344444444441    3333333232222 3446799999999999874  33333     3333344455555


Q ss_pred             HHHHHHHHHCCcEecCCC
Q 021084          300 LNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       300 l~aL~yLH~~gIvHrDLK  317 (317)
                      +       ..|++|+|+|
T Consensus       277 f-------~~GffHaDpH  287 (537)
T PRK04750        277 F-------RDGFFHADMH  287 (537)
T ss_pred             H-------hCCeeeCCCC
Confidence            4       5899999986

>PLN00181 protein SPA1-RELATED; Provisional

Probab=98.64  E-value=1.4e-08  Score=105.55  Aligned_cols=69  Identities=17%  Similarity=0.192  Sum_probs=57.0

Q ss_pred             CCC-CceeeeeeEE-------EeCCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          248 FEH-DNIVQYFGTE-------KDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       248 l~h-pnIv~l~~~~-------~~~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.| +||.+++++|       .....++++|||+ +++|.+++...  .+++..+..++.||+.||.|||++||||||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 5777777777       2234678889988 55999999653  48999999999999999999999999999998

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.63  E-value=4e-09  Score=102.45  Aligned_cols=118  Identities=22%  Similarity=0.322  Sum_probs=97.5

Q ss_pred             cccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCEEEEEEe
Q 021084          197 PLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      ++|+|+||.|+++..    ..|..||+|++++.........   ....|..++..++ ||++|.++..++.+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            479999999998754    5678899999876543222221   4446667777776 9999999999999999999999


Q ss_pred             cCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +..||+|...+.... +.+.....+...++-|++++|..||+|||+|
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k  124 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYK  124 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhccc
Confidence            999999998776554 7788888999999999999999999999996

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.63  E-value=3.3e-07  Score=83.31  Aligned_cols=124  Identities=19%  Similarity=0.238  Sum_probs=82.0

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC----------CceeeeeeE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH----------DNIVQYFGT  259 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~  259 (317)
                      .+.....||.|+++.||.+.+ .++..+|+|++....  .......+.+.+|.-....+.+          -.++-.++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            456789999999999999999 889999999998755  3445567778777765555322          122222222


Q ss_pred             EE---------eC---C-----EEEEEEecCCCCCHHHHHHh----CCC----CHHHHHHHHHHHHHHHHHHHHCCcEec
Q 021084          260 EK---------DE---N-----KLYIFLELVTQGSLAKIYQE----YHL----KDSQVSAYTWQILNGLKYLHEQNVIHR  314 (317)
Q Consensus       260 ~~---------~~---~-----~~~lVmE~~~ggsL~~~l~~----~~l----~~~~~~~i~~qil~aL~yLH~~gIvHr  314 (317)
                      ..         ..   .     +.+++|+-+. ++|.+++..    ...    ...-...+..|++..+++||+.|+||+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            21         11   1     2477888884 489887642    111    122224567899999999999999999


Q ss_pred             CCC
Q 021084          315 PGA  317 (317)
Q Consensus       315 DLK  317 (317)
                      |||
T Consensus       170 di~  172 (288)
T PF14531_consen  170 DIK  172 (288)
T ss_dssp             T-S
T ss_pred             ccc
Confidence            996

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.63  E-value=6.8e-08  Score=80.59  Aligned_cols=107  Identities=14%  Similarity=0.045  Sum_probs=75.0

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc-eeeeeeEEEeCCEEEEEEecC
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN-IVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lVmE~~  273 (317)
                      .+.++.|.++.||.+... +..|++|.......      ....+..|+.++..+.+.+ ++++++...  ...++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEec
Confidence            467899999999998654 67899998753210      1123567888888875444 345555433  2347999999


Q ss_pred             CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EecCCC
Q 021084          274 TQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV-----IHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gI-----vHrDLK  317 (317)
                      +|.++...    .   .....++.+++.+|..||+.++     +|+|++
T Consensus        74 ~G~~l~~~----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~  115 (170)
T cd05151          74 EGSELLTE----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLL  115 (170)
T ss_pred             CCCccccc----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCC
Confidence            99887643    1   1123457899999999999985     999986

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.36  E-value=2.3e-06  Score=72.29  Aligned_cols=114  Identities=14%  Similarity=0.086  Sum_probs=82.0

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCC---CccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQG---TQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      ..+++|+-+.++.+.. -|.++++|.=.++..-   ....-...+..+|+.++.++.--.|..-.=+..+++...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4578999999999844 4445666653322111   11222345577899999988766665555566777778999999


Q ss_pred             CCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          273 VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       273 ~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      ++|..|.+++...      ...++..+-.-+.-||..||||+||
T Consensus        81 I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDL  118 (204)
T COG3642          81 IEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDL  118 (204)
T ss_pred             eCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCC
Confidence            9999999888764      2456777888888999999999998

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.36  E-value=1.7e-06  Score=85.20  Aligned_cols=96  Identities=25%  Similarity=0.373  Sum_probs=79.0

Q ss_pred             cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCCCCHHH
Q 021084          212 DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQ  291 (317)
Q Consensus       212 ~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~  291 (317)
                      .++.+|.|...+...     ........+-+..|+.++||||++|+..+...+.+|||+|.+.  .|..++++.  ....
T Consensus        35 ~~~~~vsVF~~~~~~-----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--~~~~  105 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSN-----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--GKEE  105 (690)
T ss_pred             ccCCceEEEEEeCCC-----chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--HHHH
Confidence            678899998887432     1334556677888999999999999999999999999999985  677777753  4667


Q ss_pred             HHHHHHHHHHHHHHHH-HCCcEecCC
Q 021084          292 VSAYTWQILNGLKYLH-EQNVIHRPG  316 (317)
Q Consensus       292 ~~~i~~qil~aL~yLH-~~gIvHrDL  316 (317)
                      +...+.||+.||.||| ..+++|++|
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv  131 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNV  131 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccE
Confidence            7788999999999998 668999986

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.35  E-value=1e-06  Score=76.48  Aligned_cols=111  Identities=14%  Similarity=0.126  Sum_probs=84.6

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC--CceeeeeeEEEeC---CEEEEEE
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH--DNIVQYFGTEKDE---NKLYIFL  270 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lVm  270 (317)
                      +.|+.|.++.||++...+|..+++|.......    ......+..|+.++..+.+  ..+++++.+....   +..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~----~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGAL----LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCccc----CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            56899999999999776678899998753221    0123467789999998865  3456677766553   3678999


Q ss_pred             ecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          271 ELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      ||++|+++...+....++......++.+++.+|..||+..
T Consensus        80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  119 (223)
T cd05154          80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVD  119 (223)
T ss_pred             EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            9999998887654345788888899999999999999864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.31  E-value=3.7e-06  Score=71.02  Aligned_cols=122  Identities=16%  Similarity=0.106  Sum_probs=87.9

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecC---CCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQD---QGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      .+..+-+|+-+.|+.+ ...|+.+.||.=..+.   +.....-...+..+|++.|.++.--.|..-.-++.+...-+|+|
T Consensus        11 ~l~likQGAEArv~~~-~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRG-SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeee-ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5677889999999998 5667777777543221   11223334566789999999987666665555667777778999


Q ss_pred             ecCCC-CCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          271 ELVTQ-GSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       271 E~~~g-gsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      ||++| .++.+++....   ....-...++.+|-+.+.-||.++|||+||
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDL  139 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDL  139 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccc
Confidence            99987 46777775432   222233678899999999999999999998

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.13  E-value=1.4e-05  Score=68.49  Aligned_cols=107  Identities=17%  Similarity=0.178  Sum_probs=67.6

Q ss_pred             eEEEEEecCCCEEEEEEEeecCC---------------------CCccHHHHHHHHHHHHHhccCCCC--ceeeeeeEEE
Q 021084          205 SVYEGFTDDGFFFAVKEVSLQDQ---------------------GTQGEQSVLQLEQEISLLGQFEHD--NIVQYFGTEK  261 (317)
Q Consensus       205 ~Vy~~~~~~~~~vAvK~i~~~~~---------------------~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~  261 (317)
                      .||.|...+|..+|+|..+....                     .............|++.|..+..-  +++..+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999888899999999874211                     011122334577899999999765  45666644  


Q ss_pred             eCCEEEEEEecCC--CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHHCCcEecCC
Q 021084          262 DENKLYIFLELVT--QGSLAKIYQEYHLKDSQVSAYTWQILNGLKY-LHEQNVIHRPG  316 (317)
Q Consensus       262 ~~~~~~lVmE~~~--ggsL~~~l~~~~l~~~~~~~i~~qil~aL~y-LH~~gIvHrDL  316 (317)
                      ..  -+|||||++  |..+..+ ....++......++.+++..+.. +|..||||+||
T Consensus        79 ~~--~~ivME~I~~~G~~~~~l-~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDL  133 (188)
T PF01163_consen   79 NR--NVIVMEYIGEDGVPLPRL-KDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDL  133 (188)
T ss_dssp             ET--TEEEEE--EETTEEGGCH-HHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-
T ss_pred             eC--CEEEEEecCCCccchhhH-HhccccchhHHHHHHHHHHHHHHHHHhcCceecCC
Confidence            23  379999998  6555543 33333345567788888886665 57999999998

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.04  E-value=4.3e-07  Score=91.04  Aligned_cols=126  Identities=25%  Similarity=0.310  Sum_probs=101.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe--cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT--DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENK  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~  265 (317)
                      ...|.+.+.||+|+|+.|-....  .....+|+|.+....   ...........|..+-..+. |+|++.+++.......
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            34566778899999999988866  445566666665332   23344455566777777776 9999999999999999


Q ss_pred             EEEEEecCCCCCHHHHH-HhC--CCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIY-QEY--HLKDSQVSAYTWQILNGLKYLH-EQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l-~~~--~l~~~~~~~i~~qil~aL~yLH-~~gIvHrDLK  317 (317)
                      .+++++|..|+++...+ ...  +.+...+..++.|+..++.|+| ..++.|||||
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ik  151 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIK  151 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCC
Confidence            99999999999999877 332  4778888999999999999999 9999999997

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.02  E-value=8.8e-05  Score=67.22  Aligned_cols=113  Identities=12%  Similarity=0.050  Sum_probs=73.0

Q ss_pred             eeEEEEEecCCCEEEEEEEeecCCCCccH------HHHHHHHHHHHHhccCCCCce--eeeeeEEEe-----CCEEEEEE
Q 021084          204 GSVYEGFTDDGFFFAVKEVSLQDQGTQGE------QSVLQLEQEISLLGQFEHDNI--VQYFGTEKD-----ENKLYIFL  270 (317)
Q Consensus       204 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~------~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~lVm  270 (317)
                      ..|+.+ ...|+.|.||..........-.      .-...+.+|...+..|..-+|  +...+++..     ...-+|||
T Consensus        36 rrvvr~-~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRF-ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEE-EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            335554 3466789999764221000000      001136688888877743332  233334432     23578999


Q ss_pred             ecCCCC-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQG-SLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~gg-sL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |++++. +|.+++..   ...+......++.+++..+.-||..||+|+|++
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~  165 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCY  165 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCC
Confidence            999886 79998863   335566777899999999999999999999985

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.02  E-value=2.4e-05  Score=75.31  Aligned_cols=106  Identities=13%  Similarity=0.187  Sum_probs=80.2

Q ss_pred             CeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe----CCEEEEEEecCCC-C
Q 021084          203 FGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD----ENKLYIFLELVTQ-G  276 (317)
Q Consensus       203 fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lVmE~~~g-g  276 (317)
                      -.+.|++.. .+|..|++|++...+.....     ....-++.++++.|+|||.+..+|..    +..+++|++|.|+ +
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN-----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcc-----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            356789877 89999999999543221111     12244667889999999999998873    5679999999986 4


Q ss_pred             CHHHHHH-h---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 021084          277 SLAKIYQ-E---------------YHLKDSQVSAYTWQILNGLKYLHEQNVIH  313 (317)
Q Consensus       277 sL~~~l~-~---------------~~l~~~~~~~i~~qil~aL~yLH~~gIvH  313 (317)
                      +|.++.- .               .+.++..++.|+.|+..||.++|+.|+.-
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAc  416 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLAC  416 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCcee
Confidence            7777541 1               13678899999999999999999998654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.90  E-value=6.8e-05  Score=67.19  Aligned_cols=116  Identities=19%  Similarity=0.206  Sum_probs=82.6

Q ss_pred             eeeccccccCCeeEEEEEecCCCEEEEEEEeecCCC---------------Ccc--HHHHHHHHHHHHHhccCCCC--ce
Q 021084          193 QKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQG---------------TQG--EQSVLQLEQEISLLGQFEHD--NI  253 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------------~~~--~~~~~~~~~Ei~il~~l~hp--nI  253 (317)
                      .++..||-|--|.||.|.+..|.++|||.=+.....               ..+  .-......+|++.|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            467899999999999998899999999965432100               011  12234467899999998654  56


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +..+++    +.-++|||++.|-.|...-    ++...+..++..|++-+.-+-..||||+|+
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDl  228 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDL  228 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCC
Confidence            666554    5578999999997766542    234455566677777777666899999997

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=97.76  E-value=5.2e-05  Score=73.59  Aligned_cols=73  Identities=27%  Similarity=0.486  Sum_probs=64.2

Q ss_pred             hccCCCCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCc-EecCCC
Q 021084          245 LGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNV-IHRPGA  317 (317)
Q Consensus       245 l~~l~hpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gI-vHrDLK  317 (317)
                      |+.+.|.|+.+++|.+.++...++|.+||.-|+|.+.+...  .+++.-...++++++.||.|||+-.| .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            45678999999999999999999999999999999999764  36777778899999999999998876 788764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.73  E-value=1.8e-05  Score=77.04  Aligned_cols=127  Identities=20%  Similarity=0.174  Sum_probs=95.2

Q ss_pred             hccCeeeeccccccCCeeEEEEEe--cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT--DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDEN  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~  264 (317)
                      ...+|..+..||.|.|+.|+.+..  .++..|++|.+.......  ... ..-..|+.+...+ .|.+++.+...|....
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--Hhh-hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            457888999999999999998765  578899999876432111  111 1122444444444 5888888888777777


Q ss_pred             EEEEEEecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..|+-.|||.++++...+. ...+.+...+.+..|++.++.++|+..++|+|+|
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~  393 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVK  393 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhccccc
Confidence            7889999999998766442 2247788889999999999999999999999987

>PRK09902 hypothetical protein; Provisional

Probab=97.66  E-value=0.00076  Score=58.72  Aligned_cols=119  Identities=15%  Similarity=0.081  Sum_probs=78.9

Q ss_pred             cccccCCeeEEEEEecCCCEEEEEEEeecCCCCcc-HHHHHHHHHHHHHhccCCCCc--eeeeeeEEEe----CCEEEEE
Q 021084          197 PLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG-EQSVLQLEQEISLLGQFEHDN--IVQYFGTEKD----ENKLYIF  269 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~----~~~~~lV  269 (317)
                      --|+||.+.|+.... .|..+-+|.........-. +.....|.+|+..+..|..-+  ++........    ...-+||
T Consensus        25 N~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         25 NYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             CcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            356789999988744 3336777765411110100 223457889999988884322  4444422111    2347899


Q ss_pred             EecCCC-CCHHHHHHhCCC---CHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          270 LELVTQ-GSLAKIYQEYHL---KDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       270 mE~~~g-gsL~~~l~~~~l---~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +|-++| -+|.+++....+   +......++.+++..+.-||+.|+.|+|+
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdl  154 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCC  154 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence            997754 489998876544   55666789999999999999999999996

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.64  E-value=1.9e-05  Score=72.08  Aligned_cols=74  Identities=27%  Similarity=0.373  Sum_probs=61.5

Q ss_pred             HHhccCCCCceeeeeeEEEeC-----CEEEEEEecCCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC--C
Q 021084          243 SLLGQFEHDNIVQYFGTEKDE-----NKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQ--N  310 (317)
Q Consensus       243 ~il~~l~hpnIv~l~~~~~~~-----~~~~lVmE~~~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~~--g  310 (317)
                      ..|-.+.|.|||+++.++.+.     ....++.||+..|++.++|++.     .+......+|+-||+.||.|||+.  .
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            345566799999999998653     4588999999999999999753     267777789999999999999998  6


Q ss_pred             cEecCC
Q 021084          311 VIHRPG  316 (317)
Q Consensus       311 IvHrDL  316 (317)
                      |+|+++
T Consensus       199 iihgnl  204 (458)
T KOG1266|consen  199 IIHGNL  204 (458)
T ss_pred             cccCCc
Confidence            999875

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.59  E-value=0.00059  Score=60.58  Aligned_cols=118  Identities=14%  Similarity=0.116  Sum_probs=79.0

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCC-------------------CccHHHHHHHHHHHHHhccCC--CCce
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQG-------------------TQGEQSVLQLEQEISLLGQFE--HDNI  253 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-------------------~~~~~~~~~~~~Ei~il~~l~--hpnI  253 (317)
                      ...|.+|--+.||+|...++..+|+|++......                   ............|+..|.++.  +-.+
T Consensus        53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3477788888999997788999999998743110                   011111223467888888774  3344


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCC-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCC
Q 021084          254 VQYFGTEKDENKLYIFLELVTQG-SLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPG  316 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~gg-sL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDL  316 (317)
                      ++-+++..    -.|||||+... .-.-.|+.-++...++..+..++++.+.-|-. .|+||+||
T Consensus       133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDL  193 (268)
T COG1718         133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDL  193 (268)
T ss_pred             CCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccc
Confidence            44444432    37999999653 11223444445555788889999999998887 89999998

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.50  E-value=0.001  Score=57.85  Aligned_cols=82  Identities=15%  Similarity=0.199  Sum_probs=60.0

Q ss_pred             HHHHHHHHHhccCCCCc--eeeeeeEEEeC----CEEEEEEecCCCC-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH
Q 021084          236 LQLEQEISLLGQFEHDN--IVQYFGTEKDE----NKLYIFLELVTQG-SLAKIYQEY-HLKDSQVSAYTWQILNGLKYLH  307 (317)
Q Consensus       236 ~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~----~~~~lVmE~~~gg-sL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH  307 (317)
                      ....+|...+..|..-.  ++..+++....    ...++|||++++. +|.+++... ..+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            35667887777664322  33444444432    3458999999884 799988762 3566667889999999999999


Q ss_pred             HCCcEecCCC
Q 021084          308 EQNVIHRPGA  317 (317)
Q Consensus       308 ~~gIvHrDLK  317 (317)
                      .+||+|+|++
T Consensus       136 ~~gi~H~Dl~  145 (206)
T PF06293_consen  136 DAGIYHGDLN  145 (206)
T ss_pred             HCcCCCCCCC
Confidence            9999999985

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.49  E-value=7.9e-05  Score=77.01  Aligned_cols=89  Identities=20%  Similarity=0.287  Sum_probs=61.9

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ....+|..++.|..|+||.||.+++ .+.+.+|+|+ +++..          +.+-  ++.....|++|           
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----------ilRn--ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----------ILRN--ILTFAGNPFVV-----------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----------hhhc--cccccCCccee-----------
Confidence            3456888999999999999999998 7788999953 32110          1110  44444566655           


Q ss_pred             EEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                |+-..+++..+ ++...        +.+++|||+.||+|||+|
T Consensus       136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlk  170 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLK  170 (1205)
T ss_pred             ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCC
Confidence                      46666665432 43332        789999999999999997

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.42  E-value=7.7e-05  Score=72.70  Aligned_cols=124  Identities=23%  Similarity=0.225  Sum_probs=95.5

Q ss_pred             cCeeeeccccc--cCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          190 MSWQKGAPLGS--GSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       190 ~~y~~~~~LG~--G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ..|.+...+|.  |.+|.||.+..   .++..+|+|.-+...   ..+.....=.+|+....++ .|++.++.+..+...
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~---s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF---SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC---CCccccccccchhhcccccCccccccccCcccccC
Confidence            34567788999  99999999876   578889998743221   1112222233566666666 599999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHH----HHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILN----GLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~----aL~yLH~~gIvHrDLK  317 (317)
                      +..++-+|+|. .+|..+....  -++...++.++.+...    ||.++|+.+++|-|+|
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~k  249 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLK  249 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccc
Confidence            99999999995 5887776543  2788888999999999    9999999999999986

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=97.34  E-value=4.5e-05  Score=73.36  Aligned_cols=74  Identities=32%  Similarity=0.530  Sum_probs=57.6

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      .....++|..+..+|.|+||+|+.+.. .++..+|||.|-...    ......+..+|..-+.++.|++++.++..|..
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn----~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN----REESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccc----hhhhhhhhhccccchhhhcccchhhheeceec
Confidence            344567888999999999999999988 666789999987532    33445566788888888899999988776643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.18  E-value=0.0057  Score=52.88  Aligned_cols=117  Identities=15%  Similarity=0.226  Sum_probs=81.2

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCC-----------ccHHHHHHHHHHHHHhccCC------CCceeeee
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGT-----------QGEQSVLQLEQEISLLGQFE------HDNIVQYF  257 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~~~~Ei~il~~l~------hpnIv~l~  257 (317)
                      ...||+|+.-.||.-  +.....+||+........           ..........+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            467999999999963  445567889887543000           00112344556665444444      88999999


Q ss_pred             eEEEeCCEEEEEEecCCC------CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          258 GTEKDENKLYIFLELVTQ------GSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       258 ~~~~~~~~~~lVmE~~~g------gsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+.+++.-+.+|+|.+.+      .||.+++.++.++. ..   ...+-+-..||-.++|+.+||+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~  145 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-EL---RQALDEFKRYLLDHHIVIRDLN  145 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HH---HHHHHHHHHHHHHcCCeecCCC
Confidence            999999889999998742      37899998887777 33   3334455668888999999985

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.16  E-value=0.0049  Score=53.34  Aligned_cols=115  Identities=21%  Similarity=0.210  Sum_probs=79.2

Q ss_pred             cCeeeeccccccCC-eeEEEEEecCCCEEEEEEEee---cCCC-------Ccc------HHHHHHHHHHHHHhccC---C
Q 021084          190 MSWQKGAPLGSGSF-GSVYEGFTDDGFFFAVKEVSL---QDQG-------TQG------EQSVLQLEQEISLLGQF---E  249 (317)
Q Consensus       190 ~~y~~~~~LG~G~f-g~Vy~~~~~~~~~vAvK~i~~---~~~~-------~~~------~~~~~~~~~Ei~il~~l---~  249 (317)
                      .+++.++.||.|.- |.||++. -+|..||+|++.-   ....       ...      ......|..|.+...+|   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~-I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE-IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE-ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67889999999999 9999994 4566999999432   1110       000      12344688888877777   3


Q ss_pred             CCce--eeeeeEEEeC------------------CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          250 HDNI--VQYFGTEKDE------------------NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       250 hpnI--v~l~~~~~~~------------------~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      +.++  |+++|++.-.                  ....||.||++...        .+    ...-+.+|++-|..+|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~----~~~~~~~~~~dl~~~~k~  183 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PL----QIRDIPQMLRDLKILHKL  183 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------cc----chhHHHHHHHHHHHHHHC
Confidence            4455  8999987322                  23567888776533        12    233456788888999999


Q ss_pred             CcEecCCC
Q 021084          310 NVIHRPGA  317 (317)
Q Consensus       310 gIvHrDLK  317 (317)
                      ||+=+|+|
T Consensus       184 gI~~~Dv~  191 (207)
T PF13095_consen  184 GIVPRDVK  191 (207)
T ss_pred             CeeeccCc
Confidence            99999986

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.07  E-value=0.0017  Score=64.03  Aligned_cols=118  Identities=11%  Similarity=0.071  Sum_probs=72.9

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCc--------------------------cHHHHH------HHHHHH
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ--------------------------GEQSVL------QLEQEI  242 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~--------------------------~~~~~~------~~~~Ei  242 (317)
                      -+.||..+.|.||+++..+|..||||+-++.-....                          -.+..+      .|..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            368999999999999988899999999874311000                          000001      133444


Q ss_pred             HHhccC----CCCc------eeeeeeEEEeCCEEEEEEecCCCCCHHH--HHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          243 SLLGQF----EHDN------IVQYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       243 ~il~~l----~hpn------Iv~l~~~~~~~~~~~lVmE~~~ggsL~~--~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      +...++    .|-+      |++++..+.  ..-.|+||||+|..+.+  .+.+.+++...+...+.+...-+-+  ..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcC
Confidence            433322    2333      555544443  34589999999987765  4667788887666555544433333  347


Q ss_pred             cEecCC
Q 021084          311 VIHRPG  316 (317)
Q Consensus       311 IvHrDL  316 (317)
                      ++|+|-
T Consensus       322 ffHaDP  327 (538)
T KOG1235|consen  322 FFHADP  327 (538)
T ss_pred             CccCCC
Confidence            999984

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.98  E-value=0.012  Score=50.98  Aligned_cols=102  Identities=22%  Similarity=0.254  Sum_probs=76.1

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC--ceeeeeeEE---EeCCEEEEE
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD--NIVQYFGTE---KDENKLYIF  269 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lV  269 (317)
                      ++.++.|..+.||.+...+ ..+++|....      . .....+..|..++..+...  .++.++...   ......+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~------~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRP------P-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESS------H-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCC------C-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence            4678999999999997766 5899998641      1 3456677888888777322  355666544   234568999


Q ss_pred             EecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          270 LELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      |++++|.++..     ..+......++.+++..|.-||+.
T Consensus        74 ~~~i~g~~~~~-----~~~~~~~~~~~~~~~~~l~~lh~~  108 (239)
T PF01636_consen   74 MEYIPGRPLDD-----ELSPEQRPELLRQLGRALAQLHQV  108 (239)
T ss_dssp             EEEESSEEHHH-----TSTHHHHHHHHHHHHHHHHHHHHS
T ss_pred             EEEeccccccc-----cccccccccccccchhhhhhcccc
Confidence            99999988877     567778888999999999999986

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=96.92  E-value=0.0091  Score=52.34  Aligned_cols=118  Identities=13%  Similarity=0.121  Sum_probs=69.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHH------HHHHHHhccC---CCCceeeeeeE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQL------EQEISLLGQF---EHDNIVQYFGT  259 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~------~~Ei~il~~l---~hpnIv~l~~~  259 (317)
                      -++|...+.+-......|.+. .-+|..+.+|..+....  ..+.....|      .+.+..+..+   .-.....++.+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValI-ei~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALI-EIDGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             hCCceEEEeecCCCccEEEEE-EECCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            357788888888777777665 45668899998764321  111111111      2222322222   22222222222


Q ss_pred             -----EEeCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          260 -----EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       260 -----~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                           +.-....+++|||++|..|.++..   +++    .+...+.+++.-||..|+.|+|+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~  161 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDP  161 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCC
Confidence                 122345679999999988876542   232    24456778899999999999997

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN02876 acyl-CoA dehydrogenase

Probab=96.90  E-value=0.004  Score=65.23  Aligned_cols=110  Identities=14%  Similarity=0.135  Sum_probs=76.8

Q ss_pred             eccccccCCeeEEEEEecCC---CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCce--eeeeeEEEeC---CE
Q 021084          195 GAPLGSGSFGSVYEGFTDDG---FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNI--VQYFGTEKDE---NK  265 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~  265 (317)
                      ...++.|.++.+|......+   ..+++|+.+...    .......+.+|+.+|..+. |+++  ++++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~----~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK----LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc----cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            57789999999999866443   367777654221    1112345779999999885 6655  7777777654   46


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      .|+||||++|..+.+-. -..++..+...+..+++++|..||+.
T Consensus       119 ~flVME~v~G~~~~~~~-~~~~~~~~r~~l~~~l~~~La~LH~v  161 (822)
T PLN02876        119 AFYIMEYLEGRIFVDPK-LPGVAPERRRAIYRATAKVLAALHSA  161 (822)
T ss_pred             ceEEEEecCCcccCCcc-CCCCCHHHHHHHHHHHHHHHHHHhCC
Confidence            78999999986543211 01356677778999999999999975

>PRK10593 hypothetical protein; Provisional

Probab=96.85  E-value=0.0075  Score=55.50  Aligned_cols=104  Identities=13%  Similarity=0.076  Sum_probs=73.9

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC---CceeeeeeEEEe---CCEEE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH---DNIVQYFGTEKD---ENKLY  267 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~  267 (317)
                      -.+.||.|..+.||.....++ .+.+|..+.    ..   ....+..|...|+.+..   ..++++++++..   .+..+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~----~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARS----FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecc----cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            356899999999999865555 466676431    00   12357788888887743   467788887754   36689


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      ||||+++|+++.+.    ..+......+..+++++|.-||+.
T Consensus        90 LVmE~i~G~~~~~~----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         90 LLLERLRGVSVEAP----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEEeccCCEecCCC----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999887762    123444556778889999999975

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=96.68  E-value=0.01  Score=58.58  Aligned_cols=119  Identities=13%  Similarity=0.112  Sum_probs=70.0

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCC-------------------------CccHHHHHH----------HHH
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQG-------------------------TQGEQSVLQ----------LEQ  240 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-------------------------~~~~~~~~~----------~~~  240 (317)
                      ..|+.++-|.||.|...+|+.||||+.++.-..                         .........          +..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            789999999999999999999999998753110                         000111111          344


Q ss_pred             HHHHhccC-----CCCceeeeeeEEEeCCEEEEEEecCCCCCHHHH--HHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 021084          241 EISLLGQF-----EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH  313 (317)
Q Consensus       241 Ei~il~~l-----~hpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~--l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvH  313 (317)
                      |...+.++     +.|.+.--.=++...+.-.|+|||++|-.+.++  +...+++...+.....++.  +.-+-..|+.|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffH  288 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFH  288 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccc
Confidence            55555444     234432222222334456899999999988887  5556666444333222221  11222369999


Q ss_pred             cCC
Q 021084          314 RPG  316 (317)
Q Consensus       314 rDL  316 (317)
                      .|.
T Consensus       289 aDp  291 (517)
T COG0661         289 ADP  291 (517)
T ss_pred             cCC
Confidence            885

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.65  E-value=0.017  Score=54.41  Aligned_cols=121  Identities=16%  Similarity=0.124  Sum_probs=81.9

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCC---------------------CCccHHHHHHHHHHHHHhccCCCCc
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQ---------------------GTQGEQSVLQLEQEISLLGQFEHDN  252 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---------------------~~~~~~~~~~~~~Ei~il~~l~hpn  252 (317)
                      +-..|..|--+.||.+...+|..+|||+++-.-.                     .....-.......|++.|++++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            4567888889999999889999999998863210                     0111111223467888898887666


Q ss_pred             eeeeeeEEEeCCEEEEEEecCCCCC-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCC
Q 021084          253 IVQYFGTEKDENKLYIFLELVTQGS-LAKIYQEYHLKDSQVSAYTWQILNGLKYLH-EQNVIHRPG  316 (317)
Q Consensus       253 Iv~l~~~~~~~~~~~lVmE~~~ggs-L~~~l~~~~l~~~~~~~i~~qil~aL~yLH-~~gIvHrDL  316 (317)
                      |+.---....  .-.|||+|+.... -.-.|+.-.++...+..+-.|++.-|.-|- .+++||.||
T Consensus       228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADL  291 (520)
T KOG2270|consen  228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADL  291 (520)
T ss_pred             CCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccch
Confidence            5543333322  2479999995322 233556666887888888888888887765 469999997

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.42  E-value=0.012  Score=49.74  Aligned_cols=105  Identities=18%  Similarity=0.165  Sum_probs=66.7

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCcee-eeeeEEEeCCEEEEEEec
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV-QYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lVmE~  272 (317)
                      ....||+|++|.||+|. +.|..+|+|+-+..       .....+..|+++|..+.--++. +++.+..    .++.|||
T Consensus        26 v~~~L~KG~~s~Vyl~~-~~~~~~a~Kvrr~d-------s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~   93 (201)
T COG2112          26 VEKELAKGTTSVVYLGE-WRGGEVALKVRRRD-------SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY   93 (201)
T ss_pred             hhhhhhcccccEEEEee-ccCceEEEEEecCC-------cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence            45789999999999995 45558899976522       2245678999999888765544 4444432    3456999


Q ss_pred             CCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          273 VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       273 ~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +.|..|.+.....  +...+    ..+++.---|-..||-|..|
T Consensus        94 i~G~~L~~~~~~~--~rk~l----~~vlE~a~~LD~~GI~H~El  131 (201)
T COG2112          94 IDGRPLGKLEIGG--DRKHL----LRVLEKAYKLDRLGIEHGEL  131 (201)
T ss_pred             hcCcchhhhhhcc--cHHHH----HHHHHHHHHHHHhccchhhh
Confidence            9998887765421  22222    23334433344557777544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.36  E-value=0.02  Score=50.50  Aligned_cols=103  Identities=16%  Similarity=0.134  Sum_probs=71.9

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC--ceeeeeeEEEeCCEEEEEEecC
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD--NIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      ..||+|..+.||+.   .+..+++|.....   .    ....+.+|.+++..+..-  .++..+++....+..++|||++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~---~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG---F----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC---C----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            56899999999984   2446778876521   1    123457899888887533  3467777777788889999999


Q ss_pred             CCCC-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 021084          274 TQGS-LAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV  311 (317)
Q Consensus       274 ~ggs-L~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gI  311 (317)
                      +|.+ +...+.   .+......++.+++..|.-||+..+
T Consensus        77 ~G~~~~~~~~~---~~~~~~~~l~~~la~~l~~lH~~~~  112 (226)
T TIGR02172        77 VGKRSFSRIIS---DNPSRLEEIAKIFAEMAKKLHSTKC  112 (226)
T ss_pred             CCccchhhhhc---CCHHHHHHHHHHHHHHHHHHhCCCC
Confidence            9963 433332   2444556678888898999997543

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=95.97  E-value=0.00068  Score=70.34  Aligned_cols=131  Identities=17%  Similarity=0.138  Sum_probs=94.8

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      |....+.+.+.+.+-+|+++.++.+.. ..|...++|+.........  ...+....+-.++-...+|.++.....+...
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~--~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT--NDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc--ccccccCCccCccccCCCCceecccCCCCCC
Confidence            566788899999999999999998866 5565566665543221111  1112222232333334567777776666777


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+++|+|+.+++|...+...+ .+..-+..+...+.++++|||+..++|||+|
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~  931 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLK  931 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhccccc
Confidence            88999999999999999987655 6666777888899999999999999999986

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=95.78  E-value=0.056  Score=47.77  Aligned_cols=100  Identities=14%  Similarity=0.146  Sum_probs=67.0

Q ss_pred             cccccCC-eeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCEEEEEEecCC
Q 021084          197 PLGSGSF-GSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENKLYIFLELVT  274 (317)
Q Consensus       197 ~LG~G~f-g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lVmE~~~  274 (317)
                      .|..|.. ..||+.... +..+.+|......        ...+..|+.++..+. +--+++++++....+..++||++++
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   75 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP   75 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence            3445555 788988544 4678888764211        224557888877773 3446677887777677899999999


Q ss_pred             CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          275 QGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       275 ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      |.++.....     ......++.++.+.|.-||+..
T Consensus        76 G~~l~~~~~-----~~~~~~~~~~l~~~l~~lH~i~  106 (244)
T cd05150          76 GVPAAALWE-----ELEPERLVDALAEALRRLHALP  106 (244)
T ss_pred             CccHhHhhc-----ccCHHHHHHHHHHHHHHHhcCC
Confidence            988865431     1122357888899999999763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=94.90  E-value=0.33  Score=46.56  Aligned_cols=90  Identities=16%  Similarity=0.108  Sum_probs=58.6

Q ss_pred             eccccccCCeeEEEEEecCC-CEEEEEEEeecCCC-Ccc-HHHHHHHHHHHHHhccC---CCCceeeeeeEEEeCCEEEE
Q 021084          195 GAPLGSGSFGSVYEGFTDDG-FFFAVKEVSLQDQG-TQG-EQSVLQLEQEISLLGQF---EHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~~~-~~~-~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .+.||.|.+..||++...+| +.++||.-...... ... +-...+...|.+.|..+   ...++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46799999999999988666 58999985421110 011 12345666777777765   23467777766  4455789


Q ss_pred             EEecCCCCC-HHHHHHhCC
Q 021084          269 FLELVTQGS-LAKIYQEYH  286 (317)
Q Consensus       269 VmE~~~ggs-L~~~l~~~~  286 (317)
                      ||||+++.. +.+.+..+.
T Consensus       109 VME~L~~~~~lr~~Ll~g~  127 (401)
T PRK09550        109 VMEDLSDHKILRKGLIDGK  127 (401)
T ss_pred             EEecCCCccHHHHHHhcCC
Confidence            999998754 445554443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.89  E-value=0.02  Score=53.01  Aligned_cols=116  Identities=16%  Similarity=0.177  Sum_probs=75.7

Q ss_pred             eeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCC---------------Ccc--HHHHHHHHHHHHHhccCC-CCc-
Q 021084          192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQG---------------TQG--EQSVLQLEQEISLLGQFE-HDN-  252 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------------~~~--~~~~~~~~~Ei~il~~l~-hpn-  252 (317)
                      +.+++.||-|.-+.||.+-+..|.+.++|.=+.....               ..+  .-.......|+..|+.|. |.+ 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            4578999999999999998899999999864432110               000  111223567888888884 332 


Q ss_pred             eeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 021084          253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPG  316 (317)
Q Consensus       253 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDL  316 (317)
                      +++.++    .+..|+|||++.|-.|...-.-     ..+..+...++.-+--|-.+|+||+|.
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHgDF  228 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHGDF  228 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceeccc
Confidence            334443    3567999999998777664321     112334445555566788899999994

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=92.38  E-value=0.51  Score=41.23  Aligned_cols=99  Identities=12%  Similarity=0.094  Sum_probs=61.2

Q ss_pred             eccccccCCeeEEEEEecC--CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC-CceeeeeeEEEeCCEEEEEEe
Q 021084          195 GAPLGSGSFGSVYEGFTDD--GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH-DNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lVmE  271 (317)
                      ++.|..|-...+|++...+  +..|++|.......      .......|+.++..+.. .-.+++++.+. .   .++||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEE
Confidence            3567888889999986653  67888997642211      01122367777777743 23445544432 2   47999


Q ss_pred             cCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          272 LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       272 ~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      |++|.++....    +.   ...++.+++..|.-||+..
T Consensus        73 ~i~G~~l~~~~----~~---~~~~~~~la~~l~~lH~~~  104 (235)
T cd05157          73 FIPGRTLEPED----LR---NPKIYRLIARELAKLHSIK  104 (235)
T ss_pred             eeCCCcCCHHH----cc---ChHHHHHHHHHHHHHhccc
Confidence            99986654321    10   1236677888999999764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=92.13  E-value=0.37  Score=41.23  Aligned_cols=73  Identities=21%  Similarity=0.145  Sum_probs=53.4

Q ss_pred             HHHHHhccCCC-CceeeeeeEEEeCCEEEEEEecCCCCCHHH----HHHhCCCCHHHHHHHHHHHHHHHHHHHHC---Cc
Q 021084          240 QEISLLGQFEH-DNIVQYFGTEKDENKLYIFLELVTQGSLAK----IYQEYHLKDSQVSAYTWQILNGLKYLHEQ---NV  311 (317)
Q Consensus       240 ~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lVmE~~~ggsL~~----~l~~~~l~~~~~~~i~~qil~aL~yLH~~---gI  311 (317)
                      .|.-+|..+.+ +++++++|+|-.    ++|.||.+.+++..    +.+-..-+|.....|+.++++.+.+|+..   .+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            56777777765 699999999842    67899998776642    11112368999999999999999999973   34


Q ss_pred             EecCC
Q 021084          312 IHRPG  316 (317)
Q Consensus       312 vHrDL  316 (317)
                      .-.|+
T Consensus        84 ~lcDv   88 (188)
T PF12260_consen   84 YLCDV   88 (188)
T ss_pred             EEeec
Confidence            33554

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=91.30  E-value=0.032  Score=55.77  Aligned_cols=121  Identities=20%  Similarity=0.173  Sum_probs=82.5

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc-eeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN-IVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~  263 (317)
                      .+.....+.....+++|+++.+++.+....+....+.+...          ....-++++|.+++||| .+.+++-+..+
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E  306 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGE  306 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence            34445556667788999999999987633333445655321          23446778899999999 77788888888


Q ss_pred             CEEEEEEecCCCC-CHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecC
Q 021084          264 NKLYIFLELVTQG-SLAKIY--QEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRP  315 (317)
Q Consensus       264 ~~~~lVmE~~~gg-sL~~~l--~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrD  315 (317)
                      ++.++.|+++.++ +....+  ..-.+...+...+...-..+|+|||+.-=+|||
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d  361 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD  361 (829)
T ss_pred             cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc
Confidence            9999999999887 222111  111233344455666677899999988767886

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=91.20  E-value=0.46  Score=41.80  Aligned_cols=98  Identities=15%  Similarity=0.152  Sum_probs=60.8

Q ss_pred             ccccccCCe-eEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC---ceeeeeeEEEeC---CEEEE
Q 021084          196 APLGSGSFG-SVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD---NIVQYFGTEKDE---NKLYI  268 (317)
Q Consensus       196 ~~LG~G~fg-~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l  268 (317)
                      ..|+.|+.. .||..    +..+++|..+..       .....+..|..++..+...   .++.+++.....   +..|+
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc-------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            457766666 58876    235677764321       1234677888888776421   344444443332   24589


Q ss_pred             EEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          269 FLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      +|++++|.++....    +..  ...+..++.+.|.-||+..
T Consensus        72 l~~~i~G~~l~~~~----~~~--~~~l~~~la~~l~~LH~i~  107 (235)
T cd05155          72 VYRWLEGETATAAA----LSD--PSEFAEDLADFLAALRQID  107 (235)
T ss_pred             EEEeecCCCCCccc----cCC--HHHHHHHHHHHHHHHhCCC
Confidence            99999998886541    111  2357788899999999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=90.01  E-value=0.14  Score=40.33  Aligned_cols=45  Identities=29%  Similarity=0.268  Sum_probs=33.8

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ  247 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~  247 (317)
                      ...||.|+.|.||+|...+|+.||||+.++        .....+...+.+|..
T Consensus        16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP--------~i~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKDGEEVAVKVQRP--------GIEEQIEADLRILRR   60 (119)
T ss_pred             cchhhheehhhheeeeecccchhhhhhcch--------HHHHHHHHHHHHHHH
Confidence            367999999999999888899999998763        233445555555543

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PLN02756 S-methyl-5-thioribose kinase

Probab=89.23  E-value=4.5  Score=39.02  Aligned_cols=109  Identities=13%  Similarity=0.024  Sum_probs=66.2

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCcc--HHHHHHHHHHHHHhccCC---CCceeeeeeEEEeCCEEEE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG--EQSVLQLEQEISLLGQFE---HDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..+.||.|....||+.... +..++||.-.........  +....+-..|...|..+.   ..++++++.++.+  ..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            3577899999999998764 456889976522110000  112333445566665442   3578888887773  4588


Q ss_pred             EEecCCC--CCHHHHHHhCCCCHHHHHHHHHHHHHHHHH
Q 021084          269 FLELVTQ--GSLAKIYQEYHLKDSQVSAYTWQILNGLKY  305 (317)
Q Consensus       269 VmE~~~g--gsL~~~l~~~~l~~~~~~~i~~qil~aL~y  305 (317)
                      +||++++  ..+.+-+-.+...+..+..+...++..|-|
T Consensus       113 vME~L~~~~~ilr~~Ll~G~~~p~~a~~ig~~la~tLf~  151 (418)
T PLN02756        113 GMRYLEPPHIILRKGLIAGIEYPLLAEHMSDYMAKTLFF  151 (418)
T ss_pred             EEeecCCcceehhhhhccCCCCHHHHHHHHHHHHHHHhh
Confidence            9999977  356665554444455555666666665443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=86.94  E-value=5  Score=36.76  Aligned_cols=93  Identities=19%  Similarity=0.182  Sum_probs=56.3

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEEeCCEEEEEE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      ....++.|....+|... .++..+.+|+-...        ....|..|..-|+.|   .--.+++.+++....+..+|+|
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~--------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSES--------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG--------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChh--------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            45778889999999885 77788999987521        123466777766666   4456788888888777779999


Q ss_pred             ecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH
Q 021084          271 ELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE  308 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~  308 (317)
                      ||++.+..       .      ..-..++..+|+-||.
T Consensus        92 e~l~~~~~-------~------~~~~~~lg~~LA~LH~  116 (288)
T PF03881_consen   92 EFLEMGSP-------S------PPDWEELGRQLAALHQ  116 (288)
T ss_dssp             E---------------------CCHHHHHHHHHHHHHH
T ss_pred             EeecCCCC-------C------chhHHHHHHHHHHHhh
Confidence            99976410       0      1123456777888998

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=86.26  E-value=2  Score=39.19  Aligned_cols=99  Identities=14%  Similarity=0.143  Sum_probs=61.7

Q ss_pred             ccccccCCeeEEEEEecC-------CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc-eeeeeeEEEeCCEEE
Q 021084          196 APLGSGSFGSVYEGFTDD-------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN-IVQYFGTEKDENKLY  267 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~  267 (317)
                      +.+..|-...+|++...+       +..+++|+.....      ........|..++..+.... .+++++.+..    .
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV------ELLIDRERELVVFARLSERNLGPKLYGIFPN----G   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC------cceechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence            456677778899886644       5789999865321      11123456777777664322 3455555542    3


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV  311 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gI  311 (317)
                      +|++|++|.++....-.       ...++.+++..|.-||+..+
T Consensus        74 ~v~e~i~G~~l~~~~~~-------~~~~~~~ia~~L~~lH~~~~  110 (302)
T cd05156          74 RIEEFIPSRTLTTEELR-------DPDISAEIARRMAKLHSIVV  110 (302)
T ss_pred             chhheeCCCcCCHhHcC-------CcHHHHHHHHHHHHhhCCCC
Confidence            68999998776542111       12367789999999998643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR02721 ycfN_thiK thiamine kinase

Probab=86.03  E-value=1.7  Score=38.71  Aligned_cols=98  Identities=13%  Similarity=0.097  Sum_probs=57.8

Q ss_pred             cccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCce-eeeeeEEEeCCEEEEEEecCCC
Q 021084          197 PLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI-VQYFGTEKDENKLYIFLELVTQ  275 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lVmE~~~g  275 (317)
                      .+..|-.+.+|+.. .++..+++|.......     ........|..++..+....+ +++++..  .  -++||||++|
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~-----~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G   72 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCK-----ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEG   72 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccc-----cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccC
Confidence            35678888999885 5566788886542211     000123467777777743322 3444433  2  2689999998


Q ss_pred             CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 021084          276 GSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV  311 (317)
Q Consensus       276 gsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gI  311 (317)
                      ..+..-.    +.   ....+.+++..|.-||+..+
T Consensus        73 ~~~~~~~----~~---~~~~~~~la~~l~~lH~~~~  101 (256)
T TIGR02721        73 EVITLDQ----FV---ALDLLLELAALLHQLHSQPR  101 (256)
T ss_pred             ccccccc----cc---CchhHHHHHHHHHHHhCCCC
Confidence            7654310    10   11346788888899997643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=84.71  E-value=3.3  Score=37.18  Aligned_cols=76  Identities=21%  Similarity=0.211  Sum_probs=53.8

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHH---HHhccCCCCceeeeeeEEEeCCEEEEEEe
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI---SLLGQFEHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      ...+..|..+.|+.+...+|.+.++|+......          +..|.   ..|...+-...|++++.-..  .-.|++|
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~----------~~~E~~g~~~L~~w~G~GaVrll~~d~~--~~AlLLE   74 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE----------AEHEARGEAALRWWNGRGAVRLLAADPE--RGALLLE   74 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc----------chhhhhHHhHhheeCCCCceeeeccccc--cchhhhh
Confidence            345678999999999889999999998753211          11232   44667777788898886533  4578999


Q ss_pred             cC-CCCCHHHHH
Q 021084          272 LV-TQGSLAKIY  282 (317)
Q Consensus       272 ~~-~ggsL~~~l  282 (317)
                      .+ +|.+|.++.
T Consensus        75 rl~~g~~L~~~~   86 (253)
T PF04655_consen   75 RLDPGRSLASLP   86 (253)
T ss_pred             hccCCCchhhcc
Confidence            99 555777665

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=82.79  E-value=8.4  Score=36.54  Aligned_cols=105  Identities=15%  Similarity=0.054  Sum_probs=61.4

Q ss_pred             cccccCCeeEEEEEecCC-CEEEEEEEeecCC--CCccHHHHHHHHHHHHHhccCC--CC-ceeeeeeEEEeCCEEEEEE
Q 021084          197 PLGSGSFGSVYEGFTDDG-FFFAVKEVSLQDQ--GTQGEQSVLQLEQEISLLGQFE--HD-NIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       197 ~LG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~~--~~~~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lVm  270 (317)
                      .||.|....||++...+| +.++||.-..-..  +..-+-...+..-|...|....  -| .+++++.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999987543 6899997542111  1111233445556777776542  23 45555443  445567999


Q ss_pred             ecCCCC-CHHHHHHhCCCCHHHHHHHHHHHHHHH
Q 021084          271 ELVTQG-SLAKIYQEYHLKDSQVSAYTWQILNGL  303 (317)
Q Consensus       271 E~~~gg-sL~~~l~~~~l~~~~~~~i~~qil~aL  303 (317)
                      |+++.. .|...+-.+...+..+..+..-++..+
T Consensus        80 EdL~~~~ilR~~Li~g~~~p~~A~~iG~~La~tl  113 (370)
T TIGR01767        80 EDLSHHKIARKGLIEGENYPHLARHIGEFLAKTL  113 (370)
T ss_pred             hhCccchHHHHHHHcCCCChHHHHHHHHHHHHHH
Confidence            999654 455666656554554444444444443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=82.59  E-value=8.1  Score=34.92  Aligned_cols=97  Identities=16%  Similarity=0.100  Sum_probs=59.9

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC--ceeeeee------EEEeCCE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD--NIVQYFG------TEKDENK  265 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~------~~~~~~~  265 (317)
                      -...+..|....+|.....+ ..+++|+...     ..   ...+..|+.++..+.+.  .+++++.      +....+.
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~-----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~   88 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEK-----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK   88 (296)
T ss_pred             heecccCccccceEEEEeCC-CcEEEEEcCC-----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence            35678888888999985544 4688887652     11   23455666666666322  2334333      1233566


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      .+++++|++|..+..      .+.    ....++...|.-||..
T Consensus        89 ~~~l~~~i~G~~~~~------~~~----~~~~~lg~~La~lH~~  122 (296)
T cd05153          89 PAALVEFLAGEHLTR------PTA----AHCRQIGEALARLHLA  122 (296)
T ss_pred             eEEEEEeCCCCCCCC------CCH----HHHHHHHHHHHHHHHH
Confidence            789999999976543      122    2456778888888864

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=81.04  E-value=13  Score=33.27  Aligned_cols=74  Identities=16%  Similarity=0.213  Sum_probs=49.1

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEEeCCEEEEEEec
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      +.+..|..-..|... ....++-+|+-.        ......|..|+.-|..+   +--.+++++.+....++.|+||||
T Consensus        22 ~~v~gG~inea~~v~-dg~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~   92 (286)
T COG3001          22 EEVSGGDINEAWRLR-DGTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY   92 (286)
T ss_pred             cccCCccccceeEee-cCCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence            445555555555553 444567777532        33455677777655554   445677888888899999999999


Q ss_pred             CCCCCH
Q 021084          273 VTQGSL  278 (317)
Q Consensus       273 ~~ggsL  278 (317)
                      ++-|.+
T Consensus        93 L~~~~~   98 (286)
T COG3001          93 LPTGPL   98 (286)
T ss_pred             ccCCCC
Confidence            987544

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=80.90  E-value=9.3  Score=36.92  Aligned_cols=112  Identities=20%  Similarity=0.199  Sum_probs=63.3

Q ss_pred             ecccc--ccCCeeEEEEEe-cC--------CCEEEEEEEeec---------C---CCCccHHH-HHHH--------HHHH
Q 021084          195 GAPLG--SGSFGSVYEGFT-DD--------GFFFAVKEVSLQ---------D---QGTQGEQS-VLQL--------EQEI  242 (317)
Q Consensus       195 ~~~LG--~G~fg~Vy~~~~-~~--------~~~vAvK~i~~~---------~---~~~~~~~~-~~~~--------~~Ei  242 (317)
                      ...||  .|-.+.|.++.. ++        .+.||+|+....         .   ........ ...+        .+|+
T Consensus        38 ~~~Igdg~GFmS~I~lV~~dW~~~~~~~~LP~k~vlKI~S~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~HNrEv  117 (414)
T PF07914_consen   38 ATNIGDGKGFMSRIALVEPDWTGEEEDENLPKKFVLKIPSQLALRALSENMKFEGGKGFDEEKEWEEFEKFLREMHNREV  117 (414)
T ss_pred             eeeccCCcchheeEEEEEeeeccCccccCCCceEEEEeccHhhHHHHHHhhccccccccchhhHHHHHHHHHHHhhHHHH
Confidence            34454  566788888864 33        568999987521         0   00111111 2221        2344


Q ss_pred             H---HhccCCCCceeeeeeEEE----eC--CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q 021084          243 S---LLGQFEHDNIVQYFGTEK----DE--NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI  312 (317)
Q Consensus       243 ~---il~~l~hpnIv~l~~~~~----~~--~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIv  312 (317)
                      .   ++.+.+||++.-..-|+.    +.  ..-+|+|||+++.....+..  +++..++    .||++||+.+|..++-
T Consensus       118 ~~Y~~~~k~~~~~l~~PKvY~~k~f~~en~~kG~IimE~ven~~~~~~~e--~~~~eql----~~iv~aLA~~~A~sl~  190 (414)
T PF07914_consen  118 NFYKIFEKFNHPNLPYPKVYFGKKFDEENKLKGFIIMEYVENVHSMDMYE--NLSVEQL----LQIVRALAKFHALSLK  190 (414)
T ss_pred             HHHHHHHhcCCCCCCCCceeEEEecCCCCCCCCEEEEeccCCceeecccC--CCCHHHH----HHHHHHHHHHHHhHcc
Confidence            3   456677887764433331    12  23689999998754333322  4666665    5678888999987654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=80.82  E-value=3.7  Score=44.29  Aligned_cols=81  Identities=23%  Similarity=0.360  Sum_probs=61.9

Q ss_pred             HHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE----EEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHH
Q 021084          233 QSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK----LYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLH  307 (317)
Q Consensus       233 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH  307 (317)
                      ........|+..+.++.|+|++.++.+......    ..+..++|++.++...++.-+ .+......+..+++.||.|+|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            334455677788889999999999988755332    234457888888888887644 788888899999999999999


Q ss_pred             HCCcEe
Q 021084          308 EQNVIH  313 (317)
Q Consensus       308 ~~gIvH  313 (317)
                      +....|
T Consensus       304 ~~~l~~  309 (1351)
T KOG1035|consen  304 SLSLEH  309 (1351)
T ss_pred             Hhccce
Confidence            885444

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=80.82  E-value=21  Score=32.71  Aligned_cols=92  Identities=17%  Similarity=0.293  Sum_probs=49.9

Q ss_pred             cCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeee------EEEeCCEEEEEEecCC
Q 021084          201 GSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFG------TEKDENKLYIFLELVT  274 (317)
Q Consensus       201 G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~------~~~~~~~~~lVmE~~~  274 (317)
                      |.-|.||.+....| .+++|.+..      +......+..-+..|..-.-++++.++-      +...++..+++|++++
T Consensus        17 ~~~~~v~~v~T~~G-~~~Lk~~~~------~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi~   89 (309)
T TIGR02904        17 QVTGKLFKVYTDQG-VFALKKLYA------DRNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYLMPWLD   89 (309)
T ss_pred             cccCcEEEEEeCCC-CEEEEEecc------chHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEEeCCcc
Confidence            33568899855555 688888752      1111112222222232222234444422      2344566799999998


Q ss_pred             CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          275 QGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       275 ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      |..        .+...   .-+.+++..|+-||..+
T Consensus        90 G~~--------~~~~~---~~~~~~~~~LA~lH~~~  114 (309)
T TIGR02904        90 IER--------NEERN---YQHESMFQELALLHRKT  114 (309)
T ss_pred             ccc--------ccCCH---HHHHHHHHHHHHHHHhh
Confidence            721        11111   34677888888999764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK05231 homoserine kinase; Provisional

Probab=80.17  E-value=18  Score=33.09  Aligned_cols=96  Identities=13%  Similarity=0.005  Sum_probs=52.1

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-----CCCceeeee-e--EEEeCCEE
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-----EHDNIVQYF-G--TEKDENKL  266 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~-~--~~~~~~~~  266 (317)
                      .+.++.|....+|.....+| .+++|++. ..    ...   .+..|+.++..|     .-|.++... |  +....+..
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~----~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~   97 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-RL----TAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKP   97 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEec-cC----ChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEE
Confidence            45677788889999865555 68888874 11    111   222333333333     233333211 1  12335678


Q ss_pred             EEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          267 YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      +++++|++|..+..      .+.    ..+.++..+|.-||..
T Consensus        98 ~~l~~~l~G~~~~~------~~~----~~~~~~G~~LA~lH~~  130 (319)
T PRK05231         98 AAIVTFLEGKWPRA------PTA----AHCAEVGEMLARMHLA  130 (319)
T ss_pred             EEEEEecCCCCCCC------CCH----HHHHHHHHHHHHHHhh
Confidence            99999999865321      111    1234566677777753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	317
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-06
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-05
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-04
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-04
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-04
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-04
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-04
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-04
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-04
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-04
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-04
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-04
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-04
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-04

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 68/122 (55%), Gaps = 10/122 (8%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G++G VY G    +    A+KE+  +D      +    L +EI+L    +H NIVQY
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPLHEEIALHKHLKHKNIVQY 84
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQ--VSAYTWQILNGLKYLHEQNVI 312
            G+  +   + IF+E V  GSL+ + +     LKD++  +  YT QIL GLKYLH+  ++
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 313 HR 314
           HR
Sbjct: 145 HR 146

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 68/122 (55%), Gaps = 10/122 (8%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G++G VY G    +    A+KE+  +D      +    L +EI+L    +H NIVQY
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPLHEEIALHKHLKHKNIVQY 70
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQ--VSAYTWQILNGLKYLHEQNVI 312
            G+  +   + IF+E V  GSL+ + +     LKD++  +  YT QIL GLKYLH+  ++
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 313 HR 314
           HR
Sbjct: 131 HR 132

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 4/140 (2%)
Query: 178 NFSLNEKYRRR--IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSV 235
           N +L E  +R+  I  +  G PLG G FG+VY        F    +V  + Q  + E   
Sbjct: 1   NTALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-LEKEGVE 59
Query: 236 LQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA- 294
            QL +EI +     H NI++ +    D  ++Y+ LE   +G L K  Q++   D Q SA 
Sbjct: 60  HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT 119
Query: 295 YTWQILNGLKYLHEQNVIHR 314
           +  ++ + L Y HE+ VIHR
Sbjct: 120 FMEELADALHYCHERKVIHR 139

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 59/119 (49%), Gaps = 2/119 (1%)
Query: 197 PLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           PLG G FG+VY        F    +V  + Q  + E    QL +EI +     H NI++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-LEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQNVIHR 314
           +    D  ++Y+ LE   +G L K  Q++   D Q SA +  ++ + L Y HE+ VIHR
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHR 138

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 6/125 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           W+    LG G+FG VY+    +    A  +V      T+ E+ +     EI +L   +H 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDHP 94
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQ 309
           NIV+       EN L+I +E    G++  +  E    L +SQ+     Q L+ L YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 310 NVIHR 314
            +IHR
Sbjct: 155 KIIHR 159

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 6/125 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           W+    LG G+FG VY+    +    A  +V      T+ E+ +     EI +L   +H 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDHP 94
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQ 309
           NIV+       EN L+I +E    G++  +  E    L +SQ+     Q L+ L YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 310 NVIHR 314
            +IHR
Sbjct: 155 KIIHR 159

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 6/125 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           W+    LG G+FG VY+    +    A  +V      T+ E+ +     EI +L   +H 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDHP 94
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQ 309
           NIV+       EN L+I +E    G++  +  E    L +SQ+     Q L+ L YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 310 NVIHR 314
            +IHR
Sbjct: 155 KIIHR 159

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 72
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE   +G + K  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 310 NVIHR 314
            VIHR
Sbjct: 133 RVIHR 137

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 72
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE   +G + K  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 310 NVIHR 314
            VIHR
Sbjct: 133 RVIHR 137

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 62/125 (49%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY     +  F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 68  PNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 310 NVIHR 314
            VIHR
Sbjct: 128 KVIHR 132

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 13/141 (9%)
Query: 182 NEKYRRR---IMSWQKGAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQS 234
           NE+ ++R   +  ++ G PLG G FG+VY        F  A+K   +  L+  G +    
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--- 79
Query: 235 VLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA 294
             QL +E+ +     H NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A
Sbjct: 80  --QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 137
Query: 295 -YTWQILNGLKYLHEQNVIHR 314
            Y  ++ N L Y H + VIHR
Sbjct: 138 TYITELANALSYCHSKRVIHR 158

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 13/141 (9%)
Query: 182 NEKYRRR---IMSWQKGAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQS 234
           NE+ ++R   +  ++ G PLG G FG+VY        F  A+K   +  L+  G +    
Sbjct: 14  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--- 70
Query: 235 VLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA 294
             QL +E+ +     H NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A
Sbjct: 71  --QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 128
Query: 295 -YTWQILNGLKYLHEQNVIHR 314
            Y  ++ N L Y H + VIHR
Sbjct: 129 TYITELANALSYCHSKRVIHR 149

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 13/141 (9%)
Query: 182 NEKYRRR---IMSWQKGAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQS 234
           NE+ ++R   +  ++ G PLG G FG+VY        F  A+K   +  L+  G +    
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--- 79
Query: 235 VLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA 294
             QL +E+ +     H NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A
Sbjct: 80  --QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 137
Query: 295 -YTWQILNGLKYLHEQNVIHR 314
            Y  ++ N L Y H + VIHR
Sbjct: 138 TYITELANALSYCHSKRVIHR 158

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 64/125 (51%), Gaps = 13/125 (10%)
Query: 198 LGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG+G++ +VY+G     G + A+KEV L  +      ++    +EISL+ + +H+NIV+ 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIVRL 68
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQ-------VSAYTWQILNGLKYLHEQ 309
           +     ENKL +  E +    L K      + ++        V  + WQ+L GL + HE 
Sbjct: 69  YDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 310 NVIHR 314
            ++HR
Sbjct: 128 KILHR 132

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 310 NVIHR 314
            VIHR
Sbjct: 128 RVIHR 132

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 310 NVIHR 314
            VIHR
Sbjct: 131 RVIHR 135

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 68
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 310 NVIHR 314
            VIHR
Sbjct: 129 RVIHR 133

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 68
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 310 NVIHR 314
            VIHR
Sbjct: 129 RVIHR 133

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 69
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 310 NVIHR 314
            VIHR
Sbjct: 130 RVIHR 134

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 310 NVIHR 314
            VIHR
Sbjct: 128 RVIHR 132

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 69
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 310 NVIHR 314
            VIHR
Sbjct: 130 RVIHR 134

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 310 NVIHR 314
            VIHR
Sbjct: 131 RVIHR 135

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 72
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 310 NVIHR 314
            VIHR
Sbjct: 133 RVIHR 137

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 310 NVIHR 314
            VIHR
Sbjct: 131 RVIHR 135

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 310 NVIHR 314
            VIHR
Sbjct: 128 RVIHR 132

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 310 NVIHR 314
            VIHR
Sbjct: 131 RVIHR 135

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 62/123 (50%), Gaps = 6/123 (4%)
Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVL--QLEQEISLLGQFEHDN 252
           G PLG G FG+VY        F    +V  +   TQ E++ +  QL +E+ +     H N
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFK---TQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQNV 311
           I++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H + V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 312 IHR 314
           IHR
Sbjct: 134 IHR 136

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 72
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 310 NVIHR 314
            VIHR
Sbjct: 133 RVIHR 137

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 66
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 126
Query: 310 NVIHR 314
            VIHR
Sbjct: 127 RVIHR 131

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 310 NVIHR 314
            VIHR
Sbjct: 128 RVIHR 132

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 62/123 (50%), Gaps = 6/123 (4%)
Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVL--QLEQEISLLGQFEHDN 252
           G PLG G FG+VY        F    +V  +   TQ E++ +  QL +E+ +     H N
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFK---TQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQNV 311
           I++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H + V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 312 IHR 314
           IHR
Sbjct: 134 IHR 136

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 310 NVIHR 314
            VIHR
Sbjct: 128 RVIHR 132

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 68
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 310 NVIHR 314
            VIHR
Sbjct: 129 RVIHR 133

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 310 NVIHR 314
            VIHR
Sbjct: 131 RVIHR 135

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 310 NVIHR 314
            VIHR
Sbjct: 128 RVIHR 132

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 72
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 310 NVIHR 314
            VIHR
Sbjct: 133 RVIHR 137

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 310 NVIHR 314
            VIHR
Sbjct: 128 RVIHR 132

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 71
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 131
Query: 310 NVIHR 314
            VIHR
Sbjct: 132 RVIHR 136

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDDG-FFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 310 NVIHR 314
            VIHR
Sbjct: 131 RVIHR 135

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 65/118 (55%), Gaps = 5/118 (4%)
Query: 198 LGSGSFGSVYEGFTDDGF-FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG VY+G  +      A+K + L++     E  +  ++QEI++L Q +   I +Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYITRY 82
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           FG+     KL+I +E +  GS   + +   L+++ ++    +IL GL YLH +  IHR
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 140

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 195 GAPLGSGSFGSVYEGFTDD-GFFFAVK---EVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G PLG G FG+VY        F  A+K   +  L+  G +      QL +E+ +     H
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEH-----QLRREVEIQSHLRH 64
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+    D Q +A Y  ++ N L Y H +
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 124
Query: 310 NVIHR 314
            VIHR
Sbjct: 125 RVIHR 129

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 2/121 (1%)
Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           G PLG G FG+VY        F    +V  + Q  + E    QL +EI +     H NI+
Sbjct: 28  GRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ-IEKEGVEHQLRREIEIQAHLHHPNIL 86
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW-QILNGLKYLHEQNVIH 313
           + +    D  ++Y+ LE   +G L K  Q+    D Q +A    ++ + L Y H + VIH
Sbjct: 87  RLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIH 146
Query: 314 R 314
           R
Sbjct: 147 R 147

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 66/118 (55%), Gaps = 5/118 (4%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V++G  +      A+K + L++     E  +  ++QEI++L Q +   + +Y
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+   + KL+I +E +  GS   + +   L ++Q++    +IL GL YLH +  IHR
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 143

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 21/133 (15%)
Query: 197 PLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           PLG G  G V+    +D     A+K++ L D      QSV    +EI ++ + +HDNIV+
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVK 72
Query: 256 YF--------------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            F              G+  + N +YI  E + +  LA + ++  L +     + +Q+L 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  NV+HR
Sbjct: 132 GLKYIHSANVLHR 144

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 66/118 (55%), Gaps = 5/118 (4%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V++G  +      A+K + L++     E  +  ++QEI++L Q +   + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+   + KL+I +E +  GS   + +   L ++Q++    +IL GL YLH +  IHR
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 128

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 17/145 (11%)
Query: 174 ELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSL--QDQGTQG 231
           E +Y   L EKY       QK   +G G++G VY+     G   A+K + L  +D+G   
Sbjct: 12  ENLYFQGLMEKY-------QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS 64
Query: 232 EQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKD 289
                   +EISLL +  H NIV        E  L +  E + +  L K+  E    L+D
Sbjct: 65  TAI-----REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD 118
Query: 290 SQVSAYTWQILNGLKYLHEQNVIHR 314
           SQ+  Y +Q+L G+ + H+  ++HR
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHR 143

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKSQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 66/118 (55%), Gaps = 5/118 (4%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V++G  +      A+K + L++     E  +  ++QEI++L Q +   + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+   + KL+I +E +  GS   + +   L ++Q++    +IL GL YLH +  IHR
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 128

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 17/145 (11%)
Query: 174 ELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSL--QDQGTQG 231
           E +Y   L EKY       QK   +G G++G VY+     G   A+K + L  +D+G   
Sbjct: 12  ENLYFQGLMEKY-------QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS 64
Query: 232 EQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKD 289
                   +EISLL +  H NIV        E  L +  E + +  L K+  E    L+D
Sbjct: 65  TAI-----REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD 118
Query: 290 SQVSAYTWQILNGLKYLHEQNVIHR 314
           SQ+  Y +Q+L G+ + H+  ++HR
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHR 143

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 64
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 124 HSHRVLHR 131

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  AP+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 87
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 88  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 146
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 147 GLKYIHSADIIHR 159

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 66/118 (55%), Gaps = 5/118 (4%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V++G  +      A+K + L++     E  +  ++QEI++L Q +   + +Y
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+   + KL+I +E +  GS   + +   L ++Q++    +IL GL YLH +  IHR
Sbjct: 91  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 148

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 59
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 119 HSHRVLHR 126

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 59
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 119 HSHRVLHR 126

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 61
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 121 HSHRVLHR 128

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 59
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 119 HSHRVLHR 126

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 63
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 123 HSHRVLHR 130

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 62
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 122 HSHRVLHR 129

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 59
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 119 HSHRVLHR 126

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 61
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 121 HSHRVLHR 128

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 62
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 122 HSHRVLHR 129

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 61
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 121 HSHRVLHR 128

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 63
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E V Q  L K      L       + +Y +Q+L GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 123 HSHRVLHR 130

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 67
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 127 HSHRVLHR 134

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 63
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 123 HSHRVLHR 130

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 64
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 124 HSHRVLHR 131

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 62
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 122 HSHRVLHR 129

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 84
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 144 GLKYIHSADIIHR 156

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 74
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 134 GLKYIHSADIIHR 146

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 61
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 121 HSHRVLHR 128

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 82
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 142 GLKYIHSADIIHR 154

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 84
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 144 GLKYIHSADIIHR 156

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 84
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 144 GLKYIHSADIIHR 156

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 67
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 127 HSHRVLHR 134

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 73
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 133 GLKYIHSADIIHR 145

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 74
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 134 GLKYIHSADIIHR 146

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 84
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 144 GLKYIHSADIIHR 156

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 82
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 142 GLKYIHSADIIHR 154

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 82
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 142 GLKYIHSADIIHR 154

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 76
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 77  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 135
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 136 GLKYIHSADIIHR 148

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------KPFQSIIHAKRTYRELRLLKH 89
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 149 GLKYIHSADIIHR 161

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 75
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 76  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 134
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 135 GLKYIHSADIIHR 147

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 63
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E ++   L K      L       + +Y +Q+L GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 123 HSHRVLHR 130

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 96
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 156 GLKYIHSADIIHR 168

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 89
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 149 GLKYIHSADIIHR 161

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 88
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 148 GLKYIHSADIIHR 160

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 79
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 139 GLKYIHSADIIHR 151

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 89
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 149 GLKYIHSADIIHR 161

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 79
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 139 GLKYIHSADIIHR 151

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 83
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 143 GLKYIHSADIIHR 155

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 97
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 157 GLKYIHSADIIHR 169

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 82
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 142 GLKYIHSADIIHR 154

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 79
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 139 GLKYIHSADIIHR 151

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 100
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 160 GLKYIHSADIIHR 172

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 61
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E ++   L K      L       + +Y +Q+L GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 121 HSHRVLHR 128

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 83
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 143 GLKYIHSADIIHR 155

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 73
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCAKLTDDHVQFLIYQILR 132
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 133 GLKYIHSADIIHR 145

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 100
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 160 GLKYIHSADIIHR 172

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 88
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 148 GLKYIHSADIIHR 160

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG GS+GSVY+    + G   A+K+V +       E  + ++ +EIS++ Q +  ++V+Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 257 FGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+      L+I +E    GS++ I   +   L + +++      L GL+YLH    IHR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 83
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 143 GLKYIHSADIIHR 155

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W+    LG G+FG VY+    + G   A K +      T+ E+ +     EI +L   +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 75
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
             IV+  G    + KL+I +E    G++  I  E    L + Q+     Q+L  L +LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 309 QNVIHR 314
           + +IHR
Sbjct: 136 KRIIHR 141

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 79
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 139 GLKYIHSADIIHR 151

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W+    LG G+FG VY+    + G   A K +      T+ E+ +     EI +L   +H
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
             IV+  G    + KL+I +E    G++  I  E    L + Q+     Q+L  L +LH 
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 309 QNVIHR 314
           + +IHR
Sbjct: 128 KRIIHR 133

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 73
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 133 GLKYIHSADIIHR 145

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 73
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 133 GLKYIHSADIIHR 145

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 77
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 137 GLKYIHSADIIHR 149

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 97
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 157 GLKYIHSADIIHR 169

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 59
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQ--GSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
           H NIV+       ENKLY+  E V Q   +         +    + +Y +Q+L GL + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 308 EQNVIHR 314
              V+HR
Sbjct: 120 SHRVLHR 126

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 97
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 157 GLKYIHSADIIHR 169

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 96
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 156 GLKYIHSADIIHR 168

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   F T  G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 83
Query: 248 FEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++          + ++ N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 143 GLKYIHSADIIHR 155

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 20/146 (13%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQ 233
           +VYN S +         +Q  + LG G++G V        G   A+K++   D+      
Sbjct: 5   IVYNISSD---------FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-- 53
Query: 234 SVLQLEQEISLLGQFEHDNIVQYFGTEKDE-----NKLYIFLELVTQGSLAKIYQEYHLK 288
             L+  +EI +L  F+H+NI+  F  ++ +     N++YI  EL+ Q  L ++     L 
Sbjct: 54  --LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLS 110
Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
           D  +  + +Q L  +K LH  NVIHR
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHR 136

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 64/123 (52%), Gaps = 8/123 (6%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G F  VY      DG   A+K+V + D      ++     +EI LL Q  H N+++Y
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVSAYTWQILNGLKYLHEQNV 311
           + +  ++N+L I LEL   G L+++ + +      + +  V  Y  Q+ + L+++H + V
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 312 IHR 314
           +HR
Sbjct: 158 MHR 160

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 20/146 (13%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQ 233
           +VYN S +         +Q  + LG G++G V        G   A+K++   D+      
Sbjct: 5   IVYNISSD---------FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-- 53
Query: 234 SVLQLEQEISLLGQFEHDNIVQYFGTEKDE-----NKLYIFLELVTQGSLAKIYQEYHLK 288
             L+  +EI +L  F+H+NI+  F  ++ +     N++YI  EL+ Q  L ++     L 
Sbjct: 54  --LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLS 110
Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
           D  +  + +Q L  +K LH  NVIHR
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHR 136

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 20/146 (13%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQ 233
           +VYN S +         +Q  + LG G++G V        G   A+K++   D+      
Sbjct: 5   IVYNISSD---------FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-- 53
Query: 234 SVLQLEQEISLLGQFEHDNIVQYFGTEKDE-----NKLYIFLELVTQGSLAKIYQEYHLK 288
             L+  +EI +L  F+H+NI+  F  ++ +     N++YI  EL+ Q  L ++     L 
Sbjct: 54  --LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLS 110
Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
           D  +  + +Q L  +K LH  NVIHR
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHR 136

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 63
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQ--GSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
           H NIV+       ENKLY+  E + Q   +         +    + +Y +Q+L GL + H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 308 EQNVIHR 314
              V+HR
Sbjct: 124 SHRVLHR 130

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 68/141 (48%), Gaps = 24/141 (17%)
Query: 198 LGSGSFGSVYEGFT-DDGFFFAVKEVS----LQDQG-----------------TQGEQSV 235
           +G GS+G V   +  +D  ++A+K +S    ++  G                  Q    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 236 LQLEQEISLLGQFEHDNIVQYFGTEKDENK--LYIFLELVTQGSLAKIYQEYHLKDSQVS 293
            Q+ QEI++L + +H N+V+      D N+  LY+  ELV QG + ++     L + Q  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y   ++ G++YLH Q +IHR
Sbjct: 141 FYFQDLIKGIEYLHYQKIIHR 161

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+ ++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+ ++ L D  T+G  S     +EISLL +  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEGVPSTAI--REISLLKELN 59
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L K      L       + +Y +Q+L GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 119 HSHRVLHR 126

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK++ L+ Q     Q    L  E+ ++  ++H+N+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 213
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +    ++L++ +E +  G+L  I     + + Q++A    +L  L  LH Q VIHR
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 271

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 60
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E + Q  L        L       + +Y +Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 120 HSHRVLHR 127

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG FGSV++     DG  +A+K       G+  EQ+ L+     ++LGQ  H ++V+Y
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVVRY 74
Query: 257 FGTEKDENKLYIFLELVTQGSLA-KIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNV 311
           F    +++ + I  E    GSLA  I + Y    + K++++     Q+  GL+Y+H  ++
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 312 IH 313
           +H
Sbjct: 135 VH 136

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK++ L+ Q     Q    L  E+ ++  ++H+N+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 91
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +    ++L++ +E +  G+L  I     + + Q++A    +L  L  LH Q VIHR
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 149

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK++ L+ Q     Q    L  E+ ++  ++H+N+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 93
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +    ++L++ +E +  G+L  I     + + Q++A    +L  L  LH Q VIHR
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 151

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG FGSV++     DG  +A+K       G+  EQ+ L+     ++LGQ  H ++V+Y
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVVRY 74
Query: 257 FGTEKDENKLYIFLELVTQGSLA-KIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNV 311
           F    +++ + I  E    GSLA  I + Y    + K++++     Q+  GL+Y+H  ++
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 312 IH 313
           +H
Sbjct: 135 VH 136

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG FGSV++     DG  +A+K       G+  EQ+ L+     ++LGQ  H ++V+Y
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVVRY 76
Query: 257 FGTEKDENKLYIFLELVTQGSLA-KIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNV 311
           F    +++ + I  E    GSLA  I + Y    + K++++     Q+  GL+Y+H  ++
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 312 IH 313
           +H
Sbjct: 137 VH 138

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK++ L+ Q     Q    L  E+ ++  ++H+N+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +    ++L++ +E +  G+L  I     + + Q++A    +L  L  LH Q VIHR
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 140

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG FGSV++     DG  +A+K       G+  EQ+ L+     ++LGQ  H ++V+Y
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVVRY 72
Query: 257 FGTEKDENKLYIFLELVTQGSLA-KIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNV 311
           F    +++ + I  E    GSLA  I + Y    + K++++     Q+  GL+Y+H  ++
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 132
Query: 312 IH 313
           +H
Sbjct: 133 VH 134

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 17/133 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ---EISLLGQ 247
           +Q  +P+GSG++GSV   +    G   AVK++S      +  QS++  ++   E+ LL  
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS------RPFQSIIHAKRTYRELRLLKH 106
Query: 248 FEHDNIVQYF-----GTEKDE-NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILN 301
            +H+N++         T  +E N +Y+   L+    L  I +   L D  V    +QIL 
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILR 165
Query: 302 GLKYLHEQNVIHR 314
           GLKY+H  ++IHR
Sbjct: 166 GLKYIHSADIIHR 178

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK++ L+ Q     Q    L  E+ ++  ++H+N+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 136
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +    ++L++ +E +  G+L  I     + + Q++A    +L  L  LH Q VIHR
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 194

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK++ L+ Q     Q    L  E+ ++  ++H+N+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 86
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +    ++L++ +E +  G+L  I     + + Q++A    +L  L  LH Q VIHR
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 144

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 65/122 (53%), Gaps = 10/122 (8%)
Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           +G GSFG+VY  F  D       A+K++S    G Q  +    + +E+  L +  H N +
Sbjct: 23  IGHGSFGAVY--FARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 255 QYFGTEKDENKLYIFLE--LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           QY G    E+  ++ +E  L +   L +++++  L++ +++A T   L GL YLH  N+I
Sbjct: 79  QYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 313 HR 314
           HR
Sbjct: 138 HR 139

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 65/122 (53%), Gaps = 10/122 (8%)
Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           +G GSFG+VY  F  D       A+K++S    G Q  +    + +E+  L +  H N +
Sbjct: 62  IGHGSFGAVY--FARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTI 117
Query: 255 QYFGTEKDENKLYIFLE--LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           QY G    E+  ++ +E  L +   L +++++  L++ +++A T   L GL YLH  N+I
Sbjct: 118 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 313 HR 314
           HR
Sbjct: 177 HR 178

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 63
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E ++   L        L       + +Y +Q+L GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 123 HSHRVLHR 130

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++QK   +G G++G VY+      G   A+K++ L D  T+G  S     +EISLL +  
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 62
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYL 306
           H NIV+       ENKLY+  E ++   L        L       + +Y +Q+L GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 307 HEQNVIHR 314
           H   V+HR
Sbjct: 122 HSHRVLHR 129

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 312 IHR 314
           +HR
Sbjct: 150 LHR 152

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 91
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 312 IHR 314
           +HR
Sbjct: 151 LHR 153

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 312 IHR 314
           +HR
Sbjct: 146 LHR 148

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 84
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 312 IHR 314
           +HR
Sbjct: 144 LHR 146

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 88
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 312 IHR 314
           +HR
Sbjct: 148 LHR 150

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 84
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 312 IHR 314
           +HR
Sbjct: 144 LHR 146

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 312 IHR 314
           +HR
Sbjct: 146 LHR 148

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 91
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 312 IHR 314
           +HR
Sbjct: 151 LHR 153

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 92
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 312 IHR 314
           +HR
Sbjct: 152 LHR 154

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 83
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 312 IHR 314
           +HR
Sbjct: 143 LHR 145

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 312 IHR 314
           +HR
Sbjct: 150 LHR 152

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 94
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 312 IHR 314
           +HR
Sbjct: 154 LHR 156

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 312 IHR 314
           +HR
Sbjct: 146 LHR 148

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 106
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 312 IHR 314
           +HR
Sbjct: 166 LHR 168

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 65/119 (54%), Gaps = 6/119 (5%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G++G VY+   + G  FA+K++ L+ +      + ++   EIS+L + +H NIV+ +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                + +L +  E + Q  L K+    E  L+     ++  Q+LNG+ Y H++ V+HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 312 IHR 314
           +HR
Sbjct: 146 LHR 148

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 312 IHR 314
           +HR
Sbjct: 150 LHR 152

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 65/119 (54%), Gaps = 6/119 (5%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G++G VY+   + G  FA+K++ L+ +      + ++   EIS+L + +H NIV+ +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                + +L +  E + Q  L K+    E  L+     ++  Q+LNG+ Y H++ V+HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 65/119 (54%), Gaps = 6/119 (5%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G++G VY+   + G  FA+K++ L+ +      + ++   EIS+L + +H NIV+ +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                + +L +  E + Q  L K+    E  L+     ++  Q+LNG+ Y H++ V+HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL----REIKILLRFRHENIIGI 90
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 312 IHR 314
           +HR
Sbjct: 150 LHR 152

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 312 IHR 314
           +HR
Sbjct: 146 LHR 148

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 63/126 (50%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL +  Q++  +   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 136 KRYIHR 141

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 66/123 (53%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L  F H+NI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLAFRHENIIGI 88
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 312 IHR 314
           +HR
Sbjct: 148 LHR 150

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 64/118 (54%), Gaps = 5/118 (4%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V++G  +      A+K + L++     E  +  ++QEI++L Q +   + +Y
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSSYVTKY 86
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +G+    +KL+I +E +  GS   + +     + Q++    +IL GL YLH +  IHR
Sbjct: 87  YGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 144

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 312 IHR 314
           +HR
Sbjct: 150 LHR 152

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 66/123 (53%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L  F H+NI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLAFRHENIIGI 88
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 312 IHR 314
           +HR
Sbjct: 148 LHR 150

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D  G   AVK +    +   G Q     +QEI +L    H++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL----KADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 253 IVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           I++Y G  +D  E  L + +E V  GSL      + +  +Q+  +  QI  G+ YLH Q+
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQH 137
Query: 311 VIHR 314
            IHR
Sbjct: 138 YIHR 141

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 9/120 (7%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ ++    AVK +        G  SV    +E +L+   +HD +V+ +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK------PGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E + +GSL    +      +   ++  ++ QI  G+ Y+  +N IHR
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A++++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 312 IHR 314
           +HR
Sbjct: 150 LHR 152

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 65/121 (53%), Gaps = 10/121 (8%)
Query: 198 LGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG+G+F  V    E  T  G  FAVK   +  +  +G++S   +E EI++L + +H+NIV
Sbjct: 30  LGTGAFSEVVLAEEKAT--GKLFAVK--CIPKKALKGKES--SIENEIAVLRKIKHENIV 83
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
                 +  N LY+ ++LV+ G L  +I ++    +   S    Q+L+ + YLH   ++H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 314 R 314
           R
Sbjct: 144 R 144

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D  G   AVK +    +   G Q     +QEI +L    H++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL----KADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 253 IVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           I++Y G  +D  E  L + +E V  GSL      + +  +Q+  +  QI  G+ YLH Q+
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 137
Query: 311 VIHR 314
            IHR
Sbjct: 138 YIHR 141

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+ G+VY       G   A+++++LQ Q  +       +  EI ++ + ++ NIV Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRENKNPNIVNY 82
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             +    ++L++ +E +  GSL  +  E  + + Q++A   + L  L++LH   VIHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+ G+VY       G   A+++++LQ Q  +       +  EI ++ + ++ NIV Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRENKNPNIVNY 82
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             +    ++L++ +E +  GSL  +  E  + + Q++A   + L  L++LH   VIHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+ G+VY       G   A+++++LQ Q  +       +  EI ++ + ++ NIV Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRENKNPNIVNY 82
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             +    ++L++ +E +  GSL  +  E  + + Q++A   + L  L++LH   VIHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+ G+VY       G   A+++++LQ Q  +       +  EI ++ + ++ NIV Y
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRENKNPNIVNY 83
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             +    ++L++ +E +  GSL  +  E  + + Q++A   + L  L++LH   VIHR
Sbjct: 84  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+ G+VY       G   A+++++LQ Q  +       +  EI ++ + ++ NIV Y
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRENKNPNIVNY 83
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             +    ++L++ +E +  GSL  +  E  + + Q++A   + L  L++LH   VIHR
Sbjct: 84  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 95
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 156 LEENHFIHR 164

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 65/123 (52%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   + + +    A+K++S  +  T  ++++    +EI +L +F H+NI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 106
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +Y+   L+    L K+ +  HL +  +  + +QIL GLKY+H  NV
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 312 IHR 314
           +HR
Sbjct: 166 LHR 168

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 132 KRYIHR 137

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 137 KRYIHR 142

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 96
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 157 LEENHFIHR 165

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 133 KRYIHR 138

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK++ L+ Q     Q    L  E+ ++  + HDN+V  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYHHDNVVDM 107
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +    ++L++ +E +  G+L  I     + + Q++     +L  L YLH Q VIHR
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 165

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 112
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 173 LEENHFIHR 181

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 87
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 148 LEENHFIHR 156

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 136 KRYIHR 141

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 139 KRYIHR 144

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 131 KRYIHR 136

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 138 KRYIHR 143

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 96
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 157 LEENHFIHR 165

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 102
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 163 LEENHFIHR 171

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 140 KRYIHR 145

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 113
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 174 LEENHFIHR 182

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 9/120 (7%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ ++    AVK +        G  SV    +E +L+   +HD +V+ +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK------PGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E + +GSL    +      +   ++  ++ QI  G+ Y+  +N IHR
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 133 KRYIHR 138

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 136
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 197 LEENHFIHR 205

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKY 305
           IV+Y G         L + +E +  GSL    Q++     H+K  Q   YT QI  G++Y
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ---YTSQICKGMEY 147
Query: 306 LHEQNVIHR 314
           L  +  IHR
Sbjct: 148 LGTKRYIHR 156

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 122
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 183 LEENHFIHR 191

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKY 305
           IV+Y G         L + +E +  GSL    Q++     H+K  Q   YT QI  G++Y
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ---YTSQICKGMEY 147
Query: 306 LHEQNVIHR 314
           L  +  IHR
Sbjct: 148 LGTKRYIHR 156

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           +I  ++ G  LG GSF  VY   +   G   A+K +  +     G   V +++ E+ +  
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--MVQRVQNEVKIHC 66
Query: 247 QFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLK---DSQVSAYTWQILNGL 303
           Q +H +I++ +   +D N +Y+ LE+   G + + Y +  +K   +++   +  QI+ G+
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNR-YLKNRVKPFSENEARHFMHQIITGM 125
Query: 304 KYLHEQNVIHR 314
            YLH   ++HR
Sbjct: 126 LYLHSHGILHR 136

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKY 305
           IV+Y G         L + +E +  GSL    Q++     H+K  Q   YT QI  G++Y
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ---YTSQICKGMEY 160
Query: 306 LHEQNVIHR 314
           L  +  IHR
Sbjct: 161 LGTKRYIHR 169

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 133 KRYIHR 138

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 165 DDAEISLLMELVYNFSLNEKYRRRIMSWQKGAP-LGSGSFGSVYEGFTDD--GFFFAVKE 221
           +D E  LL E +    ++ +YR  +  W    P LG GSFG V+    D   GF  AVK+
Sbjct: 49  EDNEGVLLTEKLK--PVDYEYREEV-HWMTHQPRLGRGSFGEVHR-MKDKQTGFQCAVKK 104
Query: 222 VSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK- 280
           V L+         V ++E+ ++  G      IV  +G  ++   + IF+EL+  GSL + 
Sbjct: 105 VRLE---------VFRVEELVACAG-LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 154
Query: 281 IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           I Q   L + +   Y  Q L GL+YLH + ++H
Sbjct: 155 IKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQILNGLKYLHE 308
           IV+Y G         L + +E +  GSL    Q++  +   +    YT QI  G++YL  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 309 QNVIHR 314
           +  IHR
Sbjct: 134 KRYIHR 139

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 95
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I +EL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 156 LEENHFIHR 164

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VYSEQDELDFLMEALIISKFNHQNI 110
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 171 LEENHFIHR 179

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 198 LGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V +    D      +AVK ++      +   ++L+   E+ LL + +H NI+
Sbjct: 30  LGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIM 84
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + F   +D +  YI  EL T G L  +I +     +   +    Q+ +G+ Y+H+ N++H
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 314 R 314
           R
Sbjct: 145 R 145

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 17/128 (13%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD-NIVQ 255
           +G+G++G VY+G     G   A+K + +   G + E+    ++QEI++L ++ H  NI  
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEE----IKQEINMLKKYSHHRNIAT 85
Query: 256 YFGTEKDEN------KLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYL 306
           Y+G    +N      +L++ +E    GS+  + +      LK+  ++    +IL GL +L
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 307 HEQNVIHR 314
           H+  VIHR
Sbjct: 146 HQHKVIHR 153

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 63/129 (48%), Gaps = 20/129 (15%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK++         E+ +   E+EI +L   +HDN
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 253 IVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKY 305
           IV+Y G         L + +E +  GSL    Q +     H+K  Q   YT QI  G++Y
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQ---YTSQICKGMEY 132
Query: 306 LHEQNVIHR 314
           L  +  IHR
Sbjct: 133 LGTKRYIHR 141

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 198 LGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V +    D      +AVK ++      +   ++L+   E+ LL + +H NI+
Sbjct: 30  LGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIM 84
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + F   +D +  YI  EL T G L  +I +     +   +    Q+ +G+ Y+H+ N++H
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 314 R 314
           R
Sbjct: 145 R 145

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 55/129 (42%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +F H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKFNHQNI 110
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I +EL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 171 LEENHFIHR 179

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 198 LGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V +    D      +AVK ++      +   ++L+   E+ LL + +H NI+
Sbjct: 30  LGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIM 84
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + F   +D +  YI  EL T G L  +I +     +   +    Q+ +G+ Y+H+ N++H
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 314 R 314
           R
Sbjct: 145 R 145

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 59/124 (47%), Gaps = 11/124 (8%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D  G   AVK +    +   G Q     +QEI +L    H++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL----KADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 253 IVQYFGTEKDEN--KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           I++Y G  +D     L + +E V  GSL      + +  +Q+  +  QI  G+ YLH Q+
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 311 VIHR 314
            IHR
Sbjct: 155 YIHR 158

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 189 IMSWQKGAPLGSGSFGSVYEGFTDDGF-FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +  ++K   +G G++G+V++    +     A+K V L D       S L+   EI LL +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKE 57
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKY 305
            +H NIV+       + KL +  E   Q  L K +   +  L    V ++ +Q+L GL +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 306 LHEQNVIHR 314
            H +NV+HR
Sbjct: 117 CHSRNVLHR 125

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 165 DDAEISLLMELVYNFSLNEKYRRRIMSWQKGAP-LGSGSFGSVYEGFTDD--GFFFAVKE 221
           +D E  LL E +    ++ +YR  +  W    P +G GSFG V+    D   GF  AVK+
Sbjct: 35  EDNEGVLLTEKLK--PVDYEYREEV-HWMTHQPRVGRGSFGEVHR-MKDKQTGFQCAVKK 90
Query: 222 VSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK- 280
           V L+         V ++E+ ++  G      IV  +G  ++   + IF+EL+  GSL + 
Sbjct: 91  VRLE---------VFRVEELVACAG-LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140
Query: 281 IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           I Q   L + +   Y  Q L GL+YLH + ++H
Sbjct: 141 IKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 66/121 (54%), Gaps = 7/121 (5%)
Query: 198 LGSGSFG-SVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG ++    T+DG  + +KE+++    ++  +   +  +E+++L   +H NIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHPNIVQY 88
Query: 257 FGTEKDENKLYIFLELVTQGSLAK---IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
             + ++   LYI ++    G L K     +    ++ Q+  +  QI   LK++H++ ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 314 R 314
           R
Sbjct: 149 R 149

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 189 IMSWQKGAPLGSGSFGSVYEGFTDDGF-FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +  ++K   +G G++G+V++    +     A+K V L D       S L+   EI LL +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKE 57
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKY 305
            +H NIV+       + KL +  E   Q  L K +   +  L    V ++ +Q+L GL +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 306 LHEQNVIHR 314
            H +NV+HR
Sbjct: 117 CHSRNVLHR 125

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 165 DDAEISLLMELVYNFSLNEKYRRRIMSWQKGAP-LGSGSFGSVYEGFTDD--GFFFAVKE 221
           +D E  LL E +    ++ +YR  +  W    P +G GSFG V+    D   GF  AVK+
Sbjct: 51  EDNEGVLLTEKLK--PVDYEYREEV-HWMTHQPRVGRGSFGEVHR-MKDKQTGFQCAVKK 106
Query: 222 VSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK- 280
           V L+         V ++E+ ++  G      IV  +G  ++   + IF+EL+  GSL + 
Sbjct: 107 VRLE---------VFRVEELVACAG-LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 156
Query: 281 IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           I Q   L + +   Y  Q L GL+YLH + ++H
Sbjct: 157 IKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 63/123 (51%), Gaps = 5/123 (4%)
Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVL--QLEQEISLLGQFEHD 251
           G  LGSG F  V +      G  +A K +  + Q     + V   ++E+E+S+L Q  H 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           NI+      ++   + + LELV+ G L   + Q+  L + + +++  QIL+G+ YLH + 
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 311 VIH 313
           + H
Sbjct: 136 IAH 138

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 61/130 (46%), Gaps = 18/130 (13%)
Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           G  +G G FG VY+G+ ++      K  ++ D  T  E+   Q +QEI ++ + +H+N+V
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLV 87
Query: 255 QYFGTEKDENKLYIFLELVTQGSL----------AKIYQEYHLKDSQVSAYTWQILNGLK 304
           +  G   D + L +    +  GSL            +      K +Q +A      NG+ 
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 141
Query: 305 YLHEQNVIHR 314
           +LHE + IHR
Sbjct: 142 FLHENHHIHR 151

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 61/130 (46%), Gaps = 18/130 (13%)
Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           G  +G G FG VY+G+ ++      K  ++ D  T  E+   Q +QEI ++ + +H+N+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLV 93
Query: 255 QYFGTEKDENKLYIFLELVTQGSL----------AKIYQEYHLKDSQVSAYTWQILNGLK 304
           +  G   D + L +    +  GSL            +      K +Q +A      NG+ 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 147
Query: 305 YLHEQNVIHR 314
           +LHE + IHR
Sbjct: 148 FLHENHHIHR 157

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 61/130 (46%), Gaps = 18/130 (13%)
Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           G  +G G FG VY+G+ ++      K  ++ D  T  E+   Q +QEI ++ + +H+N+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLV 93
Query: 255 QYFGTEKDENKLYIFLELVTQGSL----------AKIYQEYHLKDSQVSAYTWQILNGLK 304
           +  G   D + L +    +  GSL            +      K +Q +A      NG+ 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 147
Query: 305 YLHEQNVIHR 314
           +LHE + IHR
Sbjct: 148 FLHENHHIHR 157

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V+    +D   GF  AVK+V L+         V + E+ ++  G      IV
Sbjct: 101 LGRGSFGEVHR--MEDKQTGFQCAVKKVRLE---------VFRAEELMACAG-LTSPRIV 148
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIH 313
             +G  ++   + IF+EL+  GSL ++ +E   L + +   Y  Q L GL+YLH + ++H
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 208

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V+    +D   GF  AVK+V L+         V + E+ ++  G      IV
Sbjct: 82  LGRGSFGEVHR--MEDKQTGFQCAVKKVRLE---------VFRAEELMACAG-LTSPRIV 129
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIH 313
             +G  ++   + IF+EL+  GSL ++ +E   L + +   Y  Q L GL+YLH + ++H
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 189

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 63/134 (47%), Gaps = 10/134 (7%)
Query: 191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG---------EQSVLQLEQE 241
           S+ K   LGSG++G V      +G      +V  + Q  +G         E+   ++  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQIL 300
           ISLL   +H NI++ F   +D+   Y+  E    G L  +I   +   +   +    QIL
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 301 NGLKYLHEQNVIHR 314
           +G+ YLH+ N++HR
Sbjct: 157 SGICYLHKHNIVHR 170

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 54/129 (41%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +  H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKLNHQNI 96
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 157 LEENHFIHR 165

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 80
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI +E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G FG VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 19  LGGGQFGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 73
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 64/122 (52%), Gaps = 3/122 (2%)
Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS-LQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LGSG F  V +      G  +A K +   Q + ++   S  ++E+E+S+L Q  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++      ++   + + LELV+ G L   + Q+  L + + +++  QIL+G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 312 IH 313
            H
Sbjct: 137 AH 138

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 54/129 (41%), Gaps = 14/129 (10%)
Query: 198 LGSGSFGSVYEG----FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FG VYEG      +D     V   +L +     EQ  L    E  ++ +  H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKLNHQNI 110
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKY 305
           V+  G        +I LEL+  G L    +E   + SQ S+            I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 306 LHEQNVIHR 314
           L E + IHR
Sbjct: 171 LEENHFIHR 179

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 22  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 76
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI +E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 19  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 73
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI +E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 64/122 (52%), Gaps = 3/122 (2%)
Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS-LQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LGSG F  V +      G  +A K +   Q + ++   S  ++E+E+S+L Q  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++      ++   + + LELV+ G L   + Q+  L + + +++  QIL+G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 312 IH 313
            H
Sbjct: 137 AH 138

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 64/122 (52%), Gaps = 3/122 (2%)
Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS-LQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LGSG F  V +      G  +A K +   Q + ++   S  ++E+E+S+L Q  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++      ++   + + LELV+ G L   + Q+  L + + +++  QIL+G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 312 IH 313
            H
Sbjct: 137 AH 138

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 64/122 (52%), Gaps = 3/122 (2%)
Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS-LQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LGSG F  V +      G  +A K +   Q + ++   S  ++E+E+S+L Q  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++      ++   + + LELV+ G L   + Q+  L + + +++  QIL+G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 312 IH 313
            H
Sbjct: 137 AH 138

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 75
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI +E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 62/132 (46%), Gaps = 5/132 (3%)
Query: 185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEIS 243
           Y + +  ++    +G GS+G V +    D G   A+K+    D     ++  ++   EI 
Sbjct: 20  YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIK 76
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQV-SAYTWQILNG 302
           LL Q  H+N+V      K + + Y+  E V    L  +    +  D QV   Y +QI+NG
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 303 LKYLHEQNVIHR 314
           + + H  N+IHR
Sbjct: 137 IGFCHSHNIIHR 148

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 62/119 (52%), Gaps = 8/119 (6%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G FG V++   T  G   A K +      T+G +   +++ EIS++ Q +H N++Q 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 257 FGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           +   + +N + + +E V  G L    I + Y+L +     +  QI  G++++H+  ++H
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILH 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 75
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI +E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  +Y L  + +  Y +Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 130 KRFVHR 135

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  +Y L  + +  Y +Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 130 KRFVHR 135

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 5/120 (4%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G FG VY  F   G   AVK  +  D      Q++  + QE  L    +H NI+   
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ---NVIHR 314
           G    E  L + +E    G L ++     +    +  +  QI  G+ YLH++    +IHR
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 6/118 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GS G V        G   AVK + L+ Q     Q    L  E+ ++  ++H N+V+ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHFNVVEM 107
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + +     +L++ +E +  G+L  I  +  L + Q++     +L  L YLH Q VIHR
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 64/122 (52%), Gaps = 3/122 (2%)
Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS-LQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LGSG F  V +      G  +A K +   Q + ++   S  ++E+E+S+L Q  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++      ++   + + LELV+ G L   + Q+  L + + +++  QIL+G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 312 IH 313
            H
Sbjct: 137 AH 138

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFF-FAVKEVSLQD--QGTQGE 232
           VY  +L ++Y   IMS      LGSG+ G V   F        A+K +S +    G+  E
Sbjct: 3   VYPKALRDEY---IMS----KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 55
Query: 233 Q-SVLQLEQEISLLGQFEHDNIVQ---YFGTEKDENKLYIFLELVTQGSL-AKIYQEYHL 287
               L +E EI +L +  H  I++   +F    D    YI LEL+  G L  K+     L
Sbjct: 56  ADPALNVETEIEILKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGNKRL 111
Query: 288 KDSQVSAYTWQILNGLKYLHEQNVIHR 314
           K++    Y +Q+L  ++YLHE  +IHR
Sbjct: 112 KEATCKLYFYQMLLAVQYLHENGIIHR 138

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 67
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  +Y L  + +  Y +Q+   L YL  
Sbjct: 68  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 127 KRFVHR 132

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 72
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  +Y L  + +  Y +Q+   L YL  
Sbjct: 73  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 132 KRFVHR 137

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFF-FAVKEVSLQD--QGTQGE 232
           VY  +L ++Y   IMS      LGSG+ G V   F        A+K +S +    G+  E
Sbjct: 3   VYPKALRDEY---IMS----KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 55
Query: 233 Q-SVLQLEQEISLLGQFEHDNIVQ---YFGTEKDENKLYIFLELVTQGSL-AKIYQEYHL 287
               L +E EI +L +  H  I++   +F    D    YI LEL+  G L  K+     L
Sbjct: 56  ADPALNVETEIEILKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGNKRL 111
Query: 288 KDSQVSAYTWQILNGLKYLHEQNVIHR 314
           K++    Y +Q+L  ++YLHE  +IHR
Sbjct: 112 KEATCKLYFYQMLLAVQYLHENGIIHR 138

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D  G   AVK +    +G  G Q     ++EI +L    H++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---EGC-GPQLRSGWQREIEILRTLYHEH 72
Query: 253 IVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           IV+Y G  +D  E  + + +E V  GSL      + +  +Q+  +  QI  G+ YLH Q+
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQH 132
Query: 311 VIHR 314
            IHR
Sbjct: 133 YIHR 136

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFF-FAVKEVSLQD--QGTQGE 232
           VY  +L ++Y   IMS      LGSG+ G V   F        A+K +S +    G+  E
Sbjct: 3   VYPKALRDEY---IMS----KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 55
Query: 233 Q-SVLQLEQEISLLGQFEHDNIVQ---YFGTEKDENKLYIFLELVTQGSL-AKIYQEYHL 287
               L +E EI +L +  H  I++   +F    D    YI LEL+  G L  K+     L
Sbjct: 56  ADPALNVETEIEILKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGNKRL 111
Query: 288 KDSQVSAYTWQILNGLKYLHEQNVIHR 314
           K++    Y +Q+L  ++YLHE  +IHR
Sbjct: 112 KEATCKLYFYQMLLAVQYLHENGIIHR 138

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 75
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  +Y L  + +  Y +Q+   L YL  
Sbjct: 76  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 135 KRFVHR 140

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 80
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 80
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFF-FAVKEVSLQD--QGTQGE 232
           VY  +L ++Y   IMS      LGSG+ G V   F        A+K +S +    G+  E
Sbjct: 2   VYPKALRDEY---IMS----KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 54
Query: 233 Q-SVLQLEQEISLLGQFEHDNIVQ---YFGTEKDENKLYIFLELVTQGSL-AKIYQEYHL 287
               L +E EI +L +  H  I++   +F    D    YI LEL+  G L  K+     L
Sbjct: 55  ADPALNVETEIEILKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGNKRL 110
Query: 288 KDSQVSAYTWQILNGLKYLHEQNVIHR 314
           K++    Y +Q+L  ++YLHE  +IHR
Sbjct: 111 KEATCKLYFYQMLLAVQYLHENGIIHR 137

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D  G   AVK +    +G  G Q     ++EI +L    H++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---EGC-GPQLRSGWQREIEILRTLYHEH 71
Query: 253 IVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           IV+Y G  +D  E  + + +E V  GSL      + +  +Q+  +  QI  G+ YLH Q+
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQH 131
Query: 311 VIHR 314
            IHR
Sbjct: 132 YIHR 135

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 73
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  +Y L  + +  Y +Q+   L YL  
Sbjct: 74  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 133 KRFVHR 138

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 22  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 76
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 98
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  +Y L  + +  Y +Q+   L YL  
Sbjct: 99  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 158 KRFVHR 163

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 75
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 25  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 79
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 139

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFF-FAVKEVSLQD--QGTQGE 232
           VY  +L ++Y   IMS      LGSG+ G V   F        A+K +S +    G+  E
Sbjct: 9   VYPKALRDEY---IMS----KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 61
Query: 233 Q-SVLQLEQEISLLGQFEHDNIVQ---YFGTEKDENKLYIFLELVTQGSL-AKIYQEYHL 287
               L +E EI +L +  H  I++   +F    D    YI LEL+  G L  K+     L
Sbjct: 62  ADPALNVETEIEILKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGNKRL 117
Query: 288 KDSQVSAYTWQILNGLKYLHEQNVIHR 314
           K++    Y +Q+L  ++YLHE  +IHR
Sbjct: 118 KEATCKLYFYQMLLAVQYLHENGIIHR 144

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 23  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 77
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 61/124 (49%), Gaps = 3/124 (2%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           +Q+   LGSG++G V      D      + + +  + +    S  +L +E+++L   +H 
Sbjct: 39  YQRVKKLGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           NI++ +   +D+   Y+ +E    G L  +I       +   +    Q+L+G+ YLH+ N
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 311 VIHR 314
           ++HR
Sbjct: 157 IVHR 160

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 75
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 35  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 85
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 86  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 144
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 145 LYMYQLFRSLAYIHSFGICHR 165

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 17/135 (12%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEV--SLQDQGTQGEQS----VLQLEQEISLLGQFEHD 251
           + SGS+G+V  G   +G   A+K V  ++ D  T    S      ++ +EI LL  F H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 252 NI-----VQYFGTEKDENKLYIFLELVTQGSLAKIY--QEYHLKDSQVSAYTWQILNGLK 304
           NI     +     E   +KLY+  EL+ +  LA++   Q   +    +  + + IL GL 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 305 YLHEQNVIHR---PG 316
            LHE  V+HR   PG
Sbjct: 149 VLHEAGVVHRDLHPG 163

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 24  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 74
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 75  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 133
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 134 LYMYQLFRSLAYIHSFGICHR 154

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 28  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 78
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 137
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 138 LYMYQLFRSLAYIHSFGICHR 158

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 29  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 79
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 80  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 138
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 139 LYMYQLFRSLAYIHSFGICHR 159

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 66
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 126 LYMYQLFRSLAYIHSFGICHR 146

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 66
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 126 LYMYQLFRSLAYIHSFGICHR 146

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 19  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 73
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 23  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 77
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 66
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 126 LYMYQLFRSLAYIHSFGICHR 146

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 17  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 67
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 68  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 126
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 127 LYMYQLFRSLAYIHSFGICHR 147

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 19/136 (13%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEV--SLQDQGTQGEQS----VLQLEQEISLLGQFEHD 251
           + SGS+G+V  G   +G   A+K V  ++ D  T    S      ++ +EI LL  F H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 252 NIVQ------YFGTEKDENKLYIFLELVTQGSLAKIY--QEYHLKDSQVSAYTWQILNGL 303
           NI+       +F  E   +KLY+  EL+ +  LA++   Q   +    +  + + IL GL
Sbjct: 90  NILGLRDIFVHF-EEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 304 KYLHEQNVIHR---PG 316
             LHE  V+HR   PG
Sbjct: 148 HVLHEAGVVHRDLHPG 163

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 80
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 26  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 80
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 140

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 28  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 78
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 137
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 138 LYMYQLFRSLAYIHSFGICHR 158

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 23  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 77
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 75
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQI 100
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 160 LYMYQLFRSLAYIHSFGICHR 180

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQI 100
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 160 LYMYQLFRSLAYIHSFGICHR 180

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 20  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQI 70
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 71  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 129
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 130 LYMYQLFRSLAYIHSFGICHR 150

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 21  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQI 71
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 72  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 130
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 131 LYMYQLFRSLAYIHSFGICHR 151

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 21  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 75
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 52  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQI 102
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 103 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 161
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 162 LYMYQLFRSLAYIHSFGICHR 182

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 34  LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 88
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 148

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 44  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQI 94
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 95  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 153
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 154 LYMYQLFRSLAYIHSFGICHR 174

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/119 (26%), Positives = 59/119 (49%), Gaps = 8/119 (6%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LGSG+FG V+       G  F  K ++     T        ++ EIS++ Q  H  ++  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 257 FGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
               +D+ ++ + LE ++ G L      ++Y + +++V  Y  Q   GLK++HE +++H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 54  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQI 104
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 105 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 163
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 164 LYMYQLFRSLAYIHSFGICHR 184

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  ++ L  + +  Y +Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 130 KRFVHR 135

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK+  LQ  G   ++     ++EI +L     D 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQR---DFQREIQILKALHSDF 69
Query: 253 IVQYFGTEKDENK--LYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
           IV+Y G      +  L + +E +  G L    Q +   L  S++  Y+ QI  G++YL  
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 130 RRCVHR 135

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 157 DDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF----TD 212
           DD A I D++   ++     Y     E  R RI   + G  +G G FG V++G      +
Sbjct: 365 DDYAEIIDEEDTYTMPSTRDY-----EIQRERI---ELGRCIGEGQFGDVHQGIYMSPEN 416
Query: 213 DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL 272
                A+K        +  E+ +    QE   + QF+H +IV+  G    EN ++I +EL
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDHPHIVKLIGV-ITENPVWIIMEL 471
Query: 273 VTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            T G L    Q  ++ L  + +  Y +Q+   L YL  +  +HR
Sbjct: 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 95  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQI 145
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 146 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 204
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 205 LYMYQLFRSLAYIHSFGICHR 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 17/126 (13%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V+   F     FFA+K    +V L D   + T  E+ VL L         +E
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL--------AWE 76
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD-SQVSAYTWQILNGLKYLHE 308
           H  +   F T + +  L+  +E +  G L    Q  H  D S+ + Y  +I+ GL++LH 
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 309 QNVIHR 314
           + +++R
Sbjct: 137 KGIVYR 142

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 157 DDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF----TD 212
           DD A I D++   ++     Y     E  R RI   + G  +G G FG V++G      +
Sbjct: 365 DDYAEIIDEEDTYTMPSTRDY-----EIQRERI---ELGRCIGEGQFGDVHQGIYMSPEN 416
Query: 213 DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL 272
                A+K        +  E+ +    QE   + QF+H +IV+  G    EN ++I +EL
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDHPHIVKLIGV-ITENPVWIIMEL 471
Query: 273 VTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            T G L    Q  ++ L  + +  Y +Q+   L YL  +  +HR
Sbjct: 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 25/140 (17%)
Query: 200 SGSFGSVYEGFTDDGFFF-------AVKEVSLQDQGTQGEQSVL-------------QLE 239
           SG     ++G  DD F F       A  +V L ++ + G + V+             Q+E
Sbjct: 9   SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 240 QEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-----AKIYQEYHLKDSQVSA 294
            EI +L   +H NI++ F   +D + +YI +E    G L     +   +   L +  V+ 
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 295 YTWQILNGLKYLHEQNVIHR 314
              Q++N L Y H Q+V+H+
Sbjct: 129 LMKQMMNALAYFHSQHVVHK 148

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K        +  E+ +    QE   + QF+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q  ++ L  + +  Y +Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 130 KRFVHR 135

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 17/126 (13%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V+   F     FFA+K    +V L D   + T  E+ VL L         +E
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL--------AWE 77
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD-SQVSAYTWQILNGLKYLHE 308
           H  +   F T + +  L+  +E +  G L    Q  H  D S+ + Y  +I+ GL++LH 
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 309 QNVIHR 314
           + +++R
Sbjct: 138 KGIVYR 143

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 63/123 (51%), Gaps = 10/123 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G+GSFG+V+      G   AVK   L +Q    E+ V +  +E++++ +  H NIV + 
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVK--ILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFM 100
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNGLKYLHEQN--V 311
           G       L I  E +++GSL ++  +      L + +  +  + +  G+ YLH +N  +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 312 IHR 314
           +HR
Sbjct: 161 VHR 163

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 20/140 (14%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 66
Query: 245 LGQFEHDNIVQ--YFGTEKDENKLYIFLELV---TQGSLAKIYQEYH-----LKDSQVSA 294
           + + +H NIV+  YF     E K  ++L LV      ++ ++ + Y      L    V  
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 295 YTWQILNGLKYLHEQNVIHR 314
           Y +Q+   L Y+H   + HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 63/123 (51%), Gaps = 10/123 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G+GSFG+V+      G   AVK   L +Q    E+ V +  +E++++ +  H NIV + 
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVK--ILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFM 100
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNGLKYLHEQN--V 311
           G       L I  E +++GSL ++  +      L + +  +  + +  G+ YLH +N  +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 312 IHR 314
           +HR
Sbjct: 161 VHR 163

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 20/140 (14%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQ +  +         +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFK--------NRELQI 66
Query: 245 LGQFEHDNIVQ--YFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQ------VSA 294
           + + +H NIV+  YF     E K  ++L LV     A +Y+   ++ +  Q      V  
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL 126
Query: 295 YTWQILNGLKYLHEQNVIHR 314
           Y +Q+   L Y+H   + HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 66/126 (52%), Gaps = 22/126 (17%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSGSFG+VY+G +  D    AVK + + D   +  Q+      E+++L +  H NI+ +
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQA---FRNEVAVLRKTRHVNILLF 97
Query: 257 FGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKYLHE 308
            G    +N     L +VTQ   GS   +Y+  H+++++   +       Q   G+ YLH 
Sbjct: 98  MGYMTKDN-----LAIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA 150
Query: 309 QNVIHR 314
           +N+IHR
Sbjct: 151 KNIIHR 156

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/123 (26%), Positives = 64/123 (52%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G++G V   +        A+K++S  +  T  ++++    +EI +L +F H+N++  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTL----REIQILLRFRHENVIGI 106
Query: 257 -----FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  T +    +YI  +L+ +  L K+ +   L +  +  + +QIL GLKY+H  NV
Sbjct: 107 RDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANV 165
Query: 312 IHR 314
           +HR
Sbjct: 166 LHR 168

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 228 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 282
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 21/130 (16%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D+ G   AVK +  +  G      +  L++EI +L    H+N
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 84
Query: 253 IVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEYHLKD------SQVSAYTWQILNGLK 304
           IV+Y G  TE   N + + +E +  GSL    +EY  K+       Q   Y  QI  G+ 
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSL----KEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 305 YLHEQNVIHR 314
           YL  +  +HR
Sbjct: 141 YLGSRQYVHR 150

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VYEG     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 267 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 321
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +T G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 381

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G  +     A+K +     GT   +S L+   E  ++ + +HD +VQ +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK---PGTMSPESFLE---EAQIMKKLKHDKLVQLY 70
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
               +E  +YI  E + +GSL    ++     LK   +     Q+  G+ Y+   N IHR
Sbjct: 71  AVVSEE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 12/130 (9%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +Q+  P+GSG+ G V   F T  G   AVK++S   +  Q +    +  +E+ LL    H
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLKCVNH 82
Query: 251 DNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLK 304
            NI+        +  L      Y+ +EL+       I+ E  L   ++S   +Q+L G+K
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQMLCGIK 140
Query: 305 YLHEQNVIHR 314
           +LH   +IHR
Sbjct: 141 HLHSAGIIHR 150

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 8/123 (6%)
Query: 195 GAPLGSGSFG-SVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  LG G FG ++     + G    +KE+   D+ TQ  ++ L+   E+ ++   EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ--RTFLK---EVKVMRCLEHPNV 69
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           +++ G    + +L    E +  G+L  I +  +     SQ  ++   I +G+ YLH  N+
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 312 IHR 314
           IHR
Sbjct: 130 IHR 132

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYE---GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G F   +E     T + F   +   SL  +  Q E+    +  EIS+     H ++V
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHVV 102
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIH 313
            + G  +D + +++ LEL  + SL ++++    L + +   Y  QI+ G +YLH   VIH
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 162
Query: 314 R 314
           R
Sbjct: 163 R 163

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 27/151 (17%)
Query: 176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQ-------DQG 228
           VY  +L ++Y   IMS      LGSG+ G V   F         K+V+++         G
Sbjct: 128 VYPKALRDEY---IMS----KTLGSGACGEVKLAFERK----TCKKVAIRIISKRKFAIG 176
Query: 229 TQGEQ-SVLQLEQEISLLGQFEHDNIVQ---YFGTEKDENKLYIFLELVTQGSL-AKIYQ 283
           +  E    L +E EI +L +  H  I++   +F    D    YI LEL+  G L  K+  
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG 232
Query: 284 EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
              LK++    Y +Q+L  ++YLHE  +IHR
Sbjct: 233 NKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQ +  +         +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKN--------RELQI 66
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 126 LYMYQLFRSLAYIHSFGICHR 146

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF---TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS 243
           R +  + +G  LG G F   YE     T + F   V   S+  +  Q E+    +  EI+
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 78
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNG 302
           +    ++ ++V + G  +D++ +Y+ LE+  + SL ++++    + + +   +  Q + G
Sbjct: 79  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 138
Query: 303 LKYLHEQNVIHR 314
           ++YLH   VIHR
Sbjct: 139 VQYLHNNRVIHR 150

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 27/151 (17%)
Query: 176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQ-------DQG 228
           VY  +L ++Y   IMS      LGSG+ G V   F         K+V+++         G
Sbjct: 142 VYPKALRDEY---IMS----KTLGSGACGEVKLAFERK----TCKKVAIRIISKRKFAIG 190
Query: 229 TQGEQ-SVLQLEQEISLLGQFEHDNIVQ---YFGTEKDENKLYIFLELVTQGSL-AKIYQ 283
           +  E    L +E EI +L +  H  I++   +F    D    YI LEL+  G L  K+  
Sbjct: 191 SAREADPALNVETEIEILKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG 246
Query: 284 EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
              LK++    Y +Q+L  ++YLHE  +IHR
Sbjct: 247 NKRLKEATCKLYFYQMLLAVQYLHENGIIHR 277

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK+  LQ  G   ++     ++EI +L     D 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQR---DFQREIQILKALHSDF 73
Query: 253 IVQYFGTEKDENK--LYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
           IV+Y G      +  L + +E +  G L    Q +   L  S++  Y+ QI  G++YL  
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 134 RRCVHR 139

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 65/122 (53%), Gaps = 10/122 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G   +VY    +D       A+K + +  +  + E+++ + E+E+    Q  H NIV
Sbjct: 19  LGGGGMSTVY--LAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIV 74
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA--YTWQILNGLKYLHEQNVI 312
                +++++  Y+ +E +   +L++ Y E H   S  +A  +T QIL+G+K+ H+  ++
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 313 HR 314
           HR
Sbjct: 134 HR 135

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 21/130 (16%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G FG V    Y+   D+ G   AVK +  +  G      +  L++EI +L    H+N
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 72
Query: 253 IVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEYHLKD------SQVSAYTWQILNGLK 304
           IV+Y G  TE   N + + +E +  GSL    +EY  K+       Q   Y  QI  G+ 
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSL----KEYLPKNKNKINLKQQLKYAVQICKGMD 128
Query: 305 YLHEQNVIHR 314
           YL  +  +HR
Sbjct: 129 YLGSRQYVHR 138

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF---TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS 243
           R +  + +G  LG G F   YE     T + F   V   S+  +  Q E+    +  EI+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNG 302
           +    ++ ++V + G  +D++ +Y+ LE+  + SL ++++    + + +   +  Q + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 303 LKYLHEQNVIHR 314
           ++YLH   VIHR
Sbjct: 155 VQYLHNNRVIHR 166

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYE---GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G F   +E     T + F   +   SL  +  Q E+    +  EIS+     H ++V
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHVV 84
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIH 313
            + G  +D + +++ LEL  + SL ++++    L + +   Y  QI+ G +YLH   VIH
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 144
Query: 314 R 314
           R
Sbjct: 145 R 145

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 22/141 (15%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQ +  +         +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKN--------RELQI 66
Query: 245 LGQFEHDNIVQ--YF----GTEKDENKLYIFLELVTQGSLAKIYQEYH-----LKDSQVS 293
           + + +H NIV+  YF    G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 126 LYMYQLFRSLAYIHSFGICHR 146

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK+  LQ  G   ++     ++EI +L     D 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQR---DFQREIQILKALHSDF 85
Query: 253 IVQYFGTEKDENK--LYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
           IV+Y G      +  L + +E +  G L    Q +   L  S++  Y+ QI  G++YL  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 146 RRCVHR 151

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF---TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS 243
           R +  + +G  LG G F   YE     T + F   V   S+  +  Q E+    +  EI+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNG 302
           +    ++ ++V + G  +D++ +Y+ LE+  + SL ++++    + + +   +  Q + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 303 LKYLHEQNVIHR 314
           ++YLH   VIHR
Sbjct: 155 VQYLHNNRVIHR 166

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF---TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS 243
           R +  + +G  LG G F   YE     T + F   V   S+  +  Q E+    +  EI+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNG 302
           +    ++ ++V + G  +D++ +Y+ LE+  + SL ++++    + + +   +  Q + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 303 LKYLHEQNVIHR 314
           ++YLH   VIHR
Sbjct: 155 VQYLHNNRVIHR 166

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYE---GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G F   +E     T + F   +   SL  +  Q E+    +  EIS+     H ++V
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHVV 80
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIH 313
            + G  +D + +++ LEL  + SL ++++    L + +   Y  QI+ G +YLH   VIH
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 314 R 314
           R
Sbjct: 141 R 141

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 198 LGSGSFGSV----YEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           LG G+FGSV    Y+   D+ G   AVK+  LQ  G   ++     ++EI +L     D 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQR---DFQREIQILKALHSDF 72
Query: 253 IVQYFGTEKDENK--LYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
           IV+Y G      +  L + +E +  G L    Q +   L  S++  Y+ QI  G++YL  
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 309 QNVIHR 314
           +  +HR
Sbjct: 133 RRCVHR 138

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 17/127 (13%)
Query: 198 LGSGSFGSVYEGF--TDDGFFFAVKEVSLQDQGTQG---EQSVLQLEQEISLLGQFEHDN 252
           +G+G FG VY+G   T  G     KEV +  +  +    E+  +    E  ++GQF H N
Sbjct: 52  IGAGEFGEVYKGMLKTSSG----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW-----QILNGLKYLH 307
           I++  G       + I  E +  G+L K  +E   KD + S          I  G+KYL 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 308 EQNVIHR 314
             N +HR
Sbjct: 165 NMNYVHR 171

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 67/127 (52%), Gaps = 14/127 (11%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG+   V   +        A+K ++L+    + + S+ +L +EI  + Q  H NIV Y
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINLE----KCQTSMDELLKEIQAMSQCHHPNIVSY 73
Query: 257 FGTEKDENKLYIFLELVTQGSLAKI---------YQEYHLKDSQVSAYTWQILNGLKYLH 307
           + +   +++L++ ++L++ GS+  I         ++   L +S ++    ++L GL+YLH
Sbjct: 74  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 133
Query: 308 EQNVIHR 314
           +   IHR
Sbjct: 134 KNGQIHR 140

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYE---GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G F   +E     T + F   +   SL  +  Q E+    +  EIS+     H ++V
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHVV 104
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIH 313
            + G  +D + +++ LEL  + SL ++++    L + +   Y  QI+ G +YLH   VIH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 164
Query: 314 R 314
           R
Sbjct: 165 R 165

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 75  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 76
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 77  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 83
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 84  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 67/127 (52%), Gaps = 14/127 (11%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG+   V   +        A+K ++L+    + + S+ +L +EI  + Q  H NIV Y
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLE----KCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 257 FGTEKDENKLYIFLELVTQGSLAKI---------YQEYHLKDSQVSAYTWQILNGLKYLH 307
           + +   +++L++ ++L++ GS+  I         ++   L +S ++    ++L GL+YLH
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 308 EQNVIHR 314
           +   IHR
Sbjct: 139 KNGQIHR 145

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 12/130 (9%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +Q+  P+GSG+ G V   F T  G   AVK++S   +  Q +    +  +E+ LL    H
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLKCVNH 80
Query: 251 DNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLK 304
            NI+        +  L      Y+ +EL+       I+ E  L   ++S   +Q+L G+K
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQMLCGIK 138
Query: 305 YLHEQNVIHR 314
           +LH   +IHR
Sbjct: 139 HLHSAGIIHR 148

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 75
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 76  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 79
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 80  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 81  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 70
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 71  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINAML 62
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 308 EQNVIHR 314
              + HR
Sbjct: 123 GIGITHR 129

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 55/123 (44%), Gaps = 6/123 (4%)
Query: 198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+F  V      + G  FAVK V +    +    S   L++E S+    +H +IV+ 
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 257 FGTEKDENKLYIFLELVTQGSLA-----KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
             T   +  LY+  E +    L      +    +   ++  S Y  QIL  L+Y H+ N+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 312 IHR 314
           IHR
Sbjct: 152 IHR 154

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 75  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYE---GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G F   +E     T + F   +   SL  +  Q E+    +  EIS+     H ++V
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHVV 80
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIH 313
            + G  +D + +++ LEL  + SL ++++    L + +   Y  QI+ G +YLH   VIH
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 314 R 314
           R
Sbjct: 141 R 141

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 81  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYE---GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G F   +E     T + F   +   SL  +  Q E+    +  EIS+     H ++V
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHVV 78
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIH 313
            + G  +D + +++ LEL  + SL ++++    L + +   Y  QI+ G +YLH   VIH
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 314 R 314
           R
Sbjct: 139 R 139

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 69
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 70  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 75  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           ++ G  LGSG F  V +      G      F   + +S   +G   E+    +E+E+++L
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE----IEREVNIL 62
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            +  H NI+      +++  + + LELV+ G L     E   L + + + +  QIL+G+ 
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 305 YLHEQNVIH 313
           YLH + + H
Sbjct: 123 YLHSKRIAH 131

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 82
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 83  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/83 (27%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 233 QSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQ 291
           + V + +QEI ++   +H NI++ + T +D   +Y+ +EL T G L  ++  +   ++S 
Sbjct: 48  EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD 107
Query: 292 VSAYTWQILNGLKYLHEQNVIHR 314
            +     +L+ + Y H+ NV HR
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHR 130

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 18/130 (13%)
Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           G   G G FG VY+G+ ++      K  ++ D  T  E+   Q +QEI +  + +H+N+V
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVXAKCQHENLV 84
Query: 255 QYFGTEKDENKLYIFLELVTQGSL----------AKIYQEYHLKDSQVSAYTWQILNGLK 304
           +  G   D + L +       GSL            +      K +Q +A      NG+ 
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAA------NGIN 138
Query: 305 YLHEQNVIHR 314
           +LHE + IHR
Sbjct: 139 FLHENHHIHR 148

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 59/121 (48%), Gaps = 11/121 (9%)
Query: 198 LGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LGSG+F  V+   +  T  G  FA+K +               LE EI++L + +H+NIV
Sbjct: 17  LGSGAFSEVFLVKQRLT--GKLFALKCIKKSPAFRDS-----SLENEIAVLKKIKHENIV 69
Query: 255 QYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
                 +     Y+ ++LV+ G L  +I +     +   S    Q+L+ +KYLHE  ++H
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129
Query: 314 R 314
           R
Sbjct: 130 R 130

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 84
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 85  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 23/83 (27%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 233 QSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQ 291
           + V + +QEI ++   +H NI++ + T +D   +Y+ +EL T G L  ++  +   ++S 
Sbjct: 65  EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD 124
Query: 292 VSAYTWQILNGLKYLHEQNVIHR 314
            +     +L+ + Y H+ NV HR
Sbjct: 125 AARIMKDVLSAVAYCHKLNVAHR 147

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 192 WQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++K   +G GS+G V++    D G   A+K+    +     ++  L+   EI +L Q +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLKH 61
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHE 308
            N+V      + + +L++  E      L ++  YQ   + +  V + TWQ L  + + H+
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHK 120
Query: 309 QNVIHR 314
            N IHR
Sbjct: 121 HNCIHR 126

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 60
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 308 EQNVIHR 314
              + HR
Sbjct: 121 GIGITHR 127

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 54/123 (43%), Gaps = 6/123 (4%)
Query: 198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G F  V      + G  FAVK V +    +    S   L++E S+    +H +IV+ 
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 257 FGTEKDENKLYIFLELVTQGSLA-----KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
             T   +  LY+  E +    L      +    +   ++  S Y  QIL  L+Y H+ N+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 312 IHR 314
           IHR
Sbjct: 152 IHR 154

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 143
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 144 GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHR 227

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 62
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 308 EQNVIHR 314
              + HR
Sbjct: 123 GIGITHR 129

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           ++ G  LGSG F  V +      G      F   + +S   +G   E+    +E+E+++L
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE----IEREVNIL 69
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            +  H NI+      +++  + + LELV+ G L     E   L + + + +  QIL+G+ 
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 129
Query: 305 YLHEQNVIH 313
           YLH + + H
Sbjct: 130 YLHSKRIAH 138

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 62
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 308 EQNVIHR 314
              + HR
Sbjct: 123 GIGITHR 129

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 54/123 (43%), Gaps = 6/123 (4%)
Query: 198 LGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G F  V      + G  FAVK V +    +    S   L++E S+    +H +IV+ 
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 257 FGTEKDENKLYIFLELVTQGSLA-----KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
             T   +  LY+  E +    L      +    +   ++  S Y  QIL  L+Y H+ N+
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 153
Query: 312 IHR 314
           IHR
Sbjct: 154 IHR 156

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 15/131 (11%)
Query: 196 APLGSGSFGSVYEG--FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ---FEH 250
           A +G G++G V++     + G F A+K V +Q   T  E   L   +E+++L     FEH
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ---TGEEGMPLSTIREVAVLRHLETFEH 73
Query: 251 DNIVQYFGT-----EKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGL 303
            N+V+ F          E KL +  E V Q     +    E  +    +    +Q+L GL
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 304 KYLHEQNVIHR 314
            +LH   V+HR
Sbjct: 134 DFLHSHRVVHR 144

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 62
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 308 EQNVIHR 314
              + HR
Sbjct: 123 GIGITHR 129

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 15/131 (11%)
Query: 196 APLGSGSFGSVYEG--FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ---FEH 250
           A +G G++G V++     + G F A+K V +Q   T  E   L   +E+++L     FEH
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ---TGEEGMPLSTIREVAVLRHLETFEH 73
Query: 251 DNIVQYFGT-----EKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGL 303
            N+V+ F          E KL +  E V Q     +    E  +    +    +Q+L GL
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 304 KYLHEQNVIHR 314
            +LH   V+HR
Sbjct: 134 DFLHSHRVVHR 144

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 62
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 308 EQNVIHR 314
              + HR
Sbjct: 123 GIGITHR 129

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 62
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 308 EQNVIHR 314
              + HR
Sbjct: 123 GIGITHR 129

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 12/122 (9%)
Query: 198 LGSGSFGSVYEGFTDDGF---FFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG+G+F  V     +D       A+K ++ +  +G +G      +E EI++L + +H NI
Sbjct: 26  LGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEG-----SMENEIAVLHKIKHPNI 78
Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V      +    LY+ ++LV+ G L  +I ++    +   S   +Q+L+ +KYLH+  ++
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 313 HR 314
           HR
Sbjct: 139 HR 140

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 98  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 98  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEIXINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 98  GK--HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 12/122 (9%)
Query: 198 LGSGSFGSVYEGFTDDGF---FFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG+G+F  V     +D       A+K ++ +  +G +G      +E EI++L + +H NI
Sbjct: 26  LGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEG-----SMENEIAVLHKIKHPNI 78
Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V      +    LY+ ++LV+ G L  +I ++    +   S   +Q+L+ +KYLH+  ++
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 313 HR 314
           HR
Sbjct: 139 HR 140

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 98  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 12/122 (9%)
Query: 198 LGSGSFGSVYEGFTDDGF---FFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG+G+F  V     +D       A+K ++ +  +G +G      +E EI++L + +H NI
Sbjct: 26  LGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEG-----SMENEIAVLHKIKHPNI 78
Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V      +    LY+ ++LV+ G L  +I ++    +   S   +Q+L+ +KYLH+  ++
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 313 HR 314
           HR
Sbjct: 139 HR 140

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 15/131 (11%)
Query: 196 APLGSGSFGSVYEG--FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ---FEH 250
           A +G G++G V++     + G F A+K V +Q   T  E   L   +E+++L     FEH
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ---TGEEGMPLSTIREVAVLRHLETFEH 73
Query: 251 DNIVQYFGT-----EKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGL 303
            N+V+ F          E KL +  E V Q     +    E  +    +    +Q+L GL
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 304 KYLHEQNVIHR 314
            +LH   V+HR
Sbjct: 134 DFLHSHRVVHR 144

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 4/131 (3%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R +I  +  G  LG G+FG V  G  +  G   AVK   L  Q  +    V ++ +EI  
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK--ILNRQKIRSLDVVGKIRREIQN 69
Query: 245 LGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGL 303
           L  F H +I++ +      + +++ +E V+ G L   I +   L + +      QIL+G+
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 304 KYLHEQNVIHR 314
            Y H   V+HR
Sbjct: 130 DYCHRHMVVHR 140

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEIXINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 98  GK--HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 12/122 (9%)
Query: 198 LGSGSFGSVYEGFTDDGF---FFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG+G+F  V     +D       A+K ++ +  +G +G      +E EI++L + +H NI
Sbjct: 26  LGTGAFSEVI--LAEDKRTQKLVAIKCIAKKALEGKEG-----SMENEIAVLHKIKHPNI 78
Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V      +    LY+ ++LV+ G L  +I ++    +   S   +Q+L+ +KYLH+  ++
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 313 HR 314
           HR
Sbjct: 139 HR 140

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 61/125 (48%), Gaps = 4/125 (3%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQS-VLQLEQEISLLGQFEH 250
           +Q+   LGSG++G V      D    A + + +  + +    S    L  E+++L Q +H
Sbjct: 23  YQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
            NI++ +   +D+   Y+ +E+   G L  +I       +   +    Q+L+G  YLH+ 
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 310 NVIHR 314
           N++HR
Sbjct: 141 NIVHR 145

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 89
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 90  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 147
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 148 FKDLVSCTYQLARGMEYLASQKCIHR 173

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEIXINKML 62
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 308 EQNVIHR 314
              + HR
Sbjct: 123 GIGITHR 129

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI------------YQEYHLKDSQVS 293
           G+  H NI+   G    +  LY+ +E  ++G+L +             Y    + + Q++
Sbjct: 98  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 60/129 (46%), Gaps = 26/129 (20%)
Query: 198 LGSGSFGSVYEG---FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G++ +VY+G    TD+    A+KE+ L+ +    E +     +E+SLL   +H NIV
Sbjct: 10  LGEGTYATVYKGKSKLTDN--LVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIV 63
Query: 255 QYFGTEKDENKLYIFLELVTQ---------GSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                   E  L +  E + +         G++  ++         V  + +Q+L GL Y
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN--------VKLFLFQLLRGLAY 115
Query: 306 LHEQNVIHR 314
            H Q V+HR
Sbjct: 116 CHRQKVLHR 124

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEEDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 98  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 86
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 87  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 144
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 145 FKDLVSCTYQLARGMEYLASQKCIHR 170

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 84
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +E  ++G+L +  +       EY    ++V      
Sbjct: 85  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 142
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 143 FKDLVSCTYQLARGMEYLASQKCIHR 168

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G++G V       T++    AVK V ++      E     +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 62
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 308 EQNVIHR 314
              + HR
Sbjct: 123 GIGITHR 129

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 60/121 (49%), Gaps = 10/121 (8%)
Query: 198 LGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G++G V       T++    AVK V ++      E     +++EI +     H+N+V
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKMLNHENVV 67
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           +++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH   + H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 314 R 314
           R
Sbjct: 128 R 128

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 67
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 128 YLHSLQIAH 136

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 67
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 128 YLHSLQIAH 136

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 61/130 (46%), Gaps = 14/130 (10%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFA------VKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +Q+   LGSG++G V      D    A      +K+ S+      G      L  E+++L
Sbjct: 6   YQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSG-----ALLDEVAVL 58
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLK 304
            Q +H NI++ +   +D+   Y+ +E+   G L  +I       +   +    Q+L+G  
Sbjct: 59  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 305 YLHEQNVIHR 314
           YLH+ N++HR
Sbjct: 119 YLHKHNIVHR 128

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 15/127 (11%)
Query: 197 PLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           P+GSG++GSV   +  D       AVK++S   Q     +   +   E+ LL   +H+N+
Sbjct: 35  PVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYR---ELRLLKHLKHENV 89
Query: 254 VQYF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
           +          + +D +++Y+   L+    L  I +   L D  V    +Q+L GLKY+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 308 EQNVIHR 314
              +IHR
Sbjct: 149 SAGIIHR 155

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 15/127 (11%)
Query: 197 PLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           P+GSG++GSV   +  D       AVK++S   Q     +   +   E+ LL   +H+N+
Sbjct: 27  PVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYR---ELRLLKHLKHENV 81
Query: 254 VQYF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
           +          + +D +++Y+   L+    L  I +   L D  V    +Q+L GLKY+H
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 308 EQNVIHR 314
              +IHR
Sbjct: 141 SAGIIHR 147

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 53/119 (44%), Gaps = 8/119 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG FG V  G     +  AVK +       +G  S  +  QE   + +  H  +V+++
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK------EGSMSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G    E  +YI  E ++ G L    + +   L+ SQ+    + +  G+ +L     IHR
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 57/125 (45%), Gaps = 12/125 (9%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G FG VY+G   DG   AVK   L+++ TQG +  LQ + E+ ++    H N+++  
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKR--LKEERTQGGE--LQFQTEVEMISMAVHRNLLRLR 93
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQIL-----NGLKYLHEQ--- 309
           G      +  +    +  GS+A   +E       +     Q +      GL YLH+    
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153
Query: 310 NVIHR 314
            +IHR
Sbjct: 154 KIIHR 158

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 56/121 (46%), Gaps = 4/121 (3%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG GS+G V E    +       ++  + +  +       +++EI LL +  H N++Q  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 258 GT--EKDENKLYIFLELVTQG--SLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
                +++ K+Y+ +E    G   +     E      Q   Y  Q+++GL+YLH Q ++H
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH 132
Query: 314 R 314
           +
Sbjct: 133 K 133

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 10/127 (7%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           W     LG G+ G V       T++    AVK V ++      E     +++EI +    
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAV--AVKIVDMKRAVDCPEN----IKKEICINKML 61
Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 308 EQNVIHR 314
              + HR
Sbjct: 122 GIGITHR 128

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 61/129 (47%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           ++ G  LGSG F  V +      G      F   + +    +G   E+    +E+E+++L
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREE----IEREVNIL 83
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            +  H NI+      +++  + + LELV+ G L     E   L + + + +  QIL+G+ 
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 143
Query: 305 YLHEQNVIH 313
           YLH + + H
Sbjct: 144 YLHSKRIAH 152

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 26/137 (18%)
Query: 196 APLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           A LG G+FG V +     D  ++A+K++         E+ +  +  E+ LL    H  +V
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 255 QYFGT-------------EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---- 297
           +Y+                K ++ L+I +E    G+L  +    +L + Q   Y W    
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-NQQRDEY-WRLFR 123
Query: 298 QILNGLKYLHEQNVIHR 314
           QIL  L Y+H Q +IHR
Sbjct: 124 QILEALSYIHSQGIIHR 140

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI 242
           ++R   ++ G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E 
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRER 60
Query: 243 SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILN 301
            ++ + +H   V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++
Sbjct: 61  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 120
Query: 302 GLKYLHEQNVIHR 314
            L+YLH + +IHR
Sbjct: 121 ALEYLHGKGIIHR 133

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI 242
           ++R   ++ G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRER 61
Query: 243 SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILN 301
            ++ + +H   V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++
Sbjct: 62  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 121
Query: 302 GLKYLHEQNVIHR 314
            L+YLH + +IHR
Sbjct: 122 ALEYLHGKGIIHR 134

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 15/127 (11%)
Query: 197 PLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           P+GSG++GSV   +  D       AVK++S   Q     +   +   E+ LL   +H+N+
Sbjct: 35  PVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYR---ELRLLKHLKHENV 89
Query: 254 VQYF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
           +          + +D +++Y+   L+    L  I +   L D  V    +Q+L GLKY+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 308 EQNVIHR 314
              +IHR
Sbjct: 149 SAGIIHR 155

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI 242
           ++R   ++ G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E 
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRER 58
Query: 243 SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILN 301
            ++ + +H   V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++
Sbjct: 59  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 118
Query: 302 GLKYLHEQNVIHR 314
            L+YLH + +IHR
Sbjct: 119 ALEYLHGKGIIHR 131

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI 242
           ++R   ++ G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRER 59
Query: 243 SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILN 301
            ++ + +H   V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 302 GLKYLHEQNVIHR 314
            L+YLH + +IHR
Sbjct: 120 ALEYLHGKGIIHR 132

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 60/119 (50%), Gaps = 4/119 (3%)
Query: 198 LGSGSFGSV-YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG V      D    +A+K ++ Q    + E  V  + +E+ ++   EH  +V  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE--VRNVFKELQIMQGLEHPFLVNL 80
Query: 257 FGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + + +DE  +++ ++L+  G L   + Q  H K+  V  +  +++  L YL  Q +IHR
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHR 139

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/125 (24%), Positives = 61/125 (48%), Gaps = 18/125 (14%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G++G VY+   T      A+K + L+  ++G  G        +E+SLL + +H NI+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI-----REVSLLKELQHRNII 96
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS-----AYTWQILNGLKYLHEQ 309
           +        ++L++  E           ++Y  K+  VS     ++ +Q++NG+ + H +
Sbjct: 97  ELKSVIHHNHRLHLIFEYAEND-----LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 310 NVIHR 314
             +HR
Sbjct: 152 RCLHR 156

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 16/126 (12%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G F +VY+    +     A+K++ L  +    +       +EI LL +  H NI+  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 257 ---FGTEKDENKLYIFLE-----LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
              FG + + + ++ F+E     ++   SL        L  S + AY    L GL+YLH+
Sbjct: 78  LDAFGHKSNISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYMLMTLQGLEYLHQ 130
Query: 309 QNVIHR 314
             ++HR
Sbjct: 131 HWILHR 136

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 7/120 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G+F  V        G  FA K ++ +    +  Q   +LE+E  +  + +H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVRL 70
Query: 257 FGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             + ++E+  Y+  +LVT G L +  + +E++  ++  S    QIL  + Y H   ++HR
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESIAYCHSNGIVHR 129

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V      D   G   AVK +S +    + ++    L +E+ LL Q +H NI+
Sbjct: 34  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQLDHPNIM 89
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + +   +D+   Y+  E+ T G L  +I       +   +    Q+L+G+ Y+H+  ++H
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 149
Query: 314 R 314
           R
Sbjct: 150 R 150

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 7/120 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G+F  V        G  FA K ++ +    +  Q   +LE+E  +  + +H NIV+ 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVRL 69
Query: 257 FGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             + ++E+  Y+  +LVT G L +  + +E++  ++  S    QIL  + Y H   ++HR
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESIAYCHSNGIVHR 128

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G  G V+ G+ +     AVK +       QG  S      E +L+ Q +H  +V+ +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 258 GTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                E  +YI  E +  GSL    K      L  +++     QI  G+ ++ E+N IHR
Sbjct: 75  AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +   ++G+L +  +       EY    ++V      
Sbjct: 98  GK--HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 58/129 (44%), Gaps = 12/129 (9%)
Query: 197 PLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           P+GSG++G+V      DG   A   +    +  Q E    +  +E+ LL    H+N++  
Sbjct: 32  PVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 257 FG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
                   T  D    Y+ +  +    L K+ +   L + ++    +Q+L GL+Y+H   
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 311 VIHR---PG 316
           +IHR   PG
Sbjct: 149 IIHRDLKPG 157

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 7/120 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G+F  V        G  FA K ++ +    +  Q   +LE+E  +  + +H NIV+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVRL 93
Query: 257 FGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             + ++E+  Y+  +LVT G L +  + +E++  ++  S    QIL  + Y H   ++HR
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESIAYCHSNGIVHR 152

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 16/126 (12%)
Query: 198 LGSGSFGSVYEG-FTDDG---FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G+G FG V  G     G      A+K +    +G   E+   +   E S++GQFEH NI
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW-----QILNGLKYLHE 308
           ++  G   +   + I  E +  G+L    +   L D Q +          I +G++YL E
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLAE 136
Query: 309 QNVIHR 314
            + +HR
Sbjct: 137 MSYVHR 142

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/120 (23%), Positives = 58/120 (48%), Gaps = 4/120 (3%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LGSG+FG+VY+G +  +G    +         T G ++ ++   E  ++   +H ++V+ 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            G       + +  +L+  G L +   E+  ++    +  +  QI  G+ YL E+ ++HR
Sbjct: 106 LGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 164

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 437 GICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 493

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V      D   G   AVK +S +    + ++    L +E+ LL Q +H NI+
Sbjct: 57  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQLDHPNIM 112
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + +   +D+   Y+  E+ T G L  +I       +   +    Q+L+G+ Y+H+  ++H
Sbjct: 113 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 172
Query: 314 R 314
           R
Sbjct: 173 R 173

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V      D   G   AVK +S +    + ++    L +E+ LL Q +H NI+
Sbjct: 40  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQLDHPNIM 95
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + +   +D+   Y+  E+ T G L  +I       +   +    Q+L+G+ Y+H+  ++H
Sbjct: 96  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 155
Query: 314 R 314
           R
Sbjct: 156 R 156

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 16/126 (12%)
Query: 198 LGSGSFGSVYEG-FTDDG---FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G+G FG V  G     G      A+K +    +G   E+   +   E S++GQFEH NI
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW-----QILNGLKYLHE 308
           ++  G   +   + I  E +  G+L    +   L D Q +          I +G++YL E
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLAE 134
Query: 309 QNVIHR 314
            + +HR
Sbjct: 135 MSYVHR 140

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVYEGFTDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V      D   G   AVK +S +    + ++    L +E+ LL Q +H NI+
Sbjct: 58  LGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQLDHPNIM 113
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + +   +D+   Y+  E+ T G L  +I       +   +    Q+L+G+ Y+H+  ++H
Sbjct: 114 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 173
Query: 314 R 314
           R
Sbjct: 174 R 174

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 62/131 (47%), Gaps = 9/131 (6%)
Query: 188 RIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQEIS 243
            I ++Q    LG GSFG V   + T  G   A+K ++   L     QG     ++E+EIS
Sbjct: 2   HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-----RIEREIS 56
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGL 303
            L    H +I++ +   K ++++ + +E         I Q   + + +   +  QI++ +
Sbjct: 57  YLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 116
Query: 304 KYLHEQNVIHR 314
           +Y H   ++HR
Sbjct: 117 EYCHRHKIVHR 127

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LGSG+FG+V +G+           V +            +L  E +++ Q ++  IV+  
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 258 GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G  + E+ + + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +HR
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 494

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 7/120 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G+F  V        G  FA K ++ +    +  Q   +LE+E  +  + +H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVRL 70
Query: 257 FGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             + ++E+  Y+  +LVT G L +  + +E++  ++  S    QIL  + Y H   ++HR
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESIAYCHSNGIVHR 129

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/120 (24%), Positives = 55/120 (45%), Gaps = 4/120 (3%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LGSG+FG+VY+G +  +G    +         T G ++ ++   E  ++   +H ++V+ 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--QILNGLKYLHEQNVIHR 314
            G       + +  +L+  G L +   E+           W  QI  G+ YL E+ ++HR
Sbjct: 83  LGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 141

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 62/131 (47%), Gaps = 9/131 (6%)
Query: 188 RIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQEIS 243
            I ++Q    LG GSFG V   + T  G   A+K ++   L     QG     ++E+EIS
Sbjct: 12  HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-----RIEREIS 66
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGL 303
            L    H +I++ +   K ++++ + +E         I Q   + + +   +  QI++ +
Sbjct: 67  YLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 126
Query: 304 KYLHEQNVIHR 314
           +Y H   ++HR
Sbjct: 127 EYCHRHKIVHR 137

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 30/146 (20%)
Query: 195 GAPLGSGSFGSVYE----GFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLL 245
           G PLG G+FG V      G   D        AVK   L+D  T+ + S L  E E+  ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 97
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-------EYHLKDSQVS----- 293
           G+  H NI+   G    +  LY+ +   ++G+L +  +       EY    ++V      
Sbjct: 98  GK--HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 294 -----AYTWQILNGLKYLHEQNVIHR 314
                + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 62/131 (47%), Gaps = 9/131 (6%)
Query: 188 RIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQEIS 243
            I ++Q    LG GSFG V   + T  G   A+K ++   L     QG     ++E+EIS
Sbjct: 6   HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-----RIEREIS 60
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGL 303
            L    H +I++ +   K ++++ + +E         I Q   + + +   +  QI++ +
Sbjct: 61  YLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 304 KYLHEQNVIHR 314
           +Y H   ++HR
Sbjct: 121 EYCHRHKIVHR 131

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 62/131 (47%), Gaps = 9/131 (6%)
Query: 188 RIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQEIS 243
            I ++Q    LG GSFG V   + T  G   A+K ++   L     QG     ++E+EIS
Sbjct: 11  HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-----RIEREIS 65
Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGL 303
            L    H +I++ +   K ++++ + +E         I Q   + + +   +  QI++ +
Sbjct: 66  YLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 125
Query: 304 KYLHEQNVIHR 314
           +Y H   ++HR
Sbjct: 126 EYCHRHKIVHR 136

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 28/140 (20%)
Query: 198 LGSGSFGSVY--EGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G+FG V+  E +    T D    AVK  +L+D      +     ++E  LL   +H+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 77
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSA 294
           +IV+++G   D + L +  E +  G L K  + +                  L  SQ+  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 295 YTWQILNGLKYLHEQNVIHR 314
              QI +G+ YL  Q+ +HR
Sbjct: 138 IASQIASGMVYLASQHFVHR 157

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK------------IYQEYHLKDSQVS-- 293
             H NI+   G    +  LY+ +E  ++G+L +             Y   H  + Q+S  
Sbjct: 78  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              +  +Q+  G++YL  +  IHR
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHR 159

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/123 (26%), Positives = 54/123 (43%), Gaps = 10/123 (8%)
Query: 198 LGSGSFGSVYEGFTD----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G+G FG V  G          F A+K  +L+   T+ ++       E S++GQF+H N+
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIK--TLKSGYTEKQRR--DFLSEASIMGQFDHPNV 70
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNV 311
           +   G       + I  E +  GSL    ++        Q+      I  G+KYL + N 
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 130
Query: 312 IHR 314
           +HR
Sbjct: 131 VHR 133

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTD--DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           LG+G+FG V+   T+   G  FA K V      T  E     + +EI  +    H  +V 
Sbjct: 59  LGTGAFGVVHR-VTERATGNNFAAKFVM-----TPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA--YTWQILNGLKYLHEQNVIH 313
                +D+N++ +  E ++ G L +   + H K S+  A  Y  Q+  GL ++HE N +H
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 172

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/123 (26%), Positives = 54/123 (43%), Gaps = 10/123 (8%)
Query: 198 LGSGSFGSVYEGFTD----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G+G FG V  G          F A+K  +L+   T+ ++       E S++GQF+H N+
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIK--TLKSGYTEKQRR--DFLSEASIMGQFDHPNV 96
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNV 311
           +   G       + I  E +  GSL    ++        Q+      I  G+KYL + N 
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 156
Query: 312 IHR 314
           +HR
Sbjct: 157 VHR 159

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 153 QDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTD 212
           QD F DV +  D +  +  L      FSL E  +    ++     LG G FG VY+G   
Sbjct: 6   QDHFFDVPAEEDPEVHLGQLK----RFSLRE-LQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 213 DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL 272
           DG   AVK   L+++  QG +  LQ + E+ ++    H N+++  G      +  +    
Sbjct: 61  DGTLVAVKR--LKEERXQGGE--LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 116
Query: 273 VTQGSLAKIYQEYHLKDSQVSAYTWQIL-----NGLKYLHEQ---NVIHR 314
           +  GS+A   +E       +     Q +      GL YLH+     +IHR
Sbjct: 117 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 166

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 10/120 (8%)
Query: 198 LGSGSFGSVYEGFTD--DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           LG+G+FG V+   T+   G  FA K V      T  E     + +EI  +    H  +V 
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVM-----TPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA--YTWQILNGLKYLHEQNVIH 313
                +D+N++ +  E ++ G L +   + H K S+  A  Y  Q+  GL ++HE N +H
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 278

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK------------IYQEYHLKDSQVS-- 293
             H NI+   G    +  LY+ +E  ++G+L +             Y   H  + Q+S  
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              +  +Q+  G++YL  +  IHR
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHR 174

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 18/128 (14%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQ-DQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           +G+G++G V        G   A+K++    D  T  ++++    +E+ +L  F+HDNI+ 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKHFKHDNIIA 117
Query: 256 Y---------FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYL 306
                     +G  K    +Y+ L+L+       I+    L    V  + +Q+L GLKY+
Sbjct: 118 IKDILRPTVPYGEFKS---VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 174
Query: 307 HEQNVIHR 314
           H   VIHR
Sbjct: 175 HSAQVIHR 182

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 18/128 (14%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQ-DQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           +G+G++G V        G   A+K++    D  T  ++++    +E+ +L  F+HDNI+ 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKHFKHDNIIA 118
Query: 256 Y---------FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYL 306
                     +G  K    +Y+ L+L+       I+    L    V  + +Q+L GLKY+
Sbjct: 119 IKDILRPTVPYGEFKS---VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 307 HEQNVIHR 314
           H   VIHR
Sbjct: 176 HSAQVIHR 183

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 17/126 (13%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V      + G  +AVK    +V LQD   + T  E+ +L L +         
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------- 82
Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  + Q F   +  ++L+  +E V  G L   I +     +++   Y  +I++ L +LH+
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 309 QNVIHR 314
           + +I+R
Sbjct: 143 KGIIYR 148

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 11/129 (8%)
Query: 192 WQKGAPLGSGSFGSVYE------GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +  G  LGSG F  V +      G      F   +      +G   E     +E+E+S+L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED----IEREVSIL 68
Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLK 304
            + +H N++      +++  + +  ELV  G L     E   L + + + +  QILNG+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 305 YLHEQNVIH 313
           YLH   + H
Sbjct: 129 YLHSLQIAH 137

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 51/123 (41%), Gaps = 7/123 (5%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +G G+FG V+ G    D    AVK      + T       +  QE  +L Q+ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V+  G    +  +YI +ELV  G      +     L+   +         G++YL  +  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 312 IHR 314
           IHR
Sbjct: 235 IHR 237

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 311 VIHR 314
           +IHR
Sbjct: 151 IIHR 154

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 19  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 311 VIHR 314
           +IHR
Sbjct: 135 IIHR 138

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 40  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 93
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 94  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 146
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 147 LHAKSIIHR 155

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 51/123 (41%), Gaps = 7/123 (5%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +G G+FG V+ G    D    AVK      + T       +  QE  +L Q+ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V+  G    +  +YI +ELV  G      +     L+   +         G++YL  +  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 312 IHR 314
           IHR
Sbjct: 235 IHR 237

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 14/84 (16%)
Query: 239 EQEISLLGQF-EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-------HLKDS 290
           ++E+ LL +  EH N+++YF TEKD    YI +EL      A   QEY       HL   
Sbjct: 65  DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-----AATLQEYVEQKDFAHLGLE 119
Query: 291 QVSAYTWQILNGLKYLHEQNVIHR 314
            ++    Q  +GL +LH  N++HR
Sbjct: 120 PITLLQ-QTTSGLAHLHSLNIVHR 142

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 311 VIHR 314
           +IHR
Sbjct: 151 IIHR 154

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 33  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 86
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 87  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 139
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 140 LHAKSIIHR 148

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 311 VIHR 314
           +IHR
Sbjct: 151 IIHR 154

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 12/123 (9%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQ----DQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FGSV +G     +    K++ +      QGT+ +    ++ +E  ++ Q ++  I
Sbjct: 344 LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYI 398
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V+  G  + E  L + +E+   G L K  + +   +  S V+    Q+  G+KYL E+N 
Sbjct: 399 VRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 312 IHR 314
           +HR
Sbjct: 458 VHR 460

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 311 VIHR 314
           +IHR
Sbjct: 153 IIHR 156

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 94
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 95  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 148 LHAKSIIHR 156

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI------------YQEYHLKDSQVS-- 293
             H NI+   G    +  LY+ +E  ++G+L +             Y   H  + Q+S  
Sbjct: 86  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              +  +Q+  G++YL  +  IHR
Sbjct: 144 DLVSCAYQVARGMEYLASKKCIHR 167

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 311 VIHR 314
           +IHR
Sbjct: 153 IIHR 156

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 15  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 68
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 69  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 121
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 122 LHAKSIIHR 130

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 62/155 (40%), Gaps = 24/155 (15%)
Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           NEK+     + Q G  LG+G+FG V E    G   +     V    L+      E+  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 238 LEQEI-SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI------------YQE 284
            E +I S LGQ  H+NIV   G       + +  E    G L               Y  
Sbjct: 98  SELKIMSHLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNP 155
Query: 285 YHLKDSQVSA-----YTWQILNGLKYLHEQNVIHR 314
            H  + Q+S+     ++ Q+  G+ +L  +N IHR
Sbjct: 156 SHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHR 190

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 311 VIHR 314
           +IHR
Sbjct: 153 IIHR 156

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 311 VIHR 314
           +IHR
Sbjct: 153 IIHR 156

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI------------YQEYHLKDSQVS-- 293
             H NI+   G    +  LY+ +E  ++G+L +             Y   H  + Q+S  
Sbjct: 82  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              +  +Q+  G++YL  +  IHR
Sbjct: 140 DLVSCAYQVARGMEYLASKKCIHR 163

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 311 VIHR 314
           +IHR
Sbjct: 154 IIHR 157

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 311 VIHR 314
           +IHR
Sbjct: 153 IIHR 156

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI------------YQEYHLKDSQVS-- 293
             H NI+   G    +  LY+ +E  ++G+L +             Y   H  + Q+S  
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              +  +Q+  G++YL  +  IHR
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHR 174

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 311 VIHR 314
           +IHR
Sbjct: 154 IIHR 157

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 66
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 67  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 120 LHAKSIIHR 128

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 94
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 95  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 148 LHAKSIIHR 156

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 71
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 72  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 125 LHAKSIIHR 133

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI------------YQEYHLKDSQVS-- 293
             H NI+   G    +  LY+ +E  ++G+L +             Y   H  + Q+S  
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              +  +Q+  G++YL  +  IHR
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHR 174

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 66
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 67  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 120 LHAKSIIHR 128

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 40  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 311 VIHR 314
           +IHR
Sbjct: 156 IIHR 159

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 66
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 67  LLFMGYSTAPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 120 LHAKSIIHR 128

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 60/144 (41%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-----------------EYHLKDS 290
             H NI+   G    +  LY+ +E  ++G+L +  Q                 E  L   
Sbjct: 93  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 291 QVSAYTWQILNGLKYLHEQNVIHR 314
            + +  +Q+  G++YL  +  IHR
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHR 174

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI------------YQEYHLKDSQVS-- 293
             H NI+   G    +  LY+ +E  ++G+L +             Y   H  + Q+S  
Sbjct: 85  --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              +  +Q+  G++YL  +  IHR
Sbjct: 143 DLVSCAYQVARGMEYLASKKCIHR 166

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/120 (25%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G +G VY G     +   V   +L++   + E+ +    +E +++ + +H N+VQ  
Sbjct: 40  LGGGQYGEVYVGVWKK-YSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 94
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---QILNGLKYLHEQNVIHR 314
           G    E   YI  E +  G+L    +E + ++       +   QI + ++YL ++N IHR
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHR 154

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 71
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSAYTW-----QILNGLKY 305
           + + G           L +VTQ   GS   +Y   H+ +++           Q   G+ Y
Sbjct: 72  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 125 LHAKSIIHR 133

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 311 VIHR 314
           +IHR
Sbjct: 153 IIHR 156

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +  A+K   L+ +    E  V  + +E  ++ + +H 
Sbjct: 34  GKILGEGSFSTVVLARELATSREY--AIK--ILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 311 VIHR 314
           +IHR
Sbjct: 150 IIHR 153

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 12/123 (9%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQ----DQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G+FGSV +G     +    K++ +      QGT+ +    ++ +E  ++ Q ++  I
Sbjct: 18  LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYI 72
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V+  G  + E  L + +E+   G L K  + +   +  S V+    Q+  G+KYL E+N 
Sbjct: 73  VRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 312 IHR 314
           +HR
Sbjct: 132 VHR 134

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ + T +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 311 VIHR 314
           +IHR
Sbjct: 150 IIHR 153

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKXV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQ-MELDHERMSYLLYQMLXG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKXV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 198 LGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG GSFG V    +  T  G   AVK +S +    + ++    L +E+ LL Q +H NI 
Sbjct: 34  LGKGSFGEVILCKDKIT--GQECAVKVISKRQVKQKTDKE--SLLREVQLLKQLDHPNIX 89
Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           + +   +D+   Y+  E+ T G L  +I       +   +    Q+L+G+ Y H+  ++H
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVH 149
Query: 314 R 314
           R
Sbjct: 150 R 150

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 81
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 82  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 139
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 140 IKHLHSAGIIHR 151

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 74
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 75  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 132
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 133 IKHLHSAGIIHR 144

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 60/137 (43%), Gaps = 26/137 (18%)
Query: 196 APLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           A LG G+FG V +     D  ++A+K++         E+ +  +  E+ LL    H  +V
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 255 QYFGT-------------EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---- 297
           +Y+                K ++ L+I +E     +L  +    +L + Q   Y W    
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENL-NQQRDEY-WRLFR 123
Query: 298 QILNGLKYLHEQNVIHR 314
           QIL  L Y+H Q +IHR
Sbjct: 124 QILEALSYIHSQGIIHR 140

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 15  LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 71
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLA---------- 279
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 72  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 280 ---KIYQEYHLKD----SQVSAYTWQILNGLKYLHEQNVIHR 314
              K+  E   KD      +  Y++Q+  G+++L  +  IHR
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKXV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 79
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 80  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 137
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 138 IKHLHSAGIIHR 149

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/124 (25%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G+GS+G V E +   +    A+K++    +     + +L+   EI++L +  HD++V+ 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR---EIAILNRLNHDHVVKV 117
Query: 257 FGT--EKDENK---LYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQN 310
                 KD  K   LY+ LE +      K+++   +L +  +    + +L G+KY+H   
Sbjct: 118 LDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176
Query: 311 VIHR 314
           ++HR
Sbjct: 177 ILHR 180

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 74
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 75  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 132
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 133 IKHLHSAGIIHR 144

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 73
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 131
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 132 IKHLHSAGIIHR 143

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 17  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 70
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSA-----YTWQILNGLKY 305
           + + G           L +VTQ   GS   +Y   H  +++           Q   G+ Y
Sbjct: 71  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDY 123
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 124 LHAKSIIHR 132

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 81
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 82  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 139
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 140 IKHLHSAGIIHR 151

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 41  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 157
Query: 313 HR 314
           HR
Sbjct: 158 HR 159

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 24  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 313 HR 314
           HR
Sbjct: 141 HR 142

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 15  LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 71
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLA---------- 279
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 72  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 280 ---KIYQEYHLKD----SQVSAYTWQILNGLKYLHEQNVIHR 314
              K+  E   KD      +  Y++Q+  G+++L  +  IHR
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 6   LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLA---------- 279
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 63  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 121
Query: 280 ---KIYQEYHLKD----SQVSAYTWQILNGLKYLHEQNVIHR 314
              K+  E   KD      +  Y++Q+  G+++L  +  IHR
Sbjct: 122 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 163

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 24  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 313 HR 314
           HR
Sbjct: 141 HR 142

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 26/144 (18%)
Query: 195 GAPLGSGSFGSVYE----GFTDDGFFFAVKEV--SLQDQGTQGEQSVLQLEQEI-SLLGQ 247
           G PLG G+FG V      G   D      K     L+   T+ + S L  E E+  ++G+
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI------------YQEYHLKDSQVS-- 293
             H NI+   G    +  LY+ +E  ++G+L +             Y   H  + Q+S  
Sbjct: 134 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 294 ---AYTWQILNGLKYLHEQNVIHR 314
              +  +Q+  G++YL  +  IHR
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHR 215

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 118
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 176
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 177 IKHLHSAGIIHR 188

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 220 KEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGS 277
           KEV+++  D+      S+ +L +E+ ++    H NIV+ F   + E  LY+ +E  + G 
Sbjct: 40  KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 278 LAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +   +     +K+ +  A   QI++ ++Y H++ ++HR
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 82
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSA-----YTWQILNGLKY 305
           + + G           L +VTQ   GS   +Y   H  +++           Q   G+ Y
Sbjct: 83  LLFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 136 LHAKSIIHR 144

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 24/159 (15%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+     G PLG G+FG V E    G         V    L++  T 
Sbjct: 15  LPYDASKWEFPRDRL---NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH 71
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLAK--------- 280
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 72  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 281 -----IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                +Y+++ L    +  Y++Q+  G+++L  +  IHR
Sbjct: 131 VPYKDLYKDF-LTLEHLICYSFQVAKGMEFLASRKXIHR 168

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 220 KEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGS 277
           KEV+++  D+      S+ +L +E+ ++    H NIV+ F   + E  LY+ +E  + G 
Sbjct: 40  KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 278 LAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +   +     +K+ +  A   QI++ ++Y H++ ++HR
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 15  LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 71
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLA---------- 279
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 72  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 280 ---KIYQEYHLKD----SQVSAYTWQILNGLKYLHEQNVIHR 314
              K+  E   KD      +  Y++Q+  G+++L  +  IHR
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 20  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 74
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 75  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 132
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 133 IKHLHSAGIIHR 144

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 51  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 167
Query: 313 HR 314
           HR
Sbjct: 168 HR 169

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 60/131 (45%), Gaps = 4/131 (3%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R +I  +  G  LG G+FG V  G     G   AVK   L  Q  +    V ++++EI  
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK--ILNRQKIRSLDVVGKIKREIQN 64
Query: 245 LGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGL 303
           L  F H +I++ +         ++ +E V+ G L   I +   +++ +      QIL+ +
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 304 KYLHEQNVIHR 314
            Y H   V+HR
Sbjct: 125 DYCHRHMVVHR 135

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 31  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 85
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 86  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 143
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 144 IKHLHSAGIIHR 155

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 220 KEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGS 277
           KEV+++  D+      S+ +L +E+ ++    H NIV+ F   + E  LY+ +E  + G 
Sbjct: 40  KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 278 LAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +   +     +K+ +  A   QI++ ++Y H++ ++HR
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 22/129 (17%)
Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +GSGSFG+VY+G +  D    AVK +++     Q  Q+    + E+ +L +  H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA---FKNEVGVLRKTRHVNI 82
Query: 254 VQYFGTEKDENKLYIFLELVTQ---GSLAKIYQEYHLKDSQVSA-----YTWQILNGLKY 305
           + + G           L +VTQ   GS   +Y   H  +++           Q   G+ Y
Sbjct: 83  LLFMGYSTAPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 306 LHEQNVIHR 314
           LH +++IHR
Sbjct: 136 LHAKSIIHR 144

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 29/179 (16%)
Query: 161 SISDDDAEISL---LMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDD 213
           SI  D  E+ L      L Y+ S  E  R R+   + G PLG G+FG V E    G    
Sbjct: 35  SIVMDPDELPLDEHCERLPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKT 91
Query: 214 GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLEL 272
                V    L++  T  E   L  E +I L+    H N+V   G   K    L + +E 
Sbjct: 92  ATCRTVAVKMLKEGATHSEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEF 150
Query: 273 VTQGSLA-------------KIYQEYHLKD----SQVSAYTWQILNGLKYLHEQNVIHR 314
              G+L+             K+  E   KD      +  Y++Q+  G+++L  +  IHR
Sbjct: 151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 209

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 66/138 (47%), Gaps = 17/138 (12%)
Query: 189 IMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +  ++K A +G G+FG V++      G   A+K+V ++++      + L+   EI +L  
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQL 72
Query: 248 FEHDNIVQYF--------GTEKDENKLYI---FLELVTQGSLAKIYQEYHLKDSQVSAYT 296
            +H+N+V              + +  +Y+   F E    G L+ +  ++ L  S++    
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 130
Query: 297 WQILNGLKYLHEQNVIHR 314
             +LNGL Y+H   ++HR
Sbjct: 131 QMLLNGLYYIHRNKILHR 148

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQ-MELDHERMSYLLYQMLXG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 220 KEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGS 277
           KEV+++  D+      S+ +L +E+ ++    H NIV+ F   + E  LY+ +E  + G 
Sbjct: 40  KEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 278 LAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +   +     +K+ +  A   QI++ ++Y H++ ++HR
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 60/131 (45%), Gaps = 4/131 (3%)
Query: 186 RRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R +I  +  G  LG G+FG V  G     G   AVK   L  Q  +    V ++++EI  
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK--ILNRQKIRSLDVVGKIKREIQN 64
Query: 245 LGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGL 303
           L  F H +I++ +         ++ +E V+ G L   I +   +++ +      QIL+ +
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 304 KYLHEQNVIHR 314
            Y H   V+HR
Sbjct: 125 DYCHRHMVVHR 135

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 44/84 (52%), Gaps = 1/84 (1%)
Query: 232 EQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQ 291
           E  V  + +E  ++ + +H   V+ + T +D+ KLY  L     G L K  ++    D  
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 292 VSA-YTWQILNGLKYLHEQNVIHR 314
            +  YT +I++ L+YLH + +IHR
Sbjct: 131 CTRFYTAEIVSALEYLHGKGIIHR 154

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIV 254
           +G+G FG V  G        + KE+S+  +  +    E+       E S++GQF+H NI+
Sbjct: 53  VGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVI 312
           +  G       + I  E +  GSL    +++  + +  Q+      I +G+KYL +   +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 313 HR 314
           HR
Sbjct: 170 HR 171

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 220 KEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGS 277
           KEV+++  D+      S+ +L +E+ ++    H NIV+ F   + E  LY+ +E  + G 
Sbjct: 40  KEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 99
Query: 278 LAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +   +     +K+ +  A   QI++ ++Y H++ ++HR
Sbjct: 100 VFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 73
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQ-MELDHERMSYLLYQMLXG 131
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 132 IKHLHSAGIIHR 143

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/94 (24%), Positives = 49/94 (52%), Gaps = 1/94 (1%)
Query: 222 VSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK- 280
           V + D+      S+ +L +E+ ++    H NIV+ F   + E  LY+ +E  + G +   
Sbjct: 45  VKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 104
Query: 281 IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +     +K+ +  A   QI++ ++Y H++ ++HR
Sbjct: 105 LVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHR 138

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 25/137 (18%)
Query: 198 LGSGSFGSVY--EGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G+FG V+  E +      D    AVK  +L+D      +      +E  LL   +H+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 75
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--------------HLKDSQVSAYTW 297
           +IV+++G   + + L +  E +  G L K  + +               L  SQ+     
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 298 QILNGLKYLHEQNVIHR 314
           QI  G+ YL  Q+ +HR
Sbjct: 136 QIAAGMVYLASQHFVHR 152

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 198 LGSGSFGSVY----EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG GSFG V+        D G  +A+K +    + T   +  ++ + E  +L    H  +
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLK---KATLKVRDRVRTKMERDILADVNHPFV 92
Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V+     + E KLY+ L+ +  G L  ++ +E    +  V  Y  ++  GL +LH   +I
Sbjct: 93  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGII 152
Query: 313 HR 314
           +R
Sbjct: 153 YR 154

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 220 KEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGS 277
           KEV+++  D+      S+ +L +E+ ++    H NIV+ F   + E  LY+ +E  + G 
Sbjct: 33  KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGE 92
Query: 278 LAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +   Y   H  +K+ +  A   QI++ ++Y H++ ++HR
Sbjct: 93  VFD-YLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHR 130

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 27/162 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+     G PLG G+FG V E    G         V    L++  T 
Sbjct: 16  LPYDASKWEFPRDRL---NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 72
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLAK--------- 280
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 73  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 131
Query: 281 --------IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                   +Y+++ L    +  Y++Q+  G+++L  +  IHR
Sbjct: 132 VPYKTPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHR 172

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSV---YEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   Y+   D     A+K++S   +  Q +    +  +E+ L+   
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVLMKCV 118
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      Y+ +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 176
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 177 IKHLHSAGIIHR 188

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L+++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 194 KGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQ-DQGTQGEQSVLQLEQEISLLGQFEHD 251
           K  PLG GSF    +         FAVK +S + +  TQ E + L+L +         H 
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--------HP 66
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           NIV+      D+   ++ +EL+  G L  +I ++ H  +++ S    ++++ + ++H+  
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 311 VIHR 314
           V+HR
Sbjct: 127 VVHR 130

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 57/123 (46%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEG-FTD---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G FG VYEG +T+   +    AVK    +D     ++  +    E  ++   +H +I
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFM---SEAVIMKNLDHPHI 71
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V+  G  ++E   +I +EL   G L    +  +  LK   +  Y+ QI   + YL   N 
Sbjct: 72  VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 130
Query: 312 IHR 314
           +HR
Sbjct: 131 VHR 133

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 66/138 (47%), Gaps = 17/138 (12%)
Query: 189 IMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +  ++K A +G G+FG V++      G   A+K+V ++++      + L+   EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQL 73
Query: 248 FEHDNIVQYF--------GTEKDENKLYI---FLELVTQGSLAKIYQEYHLKDSQVSAYT 296
            +H+N+V              + +  +Y+   F E    G L+ +  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 297 WQILNGLKYLHEQNVIHR 314
             +LNGL Y+H   ++HR
Sbjct: 132 QMLLNGLYYIHRNKILHR 149

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 27  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 81
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 139
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 140 IKHLHSAGIIHR 151

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVVAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKVV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L+++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ-MELDHERMSYLLYQMLVG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKVV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L+++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 66/138 (47%), Gaps = 17/138 (12%)
Query: 189 IMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +  ++K A +G G+FG V++      G   A+K+V ++++      + L+   EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQL 73
Query: 248 FEHDNIVQYF--------GTEKDENKLYI---FLELVTQGSLAKIYQEYHLKDSQVSAYT 296
            +H+N+V              + +  +Y+   F E    G L+ +  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 297 WQILNGLKYLHEQNVIHR 314
             +LNGL Y+H   ++HR
Sbjct: 132 QMLLNGLYYIHRNKILHR 149

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L+++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ-MELDHERMSYLLYQMLCG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 66/138 (47%), Gaps = 17/138 (12%)
Query: 189 IMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +  ++K A +G G+FG V++      G   A+K+V ++++      + L+   EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQL 73
Query: 248 FEHDNIVQYF------GTEKDENKLYIFL-----ELVTQGSLAKIYQEYHLKDSQVSAYT 296
            +H+N+V          +  +  K  I+L     E    G L+ +  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 297 WQILNGLKYLHEQNVIHR 314
             +LNGL Y+H   ++HR
Sbjct: 132 QMLLNGLYYIHRNKILHR 149

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 28/163 (17%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 17  LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 73
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLAK--------- 280
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 74  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 132
Query: 281 ---------IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                    +Y+++ L    +  Y++Q+  G+++L  +  IHR
Sbjct: 133 VPYKEAPEDLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHR 174

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 28  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 82
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L ++ Q   L   ++S   +Q+L G
Sbjct: 83  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQMLCG 140
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 141 IKHLHSAGIIHR 152

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 57/123 (46%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEG-FTD---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G FG VYEG +T+   +    AVK    +D     ++  +    E  ++   +H +I
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFM---SEAVIMKNLDHPHI 87
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V+  G  ++E   +I +EL   G L    +  +  LK   +  Y+ QI   + YL   N 
Sbjct: 88  VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 146
Query: 312 IHR 314
           +HR
Sbjct: 147 VHR 149

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 41/78 (52%), Gaps = 1/78 (1%)
Query: 238 LEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYT 296
           +  EI +L +  H NI++     +   ++ + LELVT G L  +I ++ +  +   +   
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 297 WQILNGLKYLHEQNVIHR 314
            QIL  + YLHE  ++HR
Sbjct: 155 KQILEAVAYLHENGIVHR 172

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 8/124 (6%)
Query: 195 GAPLGSGSFGSVY---EGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           G  LG GSF +V    E  T   +   +    L+ +    E  V  + +E  ++ + +H 
Sbjct: 42  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YTWQILNGLKYLHEQN 310
             V+ +   +D+ KLY  L     G L K  ++    D   +  YT +I++ L+YLH + 
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 311 VIHR 314
           +IHR
Sbjct: 158 IIHR 161

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/120 (22%), Positives = 59/120 (49%), Gaps = 7/120 (5%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           +G G+F  V             +EV+++  D+      S+ +L +E+ ++    H NIV+
Sbjct: 23  IGKGNFAKVKLA----RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 256 YFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            F   + E  LY+ +E  + G +   +     +K+ +  +   QI++ ++Y H++ ++HR
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR 138

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 65/162 (40%), Gaps = 26/162 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 6   LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLA---------- 279
            E   L  E +I L+    H N+V   G   K    L +  E    G+L+          
Sbjct: 63  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF 121
Query: 280 ---KIYQEYHLKD----SQVSAYTWQILNGLKYLHEQNVIHR 314
              K+  E   KD      +  Y++Q+  G+++L  +  IHR
Sbjct: 122 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 163

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 62/125 (49%), Gaps = 13/125 (10%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSV--LQLEQEISLLGQFEHDNIVQ 255
           +G GS+G VY  +  +    A K V+++      E  +   ++ +EI++L + + D I++
Sbjct: 36  IGRGSYGYVYLAYDKN----ANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIR 91
Query: 256 YFGTEKDEN-----KLYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQ 309
                  E+     +LYI LE +    L K+++    L +  V    + +L G K++HE 
Sbjct: 92  LHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHES 150
Query: 310 NVIHR 314
            +IHR
Sbjct: 151 GIIHR 155

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 57/123 (46%), Gaps = 11/123 (8%)
Query: 198 LGSGSFGSVYEG-FTD---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G FG VYEG +T+   +    AVK    +D     ++  +    E  ++   +H +I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFM---SEAVIMKNLDHPHI 75
Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V+  G  ++E   +I +EL   G L    +  +  LK   +  Y+ QI   + YL   N 
Sbjct: 76  VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 312 IHR 314
           +HR
Sbjct: 135 VHR 137

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 250 H--DNIVQYFGTEKDENKLYIFLELV--TQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE +   Q     I +   L++    ++ WQ+L  +++
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 130 CHNCGVLHR 138

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 26/161 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 17  LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH 73
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLAK--------- 280
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 74  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 132
Query: 281 -------IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                  +Y+++ L    +  Y++Q+  G+++L  +  IHR
Sbjct: 133 VPYKPEDLYKDF-LTLEHLIXYSFQVAKGMEFLASRKXIHR 172

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKVV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L+++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ-MELDHERMSYLLYQMLVG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 24/159 (15%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+     G PLG G+FG V E    G         V    L++  T 
Sbjct: 15  LPYDASKWEFPRDRL---NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH 71
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLAK--------- 280
            E   L  E +I L+    H N+V   G   K    L + +E    G+L+          
Sbjct: 72  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 281 -----IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                +Y+++ L    +  Y++Q+  G+++L  +  IHR
Sbjct: 131 VPYKDLYKDF-LTLEHLIXYSFQVAKGMEFLASRKXIHR 168

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 65/162 (40%), Gaps = 26/162 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 6   LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLA---------- 279
            E   L  E +I L+    H N+V   G   K    L +  E    G+L+          
Sbjct: 63  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF 121
Query: 280 ---KIYQEYHLKD----SQVSAYTWQILNGLKYLHEQNVIHR 314
              K+  E   KD      +  Y++Q+  G+++L  +  IHR
Sbjct: 122 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 163

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 20/127 (15%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G FG VY+G   DG      +V+L+ +  +  Q + + E EI  L    H ++V   
Sbjct: 47  IGHGVFGKVYKGVLRDG-----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQ--------ILNGLKYLH 307
           G   + N++ +  + +  G+L +     HL  S +   + +W+           GL YLH
Sbjct: 102 GFCDERNEMILIYKYMENGNLKR-----HLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 308 EQNVIHR 314
            + +IHR
Sbjct: 157 TRAIIHR 163

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 26/137 (18%)
Query: 196 APLGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           A LG G+FG V +     D  ++A+K++         E+ +  +  E+ LL    H  +V
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVXLLASLNHQYVV 65
Query: 255 QYFGT-------------EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW---- 297
           +Y+                K ++ L+I  E     +L  +    +L + Q   Y W    
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENL-NQQRDEY-WRLFR 123
Query: 298 QILNGLKYLHEQNVIHR 314
           QIL  L Y+H Q +IHR
Sbjct: 124 QILEALSYIHSQGIIHR 140

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           +Q   P+GSG+ G V   +  D       A+K++S   +  Q +    +  +E+ L+   
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKVV 80
Query: 249 EHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNG 302
            H NI+        +  L      YI +EL+   +L+++ Q   L   ++S   +Q+L G
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ-MELDHERMSYLLYQMLVG 138
Query: 303 LKYLHEQNVIHR 314
           +K+LH   +IHR
Sbjct: 139 IKHLHSAGIIHR 150

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 19/138 (13%)
Query: 187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           +R +++     +G+GSFG V++    +    A+K+V LQD+  +         +E+ ++ 
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKN--------RELQIMR 87
Query: 247 QFEHDNIV---QYF---GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQ----VSAYT 296
             +H N+V    +F   G +KDE  L + LE V +           LK +     +  Y 
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 297 WQILNGLKYLHEQNVIHR 314
           +Q+L  L Y+H   + HR
Sbjct: 148 YQLLRSLAYIHSIGICHR 165

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 20/127 (15%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G FG VY+G   DG      +V+L+ +  +  Q + + E EI  L    H ++V   
Sbjct: 47  IGHGVFGKVYKGVLRDG-----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVS--AYTWQ--------ILNGLKYLH 307
           G   + N++ +  + +  G+L +     HL  S +   + +W+           GL YLH
Sbjct: 102 GFCDERNEMILIYKYMENGNLKR-----HLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 308 EQNVIHR 314
            + +IHR
Sbjct: 157 TRAIIHR 163

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/120 (22%), Positives = 59/120 (49%), Gaps = 7/120 (5%)
Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQ--DQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           +G G+F  V             +EV+++  D+      S+ +L +E+ ++    H NIV+
Sbjct: 20  IGKGNFAKVKLA----RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 75
Query: 256 YFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            F   + E  LY+ +E  + G +   +     +K+ +  +   QI++ ++Y H++ ++HR
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR 135

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 65/162 (40%), Gaps = 26/162 (16%)
Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQ 230
           L Y+ S  E  R R+   + G PLG G+FG V E    G         V    L++  T 
Sbjct: 6   LPYDASKWEFPRDRL---KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLA---------- 279
            E   L  E +I L+    H N+V   G   K    L +  E    G+L+          
Sbjct: 63  SEHRALMSELKI-LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF 121
Query: 280 ---KIYQEYHLKD----SQVSAYTWQILNGLKYLHEQNVIHR 314
              K+  E   KD      +  Y++Q+  G+++L  +  IHR
Sbjct: 122 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 163

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 7/120 (5%)
Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G+F  V        G  +A K ++ +    +  Q   +LE+E  +    +H NIV+ 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIVRL 86
Query: 257 FGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             +  +E   Y+  +LVT G L +  + +EY+  ++  S    QIL  + + H+  V+HR
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYY-SEADASHCIQQILEAVLHCHQMGVVHR 145

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 22/153 (14%)
Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           NEK+     + Q G  LG+G+FG V E    G   +     V    L+      E+  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 238 LEQEI-SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQE----------YH 286
            E +I S LGQ  H+NIV   G       + +  E    G L    +           + 
Sbjct: 98  SELKIMSHLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 287 LKDSQVSA-----YTWQILNGLKYLHEQNVIHR 314
           + +S +S      ++ Q+  G+ +L  +N IHR
Sbjct: 156 IANSTLSTRDLLHFSSQVAQGMAFLASKNCIHR 188

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 13/128 (10%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG++GSV        G   A+K++S   +  Q E    +  +E+ LL   +H+N++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIGL 106
Query: 257 FGTEKDENKLYIFLEL-----VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  + L  F +        Q  L KI       + ++    +Q+L GLKY+H   V
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQTDLQKI-MGMEFSEEKIQYLVYQMLKGLKYIHSAGV 165
Query: 312 IHR---PG 316
           +HR   PG
Sbjct: 166 VHRDLKPG 173

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 54/135 (40%), Gaps = 15/135 (11%)
Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
            W+    LG+G FG V      D G   A+K+   +      E+  L    EI ++ +  
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL----EIQIMKKLN 70
Query: 250 HDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYH----LKDSQVSAYTWQI 299
           H N+V          KL       + +E    G L K   ++     LK+  +      I
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 300 LNGLKYLHEQNVIHR 314
            + L+YLHE  +IHR
Sbjct: 131 SSALRYLHENRIIHR 145

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 13/128 (10%)
Query: 198 LGSGSFGSVYEGFTD-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +GSG++GSV        G   A+K++S   +  Q E    +  +E+ LL   +H+N++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 257 FGTEKDENKLYIFLEL-----VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
                  + L  F +        Q  L KI       + ++    +Q+L GLKY+H   V
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKI-MGLKFSEEKIQYLVYQMLKGLKYIHSAGV 147
Query: 312 IHR---PG 316
           +HR   PG
Sbjct: 148 VHRDLKPG 155

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 54/135 (40%), Gaps = 15/135 (11%)
Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
            W+    LG+G FG V      D G   A+K+   +      E+  L    EI ++ +  
Sbjct: 16  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL----EIQIMKKLN 71
Query: 250 HDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQEYH----LKDSQVSAYTWQI 299
           H N+V          KL       + +E    G L K   ++     LK+  +      I
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 300 LNGLKYLHEQNVIHR 314
            + L+YLHE  +IHR
Sbjct: 132 SSALRYLHENRIIHR 146

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 158 CHNCGVLHR 166

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 126 CHNXGVLHR 134

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 61/153 (39%), Gaps = 22/153 (14%)
Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYE----GFTDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           NEK+     + Q G  LG+G+FG V E    G   +     V    L+      E+  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 238 LEQEI-SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQE----------YH 286
            E +I S LGQ  H+NIV   G       + +  E    G L    +           + 
Sbjct: 98  SELKIMSHLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 287 LKDSQVSA-----YTWQILNGLKYLHEQNVIHR 314
           + +S  S      ++ Q+  G+ +L  +N IHR
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 145 CHNCGVLHR 153

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 146 CHNCGVLHR 154

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 158 CHNCGVLHR 166

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 145 CHNCGVLHR 153

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 173 CHNCGVLHR 181

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 159 CHNCGVLHR 167

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 158 CHNCGVLHR 166

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 158 CHNCGVLHR 166

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 159 CHNCGVLHR 167

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 13/113 (11%)
Query: 201 GSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGT 259
           G FG V++    +D  F AVK   LQD+ +       Q E+EI      +H+N++Q+   
Sbjct: 26  GRFGCVWKAQLMND--FVAVKIFPLQDKQS------WQSEREIFSTPGMKHENLLQFIAA 77
Query: 260 EKDENKLYIFLELVT----QGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           EK  + L + L L+T    +GSL    +   +  +++      +  GL YLHE
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHE 130

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 159 CHNCGVLHR 167

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 130 CHNCGVLHR 138

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 131 CHNCGVLHR 139

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 146 CHNCGVLHR 154

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 146 CHNCGVLHR 154

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 12/124 (9%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LGSG FG+V++G +  +G    +       +   G QS   +   +  +G  +H +IV+ 
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 257 FGTEKDENKLYIFLELVTQ----GSLAKIYQEYHLKDSQVSAYTW--QILNGLKYLHEQN 310
            G     +     L+LVTQ    GSL    +++           W  QI  G+ YL E  
Sbjct: 99  LGLCPGSS-----LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 311 VIHR 314
           ++HR
Sbjct: 154 MVHR 157

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 178 CHNCGVLHR 186

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 12/124 (9%)
Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LGSG FG+V++G +  +G    +       +   G QS   +   +  +G  +H +IV+ 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 257 FGTEKDENKLYIFLELVTQ----GSLAKIYQEYHLKDSQVSAYTW--QILNGLKYLHEQN 310
            G     +     L+LVTQ    GSL    +++           W  QI  G+ YL E  
Sbjct: 81  LGLCPGSS-----LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 311 VIHR 314
           ++HR
Sbjct: 136 MVHR 139

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 131 CHNCGVLHR 139

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQFE 249
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 250 H--DNIVQYFGTEKDENKLYIFLEL--VTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE     Q     I +   L++    ++ WQ+L  +++
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 159 CHNCGVLHR 167

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	317
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-53
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-41
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-21
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-20
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-20
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-20
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-18
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-17
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-16
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-15
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-15
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-15
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-15
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-14
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-14
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-14
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-14
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-14
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-14
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-14
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-14
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-14
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-14
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-14
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-13
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-13
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-13
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-13
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-13
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-13
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-13
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-13
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-12
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-12
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-12
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-11
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-11
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-10
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-10
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-10
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-10
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-10
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-09
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-08
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-08
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-07
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-07
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-06
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-06
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-06
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-05
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-05
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-04
2l1w_B	26	Vacuolar calcium ATPase BCA1 peptide; calmodulin,	3e-04

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  174 bits (444), Expect = 5e-53
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 10/140 (7%)

Query: 180 SLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQL 238
           S   +Y            LG G++G VY G    +    A+KE+  +D      +    L
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPL 66

Query: 239 EQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH----LKDSQVSA 294
            +EI+L    +H NIVQY G+  +   + IF+E V  GSL+ + +         +  +  
Sbjct: 67  HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126

Query: 295 YTWQILNGLKYLHEQNVIHR 314
           YT QIL GLKYLH+  ++HR
Sbjct: 127 YTKQILEGLKYLHDNQIVHR 146

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  154 bits (391), Expect = 1e-44
 Identities = 40/181 (22%), Positives = 74/181 (40%), Gaps = 15/181 (8%)

Query: 136 VSSSEYTMTEAAEAGRFQDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKG 195
              +    + A            +   ++D+  + L  +L     ++ +YR  +      
Sbjct: 7   SGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKL---KPVDYEYREEVHWMTHQ 63

Query: 196 APLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
             +G GSFG V+       GF  AVK+V L+              +E+          IV
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIV 113

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIH 313
             +G  ++   + IF+EL+  GSL ++ ++   L + +   Y  Q L GL+YLH + ++H
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173

Query: 314 R 314
            
Sbjct: 174 G 174

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  144 bits (366), Expect = 2e-41
 Identities = 34/131 (25%), Positives = 65/131 (49%), Gaps = 11/131 (8%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
            +    +G GSF +VY+G  T+     A  E+  +      +    + ++E  +L   +H
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQH 84

Query: 251 DNIVQYFG----TEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKY 305
            NIV+++     T K +  + +  EL+T G+L    + +  +K   + ++  QIL GL++
Sbjct: 85  PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144

Query: 306 LHEQN--VIHR 314
           LH +   +IHR
Sbjct: 145 LHTRTPPIIHR 155

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  138 bits (351), Expect = 3e-39
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 11/141 (7%)

Query: 180 SLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQL 238
            +  +Y      + +   +GSG FGSV++     DG  +A+K       G+  EQ+ L+ 
Sbjct: 4   GMKSRYTTE---FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR- 59

Query: 239 EQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVS 293
            +  +     +H ++V+YF    +++ + I  E    GSLA    E      + K++++ 
Sbjct: 60  -EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK 118

Query: 294 AYTWQILNGLKYLHEQNVIHR 314
               Q+  GL+Y+H  +++H 
Sbjct: 119 DLLLQVGRGLRYIHSMSLVHM 139

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (324), Expect = 1e-34
 Identities = 25/140 (17%), Positives = 61/140 (43%), Gaps = 7/140 (5%)

Query: 178 NFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           + S NE    +   +     +GSG    V++   +    +A+K V+L++      Q++  
Sbjct: 44  SSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLDS 100

Query: 238 LEQEISLLGQFEH--DNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSA 294
              EI+ L + +   D I++ +  E  +  +Y+ +E      L   + ++  +   +  +
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKS 159

Query: 295 YTWQILNGLKYLHEQNVIHR 314
           Y   +L  +  +H+  ++H 
Sbjct: 160 YWKNMLEAVHTIHQHGIVHS 179

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  124 bits (313), Expect = 1e-33
 Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 6/127 (4%)

Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           S+Q+ + LG GS+G V++    +DG  +AVK      +G +     L   +  S     +
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA--EVGSHEKVGQ 115

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLH 307
           H   V+     ++   LY+  EL    SL +  + +   L ++QV  Y    L  L +LH
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 308 EQNVIHR 314
            Q ++H 
Sbjct: 175 SQGLVHL 181

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  121 bits (306), Expect = 2e-32
 Identities = 35/129 (27%), Positives = 66/129 (51%), Gaps = 8/129 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++    +G G F  VY      DG   A+K+V + D      ++     +EI LL Q  H
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA--DCIKEIDLLKQLNH 91

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKY 305
            N+++Y+ +  ++N+L I LEL   G L+++ + +      + +  V  Y  Q+ + L++
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 306 LHEQNVIHR 314
           +H + V+HR
Sbjct: 152 MHSRRVMHR 160

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  120 bits (303), Expect = 5e-32
 Identities = 22/138 (15%), Positives = 57/138 (41%), Gaps = 7/138 (5%)

Query: 180 SLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLE 239
              +    +   +     +GSG    V++   +    +A+K V+L++      Q++    
Sbjct: 18  LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLDSYR 74

Query: 240 QEISLLGQFEH--DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYT 296
            EI+ L + +   D I++ +  E  +  +Y+ +E      L    ++   +   +  +Y 
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYW 133

Query: 297 WQILNGLKYLHEQNVIHR 314
             +L  +  +H+  ++H 
Sbjct: 134 KNMLEAVHTIHQHGIVHS 151

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  120 bits (304), Expect = 5e-32
 Identities = 22/126 (17%), Positives = 55/126 (43%), Gaps = 7/126 (5%)

Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH- 250
           +     +GSG    V++   +    +A+K V+L++      Q++     EI+ L + +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQH 67

Query: 251 -DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHE 308
            D I++ +  E  +  +Y+ +E      L    ++   +   +  +Y   +L  +  +H+
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 309 QNVIHR 314
             ++H 
Sbjct: 127 HGIVHS 132

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  111 bits (280), Expect = 4e-28
 Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 12/128 (9%)

Query: 190 MSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF- 248
           +S+     LG G+ G++      D    AVK +  +             ++E+ LL +  
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--------FSFADREVQLLRESD 75

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYT--WQILNGLKYL 306
           EH N+++YF TEKD    YI +EL    +L +  ++       +   T   Q  +GL +L
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 307 HEQNVIHR 314
           H  N++HR
Sbjct: 135 HSLNIVHR 142

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  106 bits (268), Expect = 3e-27
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 11/141 (7%)

Query: 180 SLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSV 235
           SL      +I  ++ G  LG GSF  VY       G   A+K +    +   G       
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ---- 56

Query: 236 LQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVS 293
            +++ E+ +  Q +H +I++ +   +D N +Y+ LE+   G + +  +       +++  
Sbjct: 57  -RVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR 115

Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            +  QI+ G+ YLH   ++HR
Sbjct: 116 HFMHQIITGMLYLHSHGILHR 136

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  107 bits (268), Expect = 7e-27
 Identities = 32/121 (26%), Positives = 61/121 (50%), Gaps = 7/121 (5%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSFG       T+DG  + +KE+++        +   +  +E+++L   +H NIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SKEREESRREVAVLANMKHPNIVQY 88

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIH 313
             + ++   LYI ++    G L K          ++ Q+  +  QI   LK++H++ ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148

Query: 314 R 314
           R
Sbjct: 149 R 149

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  101 bits (254), Expect = 3e-25
 Identities = 37/134 (27%), Positives = 58/134 (43%), Gaps = 10/134 (7%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEV---SLQDQGTQGEQSVLQLEQE 241
            R    + +G  LG G F   +E    D    FA K V    L     +      ++  E
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-----KMSME 65

Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQIL 300
           IS+     H ++V + G  +D + +++ LEL  + SL     +   L + +   Y  QI+
Sbjct: 66  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125

Query: 301 NGLKYLHEQNVIHR 314
            G +YLH   VIHR
Sbjct: 126 LGCQYLHRNRVIHR 139

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  101 bits (255), Expect = 5e-25
 Identities = 37/134 (27%), Positives = 58/134 (43%), Gaps = 10/134 (7%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQE 241
            R    + +G  LG G F   +E    D    FA K V    L     +      ++  E
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-----KMSME 91

Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQIL 300
           IS+     H ++V + G  +D + +++ LEL  + SL     +   L + +   Y  QI+
Sbjct: 92  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151

Query: 301 NGLKYLHEQNVIHR 314
            G +YLH   VIHR
Sbjct: 152 LGCQYLHRNRVIHR 165

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 98.5 bits (246), Expect = 4e-24
 Identities = 32/157 (20%), Positives = 66/157 (42%), Gaps = 32/157 (20%)

Query: 178 NFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVL 236
             ++++++      +++   +GSG FG V++     DG  + +K V   ++         
Sbjct: 2   AHTVDKRFGMD---FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--------- 49

Query: 237 QLEQEISLLGQFEHDNIVQYFG----------------TEKDENKLYIFLELVTQGSLAK 280
           + E+E+  L + +H NIV Y G                +      L+I +E   +G+L +
Sbjct: 50  KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109

Query: 281 IYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             ++     L          QI  G+ Y+H + +I+R
Sbjct: 110 WIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINR 146

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 97.8 bits (244), Expect = 9e-24
 Identities = 37/124 (29%), Positives = 66/124 (53%), Gaps = 5/124 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           + K   +G GSFG V++G         A+K + L     + E  +  ++QEI++L Q + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 79

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
             + +Y+G+   + KL+I +E +  GS   + +   L ++Q++    +IL GL YLH + 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 139

Query: 311 VIHR 314
            IHR
Sbjct: 140 KIHR 143

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 97.4 bits (243), Expect = 1e-23
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 8/126 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W+    LG G+FG VY+    + G   A K +  +      E+ +     EI +L   +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDH 75

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
             IV+  G    + KL+I +E    G++  I  E    L + Q+     Q+L  L +LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 309 QNVIHR 314
           + +IHR
Sbjct: 136 KRIIHR 141

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.1 bits (242), Expect = 2e-23
 Identities = 33/124 (26%), Positives = 57/124 (45%), Gaps = 6/124 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
                 +G GS G V        G   AVK + L+ Q  +       L  E+ ++  ++H
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQH 101

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
            N+V+ + +     +L++ +E +  G+L  I  +  L + Q++     +L  L YLH Q 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 311 VIHR 314
           VIHR
Sbjct: 162 VIHR 165

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 96.6 bits (241), Expect = 2e-23
 Identities = 32/124 (25%), Positives = 63/124 (50%), Gaps = 6/124 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           + +   +G G+ G+VY       G   A+++++LQ Q          +  EI ++ + ++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKN 76

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
            NIV Y  +    ++L++ +E +  GSL  +  E  + + Q++A   + L  L++LH   
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 311 VIHR 314
           VIHR
Sbjct: 137 VIHR 140

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 96.1 bits (240), Expect = 2e-23
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 4/135 (2%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
           ++K +  +  ++ G PLG G FG+VY        F  A+K   L     +      QL +
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRR 58

Query: 241 EISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQI 299
           E+ +     H NI++ +G   D  ++Y+ LE    G++  ++ +     + + + Y  ++
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118

Query: 300 LNGLKYLHEQNVIHR 314
            N L Y H + VIHR
Sbjct: 119 ANALSYCHSKRVIHR 133

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.9 bits (239), Expect = 9e-23
 Identities = 34/126 (26%), Positives = 63/126 (50%), Gaps = 6/126 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +     +G GSFG+VY      +    A+K++S   + +  +   +   +E+  L +  H
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQKLRH 113

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
            N +QY G    E+  ++ +E    GS + + + +   L++ +++A T   L GL YLH 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 309 QNVIHR 314
            N+IHR
Sbjct: 173 HNMIHR 178

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 34/144 (23%), Positives = 61/144 (42%), Gaps = 22/144 (15%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           R    +++ A LG G+FG V +     D  ++A+K++         E+ +  +  E+ LL
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------EEKLSTILSEVMLL 56

Query: 246 GQFEHDNIVQYFGTEKDEN-------------KLYIFLELVTQGSLAKIYQEYHLKDSQV 292
               H  +V+Y+    +                L+I +E    G+L  +    +L   + 
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 293 SAYTW--QILNGLKYLHEQNVIHR 314
             +    QIL  L Y+H Q +IHR
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHR 140

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 94.0 bits (234), Expect = 2e-22
 Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 21/139 (15%)

Query: 193 QKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           +    LG G FG V+E     D   +A+K + L ++    E+    + +E+  L + EH 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK----VMREVKALAKLEHP 63

Query: 252 NIVQYFGTEKDENK------------LYIFLELVTQGSLAKIYQE----YHLKDSQVSAY 295
            IV+YF    ++N             LYI ++L  + +L             + S     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 296 TWQILNGLKYLHEQNVIHR 314
             QI   +++LH + ++HR
Sbjct: 124 FLQIAEAVEFLHSKGLMHR 142

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.0 bits (234), Expect = 3e-22
 Identities = 35/126 (27%), Positives = 66/126 (52%), Gaps = 10/126 (7%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +     LG GS+GSVY+    + G   A+K+V ++         + ++ +EIS++ Q + 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDS 83

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
            ++V+Y+G+      L+I +E    GS++ I +  +  L + +++      L GL+YLH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 309 QNVIHR 314
              IHR
Sbjct: 144 MRKIHR 149

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 93.0 bits (232), Expect = 4e-22
 Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 4/134 (2%)

Query: 183 EKYRRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQE 241
            K +  I  +  G PLG G FG+VY      + F  A+K V  + Q  +      QL +E
Sbjct: 7   PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALK-VLFKSQLEKEGV-EHQLRRE 64

Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQIL 300
           I +     H NI++ +    D  ++Y+ LE   +G L  ++ +     + + + +  ++ 
Sbjct: 65  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124

Query: 301 NGLKYLHEQNVIHR 314
           + L Y HE+ VIHR
Sbjct: 125 DALHYCHERKVIHR 138

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 94.5 bits (235), Expect = 5e-22
 Identities = 34/126 (26%), Positives = 55/126 (43%), Gaps = 18/126 (14%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQY 256
           LG GS G+V    +  G   AVK + +                EI LL +  +H N+++Y
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI--------ALMEIKLLTESDDHPNVIRY 74

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEY--------HLKDSQVSAYTWQILNGLKYLHE 308
           + +E  +  LYI LEL    +L  + +            K+    +   QI +G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 309 QNVIHR 314
             +IHR
Sbjct: 134 LKIIHR 139

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 14/163 (8%)

Query: 165 DDAEISLLMELVYNFSLNEKYRRRIMSWQK--------GAPLGSGSFGSVYEGF-TDDGF 215
           +++EI+L +     F   +        + K           LGSG+ G V   F      
Sbjct: 102 NNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCK 161

Query: 216 FFAVKEVS---LQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL 272
             A++ +S         +     L +E EI +L +  H  I++      D    YI LEL
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLEL 220

Query: 273 VTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +  G L  K+     LK++    Y +Q+L  ++YLHE  +IHR
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 90.8 bits (226), Expect = 2e-21
 Identities = 34/130 (26%), Positives = 57/130 (43%), Gaps = 16/130 (12%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G+GS+G   +     DG     KE+         +Q    L  E++LL + +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ---MLVSEVNLLRELKHPNIVRY 70

Query: 257 FGT--EKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQ 309
           +    ++    LYI +E    G LA +  +      +L +  V     Q+   LK  H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 310 N-----VIHR 314
           +     V+HR
Sbjct: 131 SDGGHTVLHR 140

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 90.9 bits (226), Expect = 4e-21
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 14/136 (10%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGFTDD-----GFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
           +R +   +K   LG G FG V     D      G   AVK  +L+     G Q     +Q
Sbjct: 30  KRYL---KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKA--DAGPQHRSGWKQ 82

Query: 241 EISLLGQFEHDNIVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQ 298
           EI +L    H++I++Y G   +     L + +E V  GSL      + +  +Q+  +  Q
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ 142

Query: 299 ILNGLKYLHEQNVIHR 314
           I  G+ YLH Q+ IHR
Sbjct: 143 ICEGMAYLHAQHYIHR 158

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 24/120 (20%), Positives = 48/120 (40%), Gaps = 7/120 (5%)

Query: 199 GSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           G     +V        G +  V+ ++L+    +       L+ E+ +   F H NIV Y 
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT---FLQGELHVSKLFNHPNIVPYR 92

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            T   +N+L++    +  GS   +   +    + +  ++     +L  L Y+H    +HR
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHR 152

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 89.4 bits (222), Expect = 1e-20
 Identities = 34/134 (25%), Positives = 67/134 (50%), Gaps = 17/134 (12%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-E 249
           ++    +G+G++G VY+G     G   A+K + +            +++QEI++L ++  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------GDEEEEIKQEINMLKKYSH 79

Query: 250 HDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQIL 300
           H NI  Y+G          +++L++ +E    GS+  + +      LK+  ++    +IL
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 301 NGLKYLHEQNVIHR 314
            GL +LH+  VIHR
Sbjct: 140 RGLSHLHQHKVIHR 153

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 88.2 bits (219), Expect = 4e-20
 Identities = 37/142 (26%), Positives = 60/142 (42%), Gaps = 25/142 (17%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
            R +   +  + LG G+FGSV          + G   AVK   LQ  G   ++   +   
Sbjct: 22  ERHL---KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQR--- 73

Query: 241 EISLLGQFEHDNIVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEY------HLKDSQV 292
           EI +L     D IV+Y G         L + +E +  G L    +++       L  S++
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL----RDFLQRHRARLDASRL 129

Query: 293 SAYTWQILNGLKYLHEQNVIHR 314
             Y+ QI  G++YL  +  +HR
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHR 151

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 87.8 bits (218), Expect = 4e-20
 Identities = 33/133 (24%), Positives = 67/133 (50%), Gaps = 14/133 (10%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++    +GSG+   V   +        A+K ++L     + + S+ +L +EI  + Q  H
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQAMSQCHH 72

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH---------LKDSQVSAYTWQILN 301
            NIV Y+ +   +++L++ ++L++ GS+  I +            L +S ++    ++L 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 302 GLKYLHEQNVIHR 314
           GL+YLH+   IHR
Sbjct: 133 GLEYLHKNGQIHR 145

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 88.4 bits (219), Expect = 5e-20
 Identities = 27/120 (22%), Positives = 57/120 (47%), Gaps = 7/120 (5%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG+G+ G V++      G   A K + L            Q+ +E+ +L +     IV +
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIVGF 96

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQ-NVIHR 314
           +G    + ++ I +E +  GSL ++ ++   + +  +   +  ++ GL YL E+  ++HR
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 87.9 bits (218), Expect = 5e-20
 Identities = 32/130 (24%), Positives = 55/130 (42%), Gaps = 11/130 (8%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W     LG G+  +V+ G     G  FA+K  +        +       +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV----QMREFEVLKKLNH 66

Query: 251 DNIVQYFGTEKDENKLYIFL--ELVTQGSLAKIYQE----YHLKDSQVSAYTWQILNGLK 304
            NIV+ F  E++    +  L  E    GSL  + +E    Y L +S+       ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 305 YLHEQNVIHR 314
           +L E  ++HR
Sbjct: 127 HLRENGIVHR 136

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 87.0 bits (216), Expect = 7e-20
 Identities = 42/142 (29%), Positives = 63/142 (44%), Gaps = 24/142 (16%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
           +R +   ++   LG G FG V          + G   AVK  SL+     G   +  L++
Sbjct: 20  KRFL---KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKP--ESGGNHIADLKK 72

Query: 241 EISLLGQFEHDNIVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEY------HLKDSQV 292
           EI +L    H+NIV+Y G  TE   N + + +E +  GSL    +EY       +   Q 
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL----KEYLPKNKNKINLKQQ 128

Query: 293 SAYTWQILNGLKYLHEQNVIHR 314
             Y  QI  G+ YL  +  +HR
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHR 150

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 32/130 (24%), Positives = 55/130 (42%), Gaps = 11/130 (8%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W     LG G+  +V+ G     G  FA+K  +        +       +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV----QMREFEVLKKLNH 66

Query: 251 DNIVQYFGTEKDENKLYIFL--ELVTQGSLAKIYQE----YHLKDSQVSAYTWQILNGLK 304
            NIV+ F  E++    +  L  E    GSL  + +E    Y L +S+       ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 305 YLHEQNVIHR 314
           +L E  ++HR
Sbjct: 127 HLRENGIVHR 136

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 28/128 (21%), Positives = 51/128 (39%), Gaps = 15/128 (11%)

Query: 197 PLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
            LG G F  V       DG F+A+K +   +     +Q   + ++E  +   F H NI++
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHPNILR 90

Query: 256 YFGTEKDE----NKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYL 306
                  E    ++ ++ L    +G+L    +        L + Q+      I  GL+ +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 307 HEQNVIHR 314
           H +   HR
Sbjct: 151 HAKGYAHR 158

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 33/155 (21%), Positives = 63/155 (40%), Gaps = 14/155 (9%)

Query: 169 ISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQ 227
           +S+        S  + +       +    +G G++GSV +      G   AVK +     
Sbjct: 1   MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--- 57

Query: 228 GTQGEQSVLQLEQEIS-LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH 286
            T  E+   QL  ++  ++   +   IVQ++G    E   +I +EL++  S  K Y+  +
Sbjct: 58  -TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVY 115

Query: 287 ------LKDSQVSAYTWQILNGLKYLHEQ-NVIHR 314
                 + +  +   T   +  L +L E   +IHR
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHR 150

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 38/125 (30%), Positives = 56/125 (44%), Gaps = 6/125 (4%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQEISLLGQFEH 250
              LGSG+ G V   F        A+K +S         +     L +E EI +L +  H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
             I++      D    YI LEL+  G L  K+     LK++    Y +Q+L  ++YLHE 
Sbjct: 75  PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133

Query: 310 NVIHR 314
            +IHR
Sbjct: 134 GIIHR 138

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 34/126 (26%), Positives = 54/126 (42%), Gaps = 6/126 (4%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              +G G F  V      + G  FAVK V +    +    S   L++E S+    +H +I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-----AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           V+   T   +  LY+  E +    L      +    +   ++  S Y  QIL  L+Y H+
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 309 QNVIHR 314
            N+IHR
Sbjct: 149 NNIIHR 154

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.3 bits (209), Expect = 7e-19
 Identities = 41/142 (28%), Positives = 62/142 (43%), Gaps = 25/142 (17%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
            R +   +    LG G+FGSV          + G   AVK   LQ   T+      +  +
Sbjct: 40  ERHL---KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQH-STEEHLRDFE--R 91

Query: 241 EISLLGQFEHDNIVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEY------HLKDSQV 292
           EI +L   +HDNIV+Y G         L + +E +  GSL    ++Y       +   ++
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL----RDYLQKHKERIDHIKL 147

Query: 293 SAYTWQILNGLKYLHEQNVIHR 314
             YT QI  G++YL  +  IHR
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHR 169

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 83.4 bits (207), Expect = 9e-19
 Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 12/155 (7%)

Query: 162 ISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVK 220
           +       S    L +  +  E+Y            LG GSFG V +         +AVK
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERY-------NIVCMLGKGSFGEVLKCKDRITQQEYAVK 53

Query: 221 EVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-A 279
            ++      +   ++    +E+ LL + +H NI++ F   +D +  YI  EL T G L  
Sbjct: 54  VINKASAKNKDTSTI---LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110

Query: 280 KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +I +     +   +    Q+ +G+ Y+H+ N++HR
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 83.5 bits (207), Expect = 9e-19
 Identities = 31/125 (24%), Positives = 54/125 (43%), Gaps = 13/125 (10%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS-LLGQFEHDNIVQ 255
           LG G++G V +      G   AVK +      T   Q   +L  ++   +   +    V 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDISMRTVDCPFTVT 70

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD-----SQVSAYTWQILNGLKYLHEQ- 309
           ++G    E  ++I +EL+   SL K Y++   K        +      I+  L++LH + 
Sbjct: 71  FYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 310 NVIHR 314
           +VIHR
Sbjct: 130 SVIHR 134

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 23/162 (14%), Positives = 55/162 (33%), Gaps = 23/162 (14%)

Query: 175 LVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVS----------- 223
           L+Y     ++  + I  ++    L  G F  +      D  F+A+K+             
Sbjct: 16  LIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFT 74

Query: 224 -LQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL---- 278
              +     +      + E+ ++   +++  +   G   + +++YI  E +   S+    
Sbjct: 75  KSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD 134

Query: 279 -----AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ-NVIHR 314
                        +    +      +LN   Y+H + N+ HR
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 41/142 (28%), Positives = 62/142 (43%), Gaps = 25/142 (17%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
            R +   +    LG G+FGSV          + G   AVK   LQ   T+      +  +
Sbjct: 9   ERHL---KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQH-STEEHLRDFE--R 60

Query: 241 EISLLGQFEHDNIVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEY------HLKDSQV 292
           EI +L   +HDNIV+Y G         L + +E +  GSL    ++Y       +   ++
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL----RDYLQKHKERIDHIKL 116

Query: 293 SAYTWQILNGLKYLHEQNVIHR 314
             YT QI  G++YL  +  IHR
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHR 138

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 32/123 (26%), Positives = 63/123 (51%), Gaps = 3/123 (2%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LGSG F  V +      G  +A K +  +    ++   S  ++E+E+++L +  H N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           I+      +++  + + LELV+ G L   + ++  L + + + +  QIL+G+ YLH + +
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129

Query: 312 IHR 314
            H 
Sbjct: 130 AHF 132

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 30/122 (24%), Positives = 56/122 (45%), Gaps = 5/122 (4%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LGSG++G V            A+K +      T       +L +E+++L   +H NI
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS---KLLEEVAVLKLLDHPNI 98

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           ++ +   +D+   Y+ +E    G L  +I       +   +    Q+L+G+ YLH+ N++
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158

Query: 313 HR 314
           HR
Sbjct: 159 HR 160

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 82.2 bits (204), Expect = 4e-18
 Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 7/122 (5%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LGSG+F  V+       G  FA+K +               LE EI++L + +H+NI
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-----LENEIAVLKKIKHENI 68

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V      +     Y+ ++LV+ G L  +I +     +   S    Q+L+ +KYLHE  ++
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 313 HR 314
           HR
Sbjct: 129 HR 130

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 82.0 bits (203), Expect = 4e-18
 Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 8/120 (6%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G FG   +    + G    +KE+   D     E++     +E+ ++   EH N++++
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFD-----EETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 257 FGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            G    + +L    E +  G+L  I    +     SQ  ++   I +G+ YLH  N+IHR
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 34/126 (26%), Positives = 60/126 (47%), Gaps = 10/126 (7%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LGSG+FG V+       G    +K ++      + +  + Q+E EI +L   +H NI
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINK----DRSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-----AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           ++ F   +D + +YI +E    G L     +   +   L +  V+    Q++N L Y H 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142

Query: 309 QNVIHR 314
           Q+V+H+
Sbjct: 143 QHVVHK 148

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 82.8 bits (205), Expect = 4e-18
 Identities = 37/145 (25%), Positives = 65/145 (44%), Gaps = 10/145 (6%)

Query: 173 MELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQG 231
           ME      + + Y         G  LGSG F  V +      G  +A K +  +      
Sbjct: 2   METFKQQKVEDFY-------DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR 54

Query: 232 EQSVLQ-LEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKD 289
                + +E+E+S+L Q  H NI+      ++   + + LELV+ G L   + Q+  L +
Sbjct: 55  RGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE 114

Query: 290 SQVSAYTWQILNGLKYLHEQNVIHR 314
            + +++  QIL+G+ YLH + + H 
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHF 139

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 34/123 (27%), Positives = 64/123 (52%), Gaps = 3/123 (2%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LGSG F  V +      G  +A K +  +  + ++   S  ++E+E+S+L Q  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++      ++   + + LELV+ G L   + Q+  L + + +++  QIL+G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 312 IHR 314
            H 
Sbjct: 137 AHF 139

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 33/122 (27%), Positives = 57/122 (46%), Gaps = 4/122 (3%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LG GSFG V        G   AVK   +  +  + +     L +E+ LL Q +H NI
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           ++ +   +D+   Y+  E+ T G L  +I       +   +    Q+L+G+ Y+H+  ++
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 148

Query: 313 HR 314
           HR
Sbjct: 149 HR 150

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 81.9 bits (203), Expect = 7e-18
 Identities = 33/123 (26%), Positives = 62/123 (50%), Gaps = 3/123 (2%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LGSG F  V +      G  +A K +  +  + ++   S   +E+E+S+L + +H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++      +++  + + LELV  G L   + ++  L + + + +  QILNG+ YLH   +
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135

Query: 312 IHR 314
            H 
Sbjct: 136 AHF 138

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 81.1 bits (201), Expect = 7e-18
 Identities = 30/122 (24%), Positives = 57/122 (46%), Gaps = 7/122 (5%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              +G GS+G V            A K++          + V + +QEI ++   +H NI
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-----KYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           ++ + T +D   +Y+ +EL T G L  ++  +   ++S  +     +L+ + Y H+ NV 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 313 HR 314
           HR
Sbjct: 129 HR 130

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 12/155 (7%)

Query: 162 ISDDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVK 220
           +       S    L +  +  E+Y            LG GSFG V +         +AVK
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERY-------NIVCMLGKGSFGEVLKCKDRITQQEYAVK 53

Query: 221 EVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-A 279
            ++      +   ++    +E+ LL + +H NI++ F   +D +  YI  EL T G L  
Sbjct: 54  VINKASAKNKDTSTI---LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110

Query: 280 KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +I +     +   +    Q+ +G+ Y+H+ N++HR
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 80.3 bits (199), Expect = 1e-17
 Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 5/122 (4%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LG G+F  V        G  FA K ++ +    +  Q +   E+E  +  + +H NI
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL---EREARICRKLQHPNI 67

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V+   + ++E+  Y+  +LVT G L   I       ++  S    QIL  + Y H   ++
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127

Query: 313 HR 314
           HR
Sbjct: 128 HR 129

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 80.0 bits (198), Expect = 1e-17
 Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 5/120 (4%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G FG VY  F   G   AVK  +  D      Q++  + QE  L    +H NI+   
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN---VIHR 314
           G    E  L + +E    G L ++     +    +  +  QI  G+ YLH++    +IHR
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 35/130 (26%), Positives = 58/130 (44%), Gaps = 10/130 (7%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS--------LQDQGTQGEQSVLQLEQEISLL 245
              LGSG++G V      +     A+K +           D     E+   ++  EISLL
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLK 304
              +H NI++ F   +D+   Y+  E    G L  +I   +   +   +    QIL+G+ 
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160

Query: 305 YLHEQNVIHR 314
           YLH+ N++HR
Sbjct: 161 YLHKHNIVHR 170

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 40/141 (28%), Positives = 71/141 (50%), Gaps = 22/141 (15%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V LQD+  +         +E+ +
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--------RELQI 100

Query: 245 LGQFEHDNIVQ---YF---GTEKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVS 293
           + + +H NIV+   +F   G +KDE  L + L+ V + ++ ++ + Y      L    V 
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159

Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            Y +Q+   L Y+H   + HR
Sbjct: 160 LYMYQLFRSLAYIHSFGICHR 180

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 35/140 (25%), Positives = 68/140 (48%), Gaps = 21/140 (15%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
            +R +++     +G+GSFG V++    +    A+K+V LQD+  +         +E+ ++
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKN--------RELQIM 86

Query: 246 GQFEHDNIVQ---YF---GTEKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSA 294
              +H N+V    +F   G +KDE  L + LE V + ++ +  + Y      +    +  
Sbjct: 87  RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKL 145

Query: 295 YTWQILNGLKYLHEQNVIHR 314
           Y +Q+L  L Y+H   + HR
Sbjct: 146 YMYQLLRSLAYIHSIGICHR 165

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 24/157 (15%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVS----------------- 223
           +     ++  +     +G GS+G V   +  +D  ++A+K +S                 
Sbjct: 5   SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64

Query: 224 ----LQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFG--TEKDENKLYIFLELVTQGS 277
                     Q    + Q+ QEI++L + +H N+V+      + +E+ LY+  ELV QG 
Sbjct: 65  GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124

Query: 278 LAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + ++     L + Q   Y   ++ G++YLH Q +IHR
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHR 161

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 79.7 bits (197), Expect = 5e-17
 Identities = 35/138 (25%), Positives = 68/138 (49%), Gaps = 13/138 (9%)

Query: 180 SLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQL 238
           ++N  Y     +  K   LG G FG V++   T  G   A K +      T+G +   ++
Sbjct: 84  AVNSFY-----TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEV 133

Query: 239 EQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL--AKIYQEYHLKDSQVSAYT 296
           + EIS++ Q +H N++Q +   + +N + + +E V  G L    I + Y+L +     + 
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFM 193

Query: 297 WQILNGLKYLHEQNVIHR 314
            QI  G++++H+  ++H 
Sbjct: 194 KQICEGIRHMHQMYILHL 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 78.9 bits (195), Expect = 6e-17
 Identities = 30/122 (24%), Positives = 56/122 (45%), Gaps = 10/122 (8%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS-LLGQFEHDNIVQ 255
           +GSG+ G V++      G   AVK++      +  ++   ++  ++  +L   +   IVQ
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRR----SGNKEENKRILMDLDVVLKSHDCPYIVQ 88

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQ-NVI 312
            FGT      ++I +EL+      K+ +     + +  +   T  I+  L YL E+  VI
Sbjct: 89  CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147

Query: 313 HR 314
           HR
Sbjct: 148 HR 149

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.3 bits (196), Expect = 6e-17
 Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 5/122 (4%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LG G+F  V        G  FA K ++ +    +  Q +   E+E  +  + +H NI
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL---EREARICRKLQHPNI 90

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V+   + ++E+  Y+  +LVT G L   I       ++  S    QIL  + Y H   ++
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150

Query: 313 HR 314
           HR
Sbjct: 151 HR 152

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.9 bits (197), Expect = 8e-17
 Identities = 30/123 (24%), Positives = 53/123 (43%), Gaps = 8/123 (6%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LG+G+FG V+       G  FA K V      T  E     + +EI  +    H  +
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTMSVLRHPTL 216

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V      +D+N++ +  E ++ G L +    +   + + +   Y  Q+  GL ++HE N 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 312 IHR 314
           +H 
Sbjct: 277 VHL 279

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 30/122 (24%), Positives = 52/122 (42%), Gaps = 5/122 (4%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LG G+F  V        G  +A   ++ +    +  Q +   E+E  +    +H NI
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL---EREARICRLLKHPNI 72

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V+   +  +E   Y+  +LVT G L   I    +  ++  S    QIL  + + H+  V+
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132

Query: 313 HR 314
           HR
Sbjct: 133 HR 134

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 32/122 (26%), Positives = 56/122 (45%), Gaps = 9/122 (7%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
            + LG G+   VY          +A+K +      T  ++ V     EI +L +  H NI
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIV---RTEIGVLLRLSHPNI 110

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           ++     +   ++ + LELVT G L  +I ++ +  +   +    QIL  + YLHE  ++
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 313 HR 314
           HR
Sbjct: 171 HR 172

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 33/123 (26%), Positives = 60/123 (48%), Gaps = 8/123 (6%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LGSG+FG V+       G  F  K ++     T        ++ EIS++ Q  H  +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKL 110

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNV 311
           +      +D+ ++ + LE ++ G L  +I  E Y + +++V  Y  Q   GLK++HE ++
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170

Query: 312 IHR 314
           +H 
Sbjct: 171 VHL 173

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 77.9 bits (192), Expect = 1e-16
 Identities = 29/162 (17%), Positives = 55/162 (33%), Gaps = 42/162 (25%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              +G GS+G V            A+K ++         + V +++ E+ L+ +  H NI
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL----------------------------------- 278
            + +   +DE  + + +EL   G L                                   
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 279 ------AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                  +   ++  ++  +S    QI + L YLH Q + HR
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 76.8 bits (190), Expect = 2e-16
 Identities = 32/122 (26%), Positives = 53/122 (43%), Gaps = 8/122 (6%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              LGSG FG V  G     +  AVK +    +G+  E    Q   E   + +  H  +V
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQ---EAQTMMKLSHPKLV 66

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVI 312
           +++G    E  +YI  E ++ G L    + +   L+ SQ+    + +  G+ +L     I
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126

Query: 313 HR 314
           HR
Sbjct: 127 HR 128

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 33/139 (23%), Positives = 54/139 (38%), Gaps = 15/139 (10%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           +    W+    LG+G FG V      D G   A+K+   +       ++  +   EI ++
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIM 66

Query: 246 GQFEHDNIVQYFGTEKDENKL------YIFLELVTQGSLAKIYQE----YHLKDSQVSAY 295
            +  H N+V          KL       + +E    G L K   +      LK+  +   
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 296 TWQILNGLKYLHEQNVIHR 314
              I + L+YLHE  +IHR
Sbjct: 127 LSDISSALRYLHENRIIHR 145

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 76.5 bits (189), Expect = 4e-16
 Identities = 27/123 (21%), Positives = 54/123 (43%), Gaps = 9/123 (7%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LG G FG V+    T     +  K V ++          + +++EIS+L    H NI
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNI 63

Query: 254 VQYFGTEKDENKLYIFLELVTQGSL-AKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNV 311
           +    + +   +L +  E ++   +  +I    + L + ++ +Y  Q+   L++LH  N+
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 312 IHR 314
            H 
Sbjct: 124 GHF 126

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 76.1 bits (188), Expect = 4e-16
 Identities = 26/127 (20%), Positives = 52/127 (40%), Gaps = 7/127 (5%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSV----LQLEQEISLLGQ-F 248
              LG G    V           +AVK + +   G+   + V        +E+ +L +  
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
            H NI+Q   T +     ++  +L+ +G L   + ++  L + +       +L  +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141

Query: 308 EQNVIHR 314
           + N++HR
Sbjct: 142 KLNIVHR 148

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 9/121 (7%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+FG V+ G    D    AVK      + T       +  QE  +L Q+ H NIV+ 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
            G    +  +YI +ELV  G     +   +   L+   +         G++YL  +  IH
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDF-LTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236

Query: 314 R 314
           R
Sbjct: 237 R 237

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 17/129 (13%)

Query: 198 LGSGSFGSVYEGFTDD------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG G+F  VYE    D         F +K   +Q      E  +    Q +  L      
Sbjct: 73  LGEGAFAQVYEATQGDLNDAKNKQKFVLK---VQKPANPWEFYIG--TQLMERLKPSMQH 127

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSL------AKIYQEYHLKDSQVSAYTWQILNGLKY 305
             ++++     +N   +  EL + G+L       K   E  +    V ++  ++L  ++ 
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 306 LHEQNVIHR 314
           +H+  +IH 
Sbjct: 188 VHDCEIIHG 196

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 25/126 (19%), Positives = 53/126 (42%), Gaps = 6/126 (4%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQEISLLGQ-FE 249
              +G G    V        G  FAVK +     +    Q E+      +E  +L Q   
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H +I+    + +  + +++  +L+ +G L   + ++  L + +  +    +L  + +LH 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218

Query: 309 QNVIHR 314
            N++HR
Sbjct: 219 NNIVHR 224

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 75.3 bits (186), Expect = 7e-16
 Identities = 31/130 (23%), Positives = 59/130 (45%), Gaps = 6/130 (4%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
             +  W     LG G++G V            AVK V ++    +       +++EI + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPENIKKEICIN 59

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLK 304
               H+N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 305 YLHEQNVIHR 314
           YLH   + HR
Sbjct: 120 YLHGIGITHR 129

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 26/119 (21%), Positives = 52/119 (43%), Gaps = 8/119 (6%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V  G     +  A+K +    +G+  E   ++   E  ++    H+ +VQ +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIE---EAKVMMNLSHEKLVQLY 85

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G    +  ++I  E +  G L    +E  +  +  Q+      +   ++YL  +  +HR
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 74.5 bits (184), Expect = 1e-15
 Identities = 29/123 (23%), Positives = 55/123 (44%), Gaps = 10/123 (8%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              +GSG FG V+ G+  +    A+K  ++++ G   E+  ++   E  ++ +  H  +V
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIK--TIRE-GAMSEEDFIE---EAEVMMKLSHPKLV 66

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           Q +G   ++  + +  E +  G L+  Y   Q        +      +  G+ YL E  V
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125

Query: 312 IHR 314
           IHR
Sbjct: 126 IHR 128

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 31/125 (24%), Positives = 52/125 (41%), Gaps = 13/125 (10%)

Query: 198 LGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG GSFG V  G     +      AVK   L+       +++    +E++ +   +H N+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 254 VQYFG--TEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           ++ +G         + +  EL   GSL       + H     +S Y  Q+  G+ YL  +
Sbjct: 84  IRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140

Query: 310 NVIHR 314
             IHR
Sbjct: 141 RFIHR 145

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 10/124 (8%)

Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LG G +G VYEG +       AVK +    + T   +  L+   E +++ + +H N+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLK---EAAVMKEIKHPNL 71

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           VQ  G    E   YI  E +T G+L    +      +    +     QI + ++YL ++N
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 311 VIHR 314
            IHR
Sbjct: 132 FIHR 135

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 39/130 (30%), Positives = 59/130 (45%), Gaps = 26/130 (20%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G FG VY+G   DG   A+K      + +QG +   + E EI  L    H ++V   
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALK--RRTPESSQGIE---EFETEIETLSFCRHPHLVSLI 101

Query: 258 G--TEKDENKL-YIFLELVTQGSLAKIYQEYHL--KDSQVSAYTWQI-LN-------GLK 304
           G   E++E  L Y   + +  G+L     + HL   D    + +W+  L        GL 
Sbjct: 102 GFCDERNEMILIY---KYMENGNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153

Query: 305 YLHEQNVIHR 314
           YLH + +IHR
Sbjct: 154 YLHTRAIIHR 163

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 26/128 (20%), Positives = 51/128 (39%), Gaps = 12/128 (9%)

Query: 194 KGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD- 251
               LG G F  V +      G  +A K +  + +G      +     EI++L   +   
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI---LHEIAVLELAKSCP 89

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSL-----AKIYQEYHLKDSQVSAYTWQILNGLKYL 306
            ++      ++ +++ + LE    G +      ++ +     D  V     QIL G+ YL
Sbjct: 90  RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND--VIRLIKQILEGVYYL 147

Query: 307 HEQNVIHR 314
           H+ N++H 
Sbjct: 148 HQNNIVHL 155

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 30/124 (24%), Positives = 51/124 (41%), Gaps = 12/124 (9%)

Query: 198 LGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +GSG  G V  G            A+K  +L+   T+ ++       E S++GQF+H NI
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIK--ALKAGYTERQRR--DFLSEASIMGQFDHPNI 112

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           ++  G         I  E +  GSL   +    +      Q+      +  G++YL +  
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 311 VIHR 314
            +HR
Sbjct: 172 YVHR 175

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 31/164 (18%), Positives = 62/164 (37%), Gaps = 27/164 (16%)

Query: 175 LVYNFSLNEKYRRRIMSW-------QKGAPLGSGSFGSVYEG--FTDDGFFF--AVKEVS 223
           ++ +  ++++ + ++            G  LG G FGSV E     +DG F   AVK + 
Sbjct: 1   MLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60

Query: 224 LQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFG--TEKD----ENKLYIFLELVTQGS 277
                      + +  +E + + +F+H ++ +  G               + L  +  G 
Sbjct: 61  ---ADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117

Query: 278 L-------AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           L             ++L    +  +   I  G++YL  +N IHR
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR 161

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 36/151 (23%), Positives = 58/151 (38%), Gaps = 20/151 (13%)

Query: 180 SLNEKYRRRIMSWQK---------GAPLGSGSFGSVYEG--FTDDGFFF--AVKEVSLQD 226
           +LN +  + +                 +G G FG VY G    +DG     AVK  SL  
Sbjct: 6   ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNR 63

Query: 227 QGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGT-EKDENKLYIFLELVTQGSLAKIYQE- 284
               GE S  Q   E  ++  F H N++   G   + E    + L  +  G L    +  
Sbjct: 64  ITDIGEVS--QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121

Query: 285 -YHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            ++     +  +  Q+  G+KYL  +  +HR
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKKFVHR 152

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 27/123 (21%), Positives = 53/123 (43%), Gaps = 9/123 (7%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           G  +G G FG VY G    +    A++ + ++      E  +   ++E+    Q  H+N+
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDN---EDQLKAFKREVMAYRQTRHENV 91

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           V + G       L I   L    +L  +    +  L  ++      +I+ G+ YLH + +
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 312 IHR 314
           +H+
Sbjct: 152 LHK 154

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 31/125 (24%), Positives = 57/125 (45%), Gaps = 6/125 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W     LG G++G V            AVK V +     +       +++EI +     H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 64

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           +N+V+++G  ++ N  Y+FLE  + G L  +I  +  + +     +  Q++ G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 310 NVIHR 314
            + HR
Sbjct: 125 GITHR 129

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 30/121 (24%), Positives = 58/121 (47%), Gaps = 11/121 (9%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV 254
           PLG GSF    +         FAVK +S        ++     ++EI+ L     H NIV
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQKEITALKLCEGHPNIV 69

Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           +      D+   ++ +EL+  G L  +I ++ H  +++ S    ++++ + ++H+  V+H
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129

Query: 314 R 314
           R
Sbjct: 130 R 130

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 27/131 (20%), Positives = 62/131 (47%), Gaps = 16/131 (12%)

Query: 193 QKGAPLGSGSFGSVYEG-FTDDGFFF----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +K   LGSG+FG+VY+G +  +G       A+K   L++      ++  ++  E  ++  
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELRE--ATSPKANKEILDEAYVMAS 73

Query: 248 FEHDNIVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGL 303
            ++ ++ +  G         + +  +L+  G L    +E+  ++    +  +  QI  G+
Sbjct: 74  VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 304 KYLHEQNVIHR 314
            YL ++ ++HR
Sbjct: 131 NYLEDRRLVHR 141

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 32/123 (26%), Positives = 53/123 (43%), Gaps = 12/123 (9%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDN 252
              +G GS+              FAVK +          +S     +EI +L ++ +H N
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID---------KSKRDPTEEIEILLRYGQHPN 77

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           I+       D   +Y+  EL+  G L  KI ++    + + SA  + I   ++YLH Q V
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 312 IHR 314
           +HR
Sbjct: 138 VHR 140

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 13/125 (10%)

Query: 198 LGSGSFGSVYEGF-----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           +G+G FG VY+G             A+K  +L+   T+ ++       E  ++GQF H N
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIK--TLKAGYTEKQRVDFL--GEAGIMGQFSHHN 107

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           I++  G       + I  E +  G+L K +   ++      Q+      I  G+KYL   
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 310 NVIHR 314
           N +HR
Sbjct: 167 NYVHR 171

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 12/129 (9%)

Query: 193 QKGAPLGSGSFGSVYEG-FTDDGFFF----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +K   LGSG FG+V++G +  +G        +K   ++D    G QS   +   +  +G 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK--VIED--KSGRQSFQAVTDHMLAIGS 71

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKY 305
            +H +IV+  G       L +  + +  GSL          L    +  +  QI  G+ Y
Sbjct: 72  LDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130

Query: 306 LHEQNVIHR 314
           L E  ++HR
Sbjct: 131 LEEHGMVHR 139

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 72.7 bits (179), Expect = 6e-15
 Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 8/125 (6%)

Query: 194 KGAPLGSGSFGSVYEG-FTDDGFFF--AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +   LGSG+FG+V +G +         AVK   L++          +L  E +++ Q ++
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVK--ILKN-EANDPALKDELLAEANVMQQLDN 77

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
             IV+  G  + E    + +E+   G L K  Q+  H+KD  +     Q+  G+KYL E 
Sbjct: 78  PYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 310 NVIHR 314
           N +HR
Sbjct: 137 NFVHR 141

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 33/123 (26%), Positives = 53/123 (43%), Gaps = 10/123 (8%)

Query: 198 LGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G+G FG V  G     +      A+K  +L+   T  E+       E S++GQF+H NI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIK--TLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++  G       + I  E +  GSL       +      Q+      I +G+KYL +   
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168

Query: 312 IHR 314
           +HR
Sbjct: 169 VHR 171

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 72.7 bits (179), Expect = 7e-15
 Identities = 34/122 (27%), Positives = 54/122 (44%), Gaps = 8/122 (6%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           G  +GSGSFG+VY+G        AVK +++     Q  Q+      E+ +L +  H NI+
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNIL 83

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
            + G       L I  +     SL       E   +  ++     Q   G+ YLH +++I
Sbjct: 84  LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142

Query: 313 HR 314
           HR
Sbjct: 143 HR 144

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 72.2 bits (178), Expect = 9e-15
 Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 14/125 (11%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              LG+G FG V+ G+ +     AVK +    QG+    + L    E +L+ Q +H  +V
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLV 71

Query: 255 QYFG--TEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           + +   T+     +YI  E +  GSL    K      L  +++     QI  G+ ++ E+
Sbjct: 72  RLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 310 NVIHR 314
           N IHR
Sbjct: 129 NYIHR 133

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 31/126 (24%), Positives = 59/126 (46%), Gaps = 7/126 (5%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++K   +G GS+G V++    D G   A+K+    +     ++  L+   EI +L Q +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLKH 61

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHE 308
            N+V      + + +L++  E     ++      Y   + +  V + TWQ L  + + H+
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 309 QNVIHR 314
            N IHR
Sbjct: 121 HNCIHR 126

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 33/127 (25%), Positives = 52/127 (40%), Gaps = 11/127 (8%)

Query: 195 GAPLGSGSFGSVYEG--FTDDGFFF--AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
              +G G FG VY G    +DG     AVK  SL      GE S  Q   E  ++  F H
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVS--QFLTEGIIMKDFSH 149

Query: 251 DNIVQYFGT-EKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLH 307
            N++   G   + E    + L  +  G L    +   ++     +  +  Q+  G+K+L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 308 EQNVIHR 314
            +  +HR
Sbjct: 210 SKKFVHR 216

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 33/122 (27%), Positives = 56/122 (45%), Gaps = 10/122 (8%)

Query: 198 LGSGSFGSVYEGF--TDDGFFF-AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G+FGSV +G           A+K   L+      +    ++ +E  ++ Q ++  IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTE--KADTEEMMREAQIMHQLDNPYIV 399

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVI 312
           +  G  + E  L + +E+   G L K        +  S V+    Q+  G+KYL E+N +
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458

Query: 313 HR 314
           HR
Sbjct: 459 HR 460

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 23/127 (18%), Positives = 48/127 (37%), Gaps = 15/127 (11%)

Query: 198 LGSGSFGSVYEG-FTDDGFFF-------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           LG G+F  +++G   + G +         +K   L        +S  +     S++ +  
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLK--VLDKAHRNYSESFFE---AASMMSKLS 70

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLH 307
           H ++V  +G     ++  +  E V  GSL    ++    +          Q+   + +L 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 308 EQNVIHR 314
           E  +IH 
Sbjct: 131 ENTLIHG 137

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 10/124 (8%)

Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              LG G +G VYEG +       AVK +    + T   +  L+   E +++ + +H N+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLK---EAAVMKEIKHPNL 278

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           VQ  G    E   YI  E +T G+L    +      +    +     QI + ++YL ++N
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 311 VIHR 314
            IHR
Sbjct: 339 FIHR 342

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 8/134 (5%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           + I  +  G  LG GS+G V E   ++     AVK +  + +  +       +++EI LL
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLL 60

Query: 246 GQFEHDNIVQYFG--TEKDENKLYIFLELVTQGS---LAKIYQEYHLKDSQVSAYTWQIL 300
            +  H N++Q       +++ K+Y+ +E    G    L  + ++      Q   Y  Q++
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLI 119

Query: 301 NGLKYLHEQNVIHR 314
           +GL+YLH Q ++H+
Sbjct: 120 DGLEYLHSQGIVHK 133

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 26/121 (21%), Positives = 55/121 (45%), Gaps = 8/121 (6%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIV 254
            LG G+   V           +AVK +       Q      ++ +E+ +L Q + H N++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIE-----KQPGHIRSRVFREVEMLYQCQGHRNVL 74

Query: 255 QYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           +     ++E++ Y+  E +  GS+ + I++  H  + + S     + + L +LH + + H
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAH 134

Query: 314 R 314
           R
Sbjct: 135 R 135

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 38/134 (28%), Positives = 53/134 (39%), Gaps = 18/134 (13%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
              LG G+FG VYEG              AVK  +L +  +  EQ  L    E  ++ +F
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCS--EQDELDFLMEALIISKF 90

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL--------AKIYQEYHLKDSQVSAYTWQIL 300
            H NIV+  G        +I +EL+  G L         +  Q   L    +      I 
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 301 NGLKYLHEQNVIHR 314
            G +YL E + IHR
Sbjct: 151 CGCQYLEENHFIHR 164

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 31/137 (22%), Positives = 55/137 (40%), Gaps = 21/137 (15%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
              LG GSFG VYEG              A+K  ++ +  +  E+   +   E S++ +F
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASMRERI--EFLNEASVMKEF 85

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-----------AKIYQEYHLKDSQVSAYTW 297
              ++V+  G         + +EL+T+G L           A          S++     
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 298 QILNGLKYLHEQNVIHR 314
           +I +G+ YL+    +HR
Sbjct: 146 EIADGMAYLNANKFVHR 162

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 33/135 (24%), Positives = 60/135 (44%), Gaps = 10/135 (7%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE---QSVLQLEQE 241
           + R   ++K   LG G F +VY+    +     A+K++ L  +    +   ++ L+   E
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---E 62

Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQI 299
           I LL +  H NI+        ++ + +  + +    L  I       L  S + AY    
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 300 LNGLKYLHEQNVIHR 314
           L GL+YLH+  ++HR
Sbjct: 122 LQGLEYLHQHWILHR 136

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 31/126 (24%), Positives = 58/126 (46%), Gaps = 10/126 (7%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              +G+GSFG+V+      G   AVK +  QD   +      +  +E++++ +  H NIV
Sbjct: 42  KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVN---EFLREVAIMKRLRHPNIV 97

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTW--QILNGLKYLHEQN 310
            + G       L I  E +++GSL ++        +  +    +    +  G+ YLH +N
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 311 --VIHR 314
             ++HR
Sbjct: 158 PPIVHR 163

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 33/128 (25%), Positives = 53/128 (41%), Gaps = 20/128 (15%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              +G G FG V  G    G   AVK   +++  T           E S++ Q  H N+V
Sbjct: 26  LQTIGKGEFGDVMLG-DYRGNKVAVK--CIKNDATAQA-----FLAEASVMTQLRHSNLV 77

Query: 255 QYFGT-EKDENKLYIFLELVTQGSLAKIYQEY-------HLKDSQVSAYTWQILNGLKYL 306
           Q  G   +++  LYI  E + +GSL     +Y        L    +  ++  +   ++YL
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 307 HEQNVIHR 314
              N +HR
Sbjct: 134 EGNNFVHR 141

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 39/134 (29%), Positives = 53/134 (39%), Gaps = 18/134 (13%)

Query: 195 GAPLGSGSFGSVYEGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
              LG G+FG VYEG              AVK  +L +  +  EQ  L    E  ++ +F
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCS--EQDELDFLMEALIISKF 131

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL--------AKIYQEYHLKDSQVSAYTWQIL 300
            H NIV+  G        +I LEL+  G L         +  Q   L    +      I 
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 301 NGLKYLHEQNVIHR 314
            G +YL E + IHR
Sbjct: 192 CGCQYLEENHFIHR 205

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 34/125 (27%), Positives = 59/125 (47%), Gaps = 14/125 (11%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              LG G FG V+ G  +     A+K +     GT   ++ LQ   E  ++ +  H+ +V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLV 325

Query: 255 QYFG--TEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           Q +   +E+    +YI  E +++GSL    K     +L+  Q+     QI +G+ Y+   
Sbjct: 326 QLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 310 NVIHR 314
           N +HR
Sbjct: 383 NYVHR 387

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 29/126 (23%), Positives = 59/126 (46%), Gaps = 6/126 (4%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVS---LQDQGTQGEQSVLQLEQEISLLGQFEH 250
            +PLGSG+FG V+     +      VK +    + +     +  + ++  EI++L + EH
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGS--LAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
            NI++     +++    + +E    G    A I +   L +   S    Q+++ + YL  
Sbjct: 89  ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148

Query: 309 QNVIHR 314
           +++IHR
Sbjct: 149 KDIIHR 154

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 36/135 (26%), Positives = 60/135 (44%), Gaps = 4/135 (2%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
               R +I  +  G  LG G+FG V  G     G   AVK   L  Q  +    V ++++
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK--ILNRQKIRSLDVVGKIKR 60

Query: 241 EISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQI 299
           EI  L  F H +I++ +         ++ +E V+ G L   I +   +++ +      QI
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120

Query: 300 LNGLKYLHEQNVIHR 314
           L+ + Y H   V+HR
Sbjct: 121 LSAVDYCHRHMVVHR 135

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 8/131 (6%)

Query: 188 RIMS-WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           + M  ++    +G GS+G V +    D G   A+K+    D     ++  ++   EI LL
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLL 78

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGL 303
            Q  H+N+V      K + + Y+  E V   ++    + +   L    V  Y +QI+NG+
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 304 KYLHEQNVIHR 314
            + H  N+IHR
Sbjct: 138 GFCHSHNIIHR 148

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 35/122 (28%), Positives = 61/122 (50%), Gaps = 10/122 (8%)

Query: 198 LGSGSFGSVYEGF---TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G+FGSV +G           A+K   L+  GT+ +    ++ +E  ++ Q ++  IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQ-GTE-KADTEEMMREAQIMHQLDNPYIV 73

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           +  G  + E  L + +E+   G L K  + +   +  S V+    Q+  G+KYL E+N +
Sbjct: 74  RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 313 HR 314
           HR
Sbjct: 133 HR 134

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 31/130 (23%), Positives = 50/130 (38%), Gaps = 13/130 (10%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFF----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
                +G G FG VY G   D        A+K  SL        Q V    +E  L+   
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITE--MQQVEAFLREGLLMRGL 79

Query: 249 EHDNIVQYFGT-EKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLK 304
            H N++   G     E   ++ L  +  G L   +    + +     + ++  Q+  G++
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDL-LQFIRSPQRNPTVKDLISFGLQVARGME 138

Query: 305 YLHEQNVIHR 314
           YL EQ  +HR
Sbjct: 139 YLAEQKFVHR 148

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 71.0 bits (175), Expect = 3e-14
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 8/133 (6%)

Query: 185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG-EQSVLQLEQEIS 243
           ++  +  +QK   +G G++G VY+     G   A+K + L D   +G   + ++   EIS
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL-DAEDEGIPSTAIR---EIS 71

Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILN 301
           LL +  H NIV        E  L +  E + +  L K+    +  L+DSQ+  Y +Q+L 
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLR 130

Query: 302 GLKYLHEQNVIHR 314
           G+ + H+  ++HR
Sbjct: 131 GVAHCHQHRILHR 143

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 32/127 (25%), Positives = 56/127 (44%), Gaps = 9/127 (7%)

Query: 195 GAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQS--VLQLEQEISLLGQFEHD 251
              +G G FG V++G    D    A+K + L D   + E      + ++E+ ++    H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIY--QEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           NIV+ +G     N   + +E V  G L      + + +K S        I  G++Y+  Q
Sbjct: 84  NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141

Query: 310 N--VIHR 314
           N  ++HR
Sbjct: 142 NPPIVHR 148

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 33/136 (24%), Positives = 53/136 (38%), Gaps = 19/136 (13%)

Query: 195 GAPLGSGSFGSVYEG--FTDDGFFF--AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  LG G FGSV EG    +DG     AVK +         ++ + +   E + +  F H
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK---LDNSSQREIEEFLSEAACMKDFSH 95

Query: 251 DNIVQYFG--TEKD---ENKLYIFLELVTQGSL-------AKIYQEYHLKDSQVSAYTWQ 298
            N+++  G   E       K  + L  +  G L              H+    +  +   
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 299 ILNGLKYLHEQNVIHR 314
           I  G++YL  +N +HR
Sbjct: 156 IALGMEYLSNRNFLHR 171

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 29/144 (20%), Positives = 67/144 (46%), Gaps = 18/144 (12%)

Query: 178 NFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVL 236
           ++ + ++Y       +    +G+GS+G V E +   +    A+K++    +     + +L
Sbjct: 48  DWQIPDRY-------EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL 100

Query: 237 QLEQEISLLGQFEHDNIVQ-----YFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDS 290
           +   EI++L +  HD++V+          +  ++LY+ LE+       K      +L + 
Sbjct: 101 R---EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTEL 156

Query: 291 QVSAYTWQILNGLKYLHEQNVIHR 314
            +    + +L G+KY+H   ++HR
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHR 180

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 70.8 bits (174), Expect = 4e-14
 Identities = 26/129 (20%), Positives = 60/129 (46%), Gaps = 12/129 (9%)

Query: 193 QKGAPLGSGSFGSVYEG-FTDDGFFF----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           +K   LGSG+FG+VY+G +  +G       A+K   L++      ++  ++  E  ++  
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELRE--ATSPKANKEILDEAYVMAS 73

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKY 305
            ++ ++ +  G       + +  +L+  G L       + ++    +  +  QI  G+ Y
Sbjct: 74  VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 306 LHEQNVIHR 314
           L ++ ++HR
Sbjct: 133 LEDRRLVHR 141

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 71.0 bits (174), Expect = 4e-14
 Identities = 33/134 (24%), Positives = 52/134 (38%), Gaps = 19/134 (14%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
                +G G FG V+ G    G   AVK  S ++     E+S  + E EI       H+N
Sbjct: 45  VLQESIGKGRFGEVWRG-KWRGEEVAVKIFSSRE-----ERSWFR-EAEIYQTVMLRHEN 97

Query: 253 IVQYFGTEKDENKLYIFLELVTQ----GSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           I+ +   +  +N  +  L LV+     GSL      Y +    +        +GL +LH 
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 309 Q--------NVIHR 314
           +         + HR
Sbjct: 158 EIVGTQGKPAIAHR 171

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 24/158 (15%)

Query: 173 MELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQG 231
           M L    + +E+ R+ +  +Q     G G+FG+V  G     G   A+K+V +QD   + 
Sbjct: 6   MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR- 63

Query: 232 EQSVLQLE-QEISLLGQFEHDNIVQ---YFGT----EKDENKLYIFLELVTQGSLAKIYQ 283
                  E Q +  L    H NIVQ   YF T    ++ +  L + +E V   +L +  +
Sbjct: 64  -----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR 117

Query: 284 EY-----HLKDSQVSAYTWQILNGLKYLHEQ--NVIHR 314
            Y           +  + +Q++  +  LH    NV HR
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR 155

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 70.4 bits (173), Expect = 5e-14
 Identities = 29/132 (21%), Positives = 64/132 (48%), Gaps = 10/132 (7%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQG--EQSVLQLEQEIS 243
             I  +++   LG G++G VY+   T      A+K + L +   +G    ++    +E+S
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAI----REVS 85

Query: 244 LLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNG 302
           LL + +H NI++        ++L++  E      L K + +   +    + ++ +Q++NG
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLING 144

Query: 303 LKYLHEQNVIHR 314
           + + H +  +HR
Sbjct: 145 VNFCHSRRCLHR 156

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 34/123 (27%), Positives = 58/123 (47%), Gaps = 10/123 (8%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              LG G FG V+ G  +     A+K +     GT   ++ LQ   E  ++ +  H+ +V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLV 242

Query: 255 QYFGTEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           Q +    +E  +YI  E +++GSL    K     +L+  Q+     QI +G+ Y+   N 
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 312 IHR 314
           +HR
Sbjct: 302 VHR 304

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 70.4 bits (173), Expect = 5e-14
 Identities = 29/135 (21%), Positives = 63/135 (46%), Gaps = 5/135 (3%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
               +  I +++    +G G+F  V        G   A+K +   D+      S+ +L +
Sbjct: 7   CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII---DKTQLNPTSLQKLFR 63

Query: 241 EISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQI 299
           E+ ++    H NIV+ F   + E  LY+ +E  + G +   +     +K+ +  +   QI
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123

Query: 300 LNGLKYLHEQNVIHR 314
           ++ ++Y H++ ++HR
Sbjct: 124 VSAVQYCHQKRIVHR 138

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 69.9 bits (172), Expect = 6e-14
 Identities = 39/129 (30%), Positives = 63/129 (48%), Gaps = 10/129 (7%)

Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQG--EQSVLQLEQEISLLGQ 247
           ++QK   +G G++G VY+      G   A+K++ L D  T+G    ++    +EISLL +
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI----REISLLKE 58

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQ--GSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
             H NIV+       ENKLY+  E + Q             +    + +Y +Q+L GL +
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118

Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 119 CHSHRVLHR 127

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 69.9 bits (172), Expect = 7e-14
 Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 31/169 (18%)

Query: 165 DDAEISLLMELVYNFSLNE-----KYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAV 219
           ++  + +     ++FS  E                G  +G G FG VY+G+ ++    AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AV 59

Query: 220 KEVSLQD--QGTQGEQSVLQLEQEISLLGQFEHDNIVQYFG--TEKDENKL-YIFLELVT 274
           K+++        + +Q   Q +QEI ++ + +H+N+V+  G  ++ D+  L Y     + 
Sbjct: 60  KKLAAMVDITTEELKQ---QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY---VYMP 113

Query: 275 QGSLAKIYQEYHLKDSQVSAY-TWQ--------ILNGLKYLHEQNVIHR 314
            GSL        L     +   +W           NG+ +LHE + IHR
Sbjct: 114 NGSL-----LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 69.5 bits (171), Expect = 9e-14
 Identities = 35/126 (27%), Positives = 68/126 (53%), Gaps = 8/126 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG-EQSVLQLEQEISLLGQFEH 250
           +     +G G++G VY+   + G  FA+K++ L ++  +G   + ++   EIS+L + +H
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL-EKEDEGIPSTTIR---EISILKELKH 59

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHE 308
            NIV+ +     + +L +  E + Q  L K+    E  L+     ++  Q+LNG+ Y H+
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 309 QNVIHR 314
           + V+HR
Sbjct: 119 RRVLHR 124

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 69.9 bits (172), Expect = 9e-14
 Identities = 35/134 (26%), Positives = 57/134 (42%), Gaps = 22/134 (16%)

Query: 191 SWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLE-------QEI 242
           ++ K   LG G++ +VY+G         A+KE+ L+ +           E       +E+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-----------EGAPCTAIREV 51

Query: 243 SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQIL 300
           SLL   +H NIV        E  L +  E + +  L +        +    V  + +Q+L
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 301 NGLKYLHEQNVIHR 314
            GL Y H Q V+HR
Sbjct: 111 RGLAYCHRQKVLHR 124

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 31/125 (24%), Positives = 56/125 (44%), Gaps = 14/125 (11%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              LG+G FG V+    +     AVK +        G  SV     E +++   +HD +V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 255 QYFG--TEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           +     T++    +YI  E + +GSL    K  +       ++  ++ QI  G+ ++ ++
Sbjct: 247 KLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 310 NVIHR 314
           N IHR
Sbjct: 304 NYIHR 308

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 23/127 (18%), Positives = 44/127 (34%), Gaps = 11/127 (8%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              L     G +++G    G    VK + ++D  T+  +      +E   L  F H N++
Sbjct: 15  LTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSR---DFNEECPRLRIFSHPNVL 70

Query: 255 QYFG--TEKDENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQ 309
              G           +    +  GSL  +  E   + +  SQ   +   +  G+ +LH  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 310 N--VIHR 314
              +   
Sbjct: 131 EPLIPRH 137

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 31/134 (23%), Positives = 50/134 (37%), Gaps = 19/134 (14%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           Q    +G G +G V+ G    G   AVK     +     E S  + E EI       H+N
Sbjct: 40  QMVKQIGKGRYGEVWMG-KWRGEKVAVKVFFTTE-----EASWFR-ETEIYQTVLMRHEN 92

Query: 253 IVQYFGTEKDENKLYIFLELVTQ----GSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           I+ +   +      +  L L+T     GSL    +   L    +    +  ++GL +LH 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 309 QN--------VIHR 314
           +         + HR
Sbjct: 153 EIFSTQGKPAIAHR 166

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 15/128 (11%)

Query: 195 GAPLGSGSFGSVYEG--FTDDGFFF--AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G   + +      A+K  + ++  +   +      QE   + QF+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFL--QEALTMRQFDH 75

Query: 251 DNIVQYFG--TEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKYL 306
            +IV+  G  TE   N ++I +EL T G L      ++Y L  + +  Y +Q+   L YL
Sbjct: 76  PHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 307 HEQNVIHR 314
             +  +HR
Sbjct: 133 ESKRFVHR 140

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 32/125 (25%), Positives = 52/125 (41%), Gaps = 14/125 (11%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              +G G FG V  G    G   AVK   +++  T           E S++ Q  H N+V
Sbjct: 198 LQTIGKGEFGDVMLG-DYRGNKVAVK--CIKNDATAQA-----FLAEASVMTQLRHSNLV 249

Query: 255 QYFG--TEKDENKLYIFLELVTQGSLA---KIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           Q  G    +++  LYI  E + +GSL    +      L    +  ++  +   ++YL   
Sbjct: 250 QLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 310 NVIHR 314
           N +HR
Sbjct: 309 NFVHR 313

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 29/132 (21%), Positives = 50/132 (37%), Gaps = 20/132 (15%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ-FEHDNIVQ 255
           L  G F  VYE      G  +A+K +   +     E+    + QE+  + +   H NIVQ
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGHPNIVQ 90

Query: 256 YFGTE-------KDENKLYIFLELVTQGSLA----KIYQEYHLKDSQVSAYTWQILNGLK 304
           +                 ++ L  + +G L     K+     L    V    +Q    ++
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 305 YLHEQN--VIHR 314
           ++H Q   +IHR
Sbjct: 151 HMHRQKPPIIHR 162

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 68.7 bits (169), Expect = 2e-13
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 9/127 (7%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQG-EQSVLQLEQEISLLGQFE 249
           ++K   +G G++G+V++    +     A+K V L D   +G   S L+   EI LL + +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALR---EICLLKELK 59

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLH 307
           H NIV+       + KL +  E   Q  L K +      L    V ++ +Q+L GL + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 308 EQNVIHR 314
            +NV+HR
Sbjct: 119 SRNVLHR 125

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 31/134 (23%), Positives = 51/134 (38%), Gaps = 19/134 (14%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
                +G G +G V+ G +  G   AVK  S +D     E+S  + E E+       H+N
Sbjct: 11  TLLECVGKGRYGEVWRG-SWQGENVAVKIFSSRD-----EKSWFR-ETELYNTVMLRHEN 63

Query: 253 IVQYFGTEKDEN----KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           I+ +  ++        +L++       GSL    Q   L           I +GL +LH 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 309 Q--------NVIHR 314
           +         + HR
Sbjct: 124 EIFGTQGKPAIAHR 137

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 25/138 (18%)

Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLE-------QEI 242
            +++   LG+G++ +VY+G     G + A+KEV L  +           E       +EI
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-----------EGTPSTAIREI 54

Query: 243 SLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQ------GSLAKIYQEYHLKDSQVSAYT 296
           SL+ + +H+NIV+ +     ENKL +  E +         S         L+ + V  + 
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 297 WQILNGLKYLHEQNVIHR 314
           WQ+L GL + HE  ++HR
Sbjct: 115 WQLLQGLAFCHENKILHR 132

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 34/128 (26%), Positives = 58/128 (45%), Gaps = 15/128 (11%)

Query: 195 GAPLGSGSFGSVYEG--FTDDGFFF--AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G   + +      A+K  + ++  +   +      QE   + QF+H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSDSVREKFL--QEALTMRQFDH 450

Query: 251 DNIVQYFG--TEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYL 306
            +IV+  G  TE     ++I +EL T G L    Q     L  + +  Y +Q+   L YL
Sbjct: 451 PHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507

Query: 307 HEQNVIHR 314
             +  +HR
Sbjct: 508 ESKRFVHR 515

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 24/170 (14%), Positives = 46/170 (27%), Gaps = 33/170 (19%)

Query: 178 NFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVL 236
            F +  +   R  +  +G  LG     +  E    + G  F V      ++        +
Sbjct: 61  PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120

Query: 237 QLE-----------------------QEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL- 272
           + E                           L+   +   +++    E+D   L  F    
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180

Query: 273 VTQGSLAKIYQEY--------HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
             Q +L    +           L        T Q++  L  LH   ++H 
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 34/124 (27%), Positives = 52/124 (41%), Gaps = 13/124 (10%)

Query: 198 LGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG G FG VYEG       +    AVK      +      +  +   E  ++   +H +I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCT-LDNKEKFMSEAVIMKNLDHPHI 75

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIY---QEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           V+  G  ++E   +I +EL   G L   Y    +  LK   +  Y+ QI   + YL   N
Sbjct: 76  VKLIGIIEEEP-TWIIMELYPYGELGH-YLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133

Query: 311 VIHR 314
            +HR
Sbjct: 134 CVHR 137

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 21/131 (16%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G +G+VY+G + D    AVK  S  +      Q+ +  E+ I  +   EHDNI ++ 
Sbjct: 21  IGRGRYGAVYKG-SLDERPVAVKVFSFAN-----RQNFIN-EKNIYRVPLMEHDNIARFI 73

Query: 258 G-----TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ--- 309
                 T     +  + +E    GSL K    +             +  GL YLH +   
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133

Query: 310 ------NVIHR 314
                  + HR
Sbjct: 134 GDHYKPAISHR 144

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 25/141 (17%), Positives = 53/141 (37%), Gaps = 8/141 (5%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVS-LQDQGTQGEQSVLQLE 239
            +        ++ G  LG G FG+V+ G    D    A+K +   +  G       +   
Sbjct: 23  GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82

Query: 240 QEISLL----GQFEHDNIVQYFGTEKDENKLYIFLELVTQGS--LAKIYQEYHLKDSQVS 293
            E++LL        H  +++     + +    + LE           I ++  L +    
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142

Query: 294 AYTWQILNGLKYLHEQNVIHR 314
            +  Q++  +++ H + V+HR
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHR 163

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 33/138 (23%), Positives = 57/138 (41%), Gaps = 6/138 (4%)

Query: 183 EKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVL-QLEQ 240
           ++       +Q G  LGSG FGSVY G    D    A+K V        GE     ++  
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95

Query: 241 EISLLGQFEHD--NIVQYFGTEKDENKLYIFLELVT-QGSL-AKIYQEYHLKDSQVSAYT 296
           E+ LL +       +++     +  +   + LE       L   I +   L++    ++ 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155

Query: 297 WQILNGLKYLHEQNVIHR 314
           WQ+L  +++ H   V+HR
Sbjct: 156 WQVLEAVRHCHNCGVLHR 173

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.0 bits (167), Expect = 3e-13
 Identities = 28/143 (19%), Positives = 48/143 (33%), Gaps = 27/143 (18%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
              LG   FG VY+G              A+K  +L+D+     +   +   E  L  + 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TLKDKAEGPLRE--EFRHEAMLRARL 69

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-----------------AKIYQEYHLKDSQ 291
           +H N+V   G    +  L +     + G L                      +  L+   
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 292 VSAYTWQILNGLKYLHEQNVIHR 314
                 QI  G++YL   +V+H+
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHK 152

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 4/135 (2%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ 240
               R +I  +  G  LG G+FG V  G     G   AVK   L  Q  +    V ++ +
Sbjct: 8   KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK--ILNRQKIRSLDVVGKIRR 65

Query: 241 EISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQI 299
           EI  L  F H +I++ +      + +++ +E V+ G L   I +   L + +      QI
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125

Query: 300 LNGLKYLHEQNVIHR 314
           L+G+ Y H   V+HR
Sbjct: 126 LSGVDYCHRHMVVHR 140

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 34/157 (21%), Positives = 68/157 (43%), Gaps = 22/157 (14%)

Query: 173 MELVYNFSLNEKYRRRIMSWQK-GAPLGSGSFGSVYEG---FTDDGFFFAVKEVSLQDQG 228
           M+  +   L+ +  R    ++  G  +G G++G VY+       D   +A+K++  +  G
Sbjct: 3   MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTG 60

Query: 229 TQGEQSVLQLEQEISLLGQFEHDNIVQYFG--TEKDENKLYI---FLE------LVTQGS 277
                S  +   EI+LL + +H N++          + K+++   + E      +    +
Sbjct: 61  I--SMSACR---EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA 115

Query: 278 LAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                +   L    V +  +QIL+G+ YLH   V+HR
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 152

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 67.3 bits (165), Expect = 5e-13
 Identities = 37/141 (26%), Positives = 59/141 (41%), Gaps = 28/141 (19%)

Query: 197 PLGSGSFGSVYEGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
            LG G+FG V+         T D    AVK  +L+D  T   +     ++E  LL   +H
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKD-PTLAARK--DFQREAELLTNLQH 76

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-----------------AKIYQEYHLKDSQVS 293
           ++IV+++G   D + L +  E +  G L                      +  L  SQ+ 
Sbjct: 77  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 294 AYTWQILNGLKYLHEQNVIHR 314
               QI +G+ YL  Q+ +HR
Sbjct: 137 HIASQIASGMVYLASQHFVHR 157

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 67.4 bits (165), Expect = 6e-13
 Identities = 40/141 (28%), Positives = 56/141 (39%), Gaps = 31/141 (21%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           Q       G FG V++       + AVK   +QD     +QS    E E+  L   +H+N
Sbjct: 27  QLLEVKARGRFGCVWKA-QLLNEYVAVKIFPIQD-----KQSWQN-EYEVYSLPGMKHEN 79

Query: 253 IVQYFGTEKDENKLYIFLELVTQ----GSLAKIYQEYHLKDSQVSAYT-----WQILNGL 303
           I+Q+ G EK    + + L L+T     GSL        LK + VS          +  GL
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSL-----SDFLKANVVSWNELCHIAETMARGL 134

Query: 304 KYLHEQ----------NVIHR 314
            YLHE            + HR
Sbjct: 135 AYLHEDIPGLKDGHKPAISHR 155

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 67.2 bits (165), Expect = 6e-13
 Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 19/143 (13%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSV----LQLEQE 241
                ++  A +G G++G+VY+      G F A+K V +   G  G   +    ++   E
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR---E 61

Query: 242 ISLL---GQFEHDNIVQ-----YFGTEKDENKLYIFLELVTQ--GSLAKIYQEYHLKDSQ 291
           ++LL     FEH N+V+            E K+ +  E V Q   +         L    
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAET 121

Query: 292 VSAYTWQILNGLKYLHEQNVIHR 314
           +     Q L GL +LH   ++HR
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHR 144

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 32/140 (22%), Positives = 55/140 (39%), Gaps = 27/140 (19%)

Query: 197 PLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
            LG G+FG V+     +          AVK  +L++  +  E +    ++E  LL   +H
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKE-AS--ESARQDFQREAELLTMLQH 102

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL----------------AKIYQEYHLKDSQVSA 294
            +IV++FG   +   L +  E +  G L                 +      L   Q+ A
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 295 YTWQILNGLKYLHEQNVIHR 314
              Q+  G+ YL   + +HR
Sbjct: 163 VASQVAAGMVYLAGLHFVHR 182

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 26/141 (18%), Positives = 53/141 (37%), Gaps = 25/141 (17%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF---AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EH 250
              +G G+FG V +            A+K   +++  ++ +        E+ +L +   H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHR--DFAGELEVLCKLGHH 85

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL------------AKIYQEYHLKDSQVSA---- 294
            NI+   G  +    LY+ +E    G+L               +   +   S +S+    
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 295 -YTWQILNGLKYLHEQNVIHR 314
            +   +  G+ YL ++  IHR
Sbjct: 146 HFAADVARGMDYLSQKQFIHR 166

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 28/154 (18%)

Query: 176 VYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQS 234
           ++ F L  +Y           PLG G  G V+     D     A+K++ L D      QS
Sbjct: 4   IHGFDLGSRY-------MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-----QS 51

Query: 235 VLQLEQEISLLGQFEHDNIV--------------QYFGTEKDENKLYIFLELVTQGSLAK 280
           V    +EI ++ + +HDNIV                 G+  + N +YI  E + +  LA 
Sbjct: 52  VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLAN 110

Query: 281 IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           + ++  L +     + +Q+L GLKY+H  NV+HR
Sbjct: 111 VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHR 144

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 28/130 (21%), Positives = 48/130 (36%), Gaps = 8/130 (6%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
                +     +GSG+FG              AVK +       +G      +++EI   
Sbjct: 17  HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE------RGAAIDENVQREIINH 70

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLK 304
               H NIV++         L I +E  + G L  +I       + +   +  Q+L+G+ 
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130

Query: 305 YLHEQNVIHR 314
           Y H   + HR
Sbjct: 131 YCHSMQICHR 140

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 30/134 (22%), Positives = 55/134 (41%), Gaps = 5/134 (3%)

Query: 183 EKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQE 241
              +R I  +     LG GSFG V            A+K +S Q           ++E+E
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM--RVERE 59

Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQIL 300
           IS L    H +I++ +        + + +E    G L   I ++  + + +   +  QI+
Sbjct: 60  ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQII 118

Query: 301 NGLKYLHEQNVIHR 314
             ++Y H   ++HR
Sbjct: 119 CAIEYCHRHKIVHR 132

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 65.3 bits (160), Expect = 2e-12
 Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 35/151 (23%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           G  LG G FG V +               AVK   L++  +  E     L  E ++L Q 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASPSELR--DLLSEFNVLKQV 83

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-------------------------AKIYQ 283
            H ++++ +G    +  L + +E    GSL                              
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 284 EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           E  L    + ++ WQI  G++YL E  ++HR
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHR 174

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 65.0 bits (159), Expect = 3e-12
 Identities = 28/151 (18%), Positives = 55/151 (36%), Gaps = 35/151 (23%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
              +G G+FG V++        +      AVK   L+++ +   Q+    ++E +L+ +F
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQA--DFQREAALMAEF 107

Query: 249 EHDNIVQYFGTEKDENKLYIFLELVTQGSL-------------------------AKIYQ 283
           ++ NIV+  G       + +  E +  G L                              
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 284 EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
              L  ++      Q+  G+ YL E+  +HR
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 29/128 (22%), Positives = 48/128 (37%), Gaps = 25/128 (19%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G+FG V +         A+K++  + +             E+  L +  H NIV+ +
Sbjct: 16  VGRGAFGVVCKA-KWRAKDVAIKQIESESE-------RKAFIVELRQLSRVNHPNIVKLY 67

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW--------QILNGLKYLHEQ 309
           G     N + + +E    GSL  +          +  YT         Q   G+ YLH  
Sbjct: 68  GACL--NPVCLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 310 N---VIHR 314
               +IHR
Sbjct: 122 QPKALIHR 129

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 65.1 bits (158), Expect = 4e-12
 Identities = 17/170 (10%), Positives = 47/170 (27%), Gaps = 36/170 (21%)

Query: 179 FSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
            +++    +     +   PL  G    V+     +    FA+K  ++  + ++ E  + +
Sbjct: 51  TTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE--LER 108

Query: 238 LEQEISLLGQFEHDNIVQYF-------------------------GTEKDENKLYIFLEL 272
           L +      +   ++  +                           G +      Y+ L  
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168

Query: 273 VTQGSLAKIY--------QEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                L  ++                 +   T Q++     L  + ++H 
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 36/146 (24%), Positives = 58/146 (39%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF--------AVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           G PLG G+FG V                   AVK   L+D  T+ + S   L  E+ ++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLS--DLVSEMEMMK 95

Query: 247 QF-EHDNIVQYFGTEKDENKLYIFLELVTQGSL-----------------AKIYQEYHLK 288
              +H NI+   G    +  LY+ +E  ++G+L                      E  + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              + + T+Q+  G++YL  Q  IHR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHR 181

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 34/146 (23%), Positives = 56/146 (38%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF--------AVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           G PLG G+FG V                   AVK   L+   T+ + S   L  E+ ++ 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATEKDLS--DLISEMEMMK 129

Query: 247 QF-EHDNIVQYFGTEKDENKLYIFLELVTQGSL-----------------AKIYQEYHLK 288
              +H NI+   G    +  LY+ +E  ++G+L                      E  L 
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              + +  +Q+  G++YL  +  IHR
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHR 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 64.1 bits (157), Expect = 6e-12
 Identities = 37/141 (26%), Positives = 63/141 (44%), Gaps = 17/141 (12%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEG--FTDDGFFFAVKEVSLQDQGTQG-EQSVLQLEQEIS 243
           R    ++  A +G G++G V++     + G F A+K V +   G +G   S ++   E++
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIR---EVA 63

Query: 244 LLGQ---FEHDNIVQ-----YFGTEKDENKLYIFLELVTQ--GSLAKIYQEYHLKDSQVS 293
           +L     FEH N+V+            E KL +  E V Q   +      E  +    + 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123

Query: 294 AYTWQILNGLKYLHEQNVIHR 314
              +Q+L GL +LH   V+HR
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHR 144

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 37/131 (28%), Positives = 57/131 (43%), Gaps = 14/131 (10%)

Query: 197 PLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGE---QSVLQLEQ---EISLLGQFEH 250
            + SGS+G+V  G   +G   A+K V       +           ++   EI LL  F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 251 DNI-----VQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGL 303
            NI     +     E   +KLY+  EL+ +  LA++   Q   +    +  + + IL GL
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147

Query: 304 KYLHEQNVIHR 314
             LHE  V+HR
Sbjct: 148 HVLHEAGVVHR 158

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 63.9 bits (156), Expect = 7e-12
 Identities = 30/129 (23%), Positives = 48/129 (37%), Gaps = 19/129 (14%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDN 252
              LG G  G V + F       FA+K   LQD          +  +E+ L  +  +  +
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQD--------CPKARREVELHWRASQCPH 72

Query: 253 IVQYFG----TEKDENKLYIFLELVTQGSL-AKIYQEYHLKDS--QVSAYTWQILNGLKY 305
           IV+              L I +E +  G L ++I        +  + S     I   ++Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 306 LHEQNVIHR 314
           LH  N+ HR
Sbjct: 133 LHSINIAHR 141

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 36/146 (24%), Positives = 57/146 (39%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF--------AVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           G PLG G FG V                   AVK   L+D  T+ + S   L  E+ ++ 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLS--DLVSEMEMMK 141

Query: 247 QF-EHDNIVQYFGTEKDENKLYIFLELVTQGSL-----------------AKIYQEYHLK 288
              +H NI+   G    +  LY+ +E  ++G+L                      E  + 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              + + T+Q+  G++YL  Q  IHR
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHR 227

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 64.4 bits (157), Expect = 9e-12
 Identities = 30/129 (23%), Positives = 50/129 (38%), Gaps = 19/129 (14%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDN 252
              LG G  G V + F       FA+K   LQD          +  +E+ L  +  +  +
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQD--------CPKARREVELHWRASQCPH 116

Query: 253 IVQYFGTEKD----ENKLYIFLELVTQGSL-AKIYQEYHLKDS--QVSAYTWQILNGLKY 305
           IV+     ++       L I +E +  G L ++I        +  + S     I   ++Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 306 LHEQNVIHR 314
           LH  N+ HR
Sbjct: 177 LHSINIAHR 185

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 35/146 (23%), Positives = 55/146 (37%), Gaps = 31/146 (21%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           G PLG G+FG V E               AVK   L++  T  E     L  E+ +L   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHR--ALMSELKILIHI 87

Query: 249 -EHDNIVQYFG--TEKDENKLYIFLELVTQGSL-----------------AKIYQEYHLK 288
             H N+V   G  T+     L + +E    G+L                  +   +  L 
Sbjct: 88  GHHLNVVNLLGACTKPGG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              +  Y++Q+  G+++L  +  IHR
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHR 172

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 33/146 (22%), Positives = 49/146 (33%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           G  LG+G+FG V E               AVK   L+      E+    L  E+ +L   
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTERE--ALMSELKVLSYL 83

Query: 249 -EHDNIVQYFGTEKDENKLYIFLELVTQGSL-------------------AKIYQEYHLK 288
             H NIV   G         +  E    G L                        E  L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              + ++++Q+  G+ +L  +N IHR
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHR 169

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 29/127 (22%), Positives = 46/127 (36%), Gaps = 19/127 (14%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV 254
            LG G  G V E F    G   A+K   L D          +  QE+    Q     +IV
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALK--LLYDS--------PKARQEVDHHWQASGGPHIV 85

Query: 255 QYFGT----EKDENKLYIFLELVTQGSL-AKIYQEYHLKDS--QVSAYTWQILNGLKYLH 307
                       +  L I +E +  G L ++I +      +  + +     I   +++LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 308 EQNVIHR 314
             N+ HR
Sbjct: 146 SHNIAHR 152

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 29/151 (19%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLE 239
           R  +   Q G  LG+G+FG V E               AVK   L+      E+    L 
Sbjct: 45  RNNL---QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHADEKE--ALM 97

Query: 240 QEISLLGQF-EHDNIVQYFGTEKDENKLYIFLELVTQGSL-------AKIYQEYHLKDSQ 291
            E+ ++    +H+NIV   G       + +  E    G L       +++ +        
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 292 VSAYT--------WQILNGLKYLHEQNVIHR 314
            S  +         Q+  G+ +L  +N IHR
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 32/144 (22%), Positives = 63/144 (43%), Gaps = 18/144 (12%)

Query: 178 NFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVL 236
           N  + + Y  +         +G GS+G VY  +  +     A+K+V+   +     + +L
Sbjct: 21  NVHVPDNYIIK-------HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL 73

Query: 237 QLEQEISLLGQFEHDNIVQYF-----GTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDS 290
           +   EI++L + + D I++ +           ++LYI LE+     L K       L + 
Sbjct: 74  R---EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEE 129

Query: 291 QVSAYTWQILNGLKYLHEQNVIHR 314
            +    + +L G  ++HE  +IHR
Sbjct: 130 HIKTILYNLLLGENFIHESGIIHR 153

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 30/148 (20%), Positives = 59/148 (39%), Gaps = 33/148 (22%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ----- 240
             +  ++K A +G G+FG V++      G   A+K+V +++            E+     
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN------------EKEGFPI 61

Query: 241 ----EISLLGQFEHDNIVQ--------YFGTEKDENKLYIFLELVTQGSLAKI--YQEYH 286
               EI +L   +H+N+V              + +  +Y+  +      LA +       
Sbjct: 62  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK 120

Query: 287 LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
              S++      +LNGL Y+H   ++HR
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHR 148

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 32/128 (25%), Positives = 53/128 (41%), Gaps = 14/128 (10%)

Query: 195 GAPLGSGSFGSVYEGFTD---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
              +  G  G +Y    D   +G    +K   L   G    Q++   E++   L +  H 
Sbjct: 85  KGCIAHGGLGWIYLA-LDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQF--LAEVVHP 139

Query: 252 NIVQ-Y-FGTEKDENK---LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYL 306
           +IVQ + F    D +     YI +E V   SL +   +  L  ++  AY  +IL  L YL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYL 198

Query: 307 HEQNVIHR 314
           H   +++ 
Sbjct: 199 HSIGLVYN 206

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 29/127 (22%), Positives = 48/127 (37%), Gaps = 14/127 (11%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-E 249
           +Q    LG G +  V+E     +     VK +         ++ + +   EI +L     
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKR---EIKILENLRG 89

Query: 250 HDNIVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
             NI+      KD       +  E V      ++YQ   L D  +  Y ++IL  L Y H
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCH 147

Query: 308 EQNVIHR 314
              ++HR
Sbjct: 148 SMGIMHR 154

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 54/168 (32%)

Query: 191 SWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
            +  G  LG+GSFG V E F  + G  FA+K+V    +            +E+ ++   +
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---------RELDIMKVLD 58

Query: 250 HDNIVQ---YFGTE-----------------------------------KDENKLYIFLE 271
           H NI++   YF T                                         L + +E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 272 LVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
            V   +L K+ + +      +  + +S Y +Q+   + ++H   + HR
Sbjct: 119 YVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 39/125 (31%), Positives = 62/125 (49%), Gaps = 11/125 (8%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           P+GSG++GSV   F T  G   AVK++S   Q     +   +   E+ LL   +H+N++ 
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---ELRLLKHMKHENVIG 92

Query: 256 YF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
                    + ++ N +Y+   L+    L  I +   L D  V    +QIL GLKY+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151

Query: 310 NVIHR 314
           ++IHR
Sbjct: 152 DIIHR 156

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 36/124 (29%), Positives = 62/124 (50%), Gaps = 11/124 (8%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
            LG G++G V        G   A+K++   D+     +++    +EI +L  F+H+NI+ 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENIIT 73

Query: 256 YF-----GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
            F      + ++ N++YI  EL+ Q  L ++     L D  +  + +Q L  +K LH  N
Sbjct: 74  IFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN 132

Query: 311 VIHR 314
           VIHR
Sbjct: 133 VIHR 136

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 37/133 (27%), Positives = 55/133 (41%), Gaps = 28/133 (21%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG G FG VY+G   DG   AVK   L+++ TQG +   Q + E+ ++    H N+++  
Sbjct: 38  LGRGGFGKVYKGRLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR 93

Query: 258 G--TEKDENKL-YIFLELVTQGSLAKIYQEYHL--KDSQVSAYTWQ--------ILNGLK 304
           G      E  L Y ++     GS+        L  +        W            GL 
Sbjct: 94  GFCMTPTERLLVYPYMAN---GSV-----ASCLRERPESQPPLDWPKRQRIALGSARGLA 145

Query: 305 YLHEQ---NVIHR 314
           YLH+     +IHR
Sbjct: 146 YLHDHCDPKIIHR 158

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 30/125 (24%), Positives = 56/125 (44%), Gaps = 11/125 (8%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           P+GSG++G+V        G   A+K++    Q     +   +   E+ LL    H+N++ 
Sbjct: 32  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMRHENVIG 88

Query: 256 YF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
                    T  D    Y+ +  +    L K+ +   L + ++    +Q+L GL+Y+H  
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147

Query: 310 NVIHR 314
            +IHR
Sbjct: 148 GIIHR 152

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 28/216 (12%), Positives = 55/216 (25%), Gaps = 41/216 (18%)

Query: 132 SLEDVSSSEYTMTEAAEAGRFQDLFDDVASISDDDAEISLLMELVYNFSLNEKYRRRIMS 191
            +E++ +          +   Q   D + S S  +      +E      L E+ R  +  
Sbjct: 28  VIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESE----LGERPRTLVR- 82

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI-------- 242
              G  LG     +  E    + G  F V      ++        ++ E           
Sbjct: 83  ---GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 243 ------------SLLGQFEHDNIVQYFGTEKDENKLYIFLELV----TQGSL-------- 278
                             +     +      DE  +++          Q +L        
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 279 AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           +       L        T Q++  L  LH   ++H 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 35/124 (28%), Positives = 66/124 (53%), Gaps = 11/124 (8%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
            +G G++G V   +   +    A+K++S  +  T  ++++    +EI +L +F H+NI+ 
Sbjct: 34  YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIG 89

Query: 256 YF-----GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
                   T +    +YI  +L+ +  L K+ +  HL +  +  + +QIL GLKY+H  N
Sbjct: 90  INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148

Query: 311 VIHR 314
           V+HR
Sbjct: 149 VLHR 152

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 35/144 (24%), Positives = 65/144 (45%), Gaps = 14/144 (9%)

Query: 178 NFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVL 236
                +  ++R   ++ G  LG GSF +V           +A+K   L+ +    E  V 
Sbjct: 18  AQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVP 75

Query: 237 QLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLK-----DSQ 291
            + +E  ++ + +H   V+ + T +D+ KLY  L     G L       +++     D  
Sbjct: 76  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDET 130

Query: 292 VSA-YTWQILNGLKYLHEQNVIHR 314
            +  YT +I++ L+YLH + +IHR
Sbjct: 131 CTRFYTAEIVSALEYLHGKGIIHR 154

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 16/118 (13%), Positives = 36/118 (30%), Gaps = 4/118 (3%)

Query: 201 GSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTE 260
            ++         +       +    D        +     +I  +  F   N V      
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 261 KDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTW----QILNGLKYLHEQNVIHR 314
             +  LYI ++L  + +L          + +          QI   +++LH + ++HR
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHR 188

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 24/128 (18%), Positives = 51/128 (39%), Gaps = 7/128 (5%)

Query: 188 RIMS-WQKGAPLGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           R ++ ++    +G G FG V+E     D   +A+K + L ++    E    ++ +E+  L
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKAL 58

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
            + EH  IV+YF    +      + E + +  L     ++ L            +  +  
Sbjct: 59  AKLEHPGIVRYFNAWLETPP-EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDP 117

Query: 306 LHEQNVIH 313
              +N + 
Sbjct: 118 FSTKNTVG 125

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 31/151 (20%), Positives = 53/151 (35%), Gaps = 35/151 (23%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFF------AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           G  LGSG+FG V                 AVK   L+++    E+    L  E+ ++ Q 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSERE--ALMSELKMMTQL 105

Query: 249 -EHDNIVQYFGTEKDENKLYIFLELVTQGSL------------------------AKIYQ 283
             H+NIV   G       +Y+  E    G L                         +   
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 284 EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
              L    +  + +Q+  G+++L  ++ +HR
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 31/125 (24%), Positives = 57/125 (45%), Gaps = 12/125 (9%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
            +GSG++GSV        G   A+K++S   Q     +   +   E+ LL   +H+N++ 
Sbjct: 31  HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR---ELLLLKHMQHENVIG 87

Query: 256 YF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
                    + ++    Y+ +  + Q  L KI       + ++    +Q+L GLKY+H  
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSA 145

Query: 310 NVIHR 314
            V+HR
Sbjct: 146 GVVHR 150

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 16/125 (12%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ------EISLLGQFEH 250
           LG+GSFG V      + G  +A+K +         +Q V++L+Q      E  +L     
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
             +V+   + KD + LY+ +E V  G + + + +     +     Y  QI+   +YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 310 NVIHR 314
           ++I+R
Sbjct: 161 DLIYR 165

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 12/130 (9%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +Q   P+GSG+ G V   +        A+K++S   Q     +   +   E+ L+    H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR---ELVLMKCVNH 83

Query: 251 DNIVQYF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLK 304
            NI+          + ++   +YI +EL+   +L ++ Q   L   ++S   +Q+L G+K
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQMLCGIK 141

Query: 305 YLHEQNVIHR 314
           +LH   +IHR
Sbjct: 142 HLHSAGIIHR 151

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 29/122 (23%), Positives = 56/122 (45%), Gaps = 8/122 (6%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV 254
            LG G++G V++      G   AVK++    Q +   Q   +   EI +L +   H+NIV
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR---EIMILTELSGHENIV 72

Query: 255 QYFGTEKDENK--LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
                 + +N   +Y+  + + +  L  + +   L+        +Q++  +KYLH   ++
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLL 131

Query: 313 HR 314
           HR
Sbjct: 132 HR 133

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 56.4 bits (137), Expect = 3e-09
 Identities = 29/125 (23%), Positives = 64/125 (51%), Gaps = 16/125 (12%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ------EISLLGQFEH 250
           LG+GSFG V+      +G ++A+K +         ++ V++L+Q      E  +L    H
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
             I++ +GT +D  ++++ ++ +  G L + + +     +     Y  ++   L+YLH +
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 125

Query: 310 NVIHR 314
           ++I+R
Sbjct: 126 DIIYR 130

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.6 bits (134), Expect = 7e-09
 Identities = 32/126 (25%), Positives = 59/126 (46%), Gaps = 12/126 (9%)

Query: 196 APLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
            P+GSG+ G V   +        A+K++S   Q     +   +   E+ L+    H NI+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR---ELVLMKCVNHKNII 124

Query: 255 QYF------GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
                     T ++   +Y+ +EL+   +L ++ Q   L   ++S   +Q+L G+K+LH 
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHS 182

Query: 309 QNVIHR 314
             +IHR
Sbjct: 183 AGIIHR 188

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 27/118 (22%), Positives = 52/118 (44%), Gaps = 3/118 (2%)

Query: 198 LGSGSFGSVYE-GFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+FG V           +A+K +S  +   + + +    E++I  +       +VQ 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQL 134

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           F   +D+  LY+ +E +  G L  +   Y + +     YT +++  L  +H    IHR
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 192

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 30/125 (24%), Positives = 59/125 (47%), Gaps = 16/125 (12%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ------EISLLGQFEH 250
           +G GSFG V      D    +A+K ++        +Q  ++  +      E+ ++   EH
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLEH 74

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
             +V  + + +DE  +++ ++L+  G L   + Q  H K+  V  +  +++  L YL  Q
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134

Query: 310 NVIHR 314
            +IHR
Sbjct: 135 RIIHR 139

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 53.0 bits (128), Expect = 3e-08
 Identities = 30/123 (24%), Positives = 59/123 (47%), Gaps = 6/123 (4%)

Query: 195 GAPLGSGSFGSVYEGFTDD--GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
              LG G   +VY    D       A+K  ++     + E+++ + E+E+    Q  H N
Sbjct: 16  VDKLGGGGMSTVYLA-EDTILNIKVAIK--AIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           IV     +++++  Y+ +E +   +L++ I     L       +T QIL+G+K+ H+  +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 312 IHR 314
           +HR
Sbjct: 133 VHR 135

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 31/126 (24%), Positives = 54/126 (42%), Gaps = 15/126 (11%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQDQG---TQGEQSVLQLEQEISLLGQFE 249
           +G G FG VY     D G  +A+K    +     QG      E+ +L L      +   +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL------VSTGD 250

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
              IV         +KL   L+L+  G L   + Q     ++ +  Y  +I+ GL+++H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310

Query: 309 QNVIHR 314
           + V++R
Sbjct: 311 RFVVYR 316

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 12/122 (9%), Positives = 25/122 (20%), Gaps = 6/122 (4%)

Query: 195 GAPLGSGSFGSVYEGFTDD--GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
               G       ++   D       A+  V  Q           +       L + +   
Sbjct: 36  LIFHGGVPPLQFWQA-LDTALDRQVALTFVDPQGVLPDDVLQ--ETLSRTLRLSRIDKPG 92

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           + +            +  E +  GSL ++                 +       H   V 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVA 151

Query: 313 HR 314
             
Sbjct: 152 LS 153

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 30/140 (21%), Positives = 50/140 (35%), Gaps = 17/140 (12%)

Query: 192 WQKGAPLGSGSFGSVYEGFTDDG------FFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
           W+ G P+G G FG +Y    +            VK     +     E    Q   +   +
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 246 GQFEHDNI--------VQYFGTEKDENKLYIFLELVTQG-SLAKIYQEYHLKDSQ--VSA 294
            ++                 G      K Y F+ +   G  L KIY+    + S+  V  
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156

Query: 295 YTWQILNGLKYLHEQNVIHR 314
            + +IL+ L+Y+HE   +H 
Sbjct: 157 LSLRILDILEYIHEHEYVHG 176

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAV----KEVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V           +AV    K+V +QD   + T  E+ VL L          +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL--------PGK 400

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
              + Q     +  ++LY  +E V  G L   I Q    K+     Y  +I  GL +L  
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460

Query: 309 QNVIHR 314
           + +I+R
Sbjct: 461 KGIIYR 466

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 50.2 bits (121), Expect = 3e-07
 Identities = 31/128 (24%), Positives = 53/128 (41%), Gaps = 20/128 (15%)

Query: 198 LGSGSFGSVY----EGFTDDGFFFAVK----EVSLQDQG--TQGEQSVLQLEQEISLLGQ 247
           LG GSFG V+       +D    +A+K              T+ E+ +L          +
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV---------E 82

Query: 248 FEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYL 306
             H  IV+     + E KLY+ L+ +  G L  ++ +E    +  V  Y  ++   L +L
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142

Query: 307 HEQNVIHR 314
           H   +I+R
Sbjct: 143 HSLGIIYR 150

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 31/137 (22%), Positives = 52/137 (37%), Gaps = 14/137 (10%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQ 247
           W  G  +GSG FG +Y  F T+     A   V ++ Q       E    Q   +   + +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 248 FEHDNI--------VQYFGTEKDENKLYIFLELVTQG-SLAKIYQEY-HLKDSQVSAYTW 297
           +                 G  + + + Y F+ +   G  L KI  +    K S V     
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158

Query: 298 QILNGLKYLHEQNVIHR 314
           ++L+ L+Y+HE   +H 
Sbjct: 159 RMLDVLEYIHENEYVHG 175

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 49.9 bits (120), Expect = 4e-07
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V      + G  +AVK    +V LQD   + T  E+ +L L           
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL--------ARN 82

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  + Q F   +  ++L+  +E V  G L   I +     +++   Y  +I++ L +LH+
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142

Query: 309 QNVIHR 314
           + +I+R
Sbjct: 143 KGIIYR 148

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 25/122 (20%), Positives = 49/122 (40%), Gaps = 4/122 (3%)

Query: 195 GAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
              +G G  G VYE   T      A+K   + +  +       ++++E    G+ +  ++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALK--LMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           V      + + +LY+ + L+    LA  + ++  L   +  A   QI + L   H     
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT 156

Query: 313 HR 314
           HR
Sbjct: 157 HR 158

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 30/130 (23%), Positives = 59/130 (45%), Gaps = 22/130 (16%)

Query: 198 LGSGSFGSVY----EGFTDDGFFFAVK----EVSLQDQG----TQGEQSVLQLEQEISLL 245
           LG G +G V+        + G  FA+K     + +++      T+ E+++L+        
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-------- 76

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLK 304
            + +H  IV      +   KLY+ LE ++ G L  ++ +E    +     Y  +I   L 
Sbjct: 77  -EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135

Query: 305 YLHEQNVIHR 314
           +LH++ +I+R
Sbjct: 136 HLHQKGIIYR 145

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V+   F     FFA+K    +V L D   + T  E+ VL L         +E
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA--------WE 76

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  +   F T + +  L+  +E +  G L   I   +    S+ + Y  +I+ GL++LH 
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136

Query: 309 QNVIHR 314
           + +++R
Sbjct: 137 KGIVYR 142

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 29/126 (23%), Positives = 52/126 (41%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQDQG---TQGEQSVLQLEQEISLLGQFE 249
           +G GS+  V           +A+K    E+   D+     Q E+ V +            
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ--------ASN 68

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  +V      + E++L+  +E V  G L   + ++  L +     Y+ +I   L YLHE
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128

Query: 309 QNVIHR 314
           + +I+R
Sbjct: 129 RGIIYR 134

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 48.8 bits (117), Expect = 8e-07
 Identities = 30/130 (23%), Positives = 58/130 (44%), Gaps = 21/130 (16%)

Query: 198 LGSGSFGSVY----EGFTDDGFFFAV----KEVSLQDQG----TQGEQSVLQLEQEISLL 245
           LG+G++G V+        D G  +A+    K   +Q       T+ E+ VL+  ++    
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ---- 117

Query: 246 GQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLK 304
                  +V      + E KL++ L+ +  G L   + Q     + +V  Y  +I+  L+
Sbjct: 118 ----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 173

Query: 305 YLHEQNVIHR 314
           +LH+  +I+R
Sbjct: 174 HLHKLGIIYR 183

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 48.8 bits (117), Expect = 8e-07
 Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 18/126 (14%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG G+FG V        G ++A+K    EV +       T  E  VLQ            
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ---------NTR 63

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  +       +  ++L   +E    G L   + +E    + +   Y  +I++ L+YLH 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 309 QNVIHR 314
           ++V++R
Sbjct: 124 RDVVYR 129

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 48.9 bits (117), Expect = 9e-07
 Identities = 28/126 (22%), Positives = 52/126 (41%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQDQG---TQGEQSVLQLEQEISLLGQFE 249
           +G GS+  V           +A++    E+   D+     Q E+ V +            
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ--------ASN 111

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  +V      + E++L+  +E V  G L   + ++  L +     Y+ +I   L YLHE
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171

Query: 309 QNVIHR 314
           + +I+R
Sbjct: 172 RGIIYR 177

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG GSFG V           +AVK    +V +QD   + T  E+ VL L          +
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL--------PGK 79

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
              + Q     +  ++LY  +E V  G L   I Q    K+     Y  +I  GL +L  
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139

Query: 309 QNVIHR 314
           + +I+R
Sbjct: 140 KGIIYR 145

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 27/155 (17%), Positives = 54/155 (34%), Gaps = 37/155 (23%)

Query: 177 YNFSLNE--KYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEV----SLQDQGT 229
           +++           ++       +G G+FG V      D+  ++AVK V           
Sbjct: 25  FSWKKGMLLNNAFLVIR-----KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA- 78

Query: 230 QGEQSVLQLEQE--------ISLLGQFEHDN---IVQYFGTEKDENKLYIFLELVTQGSL 278
           + E  +L+  Q         +   G+F + +   ++     E     LY  +        
Sbjct: 79  KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI----FEPLGPSLYEIIT------- 127

Query: 279 AKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
              Y  +H+    +  Y  +IL  L YL + ++ H
Sbjct: 128 RNNYNGFHI--EDIKLYCIEILKALNYLRKMSLTH 160

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 32/130 (24%), Positives = 54/130 (41%), Gaps = 18/130 (13%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++ G  +G GSFG ++EG    +    A+K    +    Q       L  E         
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-------LRDEYRTYKLLAG 64

Query: 251 -DNI--VQYFGTEKDENKLYIFLELVTQG-SLAKIYQEYHLKDSQ--VSAYTWQILNGLK 304
              I  V YFG E   N   + ++L   G SL  +      K S   V+    Q+L  ++
Sbjct: 65  CTGIPNVYYFGQEGLHN--VLVIDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120

Query: 305 YLHEQNVIHR 314
            +HE+++++R
Sbjct: 121 SIHEKSLVYR 130

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 30/121 (24%), Positives = 44/121 (36%), Gaps = 12/121 (9%)

Query: 195 GAPLGSGSFGSVYEG------FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           G PLG G+FG V E        T      AVK   L++  T  E   L    E+ +L   
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALM--SELKILIHI 82

Query: 249 -EHDNIVQYFGT-EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYL 306
             H N+V   G   K    L + +E    G+L+   +    +         +   G  Y+
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142

Query: 307 H 307
            
Sbjct: 143 G 143

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 31/126 (24%), Positives = 55/126 (43%), Gaps = 17/126 (13%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           +G GSFG V       +  F+AVK    +  L+    +    E++VL            +
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK--------NVK 97

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
           H  +V    + +  +KLY  L+ +  G L   + +E    + +   Y  +I + L YLH 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157

Query: 309 QNVIHR 314
            N+++R
Sbjct: 158 LNIVYR 163

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 32/122 (26%), Positives = 59/122 (48%), Gaps = 14/122 (11%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLLGQFEHDNIVQ 255
           +GSGSFG +Y G           +EV+++ +  + +   L  E +I  +L        V+
Sbjct: 15  IGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVR 69

Query: 256 YFGTEKDENKLYIFLELVTQG-SLAKIYQEYHLKDSQ--VSAYTWQILNGLKYLHEQNVI 312
           +FG E D N   + ++L   G SL  ++     K S   V     Q++N ++++H ++ +
Sbjct: 70  WFGVEGDYN--VLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125

Query: 313 HR 314
           HR
Sbjct: 126 HR 127

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 33/127 (25%), Positives = 63/127 (49%), Gaps = 12/127 (9%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI-SLLGQFE 249
           ++ G  +GSGSFG +Y G     G     +EV+++ +  + +   L +E +I  ++    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHIESKIYKMMQGGV 65

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQ--VSAYTWQILNGLKYLH 307
               +++ G E D N   + +EL+   SL  ++     K S   V     Q+++ ++Y+H
Sbjct: 66  GIPTIRWCGAEGDYN--VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 308 EQNVIHR 314
            +N IHR
Sbjct: 123 SKNFIHR 129

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 27/128 (21%), Positives = 51/128 (39%), Gaps = 20/128 (15%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQDQG---TQGEQSVLQLEQEISLLGQFE 249
           LG G FG V        G  +A K    +   + +G      E+ +L+         +  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE---------KVN 242

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQ--EYHLKDSQVSAYTWQILNGLKYL 306
              +V      + ++ L + L L+  G L   IY   +    +++   Y  +I  GL+ L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 307 HEQNVIHR 314
           H + +++R
Sbjct: 303 HRERIVYR 310

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 27/130 (20%), Positives = 53/130 (40%), Gaps = 22/130 (16%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQDQG---TQGEQSVLQLEQEISLLGQFE 249
           LG G FG V+       G  +A K    +   + +G      E+ +L          +  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA---------KVH 243

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-----AKIYQEYHLKDSQVSAYTWQILNGLK 304
              IV      + +  L + + ++  G +              ++ +   YT QI++GL+
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 305 YLHEQNVIHR 314
           +LH++N+I+R
Sbjct: 304 HLHQRNIIYR 313

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.8 bits (110), Expect = 6e-06
 Identities = 58/352 (16%), Positives = 108/352 (30%), Gaps = 121/352 (34%)

Query: 7   LKDFDVKPKHPSRESL---------RRWRSF---CTIVKNPTRRFRMVANLDRRSEADKK 54
           L+       +     L         + W +F   C I+   T RF+ V   D  S A   
Sbjct: 234 LRRLLKSKPYE--NCLLVLLNVQNAKAWNAFNLSCKILL--TTRFKQVT--DFLSAATTT 287

Query: 55  IRQMQEQLRLALCIRDTLKLIESHEDVPIGD--TDAGRFQEFVDDIISTVKCGDVKEKIR 112
              + +   + L   +   L+  + D    D   +          II+        E IR
Sbjct: 288 HISL-DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA--------ESIR 338

Query: 113 LALCI-----QETALQLIEVLSLLSLEDVSSSEYTMTEAAEAGRFQDL--FDDVASIS-- 163
             L            +L  ++   SL  +  +EY          F  L  F   A I   
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIES-SLNVLEPAEYR-------KMFDRLSVFPPSAHIPTI 390

Query: 164 --------DDDAEISLLMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGF 215
                      +++ +++  ++ +SL EK         K          S          
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEK-------QPKE---------STI-------- 426

Query: 216 FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEK--DENKL------ 266
                  S+           + LE ++ L  ++  H +IV ++   K  D + L      
Sbjct: 427 -------SIPS---------IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470

Query: 267 -YIFLELVTQGSLAKIYQEYHLKDSQ----VSAYTWQILNGLKYLHEQNVIH 313
            Y +  +            +HLK+ +    ++ +    L+  ++L EQ + H
Sbjct: 471 QYFYSHIG-----------HHLKNIEHPERMTLFRMVFLD-FRFL-EQKIRH 509

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 1e-04
 Identities = 47/340 (13%), Positives = 103/340 (30%), Gaps = 81/340 (23%)

Query: 5   FNLKDFDVKPKHPSRESLRRWRSFCTIVKNPTRRF--RMVANLDRRSEADKKIRQMQEQL 62
           F +     + + PS  + R +      + N  + F    V     R +   K+RQ   +L
Sbjct: 93  FLMSPIKTEQRQPSMMT-RMYIEQRDRLYNDNQVFAKYNV----SRLQPYLKLRQALLEL 147

Query: 63  RLALCIRDTLKLIESHEDVPI-GDTDAG------------RFQEFVDDIISTVKCGDVKE 109
           R               ++V I G   +G            + Q  +D  I  +   +   
Sbjct: 148 R-------------PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194

Query: 110 KIRLALCIQETALQLIEVLSLLSLEDVSSSEYTMTEAAEAGRFQDLF------------D 157
                L + +  L  I+  +  S  D SS+      + +A   + L              
Sbjct: 195 P-ETVLEMLQKLLYQID-PNWTSRSDHSSNIKLRIHSIQA-ELRRLLKSKPYENCLLVLL 251

Query: 158 DVASISDDDA-EIS--LLM----ELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF 210
           +V +    +A  +S  +L+    + V +F L+      I            S        
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDF-LSAATTTHI------------SLDHHSMTL 298

Query: 211 TDD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV-----QYFGTEKD 262
           T D          +   QD   +   +  +    +S++ +   D +      ++   +K 
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVLTTNPRR---LSIIAESIRDGLATWDNWKHVNCDKL 355

Query: 263 ENKLYIFLELVTQGSLAKIYQEYHL--KDSQVSAYTWQIL 300
              +   L ++      K++    +    + +      ++
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.0 bits (108), Expect = 7e-06
 Identities = 19/160 (11%), Positives = 41/160 (25%), Gaps = 44/160 (27%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG------------EQSVLQLEQEISLL 245
           +G G FG V++    D    A+K ++++                  E  + +    +S  
Sbjct: 28  IGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 246 GQFEHDNIVQYFG------------------------------TEKDENKLYIFLELVTQ 275
                +  +                                      +++L+I LE    
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 276 GSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ-NVIHR 314
           G   +  +      +   +   Q+   L          HR
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.2 bits (110), Expect = 7e-06
 Identities = 28/157 (17%), Positives = 50/157 (31%), Gaps = 39/157 (24%)

Query: 177 YNFSLNE--KYRRRIMSWQKGAPLGSGSFGSVYEGF--TDDGFFFAVKEV----SLQDQG 228
               + +  + R  I+       LG G+FG V E           A+K +      ++  
Sbjct: 9   LVCRIGDWLQERYEIVG-----NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA 63

Query: 229 TQGEQSVLQLEQE---------ISLLGQFEHDN---IVQYFGTEKDENKLYIFLELVTQG 276
            + E +VL+  +E         + +   F       I      E      + FL      
Sbjct: 64  -RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA----FELLGKNTFEFL------ 112

Query: 277 SLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
              K           V    +Q+ + L++LHE  + H
Sbjct: 113 ---KENNFQPYPLPHVRHMAYQLCHALRFLHENQLTH 146

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.1 bits (110), Expect = 7e-06
 Identities = 32/157 (20%), Positives = 47/157 (29%), Gaps = 39/157 (24%)

Query: 177 YNFSLNE--KYRRRIMSWQKGAPLGSGSFGSVYEGF--TDDGFFFAVKEV----SLQDQG 228
                 +    R  I+       LG G+FG V E       G   AVK V       +  
Sbjct: 4   LICQSGDVLSARYEIVD-----TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA 58

Query: 229 TQGEQSVLQLEQE---------ISLLGQFEHDN---IVQYFGTEKDENKLYIFLELVTQG 276
            + E  VL+             + +L  FEH     IV     E      Y F+      
Sbjct: 59  -RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV----FELLGLSTYDFI------ 107

Query: 277 SLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
              K       +   +    +QI   + +LH   + H
Sbjct: 108 ---KENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTH 141

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 27/127 (21%), Positives = 43/127 (33%), Gaps = 10/127 (7%)

Query: 195 GAPLGSGSFGSVYEGFTDD--GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           G  LG G    V+    D       AVK   L+    +     L+  +E        H  
Sbjct: 17  GEILGFGGMSEVHLA-RDLRDHRDVAVK--VLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 253 IVQYF--GTEKDENKL--YIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLH 307
           IV  +  G  +       YI +E V   +L   ++ E  +   +           L + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 308 EQNVIHR 314
           +  +IHR
Sbjct: 134 QNGIIHR 140

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 24/120 (20%), Positives = 53/120 (44%), Gaps = 5/120 (4%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+FG V      +    FA+K ++  +   + E +  + E+++  L   +   I   
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITTL 139

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
               +D+N LY+ ++    G L  +    E  L +     Y  +++  +  +H+ + +HR
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 34/156 (21%), Positives = 55/156 (35%), Gaps = 38/156 (24%)

Query: 177 YNFSLNE--KYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEV----SLQDQGT 229
           Y    ++   YR  ++       +G GSFG V + +        A+K V        Q  
Sbjct: 87  YVQVPHDHVAYRYEVLK-----VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA- 140

Query: 230 QGEQSVLQLEQE---------ISLLGQFEHDN---IVQYFGTEKDENKLYIFLELVTQGS 277
             E  +L+  ++         I +L  F   N   +      E     LY   EL+ +  
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT----FELLSMNLY---ELIKKNK 193

Query: 278 LAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
               +Q + L    V  +   IL  L  LH+  +IH
Sbjct: 194 ----FQGFSLP--LVRKFAHSILQCLDALHKNRIIH 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 5/120 (4%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G G+F  V        G  +A+K ++  D   +GE S  + E+++  L   +   I Q 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV--LVNGDRRWITQL 126

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
               +DEN LY+ +E    G L  +       +       Y  +I+  +  +H    +HR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 29/144 (20%), Positives = 48/144 (33%), Gaps = 25/144 (17%)

Query: 192 WQKGAPLGSGSFGSVYEGFTDDGFF---------FAVKEVSLQDQGTQGEQSVLQLE--- 239
           W+  +     + G +YE                 F++K +  +D     EQ+  Q     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKP 102

Query: 240 ---QEISLLGQFEHDNI--VQYFGTEKDENKLYIFLELVTQG-SLAKIYQEYHLKD---S 290
               +   L       I     FG  +D+   Y FL L + G SL               
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDK---YRFLVLPSLGRSLQSALDVSPKHVLSER 159

Query: 291 QVSAYTWQILNGLKYLHEQNVIHR 314
            V     ++L+ L++LHE   +H 
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHG 183

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 19/127 (14%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVK----EVSLQD---QGTQGEQSVLQLEQEISLLGQFE 249
           LG G+FG V        G ++A+K    EV +       T  E  VLQ            
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ---------NSR 206

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH- 307
           H  +     + +  ++L   +E    G L   + +E    + +   Y  +I++ L YLH 
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266

Query: 308 EQNVIHR 314
           E+NV++R
Sbjct: 267 EKNVVYR 273

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.1 bits (102), Expect = 6e-05
 Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 16/129 (12%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++ G  +G G+FG +  G       + A+K   ++ +  Q       L  E     Q   
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-------LHLEYRFYKQLGS 63

Query: 251 -DNI--VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQ--VSAYTWQILNGLKY 305
            D I  V YFG     N   + LEL+   SL  ++       S   V     Q+++ ++Y
Sbjct: 64  GDGIPQVYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 306 LHEQNVIHR 314
           +H +N+I+R
Sbjct: 121 VHSKNLIYR 129

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 32/158 (20%), Positives = 54/158 (34%), Gaps = 40/158 (25%)

Query: 177 YNFSLNE--KYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEV----SLQDQGT 229
           Y     E    R  I S      +G GSFG V + +   +  + A+K +    +  +Q  
Sbjct: 44  YIVKNGEKWMDRYEIDSL-----IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA- 97

Query: 230 QGEQSVLQLEQE---------ISLLGQFEHDN---IVQYFGTEKDENKLYIFLELVTQGS 277
           Q E  +L+L  +         + L   F   N   +V     E     LY  L       
Sbjct: 98  QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV----FEMLSYNLYDLL------- 146

Query: 278 LAKIYQEYHLKDSQVSAYTWQILNGLKYLH--EQNVIH 313
             +      +  +    +  Q+   L +L   E ++IH
Sbjct: 147 --RNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIH 182

>2l1w_B Vacuolar calcium ATPase BCA1 peptide; calmodulin, calmodulin complex, soybean calmodulin, vacuolar ATPase, metal binding protein; NMR {Glycine max} Length = 26

 Score = 36.7 bits (84), Expect = 3e-04
 Identities = 15/23 (65%), Positives = 19/23 (82%)

Query: 23 RRWRSFCTIVKNPTRRFRMVANL 45
          +RWRS  +IVKN  RRFRM++NL
Sbjct: 3  QRWRSSVSIVKNRARRFRMISNL 25

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	317
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.96
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.96
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.96
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.96
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.96
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.95
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.95
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.95
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.95
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.95
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.94
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.93
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.93
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.93
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.93
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.93
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.92
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.9
3uqc_A	286	Probable conserved transmembrane protein; structur	99.9
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.9
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.9
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.9
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.9
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.9
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.9
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.89
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.89
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.89
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.89
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.89
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.89
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.89
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.89
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.89
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.89
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.89
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.89
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.89
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.89
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.89
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.89
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.88
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.88
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.88
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.88
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.88
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.88
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.88
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.88
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.88
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.88
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.88
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.88
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.88
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.88
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.88
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.88
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.88
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.88
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.88
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.88
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.88
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.88
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.87
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.87
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.87
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.87
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.87
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.87
3niz_A	311	Rhodanese family protein; structural genomics, str	99.87
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.87
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.87
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.87
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.87
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.87
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.87
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.87
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.87
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.87
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.87
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.87
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.87
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.87
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.87
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.87
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.87
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.87
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.87
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.87
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.87
3bhy_A	283	Death-associated protein kinase 3; death associate	99.87
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.87
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.87
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.87
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.87
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.87
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.87
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.87
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.87
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.87
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.87
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.87
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.87
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.87
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.87
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.87
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.86
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.86
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.86
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.86
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.86
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.86
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.86
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.86
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.86
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.86
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.86
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.86
4aqr_D	57	Calcium-transporting ATPase 8, plasma membrane-TY;	99.86
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.86
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.86
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.86
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.86
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.86
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.86
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.86
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.86
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.86
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.86
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.86
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.86
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.86
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.86
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.86
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.86
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.86
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.86
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.86
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.86
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.86
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.86
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.86
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.86
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.86
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.85
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.85
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.85
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.85
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.85
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.85
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.85
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.85
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.85
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.85
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.85
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.85
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.85
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.85
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.85
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.85
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.85
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.85
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.85
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.85
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.85
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.85
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.85
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.85
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.85
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.85
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.85
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.84
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.84
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.84
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.84
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.84
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.84
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.84
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.84
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.84
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.84
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.84
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.84
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.84
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.84
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.84
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.84
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.84
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.84
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.84
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.84
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.84
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.84
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.84
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.84
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.84
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.84
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.84
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.83
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.83
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.83
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.83
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.83
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.83
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.83
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.83
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.83
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.83
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.83
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.83
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.82
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.82
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.82
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.82
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.82
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.82
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.82
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.82
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.82
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.82
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.82
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.82
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.81
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.81
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.81
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.81
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.81
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.81
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.81
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.81
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.81
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.81
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.81
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.81
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.81
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.8
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.8
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.8
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.8
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.8
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.8
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.8
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.8
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.8
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.79
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.78
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.77
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.77
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.76
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.72
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.71
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.67
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.6
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
2l1w_B	26	Vacuolar calcium ATPase BCA1 peptide; calmodulin,	99.06
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.91
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.53
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.29
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.62
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.32
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.04
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	96.94
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.51
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.33
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.08
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	95.72
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	95.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	92.58
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	89.09
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	88.81
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	87.79
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	87.58
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.06
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	83.83
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	83.68
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	83.08
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	82.66

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.96  E-value=1.4e-29  Score=235.85  Aligned_cols=127  Identities=24%  Similarity=0.428  Sum_probs=110.2

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|++++.||+|+||.||+|.+ .+|+.||||++.+..   ......+.+.+|+.+|+.|+|||||++++++.+++.+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   98 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL   98 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH---CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            468999999999999999999998 889999999998543   2345577899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||||+||+|.+++...   .+++..+..|+.||+.||.|||++||||||||
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK  152 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIK  152 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence            9999999999999999643   37899999999999999999999999999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.96  E-value=1.2e-29  Score=232.59  Aligned_cols=127  Identities=26%  Similarity=0.378  Sum_probs=114.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++.+...  ........+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            46799999999999999999998 8999999999975321  12233567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||||+||+|.+++.. +.+++..+..|+.||+.||+|||++||||||||
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlK  159 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK  159 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence            99999999999999865 569999999999999999999999999999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.96  E-value=4e-29  Score=232.36  Aligned_cols=124  Identities=26%  Similarity=0.417  Sum_probs=114.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ...|++++.||+|+||.||+|.+ .+|+.||||++......     ..+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            35699999999999999999998 88999999999754321     2345779999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||||+||+|.+++..+++++..+..|+.||+.||.|||++||||||||
T Consensus       148 ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK  197 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK  197 (346)
T ss_dssp             EEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence            99999999999999999999999999999999999999999999999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.96  E-value=1.2e-28  Score=234.67  Aligned_cols=124  Identities=26%  Similarity=0.417  Sum_probs=114.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ...|.+++.||+|+||.||+|.+ .+|+.||||++......     ..+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            35799999999999999999998 88999999999754321     2345789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||||+||+|.+++..+++++..+..|+.||+.||.|||++||||||||
T Consensus       225 iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiK  274 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK  274 (423)
T ss_dssp             EEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            99999999999999999999999999999999999999999999999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.96  E-value=1.9e-28  Score=221.27  Aligned_cols=127  Identities=22%  Similarity=0.376  Sum_probs=107.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|++++.||+|+||.||+|.+ .+|+.||+|++.+...  ........+.+|+.+|+.++|||||++++++.+++.+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            468999999999999999999998 8899999999975432  2233456789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||||| +|+|.+++.. +++++..+..++.||+.||+|||++||||||||
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiK  139 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK  139 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence            9999999 6799988765 469999999999999999999999999999998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.95  E-value=4.3e-28  Score=221.67  Aligned_cols=124  Identities=27%  Similarity=0.448  Sum_probs=109.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      .++|.+.+.||+|+||.||+|.+      .++..||||+++.     ......+.|.+|+.+|++++|||||+++|+|.+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-----CChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            46789999999999999999976      2578899999862     345567789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY--------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~--------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.+|||||||++|+|.+++...              .+++..+..++.||+.||.|||+++|||||||
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlK  155 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA  155 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccC
Confidence            99999999999999999999653              48999999999999999999999999999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.95  E-value=1.4e-28  Score=227.90  Aligned_cols=120  Identities=28%  Similarity=0.431  Sum_probs=110.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..+.|.+.+.||+|+||.||+|.+ .+|+.||||+++....          ..+|+.+|+.++|||||++++++.+++.+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456789999999999999999998 8899999999975421          13699999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||||+||+|.+++.. +.+++..+..|+.||+.||.|||++||||||||
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK  177 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK  177 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence            999999999999999965 569999999999999999999999999999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.95  E-value=1.7e-27  Score=217.71  Aligned_cols=125  Identities=26%  Similarity=0.421  Sum_probs=108.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC---
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN---  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---  264 (317)
                      +++|++++.||+|+||+||+|.+ .+|+.||||+++..    ......+.+.+|+.+|+.++|||||+++++|.+.+   
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP----NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC----SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence            56799999999999999999998 88999999999753    23455678999999999999999999999987644   


Q ss_pred             ---------EEEEEEecCCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 ---------KLYIFLELVTQGSLAKIYQEYH----LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ---------~~~lVmE~~~ggsL~~~l~~~~----l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                               .+|||||||+||+|.+++....    .++..+..++.||+.||+|||++||||||||
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlK  145 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLK  145 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCc
Confidence                     4799999999999999998643    4566788999999999999999999999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.95  E-value=9.8e-28  Score=222.16  Aligned_cols=124  Identities=27%  Similarity=0.409  Sum_probs=111.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ..+|.+.+.||+|+||.||+|..      .++..||||+++.     ......+.|.+|+.+|++++|||||+++|+|.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            46788999999999999999975      2578999999862     345567789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.+|||||||++|+|.+++...                ++++..+..|+.||+.||.|||+++|||||||
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK  185 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA  185 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence            99999999999999999998642                48999999999999999999999999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.95  E-value=3.1e-27  Score=214.95  Aligned_cols=122  Identities=25%  Similarity=0.449  Sum_probs=109.1

Q ss_pred             eeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe----CCEEE
Q 021084          193 QKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD----ENKLY  267 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~  267 (317)
                      ++...||+|+||.||+|.+ .++..||+|++....   ......+.+.+|+.+|+.++|||||+++++|.+    ++.+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            6778899999999999998 889999999997542   234556789999999999999999999999875    45689


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                      ||||||+||+|.+++.+ ..+++..+..|+.||+.||.|||++|  |||||||
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlK  158 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK  158 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCC
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccC
Confidence            99999999999999865 46999999999999999999999998  9999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.95  E-value=3.8e-28  Score=222.27  Aligned_cols=126  Identities=23%  Similarity=0.304  Sum_probs=106.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|++++.||+|+||+||+|++    .+++.||+|+++......   .....+.+|+.+|+.++|||||++++++.+++
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV---RDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE---EECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh---HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            35799999999999999999986    257899999997532111   11235778999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|||||||+||+|.+++.. +.+++..+..++.||+.||.|||++||||||||
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK  153 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK  153 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence            99999999999999999865 569999999999999999999999999999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.94  E-value=4e-27  Score=215.80  Aligned_cols=127  Identities=26%  Similarity=0.367  Sum_probs=111.2

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....+++.+.+.||+|+||+||+|....  .||||+++..   .......+.|.+|+.+|++++|||||++++++.. +
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~---~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVV---DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D  104 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEec---CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence            45556788999999999999999997643  5999998643   3345667889999999999999999999998754 5


Q ss_pred             EEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|||||||+||+|.+++..  ..+++..+..|+.||+.||.|||++||||||||
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlK  159 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK  159 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccC
Confidence            68999999999999999965  359999999999999999999999999999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.94  E-value=4.7e-27  Score=215.69  Aligned_cols=126  Identities=21%  Similarity=0.345  Sum_probs=109.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ...++++.+.||+|+||.||+|..      .+++.||||+++...    .....+.|.+|+.+|++++|||||+++|+|.
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~----~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C----CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc----ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            356788899999999999999975      356899999986422    2334567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQE-----------------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++.+|||||||++|+|.+++..                 ..+++..+..|+.||+.||.|||+++|||||||
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK  172 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA  172 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            99999999999999999999953                 248999999999999999999999999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.93  E-value=4.5e-26  Score=216.18  Aligned_cols=124  Identities=26%  Similarity=0.415  Sum_probs=110.1

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe------
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD------  262 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------  262 (317)
                      ++|.+++.||+|+||+||+|.+ .+|+.||||+++..   .........+.+|+.+|+.++|||||++++++..      
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA---FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcc---ccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            5799999999999999999998 89999999999643   2344556788899999999999999999998764      


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+.+|||||||+ |+|.+++.. +++++..+..|+.||+.||.|||++||||||||
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlK  185 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLK  185 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcC
Confidence            367999999996 589998865 469999999999999999999999999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.93  E-value=1.2e-25  Score=222.55  Aligned_cols=125  Identities=23%  Similarity=0.358  Sum_probs=114.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|.+++.||+|+||.||+|.+ .+|+.||+|++...     .....+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            367899999999999999999998 89999999999742     234456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||||+||+|.+++..  +.+++..+..|+.||+.||.|||++||+|||||
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlK  282 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK  282 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence            999999999999999853  469999999999999999999999999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.93  E-value=9.3e-26  Score=224.77  Aligned_cols=132  Identities=23%  Similarity=0.298  Sum_probs=113.0

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCC-CccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQG-TQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      +..+++|.+++.||+|+||.||+|.+ .+|+.||||++.+.... ............++.+++.++|||||+++++|.+.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            34578999999999999999999999 89999999999753211 11222233334557788899999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|||||||+||+|.+++.. +.+++..+..|+.||+.||.|||++||||||||
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK  319 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK  319 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence            999999999999999999865 569999999999999999999999999999998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.93  E-value=2e-25  Score=204.44  Aligned_cols=121  Identities=25%  Similarity=0.355  Sum_probs=104.6

Q ss_pred             cCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC----E
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN----K  265 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~  265 (317)
                      .+|.+.+.||+|+||.||+|.+ +|+.||||++...      .........|+..+..++|||||++++++..++    .
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            4588899999999999999976 6889999998632      112223446777778899999999999998753    6


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ--------NVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~--------gIvHrDLK  317 (317)
                      +|||||||++|+|.+++...++++..+..++.|++.||.|||++        ||||||||
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlK  135 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK  135 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCC
T ss_pred             EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCC
Confidence            89999999999999999999999999999999999999999987        99999998

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.93  E-value=1.4e-25  Score=209.45  Aligned_cols=131  Identities=25%  Similarity=0.377  Sum_probs=112.5

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC-Cceee
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH-DNIVQ  255 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~  255 (317)
                      .+|....++|++++.||+|+||.||+|.+ .     +++.||||.+..    .........+.+|+.+|.++.| ||||+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~----~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcc----ccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            35777788999999999999999999986 3     236899999863    2234456789999999999965 99999


Q ss_pred             eeeEEEe-CCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          256 YFGTEKD-ENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       256 l~~~~~~-~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|.. ++.+|||||||++|+|.++++..                 .+++..+..++.||+.||.|||+++|||||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK  212 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  212 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence            9999976 46789999999999999999642                 37899999999999999999999999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.92  E-value=4.9e-25  Score=206.56  Aligned_cols=122  Identities=19%  Similarity=0.284  Sum_probs=108.5

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEK  261 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~  261 (317)
                      ...+.|++.+.||+|+||.||+|.+    .+++.||+|.+....       ....+.+|+.+|..+ +|||||+++++|.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            3457899999999999999999976    257889999885321       134577899999988 7999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+++|||||||+||+|.+++.  ++++.++..++.||+.||.|||++||||||||
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiK  144 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVK  144 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ECCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCC
Confidence            9999999999999999999985  59999999999999999999999999999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.90  E-value=1.9e-23  Score=193.13  Aligned_cols=128  Identities=22%  Similarity=0.358  Sum_probs=116.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+++|.+.+.||+|+||.||+|.+ .+|..||+|++....   ........+.+|+.+++.++||||+++++++...+.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ---LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            3478999999999999999999998 899999999997542   244566788999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||++||+|.+++.. +.+++..+..++.|++.||.|||++||+|||||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlk  141 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK  141 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCC
Confidence            9999999999999998854 569999999999999999999999999999998

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.90  E-value=2e-23  Score=189.16  Aligned_cols=126  Identities=9%  Similarity=-0.006  Sum_probs=113.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++....  .........+.+|+.++..++||||+++++++...+.+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG--VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC--CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc--ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            36799999999999999999998 779999999987532  233556678999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||++|++|.+++..+ ....++..++.||+.||.|||++||+|||||
T Consensus       108 lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dik  156 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDH  156 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             EEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence            999999999999999764 4666788999999999999999999999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.90  E-value=2.2e-23  Score=189.59  Aligned_cols=125  Identities=26%  Similarity=0.442  Sum_probs=114.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++.....     .....+.+|+.++..++||||+++++++...+.+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            356899999999999999999998 8899999999975432     1245678999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||||+||+|.+++....+++..+..++.|++.||.|||++||+|||||
T Consensus        93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk  143 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK  143 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Confidence            999999999999999998899999999999999999999999999999997

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.90  E-value=6.6e-23  Score=186.88  Aligned_cols=124  Identities=25%  Similarity=0.419  Sum_probs=114.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|.+.     .........+.+|+.++..++||||+++++++.+++.+|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI-----RFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEES-----CCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEec-----cCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            57899999999999999999998 789999999885     234566778999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++|+|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlk  135 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN  135 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence            99999999999999986  458999999999999999999999999999997

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.90  E-value=5.9e-23  Score=186.35  Aligned_cols=127  Identities=22%  Similarity=0.364  Sum_probs=116.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|++.+.||+|+||.||+|.+ .++..||+|.+....  .........+.+|+.++..++||||+++++++...+.+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP--REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS--SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc--cccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            46799999999999999999998 789999999987543  334566778999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk  138 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK  138 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            99999999999999875 459999999999999999999999999999997

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.90  E-value=7e-24  Score=201.94  Aligned_cols=131  Identities=21%  Similarity=0.296  Sum_probs=115.5

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      +....++|.+++.||+|+||.||+|.+ .++..||+|++.....  ........+..|+.++..++||||+++++++.+.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            455678999999999999999999998 7899999999974210  0011123467899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+|+|||||+||+|.+++...++++..+..++.||+.||.|||++||||||||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLK  195 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK  195 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence            999999999999999999998899999999999999999999999999999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.90  E-value=2.5e-23  Score=193.14  Aligned_cols=128  Identities=20%  Similarity=0.262  Sum_probs=113.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|.+++.||+|+||.||+|.+ .+|+.||+|++.....  ........+..|+.++..++||||+++++++.+.+.+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence            367899999999999999999998 7899999999974311  1122345688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||++||+|..++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  132 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK  132 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC
Confidence            999999999999998865 469999999999999999999999999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.90  E-value=6.6e-23  Score=192.02  Aligned_cols=129  Identities=26%  Similarity=0.406  Sum_probs=114.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc-cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ-GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+.|.+++.||+|+||.||+|.+ .+|..||+|++........ .......+.+|+.++..++||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            56799999999999999999998 7899999999986543211 112346788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||++||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlk  142 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK  142 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9999999999999999754 59999999999999999999999999999997

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.89  E-value=3.2e-23  Score=193.56  Aligned_cols=130  Identities=25%  Similarity=0.352  Sum_probs=112.5

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ...+++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+..|..++..+ +||||+++++++.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~--~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~   96 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP   96 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH--hcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence            45578999999999999999999998 789999999997431  11223355678899999988 799999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+|||||+||+|..++.. ..+++..+..++.||+.||.|||++||||||||
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk  151 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLK  151 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Confidence            999999999999999998865 569999999999999999999999999999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.89  E-value=8.5e-23  Score=189.98  Aligned_cols=128  Identities=22%  Similarity=0.300  Sum_probs=115.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      .+++|.+++.||+|+||.||+|.+ .+++.||+|++....  .........+..|..++..+ +||||+++++++.+.+.
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG--SCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHH--hcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            367899999999999999999998 789999999998643  23445567788999999887 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  137 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK  137 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence            9999999999999998865 569999999999999999999999999999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.89  E-value=2e-23  Score=194.37  Aligned_cols=129  Identities=26%  Similarity=0.380  Sum_probs=111.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.|.+.+.||+|+||.||+|.+ .+++.||+|++...............+.+|+.++..++||||+++++++...+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35799999999999999999998 78999999999743211111123467889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||+||+|.+++...     .+++..+..++.||+.||.|||++||+|||||
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlk  157 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK  157 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence            999999999998877532     38999999999999999999999999999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.89  E-value=1.2e-22  Score=191.37  Aligned_cols=130  Identities=20%  Similarity=0.315  Sum_probs=117.8

Q ss_pred             HHHhccCeeeecccccc--CCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          185 YRRRIMSWQKGAPLGSG--SFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G--~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      +....++|++.+.||+|  +||.||+|.+ .++..||+|++....   ........+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---CSNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            44457789999999999  9999999998 789999999997542   23456678889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+.+|+|||||++|+|.+++..   ..+++..+..++.||+.||.|||++||||||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk  155 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK  155 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999999999999876   458999999999999999999999999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.89  E-value=3.1e-23  Score=193.38  Aligned_cols=129  Identities=22%  Similarity=0.310  Sum_probs=114.8

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+++|.+++.||+|+||.||+|.+ .+|..||+|++.....  ........+.+|+.++..++||||+++++++.+...
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3568999999999999999999998 7899999999974321  112234678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+|||||
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  168 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK  168 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCc
Confidence            9999999999999999875 569999999999999999999999999999997

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.89  E-value=4.4e-23  Score=189.87  Aligned_cols=128  Identities=22%  Similarity=0.380  Sum_probs=113.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|.+.+.||+|+||.||+|.+ .+|+.||+|++.....  ........+..|..++..++||||+++++++.+...+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            467899999999999999999998 7899999999974311  1112345678899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  133 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK  133 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            999999999999999876 459999999999999999999999999999997

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.3e-22  Score=186.79  Aligned_cols=123  Identities=20%  Similarity=0.328  Sum_probs=112.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|.+...      ......+.+|+.++..++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence            57899999999999999999998 78999999998632      233456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||+||+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlk  129 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR  129 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence            999999999999999764  48999999999999999999999999999997

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.89  E-value=1.2e-22  Score=186.01  Aligned_cols=126  Identities=24%  Similarity=0.395  Sum_probs=109.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC--
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN--  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--  264 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||||++....    .......+.+|+.++..++||||+++++++....  
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence            357899999999999999999998 689999999997532    2345677899999999999999999999986543  


Q ss_pred             -------------------------------------------------------EEEEEEecCCCCCHHHHHHhCC---
Q 021084          265 -------------------------------------------------------KLYIFLELVTQGSLAKIYQEYH---  286 (317)
Q Consensus       265 -------------------------------------------------------~~~lVmE~~~ggsL~~~l~~~~---  286 (317)
                                                                             .+|+|||||+||+|.+++....   
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  159 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE  159 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence                                                                   4899999999999999998653   


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          287 -LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       287 -l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       .++..+..++.||+.||.|||++||+|||||
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  191 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK  191 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence             5666789999999999999999999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.89  E-value=3.7e-23  Score=195.35  Aligned_cols=129  Identities=24%  Similarity=0.404  Sum_probs=114.9

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.+++.||+|+||.||+|.+ .++..||+|++....  .........+.+|+.+|..++||||+++++++.+.+.
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK--CVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh--cccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467899999999999999999998 789999999997432  1112235678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+.||+|..++... .+++..+..++.||+.||.|||++||||||||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlk  142 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMK  142 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCc
Confidence            99999999999999999765 59999999999999999999999999999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.89  E-value=1.5e-22  Score=189.55  Aligned_cols=126  Identities=25%  Similarity=0.392  Sum_probs=114.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++....   ........+.+|+.++..++||||+++++++.+.+.+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            46799999999999999999998 789999999997542   23455677899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||+||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlk  155 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK  155 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCc
Confidence            999999999999988654 58999999999999999999999999999997

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.89  E-value=6.2e-23  Score=191.06  Aligned_cols=131  Identities=24%  Similarity=0.341  Sum_probs=112.3

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEe
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKD  262 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  262 (317)
                      .....++|.+.+.||+|+||.||+|.+ .+|+.||+|++.....  ........+..|..++..+ +||||+++++++.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   89 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh--hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            345678999999999999999999998 7899999999974321  0112345677888888876 99999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+.+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  145 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK  145 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence            9999999999999999999875 569999999999999999999999999999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.89  E-value=2.6e-22  Score=179.78  Aligned_cols=126  Identities=25%  Similarity=0.425  Sum_probs=113.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  266 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++....   ........+.+|+..+..+ +||||+++++++...+.+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL---AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC---TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc---cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            46799999999999999999998 689999999997542   2233456788999999999 999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||++||+|.+++..     ..+++..+..++.||+.||.|||++||+|||||
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dik  142 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIK  142 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCC
Confidence            999999999999999865     458999999999999999999999999999997

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.89  E-value=2.1e-22  Score=181.96  Aligned_cols=125  Identities=29%  Similarity=0.502  Sum_probs=110.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|++.+.||+|+||.||+|.+ .++..||+|++....   ........+.+|+.++..++||||+++++++.+++.+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence            36899999999999999999998 789999999997543   23344567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++ ++.+.+..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        78 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dik  128 (292)
T 3o0g_A           78 LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK  128 (292)
T ss_dssp             EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999976 56555543  469999999999999999999999999999997

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.89  E-value=8.1e-23  Score=193.75  Aligned_cols=129  Identities=21%  Similarity=0.287  Sum_probs=112.5

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCC
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDEN  264 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~  264 (317)
                      ..+++|.+++.||+|+||.||+|.+ .++..||+|++++...  ........+..|..++..+ +||||+++++++.+.+
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT--C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            4467899999999999999999998 7899999999986432  2223345577888888876 8999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||+||+|..++.. ..+++..+..++.||+.||.|||++||||||||
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLK  180 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK  180 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence            99999999999999998865 569999999999999999999999999999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.89  E-value=5.4e-23  Score=195.93  Aligned_cols=131  Identities=21%  Similarity=0.231  Sum_probs=114.7

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .....++|.+.+.||+|+||.||+|.+ .+|+.||+|++.+..  .........+..|..++..++||||+++++++.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~--~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD--MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            445578999999999999999999998 789999999997421  11112234477899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+|||||+||+|.+++..  ..+++..+..++.||+.||.|||++||||||||
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLK  189 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK  189 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccC
Confidence            999999999999999999976  369999999999999999999999999999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.88  E-value=2e-22  Score=185.72  Aligned_cols=129  Identities=26%  Similarity=0.415  Sum_probs=113.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc-cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ-GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+.|.+.+.||+|+||.||+|.+ .++..||+|++........ .......+.+|+.++..++||||+++++++...+.+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35699999999999999999998 7899999999976532211 112356788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||++||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk  141 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK  141 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCC
Confidence            9999999999999998654 58999999999999999999999999999997

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.88  E-value=4.9e-23  Score=197.68  Aligned_cols=131  Identities=18%  Similarity=0.236  Sum_probs=113.8

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .....++|.+.+.||+|+||.||+|.+ .+++.||+|++.....  ........+..|..++..++||||++++++|.+.
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh--hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344567899999999999999999998 7789999999974210  0111122377899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+|||||+||+|.+++..  ..+++..+..++.||+.||.|||++||||||||
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLK  202 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIK  202 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccC
Confidence            999999999999999999976  469999999999999999999999999999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.88  E-value=1.5e-22  Score=189.43  Aligned_cols=124  Identities=21%  Similarity=0.232  Sum_probs=112.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||++.+ .++..||+|++.....      ....+.+|+.+++.++||||+++++++.+++.+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT------SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc------ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            357899999999999999999998 7899999999974321      124577999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||||+||+|.+++.. +++++..+..++.||+.||.|||++||+|||||
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlk  143 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK  143 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            999999999999998854 569999999999999999999999999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.88  E-value=9.9e-23  Score=187.59  Aligned_cols=126  Identities=24%  Similarity=0.446  Sum_probs=111.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.....    ......+.+|+.++..++||||+++++++.+++..
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            367899999999999999999998 7899999999974321    22335678999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlk  132 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK  132 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            9999999999999988754 59999999999999999999999999999997

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.88  E-value=8.7e-23  Score=185.05  Aligned_cols=131  Identities=29%  Similarity=0.502  Sum_probs=110.1

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc---------------------cHHHHHHHHHHHHH
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ---------------------GEQSVLQLEQEISL  244 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~---------------------~~~~~~~~~~Ei~i  244 (317)
                      ...++|.+.+.||+|+||.||+|.+ .++..||+|++........                     .....+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            3468999999999999999999998 7899999999975431110                     11224568899999


Q ss_pred             hccCCCCceeeeeeEEEe--CCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          245 LGQFEHDNIVQYFGTEKD--ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       245 l~~l~hpnIv~l~~~~~~--~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.++||||+++++++.+  .+.+|+||||+++++|.+++....+++..+..++.||+.||.|||++||+|||||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  164 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK  164 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            999999999999999987  6789999999999999988777789999999999999999999999999999997

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.88  E-value=1.2e-22  Score=189.82  Aligned_cols=130  Identities=23%  Similarity=0.264  Sum_probs=113.0

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ...+++|.+++.||+|+||.||+|.+ .+++.||+|++.....  ........+..|..++..+ +||||+++++++.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   93 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM   93 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence            45578999999999999999999998 6789999999975321  1122345678899999988 899999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||||||||
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk  148 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK  148 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence            999999999999999999875 569999999999999999999999999999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.88  E-value=1.4e-22  Score=180.96  Aligned_cols=127  Identities=21%  Similarity=0.314  Sum_probs=113.2

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....++|.+.+.||+|+||.||+|.+.++..||+|++....   .   ....+.+|+.++..++||||+++++++.+.+
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---M---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---B---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---c---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            444567899999999999999999988778899999996432   1   1346889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dik  133 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA  133 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcc
Confidence            999999999999999999754  38999999999999999999999999999997

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.88  E-value=1.3e-22  Score=190.38  Aligned_cols=130  Identities=26%  Similarity=0.457  Sum_probs=114.0

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe--------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCcee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT--------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV  254 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~--------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv  254 (317)
                      .+....++|.+++.||+|+||.||+|.+        .++..||+|++..    .........+.+|+.++..+ +||||+
T Consensus        75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hpnIv  150 (370)
T 2psq_A           75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD----DATEKDLSDLVSEMEMMKMIGKHKNII  150 (370)
T ss_dssp             TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCT----TCBHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred             cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecC----CcCHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            3445568899999999999999999976        2345799999863    23455677899999999999 899999


Q ss_pred             eeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       255 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++++...+.+|+||||+++|+|.+++...                 .+++..+..++.||+.||.|||++||||||||
T Consensus       151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  230 (370)
T 2psq_A          151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA  230 (370)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence            9999999999999999999999999999753                 37889999999999999999999999999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.88  E-value=2.1e-22  Score=193.63  Aligned_cols=127  Identities=24%  Similarity=0.291  Sum_probs=113.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||+|.+ .+|..+|+|++....   ........+.+|+.++..++||||+++++++.+.+.+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            356799999999999999999998 889999999997542   2345567789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||||+||+|.+.+.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlK  137 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLK  137 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            999999999999988765 459999999999999999999999999999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.88  E-value=4.1e-22  Score=188.33  Aligned_cols=125  Identities=23%  Similarity=0.367  Sum_probs=113.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..+.|.+.+.||+|+||.||+|.+ .++..||+|++...     .......+.+|+.+|..++||||+++++++.+...+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            357899999999999999999998 78999999998732     233455788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||||+||+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlk  176 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK  176 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence            9999999999999998654  58999999999999999999999999999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.88  E-value=2e-22  Score=189.60  Aligned_cols=129  Identities=22%  Similarity=0.311  Sum_probs=105.4

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHH-hccCCCCceeeeeeEEEeCC
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL-LGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~  264 (317)
                      ...++|.+++.||+|+||.||+|.+ .++..||+|++.+....  .......+..|..+ ++.++||||+++++++.+.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            3467899999999999999999998 78999999999764321  22334456677776 57789999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk  166 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK  166 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence            99999999999999998875 469999999999999999999999999999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.88  E-value=1.4e-22  Score=185.15  Aligned_cols=127  Identities=21%  Similarity=0.242  Sum_probs=112.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC---
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN---  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---  264 (317)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++....  .........+.+|+.++..++||||+++++++....   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT--TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc--cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            56899999999999999999998 889999999997532  334556678999999999999999999999987643   


Q ss_pred             -EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 -KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 -~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       .+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  143 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK  143 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence             45999999999999999864 469999999999999999999999999999997

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.88  E-value=2.7e-22  Score=183.71  Aligned_cols=125  Identities=25%  Similarity=0.388  Sum_probs=110.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC--E
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN--K  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~  265 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++....    .......+.+|+.++..++||||+++++++....  .
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            45799999999999999999998 779999999986432    1223556789999999999999999999998755  7


Q ss_pred             EEEEEecCCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYH----LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~----l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++|+|.+++....    +++..+..++.||+.||.|||++||+|||||
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk  139 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK  139 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence            899999999999999997532    8999999999999999999999999999997

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.88  E-value=6.3e-22  Score=180.13  Aligned_cols=126  Identities=24%  Similarity=0.398  Sum_probs=113.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|.+.+.||+|+||.||+|.+ .+|..||+|++...   .........+.+|+.++..++||||+++++++...+.++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC---CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc---ccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            57899999999999999999998 78999999998643   334455677889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|..++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlk  129 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVK  129 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence            99999999999998875 459999999999999999999999999999997

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.88  E-value=2.5e-22  Score=180.76  Aligned_cols=124  Identities=17%  Similarity=0.245  Sum_probs=111.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCC-------CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDG-------FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTE  260 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~-------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~  260 (317)
                      .++|.+.+.||+|+||.||+|.+ .++       ..||+|.+...     .......+.+|+.++..++||||+++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            56899999999999999999987 544       47999998632     334457789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          261 KDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       261 ~~~~~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..++..|+||||++||+|.+++...+  +++..+..++.||+.||.|||++||+|||||
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk  140 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC  140 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcC
Confidence            99999999999999999999997654  9999999999999999999999999999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.88  E-value=5.7e-22  Score=182.26  Aligned_cols=122  Identities=27%  Similarity=0.416  Sum_probs=111.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|.....||+|+||.||+|.+ .+|+.||||++....     ......+.+|+.++..++||||+++++++...+..|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            366778999999999999998 689999999997432     22345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||++||+|.+++....+++..+..++.|++.||.|||++||+|||||
T Consensus       121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk  168 (321)
T 2c30_A          121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK  168 (321)
T ss_dssp             ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            999999999999988889999999999999999999999999999997

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.88  E-value=3.9e-22  Score=183.64  Aligned_cols=126  Identities=25%  Similarity=0.318  Sum_probs=112.2

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCC---CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDG---FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++   ..||||.+..    .........+.+|+.++..++||||+++++++...
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA----GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECT----TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCC----CCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            356899999999999999999988 443   4599999863    22455567899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||++||+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk  178 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA  178 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence            9999999999999999999653  59999999999999999999999999999997

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.88  E-value=8.5e-22  Score=176.82  Aligned_cols=126  Identities=25%  Similarity=0.390  Sum_probs=114.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++....   ........+.+|+.++..++||||+++++++...+..|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   81 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc---CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence            57899999999999999999998 789999999997542   24455677889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+.+.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik  132 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK  132 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCC
Confidence            99999999999887654 568999999999999999999999999999997

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.88  E-value=3.8e-22  Score=180.06  Aligned_cols=125  Identities=27%  Similarity=0.493  Sum_probs=110.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +++|.+.+.||+|+||.||+|.+.++..||+|++....   ........+.+|+.+++.++||||+++++++...+.+|+
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccc---cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence            36899999999999999999988889999999996432   122234567899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++ +|.+++..  .++++..+..++.||+.||.|||++||+|||||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  127 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK  127 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            9999976 99998875  458999999999999999999999999999997

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.88  E-value=2.7e-22  Score=184.89  Aligned_cols=129  Identities=22%  Similarity=0.307  Sum_probs=106.9

Q ss_pred             hccCeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ..++|.+.+.||+|+||.||+|.+    .++..||+|++..... .........+..|+.++..++||||+++++++...
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            457899999999999999999987    4789999999975321 11223345678899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlk  148 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLK  148 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCC
Confidence            999999999999999998865 458999999999999999999999999999997

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.88  E-value=1.2e-22  Score=190.99  Aligned_cols=129  Identities=27%  Similarity=0.410  Sum_probs=115.1

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      |....++|.+.+.||+|+||.||+|.+ .++..||+|.+..    .........+.+|+.+|+.++||||+++++++...
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCT----TSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccc----cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            444567899999999999999999998 6899999999863    22344556788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk  240 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA  240 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccC
Confidence            9999999999999999998753  48999999999999999999999999999997

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.88  E-value=3.1e-22  Score=180.95  Aligned_cols=124  Identities=32%  Similarity=0.452  Sum_probs=110.6

Q ss_pred             ccCeeeeccccccCCeeEEEEE----e-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGF----T-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~----~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-  262 (317)
                      .++|++.+.||+|+||.||+|.    + .++..||+|++..     ........+.+|+.++..++||||+++++++.. 
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            5689999999999999999998    3 5789999999862     345556789999999999999999999999855 


Q ss_pred             -CCEEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ...+|+||||+++|+|.+++...+  +++..+..++.|++.||.|||++||+|||||
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik  141 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA  141 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence             456899999999999999997643  9999999999999999999999999999997

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.87  E-value=3.2e-22  Score=179.66  Aligned_cols=127  Identities=20%  Similarity=0.331  Sum_probs=111.0

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....++|.+.+.||+|+||.||++.+.++..||+|++....   .   ....+.+|+.++..++||||+++++++...+
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---M---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS---B---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC---C---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            445567899999999999999999988888899999996432   1   1356889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++++|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik  147 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA  147 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCS
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCc
Confidence            99999999999999999975  569999999999999999999999999999997

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.87  E-value=2.5e-22  Score=188.13  Aligned_cols=125  Identities=31%  Similarity=0.424  Sum_probs=111.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      .++|.+.+.||+|+||.||+|..      .++..||||+++.    .........+.+|+.++..++||||+++++++..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc----ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            56899999999999999999983      4677899999853    2344556678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY--------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~--------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ....|+|||||+||+|.+++...        .+++..+..++.||+.||.|||++||+|||||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  208 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA  208 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            99999999999999999999753        38999999999999999999999999999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.87  E-value=2.8e-22  Score=179.91  Aligned_cols=129  Identities=26%  Similarity=0.498  Sum_probs=113.8

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+.+|+.++..++||||+++++++.+.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc--cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            3578899999999999999999988 788899999986421  1112234568899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlk  136 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK  136 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCC
Confidence            9999999999999998865 569999999999999999999999999999997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.87  E-value=1.1e-22  Score=186.56  Aligned_cols=128  Identities=24%  Similarity=0.392  Sum_probs=114.4

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      +....++|.+.+.||+|+||.||+|.+.++..||+|.+...     .......+.+|+.++..++||||+++++++...+
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34457899999999999999999998888999999987632     2234667889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++|+|.+++...     .+++..+..++.|++.||.|||++||+|||||
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  166 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK  166 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCC
Confidence            999999999999999988654     38899999999999999999999999999997

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.87  E-value=4.4e-22  Score=182.14  Aligned_cols=129  Identities=25%  Similarity=0.407  Sum_probs=115.1

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      +....++|.+.+.||+|+||.||+|.+ ++..||+|++...   .........+.+|+.++..++||||+++++++...+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQ---DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCC---CCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCC---CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            344567899999999999999999965 6788999998743   334555678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYH----LKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~----l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                      .+|+||||+++|+|.+++...+    +++..+..++.||+.||.|||++|  |+|||||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dik  166 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK  166 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCC
Confidence            9999999999999999997654    899999999999999999999999  9999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.87  E-value=2.3e-22  Score=194.97  Aligned_cols=129  Identities=27%  Similarity=0.409  Sum_probs=114.6

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+++|.+++.||+|+||.||+|.+ .+|..||+|++....  .........+.+|+.+++.++||||+++++++.+.+.
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK--IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH--HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3468999999999999999999998 789999999997432  1111235678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLk  143 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK  143 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCccccc
Confidence            99999999999999998754 59999999999999999999999999999997

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.87  E-value=4.7e-22  Score=181.90  Aligned_cols=126  Identities=30%  Similarity=0.493  Sum_probs=109.7

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..++|++++.||+|+||.||+|.+.++..||+|++....   ........+.+|+.++..++||||+++++++.+++.+|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc---ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            467899999999999999999998789999999996432   22334567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++ +|.+++...  ++++..+..++.|++.||.|||++||+|||||
T Consensus        96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dik  146 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK  146 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence            99999975 888877654  38999999999999999999999999999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.87  E-value=6e-22  Score=177.34  Aligned_cols=124  Identities=24%  Similarity=0.375  Sum_probs=111.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..+|+|.+.....     .....+.+|+.++..++||||+++++++.+.+.+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            46799999999999999999998 7788999999975321     22467889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlk  133 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK  133 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence            99999999999998754 458999999999999999999999999999997

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.87  E-value=4.1e-22  Score=178.50  Aligned_cols=130  Identities=24%  Similarity=0.492  Sum_probs=114.6

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ...+++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+.+|+.++..++||||+++++++.+.+
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA--MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh--hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            34567899999999999999999998 789999999996421  111123467889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  139 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLT  139 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCC
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            999999999999999999863  58999999999999999999999999999997

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.87  E-value=2.4e-22  Score=186.54  Aligned_cols=131  Identities=25%  Similarity=0.380  Sum_probs=113.8

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEE-----e-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceee
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGF-----T-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQ  255 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~-----~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~  255 (317)
                      ..|....++|.+.+.||+|+||.||+|.     . .+++.||||++..    .........+.+|+.++..+ +||||++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecC----cCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3466677899999999999999999997     3 4668999999963    23445567799999999999 8999999


Q ss_pred             eeeEEEeCC-EEEEEEecCCCCCHHHHHHhCC------------------------------------------------
Q 021084          256 YFGTEKDEN-KLYIFLELVTQGSLAKIYQEYH------------------------------------------------  286 (317)
Q Consensus       256 l~~~~~~~~-~~~lVmE~~~ggsL~~~l~~~~------------------------------------------------  286 (317)
                      +++++...+ .+++|||||++|+|.+++....                                                
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998754 4999999999999999997532                                                


Q ss_pred             -------------------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          287 -------------------LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       287 -------------------l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                         +++..+..++.||+.||.|||++||+|||||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dik  220 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  220 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence                               8889999999999999999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.87  E-value=8.7e-22  Score=179.62  Aligned_cols=124  Identities=21%  Similarity=0.315  Sum_probs=110.0

Q ss_pred             ccCeeee-ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          189 IMSWQKG-APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       189 ~~~y~~~-~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      .+.|.+. +.||+|+||.||+|.+ .++..||+|++....     ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            4578885 7899999999999998 789999999997432     12345688999999885 79999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk  138 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLK  138 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Confidence            9999999999999999865 469999999999999999999999999999997

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.87  E-value=5.2e-22  Score=182.92  Aligned_cols=127  Identities=22%  Similarity=0.426  Sum_probs=109.3

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ..+++|.+.+.||+|+||.||+|.+ .++..||+|++....   ........+.+|+.++..++||||+++++++...+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            3467899999999999999999998 789999999986432   233345567799999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++ +|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlk  159 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK  159 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCC
Confidence            9999999975 999988765 59999999999999999999999999999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.87  E-value=5.5e-22  Score=192.15  Aligned_cols=127  Identities=26%  Similarity=0.367  Sum_probs=113.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++......  .......+.+|+.++..++||||+++++++...+.+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK--QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc--cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45799999999999999999998 78999999999754321  2234567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||.||+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk  153 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK  153 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            99999999999998765 469999999999999999999999999999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.87  E-value=7.6e-22  Score=177.97  Aligned_cols=126  Identities=27%  Similarity=0.387  Sum_probs=112.7

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..+|+|.+.....    ......+.+|+.++..++||||+++++++.+...+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS----QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc----chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            346799999999999999999998 7899999999975432    22356788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++|+|.+++..     ..+++..+..++.||+.||.|||++||+|||||
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dik  151 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK  151 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCC
Confidence            999999999999998743     459999999999999999999999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.87  E-value=1.2e-22  Score=187.67  Aligned_cols=133  Identities=22%  Similarity=0.363  Sum_probs=113.3

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .....++|.+.+.||+|+||.||+|.+ .++..||+|++...............+.+|+.++..++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            455567899999999999999999998 8899999999975322122334567889999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-----------------------------------------CCCCHHHHHHHHHHHHHH
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-----------------------------------------YHLKDSQVSAYTWQILNG  302 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-----------------------------------------~~l~~~~~~~i~~qil~a  302 (317)
                      +.+|+|||||+||+|.+++..                                         ..+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999998841                                         013567788899999999


Q ss_pred             HHHHHHCCcEecCCC
Q 021084          303 LKYLHEQNVIHRPGA  317 (317)
Q Consensus       303 L~yLH~~gIvHrDLK  317 (317)
                      |.|||++||+|||||
T Consensus       181 l~~LH~~~ivH~Dlk  195 (345)
T 3hko_A          181 LHYLHNQGICHRDIK  195 (345)
T ss_dssp             HHHHHHTTEECCCCC
T ss_pred             HHHHHHCCccccCCC
Confidence            999999999999997

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.87  E-value=4.1e-22  Score=183.68  Aligned_cols=128  Identities=21%  Similarity=0.345  Sum_probs=113.7

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeE
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGT  259 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~  259 (317)
                      ....++|.+.+.||+|+||.||+|.+.      ++..||+|++...    ........+.+|+.++..++||||++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            344678999999999999999999873      3478999998632    244556789999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHHHh-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q 021084          260 EKDENKLYIFLELVTQGSLAKIYQE-------------------------YHLKDSQVSAYTWQILNGLKYLHEQNVIHR  314 (317)
Q Consensus       260 ~~~~~~~~lVmE~~~ggsL~~~l~~-------------------------~~l~~~~~~~i~~qil~aL~yLH~~gIvHr  314 (317)
                      +...+.+|+||||+++|+|.+++..                         ..+++..+..++.||+.||.|||++||+||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999999999999999999999976                         458999999999999999999999999999


Q ss_pred             CCC
Q 021084          315 PGA  317 (317)
Q Consensus       315 DLK  317 (317)
                      |||
T Consensus       199 Dlk  201 (343)
T 1luf_A          199 DLA  201 (343)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            997

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.87  E-value=2.8e-22  Score=192.46  Aligned_cols=129  Identities=20%  Similarity=0.257  Sum_probs=105.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.+.+.||+|+||.||+|.+ .+|..||+|++.....  ........+..|+.++..++||||+++++++...+.
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            3467899999999999999999998 8899999999974321  122334567889999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||+ +||||||||
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlk  276 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK  276 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCC
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCC
Confidence            9999999999999998864 468999999999999999999998 999999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.87  E-value=1.4e-21  Score=176.61  Aligned_cols=128  Identities=27%  Similarity=0.391  Sum_probs=115.2

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||++.+ .++..+|+|++....  .........+..|+.++..++||||+++++++...+.+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhh--ccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            356899999999999999999998 788999999997543  22345567888999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~  142 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK  142 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            999999999999998865 469999999999999999999999999999997

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.87  E-value=7.5e-22  Score=181.01  Aligned_cols=129  Identities=26%  Similarity=0.411  Sum_probs=114.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc-cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ-GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+.|.+.+.||+|+||.||+|.+ .+|..||+|++........ .......+.+|+.++..++||||+++++++...+.+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            46799999999999999999998 7899999999986432221 112356788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dik  142 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK  142 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999999999764 48999999999999999999999999999997

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.87  E-value=4.1e-22  Score=181.27  Aligned_cols=129  Identities=26%  Similarity=0.433  Sum_probs=113.8

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeee
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFG  258 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~  258 (317)
                      +....++|.+.+.||+|+||.||+|.+      .++..||+|++..    .........+.+|+.++..++||||+++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE----NASPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccC----CCCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            444567899999999999999999986      2347899999863    234556678999999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHhC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQEY-------------------------HLKDSQVSAYTWQILNGLKYLHEQNVIH  313 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~~~-------------------------~l~~~~~~~i~~qil~aL~yLH~~gIvH  313 (317)
                      ++...+.+|+||||+++|+|.+++...                         .+++..+..++.||+.||.|||++||+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            999999999999999999999999753                         2789999999999999999999999999


Q ss_pred             cCCC
Q 021084          314 RPGA  317 (317)
Q Consensus       314 rDLK  317 (317)
                      ||||
T Consensus       174 ~dik  177 (314)
T 2ivs_A          174 RDLA  177 (314)
T ss_dssp             CCCS
T ss_pred             cccc
Confidence            9997

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.87  E-value=4.5e-22  Score=176.91  Aligned_cols=127  Identities=17%  Similarity=0.250  Sum_probs=113.4

Q ss_pred             HhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC--C
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE--N  264 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~  264 (317)
                      ...++|.+.+.||+|+||.||+|.+. +..||+|++...   .........+.+|+.++..++||||+++++++.+.  +
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVR---DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCT---TCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccc---ccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            34678999999999999999999764 788999999753   33445567899999999999999999999999886  7


Q ss_pred             EEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                      .+++||||+++|+|.+++....   +++..+..++.|++.||.|||++|  |+|||||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik  140 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN  140 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence            8999999999999999998654   899999999999999999999999  9999997

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.87  E-value=6.4e-22  Score=176.31  Aligned_cols=124  Identities=26%  Similarity=0.372  Sum_probs=111.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..++|.+.+.||+|+||.||+|.+.++..||+|++.....      ....+.+|+.++..++||||+++++++...+.+|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            4578999999999999999999888888999999964321      2346889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik  131 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA  131 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCS
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcC
Confidence            999999999999998753  49999999999999999999999999999997

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.87  E-value=1.4e-21  Score=180.47  Aligned_cols=128  Identities=27%  Similarity=0.391  Sum_probs=115.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||++.+ .++..||+|++....  .........+.+|+.++..++||||+++++++.+.+.+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhh--hcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            356899999999999999999998 788999999997543  22345667789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  168 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK  168 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Confidence            999999999999998865 569999999999999999999999999999997

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.87  E-value=4.5e-22  Score=196.56  Aligned_cols=129  Identities=19%  Similarity=0.253  Sum_probs=114.0

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.+.+.||+|+||.||+|.+ .+|..||+|++.....  ........+..|+.+|..++||||+++++++.+.+.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh--hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            4567899999999999999999998 7899999999974321  112234567899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||++||+|.+++...   .+++..+..++.||+.||.|||++||||||||
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLK  313 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK  313 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCc
Confidence            99999999999999998754   39999999999999999999999999999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.87  E-value=6.8e-22  Score=183.69  Aligned_cols=121  Identities=24%  Similarity=0.375  Sum_probs=107.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENK  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~  265 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++.....         ....|+.++..+ +||||+++++++.+.+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            356799999999999999999998 7899999999975421         123677777777 79999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlk  143 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLK  143 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCC
Confidence            99999999999999988654 58999999999999999999999999999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.87  E-value=6.2e-22  Score=192.52  Aligned_cols=126  Identities=24%  Similarity=0.368  Sum_probs=108.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.|.+++.||+|+||.||+|.+ .++..||+|++......   ......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS---TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC---chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            45699999999999999999998 78999999999754321   222456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||+||+|.+++. ...+++..+..++.||+.||.|||++||||||||
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk  163 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK  163 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence            9999999999988765 4579999999999999999999999999999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.87  E-value=1.1e-21  Score=191.35  Aligned_cols=130  Identities=27%  Similarity=0.350  Sum_probs=110.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc--------cHHHHHHHHHHHHHhccCCCCceeeeee
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ--------GEQSVLQLEQEISLLGQFEHDNIVQYFG  258 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~  258 (317)
                      ..++|.+++.||+|+||.||+|.+ .++..||+|++........        .......+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            357899999999999999999998 7899999999975432110        0133567889999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.+...+|+|||||+||+|.+++. ...+++..+..++.||+.||.|||++||+|||||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk  173 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIK  173 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCc
Confidence            9999999999999999999988775 4569999999999999999999999999999997

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.87  E-value=1.3e-21  Score=175.50  Aligned_cols=128  Identities=26%  Similarity=0.416  Sum_probs=113.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc-cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ-GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|++........ .......+.+|+.++..++||||+++++++...+.+|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            5699999999999999999998 6899999999976532211 1123567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  135 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLK  135 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence            99999999999999864 569999999999999999999999999999997

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.87  E-value=3.3e-22  Score=185.48  Aligned_cols=127  Identities=22%  Similarity=0.334  Sum_probs=111.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|.+.+.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++.+++.+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            478999999999999999999998 8999999999874211  1112234688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+ +|+|.+++. ...+++..+..++.||+.||.|||++||+|||||
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk  135 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK  135 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCS
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCc
Confidence            9999999 668888764 5669999999999999999999999999999997

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.87  E-value=5.3e-22  Score=180.47  Aligned_cols=133  Identities=25%  Similarity=0.360  Sum_probs=116.3

Q ss_pred             cchHHHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCce
Q 021084          181 LNEKYRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNI  253 (317)
Q Consensus       181 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnI  253 (317)
                      ....+....++|.+.+.||+|+||.||+|.+      .++..||+|.+...    ........+.+|+.++..+ +||||
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i   89 (313)
T 1t46_A           14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNI   89 (313)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc----hhHHHHHHHHHHHHHHhhcccCCCe
Confidence            3344556678999999999999999999974      46789999998632    2344567899999999999 99999


Q ss_pred             eeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q 021084          254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-------------------HLKDSQVSAYTWQILNGLKYLHEQNVIHR  314 (317)
Q Consensus       254 v~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-------------------~l~~~~~~~i~~qil~aL~yLH~~gIvHr  314 (317)
                      +++++++..++..++||||+++|+|.+++...                   .+++..+..++.||+.||.|||++||+||
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  169 (313)
T 1t46_A           90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR  169 (313)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99999999999999999999999999998754                   28999999999999999999999999999


Q ss_pred             CCC
Q 021084          315 PGA  317 (317)
Q Consensus       315 DLK  317 (317)
                      |||
T Consensus       170 dlk  172 (313)
T 1t46_A          170 DLA  172 (313)
T ss_dssp             CCS
T ss_pred             CCc
Confidence            997

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.87  E-value=1.3e-21  Score=178.52  Aligned_cols=131  Identities=19%  Similarity=0.226  Sum_probs=114.7

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .....++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+.+|+.++..++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            345578999999999999999999998 789999999986432  23345567889999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlk  161 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVK  161 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCC
Confidence            999999999999999999875 459999999999999999999999999999997

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.87  E-value=2.3e-21  Score=180.28  Aligned_cols=123  Identities=23%  Similarity=0.324  Sum_probs=110.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-----CCceeeeeeEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-----HDNIVQYFGTEK  261 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~  261 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++..      .......+..|+.++..+.     ||||+++++++.
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            357899999999999999999998 7899999999852      2344556778999998886     999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+.+|+||||+ +++|.+++....   +++..+..++.||+.||.|||++||||||||
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  164 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLK  164 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            999999999999 889999997654   8999999999999999999999999999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.87  E-value=1.6e-21  Score=176.96  Aligned_cols=125  Identities=30%  Similarity=0.543  Sum_probs=114.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.|.+.+.||+|+||.||+|.+ .++..||+|++.....    ......+.+|+.++..++||||+++++++...+.+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC----STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            35699999999999999999988 7899999999975421    233567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++..+.+++..+..++.|++.||.|||++||+|||||
T Consensus        97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  146 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK  146 (303)
T ss_dssp             EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence            99999999999999998889999999999999999999999999999997

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.87  E-value=7e-22  Score=182.19  Aligned_cols=136  Identities=25%  Similarity=0.443  Sum_probs=116.4

Q ss_pred             cCCcchHHHHhccCeeeeccccccCCeeEEEEEe--------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-
Q 021084          178 NFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFT--------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-  248 (317)
Q Consensus       178 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~--------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-  248 (317)
                      .++....|....++|.+.+.||+|+||.||+|.+        .++..||+|++..    .........+.+|+.++..+ 
T Consensus        23 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~   98 (334)
T 2pvf_A           23 ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD----DATEKDLSDLVSEMEMMKMIG   98 (334)
T ss_dssp             CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCT----TCCHHHHHHHHHHHHHHHHHC
T ss_pred             cCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeecc----CCcHHHHHHHHHHHHHHHHhh
Confidence            3444445666678999999999999999999986        2467899999863    22445667889999999999 


Q ss_pred             CCCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCc
Q 021084          249 EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----------------LKDSQVSAYTWQILNGLKYLHEQNV  311 (317)
Q Consensus       249 ~hpnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~-----------------l~~~~~~~i~~qil~aL~yLH~~gI  311 (317)
                      +||||+++++++...+.+|+||||+++|+|.+++....                 +++..+..++.||+.||.|||++||
T Consensus        99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  178 (334)
T 2pvf_A           99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC  178 (334)
T ss_dssp             CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            99999999999999999999999999999999997542                 8899999999999999999999999


Q ss_pred             EecCCC
Q 021084          312 IHRPGA  317 (317)
Q Consensus       312 vHrDLK  317 (317)
                      +|||||
T Consensus       179 vH~Dlk  184 (334)
T 2pvf_A          179 IHRDLA  184 (334)
T ss_dssp             ECSCCS
T ss_pred             eCCCCc
Confidence            999997

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.87  E-value=5.1e-22  Score=192.66  Aligned_cols=127  Identities=25%  Similarity=0.389  Sum_probs=113.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++.....   .......+.+|+.++..++||||+++++++.+.+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH---BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            356799999999999999999998 7899999999974321   112346788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||||+||+|.+.+. ...+++..+..++.||+.||.|||++||||||||
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk  148 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK  148 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCc
Confidence            99999999999988775 4569999999999999999999999999999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.87  E-value=6.5e-22  Score=186.14  Aligned_cols=132  Identities=25%  Similarity=0.437  Sum_probs=115.4

Q ss_pred             chHHHHhccCeeeeccccccCCeeEEEEEe-c-------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCc
Q 021084          182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGFT-D-------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDN  252 (317)
Q Consensus       182 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpn  252 (317)
                      ...+....++|.+.+.||+|+||.||+|.+ .       .+..||+|++..    .........+.+|+.++..+ +|||
T Consensus        61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hpn  136 (382)
T 3tt0_A           61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMKMIGKHKN  136 (382)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecc----ccCHHHHHHHHHHHHHHHHhcCCch
Confidence            334555668999999999999999999986 2       235799999863    23455667899999999999 9999


Q ss_pred             eeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCcEecC
Q 021084          253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----------------LKDSQVSAYTWQILNGLKYLHEQNVIHRP  315 (317)
Q Consensus       253 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~-----------------l~~~~~~~i~~qil~aL~yLH~~gIvHrD  315 (317)
                      |+++++++...+.+|+||||+++|+|.+++....                 +++..+..++.||+.||.|||++||+|||
T Consensus       137 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  216 (382)
T 3tt0_A          137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD  216 (382)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             hhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence            9999999999999999999999999999997643                 89999999999999999999999999999


Q ss_pred             CC
Q 021084          316 GA  317 (317)
Q Consensus       316 LK  317 (317)
                      ||
T Consensus       217 lk  218 (382)
T 3tt0_A          217 LA  218 (382)
T ss_dssp             CC
T ss_pred             CC
Confidence            98

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.87  E-value=1.8e-21  Score=182.88  Aligned_cols=120  Identities=24%  Similarity=0.413  Sum_probs=103.3

Q ss_pred             eeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEe
Q 021084          193 QKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      ...+.||+|+||.||+|.+ .+|..||+|++...     .......+.+|+.++..++||||+++++++...+.+|+|||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E  166 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME  166 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3367899999999999998 78999999999742     33456778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          272 LVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       272 ~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+++|+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  214 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK  214 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence            99999999988654  48999999999999999999999999999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.87  E-value=1.1e-21  Score=182.50  Aligned_cols=123  Identities=24%  Similarity=0.288  Sum_probs=105.8

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..+.|.+.+.||+|+||.||+|.+ .++..||+|++....       ....+.+|+.++..++||||+++++++..++.+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence            356799999999999999999998 688999999997421       234577899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik  175 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK  175 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence            9999999999999988754 48999999999999999999999999999997

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.87  E-value=1.7e-21  Score=177.77  Aligned_cols=126  Identities=21%  Similarity=0.292  Sum_probs=110.4

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe---
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD---  262 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---  262 (317)
                      ...++|.+.+.||+|+||.||++.+ .++..||+|++..     ........+.+|+.++..++||||+++++++..   
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-----CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            3456899999999999999999998 8899999999864     234556788999999999999999999999873   


Q ss_pred             -CCEEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ...+|+||||+++|+|.+++..     ..+++..+..++.||+.||.|||++||+|||||
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlk  161 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLK  161 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence             4579999999999999998865     458999999999999999999999999999997

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.87  E-value=3.8e-21  Score=175.04  Aligned_cols=128  Identities=27%  Similarity=0.471  Sum_probs=113.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||+|.+ .+|..||+|++....  .........+.+|+.++..++||||+++++++...+.+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS--SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh--ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            356899999999999999999998 789999999997432  23455677889999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++||||+++|+|.+++..     ..+++..+..++.|++.||.|||++||+|||||
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~  163 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK  163 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCc
Confidence            999999999999998864     348999999999999999999999999999997

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.87  E-value=1.9e-21  Score=179.18  Aligned_cols=120  Identities=25%  Similarity=0.390  Sum_probs=107.0

Q ss_pred             cCeeee---ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCC
Q 021084          190 MSWQKG---APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDEN  264 (317)
Q Consensus       190 ~~y~~~---~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~  264 (317)
                      ++|.+.   +.||+|+||.||+|.+ .++..||+|++...        ....+.+|+.++..+. ||||+++++++.+..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            345553   7899999999999998 78999999998632        2345678999999996 999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  133 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK  133 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Confidence            999999999999999998765 59999999999999999999999999999997

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.87  E-value=1.7e-21  Score=177.00  Aligned_cols=124  Identities=27%  Similarity=0.370  Sum_probs=109.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||+|++....     ......+.+|+.++..++||||+++++++...+.+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            45799999999999999999998 789999999997432     122346789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++. ...+++..+..++.|++.||.|||++||+|||||
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dik  133 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK  133 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCC
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            9999999999999875 4568999999999999999999999999999997

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.87  E-value=6.4e-22  Score=185.92  Aligned_cols=125  Identities=26%  Similarity=0.396  Sum_probs=111.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEec----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTD----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|.+.+.||+|+||.||+|.+.    ++..||+|.+...    ........+.+|+.++..++||||+++++++...+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            457899999999999999999763    5678999998632    24455678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++|+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  174 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA  174 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence            999999999999999999764  48999999999999999999999999999997

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.86  E-value=7.5e-22  Score=180.94  Aligned_cols=124  Identities=31%  Similarity=0.591  Sum_probs=96.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|++++.||+|+||.||+|.+ .+|..||+|++.....    ......+.+|+.+++.++||||+++++++..++.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE----EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST----TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc----cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            56799999999999999999988 7899999999975431    122346779999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||++ |+|.+++...       .+++..+..++.||+.||.|||++||+|||||
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk  135 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK  135 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            9999998 5999988642       48999999999999999999999999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.86  E-value=8.6e-22  Score=193.62  Aligned_cols=129  Identities=20%  Similarity=0.267  Sum_probs=114.0

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.+.+.||+|+||.||+|.+ .+|+.||+|++.....  ........+..|+.++..++||||+++++++.+...
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            3457899999999999999999998 7899999999974321  112234568899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||++||+|.+++...     .+++..+..++.||+.||.|||++||||||||
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLK  316 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK  316 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence            99999999999999998753     49999999999999999999999999999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.86  E-value=2.5e-21  Score=178.21  Aligned_cols=129  Identities=26%  Similarity=0.407  Sum_probs=115.5

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ...+++|++.+.||+|+||.||+|.+ .++..||+|++...   .........+.+|+.++..++||||+++++++...+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC---SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC---CCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            34478899999999999999999998 78999999998643   334455667889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++++|..++.. .++++..+..++.||+.||.|||++||+|||||
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk  151 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK  151 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcC
Confidence            99999999999999988653 469999999999999999999999999999997

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.86  E-value=1.3e-21  Score=179.63  Aligned_cols=126  Identities=26%  Similarity=0.373  Sum_probs=110.5

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      +....++|++.+.||+|+||.||+|.+. +..||||++...      .........|+.++..++||||+++++++....
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT   91 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence            3445678999999999999999999764 789999998532      233445667999999999999999999998743


Q ss_pred             ----EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC----------CcEecCCC
Q 021084          265 ----KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ----------NVIHRPGA  317 (317)
Q Consensus       265 ----~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~----------gIvHrDLK  317 (317)
                          .+|+|||||++|+|.+++....+++..+..++.|++.||.|||+.          ||+|||||
T Consensus        92 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlk  158 (322)
T 3soc_A           92 SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK  158 (322)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCS
T ss_pred             CCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCC
Confidence                479999999999999999998999999999999999999999999          99999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.86  E-value=1.1e-21  Score=175.48  Aligned_cols=128  Identities=26%  Similarity=0.386  Sum_probs=113.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+.+|+.+++.++||||+++++++...+.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK--IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc--ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            467899999999999999999998 689999999986421  11122355788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  138 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK  138 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCC
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence            999999999999999864 468999999999999999999999999999997

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.86  E-value=7.4e-22  Score=186.71  Aligned_cols=125  Identities=25%  Similarity=0.385  Sum_probs=110.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC--E
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN--K  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~  265 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++....    .......+.+|+.++..++||||+++++++...+  .
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            45799999999999999999998 779999999996432    1223456789999999999999999999998754  7


Q ss_pred             EEEEEecCCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|||||+||+|.+++...    .+++..+..++.||+.||.|||++||+|||||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  139 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK  139 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcC
Confidence            89999999999999998653    28999999999999999999999999999998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.86  E-value=9.6e-22  Score=174.76  Aligned_cols=125  Identities=22%  Similarity=0.304  Sum_probs=112.2

Q ss_pred             HhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...++|.+.+.||+|+||.||+|.+.++..||+|.+....   .   ....+.+|+.++..++||||+++++++...+.+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---M---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT---B---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC---C---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            3457899999999999999999988888899999996432   1   135688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  131 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA  131 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCc
Confidence            9999999999999999764  48999999999999999999999999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.86  E-value=2.2e-21  Score=182.72  Aligned_cols=127  Identities=22%  Similarity=0.408  Sum_probs=105.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCC
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDEN  264 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~  264 (317)
                      ...++|.+++.||+|+||.||+|.+ .+|..||+|++...   .........+.+|+.++..+. ||||+++++++...+
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc---ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            3467999999999999999999998 88999999998632   334556677889999999997 999999999997644


Q ss_pred             --EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 --KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 --~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        .+|+|||||+ |+|..++....+++..+..++.||+.||.|||++||||||||
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk  136 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMK  136 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             CCEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence              7999999997 599999998889999999999999999999999999999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.86  E-value=1.8e-21  Score=179.09  Aligned_cols=121  Identities=22%  Similarity=0.301  Sum_probs=108.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  266 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||||++.....       ...+..|+.++..+ +||||+++++++...+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            36799999999999999999998 8899999999874321       12477899999999 999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+ +++|.+++..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlk  132 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVK  132 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            9999999 8999999984  569999999999999999999999999999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=8.5e-22  Score=181.95  Aligned_cols=130  Identities=24%  Similarity=0.394  Sum_probs=111.4

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQY  256 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l  256 (317)
                      .+....++|.+.+.||+|+||.||+|.+      .++..||+|++....    .......+.+|+.++..+ +||||+++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~  114 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNL  114 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            3555678999999999999999999986      245689999996421    233456788999999999 99999999


Q ss_pred             eeEEEeCCEEEEEEecCCCCCHHHHHHhCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcE
Q 021084          257 FGTEKDENKLYIFLELVTQGSLAKIYQEYH------------------------LKDSQVSAYTWQILNGLKYLHEQNVI  312 (317)
Q Consensus       257 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~------------------------l~~~~~~~i~~qil~aL~yLH~~gIv  312 (317)
                      ++++...+.+|+||||+++|+|.+++....                        +++..+..++.||+.||.|||++||+
T Consensus       115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  194 (344)
T 1rjb_A          115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV  194 (344)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            999999999999999999999999997532                        78899999999999999999999999


Q ss_pred             ecCCC
Q 021084          313 HRPGA  317 (317)
Q Consensus       313 HrDLK  317 (317)
                      |||||
T Consensus       195 H~Dik  199 (344)
T 1rjb_A          195 HRDLA  199 (344)
T ss_dssp             ETTCS
T ss_pred             cCCCC
Confidence            99997

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.86  E-value=1.9e-21  Score=176.09  Aligned_cols=125  Identities=29%  Similarity=0.509  Sum_probs=110.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..+.|.+.+.||+|+||.||+|.+ .++..||+|++...     .......+..|+.++..++||||+++++++...+.+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            356899999999999999999998 78999999998643     223356788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  144 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK  144 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence            999999999999998864  569999999999999999999999999999997

>4aqr_D Calcium-transporting ATPase 8, plasma membrane-TY; Ca-binding protein-hydrolase complex, plasma-membrane calciu; 1.95A {Arabidopsis thaliana}

Probab=99.86  E-value=2.4e-23  Score=136.38  Aligned_cols=55  Identities=25%  Similarity=0.506  Sum_probs=49.3

Q ss_pred             CCHHHHHHHHhhhhhhcCCCcccccccccCcchHHHHHHHHHHHHHHHHH-HHHHHHHHHh
Q 021084           17 PSRESLRRWRSFCTIVKNPTRRFRMVANLDRRSEADKKIRQMQEQLRLAL-CIRDTLKLIE   76 (317)
Q Consensus        17 ~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~   76 (317)
                      +|+|+|+|||+|+ ||+||+||||||+||+|+++++.++    +|||++. +++||++|++
T Consensus         1 ~s~e~L~rWR~a~-lVlNa~RRFR~t~dL~K~~e~~~~~----rkiR~~~~v~rAa~~F~~   56 (57)
T 4aqr_D            1 SSIERLQQWRKAA-LVLNASRRFRYTLDLKKEQETREMR----QKIRSHAHALLAANRFMD   56 (57)
T ss_dssp             CHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHH-HHhchHhhhhhhcchhhHHHHHHHH----HHHHHHHHHHHHHHHhhc
Confidence            4789999999996 9999999999999999999665554    7999966 9999999997

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.86  E-value=1.3e-21  Score=188.38  Aligned_cols=125  Identities=22%  Similarity=0.436  Sum_probs=101.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-----  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----  262 (317)
                      .++|.+++.||+|+||.||+|.+ .++..||||++...   .........+.+|+.+|..++||||+++++++..     
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECST---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh---hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence            46899999999999999999998 78999999998632   3345567789999999999999999999999844     


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+|+||||+ +|+|.+++... .+++..+..++.||+.||.|||++||||||||
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlK  183 (458)
T 3rp9_A          129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK  183 (458)
T ss_dssp             CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            35799999998 56999988765 49999999999999999999999999999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.86  E-value=1e-21  Score=176.68  Aligned_cols=129  Identities=29%  Similarity=0.505  Sum_probs=113.2

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.+.+.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++..++||||+++++++...+.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR   88 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence            3467899999999999999999998 7888999999864211  111224568899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  141 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIK  141 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence            9999999999999998865 469999999999999999999999999999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.86  E-value=9.2e-22  Score=176.98  Aligned_cols=127  Identities=28%  Similarity=0.419  Sum_probs=114.3

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      |....++|.+.+.||+|+||.||+|.+ .++..||+|.+...      ......+.+|+.++..++||||+++++++...
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            445677899999999999999999998 77999999998632      22456788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||++|++|.+++...   .+++..+..++.||+.||.|||++||+|||||
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dik  138 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA  138 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence            9999999999999999999753   38999999999999999999999999999997

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.86  E-value=1.6e-21  Score=174.23  Aligned_cols=126  Identities=24%  Similarity=0.448  Sum_probs=113.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++....    .......+.+|+.++..++||||+++++++...+..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG----CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc----chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence            357899999999999999999998 789999999997532    123456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+++++|.+++... .+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~  132 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK  132 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            9999999999999988654 58999999999999999999999999999997

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.86  E-value=3.1e-21  Score=174.10  Aligned_cols=123  Identities=26%  Similarity=0.467  Sum_probs=110.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-----  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----  262 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|.+..      .......+.+|+.++..++||||+++++++..     
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            46799999999999999999998 7899999999863      23456778999999999999999999998865     


Q ss_pred             --------CCEEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 --------ENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 --------~~~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                              .+.+|+||||+++|+|.+++...+  +++..+..++.|++.||.|||++||+|||||
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk  143 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLK  143 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCC
Confidence                    467899999999999999997543  7888999999999999999999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.86  E-value=2.8e-21  Score=175.88  Aligned_cols=123  Identities=32%  Similarity=0.501  Sum_probs=106.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE------
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK------  261 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------  261 (317)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++..     ........+.+|+.++..++||||+++++++.      
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-----TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC-----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec-----CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            46899999999999999999998 6799999999873     24556778899999999999999999999873      


Q ss_pred             --------eCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 --------DENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 --------~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                              ....+|+||||++ |+|.+++..+.+++..+..++.|++.||.|||++||+|||||
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  147 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLK  147 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence                    4578999999997 599999988889999999999999999999999999999997

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.86  E-value=3.3e-21  Score=179.31  Aligned_cols=125  Identities=22%  Similarity=0.386  Sum_probs=114.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++...    ........+.+|+.++..++||||+++++++..++.+|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            46899999999999999999998 78999999999743    24456678999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      +||||++|++|.+++.. ..+++..+..++.|++.||.|||+. ||+|||||
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk  159 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK  159 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCS
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCcc
Confidence            99999999999999875 4699999999999999999999996 99999997

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.86  E-value=1.9e-21  Score=178.76  Aligned_cols=131  Identities=25%  Similarity=0.398  Sum_probs=114.3

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEe-cCC-----CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceee
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDG-----FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQ  255 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~  255 (317)
                      ..+....++|.+.+.||+|+||.||+|.+ .++     ..||+|.+...    ........+.+|+.++..+ +||||++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~  114 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST----AHADEKEALMSELKIMSHLGQHENIVN  114 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc----cChHHHHHHHHHHHHHHhhcCCCCeee
Confidence            34556678999999999999999999987 444     47999998632    2345567889999999999 8999999


Q ss_pred             eeeEEEeCCEEEEEEecCCCCCHHHHHHh---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          256 YFGTEKDENKLYIFLELVTQGSLAKIYQE---------------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       256 l~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++++...+.+|+||||+++|+|.+++..               ..+++..+..++.||+.||.|||++||+|||||
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  191 (333)
T 2i1m_A          115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA  191 (333)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence            99999999999999999999999998864               247899999999999999999999999999997

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=1.6e-21  Score=182.81  Aligned_cols=125  Identities=23%  Similarity=0.461  Sum_probs=106.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|.+.+.||+|+||.||+|.+ .+|..||||++...   .........+.+|+.+++.++||||+++++++...    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc---ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence            46899999999999999999998 88999999998642   23455667889999999999999999999999765    


Q ss_pred             --CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 --NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 --~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        ..+|+||||+ +++|.+++....+++..+..++.||+.||.|||++||+|||||
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  155 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK  155 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence              3469999999 7899999998889999999999999999999999999999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.86  E-value=1.4e-21  Score=174.31  Aligned_cols=128  Identities=26%  Similarity=0.413  Sum_probs=108.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..++|.+.+.||+|+||.||+|.+ .+..+|+|++..... .........+.+|+.++..++||||+++++++..++.+|
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPD-EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCc-ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            357899999999999999999976 478999999865322 112334567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN---VIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g---IvHrDLK  317 (317)
                      +||||+++++|.+++...++++..+..++.|++.||.|||++|   |+|||||
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dik  135 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLK  135 (271)
T ss_dssp             EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCS
T ss_pred             EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCc
Confidence            9999999999999998888999999999999999999999999   9999997

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.86  E-value=9.8e-22  Score=177.72  Aligned_cols=129  Identities=26%  Similarity=0.429  Sum_probs=97.9

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      +....++|.+.+.||+|+||.||+|.+ .++..||+|.+....    .......+.+|+.++..++||||+++++++...
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK   85 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESS
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence            455578999999999999999999988 789999999886432    123456688999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE---------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~---------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +..|+||||+++++|.+++..         ..+++..+..++.||+.||.|||++||+|||||
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~  148 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVK  148 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999863         348999999999999999999999999999997

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.86  E-value=2.4e-21  Score=175.36  Aligned_cols=124  Identities=29%  Similarity=0.449  Sum_probs=107.1

Q ss_pred             cCeeeeccccccCCeeEEEEE----e-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC-
Q 021084          190 MSWQKGAPLGSGSFGSVYEGF----T-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE-  263 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~----~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-  263 (317)
                      ..|++.+.||+|+||.||+|.    + .++..||+|++....    .......+.+|+.++..++||||+++++++... 
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            458999999999999999998    3 678999999987432    223356788999999999999999999999876 


Q ss_pred             -CEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..+++||||+++|+|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik  153 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA  153 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCc
Confidence             679999999999999999854  359999999999999999999999999999997

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.86  E-value=3.4e-21  Score=176.89  Aligned_cols=126  Identities=23%  Similarity=0.424  Sum_probs=109.2

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEE--EEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFF--AVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~v--AvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..+  |+|.+...    ........+.+|+.++..+ +||||+++++++...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            357899999999999999999988 677655  89988632    2233456688999999999 999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||+++|+|.+++...                 .+++..+..++.||+.||.|||++||+|||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  169 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA  169 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence            9999999999999999999754                 48999999999999999999999999999997

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.86  E-value=4e-21  Score=177.98  Aligned_cols=125  Identities=18%  Similarity=0.335  Sum_probs=112.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC--CceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH--DNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~  266 (317)
                      -+.|.+.+.||+|+||.||++.+.++..||+|++...   .........+.+|+.++..+.|  |||+++++++...+.+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecc---ccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4579999999999999999998888999999999754   3345566788999999999976  9999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||+ .+|+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDik  135 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK  135 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            999994 577999998765 58999999999999999999999999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.86  E-value=5.8e-21  Score=172.56  Aligned_cols=132  Identities=20%  Similarity=0.277  Sum_probs=114.5

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCcc----HHHHHHHHHHHHHhccCC-CCceeeeeeE
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQG----EQSVLQLEQEISLLGQFE-HDNIVQYFGT  259 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~----~~~~~~~~~Ei~il~~l~-hpnIv~l~~~  259 (317)
                      ....++|.+.+.||+|+||.||+|.+ .++..||+|++.........    ......+.+|+.++.++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            34467899999999999999999998 78999999999754321111    234567889999999995 9999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          260 EKDENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       260 ~~~~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +...+.+|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  151 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK  151 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9999999999999999999999875 469999999999999999999999999999997

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.86  E-value=6.1e-21  Score=174.80  Aligned_cols=122  Identities=33%  Similarity=0.443  Sum_probs=109.9

Q ss_pred             eeeeccccccCCeeEEEEEe-----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CC
Q 021084          192 WQKGAPLGSGSFGSVYEGFT-----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--EN  264 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~  264 (317)
                      |++++.||+|+||.||++..     .++..||+|++...    ........+.+|+.++..++||||+++++++.+  ..
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            58999999999999988853     47889999999642    344567789999999999999999999999988  47


Q ss_pred             EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+++||||+++|+|.+++...++++..+..++.||+.||.|||++||+|||||
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dik  161 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA  161 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             eEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence            89999999999999999998889999999999999999999999999999997

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.86  E-value=9.3e-22  Score=191.53  Aligned_cols=127  Identities=28%  Similarity=0.419  Sum_probs=113.4

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      |.....+|.+.+.||+|+||.||+|.+ .++..||||.+....      .....+.+|+.+|+.++||||+++++++...
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc------cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            444567899999999999999999998 678999999986421      1256788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+|||||++|+|.+++...   .+++..+..++.||+.||.|||++||||||||
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk  345 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA  345 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999999999999999999753   48999999999999999999999999999997

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.86  E-value=2.1e-21  Score=178.32  Aligned_cols=125  Identities=30%  Similarity=0.422  Sum_probs=108.3

Q ss_pred             ccCeeeeccccccCCeeEEEEE-----e-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGF-----T-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~-----~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      .++|.+.+.||+|+||.||+|.     . .++..||+|.+..    .........+.+|+.++..++||||+++++++..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc----ccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            5689999999999999999998     3 5678999999863    2244556678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY--------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~--------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+..|+||||+++|+|.+++...        .+++..+..++.||+.||.|||++||+|||||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlk  167 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA  167 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCC
Confidence            99999999999999999999764        28899999999999999999999999999997

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.86  E-value=2.9e-21  Score=180.28  Aligned_cols=125  Identities=16%  Similarity=0.226  Sum_probs=106.2

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEE-----e-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC---CCceee
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGF-----T-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE---HDNIVQ  255 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~-----~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~  255 (317)
                      +....++|.+.+.||+|+||.||+|.     + .++..||+|++...     .   ...+..|+.++..+.   |+||+.
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~---~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----N---PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----C---HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----C---hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            33445789999999999999999994     4 67899999998632     2   234556666666665   999999


Q ss_pred             eeeEEEeCCEEEEEEecCCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          256 YFGTEKDENKLYIFLELVTQGSLAKIYQE------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       256 l~~~~~~~~~~~lVmE~~~ggsL~~~l~~------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++++...+..|+|||||+||+|.+++..      ..+++..+..++.||+.||.|||++||||||||
T Consensus       132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiK  199 (365)
T 3e7e_A          132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK  199 (365)
T ss_dssp             EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred             hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC
Confidence            99999999999999999999999999963      459999999999999999999999999999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.86  E-value=1.6e-21  Score=178.80  Aligned_cols=128  Identities=29%  Similarity=0.414  Sum_probs=106.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCC---CccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQG---TQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||||++......   .........+.+|+.++..++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            46799999999999999999998 78999999998653211   111223345789999999999999999999987765


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       +|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  141 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK  141 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence             8999999999999998865 458999999999999999999999999999997

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.86  E-value=9.6e-22  Score=180.24  Aligned_cols=130  Identities=25%  Similarity=0.384  Sum_probs=113.7

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .+....++|.+.+.||+|+||.||+|...++..||+|++......    .....+.+|+.++..++||||+++++++..+
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            466778899999999999999999998778999999998643211    1122578999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYH-----LKDSQVSAYTWQILNGLKYLHEQ---NVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~-----l~~~~~~~i~~qil~aL~yLH~~---gIvHrDLK  317 (317)
                      +..++||||+++|+|.+++....     +++..+..++.|++.||.|||++   ||+|||||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk  161 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK  161 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence            99999999999999999997542     89999999999999999999999   99999997

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.86  E-value=1.7e-21  Score=185.71  Aligned_cols=130  Identities=27%  Similarity=0.386  Sum_probs=109.6

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCC---ccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGT---QGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ...++|.+.+.||+|+||.||+|.+ .++..||+|++.......   ........+.+|+.+|.+++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4467899999999999999999998 889999999997643211   11222335789999999999999999999975 


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk  266 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK  266 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            4568999999999999988764 459999999999999999999999999999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.86  E-value=3.5e-21  Score=172.36  Aligned_cols=127  Identities=28%  Similarity=0.395  Sum_probs=112.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--EN  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~  264 (317)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.+...   .........+.+|+.++..++||||+++++++..  ..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG---SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcc---cCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            467899999999999999999998 78999999999753   2244556789999999999999999999998854  67


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGLKYLHEQN-----VIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-----~l~~~~~~~i~~qil~aL~yLH~~g-----IvHrDLK  317 (317)
                      .+|+||||+++|+|.+++...     .+++..+..++.|++.||.|||++|     |+|||||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~  143 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK  143 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence            899999999999999998643     3899999999999999999999999     9999997

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.86  E-value=1.1e-20  Score=170.48  Aligned_cols=125  Identities=25%  Similarity=0.424  Sum_probs=111.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe----CC
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD----EN  264 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~  264 (317)
                      ..|.+...||+|+||.||+|.+ .++..||+|.+....   ........+.+|+.+++.++||||+++++++..    ..
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh---hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            3578899999999999999998 889999999997542   244557788999999999999999999999875    46


Q ss_pred             EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                      .+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++|  |+|||||
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dik  158 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK  158 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCC
Confidence            69999999999999999976 56999999999999999999999999  9999997

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.86  E-value=6.8e-21  Score=177.27  Aligned_cols=125  Identities=28%  Similarity=0.471  Sum_probs=110.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ..|...+.||+|+||.||+|.+ .++..||+|++....  .........+.+|+.++..++||||+++++++...+..|+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS--SCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc--ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            4588999999999999999998 889999999997542  2334556778999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+. |+|.+++.  ...+++..+..++.|++.||.|||++||+|||||
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  181 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK  181 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            999997 58888774  3469999999999999999999999999999997

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.85  E-value=6.2e-21  Score=175.18  Aligned_cols=124  Identities=29%  Similarity=0.434  Sum_probs=110.7

Q ss_pred             ccCeeeeccccccCCeeEEEEE----e-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE--
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGF----T-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK--  261 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~----~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--  261 (317)
                      .++|++.+.||+|+||.||+|.    + .++..||+|++..     ........+.+|+.++..++||||+++++++.  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-----SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc-----CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            4579999999999999999998    3 5788999999863     24455677899999999999999999999886  


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ....+|+||||+++++|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dik  154 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA  154 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence            46779999999999999999875  359999999999999999999999999999997

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.85  E-value=3.8e-21  Score=184.00  Aligned_cols=125  Identities=23%  Similarity=0.439  Sum_probs=112.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||||++...   .........+.+|+.+|..++||||+++++++...    
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST---TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch---hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            56899999999999999999998 88999999999642   33455677899999999999999999999999776    


Q ss_pred             -CEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..+|+||||+. |+|.+++.... +++..+..++.||+.||.|||++||+|||||
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk  156 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLK  156 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence             67999999996 59999998654 9999999999999999999999999999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.85  E-value=5.9e-23  Score=189.57  Aligned_cols=128  Identities=16%  Similarity=0.221  Sum_probs=103.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCC---CccHHHHHHHHHHHHHhccCC---------CCceeee
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQG---TQGEQSVLQLEQEISLLGQFE---------HDNIVQY  256 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~---------hpnIv~l  256 (317)
                      .++|.+.+.||+|+||.||+|.+ +|..||||++......   .........+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999987 7899999999865321   112233466778888888775         6666666


Q ss_pred             eeEEE-----------------e-------------CCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHH
Q 021084          257 FGTEK-----------------D-------------ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYL  306 (317)
Q Consensus       257 ~~~~~-----------------~-------------~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yL  306 (317)
                      .+.+.                 +             .+.+|||||||++|++.+.+....+++..+..++.||+.||.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence            66542                 2             68899999999999776666667799999999999999999999


Q ss_pred             H-HCCcEecCCC
Q 021084          307 H-EQNVIHRPGA  317 (317)
Q Consensus       307 H-~~gIvHrDLK  317 (317)
                      | ++||||||||
T Consensus       178 H~~~~ivHrDlK  189 (336)
T 2vuw_A          178 EASLRFEHRDLH  189 (336)
T ss_dssp             HHHHCCBCSCCC
T ss_pred             HHhCCEeECCCC
Confidence            9 9999999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.85  E-value=1.6e-21  Score=180.55  Aligned_cols=130  Identities=22%  Similarity=0.335  Sum_probs=112.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc---cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++........   .......+..|+.++..++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            356899999999999999999998 8899999999986432111   111233566899999999999999999999999


Q ss_pred             CEEEEEEecCCCC-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQG-SLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~gg-sL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+++||||+.+| +|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk  157 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIK  157 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccC
Confidence            9999999999776 999999765 59999999999999999999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.85  E-value=5.1e-21  Score=172.42  Aligned_cols=128  Identities=25%  Similarity=0.386  Sum_probs=113.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.+.+.||+|+||.||+|.+ .++..||+|++......   ......+.+|+.+++.++||||+++++++...+.
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            3456899999999999999999998 68999999999754322   2335678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++++|.+++. ...+++..+..++.||+.||.|||++||+|||||
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~  148 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK  148 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            999999999999988775 4569999999999999999999999999999997

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.85  E-value=2.6e-21  Score=176.91  Aligned_cols=129  Identities=24%  Similarity=0.389  Sum_probs=113.4

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeee
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFG  258 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~  258 (317)
                      +....++|.+.+.||+|+||.||+|.+.      ++..||+|.+..    .........+.+|+.+++.++||||+++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc----ccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            4555678999999999999999999763      467899999863    223445667899999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQE-----------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~~-----------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++...+..|+||||+++|+|.+++..           ..+++..+..++.||+.||.|||++||+|||||
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik  165 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLA  165 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCS
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCc
Confidence            99999999999999999999999864           346899999999999999999999999999997

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.85  E-value=1.9e-21  Score=187.25  Aligned_cols=126  Identities=23%  Similarity=0.366  Sum_probs=111.7

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      +....++|.+.+.||+|+||.||+|.+.++..||||.+....      ...+.+.+|+.+|+.++||||+++++++. ..
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS------MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            455567899999999999999999988778899999986422      23567899999999999999999999986 56


Q ss_pred             EEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||++|+|.+++...   .+++..+..++.||+.||.|||++||||||||
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk  311 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR  311 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCS
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence            789999999999999999743   58999999999999999999999999999997

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.85  E-value=2.9e-21  Score=176.85  Aligned_cols=128  Identities=23%  Similarity=0.338  Sum_probs=102.5

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCC---EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGF---FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ...++|.+.+.||+|+||.||+|.+ .++.   .||+|++....   ........+.+|+.+++.++||||+++++++..
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI---IASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc---cCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3456899999999999999999987 4443   89999986432   233456789999999999999999999999987


Q ss_pred             CCEE------EEEEecCCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKL------YIFLELVTQGSLAKIYQEY-------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~------~lVmE~~~ggsL~~~l~~~-------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ....      ++||||+++|+|.+++...       .+++..+..++.||+.||.|||++||+|||||
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dik  164 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLA  164 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Confidence            6655      9999999999999988542       48999999999999999999999999999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.85  E-value=2.2e-21  Score=174.28  Aligned_cols=127  Identities=28%  Similarity=0.422  Sum_probs=109.8

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ....++|.+.+.||+|+||.||+|.+ .   .+..||+|.+..    .........+.+|+.++..++||||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            34467899999999999999999987 3   245799998753    234556678999999999999999999999984


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       .+..|+||||+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  143 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA  143 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence             46689999999999999999754  48999999999999999999999999999997

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.85  E-value=4.6e-21  Score=174.44  Aligned_cols=129  Identities=26%  Similarity=0.454  Sum_probs=105.2

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~  263 (317)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||+|++...............+.+|+.++..+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999998 8899999999976432222222223455677666655   599999999999875


Q ss_pred             C-----EEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 N-----KLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~-----~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .     .+++||||+. |+|.+++....   +++..+..++.||+.||.|||++||+|||||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk  147 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK  147 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            5     6899999997 59999987653   8999999999999999999999999999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.85  E-value=1.8e-21  Score=174.44  Aligned_cols=126  Identities=25%  Similarity=0.393  Sum_probs=110.8

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....++|.+.+.||+|+||.||+|.+.++..||+|.+....      .....+.+|+.++..++||||+++++++.. +
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   80 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc------ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence            555668899999999999999999988888899999986422      124568899999999999999999999864 4


Q ss_pred             EEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik  136 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR  136 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            589999999999999998643   59999999999999999999999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.85  E-value=7.3e-21  Score=171.49  Aligned_cols=124  Identities=33%  Similarity=0.542  Sum_probs=107.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.|.....||+|+||.||+|.+ .++..||+|.+...     .......+.+|+.++..++||||+++++++...+.++
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            34455566899999999999998 78999999998743     2234567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++++|.+++...    .+++..+..++.|++.||.|||++||+|||||
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~  149 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK  149 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCC
Confidence            999999999999999764    36688899999999999999999999999997

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.85  E-value=4.3e-21  Score=176.62  Aligned_cols=124  Identities=23%  Similarity=0.408  Sum_probs=101.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEE----EEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFF----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~v----AvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..+    |+|.+..    .........+.+|+.++..++||||+++++++...
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            46799999999999999999987 566554    6666542    22334456789999999999999999999999876


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      . .++||+|+.+|+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dik  144 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA  144 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCC
Confidence            5 78999999999999998763  48999999999999999999999999999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.85  E-value=1e-20  Score=177.10  Aligned_cols=134  Identities=19%  Similarity=0.315  Sum_probs=116.0

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc---cHHHHHHHHHHHHHhccC-CCCceeeeee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQF-EHDNIVQYFG  258 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l-~hpnIv~l~~  258 (317)
                      ......++|.+.+.||+|+||.||+|.+ .+|..||||++........   .......+..|+.++..+ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            3445567899999999999999999998 6899999999975432111   123356688999999999 8999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++...+..|+||||++|++|.+++.. ..+++..+..++.||+.||.|||+.||+|||||
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlk  227 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLK  227 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999999999999998875 469999999999999999999999999999997

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.85  E-value=1.7e-21  Score=179.09  Aligned_cols=124  Identities=28%  Similarity=0.476  Sum_probs=106.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|.+++.||+|+||.||+|.+ .++..||+|++.....    ......+.+|+.++..++||||+++++++...+.+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   76 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence            36899999999999999999998 7899999999864321    111123457999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+++ +|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dik  127 (324)
T 3mtl_A           77 LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK  127 (324)
T ss_dssp             EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCC
T ss_pred             EEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcC
Confidence            99999975 898888754  38999999999999999999999999999997

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.85  E-value=6.9e-21  Score=172.14  Aligned_cols=125  Identities=30%  Similarity=0.507  Sum_probs=108.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|++.+.||+|+||.||+|.+ .++..||+|++....   ........+.+|+.++..++||||+++++++...+.+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   78 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCc---cchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceE
Confidence            57899999999999999999998 789999999986432   12223456789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+. |+|.+++...   .+++..+..++.|++.||.|||++||+|||||
T Consensus        79 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  130 (299)
T 2r3i_A           79 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK  130 (299)
T ss_dssp             EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence            9999997 5999988754   58999999999999999999999999999997

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.85  E-value=8.3e-21  Score=173.49  Aligned_cols=125  Identities=26%  Similarity=0.334  Sum_probs=106.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  266 (317)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++...   ............|+..+..+ +||||+++++++...+.+
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP---FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSS---CCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccc---ccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            35799999999999999999998 68999999987643   22333444555666655555 999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+ +++|.+++..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  184 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVK  184 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence            9999999 6699888765  349999999999999999999999999999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.85  E-value=7.2e-21  Score=173.36  Aligned_cols=124  Identities=28%  Similarity=0.520  Sum_probs=105.9

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...+.|.+.+.||+|+||.||+|.+ .+|..||+|.+....       ....+.+|+.++..++||||+++++++...+.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            4467899999999999999999988 789999999997431       13467899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++++|.+++.  ...+++..+..++.|++.||.|||++||+|||||
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~  152 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK  152 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcC
Confidence            999999999999999986  3569999999999999999999999999999997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.85  E-value=3.1e-21  Score=175.60  Aligned_cols=130  Identities=25%  Similarity=0.384  Sum_probs=112.5

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQY  256 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l  256 (317)
                      .+....++|.+.+.||+|+||.||+|.+      .++..||+|++...    ........+.+|+.++..+ +||||+++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC----CCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3555678999999999999999999974      45689999998632    2345567789999999999 79999999


Q ss_pred             eeEEEeC-CEEEEEEecCCCCCHHHHHHhCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          257 FGTEKDE-NKLYIFLELVTQGSLAKIYQEYH-----------------LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       257 ~~~~~~~-~~~~lVmE~~~ggsL~~~l~~~~-----------------l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++... ..+|+||||+++|+|.+++....                 +++..+..++.|++.||.|||++||+|||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik  175 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  175 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence            9998775 45999999999999999997643                 7899999999999999999999999999997

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.85  E-value=9e-21  Score=176.99  Aligned_cols=124  Identities=27%  Similarity=0.462  Sum_probs=111.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++..    .........+.+|+.++..++||||+++++++...    
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc----ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence            35899999999999999999998 7899999999863    23445567889999999999999999999999765    


Q ss_pred             -CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..+|+||||+.+ +|.+++...++++..+..++.||+.||.|||++||+|||||
T Consensus       102 ~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  155 (364)
T 3qyz_A          102 MKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK  155 (364)
T ss_dssp             CCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             cceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence             479999999975 99999998899999999999999999999999999999997

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.85  E-value=3.9e-21  Score=193.82  Aligned_cols=130  Identities=23%  Similarity=0.264  Sum_probs=112.7

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ...+++|.+++.||+|+||.||+|.+ .+++.||||++.....  ........+..|..++..+ +||+|+.+++++.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            45678999999999999999999998 7899999999974311  1122345677899999887 799999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+||||||++||+|.+++.. +.+++..+..|+.||+.||.|||++||||||||
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLK  469 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK  469 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCC
Confidence            999999999999999999875 569999999999999999999999999999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.85  E-value=5.3e-21  Score=180.70  Aligned_cols=125  Identities=18%  Similarity=0.342  Sum_probs=111.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC--CCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE--HDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~  266 (317)
                      ...|.+.+.||+|+||.||+|.+.++..||||++....   ........+.+|+.+|..+.  ||||+++++++...+.+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc---ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            34699999999999999999988779999999997542   34556778999999999996  59999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||| +.+++|.+++... .+++..+..++.||+.||.|||++||||||||
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk  182 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK  182 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCC
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            99999 5678999998764 58899999999999999999999999999998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.85  E-value=6.8e-21  Score=175.47  Aligned_cols=124  Identities=23%  Similarity=0.407  Sum_probs=106.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEE----EEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFF----AVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~v----AvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .++|++.+.||+|+||.||+|.+ .++..+    |+|.+..    .........+.+|+.++..++||||+++++++...
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECC----CSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecc----ccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            46899999999999999999987 666655    5555542    22333456788999999999999999999999876


Q ss_pred             CEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      . .++||+|+.+|+|.+++..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  144 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA  144 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCC
Confidence            5 7899999999999999875  358999999999999999999999999999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.85  E-value=4.1e-21  Score=184.77  Aligned_cols=125  Identities=26%  Similarity=0.404  Sum_probs=109.5

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....++|.+.+.||+|+||.||+|... +..||||+++...       ..+.+.+|+.+|+.++||||+++++++....
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            3445678999999999999999999664 6799999986321       2457889999999999999999999987754


Q ss_pred             -EEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 -KLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 -~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       .+|+|||||++|+|.+++...+   +++..+..++.||+.||.|||++||||||||
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk  316 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA  316 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence             7999999999999999997543   7899999999999999999999999999997

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.85  E-value=1.7e-21  Score=181.55  Aligned_cols=129  Identities=22%  Similarity=0.302  Sum_probs=110.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEe
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKD  262 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~  262 (317)
                      .+++|.+.+.||+|+||.||+|.+    .++..||||+++..... ........+..|+.++..+ +||||+++++++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-hhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            467899999999999999999987    37899999998643210 0111223456788999998 79999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk  186 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK  186 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9999999999999999998865 569999999999999999999999999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.85  E-value=1.8e-21  Score=180.48  Aligned_cols=130  Identities=25%  Similarity=0.426  Sum_probs=104.1

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|.+.+.||+|+||.||+|.+ .+|..||+|++...............+.+|+.++..++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3467899999999999999999998 789999999987533222222223467899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+++ +|..++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  139 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK  139 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCC
Confidence            9999999986 898888764  38899999999999999999999999999997

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.85  E-value=1.4e-20  Score=177.05  Aligned_cols=121  Identities=25%  Similarity=0.436  Sum_probs=102.1

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe---
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD---  262 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---  262 (317)
                      ...++|.+.+.||+|+||.||+|.+ .+|..||+|++......         ..+|+.+++.++||||+++++++..   
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence            3467899999999999999999998 88999999998643211         1279999999999999999999844   


Q ss_pred             -----------------------------------CCEEEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHH
Q 021084          263 -----------------------------------ENKLYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNG  302 (317)
Q Consensus       263 -----------------------------------~~~~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~a  302 (317)
                                                         ...+++||||+++ +|.+.+..     ..+++..+..++.||+.|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                               3458999999985 88776653     459999999999999999


Q ss_pred             HHHHHHCCcEecCCC
Q 021084          303 LKYLHEQNVIHRPGA  317 (317)
Q Consensus       303 L~yLH~~gIvHrDLK  317 (317)
                      |.|||++||+|||||
T Consensus       154 L~~LH~~gi~H~Dik  168 (383)
T 3eb0_A          154 VGFIHSLGICHRDIK  168 (383)
T ss_dssp             HHHHHTTTEECSCCC
T ss_pred             HHHHHHCcCccCccC
Confidence            999999999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.84  E-value=1.4e-20  Score=170.85  Aligned_cols=120  Identities=23%  Similarity=0.273  Sum_probs=105.9

Q ss_pred             hccCeeee-ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHh-ccCCCCceeeeeeEEEe--
Q 021084          188 RIMSWQKG-APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL-GQFEHDNIVQYFGTEKD--  262 (317)
Q Consensus       188 ~~~~y~~~-~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~--  262 (317)
                      .+++|.+. +.||+|+||.||+|.+ .++..||+|++...          ..+.+|+.++ ..++||||+++++++..  
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            46788887 7899999999999998 88999999998621          2455788877 56699999999999987  


Q ss_pred             --CCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 --ENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 --~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        ...+|+||||++||+|.+++...   .+++..+..++.||+.||.|||++||+|||||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlk  144 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK  144 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence              77899999999999999999764   49999999999999999999999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.84  E-value=8.2e-21  Score=180.00  Aligned_cols=120  Identities=23%  Similarity=0.264  Sum_probs=104.3

Q ss_pred             hccCeeee-ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhc-cCCCCceeeeeeEEEe--
Q 021084          188 RIMSWQKG-APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG-QFEHDNIVQYFGTEKD--  262 (317)
Q Consensus       188 ~~~~y~~~-~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~--  262 (317)
                      .+++|.+. +.||+|+||.||+|.+ .++..||||++...          ..+.+|+.++. ..+||||+++++++..  
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            46778876 7899999999999998 78999999998621          24557777764 4589999999999876  


Q ss_pred             --CCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 --ENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 --~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        ...+|||||||+||+|.+++...   .+++..+..++.||+.||.|||++||||||||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  188 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK  188 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence              66799999999999999999764   38999999999999999999999999999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.84  E-value=1.1e-20  Score=171.59  Aligned_cols=122  Identities=28%  Similarity=0.447  Sum_probs=106.9

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEecC
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      .++.||+|+||.||+|.. ++..||+|.+..... .........+.+|+.++..++||||+++++++...+..|+||||+
T Consensus        35 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TCCEEEECSSEEEEEEES-SSCEEEEEEECCCTT-SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cCCccccCCCeEEEEEEE-CCceEEEEEEecccC-cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            348999999999999965 678999999864321 223445677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          274 TQGSLAKIYQE----YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       274 ~ggsL~~~l~~----~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+|.+++..    ..+++..+..++.|++.||.|||++||+|||||
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlk  160 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIK  160 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence            99999999863    348999999999999999999999999999997

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.84  E-value=1e-20  Score=170.78  Aligned_cols=126  Identities=27%  Similarity=0.375  Sum_probs=108.3

Q ss_pred             hccCeeeec-cccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGA-PLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~-~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ..++|.+.+ .||+|+||.||+|.+   .++..||+|++...   .........+.+|+.++..++||||+++++++ ..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc---ccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            356788888 999999999999954   45789999998743   22334567799999999999999999999999 56


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||+++++|.+++...+ +++..+..++.||+.||.|||++||+|||||
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dik  144 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA  144 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCC
Confidence            67899999999999999997654 9999999999999999999999999999997

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.84  E-value=8.9e-21  Score=183.23  Aligned_cols=125  Identities=26%  Similarity=0.411  Sum_probs=109.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC---
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE---  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---  263 (317)
                      ..++|.+++.||+|+||.||+|.+ .++..||||++...   .........+.+|+.+|+.++||||+++++++...   
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence            367899999999999999999998 78999999999743   23445667888999999999999999999999654   


Q ss_pred             ---CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 ---NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ---~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         ..+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlk  191 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence               468999999976 5766665 359999999999999999999999999999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.84  E-value=1.1e-20  Score=174.48  Aligned_cols=125  Identities=27%  Similarity=0.426  Sum_probs=110.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cC----CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~----~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ..+|.+.+.||+|+||.||+|.+ .+    +..||+|.+...    ........+.+|+.++..++||||+++++++...
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            56899999999999999999987 33    246999998632    2345566789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+++||||+++|+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  174 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA  174 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            9999999999999999999753  58999999999999999999999999999997

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.84  E-value=1.2e-20  Score=174.62  Aligned_cols=124  Identities=29%  Similarity=0.493  Sum_probs=111.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|.+.+.||+|+||.||+|.+ .+|..||||++..    .........+.+|+.++..++||||+++++++...    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc----cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            46899999999999999999998 7899999999853    23445566788999999999999999999988664    


Q ss_pred             -CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..+|+||||+. |+|.+++....+++..+..++.|++.||.|||++||+|||||
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  139 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLK  139 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             cceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence             67999999997 599999998889999999999999999999999999999997

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.84  E-value=1.2e-20  Score=173.27  Aligned_cols=124  Identities=32%  Similarity=0.451  Sum_probs=109.1

Q ss_pred             ccCeeeeccccccCCeeEEEEE----e-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGF----T-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~----~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .++|++.+.||+|+||.||+|.    . .++..||+|++..     ........+.+|+.++..++||||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-----CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            4579999999999999999998    3 5789999999863     2344567889999999999999999999998664


Q ss_pred             C--EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 N--KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~--~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +  .+++||||+++++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik  172 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA  172 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC
Confidence            3  789999999999999999764  38999999999999999999999999999997

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.84  E-value=1.4e-20  Score=169.27  Aligned_cols=126  Identities=24%  Similarity=0.367  Sum_probs=109.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHH---HHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQS---VLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++....... ....   ...+.+|+.++..++||||+++++++.+..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG-ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC-CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc-chhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            56899999999999999999998 789999999987543221 1111   167889999999999999999999997766


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                        ++||||+++|+|.+++...  .+++..+..++.|++.||.|||++|  |+|||||
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dik  151 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR  151 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCS
T ss_pred             --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCC
Confidence              7999999999999888543  5899999999999999999999999  9999997

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.84  E-value=1.1e-20  Score=169.11  Aligned_cols=120  Identities=28%  Similarity=0.460  Sum_probs=106.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-----  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----  262 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|.+....         ..+.+|+.++..++||||+++++++..     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            46799999999999999999998 689999999997431         235689999999999999999998864     


Q ss_pred             -----------CCEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -----------ENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -----------~~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                 ...+|+||||+++|+|.+++..   ..+++..+..++.||+.||.|||++||+|||||
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlk  149 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLK  149 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence                       4568999999999999999964   358999999999999999999999999999997

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.84  E-value=2.2e-20  Score=174.97  Aligned_cols=125  Identities=26%  Similarity=0.406  Sum_probs=110.8

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC--
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN--  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--  264 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++...   .........+.+|+.+++.++||||+++++++...+  
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc---cCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence            357899999999999999999998 78999999999743   234455677889999999999999999999997654  


Q ss_pred             ----EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 ----KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ----~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          .+|+||||+++ +|.+++. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       100 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk  154 (371)
T 2xrw_A          100 EEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  154 (371)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence                89999999975 7888876 469999999999999999999999999999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.84  E-value=1.1e-20  Score=170.33  Aligned_cols=125  Identities=26%  Similarity=0.384  Sum_probs=108.7

Q ss_pred             hccCeeeec-cccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGA-PLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~-~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      ..++|.+.. .||+|+||.||+|.+   .++..||+|++...    ........+.+|+.++..++||||+++++++ ..
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~   81 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA   81 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence            346777777 999999999999975   36788999998642    3455677899999999999999999999999 45


Q ss_pred             CEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+++||||+++++|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  137 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA  137 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCc
Confidence            669999999999999999854  348999999999999999999999999999997

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.84  E-value=1.1e-20  Score=169.78  Aligned_cols=127  Identities=22%  Similarity=0.322  Sum_probs=106.9

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++...   .........+..+...+..++||||+++++++..++.
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc---cCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            3467899999999999999999998 78999999998643   2233334445555666888999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      .|+||||++| +|.+++..     ..+++..+..++.|++.||.|||++ ||+|||||
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlk  137 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK  137 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCS
T ss_pred             EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence            9999999975 88777653     4599999999999999999999998 99999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.84  E-value=1.7e-20  Score=172.06  Aligned_cols=119  Identities=24%  Similarity=0.406  Sum_probs=107.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEe--CC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKD--EN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~  264 (317)
                      .++|++.+.||+|+||.||+|.+ .++..||+|++...        ....+.+|+.++..+. ||||+++++++..  ..
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            46899999999999999999998 88999999998621        1356789999999996 9999999999988  67


Q ss_pred             EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..++||||+++++|.+++..  +++..+..++.||+.||.|||++||+|||||
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik  157 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVK  157 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             ceEEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            89999999999999998864  8999999999999999999999999999997

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.84  E-value=5.4e-21  Score=179.29  Aligned_cols=125  Identities=31%  Similarity=0.509  Sum_probs=103.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|.+++.||+|+||.||+|.+ .+|..||||++...   .........+.+|+.+++.++||||+++++++...    
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc---ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            47899999999999999999998 88999999998642   23445667888999999999999999999998654    


Q ss_pred             --CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 --NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 --~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        ..+|+|||++ +++|.+++....+++..+..++.||+.||.|||++||+|||||
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk  159 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  159 (367)
T ss_dssp             GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence              5689999999 6799999988889999999999999999999999999999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.84  E-value=4.5e-21  Score=184.56  Aligned_cols=126  Identities=25%  Similarity=0.374  Sum_probs=110.6

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....++|.+.+.||+|+||.||+|.+..+..||||++....   .   ..+.+.+|+.+|+.++||||+++++++.. +
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---M---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---C---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            445567899999999999999999988777789999986432   1   23568899999999999999999999876 6


Q ss_pred             EEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++|+|.+++..   ..+++..+..++.||+.||.|||++||+|||||
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk  307 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR  307 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            78999999999999999964   358999999999999999999999999999997

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.84  E-value=1.6e-20  Score=169.43  Aligned_cols=125  Identities=25%  Similarity=0.366  Sum_probs=107.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC---EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF---FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ...|.+.+.||+|+||.||+|.+ .++.   .+|+|.+..    .......+.+.+|+.+++.++||||+++++++...+
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   95 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR----ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc----cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence            34577889999999999999986 3333   799998853    334456778999999999999999999999998765


Q ss_pred             EE-EEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KL-YIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~-~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .. ++||||+.+|+|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dik  151 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA  151 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            54 999999999999999976  458899999999999999999999999999997

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.84  E-value=1.2e-20  Score=174.96  Aligned_cols=126  Identities=24%  Similarity=0.474  Sum_probs=108.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe----
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD----  262 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----  262 (317)
                      ..++|.+.+.||+|+||.||+|.+ .+|..||+|++.....   .......+.+|+.++..++||||+++++++..    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC---SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc---cccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            467899999999999999999998 8899999999865432   22223457789999999999999999999987    


Q ss_pred             ----CCEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ----ENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ----~~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          .+.+|+||||+++ +|.+.+..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  151 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK  151 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence                4579999999976 77777764  359999999999999999999999999999997

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.84  E-value=1.3e-20  Score=172.51  Aligned_cols=126  Identities=28%  Similarity=0.528  Sum_probs=111.3

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEe-
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKD-  262 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-  262 (317)
                      ....++|.+.+.||+|+||.||+|.+ .++..||+|++.....      ....+.+|+.++..+ +||||+++++++.. 
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            34567899999999999999999998 7899999999974321      234677999999998 89999999999987 


Q ss_pred             -----CCEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -----ENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -----~~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                           .+.+|+||||+++|+|.+++..   ..+++..+..++.||+.||.|||++||+|||||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk  156 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK  156 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence                 5689999999999999999975   358999999999999999999999999999997

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.84  E-value=1.7e-21  Score=178.99  Aligned_cols=124  Identities=27%  Similarity=0.399  Sum_probs=104.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCE----EEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFF----FAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .++|++.+.||+|+||.||+|.+ .++..    +|+|.+....    .......+.+|+.++..++||||+++++++.. 
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            46899999999999999999988 66665    6777664321    11223356689999999999999999998864 


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +..++||||+++|+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik  142 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA  142 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            5689999999999999998754  58999999999999999999999999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.84  E-value=2.1e-20  Score=168.97  Aligned_cols=120  Identities=23%  Similarity=0.303  Sum_probs=103.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc--CCCCceeeeeeEEEe----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ--FEHDNIVQYFGTEKD----  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~----  262 (317)
                      .++|.+.+.||+|+||.||+|.+ ++..||+|++...        ....+..|.+++..  ++||||+++++++..    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            56899999999999999999976 7889999998532        12334455555554  899999999998754    


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH--------EQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH--------~~gIvHrDLK  317 (317)
                      ...+|+||||+++|+|.++++...+++..+..++.|++.||.|||        ++||+|||||
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk  140 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK  140 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCC
T ss_pred             CceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCC
Confidence            356899999999999999998888999999999999999999999        9999999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.84  E-value=3e-20  Score=170.58  Aligned_cols=122  Identities=22%  Similarity=0.321  Sum_probs=104.7

Q ss_pred             HhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc--CCCCceeeeeeEEEeC-
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ--FEHDNIVQYFGTEKDE-  263 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~-  263 (317)
                      ...++|++.+.||+|+||.||+|.+. +..||+|++...      .  ...+..|.+++..  ++||||+++++++... 
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT------E--EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG------G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc------c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            34568999999999999999999765 889999998632      1  1233344555544  4999999999999887 


Q ss_pred             ---CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCC
Q 021084          264 ---NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ--------NVIHRPGA  317 (317)
Q Consensus       264 ---~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~--------gIvHrDLK  317 (317)
                         ..+|+||||+++|+|.+++....+++..+..++.|++.||.|||++        ||+|||||
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik  169 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK  169 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence               7899999999999999999988999999999999999999999999        99999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.84  E-value=3.2e-20  Score=167.49  Aligned_cols=121  Identities=19%  Similarity=0.266  Sum_probs=108.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~  266 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++.....       ...+.+|+.++..+ +|||++.+++++......
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            46799999999999999999998 8899999999864321       12466899999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+||||+ +++|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk  133 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK  133 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            9999999 89999999853  49999999999999999999999999999997

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.84  E-value=4.3e-21  Score=180.12  Aligned_cols=127  Identities=17%  Similarity=0.213  Sum_probs=104.2

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHH---HHhccCCCCceeeee------
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI---SLLGQFEHDNIVQYF------  257 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~------  257 (317)
                      ..++|.+.+.||+|+||.||+|.+ .+|..||||++.....  ........+.+|+   .+++.++||||++++      
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc--cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            357899999999999999999998 7899999999985432  2334567788999   566666899999998      


Q ss_pred             -eEEEeCC-----------------EEEEEEecCCCCCHHHHHHhC-CCC-------HHHHHHHHHHHHHHHHHHHHCCc
Q 021084          258 -GTEKDEN-----------------KLYIFLELVTQGSLAKIYQEY-HLK-------DSQVSAYTWQILNGLKYLHEQNV  311 (317)
Q Consensus       258 -~~~~~~~-----------------~~~lVmE~~~ggsL~~~l~~~-~l~-------~~~~~~i~~qil~aL~yLH~~gI  311 (317)
                       +++..++                 ..|+||||+ +|+|.+++... .++       +..+..++.||+.||.|||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence             6666553                 289999999 67999998753 244       47778899999999999999999


Q ss_pred             EecCCC
Q 021084          312 IHRPGA  317 (317)
Q Consensus       312 vHrDLK  317 (317)
                      ||||||
T Consensus       228 vHrDik  233 (377)
T 3byv_A          228 VHTYLR  233 (377)
T ss_dssp             ECSCCC
T ss_pred             ecCCCC
Confidence            999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.84  E-value=1e-20  Score=171.46  Aligned_cols=128  Identities=26%  Similarity=0.432  Sum_probs=106.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE--eCC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK--DEN  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~  264 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||+|++..... .........+.+|+.++..++||||+++++++.  ...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH-HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc-cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            357899999999999999999998 7899999999964321 011234567899999999999999999999984  456


Q ss_pred             EEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||++++ |.+++..   ..+++..+..++.||+.||.|||++||+|||||
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlk  136 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIK  136 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            899999999876 7776654   458999999999999999999999999999997

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.84  E-value=1.8e-20  Score=170.70  Aligned_cols=129  Identities=25%  Similarity=0.375  Sum_probs=107.1

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ....++|.+.+.||+|+||.||+|.. .   ++..||+|.+...   .........+.+|+.++..++||||+++++++.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD---NSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC------CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc---ccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            34457899999999999999999976 3   4558999998743   234455678999999999999999999999997


Q ss_pred             eCC-----EEEEEEecCCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DEN-----KLYIFLELVTQGSLAKIYQE-------YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~-----~~~lVmE~~~ggsL~~~l~~-------~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...     ..++||||+++|+|.+++..       ..+++..+..++.||+.||.|||++||+|||||
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik  174 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLA  174 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCS
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            754     35999999999999999842       348999999999999999999999999999997

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.84  E-value=6.2e-21  Score=187.45  Aligned_cols=126  Identities=25%  Similarity=0.374  Sum_probs=111.0

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....++|.+.+.||+|+||.||+|.+..+..||||++....      ...+.+.+|+.+|+.++||||+++++++.. +
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC------CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            455567899999999999999999988777789999986432      123568899999999999999999999876 6


Q ss_pred             EEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|||||||.+|+|.+++..   ..+++..+..++.||+.||.|||++||||||||
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk  390 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR  390 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            78999999999999999964   348999999999999999999999999999997

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.83  E-value=9.7e-21  Score=191.10  Aligned_cols=124  Identities=22%  Similarity=0.314  Sum_probs=107.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-c-CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE-
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-D-DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK-  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-  265 (317)
                      .++|.+.+.||+|+||.||+|.+ . +++.||||++..    .........+..|+.++..++||||+++++++...+. 
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS----SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc----cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            37899999999999999999988 3 789999998853    2234556778999999999999999999999987655 


Q ss_pred             ----EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 ----LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ----~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          .||||||++|++|.+++.. .+++..+..++.||+.||.|||++||||||||
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlk  209 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLK  209 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Confidence                7999999999999998765 79999999999999999999999999999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.83  E-value=2.2e-20  Score=168.62  Aligned_cols=125  Identities=26%  Similarity=0.369  Sum_probs=107.4

Q ss_pred             HhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ...++|.+.+.||+|+||.||+|.+..  .+|+|++...   .........+.+|+.++..++||||+.+++++ ....+
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVT---APTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEecc---CCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            345689999999999999999997533  5999998743   33456677899999999999999999999965 45668


Q ss_pred             EEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++||||+++++|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlk  147 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK  147 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence            999999999999999854  348999999999999999999999999999997

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.83  E-value=3.6e-20  Score=172.34  Aligned_cols=132  Identities=27%  Similarity=0.389  Sum_probs=112.5

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCC------ccHHHHHHHHHHHHHhccCCCCceeeeee
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGT------QGEQSVLQLEQEISLLGQFEHDNIVQYFG  258 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~~~Ei~il~~l~hpnIv~l~~  258 (317)
                      .....++|.+.+.||+|+||.||+|.+.+|..||+|++.......      ........+.+|+.++..++||||+++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            455678999999999999999999988779999999996543221      22344578899999999999999999999


Q ss_pred             EEEe-----CCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKD-----ENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~-----~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++..     ...+|+||||++ |+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  161 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH  161 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCC
Confidence            9854     347999999997 5888887654  48999999999999999999999999999997

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.83  E-value=2.6e-20  Score=168.45  Aligned_cols=125  Identities=24%  Similarity=0.402  Sum_probs=107.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cC---CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEE-EeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTE-KDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~  263 (317)
                      ...|.+.+.||+|+||.||+|.+ .+   +..+|+|.+..    .........+.+|+.+++.++||||+++++++ ...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc----CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            45799999999999999999986 22   23688888753    33455667899999999999999999999986 456


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +..|+||||+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dik  155 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA  155 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence            7889999999999999999753  48899999999999999999999999999997

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.83  E-value=5.5e-21  Score=176.63  Aligned_cols=129  Identities=17%  Similarity=0.303  Sum_probs=112.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCcc------------HHHHHHHHHHHHHhccCCCCceee
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQG------------EQSVLQLEQEISLLGQFEHDNIVQ  255 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~------------~~~~~~~~~Ei~il~~l~hpnIv~  255 (317)
                      ..++|.+.+.||+|+||.||+|.+ ++..||+|++.........            ......+.+|+.++..++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            367999999999999999999988 9999999999753211110            111267889999999999999999


Q ss_pred             eeeEEEeCCEEEEEEecCCCCCHHHH------HHh---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          256 YFGTEKDENKLYIFLELVTQGSLAKI------YQE---YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       256 l~~~~~~~~~~~lVmE~~~ggsL~~~------l~~---~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +++++...+.+|+||||+++|+|.++      +..   ..+++..+..++.|++.||.|||+ +||+|||||
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~  179 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK  179 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence            99999999999999999999999998      553   458999999999999999999999 999999997

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.83  E-value=1.6e-20  Score=172.72  Aligned_cols=128  Identities=20%  Similarity=0.307  Sum_probs=111.1

Q ss_pred             HhccCeeee-ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          187 RRIMSWQKG-APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       187 ~~~~~y~~~-~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ...+.|.+. +.||+|+||.||+|.+ .++..||+|++.....   .......+.+|+.++..+ +||||+++++++...
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR---GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET---TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            334567776 8999999999999998 7899999999975432   223356788999999998 569999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+||||+++|+|.+++..   ..+++..+..++.||+.||.|||++||+|||||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dik  158 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK  158 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC
Confidence            999999999999999998854   458999999999999999999999999999997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.83  E-value=1.6e-20  Score=176.10  Aligned_cols=122  Identities=25%  Similarity=0.318  Sum_probs=104.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC--------CCceeeeeeE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE--------HDNIVQYFGT  259 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~~  259 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++..      .......+.+|+.++..+.        ||||++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec------CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            46899999999999999999998 7899999999852      2345667889999999885        7889999999


Q ss_pred             EE----eCCEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          260 EK----DENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       260 ~~----~~~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      +.    ....+|+||||+ +++|.+.+..   .++++..+..++.||+.||.|||++ ||||||||
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDik  174 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIK  174 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCS
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            87    456899999999 5566665543   3499999999999999999999998 99999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.83  E-value=1.6e-20  Score=175.30  Aligned_cols=128  Identities=20%  Similarity=0.344  Sum_probs=102.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEecC------CCEEEEEEEeecCCCCcc-HH-----HHHHHHHHHHHhccCCCCceeee
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDD------GFFFAVKEVSLQDQGTQG-EQ-----SVLQLEQEISLLGQFEHDNIVQY  256 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~i~~~~~~~~~-~~-----~~~~~~~Ei~il~~l~hpnIv~l  256 (317)
                      .++|.+.+.||+|+||.||+|.+..      +..||+|++......... ..     ....+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998732      578999998743210000 00     01123456667888899999999


Q ss_pred             eeEEEeC----CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          257 FGTEKDE----NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       257 ~~~~~~~----~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++...    ..+||||||| |++|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlk  179 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK  179 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCC
Confidence            9998764    5689999999 99999999764  59999999999999999999999999999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.83  E-value=3e-20  Score=166.75  Aligned_cols=127  Identities=27%  Similarity=0.378  Sum_probs=109.1

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ....++|.+.+.||+|+||.||+|.+ .   ++..||+|.+...    ........+.+|+.++..++||||+++++++.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT----SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc----cCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            44567899999999999999999986 2   2346999988632    23455678999999999999999999999987


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+ ..|+||||+++++|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  140 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA  140 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence            54 468999999999999998653  48999999999999999999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.83  E-value=5.7e-20  Score=168.33  Aligned_cols=122  Identities=22%  Similarity=0.301  Sum_probs=107.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe--cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC------ceeeeeeEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT--DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD------NIVQYFGTE  260 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l~~~~  260 (317)
                      .++|.+.+.||+|+||.||+|.+  .++..||+|++..      .......+.+|+.++..++|+      +++++++++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            46899999999999999999987  4788999999852      234456788899988888665      499999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          261 KDENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       261 ~~~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+.+|+||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+|||||
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  145 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLK  145 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence            9999999999999 88999998765   48899999999999999999999999999997

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.82  E-value=1.2e-20  Score=169.15  Aligned_cols=124  Identities=26%  Similarity=0.389  Sum_probs=106.6

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-CC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-EN  264 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~  264 (317)
                      ....++|++.+.||+|+||.||++.+ +|..||+|++...       ...+.+.+|+.++..++||||+++++++.. .+
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch-------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            34567899999999999999999965 5789999998632       134578899999999999999999998755 45


Q ss_pred             EEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++|+|.+++...+   +++..+..++.|++.||.|||++||+|||||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  144 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA  144 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence            7899999999999999987543   8999999999999999999999999999997

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.82  E-value=9.3e-20  Score=167.53  Aligned_cols=125  Identities=24%  Similarity=0.328  Sum_probs=103.3

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe---
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD---  262 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---  262 (317)
                      ...+++|.+.+.||+|+||.||+|.. ++..||+|++....      ........|+..+..++||||+++++.+..   
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            34578999999999999999999965 67899999986321      111122344444556899999999986643   


Q ss_pred             --CCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEecCCC
Q 021084          263 --ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ---------NVIHRPGA  317 (317)
Q Consensus       263 --~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~---------gIvHrDLK  317 (317)
                        ...+|+|||||++|+|.+++.....++..+..++.||+.||.|||++         ||||||||
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dik  147 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN  147 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCS
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccc
Confidence              34689999999999999999988899999999999999999999999         99999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.82  E-value=3.9e-20  Score=166.36  Aligned_cols=126  Identities=25%  Similarity=0.349  Sum_probs=101.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe--cCCC--EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT--DDGF--FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~--~~~~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|++.+.||+|+||.||+|.+  .++.  .||+|++....  .........+.+|+.++..++||||+++++++..+.
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc--cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            46799999999999999999986  3333  68999886432  123355678999999999999999999999998765


Q ss_pred             EEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       .++||||+++|+|.+++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik  148 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA  148 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCc
Confidence             8999999999999998865  359999999999999999999999999999997

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.82  E-value=7.9e-20  Score=166.66  Aligned_cols=127  Identities=17%  Similarity=0.332  Sum_probs=112.4

Q ss_pred             HhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC--CCceeeeeeEEEeCC
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE--HDNIVQYFGTEKDEN  264 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~  264 (317)
                      ...++|.+.+.||+|+||.||++.+.++..||+|++...   .........+.+|+.++..+.  ||||+++++++...+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECS---SCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccc---cccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            345679999999999999999998877999999999754   234556778899999999996  599999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||| +.+++|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  154 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK  154 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence            9999999 5578999998764 58999999999999999999999999999997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.82  E-value=1.2e-19  Score=173.40  Aligned_cols=122  Identities=21%  Similarity=0.301  Sum_probs=106.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC------CCCceeeeeeEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF------EHDNIVQYFGTEK  261 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~  261 (317)
                      ..+|.+.+.||+|+||.||+|.+ .++..||||++..      .......+..|+.++..+      +||||+.+++++.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            45799999999999999999988 7899999999853      233445666777777665      6789999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~~---l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+.+|+||||+. ++|.+++....   +++..+..++.||+.||.|||++||||||||
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK  227 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLK  227 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCS
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            9999999999996 59999887643   8999999999999999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.82  E-value=7e-20  Score=167.80  Aligned_cols=123  Identities=24%  Similarity=0.368  Sum_probs=107.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEE-----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEK-----  261 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~-----  261 (317)
                      ..+|++.+.||+|+||.||+|.+ .++..||+|++...     .......+.+|+.++..+. ||||+++++++.     
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            45799999999999999999998 78999999998632     3455667889999999995 999999999984     


Q ss_pred             ---eCCEEEEEEecCCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          262 ---DENKLYIFLELVTQGSLAKIYQE----YHLKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       262 ---~~~~~~lVmE~~~ggsL~~~l~~----~~l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                         ....+++||||+. |+|.+++..    ..+++..+..++.||+.||.|||++|  |+|||||
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dik  165 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLK  165 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCC
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCC
Confidence               3456899999996 599888754    45999999999999999999999999  9999997

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.82  E-value=5.7e-20  Score=183.40  Aligned_cols=124  Identities=26%  Similarity=0.380  Sum_probs=105.9

Q ss_pred             ccCeeeec-cccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGA-PLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~-~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .+++.+.+ .||+|+||.||+|.+   .++..||||+++..    ........+.+|+.+|..++|||||++++++.. +
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC----CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            34555555 899999999999976   35667999998643    122345678999999999999999999999976 5


Q ss_pred             EEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||++|+|.+++..  ..+++..+..++.||+.||.|||++||||||||
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk  463 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA  463 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCC
Confidence            59999999999999999864  348999999999999999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.82  E-value=7.8e-20  Score=167.68  Aligned_cols=129  Identities=23%  Similarity=0.376  Sum_probs=109.2

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHH-HhccCCCCceeeeeeEEE
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS-LLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~  261 (317)
                      .+....++|.+.+.||+|+||.||+|.+ .+|..||+|++...    ........+..|+. ++..++||||+++++++.
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC----CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc----cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            3455678999999999999999999998 78999999999743    12333445556665 778889999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQ------EYHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~------~~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      ..+..|+||||+++ +|.+++.      ...+++..+..++.|++.||.|||++ ||+|||||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk  153 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK  153 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC
Confidence            99999999999986 8888775      34689999999999999999999999 99999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.82  E-value=5.2e-20  Score=172.42  Aligned_cols=124  Identities=26%  Similarity=0.456  Sum_probs=109.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE-
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL-  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-  266 (317)
                      .++|.+.+.||+|+||.||+|.+ .+|..||+|++...   .........+.+|+.+++.++||||+++++++...+.. 
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc---ccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            46899999999999999999998 78999999998643   23455667889999999999999999999999876654 


Q ss_pred             -----EEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 -----YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 -----~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                           |+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  171 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK  171 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             cceeEEEEEcccc-ccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcC
Confidence                 99999997 58888774 459999999999999999999999999999997

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.82  E-value=3.9e-20  Score=173.85  Aligned_cols=124  Identities=25%  Similarity=0.416  Sum_probs=106.2

Q ss_pred             cCeeeeccccccCCeeEEEEEe-c-CC--CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-CC
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-D-DG--FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-EN  264 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~-~~--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~  264 (317)
                      ..|.+.+.||+|+||.||+|.. . ++  ..||+|.+..    .........+.+|+.+++.++||||+++++++.. .+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS----CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC----CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            4578899999999999999986 2 32  4688998753    2234556789999999999999999999998754 56


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..|+||||+++|+|.+++...  .+++..+..++.||+.||.|||++||+|||||
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  219 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA  219 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccc
Confidence            789999999999999999754  48899999999999999999999999999997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.82  E-value=8.7e-20  Score=167.97  Aligned_cols=121  Identities=22%  Similarity=0.343  Sum_probs=107.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc--CCCCceeeeeeEEEeCC-
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ--FEHDNIVQYFGTEKDEN-  264 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~-  264 (317)
                      ..++|.+.+.||+|+||.||+|.+ ++..||+|++...        ....+..|+.++..  ++||||+++++++.... 
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            356899999999999999999976 5889999998531        23456678888876  79999999999998875 


Q ss_pred             ---EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEecCCC
Q 021084          265 ---KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH--------EQNVIHRPGA  317 (317)
Q Consensus       265 ---~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH--------~~gIvHrDLK  317 (317)
                         .+|+||||+++|+|.+++...++++..+..++.|++.||.|||        ++||+|||||
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk  174 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK  174 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred             ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence               8999999999999999999889999999999999999999999        8999999997

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.81  E-value=4.9e-20  Score=168.05  Aligned_cols=119  Identities=23%  Similarity=0.354  Sum_probs=104.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .++|.+.+.||+|+||.||++.. .+..||+|.+..       ......+..|+.++..++||||+++++++.+  ..|+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence            56799999999999999999976 467899998752       1235678899999999999999999998774  4799


Q ss_pred             EEecCCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHH---CCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEYH----LKDSQVSAYTWQILNGLKYLHE---QNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~----l~~~~~~~i~~qil~aL~yLH~---~gIvHrDLK  317 (317)
                      ||||+++|+|.+++....    ++...+..++.|++.||.|||+   +||+|||||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlk  132 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK  132 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCS
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCC
Confidence            999999999999997643    7889999999999999999999   899999997

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.81  E-value=5.4e-20  Score=170.78  Aligned_cols=124  Identities=25%  Similarity=0.452  Sum_probs=109.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE--
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK--  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--  265 (317)
                      .++|.+.+.||+|+||.||+|.+ .+|..||||++...   .........+.+|+.++..++||||+++++++.....  
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            46899999999999999999998 78999999998643   2345556788999999999999999999999987643  


Q ss_pred             ----EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 ----LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ----~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          +|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlk  153 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIMG-LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK  153 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred             cceeEEEEecccc-CCHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence                599999997 58888775 359999999999999999999999999999997

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.81  E-value=2.7e-19  Score=161.28  Aligned_cols=121  Identities=22%  Similarity=0.309  Sum_probs=104.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEE-EeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTE-KDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~  266 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++.....       ...+..|+.++..+.|++++..+..+ ...+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-------hhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence            46899999999999999999998 8899999999874321       12477899999999888766655544 668889


Q ss_pred             EEEEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++||||+ +++|.+++.  ...+++..+..++.|++.||.|||++||+|||||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk  132 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK  132 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            9999999 889999997  3469999999999999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.81  E-value=8.6e-20  Score=182.81  Aligned_cols=118  Identities=30%  Similarity=0.438  Sum_probs=103.2

Q ss_pred             ccccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          196 APLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      +.||+|+||.||+|.+   .++..||||+++..   .........+.+|+.+|..++|||||++++++.. +.+++||||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~  450 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM  450 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGG---GGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccc---cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEc
Confidence            4799999999999965   45688999998643   2233456789999999999999999999999865 458999999


Q ss_pred             CCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |++|+|.+++... .+++..+..++.||+.||.|||++||||||||
T Consensus       451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLk  496 (635)
T 4fl3_A          451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA  496 (635)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCC
Confidence            9999999999765 48999999999999999999999999999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.81  E-value=8.1e-21  Score=173.23  Aligned_cols=129  Identities=21%  Similarity=0.409  Sum_probs=111.5

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .+....++|.+.+.||+|+||.||+|.+..  .+|+|++......   ......+.+|+.++..++||||+++++++...
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN---EDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCC---CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCC---HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            355667899999999999999999997743  4999998754221   12234566899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+++||||++|++|.+++...+  +++..+..++.||+.||.|||++||+|||||
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlk  157 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK  157 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence            99999999999999999997654  8999999999999999999999999999997

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.81  E-value=3.9e-20  Score=171.42  Aligned_cols=128  Identities=22%  Similarity=0.293  Sum_probs=101.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccH------HHHHHHHHHHHHhccCCCCceeeeee
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGE------QSVLQLEQEISLLGQFEHDNIVQYFG  258 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~------~~~~~~~~Ei~il~~l~hpnIv~l~~  258 (317)
                      .++|.+.+.||+|+||.||+|.+ .   ++..+|+|++.........+      .....+..|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            35799999999999999999988 4   78899999987432100000      01123667888999999999999999


Q ss_pred             EEEe----CCEEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKD----ENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~----~~~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++..    ...+|+||||+ |++|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  178 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIK  178 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcC
Confidence            9988    78899999999 99999998754 69999999999999999999999999999997

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.81  E-value=1.1e-19  Score=163.67  Aligned_cols=121  Identities=22%  Similarity=0.309  Sum_probs=101.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEE-EeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTE-KDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~  266 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++.....       ...+..|+.++..+.|++++..++.+ ...+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            46899999999999999999998 8899999998764321       12467899999999888777665554 678899


Q ss_pred             EEEEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++||||+ +++|.+++.  ...+++..+..++.||+.||.|||++||+|||||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  132 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK  132 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            9999999 889999997  4569999999999999999999999999999997

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.81  E-value=4.5e-20  Score=171.39  Aligned_cols=118  Identities=18%  Similarity=0.220  Sum_probs=102.8

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-c--------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceee----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-D--------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ----  255 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~--------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~----  255 (317)
                      .++|.+.+.||+|+||.||+|.+ .        .+..||+|++...          ..+.+|+.++..++||||++    
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence            36899999999999999999988 4        4889999998732          24678999999999999887    


Q ss_pred             -----------eeeEEEe-CCEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          256 -----------YFGTEKD-ENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       256 -----------l~~~~~~-~~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                                 +++++.. ...+|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||++||+|||||
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik  186 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVT  186 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence                       6677766 78999999999 9999999976   469999999999999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.81  E-value=2.5e-19  Score=163.79  Aligned_cols=126  Identities=27%  Similarity=0.460  Sum_probs=104.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEe--cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEE-
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT--DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEK-  261 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~-  261 (317)
                      ..++|.+.+.||+|+||.||+|.+  .++..||+|++.........   ...+.+|+.++..+   +||||+++++++. 
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            357899999999999999999988  46889999999754322111   12344666666555   8999999999987 


Q ss_pred             ----eCCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          262 ----DENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       262 ----~~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          ....+++||||++ |+|.+++...   .+++..+..++.||+.||.|||++||+|||||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlk  147 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK  147 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence                5678999999997 5999998764   38999999999999999999999999999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.81  E-value=1.3e-19  Score=182.04  Aligned_cols=130  Identities=28%  Similarity=0.434  Sum_probs=111.6

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEe-c---CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeee
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFT-D---DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFG  258 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~  258 (317)
                      ..+....++|.+.+.||+|+||.||+|.+ .   .+..+|+|.+..    .........+.+|+.++..++||||+++++
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~  458 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIG  458 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS----TTCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34555667899999999999999999987 2   245789998753    234455678999999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++. .+.+|+||||+++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus       459 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDik  518 (656)
T 2j0j_A          459 VIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA  518 (656)
T ss_dssp             EEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence            985 45689999999999999999754  48899999999999999999999999999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.81  E-value=1.9e-19  Score=166.38  Aligned_cols=121  Identities=21%  Similarity=0.228  Sum_probs=101.2

Q ss_pred             hccCeeeec-cccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe---
Q 021084          188 RIMSWQKGA-PLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD---  262 (317)
Q Consensus       188 ~~~~y~~~~-~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---  262 (317)
                      ..++|.+.+ .||+|+||.||+|.+ .++..||+|++...      ......   ....+..+.||||+++++++..   
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQE---VDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHH---HHHHHHhcCCCChHHHHHHHhhccC
Confidence            467898855 699999999999998 78999999998631      222222   2233556799999999999976   


Q ss_pred             -CCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ...+|+|||||+||+|.+++...   .+++..+..++.||+.||.|||++||+|||||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlk  155 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVK  155 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence             55689999999999999999765   48999999999999999999999999999997

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.81  E-value=1.7e-19  Score=171.99  Aligned_cols=119  Identities=26%  Similarity=0.414  Sum_probs=100.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-----  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----  262 (317)
                      ..+|.+.+.||+|+||.||+|.+ .+|..||||++.....         ...+|+.+|+.++||||+++++++..     
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            44799999999999999999998 7899999999864321         12369999999999999999998854     


Q ss_pred             -CCEEEEEEecCCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQ-----EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~-----~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ..++++||||+++ +|..++.     ...+++..+..++.||+.||.|||++||+|||||
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  183 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK  183 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence             2347899999986 6766554     2459999999999999999999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.81  E-value=2.4e-20  Score=169.84  Aligned_cols=132  Identities=19%  Similarity=0.281  Sum_probs=101.8

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCc-cHHHHHHHHHHHHHhccC----CCCceeeeeeE
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQ-GEQSVLQLEQEISLLGQF----EHDNIVQYFGT  259 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l----~hpnIv~l~~~  259 (317)
                      ....++|.+.+.||+|+||.||+|.+ .++..||+|++........ .......+..|+.++..+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34467899999999999999999988 7899999999865432110 011223455788888888    89999999999


Q ss_pred             EEeCCEEEEEEec-CCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          260 EKDENKLYIFLEL-VTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       260 ~~~~~~~~lVmE~-~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +...+..++|||+ +.+++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  166 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIK  166 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            9999999999999 789999999875 459999999999999999999999999999997

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.80  E-value=4.3e-19  Score=161.51  Aligned_cols=130  Identities=26%  Similarity=0.355  Sum_probs=102.7

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      .+...+++|.+.+.||+|+||.||+|.+ .+|..||+|++...   .........+..+..++..++||||+++++++..
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETT---SCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            3555678999999999999999999998 78999999999743   2223333445555567888899999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      .+.+|+||||+ ++.+..+...  ..+++..+..++.|++.||.|||++ ||+|||||
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlk  152 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK  152 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCC
Confidence            99999999999 5567666653  5699999999999999999999995 99999997

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.80  E-value=2.3e-19  Score=169.64  Aligned_cols=120  Identities=21%  Similarity=0.308  Sum_probs=98.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN----  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----  264 (317)
                      ..+|.+.+.||+|+||.||+|.+..+..+|+|.+......         ..+|+.+++.++||||+++++++...+    
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            4579999999999999999999855556999988643211         126899999999999999999996543    


Q ss_pred             --EEEEEEecCCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 --KLYIFLELVTQGSLAKIYQ----EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 --~~~lVmE~~~ggsL~~~l~----~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        .+|+||||++++.+..+..    ...+++..+..++.||+.||.|||++||+|||||
T Consensus       110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  168 (394)
T 4e7w_A          110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIK  168 (394)
T ss_dssp             CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence              3899999998744333322    3469999999999999999999999999999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.80  E-value=2.3e-19  Score=167.11  Aligned_cols=122  Identities=20%  Similarity=0.268  Sum_probs=107.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-----------CCceeee
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-----------HDNIVQY  256 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l  256 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||+|++..      .......+.+|+.++..+.           ||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            56899999999999999999998 8899999999852      2334566788999888876           8999999


Q ss_pred             eeEEEeCC----EEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCC
Q 021084          257 FGTEKDEN----KLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQ-NVIHRPGA  317 (317)
Q Consensus       257 ~~~~~~~~----~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~-gIvHrDLK  317 (317)
                      ++++...+    .+++||||+ +++|.+++..   .++++..+..++.||+.||.|||++ ||+|||||
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dik  159 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK  159 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCS
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence            99998654    899999999 8899999875   3499999999999999999999998 99999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.80  E-value=1.7e-19  Score=168.71  Aligned_cols=125  Identities=12%  Similarity=0.058  Sum_probs=91.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHH---HHhccCCCCceeeee-------
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEI---SLLGQFEHDNIVQYF-------  257 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~-------  257 (317)
                      ...|.+.+.||+|+||.||+|.+ .++..||+|++....  .........+..|+   ..|.. +||||++++       
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~  137 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGA--ENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS  137 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCS--TTHHHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecc--cccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence            44699999999999999999998 789999999998643  22345566777885   45555 799988755       


Q ss_pred             eEEEeC-----------------CEEEEEEecCCCCCHHHHHHhC--CCCHHHH------HHHHHHHHHHHHHHHHCCcE
Q 021084          258 GTEKDE-----------------NKLYIFLELVTQGSLAKIYQEY--HLKDSQV------SAYTWQILNGLKYLHEQNVI  312 (317)
Q Consensus       258 ~~~~~~-----------------~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~------~~i~~qil~aL~yLH~~gIv  312 (317)
                      +++..+                 ..+|+|||||+ |+|.+++...  .+++...      ..++.||+.||.|||++|||
T Consensus       138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv  216 (371)
T 3q60_A          138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV  216 (371)
T ss_dssp             EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence            455433                 34899999998 7999999753  3444444      56779999999999999999


Q ss_pred             ecCCC
Q 021084          313 HRPGA  317 (317)
Q Consensus       313 HrDLK  317 (317)
                      |||||
T Consensus       217 HrDik  221 (371)
T 3q60_A          217 HGHFT  221 (371)
T ss_dssp             ETTCS
T ss_pred             cCcCC
Confidence            99998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.80  E-value=3.8e-19  Score=164.02  Aligned_cols=122  Identities=20%  Similarity=0.245  Sum_probs=104.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCC-CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc------eeeeeeEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDG-FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN------IVQYFGTE  260 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~-~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~  260 (317)
                      .++|.+.+.||+|+||.||+|.+ .++ ..||+|++..      .......+..|+.++..+.|++      ++.+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            46899999999999999999988 555 6899999852      2344567788999998887655      89999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          261 KDENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       261 ~~~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...+.+|+||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+|||||
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlk  150 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK  150 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9999999999999 55777766543   48999999999999999999999999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.80  E-value=1.2e-19  Score=171.75  Aligned_cols=120  Identities=25%  Similarity=0.446  Sum_probs=95.9

Q ss_pred             cCeee-eccccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--C
Q 021084          190 MSWQK-GAPLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--E  263 (317)
Q Consensus       190 ~~y~~-~~~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~  263 (317)
                      +.|.+ ++.||+|+||.||+|.+   .++..||+|++....   .    ...+.+|+.+|..++||||+++++++..  .
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---I----SMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---C----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---C----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            34665 55899999999999985   368899999986321   1    2357789999999999999999999955  7


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY----------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~----------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..+|+||||+.+ +|.+++...          .+++..+..++.||+.||.|||++||||||||
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlk  155 (405)
T 3rgf_A           93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK  155 (405)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcC
Confidence            789999999965 888877521          38999999999999999999999999999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.80  E-value=6.1e-19  Score=171.18  Aligned_cols=121  Identities=21%  Similarity=0.284  Sum_probs=105.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC-CceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH-DNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~  266 (317)
                      .++|.+.+.||+|+||.||+|.+ .++..||||++......       ..+..|+.++..+.| ++|+.+..++...+..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            46899999999999999999998 88999999988743221       236789999999976 5666677777889999


Q ss_pred             EEEEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||||+ +++|.+++.  ...+++..+..++.||+.||.|||++||||||||
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIK  130 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK  130 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence            9999999 889999997  4569999999999999999999999999999998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.80  E-value=9.2e-20  Score=167.19  Aligned_cols=133  Identities=24%  Similarity=0.378  Sum_probs=110.6

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCcc-HHHHHHHHHHHHHhccCC--CCceeeeeeEE
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQG-EQSVLQLEQEISLLGQFE--HDNIVQYFGTE  260 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~  260 (317)
                      .....++|.+.+.||+|+||.||+|.+ .++..||+|++......... ......+..|+.++..+.  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            344567899999999999999999988 78999999999754321100 011234567888999885  59999999999


Q ss_pred             EeCCEEEEEEecCCC-CCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          261 KDENKLYIFLELVTQ-GSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       261 ~~~~~~~lVmE~~~g-gsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..++.+++|||++.+ ++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk  176 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIK  176 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCC
Confidence            999999999999976 899998865 569999999999999999999999999999997

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.80  E-value=1.6e-19  Score=167.46  Aligned_cols=128  Identities=24%  Similarity=0.304  Sum_probs=95.2

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEE
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEK  261 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  261 (317)
                      ......+++|.+.+.||+|+||.||+|.+ .++..||||++......      ......++..+..++||||+++++++.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF------RNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC------CCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc------cHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            34567789999999999999999999998 78999999998643211      124557777888889999999999997


Q ss_pred             eCCE-------EEEEEecCCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCC
Q 021084          262 DENK-------LYIFLELVTQGSLAKIYQ-----EYHLKDSQVSAYTWQILNGLKYLH--EQNVIHRPGA  317 (317)
Q Consensus       262 ~~~~-------~~lVmE~~~ggsL~~~l~-----~~~l~~~~~~~i~~qil~aL~yLH--~~gIvHrDLK  317 (317)
                      ..+.       +|+||||+++ +|...+.     ...+++..+..++.|++.||.|||  ++||+|||||
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlk  158 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIK  158 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCC
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCC
Confidence            6433       8999999987 5554433     235889999999999999999999  9999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.79  E-value=3.4e-20  Score=185.55  Aligned_cols=127  Identities=24%  Similarity=0.397  Sum_probs=108.8

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe---
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD---  262 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---  262 (317)
                      ...++|.+.+.||+|+||.||+|.+ .+|..||+|++..    .........+.+|+.++..++||||+++++++..   
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~----~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCS----CCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            3457899999999999999999988 7899999998863    2345566789999999999999999999998755   


Q ss_pred             ---CCEEEEEEecCCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ---ENKLYIFLELVTQGSLAKIYQEY----HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ---~~~~~lVmE~~~ggsL~~~l~~~----~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         .+..|+|||||+||+|.+++...    ++++..+..++.|++.||.|||++||+|||||
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLK  148 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLK  148 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCC
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence               67789999999999999999763    48899999999999999999999999999997

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.78  E-value=7.5e-19  Score=168.16  Aligned_cols=118  Identities=29%  Similarity=0.325  Sum_probs=98.2

Q ss_pred             CeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|.+.+.||+|+||+||.+...+|..||||++...        ....+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            45567889999999998775688999999998632        134567899999876 899999999999999999999


Q ss_pred             EecCCCCCHHHHHHhCCC--------CHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYHL--------KDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~l--------~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+ |+|.+++.....        ++..+..++.||+.||.|||++||||||||
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLk  142 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK  142 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            99996 599999986542        222356799999999999999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.77  E-value=2.3e-18  Score=161.75  Aligned_cols=123  Identities=21%  Similarity=0.301  Sum_probs=105.9

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CC-----ceeeeeeEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HD-----NIVQYFGTE  260 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~  260 (317)
                      ..++|.+.+.||+|+||.||+|.+ .++..||||++..      .......+..|+.++..+. |+     +|+.+++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            367899999999999999999998 7889999999852      2334556777888877774 44     599999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCC
Q 021084          261 KDENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLH--EQNVIHRPGA  317 (317)
Q Consensus       261 ~~~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH--~~gIvHrDLK  317 (317)
                      ...+.+|+||||+++ +|.+++...   ++++..+..++.|++.||.|||  ..||||||||
T Consensus       126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlk  186 (382)
T 2vx3_A          126 MFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLK  186 (382)
T ss_dssp             EETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCS
T ss_pred             ccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCC
Confidence            999999999999965 999998764   4899999999999999999999  5799999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.77  E-value=5.3e-19  Score=169.27  Aligned_cols=120  Identities=28%  Similarity=0.323  Sum_probs=101.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~  267 (317)
                      ..+|.+.+.||+|+||.|+.....+++.||||++.....        ..+.+|+.+|..+ +||||+++++++.+...+|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            346899999999999997755458899999999863211        1245799999998 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||. |+|.+++....  +++..+..++.||+.||.|||++||||||||
T Consensus        95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK  145 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLK  145 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCC
Confidence            9999996 59999997654  4555678899999999999999999999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.76  E-value=1.7e-18  Score=171.27  Aligned_cols=119  Identities=13%  Similarity=0.052  Sum_probs=92.2

Q ss_pred             ccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCC-----ccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeCCEEEE
Q 021084          196 APLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGT-----QGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~-----~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ...+.|++|.+..++. ..|..|++|++.+.....     ..+...+.|.+|+.+|.++ .|+||+++++++.+++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3456777777666655 678899999997543211     2244556799999999999 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEYH-LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~-l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||+|++|.+++...+ ++..   .|+.||+.||+|||++||||||||
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIK  366 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVR  366 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCC
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCc
Confidence            999999999999998754 6654   588999999999999999999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.72  E-value=7.1e-18  Score=165.84  Aligned_cols=116  Identities=14%  Similarity=0.129  Sum_probs=89.5

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCc---cHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      ..+.||+|+||.||+| ...+..+++|..........   .....+.+.+|+.+++.++||||+.+..++...+..||||
T Consensus       340 ~~~~LG~G~fg~Vy~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRD-SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEE-ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEE-EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            3568999999999999 55677899998754322111   1222456899999999999999997766666777889999


Q ss_pred             ecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          271 ELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||+|++|.+++..       +..++.|++.||.|||++||+|||||
T Consensus       419 E~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiK  458 (540)
T 3en9_A          419 SYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLT  458 (540)
T ss_dssp             ECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCC
T ss_pred             ECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCC
Confidence            99999999999875       56899999999999999999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.71  E-value=1.9e-17  Score=149.70  Aligned_cols=120  Identities=12%  Similarity=0.093  Sum_probs=92.5

Q ss_pred             hccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCc---c-H---------HHHHHHHHHHHHhccCCCCcee
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQ---G-E---------QSVLQLEQEISLLGQFEHDNIV  254 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~---~-~---------~~~~~~~~Ei~il~~l~hpnIv  254 (317)
                      .-..|.+++.||+|+||.||+|.+.+|..||+|+++.......   . .         .....+.+|+.+|+.++  | +
T Consensus        88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            3456778899999999999999887899999999964321110   0 0         23567889999999998  4 6


Q ss_pred             eeeeEEEeCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       255 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.+++.. +..|+|||||+||+|.+ +.   .  .....++.|++.||.|||++||||||||
T Consensus       165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---~--~~~~~i~~qi~~~l~~lH~~giiHrDlk  220 (282)
T 1zar_A          165 AVPKVYAW-EGNAVLMELIDAKELYR-VR---V--ENPDEVLDMILEEVAKFYHRGIVHGDLS  220 (282)
T ss_dssp             SSCCEEEE-ETTEEEEECCCCEEGGG-CC---C--SCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CcCeEEec-cceEEEEEecCCCcHHH-cc---h--hhHHHHHHHHHHHHHHHHHCCCEeCCCC
Confidence            66665544 45699999999999988 42   1  2345799999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.67  E-value=1.1e-16  Score=152.15  Aligned_cols=127  Identities=17%  Similarity=0.166  Sum_probs=93.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC-Ccee---------e-
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH-DNIV---------Q-  255 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv---------~-  255 (317)
                      ....|...+.||+|+||.||+|.+ .+|+.||||++....  .......+.+.+|+.++..+.| +|..         . 
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~--~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~  153 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  153 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSC--C----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCC--CccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence            345688899999999999999998 889999999987432  2223345678899999999976 2111         1 


Q ss_pred             -----------eeeEEEe-----CCEEEEEEecCCCCCHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 021084          256 -----------YFGTEKD-----ENKLYIFLELVTQGSLAKIYQ--------EYHLKDSQVSAYTWQILNGLKYLHEQNV  311 (317)
Q Consensus       256 -----------l~~~~~~-----~~~~~lVmE~~~ggsL~~~l~--------~~~l~~~~~~~i~~qil~aL~yLH~~gI  311 (317)
                                 +..++..     ...++++|+++ +++|.+++.        ...+++..+..++.||+.||.|||++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  232 (413)
T 3dzo_A          154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  232 (413)
T ss_dssp             CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence                       1111111     23467888877 569999885        2237778888999999999999999999


Q ss_pred             EecCCC
Q 021084          312 IHRPGA  317 (317)
Q Consensus       312 vHrDLK  317 (317)
                      ||||||
T Consensus       233 iHrDiK  238 (413)
T 3dzo_A          233 VHTYLR  238 (413)
T ss_dssp             ECSCCC
T ss_pred             ccCCcc
Confidence            999998

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.60  E-value=1.4e-15  Score=135.42  Aligned_cols=121  Identities=20%  Similarity=0.236  Sum_probs=89.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCE--EEEEEEeecCCCCc-------------------cHHHHHHHHHHHHHhccC
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFF--FAVKEVSLQDQGTQ-------------------GEQSVLQLEQEISLLGQF  248 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~--vAvK~i~~~~~~~~-------------------~~~~~~~~~~Ei~il~~l  248 (317)
                      -|.+...||+|+||.||+|.+ .+|..  ||||+++.......                   .......+..|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999988 78989  99999764311100                   011224678999999999


Q ss_pred             CCCce--eeeeeEEEeCCEEEEEEecCCC-C----CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCC
Q 021084          249 EHDNI--VQYFGTEKDENKLYIFLELVTQ-G----SLAKIYQEYHLKDSQVSAYTWQILNGLKYLH-EQNVIHRPGA  317 (317)
Q Consensus       249 ~hpnI--v~l~~~~~~~~~~~lVmE~~~g-g----sL~~~l~~~~l~~~~~~~i~~qil~aL~yLH-~~gIvHrDLK  317 (317)
                      .|+++  +..++.    +..||||||+.+ |    +|.++...  .++..+..++.|++.||.||| ++||||||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk  198 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLS  198 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence            88764  333332    246899999942 3    67766432  234567889999999999999 9999999997

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=1.1e-14  Score=136.86  Aligned_cols=121  Identities=12%  Similarity=0.090  Sum_probs=84.8

Q ss_pred             cCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCC------------CccH-HH----HHHHHHHHHHhccCCCCc
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQG------------TQGE-QS----VLQLEQEISLLGQFEHDN  252 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------------~~~~-~~----~~~~~~Ei~il~~l~hpn  252 (317)
                      .-|.++..||.|+||.||+|.+.+|+.||||+++.....            .... ..    ......|...|.++.+++
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            348899999999999999998888999999998642110            0000 00    111245777777775555


Q ss_pred             eeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       253 Iv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +....-+....  .+|||||++|++|..+..     ...+..++.||+.+|.|||++||||||||
T Consensus       175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLK  232 (397)
T 4gyi_A          175 FPVPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFN  232 (397)
T ss_dssp             CSCCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCCCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence            43322222222  379999999988876532     22356788999999999999999999998

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.91  E-value=5.3e-09  Score=92.29  Aligned_cols=114  Identities=11%  Similarity=0.105  Sum_probs=88.1

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDE  263 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~  263 (317)
                      +...++.|.+...++.|+.+.||++... +..+++|..+......     ...+.+|+.++..+. +..++++++++...
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~   82 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence            4556778999999999999999998544 6789999986421111     124778898888884 67788999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE  308 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~  308 (317)
                      +..|+||||++|.+|.+.+.    +......++.++..+|..||+
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHH
T ss_pred             CceEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhC
Confidence            99999999999999887531    122334688899999999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.53  E-value=1.1e-07  Score=83.17  Aligned_cols=110  Identities=14%  Similarity=0.135  Sum_probs=76.0

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc--eeeeeeEEEeC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN--IVQYFGTEKDE  263 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~  263 (317)
                      ......+.+....+.|..+.||++...+|..+++|.....        ....+..|+.++..+.+.+  +++++++...+
T Consensus        16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            3344556665544566779999996677788999987532        1124668888888774433  56788888888


Q ss_pred             CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      +..++||||++|.+|.  ..  ...   ...++.+++..|..||+.+
T Consensus        88 ~~~~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~  127 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLD  127 (264)
T ss_dssp             SCEEEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSC
T ss_pred             CCCEEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCC
Confidence            8899999999998884  21  122   2256677788888888653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.29  E-value=1.1e-06  Score=81.12  Aligned_cols=109  Identities=11%  Similarity=0.140  Sum_probs=77.3

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEe--ecCCCCccHHHHHHHHHHHHHhccCC--CCceeeeeeEEEeC---CEE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVS--LQDQGTQGEQSVLQLEQEISLLGQFE--HDNIVQYFGTEKDE---NKL  266 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~  266 (317)
                      ....|+.|.++.||++...+ ..+++|...  ...    .......+.+|+.++..+.  +..+++++.++.+.   +..
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~----~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK----LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC----CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            46778999999999986544 578888764  211    1112345778999998886  45578888888776   458


Q ss_pred             EEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH
Q 021084          267 YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE  308 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~  308 (317)
                      |+||||++|.++.+..- ..++......++.+++..|..||+
T Consensus       117 ~~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             EEEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhC
Confidence            99999999987744111 236778888899999999999997

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.04  E-value=0.01  Score=51.71  Aligned_cols=102  Identities=11%  Similarity=0.090  Sum_probs=74.2

Q ss_pred             ccccCCe-eEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCEEEEEEecCC
Q 021084          198 LGSGSFG-SVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENKLYIFLELVT  274 (317)
Q Consensus       198 LG~G~fg-~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lVmE~~~  274 (317)
                      +..|..| .||+... ..+..+++|.-+.        .....+..|...|..+. +--++++++++.+.+..|+|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            4445444 6898766 5667899998652        12445778888887773 3346788889999999999999999


Q ss_pred             CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          275 QGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       275 ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      |.++.+.....   ......+..++...|.-||+..
T Consensus       104 G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~  136 (272)
T 4gkh_A          104 GKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIP  136 (272)
T ss_dssp             SEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSC
T ss_pred             CccccccccCC---HHHHHHHHHHHHHHHHHhcCCC
Confidence            99988876542   2334467888999999999753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=96.94  E-value=0.007  Score=54.30  Aligned_cols=104  Identities=19%  Similarity=0.089  Sum_probs=78.1

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCC---ceeeeeeEEE-eCCEEEEEE
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD---NIVQYFGTEK-DENKLYIFL  270 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lVm  270 (317)
                      ...++.|....||..    +..+++|+..       .......+..|+.+|..+.+.   .++..+.+.. ..+..++||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence            455788888999988    5678888742       223456788999999988642   3566666664 355678999


Q ss_pred             ecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          271 ELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      ++++|.++....- ..++......++.++...|..||+.+
T Consensus        93 e~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~  131 (306)
T 3tdw_A           93 RKVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFP  131 (306)
T ss_dssp             ECCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred             eccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            9999988877422 24677788889999999999999864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.51  E-value=0.019  Score=51.94  Aligned_cols=95  Identities=14%  Similarity=0.117  Sum_probs=72.2

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC---CCceeeeeeEEEeCCEEEEEE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE---HDNIVQYFGTEKDENKLYIFL  270 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lVm  270 (317)
                      -...|+.|....+|+... ++..+++|+....        ....+..|+..|..|.   ...+++.+.+....+..++||
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm  110 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL  110 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence            356789999999999864 4668889987521        2456778888888773   366888888888888999999


Q ss_pred             ecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          271 ELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       271 E~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      ||++|..+..             ....++...|+-||..+
T Consensus       111 e~l~G~~~~~-------------~~~~~lG~~LA~LH~~~  137 (312)
T 3jr1_A          111 EALNKSKNKQ-------------SSFTIFAEKIAQLHQIQ  137 (312)
T ss_dssp             ECCCCCCCCT-------------THHHHHHHHHHHHHHCC
T ss_pred             EeccCCCCCc-------------hhHHHHHHHHHHHHcCC
Confidence            9999976421             24567889999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.33  E-value=0.0066  Score=54.17  Aligned_cols=104  Identities=16%  Similarity=0.056  Sum_probs=74.4

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCc--eeeeeeEEEeCC---EEEE
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDN--IVQYFGTEKDEN---KLYI  268 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~l  268 (317)
                      ...++.|.+..||.+.    ..+++|...       .......+..|+.+|..+ .+..  ++..+......+   ..|+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~-------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPK-------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEES-------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecC-------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            4568999999999862    468888753       123456788999999877 3333  344444433322   3588


Q ss_pred             EEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          269 FLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      ||++++|.+|..... ..++..+...++.|++..|..||+..
T Consensus        94 vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~  134 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSIN  134 (304)
T ss_dssp             EEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred             EEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCC
Confidence            999999988875432 35788888999999999999999853

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=95.72  E-value=0.015  Score=53.78  Aligned_cols=108  Identities=14%  Similarity=0.053  Sum_probs=61.9

Q ss_pred             eeccccccCCeeEEEEEe-cCCCEEEEEEEeecCC--CCccHHHHHHHHHHHHHhccCCC--C-ceeeeeeEEEeCCEEE
Q 021084          194 KGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQ--GTQGEQSVLQLEQEISLLGQFEH--D-NIVQYFGTEKDENKLY  267 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~--~~~~~~~~~~~~~Ei~il~~l~h--p-nIv~l~~~~~~~~~~~  267 (317)
                      ..+.||.|.++.||++.. .++..+++|.......  .........++..|..++..+..  | .++.++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            356799999999999976 4578899998653211  00000112345678888776632  3 34455543  344568


Q ss_pred             EEEecCCCCC-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Q 021084          268 IFLELVTQGS-LAKIYQEYHLKDSQVSAYTWQILNGLKYLH  307 (317)
Q Consensus       268 lVmE~~~ggs-L~~~l~~~~l~~~~~~~i~~qil~aL~yLH  307 (317)
                      +|||+++|.. +...+..+....    ..+.++...|.-+|
T Consensus       112 lvmE~l~g~~~~~~~l~~~~~~~----~~~~~l~~~La~lH  148 (397)
T 2olc_A          112 TVMEDLSHLKIARKGLIEGENYP----HLSQHIGEFLGKTL  148 (397)
T ss_dssp             EEECCCTTSEEHHHHHHTTCCCT----THHHHHHHHHHHHH
T ss_pred             EEEEeCCCcchHHHHHhcCCcCH----HHHHHHHHHHHHHh
Confidence            9999998753 333333322222    23456666677777

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.32  E-value=0.051  Score=47.92  Aligned_cols=98  Identities=16%  Similarity=0.033  Sum_probs=64.8

Q ss_pred             CeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC---CceeeeeeEEEeCCEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH---DNIVQYFGTEKDENKLY  267 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~  267 (317)
                      ...-...+|.|..+.||+....+|+.|.+|+.+....     .....+..|+..|..|..   -.+++.+++  +.  -+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~   86 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT   86 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-----chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence            3456788999999999999889999999997653221     112346688888877732   234455443  22  37


Q ss_pred             EEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          268 IFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      +||||+.++..         +..    ...++...|.-||..+
T Consensus        87 lv~e~l~~~~~---------~~~----~~~~lg~~La~lH~~~  116 (288)
T 3f7w_A           87 LAMEWVDERPP---------TPE----AAERFGHQLAAMHLAG  116 (288)
T ss_dssp             EEEECCCCCCC---------CHH----HHHHHHHHHHHHHHTC
T ss_pred             EEEEeecccCC---------ChH----HHHHHHHHHHhhhhcc
Confidence            89999987542         222    2345677788899753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=95.19  E-value=0.012  Score=53.64  Aligned_cols=114  Identities=6%  Similarity=0.010  Sum_probs=74.6

Q ss_pred             eeccc-cccCCeeEEEEEec-------CCCEEEEEEEeecCC-CCccHHHHHHHHHHHHHhccCC-C--CceeeeeeEEE
Q 021084          194 KGAPL-GSGSFGSVYEGFTD-------DGFFFAVKEVSLQDQ-GTQGEQSVLQLEQEISLLGQFE-H--DNIVQYFGTEK  261 (317)
Q Consensus       194 ~~~~L-G~G~fg~Vy~~~~~-------~~~~vAvK~i~~~~~-~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~  261 (317)
                      ..+.| +.|..+.+|.....       ++..+++|....... ....   ...+..|+.++..+. +  ..+++++.++.
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~  100 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIET  100 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence            34667 88889999988653       266788887643210 0000   123557777777663 2  35677777766


Q ss_pred             eC---CEEEEEEecCCCCCHHHHHH----h---CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          262 DE---NKLYIFLELVTQGSLAKIYQ----E---YHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       262 ~~---~~~~lVmE~~~ggsL~~~l~----~---~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      +.   +..|+||||++|.++.+.+.    .   ..++..+...++.++...|.-||+..
T Consensus       101 ~~~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~  159 (357)
T 3ats_A          101 TGDVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIP  159 (357)
T ss_dssp             SSTTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             CCCccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            54   35689999999987765321    0   13566666778899999999999754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=92.58  E-value=0.43  Score=42.37  Aligned_cols=95  Identities=16%  Similarity=0.154  Sum_probs=53.1

Q ss_pred             eccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-----CCCceeeee-e--EEEeCCEE
Q 021084          195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-----EHDNIVQYF-G--TEKDENKL  266 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~-~--~~~~~~~~  266 (317)
                      ...|+.|..+.||++...+| .+++|....      ..   ..+..|..++..|     ..|.++... |  +....+..
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~------~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~  106 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR------PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL  106 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECS------CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCC------CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence            34566778899999866554 488998852      11   1222344444333     234444311 1  22356788


Q ss_pred             EEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          267 YIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      +++|+|++|.++..      .+.    ..+.++...|.-||..
T Consensus       107 ~~l~~~i~G~~~~~------~~~----~~~~~~g~~La~lH~~  139 (346)
T 2q83_A          107 FVVYDWIEGRPFEL------TVK----QDLEFIMKGLADFHTA  139 (346)
T ss_dssp             EEEEECCCCBCCCT------TSH----HHHHHHHHHHHHHHHH
T ss_pred             EEEEEeecCccCCC------CCH----HHHHHHHHHHHHHHHh
Confidence            99999999876531      122    2347778888888864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=89.09  E-value=0.45  Score=44.00  Aligned_cols=99  Identities=12%  Similarity=0.088  Sum_probs=59.0

Q ss_pred             eccccccCCeeEEEEEec--------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEeCCE
Q 021084          195 GAPLGSGSFGSVYEGFTD--------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKDENK  265 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~  265 (317)
                      ...|..|-...+|++...        ++..+++|+....   .   .....+.+|..++..+. +.-.+++++.+.+   
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE---  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---
Confidence            456777888899998763        3478888875211   1   12344558888887773 3223566666543   


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                       .+||||++|.+|..-    .+..   ..+..+++..|.-||+..
T Consensus       126 -g~v~e~i~G~~l~~~----~l~~---p~~~~~ia~~La~LH~~~  162 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQ----ELRE---PVLSAAIATKMAQFHGME  162 (379)
T ss_dssp             -EEEEECCSEEECCGG----GGGC---HHHHHHHHHHHHHHHTCC
T ss_pred             -ccEEEEecCccCChh----HhCC---HHHHHHHHHHHHHHhCCC
Confidence             299999998665421    1111   235678999999999864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=88.81  E-value=1  Score=40.11  Aligned_cols=103  Identities=10%  Similarity=0.100  Sum_probs=56.3

Q ss_pred             eccccccCCee-EEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC--CCceeeeeeEEEeCCEEEEEEe
Q 021084          195 GAPLGSGSFGS-VYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE--HDNIVQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       195 ~~~LG~G~fg~-Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lVmE  271 (317)
                      ...|+.|.... +|+....++..+++|.......        ..+..|+.++..+.  .-.+++++.+....+  +++||
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e   92 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIE   92 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT--------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEEC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEe
Confidence            34565555444 6666444467777775432110        11234555555442  123555665543344  68999


Q ss_pred             cCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          272 LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       272 ~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      ++.+.++.+.+.......   ...+.+++..|.-||...
T Consensus        93 ~l~~~~l~~~l~~~~~~~---~~~~~~~~~~La~lH~~~  128 (333)
T 3csv_A           93 DLGDALFTEVINNDPAQE---MPLYRAAVDLLIHLHDAQ  128 (333)
T ss_dssp             CCCSCBHHHHHHHCGGGH---HHHHHHHHHHHHHHHTSC
T ss_pred             eCCCcchHHHhcCCCccH---HHHHHHHHHHHHHHhcCC
Confidence            998888888776543321   356788999999999753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=87.79  E-value=0.9  Score=40.25  Aligned_cols=97  Identities=14%  Similarity=0.033  Sum_probs=57.9

Q ss_pred             ccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC--CceeeeeeE-----EEeCCEEEE
Q 021084          196 APLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH--DNIVQYFGT-----EKDENKLYI  268 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~-----~~~~~~~~l  268 (317)
                      ..++ |....||.+...+|..+++|......   ..   ...+..|..++..+..  -.++.++..     ....+..++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~---~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER---WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT---SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC---CC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence            3456 77889998865667789999885221   11   2345566666665521  113333332     233667889


Q ss_pred             EEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          269 FLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      +|++++|.++..      .+.    ..+.++...|.-||..
T Consensus       105 l~~~i~G~~~~~------~~~----~~~~~~g~~La~lH~~  135 (328)
T 1zyl_A          105 VFPSVGGRQFEA------DNI----DQMEAVGRYLGRMHQT  135 (328)
T ss_dssp             EEECCCCEECCS------SCH----HHHHHHHHHHHHHHHH
T ss_pred             EEEecCCCCCCC------CCH----HHHHHHHHHHHHHHHh
Confidence            999998865431      122    2356677777778853

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=87.58  E-value=1.3  Score=40.96  Aligned_cols=110  Identities=9%  Similarity=-0.031  Sum_probs=61.4

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCC--CCc-c-HHHHHHHHHHHHHhc-cCCCCceeeeeeEEEeCCEEEE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQ--GTQ-G-EQSVLQLEQEISLLG-QFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~-~-~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ....||.|..+.||++.. ++..+++|.......  ... . ......+..|+..+. ......+++++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            456789999999999853 567899995432111  010 0 001122333332222 12234566666665  456799


Q ss_pred             EEecC-CCC-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          269 FLELV-TQG-SLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       269 VmE~~-~gg-sL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      ||||+ +|. .+...+..+....    ..+.++...|.-||...
T Consensus       115 v~e~l~~g~~~l~~~l~~~~~~~----~~~~~lg~~La~lH~~~  154 (420)
T 2pyw_A          115 GMRYLEPPHIILRKGLIAGIEYP----FLADHMSDYMAKTLFFT  154 (420)
T ss_dssp             EECCCCTTCEEHHHHHHHTCCCT----THHHHHHHHHHHHHHTT
T ss_pred             EEeecCCcchhHHHHHhcCCCCH----HHHHHHHHHHHHHHHhc
Confidence            99999 873 4544443322221    24566777888888643

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.06  E-value=0.12  Score=49.22  Aligned_cols=64  Identities=6%  Similarity=0.003  Sum_probs=18.8

Q ss_pred             eeeccccccCCeeEEEEEe-cCCCEEEE------EEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          193 QKGAPLGSGSFGSVYEGFT-DDGFFFAV------KEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~-~~~~~vAv------K~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      .+.+.||   ||.||++.. ....+||+      |.....   .........+.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~---~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQD---GVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccc---cccccccccccccccccccccccccCCCcceEEe
Confidence            3456676   999999977 44567888      554321   2233444567889999999999999999887643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=83.83  E-value=6.7  Score=35.09  Aligned_cols=92  Identities=14%  Similarity=0.106  Sum_probs=55.9

Q ss_pred             cccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC---CCCceeeeeeE------EEeCCEEEEE
Q 021084          199 GSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGT------EKDENKLYIF  269 (317)
Q Consensus       199 G~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~------~~~~~~~~lV  269 (317)
                      |.|....||++...+| .+++|+......           ..|+.++..|   .-|+++..+..      ....+..+++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l   99 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIA   99 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC-----------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEE
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc-----------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEE
Confidence            4444688999976666 899998764321           1333333333   22223443321      2346788999


Q ss_pred             EecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          270 LELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      |+|++|..+..    ..++..    .+.++...|.-||...
T Consensus       100 ~~~i~G~~~~~----~~~~~~----~~~~lg~~La~LH~~~  132 (339)
T 3i1a_A          100 YPFIHAPNGFT----QNLTGK----QWKQLGKVLRQIHETS  132 (339)
T ss_dssp             EECCCCCBTTT----SCCCHH----HHHHHHHHHHHHHTCC
T ss_pred             EeccCCCcCcc----cCCCHH----HHHHHHHHHHHHhCcC
Confidence            99999877621    223433    2457888899999764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=83.68  E-value=4.4  Score=38.21  Aligned_cols=101  Identities=14%  Similarity=0.102  Sum_probs=62.1

Q ss_pred             eeccccccCCeeEEEEEecC-CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCce-eeeeeEEEeCCEEEEEEe
Q 021084          194 KGAPLGSGSFGSVYEGFTDD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI-VQYFGTEKDENKLYIFLE  271 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lVmE  271 (317)
                      ....|+.|-...+|++...+ +..+++|+.........+      ...|..++..|...++ +++++.+.  +  .+|||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id------R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e  181 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN------REREKKISCILYNKNIAKKIYVFFT--N--GRIEE  181 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC------HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC------HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence            35678888899999997644 578888876422111111      1367777777754433 56777663  3  25999


Q ss_pred             cCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 021084          272 LVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNV  311 (317)
Q Consensus       272 ~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gI  311 (317)
                      |++|.+|..    ..+..   ..++.+++..|.-||+..+
T Consensus       182 ~I~G~~l~~----~~l~~---~~~~~~ia~~La~LH~~~~  214 (458)
T 2qg7_A          182 FMDGYALSR----EDIKN---PKFQKLIAKNLKLLHDIKL  214 (458)
T ss_dssp             CCCSEECCT----TTTTS---HHHHHHHHHHHHHHHTCCC
T ss_pred             eeCCccCCh----hhcCC---HHHHHHHHHHHHHHhcCCc
Confidence            999865532    11211   2457788999999997654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=83.08  E-value=1.8  Score=40.45  Aligned_cols=99  Identities=8%  Similarity=0.046  Sum_probs=63.2

Q ss_pred             eeccccccCCeeEEEEEecC--------CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc-eeeeeeEEEeCC
Q 021084          194 KGAPLGSGSFGSVYEGFTDD--------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN-IVQYFGTEKDEN  264 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~  264 (317)
                      ....|+.|....+|++...+        +..+++|+....    ..   ...+..|..++..+...+ .+++++.+.  +
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C
Confidence            35678888899999997642        578899887311    11   133447888887773323 356666554  2


Q ss_pred             EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                        .+||+|++|.+|..-    .+.   -..++.+++..|.-||...
T Consensus       148 --g~v~e~l~G~~l~~~----~l~---~~~~~~~ia~~La~LH~~~  184 (429)
T 1nw1_A          148 --GRLEEYIPSRPLSCH----EIS---LAHMSTKIAKRVAKVHQLE  184 (429)
T ss_dssp             --EEEECCCCEEECCTT----GGG---SHHHHHHHHHHHHHHTTCC
T ss_pred             --CEEEEEeCCcccChh----hcC---CHHHHHHHHHHHHHHhCCc
Confidence              389999987555321    011   1235778899999999754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=82.66  E-value=3.4  Score=36.33  Aligned_cols=98  Identities=10%  Similarity=-0.006  Sum_probs=55.3

Q ss_pred             eeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-----CCceeeee-e--EEEeCCE
Q 021084          194 KGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-----HDNIVQYF-G--TEKDENK  265 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~  265 (317)
                      -.+.|+.|....+|.+...+| .+++|......    .   ...+..|+.++..+.     -|.++... |  +....+.
T Consensus        26 ~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             EEEEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             EeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            456678888899999866555 68889876311    1   123345666555442     23333211 1  1233567


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ  309 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~  309 (317)
                      .+++|+|++|..+..      .+    ...+.++...|.-||..
T Consensus        98 ~~~l~~~l~G~~~~~------~~----~~~~~~~g~~La~lH~~  131 (322)
T 2ppq_A           98 PAALISFLEGMWLRK------PE----AKHCREVGKALAAMHLA  131 (322)
T ss_dssp             EEEEEECCCCBCCSS------CC----HHHHHHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCC------CC----HHHHHHHHHHHHHHHHH
Confidence            899999999866432      12    23456777788888864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	317
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-26
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-26
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-25
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-25
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-24
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-24
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-24
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-24
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-24
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-22
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-22
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-22
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-21
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-21
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-21
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-21
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-21
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-21
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-21
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-21
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-20
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-20
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-20
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-20
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-20
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-19
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-19
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-19
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-19
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-19
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-19
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-19
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-18
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-18
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-18
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-18
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-18
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-18
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-18
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-17
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-17
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-17
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-17
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-17
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-17
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-17
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-17
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-16
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-16
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-16
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-16
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-16
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-16
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-15
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-15
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-14
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-14
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-13
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-10
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-09

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-26
 Identities = 37/126 (29%), Positives = 58/126 (46%), Gaps = 8/126 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W+    LG G+FG VY+    +     A K +  +      E+ +     EI +L   +H
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-----EEELEDYMVEIDILASCDH 68

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
            NIV+       EN L+I +E    G++  +  E    L +SQ+     Q L+ L YLH+
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 309 QNVIHR 314
             +IHR
Sbjct: 129 NKIIHR 134

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 6e-26
 Identities = 36/144 (25%), Positives = 68/144 (47%), Gaps = 13/144 (9%)

Query: 172 LMELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQ 230
           L  +V      +KY        +   +G G+ G+VY       G   A+++++LQ Q   
Sbjct: 9   LRSIVSVGDPKKKY-------TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--- 58

Query: 231 GEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS 290
                  +  EI ++ + ++ NIV Y  +    ++L++ +E +  GSL  +  E  + + 
Sbjct: 59  --PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 116

Query: 291 QVSAYTWQILNGLKYLHEQNVIHR 314
           Q++A   + L  L++LH   VIHR
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHR 140

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.3 bits (247), Expect = 5e-25
 Identities = 34/125 (27%), Positives = 59/125 (47%), Gaps = 4/125 (3%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++ G PLG G FG+VY        F  A+K +       +      QL +E+ +     H
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRH 65

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
            NI++ +G   D  ++Y+ LE    G++ +  Q+     + + + Y  ++ N L Y H +
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 310 NVIHR 314
            VIHR
Sbjct: 126 RVIHR 130

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  100 bits (251), Expect = 5e-25
 Identities = 30/126 (23%), Positives = 59/126 (46%), Gaps = 8/126 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +     LGSG+FG V+       G  F  K ++              ++ EIS++ Q  H
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHH 85

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIY--QEYHLKDSQVSAYTWQILNGLKYLHE 308
             ++      +D+ ++ + LE ++ G L      ++Y + +++V  Y  Q   GLK++HE
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 309 QNVIHR 314
            +++H 
Sbjct: 146 HSIVHL 151

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 98.5 bits (245), Expect = 2e-24
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 4/120 (3%)

Query: 197 PLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
            +G GSFG+VY      +    A+K++S   +  Q  +    + +E+  L +  H N +Q
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 256 YFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           Y G    E+  ++ +E     +       +  L++ +++A T   L GL YLH  N+IHR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.4 bits (242), Expect = 3e-24
 Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 4/131 (3%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           ++R   ++ G  LG GSF +V           +A+K +  +      E  V  + +E  +
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDV 61

Query: 245 LGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGL 303
           + + +H   V+ + T +D+ KLY  L     G L K  ++     ++    YT +I++ L
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 304 KYLHEQNVIHR 314
           +YLH + +IHR
Sbjct: 122 EYLHGKGIIHR 132

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 97.4 bits (242), Expect = 6e-24
 Identities = 32/125 (25%), Positives = 59/125 (47%), Gaps = 6/125 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +     LG+G+F  V            A+K ++ +      E     +E EI++L + +H
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----EGKEGSMENEIAVLHKIKH 66

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
            NIV      +    LY+ ++LV+ G L   I ++    +   S   +Q+L+ +KYLH+ 
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 310 NVIHR 314
            ++HR
Sbjct: 127 GIVHR 131

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.2 bits (239), Expect = 7e-24
 Identities = 30/125 (24%), Positives = 57/125 (45%), Gaps = 6/125 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           W     LG G++G V            AVK V ++    +       +++EI +     H
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPENIKKEICINKMLNH 62

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGS-LAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
           +N+V+++G  ++ N  Y+FLE  + G    +I  +  + +     +  Q++ G+ YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 310 NVIHR 314
            + HR
Sbjct: 123 GITHR 127

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 97.8 bits (243), Expect = 7e-24
 Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 8/126 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +     LG+G+FG V+       G  FA K V         E     + +EI  +    H
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRH 82

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
             +V      +D+N++ +  E ++ G L +   + H  + + +   Y  Q+  GL ++HE
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 309 QNVIHR 314
            N +H 
Sbjct: 143 NNYVHL 148

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.7 bits (235), Expect = 5e-23
 Identities = 28/126 (22%), Positives = 64/126 (50%), Gaps = 7/126 (5%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++K + LG+G+ G V++      G   A K + L+ +         Q+ +E+ +L +   
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNS 63

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQ 309
             IV ++G    + ++ I +E +  GSL ++ ++   + +  +   +  ++ GL YL E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 310 N-VIHR 314
           + ++HR
Sbjct: 124 HKIMHR 129

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.2 bits (231), Expect = 2e-22
 Identities = 30/137 (21%), Positives = 56/137 (40%), Gaps = 16/137 (11%)

Query: 181 LNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLE 239
           L EKY            LG G FG V+    T     +  K V ++            ++
Sbjct: 3   LYEKYM-------IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVK 49

Query: 240 QEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTW 297
           +EIS+L    H NI+    + +   +L +  E ++   + +      + L + ++ +Y  
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109

Query: 298 QILNGLKYLHEQNVIHR 314
           Q+   L++LH  N+ H 
Sbjct: 110 QVCEALQFLHSHNIGHF 126

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.3 bits (226), Expect = 5e-22
 Identities = 34/136 (25%), Positives = 60/136 (44%), Gaps = 10/136 (7%)

Query: 182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQE 241
            +++     + +    LG+G FG V+ G+ +     AVK +       QG  S      E
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAE 58

Query: 242 ISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQ 298
            +L+ Q +H  +V+ +     E  +YI  E +  GSL    +      L  +++     Q
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 299 ILNGLKYLHEQNVIHR 314
           I  G+ ++ E+N IHR
Sbjct: 118 IAEGMAFIEERNYIHR 133

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.2 bits (226), Expect = 5e-22
 Identities = 34/126 (26%), Positives = 55/126 (43%), Gaps = 8/126 (6%)

Query: 191 SWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
               G  +GSGSFG+VY+G        AVK +++     Q  Q     + E+ +L +  H
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQ---AFKNEVGVLRKTRH 63

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHE 308
            NI+ + G      +L I  +     SL       E   +  ++     Q   G+ YLH 
Sbjct: 64  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 309 QNVIHR 314
           +++IHR
Sbjct: 123 KSIIHR 128

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.1 bits (228), Expect = 7e-22
 Identities = 32/120 (26%), Positives = 56/120 (46%), Gaps = 3/120 (2%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFEHDNIVQ 255
           +G G FG VY     D G  +A+K +  +  +  QGE   L     +SL+   +   IV 
Sbjct: 12  IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 71

Query: 256 YFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                   +KL   L+L+  G L   + Q     ++ +  Y  +I+ GL+++H + V++R
Sbjct: 72  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 1e-21
 Identities = 29/119 (24%), Positives = 51/119 (42%), Gaps = 2/119 (1%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G F +VY+    +     A+K++ L  +    +       +EI LL +  H NI+  
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
                 ++ + +  + +       I      L  S + AY    L GL+YLH+  ++HR
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.2 bits (223), Expect = 1e-21
 Identities = 31/122 (25%), Positives = 56/122 (45%), Gaps = 10/122 (8%)

Query: 198 LGSGSFGSVYEGF---TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LG G+FGSV +G           A+K +    +    +    ++ +E  ++ Q ++  IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIV 72

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIY--QEYHLKDSQVSAYTWQILNGLKYLHEQNVI 312
           +  G  +    L + +E+   G L K    +   +  S V+    Q+  G+KYL E+N +
Sbjct: 73  RLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 313 HR 314
           HR
Sbjct: 132 HR 133

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.2 bits (223), Expect = 2e-21
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 3/119 (2%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG GSFG V+         FFA+K +         +     +E+ + L   +EH  +   
Sbjct: 10  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHM 68

Query: 257 FGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           F T + +  L+  +E +  G L   I   +    S+ + Y  +I+ GL++LH + +++R
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.6 bits (219), Expect = 4e-21
 Identities = 25/119 (21%), Positives = 49/119 (41%), Gaps = 8/119 (6%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +GSG FG V+ G+  +    A+K +       +         +E  ++ +  H  +VQ +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE------DFIEEAEVMMKLSHPKLVQLY 66

Query: 258 GTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNVIHR 314
           G   ++  + +  E +  G L+   +      +   +      +  G+ YL E  VIHR
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.6 bits (219), Expect = 4e-21
 Identities = 23/119 (19%), Positives = 46/119 (38%), Gaps = 8/119 (6%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           LG+G FG V  G     +  A+K +              +  +E  ++    H+ +VQ +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEAKVMMNLSHEKLVQLY 65

Query: 258 GTEKDENKLYIFLELVTQGSLAKI--YQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           G    +  ++I  E +  G L        +  +  Q+      +   ++YL  +  +HR
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 88.6 bits (219), Expect = 4e-21
 Identities = 28/140 (20%), Positives = 45/140 (32%), Gaps = 15/140 (10%)

Query: 181 LNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLE 239
           L+++Y         G  LG G    V+           AVK +       +     L+  
Sbjct: 5   LSDRYE-------LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFR 55

Query: 240 QEISLLGQFEHDNIVQYFGTEKDENK----LYIFLELVTQGSLAKIYQEY-HLKDSQVSA 294
           +E        H  IV  + T + E       YI +E V   +L  I      +   +   
Sbjct: 56  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 115

Query: 295 YTWQILNGLKYLHEQNVIHR 314
                   L + H+  +IHR
Sbjct: 116 VIADACQALNFSHQNGIIHR 135

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 9e-21
 Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 6/129 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE-QSVLQLEQEISLLGQF- 248
           +Q G  LGSG FGSVY G    D    A+K V        GE  +  ++  E+ LL +  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 249 -EHDNIVQYFGTEKDENKLYIFLELVTQGSLAK--IYQEYHLKDSQVSAYTWQILNGLKY 305
                +++     +  +   + LE           I +   L++    ++ WQ+L  +++
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 306 LHEQNVIHR 314
            H   V+HR
Sbjct: 126 CHNCGVLHR 134

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.9 bits (217), Expect = 9e-21
 Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 8/121 (6%)

Query: 198 LGSGSFGSVYEGF---TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
           LGSG+FG+V +G+          AVK +  +      +    +L  E +++ Q ++  IV
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPYIV 71

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
           +  G  + E+   + +E+   G L K + Q  H+KD  +     Q+  G+KYL E N +H
Sbjct: 72  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 314 R 314
           R
Sbjct: 131 R 131

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 88.0 bits (217), Expect = 1e-20
 Identities = 32/123 (26%), Positives = 61/123 (49%), Gaps = 4/123 (3%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
                +G G++G VY+   + G  FA+K++ L+ +            +EIS+L + +H N
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSN 61

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKI-YQEYHLKDSQVSAYTWQILNGLKYLHEQNV 311
           IV+ +     + +L +  E + Q     +   E  L+     ++  Q+LNG+ Y H++ V
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 312 IHR 314
           +HR
Sbjct: 122 LHR 124

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 85.9 bits (212), Expect = 5e-20
 Identities = 27/130 (20%), Positives = 56/130 (43%), Gaps = 7/130 (5%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQ----EISLLG 246
           ++    LG G    V           +AVK + +   G+   + V +L +    E+ +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 247 QF-EHDNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLK 304
           +   H NI+Q   T +     ++  +L+ +G L   + ++  L + +       +L  + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 305 YLHEQNVIHR 314
            LH+ N++HR
Sbjct: 125 ALHKLNIVHR 134

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.4 bits (211), Expect = 5e-20
 Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 12/126 (9%)

Query: 193 QKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           +    +G G FG V  G    G   AVK +         + +      E S++ Q  H N
Sbjct: 10  KLLQTIGKGEFGDVMLG-DYRGNKVAVKCIKN-------DATAQAFLAEASVMTQLRHSN 61

Query: 253 IVQYFGT-EKDENKLYIFLELVTQGSLAKIYQEYH---LKDSQVSAYTWQILNGLKYLHE 308
           +VQ  G   +++  LYI  E + +GSL    +      L    +  ++  +   ++YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 309 QNVIHR 314
            N +HR
Sbjct: 122 NNFVHR 127

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.1 bits (212), Expect = 6e-20
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 6/126 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +QK   +G G++G VY+      G   A+K++ L    T+ E       +EISLL +  H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD---TETEGVPSTAIREISLLKELNH 60

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
            NIV+       ENKLY+  E + Q     +       +    + +Y +Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 309 QNVIHR 314
             V+HR
Sbjct: 121 HRVLHR 126

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.8 bits (214), Expect = 6e-20
 Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 20/140 (14%)

Query: 186 RRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISL 244
           R + +S+     +G+GSFG VY+    D G   A+K+V    +            +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQI 66

Query: 245 LGQFEHDNIVQYF------GTEKDENKLYIFLELVTQGSLAKIYQ----EYHLKDSQVSA 294
           + + +H NIV+        G +KDE  L + L+ V +            +  L    V  
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126

Query: 295 YTWQILNGLKYLHEQNVIHR 314
           Y +Q+   L Y+H   + HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.3 bits (210), Expect = 1e-19
 Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 9/132 (6%)

Query: 192 WQKGAPLGSGSFGSVYEGF--TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE 249
           ++  A +G G++G V++     + G F A+K V +Q        S ++    +  L  FE
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 250 HDNIVQYFG-----TEKDENKLYIFLELVTQGSLA--KIYQEYHLKDSQVSAYTWQILNG 302
           H N+V+ F          E KL +  E V Q          E  +    +    +Q+L G
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 303 LKYLHEQNVIHR 314
           L +LH   V+HR
Sbjct: 129 LDFLHSHRVVHR 140

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (210), Expect = 1e-19
 Identities = 31/146 (21%), Positives = 48/146 (32%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVYEGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           G  LG+G+FG V E        +D     AVK +               L  E+ +L   
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYL 83

Query: 249 E-HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-------------------LK 288
             H NIV   G         +  E    G L    +                      L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              + ++++Q+  G+ +L  +N IHR
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHR 169

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.3 bits (208), Expect = 2e-19
 Identities = 34/136 (25%), Positives = 59/136 (43%), Gaps = 16/136 (11%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++    +G+GS+G   +     DG     KE+         +Q    L  E++LL + +H
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ---MLVSEVNLLRELKH 62

Query: 251 DNIVQYF--GTEKDENKLYIFLELVTQGSLAKIYQEY-----HLKDSQVSAYTWQILNGL 303
            NIV+Y+    ++    LYI +E    G LA +  +      +L +  V     Q+   L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 304 KYLHEQN-----VIHR 314
           K  H ++     V+HR
Sbjct: 123 KECHRRSDGGHTVLHR 138

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.0 bits (207), Expect = 2e-19
 Identities = 34/126 (26%), Positives = 61/126 (48%), Gaps = 3/126 (2%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQD-QGTQGEQSVLQLEQEISLLGQFE 249
           +  G  LGSG F  V +      G  +A K +  +  + ++   S   +E+E+S+L + +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 250 HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHE 308
           H N++      +++  + + LELV  G L     E   L + + + +  QILNG+ YLH 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 309 QNVIHR 314
             + H 
Sbjct: 132 LQIAHF 137

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.6 bits (206), Expect = 5e-19
 Identities = 31/138 (22%), Positives = 67/138 (48%), Gaps = 12/138 (8%)

Query: 179 FSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           +SL +        +Q    LG+GSFG V+      +G ++A+K +  +       + V  
Sbjct: 1   YSLQD--------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEH 50

Query: 238 LEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSA-YT 296
              E  +L    H  I++ +GT +D  ++++ ++ +  G L  + ++     + V+  Y 
Sbjct: 51  TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 110

Query: 297 WQILNGLKYLHEQNVIHR 314
            ++   L+YLH +++I+R
Sbjct: 111 AEVCLALEYLHSKDIIYR 128

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 83.3 bits (205), Expect = 6e-19
 Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 10/123 (8%)

Query: 198 LGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G+G FG V  G          F A+K +         E+       E S++GQF+H N+
Sbjct: 34  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNV 89

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHEQNV 311
           +   G       + I  E +  GSL    ++   + +  Q+      I  G+KYL + N 
Sbjct: 90  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 149

Query: 312 IHR 314
           +HR
Sbjct: 150 VHR 152

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 6e-19
 Identities = 31/124 (25%), Positives = 54/124 (43%), Gaps = 9/124 (7%)

Query: 198 LGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           LG GSFG V  G     +      AVK   L+       +++    +E++ +   +H N+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 254 VQYFGTEKDENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNV 311
           ++ +G       + +  EL   GSL    +++  H     +S Y  Q+  G+ YL  +  
Sbjct: 74  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132

Query: 312 IHRP 315
           IHR 
Sbjct: 133 IHRD 136

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.6 bits (201), Expect = 1e-18
 Identities = 35/125 (28%), Positives = 64/125 (51%), Gaps = 11/125 (8%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           +G GSF +VY+G  T+     A  E+  +       Q   + ++E  +L   +H NIV++
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEMLKGLQHPNIVRF 73

Query: 257 FG----TEKDENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQN- 310
           +     T K +  + +  EL+T G+L    + +  +K   + ++  QIL GL++LH +  
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 133

Query: 311 -VIHR 314
            +IHR
Sbjct: 134 PIIHR 138

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 2e-18
 Identities = 35/142 (24%), Positives = 66/142 (46%), Gaps = 18/142 (12%)

Query: 179 FSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           F +  +Y          + +G G++G V   +   +    A+K++S  +     +    +
Sbjct: 4   FDVGPRYT-------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH----QTYCQR 52

Query: 238 LEQEISLLGQFEHDNIVQYFG-----TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQV 292
             +EI +L +F H+NI+         T +    +Y+   L+    L K+ +  HL +  +
Sbjct: 53  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHI 111

Query: 293 SAYTWQILNGLKYLHEQNVIHR 314
             + +QIL GLKY+H  NV+HR
Sbjct: 112 CYFLYQILRGLKYIHSANVLHR 133

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.6 bits (198), Expect = 3e-18
 Identities = 34/126 (26%), Positives = 54/126 (42%), Gaps = 11/126 (8%)

Query: 195 GAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           G  +G G FG V++G      +     A+K           +    +  QE   + QF+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS----DSVREKFLQEALTMRQFDH 67

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHE 308
            +IV+  G    EN ++I +EL T G L    Q     L  + +  Y +Q+   L YL  
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 309 QNVIHR 314
           +  +HR
Sbjct: 127 KRFVHR 132

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.1 bits (197), Expect = 6e-18
 Identities = 30/123 (24%), Positives = 52/123 (42%), Gaps = 10/123 (8%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIV 254
              LG G FG V+ G  +     A+K +       +         QE  ++ +  H+ +V
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQEAQVMKKLRHEKLV 75

Query: 255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKD---SQVSAYTWQILNGLKYLHEQNV 311
           Q +    +E  +YI  E +++GSL    +    K     Q+     QI +G+ Y+   N 
Sbjct: 76  QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 312 IHR 314
           +HR
Sbjct: 135 VHR 137

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.7 bits (198), Expect = 6e-18
 Identities = 28/129 (21%), Positives = 56/129 (43%), Gaps = 7/129 (5%)

Query: 192 WQKGAPLGSGSFGSVYEGF----TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ 247
           ++    LG+G++G V+        D G  +A+K +       Q  ++      E  +L  
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEH 84

Query: 248 FEH-DNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKY 305
                 +V      + E KL++ L+ +  G L   + Q     + +V  Y  +I+  L++
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144

Query: 306 LHEQNVIHR 314
           LH+  +I+R
Sbjct: 145 LHKLGIIYR 153

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.7 bits (198), Expect = 8e-18
 Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 16/142 (11%)

Query: 179 FSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           + + E+Y       Q  +P+GSG++GSV   F T  G   AVK++S   Q     +   +
Sbjct: 14  WEVPERY-------QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---R 63

Query: 238 LEQEISLLGQFEHDNIVQYFG-----TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQV 292
             +E+ LL   +H+N++            +E      +  +    L  I +   L D  V
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123

Query: 293 SAYTWQILNGLKYLHEQNVIHR 314
               +QIL GLKY+H  ++IHR
Sbjct: 124 QFLIYQILRGLKYIHSADIIHR 145

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 79.8 bits (196), Expect = 9e-18
 Identities = 33/121 (27%), Positives = 54/121 (44%), Gaps = 10/121 (8%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQY 256
           LG G +G VYEG         AVK +       +      +  +E +++ + +H N+VQ 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------EFLKEAAVMKEIKHPNLVQL 78

Query: 257 FGTEKDENKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIH 313
            G    E   YI  E +T G+L    +E     +    +     QI + ++YL ++N IH
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 138

Query: 314 R 314
           R
Sbjct: 139 R 139

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (197), Expect = 1e-17
 Identities = 26/125 (20%), Positives = 52/125 (41%), Gaps = 4/125 (3%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           +     LG G+FG V        G ++A+K +  +      +  V     E  +L    H
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRH 64

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAK-IYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
             +       +  ++L   +E    G L   + +E    + +   Y  +I++ L+YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 310 NVIHR 314
           +V++R
Sbjct: 125 DVVYR 129

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 1e-17
 Identities = 30/129 (23%), Positives = 49/129 (37%), Gaps = 19/129 (14%)

Query: 198 LGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF 257
           +G G FG V+ G    G   AVK  S +      E+     E EI       H+NI+ + 
Sbjct: 11  IGKGRFGEVWRG-KWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFI 63

Query: 258 GTEKDEN----KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQ---- 309
             +  +N    +L++  +    GSL      Y +    +        +GL +LH +    
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 310 ----NVIHR 314
                + HR
Sbjct: 124 QGKPAIAHR 132

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.2 bits (194), Expect = 2e-17
 Identities = 28/138 (20%), Positives = 58/138 (42%), Gaps = 13/138 (9%)

Query: 187 RRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
             +  ++K A +G G+FG V++      G   A+K+V ++++    E   +   +EI +L
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKIL 63

Query: 246 GQFEHDNIVQYFGT--------EKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYT 296
              +H+N+V              + +  +Y+  +                   S++    
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 297 WQILNGLKYLHEQNVIHR 314
             +LNGL Y+H   ++HR
Sbjct: 124 QMLLNGLYYIHRNKILHR 141

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 2e-17
 Identities = 32/142 (22%), Positives = 59/142 (41%), Gaps = 16/142 (11%)

Query: 179 FSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQ 237
           + +   YR          P+GSG++G+V        G   A+K++    Q    E    +
Sbjct: 14  WEVRAVYR-------DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS---ELFAKR 63

Query: 238 LEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVT-----QGSLAKIYQEYHLKDSQV 292
             +E+ LL    H+N++        +  L  F +           L K+ +   L + ++
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 293 SAYTWQILNGLKYLHEQNVIHR 314
               +Q+L GL+Y+H   +IHR
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHR 145

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 79.5 bits (195), Expect = 2e-17
 Identities = 29/143 (20%), Positives = 61/143 (42%), Gaps = 4/143 (2%)

Query: 174 ELVYNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGE 232
           + +  +    +   ++  + +   LG+GSFG V      + G  +A+K +  Q       
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKL 82

Query: 233 QSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLELVTQGSL-AKIYQEYHLKDSQ 291
           + +     E  +L       +V+   + KD + LY+ +E V  G + + + +     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142

Query: 292 VSAYTWQILNGLKYLHEQNVIHR 314
              Y  QI+   +YLH  ++I+R
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYR 165

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.0 bits (194), Expect = 2e-17
 Identities = 28/126 (22%), Positives = 46/126 (36%), Gaps = 19/126 (15%)

Query: 198 LGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ-FEHDNIVQ 255
           LG G  G V + F       FA+K +          Q   +  +E+ L  +  +  +IV+
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRASQCPHIVR 69

Query: 256 YFGT----EKDENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHE 308
                         L I +E +  G L    Q+       + + S     I   ++YLH 
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 309 QNVIHR 314
            N+ HR
Sbjct: 130 INIAHR 135

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (193), Expect = 3e-17
 Identities = 30/151 (19%), Positives = 50/151 (33%), Gaps = 35/151 (23%)

Query: 195 GAPLGSGSFGSVYEGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF 248
           G  LGSG+FG V          T      AVK +  +            L  E+ ++ Q 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQL 97

Query: 249 E-HDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH--------------------- 286
             H+NIV   G       +Y+  E    G L    +                        
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 287 ---LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
              L    +  + +Q+  G+++L  ++ +HR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.1 bits (191), Expect = 4e-17
 Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 5/125 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++K   +G G++G+V++    +     A+K V L D       S L+   EI LL + +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHEQ 309
            NIV+       + KL +  E   Q            L    V ++ +Q+L GL + H +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 310 NVIHR 314
           NV+HR
Sbjct: 121 NVLHR 125

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.8 bits (188), Expect = 1e-16
 Identities = 33/146 (22%), Positives = 57/146 (39%), Gaps = 30/146 (20%)

Query: 195 GAPLGSGSFGSVYEG--------FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG 246
           G PLG G+FG V             +     AVK +         E+ +  L  E+ ++ 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMK 73

Query: 247 QF-EHDNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQ-----------------EYHLK 288
              +H NI+   G    +  LY+ +E  ++G+L +  Q                 E  L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 289 DSQVSAYTWQILNGLKYLHEQNVIHR 314
              + +  +Q+  G++YL  +  IHR
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHR 159

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 76.0 bits (186), Expect = 2e-16
 Identities = 26/126 (20%), Positives = 49/126 (38%), Gaps = 10/126 (7%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++ G  +GSGSFG +Y G     G   A+K   ++ +  Q       L  E  +    + 
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-------LHIESKIYKMMQG 61

Query: 251 DN-IVQYFGTEKDENKLYIFLELVTQGSLA-KIYQEYHLKDSQVSAYTWQILNGLKYLHE 308
              I        + +   + +EL+         +         V     Q+++ ++Y+H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 309 QNVIHR 314
           +N IHR
Sbjct: 122 KNFIHR 127

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (185), Expect = 2e-16
 Identities = 33/124 (26%), Positives = 51/124 (41%), Gaps = 11/124 (8%)

Query: 198 LGSGSFGSVYEGFTDDG-----FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN 252
           +G+G FG VY+G             A+K +         E+  +    E  ++GQF H N
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT----EKQRVDFLGEAGIMGQFSHHN 70

Query: 253 IVQYFGTEKDENKLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQN 310
           I++  G       + I  E +  G+L K  +E        Q+      I  G+KYL   N
Sbjct: 71  IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130

Query: 311 VIHR 314
            +HR
Sbjct: 131 YVHR 134

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 76.0 bits (186), Expect = 3e-16
 Identities = 27/127 (21%), Positives = 48/127 (37%), Gaps = 14/127 (11%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-E 249
           +Q    LG G +  V+E     +     VK +    +         ++++EI +L     
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--------KIKREIKILENLRG 88

Query: 250 HDNIVQYFGT--EKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLH 307
             NI+       +       +  E V      ++YQ   L D  +  Y ++IL  L Y H
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCH 146

Query: 308 EQNVIHR 314
              ++HR
Sbjct: 147 SMGIMHR 153

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.7 bits (185), Expect = 3e-16
 Identities = 30/134 (22%), Positives = 54/134 (40%), Gaps = 21/134 (15%)

Query: 198 LGSGSFGSVYEGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           LG GSFG VYEG        +     A+K V+         +  ++   E S++ +F   
Sbjct: 28  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS----MRERIEFLNEASVMKEFNCH 83

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----------LKDSQVSAYTWQIL 300
           ++V+  G         + +EL+T+G L    +                 S++     +I 
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 301 NGLKYLHEQNVIHR 314
           +G+ YL+    +HR
Sbjct: 144 DGMAYLNANKFVHR 157

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (182), Expect = 8e-16
 Identities = 26/136 (19%), Positives = 51/136 (37%), Gaps = 21/136 (15%)

Query: 198 LGSGSFGSVYEG-FTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQ 255
           +G G+FG V +     DG         +++  ++ +        E+ +L +   H NI+ 
Sbjct: 18  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIIN 75

Query: 256 YFGTEKDENKLYIFLELVTQGSLAKIYQEYH-----------------LKDSQVSAYTWQ 298
             G  +    LY+ +E    G+L    ++                   L   Q+  +   
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 299 ILNGLKYLHEQNVIHR 314
           +  G+ YL ++  IHR
Sbjct: 136 VARGMDYLSQKQFIHR 151

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.2 bits (181), Expect = 1e-15
 Identities = 33/145 (22%), Positives = 64/145 (44%), Gaps = 12/145 (8%)

Query: 177 YNFSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSV 235
           Y+  + +     +  +Q   P+GSG+ G V   +        A+K++S      Q +   
Sbjct: 4   YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHA 60

Query: 236 LQLEQEISLLGQFEHDNIVQYFG------TEKDENKLYIFLELVTQGSLAKIYQEYHLKD 289
            +  +E+ L+    H NI+          T ++   +Y+ +EL+       I  E   + 
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE- 119

Query: 290 SQVSAYTWQILNGLKYLHEQNVIHR 314
            ++S   +Q+L G+K+LH   +IHR
Sbjct: 120 -RMSYLLYQMLCGIKHLHSAGIIHR 143

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 71.8 bits (175), Expect = 6e-15
 Identities = 26/148 (17%), Positives = 52/148 (35%), Gaps = 35/148 (23%)

Query: 198 LGSGSFGSVYEGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHD 251
           +G G+FG V++         +     AVK +  +             ++E +L+ +F++ 
Sbjct: 21  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS----ADMQADFQREAALMAEFDNP 76

Query: 252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYH------------------------- 286
           NIV+  G       + +  E +  G L +  +                            
Sbjct: 77  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 287 LKDSQVSAYTWQILNGLKYLHEQNVIHR 314
           L  ++      Q+  G+ YL E+  +HR
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERKFVHR 164

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.3 bits (174), Expect = 1e-14
 Identities = 28/124 (22%), Positives = 48/124 (38%), Gaps = 11/124 (8%)

Query: 198 LGSGSFGSVYEGFTDD----GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNI 253
           +G G FG VY G   D        AVK ++           V Q   E  ++  F H N+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHPNV 90

Query: 254 VQYFGT-EKDENKLYIFLELVTQGSLAKIY--QEYHLKDSQVSAYTWQILNGLKYLHEQN 310
           +   G   + E    + L  +  G L      + ++     +  +  Q+  G+K+L  + 
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 311 VIHR 314
            +HR
Sbjct: 151 FVHR 154

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (174), Expect = 1e-14
 Identities = 24/126 (19%), Positives = 57/126 (45%), Gaps = 4/126 (3%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++K   LGSG+FG+VY+G    +G    +     + +     ++  ++  E  ++   ++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDS--QVSAYTWQILNGLKYLHE 308
            ++ +  G       + +  +L+  G L    +E+        +  +  QI  G+ YL +
Sbjct: 71  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 309 QNVIHR 314
           + ++HR
Sbjct: 130 RRLVHR 135

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 67.5 bits (164), Expect = 2e-13
 Identities = 28/124 (22%), Positives = 50/124 (40%), Gaps = 6/124 (4%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH 250
           ++ G  +G GSFG ++EG    +    A+K    +         +    +   LL     
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTG 62

Query: 251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN 310
              V YFG E   N L I L   +   L  +          V+    Q+L  ++ +HE++
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 311 VIHR 314
           +++R
Sbjct: 122 LVYR 125

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.7 bits (159), Expect = 7e-13
 Identities = 37/147 (25%), Positives = 57/147 (38%), Gaps = 27/147 (18%)

Query: 192 WQKGAPLGSGSFGSVYEGF------TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLL 245
            + G PLG G+FG V E        T      AVK   L++  T  E   L  E +I L+
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKI-LI 71

Query: 246 GQFEHDNIVQYFG-TEKDENKLYIFLELVTQGSLAKIYQEY-----------------HL 287
               H N+V   G   K    L + +E    G+L+   +                    L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 288 KDSQVSAYTWQILNGLKYLHEQNVIHR 314
               +  Y++Q+  G+++L  +  IHR
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHR 158

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 57.5 bits (138), Expect = 1e-10
 Identities = 17/129 (13%), Positives = 40/129 (31%), Gaps = 15/129 (11%)

Query: 195 GAPLGSGSFGSVYEGFTDDGFFFAVKEV-----SLQDQGTQGEQSVLQLEQEISLLGQFE 249
           G  +G G   +V+  +++      VK       S +    + +   L          + E
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 250 HDNIVQYFG----TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKY 305
              + +  G             + +EL+    L ++  E   +          IL  +  
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE------VLDMILEEVAK 118

Query: 306 LHEQNVIHR 314
            + + ++H 
Sbjct: 119 FYHRGIVHG 127

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.7 bits (130), Expect = 4e-09
 Identities = 26/136 (19%), Positives = 52/136 (38%), Gaps = 13/136 (9%)

Query: 192 WQKGAPLGSGSFGSVYEGF-TDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEIS-----LL 245
           +     LG G F +V+      +    A+K V      T+  +  ++L Q ++       
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 246 GQFEHDNIVQY--FGTEKDENKLYIFLELVTQG----SLAKIYQEYHLKDSQVSAYTWQI 299
                ++I++       K  N +++ +     G    +L K Y+   +    V   + Q+
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 300 LNGLKYL-HEQNVIHR 314
           L GL Y+     +IH 
Sbjct: 135 LLGLDYMHRRCGIIHT 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	317
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.95
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.95
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.95
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.95
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.95
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.95
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.95
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.95
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.95
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.95
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.95
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.94
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.94
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.94
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.94
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.94
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.94
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.94
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.94
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.93
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.93
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.93
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.93
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.93
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.93
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.93
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.93
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.93
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.93
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.93
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.92
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.92
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.92
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.92
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.92
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.92
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.92
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.92
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.92
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.91
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.91
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.91
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.91
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.91
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.91
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.91
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.91
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.91
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.91
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.91
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.9
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.9
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.9
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.9
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.89
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.89
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.89
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.89
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.88
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.88
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.87
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.76
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.73
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.19
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	95.39
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	92.42

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.7e-28  Score=221.66  Aligned_cols=123  Identities=26%  Similarity=0.457  Sum_probs=114.0

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      ++|.+++.||+|+||.||+|.+ .+|..||||++.....     ...+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            4799999999999999999998 8899999999975432     124568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||+||+|.+++..+++++..+..++.||+.||.|||++||||||||
T Consensus        95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiK  143 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK  143 (293)
T ss_dssp             EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCc
Confidence            9999999999999998899999999999999999999999999999998

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1e-28  Score=220.74  Aligned_cols=125  Identities=24%  Similarity=0.460  Sum_probs=111.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|++++.||+|+||.||+|.+ .+|+.||||++....    .....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence            57899999999999999999998 789999999997542    1223456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||||+||+|.+++... .+++..+..++.||+.||.|||++||||||||
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiK  130 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK  130 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCccc
Confidence            999999999999998654 59999999999999999999999999999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.2e-28  Score=217.63  Aligned_cols=127  Identities=27%  Similarity=0.512  Sum_probs=114.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|.+++.||+|+||.||+|.+ .+++.||+|++.+..  .........+.+|+.+++.++|||||++++++.+++.+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH--ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            67899999999999999999999 789999999997432  112233567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||||||||
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiK  133 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIK  133 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeec
Confidence            99999999999998865 569999999999999999999999999999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.1e-28  Score=216.63  Aligned_cols=129  Identities=26%  Similarity=0.416  Sum_probs=115.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCC-ccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGT-QGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+.|.+++.||+|+||+||+|.+ .+|..||||++.+..... ......+.+.+|+.+|++++|||||++++++.+++.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35799999999999999999998 889999999998654322 2223456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||||+||+|.+++.. +++++..+..++.||+.||.|||++||||||||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiK  140 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK  140 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccc
Confidence            999999999999999865 569999999999999999999999999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.7e-28  Score=216.79  Aligned_cols=123  Identities=30%  Similarity=0.511  Sum_probs=111.9

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +.|++++.||+|+||.||+|.+ .++..||+|++....     ....+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            5689999999999999999998 889999999997432     2335578899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||+||+|.+++.+  .++++..+..++.||+.||.|||++||||||||
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiK  137 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK  137 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecC
Confidence            9999999999998754  459999999999999999999999999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.95  E-value=1.4e-27  Score=220.71  Aligned_cols=125  Identities=23%  Similarity=0.358  Sum_probs=114.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|.+++.||+|+||.||+|.+ .+|..||||++...     .....+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467899999999999999999998 88999999998632     334467788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||||+||+|.+++..  +.+++..+..++.||+.||.|||++||||||||
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiK  151 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK  151 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeec
Confidence            999999999999999843  459999999999999999999999999999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=1.8e-27  Score=216.39  Aligned_cols=125  Identities=26%  Similarity=0.424  Sum_probs=113.2

Q ss_pred             CeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEE
Q 021084          191 SWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIF  269 (317)
Q Consensus       191 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV  269 (317)
                      .|..++.||+|+||.||+|.+ .+|..||||++....  .......+.+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS--SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhh--ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            489999999999999999998 889999999997543  33445667899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+||+|..++. ..++++..+..++.||+.||.|||++||||||||
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiK  142 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK  142 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC
Confidence            99999999987665 4569999999999999999999999999999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.2e-27  Score=216.87  Aligned_cols=124  Identities=20%  Similarity=0.322  Sum_probs=112.8

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      ..++|.+++.||+|+||+||+|.+ .+|..||+|+++...      .....+.+|+.+|+.++|||||++++++.+++.+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            357899999999999999999998 789999999996431      2234678999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||||+||+|.+++...  .+++.++..++.||+.||.|||++||||||||
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlK  129 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR  129 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCccccc
Confidence            9999999999999999754  58999999999999999999999999999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=1.2e-27  Score=217.29  Aligned_cols=125  Identities=26%  Similarity=0.378  Sum_probs=109.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.|++.+.||+|+||.||+|.+ .+|+.||||++.....    ......+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45699999999999999999998 7899999999975432    122356789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||||+||+|.+++... .+++..+..++.||+.||.|||++||||||||
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiK  134 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK  134 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEec
Confidence            999999999999998754 59999999999999999999999999999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.95  E-value=2.8e-27  Score=218.88  Aligned_cols=124  Identities=23%  Similarity=0.375  Sum_probs=112.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .+.|++++.||+|+||.||+|.+ .+|..||||+++..     .......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56799999999999999999998 78999999998742     2334567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||||+||+|.+++...  ++++.++..++.||+.||.|||++||||||||
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiK  154 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK  154 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            999999999999877543  58999999999999999999999999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.2e-28  Score=216.96  Aligned_cols=127  Identities=26%  Similarity=0.378  Sum_probs=113.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|++++.||+|+||.||+|.+ .+|+.||||++.....  ........+.+|+.+|++++||||+++++++.+++.+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            36799999999999999999998 7899999999974321  12233567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||+||+|.+++.. +.+++..+..++.|++.||.|||++||||||||
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiK  135 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK  135 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCC
Confidence            99999999999998764 569999999999999999999999999999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=220.39  Aligned_cols=128  Identities=20%  Similarity=0.262  Sum_probs=115.1

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|.+++.||+|+||.||+|.+ .+|+.||||++++...  ........+.+|+.+|+.++||||+++++++.+++.+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            467899999999999999999998 8999999999975321  1122356788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |+|||||+||+|.+++.. +.+++..+..++.||+.||+|||++||||||||
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlK  132 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK  132 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccC
Confidence            999999999999998875 569999999999999999999999999999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.94  E-value=8.4e-28  Score=216.41  Aligned_cols=128  Identities=28%  Similarity=0.425  Sum_probs=114.7

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      +|....++|++.+.||+|+||+||+|.+ .++..||||+++...      ...+.+.+|+.+|+.++|||||++++++.+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc------chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            3555667899999999999999999998 789999999986321      124578899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.+|+|||||++|+|.+++...   .+++..+..++.||+.||.|||++||||||||
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlK  142 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA  142 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccc
Confidence            99999999999999999998653   48999999999999999999999999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.6e-27  Score=217.92  Aligned_cols=125  Identities=22%  Similarity=0.380  Sum_probs=113.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      .++|++++.||+|+||+||+|.+ .+|..||+|+++...    .......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46899999999999999999998 789999999997532    2344567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      ||||||+||+|.+++.+ +.+++..+..++.|++.||.|||+ +||||||||
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiK  132 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK  132 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCS
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccC
Confidence            99999999999999864 569999999999999999999997 599999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.94  E-value=5.2e-27  Score=210.17  Aligned_cols=129  Identities=20%  Similarity=0.292  Sum_probs=115.2

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCcc----HHHHHHHHHHHHHhccCC-CCceeeeeeEEEe
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQG----EQSVLQLEQEISLLGQFE-HDNIVQYFGTEKD  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~----~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~  262 (317)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++++.......    ....+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999999998 88999999999865433322    233456889999999996 9999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++.+|||||||+||+|.+++.. +++++..+..++.||+.||.|||++||||||||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlk  137 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK  137 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccc
Confidence            9999999999999999999854 569999999999999999999999999999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.94  E-value=6.9e-27  Score=209.02  Aligned_cols=127  Identities=20%  Similarity=0.219  Sum_probs=113.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC---
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN---  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---  264 (317)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||+++...  ..+......+.+|+.+++.++|||||++++++...+   
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh--ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            35799999999999999999998 889999999997543  334566778999999999999999999999997643   


Q ss_pred             -EEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 -KLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 -~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       .+|||||||+||+|.+++.. +.+++..+..++.||+.||.|||++||||||||
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiK  138 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK  138 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCcccc
Confidence             48999999999999988754 469999999999999999999999999999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7.4e-27  Score=208.27  Aligned_cols=126  Identities=28%  Similarity=0.389  Sum_probs=105.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe--CCE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD--ENK  265 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~  265 (317)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|++....   ......+.+.+|+.+|++++|||||++++++.+  .+.
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT---SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh---CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence            46899999999999999999998 889999999997542   244556789999999999999999999999865  566


Q ss_pred             EEEEEecCCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-----YHLKDSQVSAYTWQILNGLKYLHEQN-----VIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-----~~l~~~~~~~i~~qil~aL~yLH~~g-----IvHrDLK  317 (317)
                      +|+|||||+||+|.+++..     ..+++..+..++.||+.||.|||++|     |||||||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiK  141 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK  141 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCc
Confidence            8999999999999998853     35999999999999999999999876     9999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.94  E-value=5.9e-27  Score=213.60  Aligned_cols=127  Identities=22%  Similarity=0.387  Sum_probs=113.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|++++.||+|+||+||+|++ .+|+.||||+++...  .......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH--ccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            57899999999999999999998 889999999997432  112233567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||+||+|..++... .+++..+..++.||+.||.|||++||||||||
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiK  131 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK  131 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccC
Confidence            999999999999988764 58899999999999999999999999999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.4e-26  Score=205.05  Aligned_cols=122  Identities=25%  Similarity=0.449  Sum_probs=108.7

Q ss_pred             eeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe----CCEEE
Q 021084          193 QKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD----ENKLY  267 (317)
Q Consensus       193 ~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~  267 (317)
                      ++...||+|+||+||+|.+ .++..||+|.+....   ......+.+.+|+++|++++|||||++++++.+    ...+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            6777899999999999998 789999999997542   234556789999999999999999999999865    45689


Q ss_pred             EEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQN--VIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IvHrDLK  317 (317)
                      +|||||+||+|.+++.. ..+++..+..++.||+.||.|||++|  |||||||
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiK  141 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK  141 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcC
Confidence            99999999999999865 46999999999999999999999998  9999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-26  Score=205.71  Aligned_cols=123  Identities=22%  Similarity=0.326  Sum_probs=110.7

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .++|++++.||+|+||.||+|.+.++..||||+++...   .   ..+.+.+|+.++.+++|||||+++|++..++.+|+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---M---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---C---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            35799999999999999999988888899999986421   1   23568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||++|+|.+++...  .+++..+..++.|++.||.|||++||+|||||
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlK  128 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA  128 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCS
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccc
Confidence            99999999999998653  48899999999999999999999999999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.2e-26  Score=207.95  Aligned_cols=126  Identities=29%  Similarity=0.467  Sum_probs=107.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|++++.||+|+||.||+|.+ .+|+.||||+++...   ........+.+|+.+|++++|||||++++++.+++.+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~   77 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   77 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---cChHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence            47899999999999999999998 889999999996432   22234567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|||||.++.+..+...  .++++..+..++.||+.||.|||++||||||||
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiK  129 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK  129 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccC
Confidence            99999976444433332  359999999999999999999999999999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.93  E-value=1.1e-26  Score=214.60  Aligned_cols=128  Identities=23%  Similarity=0.318  Sum_probs=114.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  266 (317)
                      .+++|++++.||+|+||.||+|.+ .+|+.||||++.+..  .......+.+.+|+.+|+.++|||||++++++.+...+
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH--ccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            368899999999999999999998 789999999997432  11223356788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++||||+.||+|..++.. +.+++..+..++.||+.||.|||++||||||||
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIK  168 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK  168 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCC
Confidence            999999999999998764 569999999999999999999999999999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.6e-26  Score=211.03  Aligned_cols=127  Identities=25%  Similarity=0.364  Sum_probs=110.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhc-cCCCCceeeeeeEEEeCCEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLG-QFEHDNIVQYFGTEKDENKL  266 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~  266 (317)
                      +++|.+++.||+|+||+||+|.+ .+|+.||||++++...  ........+..|..++. .++|||||++++++.+++.+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence            47899999999999999999999 8899999999974321  11122445667777665 68999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          267 YIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       267 ~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |||||||+||+|.+++.. .++++..+..++.||+.||.|||++||||||||
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDik  130 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK  130 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            999999999999999865 569999999999999999999999999999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.93  E-value=2.7e-26  Score=207.56  Aligned_cols=125  Identities=28%  Similarity=0.438  Sum_probs=109.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCC---EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGF---FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~---~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|++.+.||+|+||.||+|.+ .++.   .||||.+..    .......+.|.+|+.+|++++|||||+++|++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS----SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            46799999999999999999987 4443   578887753    234556678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||++|+|.+++...  .+++..+..++.||+.||.|||++||||||||
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlK  155 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLA  155 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccc
Confidence            999999999999999988753  48999999999999999999999999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.2e-26  Score=207.63  Aligned_cols=127  Identities=25%  Similarity=0.348  Sum_probs=109.6

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....++|.+++.||+|+||.||+|...  ..||||+++...   ......+.|.+|+.+|.+++|||||++++++.. +
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~   76 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P   76 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSS---CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c
Confidence            3445678999999999999999999753  359999987542   234456789999999999999999999998754 5


Q ss_pred             EEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||+||+|.+++..  ..+++..+..++.||+.||.|||++||||||||
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlK  131 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK  131 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccC
Confidence            68999999999999999964  348999999999999999999999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.2e-26  Score=207.13  Aligned_cols=127  Identities=24%  Similarity=0.399  Sum_probs=110.6

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .|....++|++.+.||+|+||.||+|.+.++..||||+++...      ...+.+.+|+.+|.+++|||||++++++.+ 
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-   79 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc------CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence            4555667899999999999999999988888899999986321      123568999999999999999999998755 


Q ss_pred             CEEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+|||||++|+|.+++..   .++++..+..++.||+.||.|||++||||||||
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiK  136 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR  136 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccc
Confidence            567999999999999987643   259999999999999999999999999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=4.6e-26  Score=211.55  Aligned_cols=130  Identities=24%  Similarity=0.307  Sum_probs=110.6

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCC-CccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQG-TQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      .+++|.+++.||+|+||.||+|.+ .+|..||||++.+.... ............++.+++.++|||||++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            368999999999999999999998 78999999999643211 1112222333455788889999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||||||||
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlK  134 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK  134 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeec
Confidence            9999999999999998864 458999999999999999999999999999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9.6e-26  Score=202.63  Aligned_cols=124  Identities=27%  Similarity=0.382  Sum_probs=107.1

Q ss_pred             ccCeeeecc-ccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          189 IMSWQKGAP-LGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       189 ~~~y~~~~~-LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      .++|.+.+. ||+|+||.||+|.+   .++..||||+++.    .......+.|.+|+.+|++++|||||+++|++.++ 
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~----~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEECh----hcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence            356777774 99999999999976   3455899999863    23455677899999999999999999999998754 


Q ss_pred             EEEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|||||||++|+|.+++..  ..+++..+..++.||+.||.|||++||||||||
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK  136 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA  136 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCc
Confidence            58999999999999998854  359999999999999999999999999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.1e-26  Score=208.04  Aligned_cols=132  Identities=23%  Similarity=0.378  Sum_probs=110.9

Q ss_pred             chHHHHhccCeeeeccccccCCeeEEEEEe-cCC-----CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCcee
Q 021084          182 NEKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DDG-----FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIV  254 (317)
Q Consensus       182 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv  254 (317)
                      ..+|....++|.+++.||+|+||+||+|.+ ..+     ..||+|.+....    .......+.+|+.+|.++ +|||||
T Consensus        29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv  104 (325)
T d1rjba_          29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIV  104 (325)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEe
Confidence            345666678999999999999999999987 333     368999886422    233445788999999998 899999


Q ss_pred             eeeeEEEeCCEEEEEEecCCCCCHHHHHHhC------------------------CCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          255 QYFGTEKDENKLYIFLELVTQGSLAKIYQEY------------------------HLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       255 ~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~------------------------~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      ++++++.+.+.+|+|||||++|+|.+++...                        .+++..+..++.||+.||.|||++|
T Consensus       105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~  184 (325)
T d1rjba_         105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  184 (325)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999643                        3788999999999999999999999


Q ss_pred             cEecCCC
Q 021084          311 VIHRPGA  317 (317)
Q Consensus       311 IvHrDLK  317 (317)
                      |||||||
T Consensus       185 IiHRDlK  191 (325)
T d1rjba_         185 CVHRDLA  191 (325)
T ss_dssp             EEETTCS
T ss_pred             eeeccCc
Confidence            9999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.1e-26  Score=202.17  Aligned_cols=123  Identities=21%  Similarity=0.337  Sum_probs=110.9

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .++|++++.||+|+||+||+|+..++..||||+++....      ..+.+.+|+.++.+++||||++++|++.+++.+++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            368899999999999999999988888999999975321      13468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||+++|+|..++..  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk  127 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA  127 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCS
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCccccccc
Confidence            9999999999998754  458999999999999999999999999999997

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.92  E-value=1e-25  Score=202.14  Aligned_cols=126  Identities=25%  Similarity=0.436  Sum_probs=112.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l  268 (317)
                      +++|.+++.||+|+||.||+|.+.+|+.||||++....   ........+.+|+.+|++++|||||++++++..++..|+
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhh---cChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence            46899999999999999999998889999999997542   223335678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          269 FLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       269 VmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||++.++.+..+... +.+++..+..++.||+.||+|||++||||||||
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiK  127 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK  127 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCC
Confidence            9999988777777663 459999999999999999999999999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.4e-25  Score=200.69  Aligned_cols=118  Identities=31%  Similarity=0.445  Sum_probs=101.4

Q ss_pred             ccccccCCeeEEEEEe---cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          196 APLGSGSFGSVYEGFT---DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       196 ~~LG~G~fg~Vy~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      +.||+|+||.||+|.+   .+++.||||+++..   ..+....+.+.+|+.+|++++|||||++++++.++ .+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh---hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEc
Confidence            4699999999999976   34578999998643   22344567899999999999999999999998654 57899999


Q ss_pred             CCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |++|+|.+++... .+++..+..++.||+.||.|||++||||||||
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlK  134 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA  134 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCc
Confidence            9999999998764 59999999999999999999999999999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.8e-26  Score=207.11  Aligned_cols=124  Identities=24%  Similarity=0.393  Sum_probs=103.0

Q ss_pred             eeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEEEEEec
Q 021084          194 KGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLYIFLEL  272 (317)
Q Consensus       194 ~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lVmE~  272 (317)
                      .++.||+|+||+||+|.+ .+|+.||||+++..............+.+|+.+|+.++|||||++++++..++.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            467899999999999998 7899999999975443222333345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          273 VTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       273 ~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      |.|+++..+... ..+++..+..++.||+.||.|||++||||||||
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiK  127 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK  127 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCC
Confidence            999877776653 358999999999999999999999999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.9e-25  Score=198.23  Aligned_cols=126  Identities=27%  Similarity=0.442  Sum_probs=114.6

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCEEE
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENKLY  267 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  267 (317)
                      +++|++++.||+|+||+||+|.+ .+++.||||+++...   ........+.+|+.+|+.++||||+++++++.+...++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   77 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---CChHHHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence            36899999999999999999999 889999999997543   23455678899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++|+++.+++|..++... .+++..+..++.|++.||+|||++||||||||
T Consensus        78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiK  128 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK  128 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeeccc
Confidence            999999999998887654 58999999999999999999999999999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.9e-25  Score=205.18  Aligned_cols=120  Identities=23%  Similarity=0.273  Sum_probs=105.4

Q ss_pred             hccCeeeec-cccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc-CCCCceeeeeeEEEe--
Q 021084          188 RIMSWQKGA-PLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ-FEHDNIVQYFGTEKD--  262 (317)
Q Consensus       188 ~~~~y~~~~-~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~--  262 (317)
                      .+++|.+.. .||+|+||.||+|.+ .+++.||||+++..          ..+.+|+.++.+ ++|||||+++++|.+  
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            467898875 699999999999998 88999999998631          245689988654 489999999999976  


Q ss_pred             --CCEEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 --ENKLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 --~~~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                        ...+|||||||+||+|.+++...   ++++.++..|+.||+.||.|||++||+|||||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiK  138 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK  138 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccc
Confidence              46799999999999999999763   48999999999999999999999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.7e-25  Score=201.96  Aligned_cols=135  Identities=24%  Similarity=0.361  Sum_probs=117.2

Q ss_pred             CCcchHHHHhccCeeeeccccccCCeeEEEEEe------cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCC
Q 021084          179 FSLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFT------DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHD  251 (317)
Q Consensus       179 ~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hp  251 (317)
                      ++...+|....++|++++.||+|+||.||+|..      .+++.||||+++..    ........+.+|+.+++.+ +||
T Consensus        12 ~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~Hp   87 (311)
T d1t46a_          12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHM   87 (311)
T ss_dssp             SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc----cCHHHHHHHHHHHHHHHhccCCC
Confidence            344445666678999999999999999999975      35679999998642    2345566799999999999 799


Q ss_pred             ceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcE
Q 021084          252 NIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-------------------HLKDSQVSAYTWQILNGLKYLHEQNVI  312 (317)
Q Consensus       252 nIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-------------------~l~~~~~~~i~~qil~aL~yLH~~gIv  312 (317)
                      |||++++++.+++.+|+|||||++|+|.+++...                   .+++..+..++.||+.||.|||++|||
T Consensus        88 nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~iv  167 (311)
T d1t46a_          88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI  167 (311)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            9999999999999999999999999999998643                   388999999999999999999999999


Q ss_pred             ecCCC
Q 021084          313 HRPGA  317 (317)
Q Consensus       313 HrDLK  317 (317)
                      |||||
T Consensus       168 HrDLK  172 (311)
T d1t46a_         168 HRDLA  172 (311)
T ss_dssp             CSCCS
T ss_pred             ecccc
Confidence            99998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.2e-25  Score=200.23  Aligned_cols=126  Identities=25%  Similarity=0.374  Sum_probs=109.7

Q ss_pred             HHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          185 YRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       185 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      |....++|++.+.||+|+||.||+|.+.++..||||++....   .   ..+.|.+|+.+|.+++|||||++++++.+ +
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~   84 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---M---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E   84 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---C---CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence            344457899999999999999999988777789999986332   1   23568899999999999999999999855 5


Q ss_pred             EEEEEEecCCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQE---YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~---~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||++|+|..++..   ..+++..+..++.||+.||.|||++||+|||||
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlK  140 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR  140 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheeccccc
Confidence            58999999999999988753   459999999999999999999999999999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.9e-25  Score=203.57  Aligned_cols=125  Identities=23%  Similarity=0.463  Sum_probs=107.1

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC---
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN---  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---  264 (317)
                      .++|++++.||+|+||+||+|.+ .+|+.||||+++..   .......+.+.+|+.+|+.++|||||+++++|...+   
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh---hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence            46899999999999999999998 78999999998643   334556778999999999999999999999997654   


Q ss_pred             ---EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 ---KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ---~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                         .+|+||||| +++|..+++..++++..+..++.||+.||.|||++||||||||
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiK  148 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK  148 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             ccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence               579999999 6689999988899999999999999999999999999999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.8e-25  Score=203.52  Aligned_cols=126  Identities=29%  Similarity=0.435  Sum_probs=111.0

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE----  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----  263 (317)
                      .++|++++.||+|+||+||+|.+ .+|+.||||+++..   ..+....+.+.+|+.+|+.++|||||++++++...    
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECch---hcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            46799999999999999999998 88999999998743   33445567788999999999999999999998643    


Q ss_pred             -CEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 -NKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 -~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ...+++|+|+.||+|.+++...++++..+..++.||+.||.|||++||||||||
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiK  148 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  148 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             cCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence             334566777789999999988899999999999999999999999999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.3e-25  Score=199.52  Aligned_cols=134  Identities=25%  Similarity=0.417  Sum_probs=110.3

Q ss_pred             CcchHHHHhccCeeeeccccccCCeeEEEEEe-cC-------CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CC
Q 021084          180 SLNEKYRRRIMSWQKGAPLGSGSFGSVYEGFT-DD-------GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EH  250 (317)
Q Consensus       180 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~-------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~h  250 (317)
                      +...+|....++|.+++.||+|+||.||+|+. .+       +..||||+++.    .........+..|+..+.++ +|
T Consensus         3 ~~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~e~~~l~~~~~H   78 (299)
T d1fgka_           3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMKMIGKH   78 (299)
T ss_dssp             CCCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT----TCCHHHHHHHHHHHHHHHHHCCC
T ss_pred             CcCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc----ccChHHHHHHHHHHHHHHHhcCC
Confidence            34445666778999999999999999999986 32       24799999863    23345567788999999888 89


Q ss_pred             CceeeeeeEEEeCCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 021084          251 DNIVQYFGTEKDENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIH  313 (317)
Q Consensus       251 pnIv~l~~~~~~~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvH  313 (317)
                      ||||++++++.+++.+++|||||.+|+|.+++...                 .+++..+..++.||+.||.|||++||||
T Consensus        79 pnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH  158 (299)
T d1fgka_          79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH  158 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             CeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEe
Confidence            99999999999999999999999999999999643                 3899999999999999999999999999


Q ss_pred             cCCC
Q 021084          314 RPGA  317 (317)
Q Consensus       314 rDLK  317 (317)
                      ||||
T Consensus       159 rDiK  162 (299)
T d1fgka_         159 RDLA  162 (299)
T ss_dssp             SCCS
T ss_pred             eeec
Confidence            9998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.9e-25  Score=198.33  Aligned_cols=124  Identities=26%  Similarity=0.388  Sum_probs=106.9

Q ss_pred             HHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-CC
Q 021084          186 RRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-EN  264 (317)
Q Consensus       186 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~  264 (317)
                      ....++|++++.||+|+||.||+|.. .|..||||+++..       ...+.+.+|+.++++++||||++++|++.+ .+
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            34567899999999999999999976 5678999998632       124568899999999999999999999855 46


Q ss_pred             EEEEEEecCCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY---HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~---~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+||||+++|+|.+++...   .+++..+..++.||+.||.|||+++|||||||
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlk  130 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA  130 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccc
Confidence            689999999999999998643   38999999999999999999999999999997

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=9.8e-25  Score=200.96  Aligned_cols=123  Identities=25%  Similarity=0.451  Sum_probs=105.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC----
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN----  264 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----  264 (317)
                      .+|.+++.||+|+||+||+|.+ .+|+.||||++.+.    ......+.+.+|+.+|++++||||+++++++....    
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            4699999999999999999998 89999999999642    24455678899999999999999999999997643    


Q ss_pred             -EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 -KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 -~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       .+|++| |+.||+|.+++...++++..+..++.||+.||.|||++||||||||
T Consensus        84 ~~~~l~~-~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIK  136 (345)
T d1pmea_          84 KDVYLVT-HLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK  136 (345)
T ss_dssp             CCEEEEE-ECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             ceEEEEE-eecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence             355554 5668899999999999999999999999999999999999999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.9e-25  Score=195.54  Aligned_cols=126  Identities=28%  Similarity=0.424  Sum_probs=108.1

Q ss_pred             HhccCeeeeccccccCCeeEEEEEe-cC---CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFT-DD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD  262 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~  262 (317)
                      ...++|++++.||+|+||.||+|.+ .+   +..||||.++.    .........+.+|+.+|++++|||||++++++. 
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   78 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            3456899999999999999999987 32   34678887642    334555678999999999999999999999986 


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+.+|+|||||++|+|.+++...  .+++..+..++.||+.||.|||++||||||||
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlK  135 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA  135 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccc
Confidence            46789999999999999987543  58999999999999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.7e-24  Score=196.39  Aligned_cols=126  Identities=23%  Similarity=0.410  Sum_probs=107.4

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCC--EEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeeeeeEEEeC
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGF--FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQYFGTEKDE  263 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  263 (317)
                      ..++|++.+.||+|+||.||+|.+ .+|.  .||||.+...    ......+.+.+|+.+|.++ +|||||++++++.+.
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc----cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            357899999999999999999988 6665  4667776532    2233456789999999998 799999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+|+|||||+||+|.+++...                 .+++..+..++.||+.||.|||++||||||||
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlk  154 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA  154 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccc
Confidence            9999999999999999998643                 48999999999999999999999999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.7e-24  Score=194.09  Aligned_cols=125  Identities=27%  Similarity=0.429  Sum_probs=109.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCC----CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDG----FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDE  263 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  263 (317)
                      .+.|...+.||+|+||.||+|.. .++    ..||||.+..    .........|.+|+.+|++++|||||+++|++.+.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECc----ccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            35788999999999999999987 332    4799999863    23345566789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          264 NKLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       264 ~~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.+++|||||.+|++.+++...  .+++..+..++.||+.||.|||++||||||||
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlK  137 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA  137 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccc
Confidence            9999999999999999987653  58999999999999999999999999999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=5.1e-25  Score=196.51  Aligned_cols=128  Identities=24%  Similarity=0.404  Sum_probs=108.8

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCcc-HHHHHHHHHHHHHhccCC--CCceeeeeeEEEeCCE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQG-EQSVLQLEQEISLLGQFE--HDNIVQYFGTEKDENK  265 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~  265 (317)
                      ++|++.+.||+|+||.||+|.+ .+|..||||++......... ......+.+|+.+|++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999998 78999999999754322111 111233568999999886  8999999999999999


Q ss_pred             EEEEEecCCC-CCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQ-GSLAKIYQ-EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~g-gsL~~~l~-~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +|+||||+.+ +++.+++. ...+++..+..++.||+.||.|||++||||||||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiK  137 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIK  137 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCc
Confidence            9999999976 57888775 4569999999999999999999999999999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.91  E-value=2.3e-24  Score=196.88  Aligned_cols=119  Identities=24%  Similarity=0.393  Sum_probs=106.3

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEEe--CC
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEKD--EN  264 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~  264 (317)
                      .++|++++.||+|+||+||+|++ .+|+.||||+++..        ....+.+|+.+|..+. ||||++++++|..  ..
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            46899999999999999999999 88999999998632        1356789999999995 9999999999975  45


Q ss_pred             EEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      .+|+|||||.+++|..+.  ..+++..+..++.||+.||.|||++||||||||
T Consensus       106 ~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiK  156 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK  156 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             ceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhccccccccc
Confidence            699999999999998764  369999999999999999999999999999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.6e-24  Score=193.31  Aligned_cols=125  Identities=26%  Similarity=0.369  Sum_probs=100.1

Q ss_pred             cCeeeeccccccCCeeEEEEEe--cCC--CEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCCE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT--DDG--FFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDENK  265 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~--~~~--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  265 (317)
                      ++|++.+.||+|+||.||+|..  .++  ..||||++....  .......+.|.+|+.+|.+++||||++++|++.++ .
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~--~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhh--cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence            5799999999999999999976  333  378999886543  23345667899999999999999999999999764 6


Q ss_pred             EEEEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++|||||++|++.+++..  ..+++..+..++.||+.||.|||++||+|||||
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDik  138 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA  138 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeec
Confidence            7899999999999987653  459999999999999999999999999999998

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.8e-24  Score=197.73  Aligned_cols=124  Identities=25%  Similarity=0.382  Sum_probs=106.4

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-----
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-----  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----  262 (317)
                      .++|++++.||+|+||+||+|.+ .+|..||||+++..   .........+.+|+.+++.++|||||+++++|..     
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh---hcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence            46899999999999999999998 78999999999754   2345566788999999999999999999999964     


Q ss_pred             -CCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 -ENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 -~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       ...+|+|||||.++.+ +.+. ..+++..+..++.||+.||.|||++||+|||||
T Consensus        93 ~~~~~~iv~Ey~~~~l~-~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlK  146 (355)
T d2b1pa1          93 EFQDVYLVMELMDANLC-QVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  146 (355)
T ss_dssp             TCCEEEEEEECCSEEHH-HHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             cCceeEEEEeccchHHH-Hhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCC
Confidence             4789999999977544 4443 469999999999999999999999999999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3e-24  Score=195.48  Aligned_cols=123  Identities=23%  Similarity=0.417  Sum_probs=102.8

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCC----EEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGF----FFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN  264 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  264 (317)
                      ++|++++.||+|+||+||+|.+ .+|+    .||+|.+..    .......+.+.+|+.+|++++|||||+++|++.+++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            5799999999999999999987 5665    577787753    223344677999999999999999999999998754


Q ss_pred             EEEEEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          265 KLYIFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       265 ~~~lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                       .+++|+|+.+|+|.+++...  .+++..+..++.||+.||.|||++||||||||
T Consensus        85 -~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlK  138 (317)
T d1xkka_          85 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA  138 (317)
T ss_dssp             -EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             -eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcch
Confidence             67888999999999887654  58999999999999999999999999999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.90  E-value=3.1e-24  Score=193.95  Aligned_cols=127  Identities=21%  Similarity=0.349  Sum_probs=112.3

Q ss_pred             HhccCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEE
Q 021084          187 RRIMSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTE  260 (317)
Q Consensus       187 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~  260 (317)
                      ...++|++++.||+|+||.||+|+..      ++..||||++..    .......+.+.+|+.+|+.++||||+++++++
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~----~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh----hcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            34678999999999999999999862      457899999863    23445567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHHHhC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecC
Q 021084          261 KDENKLYIFLELVTQGSLAKIYQEY-------------------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRP  315 (317)
Q Consensus       261 ~~~~~~~lVmE~~~ggsL~~~l~~~-------------------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrD  315 (317)
                      ...+..+++|||+++|+|.+++...                         .+++..+..++.|++.||.|||++||||||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            9999999999999999999998642                         278889999999999999999999999999


Q ss_pred             CC
Q 021084          316 GA  317 (317)
Q Consensus       316 LK  317 (317)
                      ||
T Consensus       166 lK  167 (301)
T d1lufa_         166 LA  167 (301)
T ss_dssp             CS
T ss_pred             Ec
Confidence            98

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5.9e-24  Score=196.03  Aligned_cols=119  Identities=26%  Similarity=0.380  Sum_probs=100.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe------
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD------  262 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------  262 (317)
                      .+|..+++||+|+||+||+|.+ .+|+.||||++......         ..+|+.+|++++||||++++++|..      
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            3688999999999999999999 78999999999754321         2379999999999999999999854      


Q ss_pred             CCEEEEEEecCCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQ----EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~----~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ..++|||||||+++.+..+..    ...+++..+..++.||+.||+|||++||||||||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiK  149 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK  149 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence            346899999998764444332    2359999999999999999999999999999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=3.6e-24  Score=194.21  Aligned_cols=130  Identities=24%  Similarity=0.394  Sum_probs=113.3

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEec------CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFTD------DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYF  257 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~  257 (317)
                      +|....++|.+++.||+|+||.||+|.+.      ++..||||+++.    .........+.+|+.++++++|||||+++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~----~~~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECc----ccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            35555689999999999999999999762      357899999863    23445567799999999999999999999


Q ss_pred             eEEEeCCEEEEEEecCCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          258 GTEKDENKLYIFLELVTQGSLAKIYQEY-----------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       258 ~~~~~~~~~~lVmE~~~ggsL~~~l~~~-----------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +++...+..++|||||++|+|.+++...           .+++..+..++.|++.||.|||+++|||||||
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk  160 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLA  160 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCS
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEc
Confidence            9999999999999999999999988532           26888999999999999999999999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=6.2e-24  Score=193.05  Aligned_cols=127  Identities=22%  Similarity=0.431  Sum_probs=105.3

Q ss_pred             hccCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe----
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD----  262 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----  262 (317)
                      .+++|++++.||+|+||+||+|.+ .+|+.||||++.....   .......+.+|+.+|+.++||||+++++++..    
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C---TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            368999999999999999999998 7999999999865432   22334567899999999999999999998855    


Q ss_pred             ----CCEEEEEEecCCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ----ENKLYIFLELVTQGSLAKIYQE-YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ----~~~~~lVmE~~~ggsL~~~l~~-~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          .+.+|+|||||.++++..+... ..+++..+..++.|++.||.|||++||||||||
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlK  144 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK  144 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcC
Confidence                4568999999988766655443 358999999999999999999999999999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.4e-23  Score=189.17  Aligned_cols=130  Identities=25%  Similarity=0.382  Sum_probs=107.5

Q ss_pred             HHHHhccCeeeeccccccCCeeEEEEEe-c-----CCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccC-CCCceeee
Q 021084          184 KYRRRIMSWQKGAPLGSGSFGSVYEGFT-D-----DGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQF-EHDNIVQY  256 (317)
Q Consensus       184 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l  256 (317)
                      +|....++|++++.||+|+||.||+|.+ .     +++.||||+++..    ........+..|+.++.++ +||||+.+
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc----cCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            4555668899999999999999999986 2     3468999998632    2344456778888888776 78999999


Q ss_pred             eeEEEe-CCEEEEEEecCCCCCHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          257 FGTEKD-ENKLYIFLELVTQGSLAKIYQEY-----------------HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       257 ~~~~~~-~~~~~lVmE~~~ggsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ++++.. ...+++|||||++|+|.+++...                 .+++..+..++.||+.||.|||++||||||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK  161 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  161 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence            998866 45689999999999999998642                 37899999999999999999999999999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=4.9e-24  Score=194.59  Aligned_cols=129  Identities=21%  Similarity=0.297  Sum_probs=111.0

Q ss_pred             hccCeeeeccccccCCeeEEEEEe----cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC-CceeeeeeEEEe
Q 021084          188 RIMSWQKGAPLGSGSFGSVYEGFT----DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH-DNIVQYFGTEKD  262 (317)
Q Consensus       188 ~~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~  262 (317)
                      .+++|++++.||+|+||.||+|.+    .+|+.||||++++..... .....+.+.+|+.+|++++| |||+++++++.+
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc-chHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            467899999999999999999986    358899999986532111 12224457799999999966 899999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ENKLYIFLELVTQGSLAKIYQEY-HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ~~~~~lVmE~~~ggsL~~~l~~~-~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ...++++|||+.+|+|.+++... .+++..+..++.||+.||.|||++||||||||
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiK  156 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK  156 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCC
Confidence            99999999999999999988654 58899999999999999999999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=6.4e-23  Score=186.20  Aligned_cols=119  Identities=24%  Similarity=0.411  Sum_probs=103.4

Q ss_pred             eccccccCCeeEEEEEe-cC---CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEe-CCEEEEE
Q 021084          195 GAPLGSGSFGSVYEGFT-DD---GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKD-ENKLYIF  269 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~-~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV  269 (317)
                      .++||+|+||+||+|.+ .+   ...||||.++.    .........|.+|+.+|++++||||++++|++.. ++.+++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECC----CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            57899999999999987 32   23689999863    2345667889999999999999999999999876 5689999


Q ss_pred             EecCCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          270 LELVTQGSLAKIYQEYH--LKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       270 mE~~~ggsL~~~l~~~~--l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      ||||++|+|.+++....  +++..+..++.|++.||.|||+.||+|||||
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK  157 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA  157 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCcc
Confidence            99999999999987543  7788899999999999999999999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=7e-23  Score=185.26  Aligned_cols=121  Identities=25%  Similarity=0.350  Sum_probs=103.1

Q ss_pred             cCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCceeeeeeEEEeCC----E
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDNIVQYFGTEKDEN----K  265 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~  265 (317)
                      .+|.+.+.||+|+||.||+|+. +|..||||+++..      .........|+..+..++|||||++++++.+.+    .
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            4678899999999999999975 6789999998532      112222345666777889999999999997653    6


Q ss_pred             EEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH--------CCcEecCCC
Q 021084          266 LYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHE--------QNVIHRPGA  317 (317)
Q Consensus       266 ~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~--------~gIvHrDLK  317 (317)
                      +|+|||||++|+|.+++++.++++.....++.|++.||.|||+        +||||||||
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlK  135 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK  135 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCC
T ss_pred             EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccC
Confidence            8999999999999999999999999999999999999999996        599999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=5.3e-23  Score=185.65  Aligned_cols=126  Identities=29%  Similarity=0.457  Sum_probs=100.5

Q ss_pred             ccCeeeeccccccCCeeEEEEEe-cC-CCEEEEEEEeecCCCCccHHHHHHHHHHHHHhcc---CCCCceeeeeeEEEe-
Q 021084          189 IMSWQKGAPLGSGSFGSVYEGFT-DD-GFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQ---FEHDNIVQYFGTEKD-  262 (317)
Q Consensus       189 ~~~y~~~~~LG~G~fg~Vy~~~~-~~-~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~---l~hpnIv~l~~~~~~-  262 (317)
                      .++|++++.||+|+||+||+|.+ .+ ++.||||+++........   ...+.+|+.+|+.   ++||||++++++|.. 
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            47899999999999999999998 44 667999999764322211   1234466666554   489999999999853 


Q ss_pred             ----CCEEEEEEecCCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          263 ----ENKLYIFLELVTQGSLAKIYQ--EYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       263 ----~~~~~lVmE~~~ggsL~~~l~--~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                          ...+|++||||.++++.....  ...+++..+..++.|++.||+|||++||||||||
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiK  143 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK  143 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCC
Confidence                357999999998876655443  3458999999999999999999999999999998

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.88  E-value=2.7e-22  Score=180.38  Aligned_cols=120  Identities=19%  Similarity=0.282  Sum_probs=105.5

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCC-CceeeeeeEEEeCCEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEH-DNIVQYFGTEKDENKLY  267 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~  267 (317)
                      ++|++++.||+|+||+||+|.+ .+|+.||||+++....       ...+..|++.+..+.| +|++.+++++..+...|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            5799999999999999999998 7899999999864321       1235678888888865 89999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQEY--HLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~~--~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+ +++|.+++...  .++...+..++.|++.||.|||++||||||||
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiK  128 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK  128 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence            999999 67999988653  48999999999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.87  E-value=1.1e-21  Score=176.67  Aligned_cols=120  Identities=23%  Similarity=0.321  Sum_probs=100.8

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCCCCc-eeeeeeEEEeCCEEE
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFEHDN-IVQYFGTEKDENKLY  267 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~  267 (317)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++.....       ...+..|+++++.++|++ |+.+.+++...+..+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            4699999999999999999998 8899999999875321       123678999999997766 555566678889999


Q ss_pred             EEEecCCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          268 IFLELVTQGSLAKIYQE--YHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       268 lVmE~~~ggsL~~~l~~--~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +||||+. ++|...+..  ..+++..+..++.|++.||+|||++||||||||
T Consensus        80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiK  130 (299)
T d1ckia_          80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK  130 (299)
T ss_dssp             EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence            9999994 577666543  459999999999999999999999999999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.76  E-value=2e-18  Score=158.54  Aligned_cols=122  Identities=20%  Similarity=0.235  Sum_probs=97.6

Q ss_pred             cCeeeeccccccCCeeEEEEEe-cCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-----------CCceeeee
Q 021084          190 MSWQKGAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-----------HDNIVQYF  257 (317)
Q Consensus       190 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~  257 (317)
                      ++|++++.||+|+||+||+|.+ .+|+.||||+++.      .......+.+|+.+++.++           ||||++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec------cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            3599999999999999999998 8899999999963      2233456778888887764           58899999


Q ss_pred             eEEEe--CCEEEEEEecCCCCCHHH-HHH---hCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCC
Q 021084          258 GTEKD--ENKLYIFLELVTQGSLAK-IYQ---EYHLKDSQVSAYTWQILNGLKYLHE-QNVIHRPGA  317 (317)
Q Consensus       258 ~~~~~--~~~~~lVmE~~~ggsL~~-~l~---~~~l~~~~~~~i~~qil~aL~yLH~-~gIvHrDLK  317 (317)
                      +++..  ....+++|.++..+.... ...   ...+++..+..++.||+.||.|||+ .||+|||||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlK  153 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK  153 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCS
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCC
Confidence            88754  567777777776554332 222   2358999999999999999999998 899999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.73  E-value=5.1e-18  Score=142.54  Aligned_cols=116  Identities=13%  Similarity=0.139  Sum_probs=88.9

Q ss_pred             eeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCC-------------ccHHHHHHHHHHHHHhccCCCCceeeeee
Q 021084          192 WQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGT-------------QGEQSVLQLEQEISLLGQFEHDNIVQYFG  258 (317)
Q Consensus       192 y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------------~~~~~~~~~~~Ei~il~~l~hpnIv~l~~  258 (317)
                      +.+++.||+|+||+||+|.+.+|+.||||+++......             ...........|...+..+.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            35789999999999999988889999999876421110             00112234567888999999999998876


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 021084          259 TEKDENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQNVIHRPGA  317 (317)
Q Consensus       259 ~~~~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~gIvHrDLK  317 (317)
                      +.  .  .+++|||++++.+..      ++...+..++.|++.||.|||++||+|||||
T Consensus        82 ~~--~--~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiK  130 (191)
T d1zara2          82 WE--G--NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLS  130 (191)
T ss_dssp             EE--T--TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             ec--C--CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCC
Confidence            53  2  279999998866543      4555567899999999999999999999998

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.19  E-value=0.00073  Score=56.69  Aligned_cols=118  Identities=10%  Similarity=0.111  Sum_probs=79.5

Q ss_pred             hHHHHhccCeeeeccccccCCeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC-CCceeeeeeEEE
Q 021084          183 EKYRRRIMSWQKGAPLGSGSFGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE-HDNIVQYFGTEK  261 (317)
Q Consensus       183 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~  261 (317)
                      ......+..|++.+..+.++.+.||+.. .++..+.+|........     ....+..|...+..+. +--+++++.+..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~-----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~   80 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKG-----TTYDVEREKDMMLWLEGKLPVPKVLHFER   80 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTT-----STTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCccc-----chhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence            4455667788887776666678899874 45556788877533211     1223456777766552 334677788888


Q ss_pred             eCCEEEEEEecCCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          262 DENKLYIFLELVTQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       262 ~~~~~~lVmE~~~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      .++..++||++++|.++......    ......++.++...|.-||+..
T Consensus        81 ~~~~~~lv~~~l~G~~~~~~~~~----~~~~~~~~~~l~~~l~~lH~~~  125 (263)
T d1j7la_          81 HDGWSNLLMSEADGVLCSEEYED----EQSPEKIIELYAECIRLFHSID  125 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHTTT----CSCHHHHHHHHHHHHHHHHTSC
T ss_pred             cCCceEEEEEecccccccccccc----cccHHHHHHHHHHHHHHHhccC
Confidence            88999999999999888765432    1223446778888899999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=95.39  E-value=0.023  Score=46.69  Aligned_cols=99  Identities=14%  Similarity=0.112  Sum_probs=64.6

Q ss_pred             cccccC-CeeEEEEEecCCCEEEEEEEeecCCCCccHHHHHHHHHHHHHhccCC--CCceeeeeeEEEeCCEEEEEEecC
Q 021084          197 PLGSGS-FGSVYEGFTDDGFFFAVKEVSLQDQGTQGEQSVLQLEQEISLLGQFE--HDNIVQYFGTEKDENKLYIFLELV  273 (317)
Q Consensus       197 ~LG~G~-fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~lVmE~~  273 (317)
                      .+..|. .+.||+....++..+++|.......        ..+..|...+..+.  .-.+++++.+..+++..++||+++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence            344444 4678998777788889997653211        12456666666552  233677788888888999999999


Q ss_pred             CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021084          274 TQGSLAKIYQEYHLKDSQVSAYTWQILNGLKYLHEQN  310 (317)
Q Consensus       274 ~ggsL~~~l~~~~l~~~~~~~i~~qil~aL~yLH~~g  310 (317)
                      +|.++...    .....   ..+.++...|.-||+..
T Consensus        89 ~G~~~~~~----~~~~~---~~~~~l~~~la~LH~~~  118 (255)
T d1nd4a_          89 PGQDLLSS----HLAPA---EKVSIMADAMRRLHTLD  118 (255)
T ss_dssp             SSEETTTS----CCCHH---HHHHHHHHHHHHHTTSC
T ss_pred             eccccccc----cccHH---HHHHHHHHHHHHHccCC
Confidence            98766441    22322   34567778888888653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=92.42  E-value=0.13  Score=45.50  Aligned_cols=111  Identities=14%  Similarity=0.050  Sum_probs=60.0

Q ss_pred             eccccccCCeeEEEEEe-cCCCEEEEEEEeecC--CCCccHHHHHHHHHHHHHhccC---CCCceeeeeeEEEeCCEEEE
Q 021084          195 GAPLGSGSFGSVYEGFT-DDGFFFAVKEVSLQD--QGTQGEQSVLQLEQEISLLGQF---EHDNIVQYFGTEKDENKLYI  268 (317)
Q Consensus       195 ~~~LG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~--~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~l  268 (317)
                      .+.||.|....||++.. .+++.+++|.-....  ....-+....+...|...|..+   -...+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45689999999999987 567889999764311  0010111122344566666554   22345666654  3445578


Q ss_pred             EEecCCCCCH-HHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Q 021084          269 FLELVTQGSL-AKIYQEYHLKDSQVSAYTWQILNGLKYLH  307 (317)
Q Consensus       269 VmE~~~ggsL-~~~l~~~~l~~~~~~~i~~qil~aL~yLH  307 (317)
                      |||++++..+ ...+.........+..+...++.-+.+.|
T Consensus       109 vmE~L~~~~~~~~~l~~~~~~~~~a~~lg~~La~~h~~~~  148 (392)
T d2pula1         109 VMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSS  148 (392)
T ss_dssp             EECCCTTSEEHHHHHHHTCCCTTHHHHHHHHHHHHHHHTS
T ss_pred             EEeccCCcccchhhhcccchhHHHHHHHHHHHHHHHHHhc
Confidence            9999987654 44444444333334334444443333333